<SEC-DOCUMENT>0001683168-22-006426.txt : 20220915
<SEC-HEADER>0001683168-22-006426.hdr.sgml : 20220915
<ACCEPTANCE-DATETIME>20220915170950
ACCESSION NUMBER:		0001683168-22-006426
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		67
FILED AS OF DATE:		20220915
DATE AS OF CHANGE:		20220915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vivakor, Inc.
		CENTRAL INDEX KEY:			0001450704
		STANDARD INDUSTRIAL CLASSIFICATION:	REFUSE SYSTEMS [4953]
		IRS NUMBER:				262178141
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-267444
		FILM NUMBER:		221246415

	BUSINESS ADDRESS:	
		STREET 1:		4101 NORTH THANKSGIVING WAY
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		(949) 887-6890

	MAIL ADDRESS:	
		STREET 1:		4101 NORTH THANKSGIVING WAY
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>vivakor_s1.htm
<DESCRIPTION>FORM S-1
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:VIVK="http://vivakor.com/20220630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_VIVK_vivakor.com_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20220101_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001450704 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DDocumentFiscalPeriodFocus_Q2 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityCentralIndexKey">0001450704</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0332" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0336" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0339" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0340" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0345" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0352" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0359" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0360" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0378" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:ConversionOfSeriesPreferredStockToCommonStock" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:ConversionOfSeriesPreferredStockToCommonStock" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:ConversionOfSeriesPreferredStockToCommonStock" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:ConversionOfSeriesPreferredStockToCommonStock" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0407" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0416" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0426" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0438" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0440" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0445" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0446" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0447" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0453" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0459" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0460" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_custom_SeriesAPreferredStocksMember" id="xdx2ixbrl0473" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0501" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0506" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0510" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0517" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0522" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0523" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0527" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0528" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0534" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0535" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0536" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0575" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0576" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicense" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicense" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0584" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicense" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockIssuedForConversionOfTemporaryEquityValue" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0592" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockIssuedForConversionOfTemporaryEquityValue" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0593" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockIssuedForConversionOfTemporaryEquityValue" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0594" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0599" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0601" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0602" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0603" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0606" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0608" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0609" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0610" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0613" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0614" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0616" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0620" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0622" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0627" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0628" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0629" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="VIVK:GainOnDispositionOfAsset" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0665" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" id="xdx2ixbrl0892" decimals="0" sign="-" unitRef="USD">41237559</ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesBMember" id="xdx2ixbrl1341" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesB1Member" id="xdx2ixbrl1343" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesC1Member" id="xdx2ixbrl1345" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesBMember" id="xdx2ixbrl1368" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesB1Member" id="xdx2ixbrl1370" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesC1Member" id="xdx2ixbrl1372" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="vivk-20220630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_SeriesAPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SeriesAPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_SeriesAPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeriesAPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SeriesAPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SeriesAPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SeriesAPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-02-132022-02-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-02-13</xbrli:startDate>
        <xbrli:endDate>2022-02-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaventuresUtsiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaventuresUtsiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaventuresRoyaltyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaventuresRoyaltyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaopportunityFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaopportunityFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:InternationalMetalsExchangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:InternationalMetalsExchangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RPCDesignAndManufacturingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">VIVK:RPCDesignAndManufacturingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RPCDesignAndManufacturingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">VIVK:RPCDesignAndManufacturingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RdmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">VIVK:RdmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RdmMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">VIVK:RdmMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_VivaWealthFundIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaWealthFundIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VivaWealthFundIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaWealthFundIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_ConvertibleSeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:ConvertibleSeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_ConvertibleSeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:ConvertibleSeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_StockOptionsGrantedToEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:StockOptionsGrantedToEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_StockOptionsGrantedToEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:StockOptionsGrantedToEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_StockOptionsGrantedToBoardMembersOrConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:StockOptionsGrantedToBoardMembersOrConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_StockOptionsGrantedToBoardMembersOrConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:StockOptionsGrantedToBoardMembersOrConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">VIVK:PublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_VendorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:VendorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ProfessionalServiceAgenciesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ProfessionalServiceAgenciesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_OdysseyGroupMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OdysseyGroupMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_OdysseyGroupMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_OdysseyGroupMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ScepterHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_OdysseyGroupMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-012021-08-31_custom_ScepterHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_ScepterHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_ScepterHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_ScepterHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_ScepterHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ScepterHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ScepterHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_FexixIronMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">VIVK:FexixIronMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PreciousMetalExtractionMachine1TonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:PreciousMetalExtractionMachine1TonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PreciousMetalExtractionMachine1TonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:PreciousMetalExtractionMachine1TonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PreciousMetalExtractionMachine10TonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:PreciousMetalExtractionMachine10TonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PreciousMetalExtractionMachine10TonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:PreciousMetalExtractionMachine10TonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BioreactorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:BioreactorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_BioreactorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:BioreactorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NanospongeCavitationDeviceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:NanospongeCavitationDeviceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NanospongeCavitationDeviceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:NanospongeCavitationDeviceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RemediationProcessingUnit1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnit1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RemediationProcessingUnit1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnit1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RemediationProcessingUnit2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnit2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RemediationProcessingUnit2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnit2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RemediationProcessingUnitSystemAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnitSystemAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RemediationProcessingUnitSystemAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnitSystemAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RemediationProcessingUnitSystemBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnitSystemBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RemediationProcessingUnitSystemBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnitSystemBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_EquipmentMember_custom_SeriesC1PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:SeriesC1PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_VariousPromissoryNotesAndConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousPromissoryNotesAndConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VariousPromissoryNotesAndConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousPromissoryNotesAndConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NovusCapitalGroupLLCNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:NovusCapitalGroupLLCNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NovusCapitalGroupLLCNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:NovusCapitalGroupLLCNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_TripleTNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:TripleTNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TripleTNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:TripleTNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NationalBuickGMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:NationalBuickGMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NationalBuickGMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:NationalBuickGMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_VariousConvertibleBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousConvertibleBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VariousConvertibleBridgeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousConvertibleBridgeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BlueRidgeBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:BlueRidgeBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_BlueRidgeBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:BlueRidgeBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:SmallBusinessAdministrationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:SmallBusinessAdministrationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_JPMorganChaseBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:JPMorganChaseBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_JPMorganChaseBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:JPMorganChaseBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_VariousPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VariousPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_JamboreeCenterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:JamboreeCenterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-15_custom_JamboreeCenterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:JamboreeCenterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SpeedwayCommerceCenterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:SpeedwayCommerceCenterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-15_custom_SpeedwayCommerceCenterMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:SpeedwayCommerceCenterMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_VictoryHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:VictoryHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-15_custom_VictoryHoldingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:VictoryHoldingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_LongTermDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_LongTermDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesC1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesC1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesC1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesB1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VivaWealthFundILLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VivaWealthFundILLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember147106531">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaWealthFundILLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember147106531">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaWealthFundILLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-012018-12-31_custom_ShareStockAwardMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:ShareStockAwardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_StockOptionsMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:StockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:NonStatutoryStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:NonStatutoryStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:NonStatutoryStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_NonStatutoryStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:NonStatutoryStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001450704</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000299" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000300" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000301" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000302" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000304" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000305" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000306" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000307" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000309" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000310" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000311" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000312" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000314" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000315" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000316" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000317" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000319" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000320" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000321" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact000322" toRefs="Footnote000323"></ix:relationship>
  <ix:relationship fromRefs="Fact001145" toRefs="Footnote001201"></ix:relationship>
  <ix:relationship fromRefs="Fact001147" toRefs="Footnote001201"></ix:relationship>
  <ix:relationship fromRefs="Fact001157" toRefs="Footnote001202"></ix:relationship>
  <ix:relationship fromRefs="Fact001159" toRefs="Footnote001202"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><a href="#toc">Table of Contents&#160;</a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">As filed with the U.S. Securities and Exchange
Commission on September 15, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION<br />
Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>_________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_908_edei--DocumentType_c20220101__20220630_zMvsr5f2XxC1"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentType">S-1</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><br />
REGISTRATION STATEMENT<br />
UNDER<br />
THE SECURITIES ACT OF 1933</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>_________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90E_edei--EntityRegistrantName_c20220101__20220630_z2uoirlPdfPa"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityRegistrantName">VIVAKOR, INC.</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Exact name of registrant as specified in charter)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 34%; text-align: center"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20220101__20220630_zkeo8Ojufvi6"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 31%; text-align: center"><b>8731</b></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 33%; text-align: center"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20220101__20220630_zuycE7lsORLi"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityTaxIdentificationNumber">26-2178141</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><i>(State or other jurisdiction <br />
of incorporation)</i></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><i>(Primary Standard Classification <br />
Code Number)</i></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><i>(IRS Employer <br />
I.D. Number)</i></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Vivakor, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><br />
<span id="xdx_904_edei--EntityAddressAddressLine1_c20220101__20220630_zBHogbY0G1Rj"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressAddressLine1">4101 North Thanksgiving Way</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20220101__20220630_zLgghYNV9mqd"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressPostalZipCode">Lehi,
UT</ix:nonNumeric></span><b>84043</b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">(949) 281-2606<br />
</span></b><i>(Address and telephone number of principal executive offices)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>_________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Matthew Nicosia<br />
Chief Executive Officer</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Vivakor, Inc.<br />
<span style="font-size: 10pt">4101 North Thanksgiving Way</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Lehi, UT</b> <b>84043</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">(949) 281-2606</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Name, address, including zip code, and telephone
number including area code, of agent for service)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>_________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">With copies to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Joseph M. Lucosky, Esq. </b> <b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Scott E. Linsky, Esq.<br /> Lucosky Brookman LLP<br /> 101 Wood Avenue South, 5th Floor<br /> Woodbridge, NJ 08830<br /> Tel. No.: (732) 395-4400<br /> Fax No.: (732) 395-4401</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>_________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Approximate date of commencement of proposed
sale to the public:</b> As soon as practicable after this Registration Statement is declared effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.
<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;
and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 23%; text-align: justify">Large-Accelerated Filer</td>
    <td style="white-space: nowrap; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 18%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="white-space: nowrap; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 31%; text-align: justify">Accelerated Filer</td>
    <td style="white-space: nowrap; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 23%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span id="xdx_90D_edei--EntityFilerCategory_c20220101__20220630_z87siTyedri3"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-Accelerated Filer</ix:nonNumeric></span></td>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify">Smaller Reporting Company</td>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntitySmallBusiness_c20220101__20220630_zQixOh7joF1a"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify">Emerging Growth Company</td>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20220101__20220630_zX5MrmuidbK9"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act: <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--EntityExTransitionPeriod_c20220101__20220630_zuf4va0e9Jf1"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The registrant hereby amends this Registration
Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which
specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section
8(a), may determine.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: Red">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: Red"><b>The information contained
in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement
filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities
and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: Red"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 37%"><span style="color: Red"><b>PRELIMINARY PROSPECTUS </b></span></td>
    <td style="white-space: nowrap; width: 1%"><span style="color: Red">&#160;</span></td>
    <td style="width: 30%; text-align: center"><span style="color: Red"><b>SUBJECT TO COMPLETION</b></span></td>
    <td style="white-space: nowrap; width: 1%"><span style="color: Red">&#160;</span></td>
    <td style="width: 31%; text-align: right"><span style="color: Red"><b>DATED&#160;&#160;&#160;September 15, 2022</b></span><b> </b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>3,009,552 Shares of Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_001.jpg" alt="" style="height: 90px; width: 300px" /></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Vivakor, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus relates to the offering and resale,
from time to time, by the selling stockholders (the &#8220;Selling Stockholders&#8221;) identified herein, of up to 3,009,552 shares (the
&#8220;Shares&#8221;) of common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), of Vivakor, Inc. (the &#8220;Company&#8221;)
that were issued to the Selling Stockholders in connection with an August 1, 2022 closing under a June 15, 2022 Membership Interest Purchase
Agreement among the Company and the Selling Stockholders. We are not selling any of the Shares being offered under this prospectus and
will not receive any proceeds from the sale or disposition of the Shares. <span style="font-size: 10pt">The Selling Stockholders may sell
or otherwise dispose of the shares of our Common Stock offered by this prospectus from time to time through the means described in this
prospectus under the section titled &#8220;<a href="#a_316">Plan of Distribution</a>&#8221;. Th</span>e Selling Stockholders will bear all commissions and
discounts, if any, attributable to the sale or disposition of the Shares. We will bear all costs, expenses and fees in connection with
the registration of the resale of the Shares<span style="font-size: 10pt">. For a list of the selling stockholders, see the section titled
&#8220;<a href="#a_311">Selling Stockholders</a>&#8221;. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is listed on the Nasdaq Capital
Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;VIVK.&#8221; On September 9, 2022, the last reported sale price for our common stock
on Nasdaq was $1.59.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We may amend or supplement this prospectus
from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements
carefully before you make your investment decision.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are an &#8220;emerging growth company&#8221;
and a &#8220;smaller reporting company&#8221; as defined under the federal securities laws and, as such, are eligible for reduced public
company reporting requirements. See &#8220;<a href="#a_301">Prospectus Summary</a>&#8201;&#8212;&#8201;Implications of Being an Emerging Growth Company and
a Smaller Reporting Company&#8221;.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Investing in our Common Stock should be considered
speculative and involves a high degree of risk. See &#8220;<a href="#a_302">Risk Factors</a>&#8221; beginning on page 13 to read about the risks you should
consider before buying shares of our Common Stock.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is , 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_002.jpg" alt="" style="height: 800px; width: 617px" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="toc"></span>TABLE OF CONTENTS</b><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 94%">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 5%; text-align: center"><b>Page</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_301">PROSPECTUS SUMMARY</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">1</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_302">RISK FACTORS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">13</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_303">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">26</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_304">USE OF PROCEEDS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">27</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_305">MARKET FOR OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">28</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_306">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">29</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_307">BUSINESS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">36</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_308">MANAGEMENT</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">53</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_309">EXECUTIVE COMPENSATION</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">58</td></tr>
  <tr style="vertical-align: bottom">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="#a_310">PRINCIPAL SHAREHOLDERS</a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"></span></p></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">60</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_311">SELLING STOCKHOLDERS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">62</td></tr>
  <tr style="vertical-align: bottom">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="#a_312">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">63</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_313">DIVIDEND POLICY</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">64</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_314">DETERMINATION OF OFFERING PRICE</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">64</td></tr>
  <tr style="vertical-align: bottom">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="#a_315">DESCRIPTION OF SECURITIES</a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">65</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_316">PLAN OF DISTRIBUTION</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">69</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_317">LEGAL MATTERS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">71</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_318">EXPERTS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">71</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_319">WHERE YOU CAN FIND MORE INFORMATION</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">71</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="#a_004">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</a></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right">F-1</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>You should rely only on information contained
in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. We have not authorized
anyone to provide you with additional information or information different from that contained in this prospectus or in any free writing
prospectus. Neither the delivery of this prospectus nor the sale of our Common Stock means that the information contained in this prospectus
or any free writing prospectus is correct after the date of this prospectus or such free writing prospectus. This prospectus is not an
offer to sell or the solicitation of an offer to buy our Common Stock in any circumstances under which the offer or solicitation is unlawful
or in any state or other jurisdiction where the offer is not permitted.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No person is authorized in connection with
this prospectus to give any information or to make any representations about us, the Common Stock offered hereby or any matter discussed
in this prospectus, other than the information and representations contained in this prospectus. If any other information or representation
is given or made, such information or representation may not be relied upon as having been authorized by us.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also use certain trademarks, trade names, and
logos that have not been registered. We claim common law rights to these unregistered trademarks, trade names and logos.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_301"></span>PROSPECTUS SUMMARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>This summary highlights selected information
appearing elsewhere in this prospectus. Because this is only a summary, it does not contain all of the information you should consider
before investing in our securities. You should read this prospectus carefully, especially the risks and other information set forth under
the heading &#8220;<a href="#a_302">Risk Factors</a>&#8221;, &#8220;<a href="#a_306">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a>&#8221;
and our consolidated financial statements and related notes included elsewhere in this prospectus before making an investment decision.
Our fiscal year end is December 31 and our fiscal years ended December 31, 2021 and December 31, 2020 are sometimes referred to herein
as fiscal years 2021 and 2020, respectively. Some of the statements made in this prospectus discuss future events and developments, including
our future strategy and our ability to generate revenue, income and cash flow. These forward-looking statements involve risks and uncertainties
that could cause actual results to differ materially from those contemplated in these forward-looking statements. See &#8220;<a href="#a_303">Cautionary Note Regarding Forward-Looking Statements</a>&#8221;. Unless otherwise indicated or the context requires otherwise, the words &#8220;we,&#8221;
&#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company,&#8221; or &#8220;our Company,&#8221; and &#8220;Vivakor&#8221; refer to Vivakor,
Inc., a Nevada corporation, and its wholly owned subsidiaries.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14, 2022, we effected a 1-for-30 reverse
split of our authorized and outstanding shares of common stock (the &#8220;Reverse Stock Split&#8221;) via the filing of a certificate
of change with the Nevada Secretary of State. As a result of the Reverse Stock Split, all authorized and outstanding common stock, preferred
stock, and per share amounts in this prospectus, including, but not limited to, the consolidated financial statements and footnotes included
herein, have been adjusted to reflect the Reverse Stock Split for all periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a socially responsible operator, acquirer
and developer of clean energy technologies and environmental solutions. Our current efforts are primarily focused on soil remediation
and owning and operating crude oil gathering, storage and transportation facilities. We specialize in the remediation of soil and the
extraction of hydrocarbons, such as oil, from properties contaminated by or laden with heavy crude oil and other hydrocarbon-based substances.
Our patented process allows us to successfully recover the hydrocarbons which we believe could then be used to produce asphaltic cement
and/or other petroleum-based products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are focused on the remediation of contaminated
soil and water resulting from either man-made spills or naturally occurring deposits of oil. Our primary focus has been the remediation
of oil spills resulting from the Iraqi invasion of Kuwait and naturally occurring oil sands deposits in the Uinta basin located in Eastern
Utah. We plan to expand into other markets, both in Utah and globally, where we believe our technology and services will provide a distinct
competitive advantage over our competition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current focus is on the clean-up of greater
than 7% hydrocarbon contaminated soil located in Kuwait as a result of the Iraqi invasion, and naturally occurring oil sands deposits
in Utah. We have deployed two RPC units to date including one unit to Kuwait (for which operations were temporarily suspended due to COVID-19)
and another to Vernal, Utah (which is presently operating). We expect to deploy two additional RCPs to Vernal, Utah and believe that there
may be an opportunity to deploy additional RPCs in Utah as well as to Kuwait and the Middle East.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Market Opportunity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the market for remediating oil
from both soil and water is significant. According to Grandview Research, the market for environmental clean-up of oil spills will reach
$177 billion by 2025. We believe that a large portion of that market will originate from contamination of more than 7% hydrocarbon content
and that our technology is currently the only one that can economically remediate these environmental disasters, while allowing for the
capture and reuse of the crude.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we believe that the heavy crude that
we have been recovering in Utah is ideal for producing asphaltic cement. The demand for asphaltic cement in the United States is presently
estimated to be $93 billion this year according to Transparency Market Research. We provided our material to asphalt companies for testing
to determine what modifications, if any, needed to be made to meet general asphalt specifications. We recently received notification that
our asphaltic cement now meets the general classification of AC20 asphaltic cement and that it passed the specifications of several potential
clients. We are expecting several orders in the near term and we believe that we will be able to offer our product at very competitive
prices and in an environmentally friendly manner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Revenue</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Remediation Processing Centers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We presently have two projects utilizing our first
two manufactured RPCs - our project in Kuwait (which was temporarily suspended due to COVID-19) and our project in Vernal, Utah (which
is currently operating).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In Kuwait, pursuant to an agreement with Al Dali
International Co., a company organized under the laws of Kuwait (&#8220;DIC&#8221;), we will receive $50,000 for the successful remediation
of the first 100 tons ($500 per ton) under its subcontractor services for the Kuwait Oil Company (&#8220;KOC&#8221;) Remediation Contract.
In addition, we will receive $20 per treated ton of soil after the initial 100 tons. The treatment process using the RPC plants is anticipated
to generate a bitumen sub-product. We have agreed with DIC to sell this sub-product and share the net profits equally (50% to the us and
50% to DIC), after allocating 30% of the net profits to DIC in the form of a sales and marketing payment, which will be invoiced on a
monthly basis, in accordance with the Agreement. Pursuant to the Agreement, we will have a stockpile of at least 444,311 tons with at
least 5% oil contamination for us to remediate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our RPC situated in Vernal, Utah has the capacity
to process 500 tons or more of naturally occurring oil sands deposits per day. We estimate that if the extracted material is composed
of at least 10% oil, we will recover approximately 250 barrels of extracted hydrocarbons each day, which could then be sold for energy
or converted to asphaltic cement and sold for use in roads at higher prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide precious metal extraction services
on a service fee basis for customers. We also market and sell the precious metals we have extracted from our own soils. As we continue
our efforts, we anticipate increased opportunities to monetize our precious metals end product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Kuwait Project</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The United Nations (UN) had allocated up to $14.7
billion for post-Iraq war reparations in order to clean up Kuwait. Kuwait suffered extensive contamination as a result of the 1991 Persian
Gulf War. At the close of the Gulf War, Saddam Hussein ordered Kuwaiti oil wells to be blown up, resulting in the destruction of approximately
600 oil wells. The damage resulting from such fires, which burned for seven months, included a layer of hardened &#8220;tarcrete,&#8221;
caused by the sand and gravel on the land's surface combining with oil and soot, forming over almost 5% of the country's area.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We were engaged by a subcontractor, DIC, which
is approved by KOC for the Kuwait Environmental Remediation Program (&#8220;KERP&#8221;) project.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our technology has been successful in reducing
the amount of contaminated material in Kuwait from 20% hydrocarbon contamination to just 0.2% hydrocarbon contamination, based on third
party independent testing performed by ALS Arabia in March 2020. We believe we possess the only technology that has been successful at
remediating such highly contaminated soil (defined as anything above 20% hydrocarbon contamination), while also returning usable hydrocarbons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The KERP project is anticipated to involve approximately
26 million cubic meters of contaminated oil sands requiring remediation. We expect that as much as 20% of the contaminated soil will contain
more than 5% hydrocarbon contamination. Our agreement with DIC is for cleanup of a portion of the KERP project.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The oil recovered from these projects in Kuwait
is considered a sovereign asset, so the ability to reclaim this asset also creates a social value for the country. In order to remediate
all of the contaminated sand exhibiting greater than 7% contamination in the timeframe required by the UN, the Company anticipates obtaining
further agreements through KOC to expand its service contract to deploy 10 RPC units to Kuwait over the next several years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 14, 2021, we, together with our subsidiary,
Vivaventures Energy Group, Inc., entered into a Services Agreement (the &#8220;Services Agreement&#8221;) with Al Dali International Co.,
a company organized under the laws of Kuwait (&#8220;DIC&#8221;). The Government of Kuwait and the United Nations, acting through the
Kuwait Oil Company (&#8220;KOC&#8221;) has awarded to Enshaat Al Sayer rights to remediate contaminated soil under the Kuwait Remediation
Program pursuant to the South Kuwait Excavation, Transportation and Remediation Project (&#8220;KOC Remediation Contract&#8221;). To fulfill
its role, Enshaat Al Sayer has engaged the Company, through the Company&#8217;s agreement with DIC, to perform contaminated soil treatment
for the KOC Remediation Contract using the Company&#8217;s patented technology for extracting hydrocarbons, through the Company&#8217;s
Remediation Processing Center (&#8220;RPC&#8221;) plants. The Services Agreement is subject to DIC and Enshaat Al Sayer entering into
a subcontractor agreement and the Company has received a notice letter from such parties, which confirms that such subcontractor agreement
has been entered into and is in full force and effect. Such subcontractor agreement is subject to termination upon terms substantially
similar to those set forth in the Services Agreement, specifically, providing for a 42-month term with termination upon (i) written consent
of both parties; (ii) bankruptcy, dissolution or similar event; (iii) for material breach that is not cured within 60 days&#8217; notice
thereof (other than non-payment, which is not subject to a cure period); and (iv) non-approval of total optimized study including the
bench scale study and pilot plant commissioning results by KOC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Services Agreement, the Company
and DIC will work together in performing remediation treatment services as subcontractors to Enshaat Al Sayer for the KOC Remediation
Contract. Under the Agreement, the Company will supply one pilot RPC plant already located in Kuwait, one 40-ton per hour RPC plant, and
one technical expert to oversee the hydrocarbons contaminated soil treatment service operations pertaining to this contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will receive $50,000 for the successful
remediation of the first 100 tons ($500 per ton) under its subcontractor services for the KOC Remediation Contract. In addition, the Company
will receive $20 per treated ton of soil after the initial 100 tons. The treatment process using the RPC plants is anticipated to generate
a bitumen sub-product. The Company and DIC have agreed to sell this sub-product and share the net profits equally (50% to the Company
and 50% to DIC), after allocating 30% of the net profits to DIC in the form of a sales and marketing payment, which will be invoiced on
a monthly basis, in accordance with the Agreement. Pursuant to the Agreement, we will have a stockpile of at least 444,311 tons with at
least 5% oil contamination for us to remediate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Agreement, we will provide our
pilot RPC plant (already in Kuwait) within two to four months after retrofitting, and within one year of certain contract milestones,
including the successful testing of the first 100 tons, we will provide a RPC plant capable of processing 40 tons of soil per hour. We
will bear the cost of the related manufacturing, deployment, break-down and spare parts of the RPCs. The RPC plant remediation services
must reduce TPH contamination to less than 1%. DIC will provide all other costs for bonds, infrastructure, and operations of the plant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other International Projects</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to managing the projects in Kuwait,
the UN is overseeing the funds allocated to the remediation and clean-up of the Ogoni Lands in Africa, which is estimated to contain millions
of tons of both contaminated soil and water and has allocated significant funding for its cleanup. Taking into consideration this particular
environmental disaster, plus other global oil contamination projects involving oversight by the UN, together with our successful testing
on the UN-managed SEED Project in Kuwait and our recent agreement with DIC, we believe we will be a contender for significant additional
contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Vernal, Utah Project</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The State of Utah has, according to the U.S. Geological
Survey, approximately 14 billion barrels of measured oil in place with an additional estimated 23 to 28 billion barrels of oil contained
in contaminated oil sands that are deposited near the ground surface. We believe that the crude from these oil sands can be turned into
asphaltic cement for making roads, or upgraded for polymers or fuel. Vernal is the county seat, and largest city in Uintah County, located
in northeastern Utah, approximately 175 miles east of Salt Lake City, and 20 miles west of the Colorado border. In June 2021, we entered
into an agreement with the owner of such parcel of land that permitted us to continue to operate on the land on a month-to-month basis.
In March 2022, we entered into a land lease with the land owner for a five year term, with an optional 5 year extension, allowing us to
process up to 2,000 tons per day of oil sand material, with a guarantee by the land owner to deliver material with a minimum of 10% hydrocarbon
by weight, which would produce up to 200 tons of asphalt cement product per day when processed through four of our patented RPCs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Vernal property contains approximately 100
million cubic yards of oil sand material available for processing. The property is located on approximately 600 acres. We believe that
we could ultimately recover as much as 40 million barrels of oil from this property as a whole if we are able to economically scale our
operations and obtain further land leases from the land owner. We believe, based on the number of estimated barrels of oil contained in
oil sands deposits located on SITLA property, that if the State of Utah would allow us to process the oil sand material on these properties
over the next thirty years that we would need as many as 100 RPCs to process the oil sands deposits owned by the State of Utah.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Material extracted from our Vernal, Utah project
can be sold for energy or converted into asphaltic cement, which we believe is less affected by daily changes in oil prices. With our
one RPC unit, assuming full utilization, we anticipate producing approximately 50 tons of asphaltic cement per day. We anticipate that
we will be able to sell our asphaltic cement for, referencing present pricing, approximately $575 per ton.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Crude Oil Gathering, Storage and Transportation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1, 2022, we acquired 100% of the
outstanding ownership interests of Silver Fuels Delhi, LLC, a Louisiana limited liability company (&#8220;SFD&#8221;) and White Claw
Colorado City, LLC, a Texas limited liability company (&#8220;WCCC&#8221;), which are now wholly-owned subsidiaries of ours, and are
generating revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SFD owns and operates a crude oil gathering, storage,
and transportation facility located on approximately 9.3 acres near Delhi, Louisiana. Under existing agreements, a subsidiary of a large
NYSE traded energy company (the &#8220;Purchaser&#8221;) is obligated to purchase blended crude oil from SFD in amounts up to 60,000 barrels
per month. With prior approval, SFD is eligible to sell to the Purchaser amounts greater than 60,000 barrels of crude oil per month. Additionally,
for a period of 10 years, SFD is, under existing crude oil supply agreements with WC Crude, guaranteed a minimum gross margin of $5.00
per barrel on all quantities of blended crude oil sold thereunder. At present, SFD is blending and selling approximately 1,400 to 1,700
barrels of blended crude oil on a daily basis. Additionally, the acquisition of SFD provides us with the infrastructure needed to place
a Remediation Processing Machine (&#8220;RPC&#8221;) to clean soil which has been contaminated by hydrocarbons as well as tank bottom
sludge. Management believes SFD&#8217;s location in the heart of the Smackover formation would provide the Company with access to significant
amounts of tank bottom sludge and contaminated soil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WCCC owns a 120,000 barrel crude oil storage
tank, in the heart of the Permian Basin, located near Colorado City, Texas. The storage tank is presently connected to the Lotus
pipeline system and the Company intends to further connect the tank to major pipeline systems. Under the terms of an existing
agreement, WC Crude has agreed to lease the oil storage tank for a period of 10 years. As with SFD, WCCC would provide the Company
with the infrastructure to blend and sell oil which has been recovered via a RPC machine from tank bottom sludge and contaminated
soil which exists in the Permian Basin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competitive Strengths and Growth Strategy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Remediation Processing Centers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are focused on the remediation of contaminated
soil and water resulting from either man-made spills or naturally occurring deposits of oil. Our primary focus has been the remediation
of oil spills resulting from the Iraqi invasion of Kuwait and naturally occurring oil sands deposits in the Uinta basin located in Eastern
Utah. We plan to expand into other markets, both in Utah and globally, where we believe our technology and services will provide a distinct
competitive advantage over our competition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Crude Oil Gathering, Storage and Transportation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through recent acquisitions, we have entered into
a synergistic segment of the energy industry, which entails a combination of a crude oil gathering, storage, and transportation. In addition,
these facilities feature long-term ten year take or pay contracts, which may provide Vivakor&#160;with the infrastructure to blend and
sell oil, which has been recovered via&#160;Vivakor's&#160;RPC machine from tank bottom sludge and contaminated soil which exists in the&#160;Permian
Basin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Competitive Strengths</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe the following strengths provide us
with a distinct competitive advantage and will enable us to effectively compete on a global basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td>Proprietary patented technology;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Environmental advantages;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Strong relationships with customers and regulatory agencies; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Experienced and highly-skilled management, Board of Directors and Advisory Board.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Proprietary Patented Technology</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In total, we, together with our subsidiaries,
have intellectual property that is in the form of both proprietary knowledge and patents. Our patent portfolio consists of four issued
U.S. patents, one pending international patent application filed through the Paris Cooperation Treaty (PCT), and one pending patent application
in Kuwait. In addition, we have licensed from our partners the right to use additional patented technologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We presently have two US patent and pending foreign
applications related to our RPCs and two issued US patents related to our other remediation technologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe, based on direct and ongoing conversations
with our customers and third-party independent test results, that our technology is the only commercially available technology that can
not only clean soil that contains greater than 7% hydrocarbon, but also preserves the hydrocarbons extracted from such soil for future
use. We believe that this provides us with a true competitive advantage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our main technology has been tested and validated
for all of its claims by separate, independent expert firms both in the United States and the Middle East, whose reports confirm that
we have reclamation technology, which has been tested and reviewed, that possesses the ability to clean soil with more than 7% hydrocarbon
contamination and still leave the recovered hydrocarbons in a usable state.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Environmental Advantages</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Among our key corporate objectives is to be at
the forefront of social responsibility for its technological impact. We strive for all of our systems to ultimately become closed loop
systems, to minimize adverse impacts on air quality and reduce the need for use of clean water. Our ability to turn waste into value is
in line with this core objective. Our remediation projects in Kuwait are expected to reduce emissions from vaporization of the oil spilled
in the soil. The ability to clean produced water from oil production can eliminate the need for evaporation ponds, improving air quality
and saving on the use of clean water.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe our technology and service offerings
will position us well to conduct our business in any geographical region in which soil or water has been contaminated by hydrocarbons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Strong Relationships with Customers and Regulatory
Agencies</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have developed close relationships with customers
and government agencies, including SITLA and the KOC. We anticipate receiving access to additional oil sands deposits located in Utah
from SITLA, based on our existing relationship with SITLA and our conversations with them. Indeed, our relationships have helped give
rise to our December 2021 agreement with DIC in Kuwait, which will result in our having a stockpile of at least 444,311 tons with at least
5% oil contamination for us to remediate. We also anticipate receiving additional contracts from KOC to remediate contaminated properties
in Kuwait, based on our existing relationship with KOC and conversations with them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Experienced and Highly Skilled Management,
Board of Directors and Advisory Board</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management team has started and successfully
grown numerous technology-based companies and has utilized this experience to develop a strategic vision for the Company. The implementation
of this plan has resulted in the acquisition and in-house development of numerous technologies, which are currently in operation. We have
demonstrated the effectiveness of our technologies in both Vernal, Utah and Kuwait, accomplishing the clean-up of contaminated areas while
also recovering precious metals through our metallic separation technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board of Directors is comprised of accomplished
professionals who bring decades of experience to the Company. Our Board of Directors includes a director who has served as a member of
the Executive Committee of one of the largest global accounting firms and has served on the Board of Directors of two multi-billion dollar
publicly traded companies, a successful investor and entrepreneur who has founded and provided initial financing for numerous life science
companies, several of which have grown to multi-billion dollar publicly traded companies, and the mayor of a city in Utah.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we have an Advisory Board comprised
of former senior members of oil and gas companies, both in the United States and in the Middle East. Our Advisory Board is led by one
member who is an accomplished business professional and a member of a royal family based in the Middle East and another member who is
an experienced health and safety expert operating in the oil and gas industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We rely on our Board of Directors and Advisory
Board to provide it both high level advice and guidance along with using their contacts to help open various markets. Additionally, the
Advisory Board acts as a preliminary informal sounding board for the Board and management for these particular areas in which the Advisory
Board members have expertise. We believe the combination of our management team, Board of Directors and Advisory Board provides us with
a significant competitive advantage over our competitors due to their breadth of experiences and relationships.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Growth Strategies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify"><span style="text-decoration: underline">Remediation Processing Centers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will strive to grow our RPC business by
pursuing the following strategies:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td>Expansion of our oil recovery projects in Utah;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Expansion of our remediation projects in Kuwait;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Expansion into new and complementary markets;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Increase of revenue via new service and product offerings;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Strategic acquisitions and licenses targeting complementary technologies; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Redeployment of the metallic separation technologies.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Expansion of our Oil Recovery Projects in Utah</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The State of Utah has, according to the U.S. Geological
Survey, approximately 14 billion barrels of measured oil in place with an additional estimated 23 to 28 billion barrels of oil contained
in contaminated oil sands that are deposited near the ground surface. The majority of these oil sands deposits are located on land owned
by SITLA. While our current project in Vernal, Utah is not located on SITLA land and we do not yet have a definitive agreement, SITLA
has expressed an interest in providing us leased access to these lands in exchange for a royalty to be paid by us in an amount equal to
8% of all revenue generated from any hydrocarbon-based products produced by us from hydrocarbons extracted from these lands. All royalty
payments to SITLA would result in direct funding to the State&#8217;s school system. We will seek to acquire additional properties and
mineral rights in the vicinity of Vernal, Utah from individual land owners and the State of Utah.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Expansion of our Remediation Projects in Kuwait</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our RPC technology was successfully used in our
initial project for KOC in Kuwait, where we removed hydrocarbons from soil with more than 7% contamination and, following the process,
the hydrocarbon contamination level of the soil was reduced to less than 0.5%, which was lower than the level needed to meet the project
specifications. There is still approximately 26 million cubic meters of soil contaminated by oil from the Iraqi invasion of Kuwait. Pursuant
to our recent agreement with DIC, we will receive $50,000 for the successful remediation of the first 100 tons ($500 per ton) under its
subcontractor services for the KOC Remediation Contract. In addition, we will receive $20 per treated ton of soil after the initial 100
tons. The treatment process using the RPC plants is anticipated to generate a bitumen sub-product. We have agreed with DIC to sell this
sub-product and share the net profits equally (50% to us and 50% to DIC), after allocating 30% of the net profits to DIC in the form of
a sales and marketing payment, which will be invoiced on a monthly basis, in accordance with the Agreement. Pursuant to the Agreement,
we will have a stockpile of at least 444,311 tons with at least 5% oil contamination for us to remediate. Other technologies may also
be used for the less contaminated soils.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Expansion into New and Complementary Markets</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to explore expansion opportunities on
a global basis, including in places with extreme contamination such as the Ogoni Lands region of Nigeria, oil spill lakes located in Saudi
Arabia and Turkmenistan, and naturally occurring oil sands deposits in Kazakhstan, where we believe our technology and service offerings
may provide a distinct competitive advantage. We are currently in discussions with several groups for deploying our RPCs for remediation
projects (primarily for oil spills, tank bottom sludge and drill cuttings) in Saudi Arabia, Qatar and Texas. Saudi Arabia has the objective
to create a circular carbon economy that will ultimately have zero wasted hydrocarbons. Our technology is able to process tank bottom
sludge, drill cuttings, and soils form hydrocarbon spills, returning the sand to less than 0.5% contamination while reclaiming the oil
for waste energy use.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Increase of Revenue via New Service and Product
Offerings</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To date, we have focused on the remediation of
soil contaminated by oil. We intend to target other hydrocarbon remediation businesses that focus on, among other things, the cleaning
of tank bottom sludge, and the cleaning of the water used from drilling oil wells. Oil producers generally pay to dispose of sludge at
the bottom of storage tanks and contaminated water produced from the drilling of oil wells. We believe that our technologies could be
used to clean the contaminated water produced from drilling, while simultaneously recovering the heavy crude. We believe we will be able
to offer these services at a cost that is very competitive with current methods and that our ability to recover the heavy crude for resale
will give us a competitive advantage. We are currently in early stage discussions relating to some of these remediation projects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Strategic Acquisitions and Licenses Targeting
Complementary Technologies</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to seek out opportunities to acquire
or license only specific technologies that are either complementary to our existing product offerings or that will allow us to expand
into the environmental infrastructure markets. We <span style="background-color: white">recently entered into a worldwide, exclusive license
agreement with TBT Group, Inc. to license piezo electric and energy harvesting technologies for creating self-powered sensors for making
smart roadways</span>, which we believe could be embedded directly into the asphaltic cement we intend to produce from the hydrocarbons
we extract, providing the basis for smart roads and infrastructure. We believe that these sensors, which are self-powered, could be used
to provide information about traffic, road conditions and repair needs as well as allowing the roads to communicate directly with autonomous
vehicles enabling these vehicles to sense the road in all weather conditions. By complementing the asphaltic cement we expect to produce
with integrated sensors for automated vehicles, we believe that we will be able to offer a smart road.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Redeployment of the Metallic Separation Technology</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our licensed metallic separation technology has
successfully recovered precious metals including, but not limited to, gold, palladium, platinum, rodium and silver. We intend to redeploy
our metallic separation technology machines to standalone locations to process mine tailings and other soils.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0"><span style="text-decoration: underline">Crude Oil Gathering, Storage and Transportation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">WCCC owns a 120,000
barrel crude oil storage tank, in the heart of the Permian Basin, located near Colorado City, Texas. The Company intends to further
connect the tank to major pipeline systems. In doing so, WCCC would provide the Company with the infrastructure to blend and sell
oil which has been recovered via a RPC from tank bottom sludge and contaminated soil which exists in the Permian Basin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">SFD owns and operates a crude oil gathering, storage, and
transportation facility, which is presently blending and selling approximately 1,400 to 1,700 barrels of blended crude oil on a daily
basis. We plan to increase operations at the facility to ramp up to the facility daily maximum of blending and selling approximately 4,000
barrels of blended crude oil on a daily basis in the near future. Additionally, this facility may also provide us with the infrastructure
needed to place a RPC to clean soil which has been contaminated by hydrocarbons as well as tank bottom sludge from the area.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Developments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Off-Take Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 26, 2022, our
subsidiary Vivaventures Energy Group, Inc., entered into a Product Off-Take Agreement (the &#8220;Off-Take Agreement&#8221;), with Hot
Oil Transport, LLC, a Nevada limited liability company (&#8220;HOT&#8221;). Pursuant to the Off-Take Agreement, the Company plans to produce
asphalt that meets the specifications for PG 64-22 grade, as set forth by the Nevada Department of Transportation and the American Association
of State Highway and Transportation Officials (the &#8220;Product&#8221;) from a to-be-scaled processing plant to be located in Uintah
County, Utah, and as may be relocated from time to time by the Company (the &#8220;Plant&#8221;). HOT will be obligated to purchase from
the Company certain quantities of the Product from the Plant once the Plant begins to produce the Product, on the terms and conditions
set forth in the Off-Take Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The quantity of the Product
to be sold and purchased pursuant to this Agreement will be (i) 1,000 tons of the Product per week, or (ii) the entirety of any lesser
amount that may be produced by the Company during any given week. HOT will also have the first right of refusal to purchase all or any
portion of additional Product that may be produced by the Company within the state of Utah upon the same terms and conditions, except
that the purchase price shall be at market rate as determined in the Company&#8217;s sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the Off-Take
Agreement, the rates for the sale and purchase of up to 1,000 tons of Product per week will be determined on the basis of an average 1,000
tons per week, a price per ton using the &#8220;Argus Rockies Rail Low&#8221; price for asphalt in the Rocky Mountain region as set forth
in the most recent edition of <i>Argus Americas Asphalt</i>&#160;report, produced by Argus Media Group, as of the date of delivery (the
&#8220;Unit Price&#8221;). Once calculated, the weekly purchase price will be reduced by $1,500 in order to compensate Buyer for costs
associated with testing, providing storage tanks for Buyer&#8217;s minimum quantity purchases, and certifying the quality of the Product,
for so long as Buyer is providing the testing facilities for the Product. As noted above, the purchase price for any Product over 1,000
tons per week will be at market rate, as determined by the Company. In the event the Unit Price drops below $250, the Company will have
the right to suspend production of the Product upon written notice to HOT.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Off-Take Agreement
provides for an initial term of ten years. The Off-Take Agreement will automatically renew for two successive ten-year terms, subject
to the Company&#8217;s right to continue operating at the current Plant site, unless either party terminates the Off-Take Agreement by
written notice to the other party not less than three months prior to the expiration of the term. During a term, the Off-Take Agreement
can only be terminated for (i) abandonment or termination of Project by the Company; (ii) default by the other party; or (iii) in connection
with occurrence of a force majeure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Acquisition of Silver
Fuels Delhi, LLC and White Claw Colorado City, LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On June 15, 2022, we
entered into a Membership Interest Purchase Agreement (the &#8220;MIPA&#8221;), with Jorgan Development, LLC, a Louisiana limited liability
company (&#34;Jorgan&#34;) and JBAH Holdings, LLC, a Texas limited liability company (&#8220;JBAH&#8221; and, together with Jorgan,
the &#8220;Sellers&#8221;), as the equity holders of Silver Fuels Delhi, LLC, a Louisiana limited liability company (&#8220;SFD&#8221;)
and White Claw Colorado City, LLC, a Texas limited liability company (&#8220;WCCC&#8221;) whereby, at closing, which occurred on August
1, 2022, the Company acquired all of the issued and outstanding membership interests in each of SFD and WCCC (the &#8220;Membership Interests&#8221;),
making SFD and WCCC wholly owned subsidiaries of the Company (the &#8220;Silver Fuels and White Claw Acquisition&#8221;). The purchase
price for the Membership Interests was approximately $37.4 million, subject to post-closing adjustments, and was paid by the Company to
the Sellers in a combination of 3,009,552 shares of the Common Stock valued at an aggregate of $4,278,655, (the &#8220;Purchaser Stock
Consideration&#8221;), secured three-year promissory notes in the aggregate principal amount of $28,664,284 (the &#8220;Notes&#8221;),
and the assumption of certain liabilities of SFD and WCCC. The shares of Common Stock comprising the Purchaser Stock Consideration represented
19.99% of the number of issued and outstanding shares of the Company&#8217;s Common Stock immediately prior to issuance and were valued
at the volume-weighted average price for the Company&#8217;s Common Stock on Nasdaq during the five trading days immediately preceding
the closing date. In conjunction with the closing, Sellers entered into lock-up agreements for a period of up to 18 months with regard
to the Purchaser Stock Consideration (the &#8220;Lock-up Agreements&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The MIPA contains customary
representations and warranties, pre- and post-closing covenants of each party and customary closing condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The principal amount
of the Notes, together with any and all accrued and unpaid interest thereon, will be paid to the Sellers on a monthly basis, in an amount
equal to the Monthly Free Cash Flow (as defined in the Notes) beginning on September 20, 2022, and continuing thereafter on the twentieth
(20<span style="font-size: 10pt"><sup>th</sup></span>) calendar day of each calendar month thereafter, as set forth in the MIPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Without in any way limiting
the foregoing, the then outstanding principal amount of the Notes, together with any and all accrued and unpaid interest thereon, will
be due and payable in full in cash or unrestricted common stock of the Company on or prior to the three-year anniversary of the date of
issuance, as set forth in the MIPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The obligations of the
Company under the MIPA are secured by the membership units of SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The timely and full payment
of any and all principal, interest and other amounts due and owing to the Sellers pursuant to the Notes and the other transaction documents
and the payment of any and all other obligations owed to the Sellers by the Company under the Notes or thereunder are guaranteed solely
by, and to the extent set forth in, the Guaranty Agreements between each of the Sellers and SFD and WCCC.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">SFD owns and operates
a crude oil gathering, storage, and transportation facility located on approximately 9.3 acres near Delhi, Louisiana. Under existing agreements,
a subsidiary of a large NYSE traded energy company (the &#8220;Purchaser&#8221;) is obligated to purchase blended crude oil from SFD in
amounts up to 60,000 barrels per month. With prior approval, SFD is eligible to sell to the Purchaser amounts greater than 60,000 barrels
of crude oil per month. Additionally, for a period of 10 years, SFD is, under existing crude oil supply agreements with WC Crude, guaranteed
a minimum gross margin of $5.00 per barrel on all quantities of blended crude oil sold thereunder. At present, SFD is blending and selling
approximately 1,400 to 1,700 barrels of blended crude oil on a daily basis. Additionally, the acquisition of SFD would provide the Company
with the infrastructure needed to place a Remediation Processing Machine (&#8220;RPC&#8221;) to clean soil which has been contaminated
by hydrocarbons as well as tank bottom sludge. Management believes SFD&#8217;s location in the heart of the Smackover formation would
provide the Company with access to significant amounts of tank bottom sludge and contaminated soil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">WCCC owns a 120,000
barrel crude oil storage tank, in the heart of the Permian Basin, located near Colorado City, Texas. The storage tank is presently
connected to the Lotus pipeline system and the Company intends to further connect the tank to major pipeline
systems. Under the terms of an existing agreement, WC Crude has agreed to lease the oil storage tank for a period of 10 years. As
with SFD, WCCC would provide the Company with the infrastructure to blend and sell oil which has been recovered via a RPC machine
from tank bottom sludge and contaminated soil which exists in the Permian Basin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This disclosure should be read in connection
with, and is subject to, the MIPA, a copy of which is attached hereto as Exhibit 2.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For a more detailed discussion
of the Acquisition of Silver Fuels Delhi, LLC and White Claw Colorado City, LLC, see &#8220;<a href="#a_307">BUSINESS</a>- Acquisition of Silver Fuels Delhi,
LLC and White Claw Colorado City, LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Cancellation of Stock Options</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 1, 2022, the Company and certain
option holders cancelled 166,667 stock options that were previously issued to Matthew Nicosia, our Chief Executive Officer and 333,334
stock options that were previously issued to a consultant, LBL Professional Consulting, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Associated with Our Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is subject to a number of risks of
which you should be aware before making a decision to invest in our common shares. The following, and other risks, are discussed more
fully in the &#8220;<a href="#a_302">Risk Factors</a>&#8221; section of this prospectus:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>We are an early-stage operating company and we are subject to substantial risks inherent in the establishment of a new business venture;</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="background-color: white"><i>We have historically suffered net losses and we may not be able to achieve or sustain future profitability;</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>We will require additional funding beyond this contemplated offering to fund our operations generally and such funding may not be available on acceptable terms or at all;</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>The COVID-19 pandemic has had and may continue to have a negative impact on our business and operations;</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>We rely on the experience and knowledge of our management team, Board of Directors and Advisory Board, and the loss of one or more members of our management team, Board of Directors and/or Advisory Board would adversely impact our business;</i></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>Our business is subject to extensive legal regulation and unexpected changes to law or increases to fees could have a significant adverse impact on our business;</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>Our primary business is impacted by the oil industry and manufacturing industry, which are subject to uncertain economic conditions;</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>We currently depend and are likely to continue to depend on a limited number of customers for a significant portion of our revenues;</i> and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>We may not be able to adequately protect our proprietary rights.</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><i>If we fail to make the Threshold Payment, or otherwise breach the terms of the MIPA, the transaction consummated by the MIPA may be unwound.</i></td></tr>

<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Our
                                            &#160;operations are subject to unforeseen interruptions and hazards inherent in the oil
                                            industry, such as oil spills and other environmental hazards and our insurance may not be
                                            sufficient to cover such costs.</i></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Our
                                            business could be negatively impacted by supply chain issues if we are unable to receive
                                            parts for our equipment.&#160; Such issues have been significantly more pronounced during
                                            the COVID-19 pandemic.</i></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><i>Doing
                                            business internationally subjects us to a number of risks, including multiple, conflicting
                                            and changing laws and regulations and inherent disadvantages of being a foreign company in
                                            these countries.</i></td></tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt; text-align: justify"></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt 0pt 0; text-align: justify"><b>Implications of Being an Emerging
Growth Company and a Smaller Reporting Company</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We qualify as an &#8220;emerging growth company&#8221;
as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). As an emerging growth company, we may take
advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. See &#8220;<i><a href="#a_302">Risk Factors</a>&#8201;&#8212;&#8201;Risks Relating to Our Common Stock and the Offering&#8201;&#8212;&#8201;We are an &#8216;emerging growth
company&#8217; and will be able to avail ourselves of reduced disclosure requirements applicable to emerging growth companies, which could
make our common stock less attractive to investors</i>.&#8221; These provisions include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt; text-indent: 20pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">being permitted to provide only two years of audited financial statements in addition to any required unaudited interim financial statements with correspondingly reduced &#8220;<a href="#a_306">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a>&#8221; disclosure;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">reduced disclosure obligations regarding executive compensation arrangements;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">not being required to hold a non-binding advisory vote on executive compensation or golden parachute arrangements; and</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 15.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.8pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have irrevocably elected to opt-out of the
extended transition period for complying with new or revised accounting standards pursuant to Section 107(b) of the JOBS Act. As a result,
we will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-
emerging growth companies.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will remain an emerging growth company until
the earlier of&#8201; (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of the initial public
offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated
filer, which means the market value of our common stock that is held by non-affiliates exceeded $700.0 million as of the prior June 30th,
and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. We may choose
to take advantage of some but not all of these exemptions. We have taken advantage of reduced reporting requirements in this prospectus.
Accordingly, the information contained herein may be different than the information you receive from other public companies in which you
hold stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the above, we are also
currently qualified as a &#8220;smaller reporting company&#8221; under SEC rules. In the event that we are still considered a
smaller reporting company at such time as we cease to be an emerging growth company, the disclosure we will be required to provide
in our filings with the SEC will increase but will still be less than it would be if we were not considered either an emerging
growth company or a smaller reporting company. Specifically, similar to emerging growth companies, smaller reporting companies are
able to provide simplified executive compensation disclosures in their filings; are exempt from the provisions of Section 404(b) of
the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;) requiring that independent registered public accounting firms
provide an attestation report on the effectiveness of their internal control over financial reporting; and have certain other
decreased disclosure obligations in their SEC filings, including, among other things, only being required to provide two years of
audited financial statements in their annual reports.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 29.8pt 0pt 0; text-align: justify"><b>Corporate History and Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was originally organized on November
1, 2006 as a limited liability company in the State of Nevada as Genecular Holdings, LLC. The Company&#8217;s name was changed to NGI
Holdings, LLC on November 3, 2006. On April 30, 2008, the Company was converted to a Nevada corporation and changed its name to Vivakor,
Inc. pursuant to Articles of Conversion filed with the Nevada Secretary of State.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have the following direct and indirect wholly-owned
active subsidiaries: VivaVentures Management Company, Inc., a Nevada corporation, VivaSphere, Inc., a Nevada corporation, VivaVentures
Oil Sands, Inc., a Utah corporation, RPC Design and Manufacturing LLC (&#8220;RDM&#8221;), a Utah limited liability company, Silver Fuels
Delhi, LLC, a Louisiana limited liability company, and White Claw Colorado City, LLC, a Texas limited liability company. We have a 99.95%
ownership interest in VivaVentures Energy Group, Inc., a Nevada Corporation; the 0.05% minority interest in VivaVentures Energy Group,
Inc. is held by a private investor unaffiliated with the Company. We also have an approximate 49% ownership interest in Vivakor Middle-East
Limited Liability Company, a Qatar limited liability company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our address is 4101 North Thanksgiving Way, Lehi,
UT&#160; 84043. Our phone number is (949) 281-2606. Our website is: <i>www.vivakor.com</i>. The information on, or that can be accessed
through, this website is not part of this prospectus, and you should not rely on any such information in making the decision whether to
purchase our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: justify">&#160;&#160;</p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="border: Black 1pt solid; margin: 0.1in; padding: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE OFFERING </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%"><b>Common stock offered by the Selling Stockholders:</b></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="width: 74%; text-align: justify">3,009,552 shares.</td></tr>
  <tr style="vertical-align: top">
    <td><b>&#160;</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Shares of Common Stock outstanding before the Offering:</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="background-color: white">18,064,838 shares.</span></td></tr>
  <tr style="vertical-align: top">
    <td><b>&#160;</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Shares of Common Stock outstanding after completion of this offering, assuming the sale of all shares offered hereby (1):</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">18,064,838 shares. </td></tr>
  <tr style="vertical-align: top">
    <td><b>&#160;</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><p style="margin-top: 0; margin-bottom: 0"><b>Use of proceeds:</b></p>
        <p style="margin-top: 0; margin-bottom: 0"></p></td>
    <td style="white-space: nowrap">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not receive any proceeds from the
resale of the Common Stock by the Selling Stockholders.</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Offering price:</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">The Selling Stockholders may
    sell or otherwise dispose of all or a portion of the shares of our Common Stock offered hereby through public or private transactions
    at prevailing market prices or at privately negotiated prices.</td></tr>
  <tr style="vertical-align: top">
    <td><b>&#160;</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Risk factors:</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">Investing in our securities is highly speculative and involves a high degree of risk. You should carefully consider the information set forth in the &#8220;<a href="#a_302">Risk Factors</a>&#8221; section of this prospectus beginning on page 13 before deciding to invest in our securities.</td></tr>
  <tr style="vertical-align: top">
    <td><b>&#160;</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Market for Common Stock</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">Our Common Stock is listed on The Nasdaq Capital Market under the symbol &#8220;VIVK&#8221;.</td></tr>
  <tr style="vertical-align: top">
    <td><b>&#160;</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) The number of shares of common stock shown
above to be outstanding after this offering is based on 18,064,838 shares outstanding as of September 9, 2022, and excludes the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>14,560
shares of common stock issuable upon the conversion of $50,960 of various convertible notes payable that convert at a range between $3.00
and $3.75 per share;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">2,000,000 shares of common stock reserved for future issuance
under the new Vivakor Inc. 2021 Equity Incentive Plan (the &#8220;Vivakor 2021 Plan&#8221;), options to purchase 955,093 shares to be
issued to Matthew Nicosia, our Chief Executive Officer, and options to purchase 917,825 shares to be issued to Tyler Nelson, our Chief
Financial Officer, pursuant to their employment agreements, all in the form of stock options that will be issued under the Vivakor 2021
Plan;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: left">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Non-statutory
options to purchase 100,000 shares of common stock issued to the Board of Directors (Al Ferrara, Trent Staggs, and Matthew
Balk).</p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Warrants to purchase 80,000 shares of common stock to EF Hutton, which were related to and granted during the close of the underwritten
    public offering in February 2022.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Symbol"></span>Any shares
that may be issuable in exchange for convertible notes or LLC units of Viva Wealth Fund I, LLC, Vivaventures Royalty II LLC, and/or Vivaventures
Opportunity Fund pursuant to the respective operating agreements of such entities, as described in this prospectus.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><span id="a_302"></span>RISK FACTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>An investment in our Common Stock is highly
speculative and involves a high degree of risk. We face a variety of risks that may affect our operations or financial results and many
of those risks are driven by factors that we cannot control or predict. In addition to the other information set forth in this prospectus,
you should carefully consider the risk factors discussed below when considering an investment in our Common Stock. If any of the risks
described below occur, our business, financial condition, results of operations and prospects could be materially adversely affected.
In that case, the market price of our Common Stock would likely decline and investors could lose all or a part of their investment. Only
those investors who can bear the risk of loss of their entire investment should consider an investment in our Common Stock. Additional
risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business and results of operations.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Relating to our Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are at an early operational stage, and
our success is subject to the substantial risks inherent in the establishment of a new business venture.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business and operations are in an early stage
and subject to all of the risks inherent with new business ventures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our RPC business and operations are in an
early stage, and our initial operations focused on the remediation of soil and the extraction of hydrocarbons, such as oil, from
properties contaminated by or laden with heavy crude oil and hydrocarbon-based substances. We intend to, but have not yet, completed
the second stage of our operational strategy related to our RPCs, which involves the selling the asphaltic cement and/or other
petroleum-based products we are able to produce from the hydrocarbons we recover. Our business and operations related to SFD
and WCCC, the gathering, storage and transportation, are also in their early stages.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business and operations related to our RPCs may not prove to be
successful. We have deployed only two RPC units to date, including one unit to Kuwait (for which operations were temporarily suspended
due to COVID-19) and another to Vernal, Utah (which is presently operating). We will need to scale our remediation business beyond these
two RPCs and demonstrate that our scaled-up recovery and remediation business can be profitable. Any future success that we may enjoy
related to our RPC business will depend on many factors, some of which may be beyond our control, and others which cannot be predicted
at this time. Although we began operations in 2008 as a technology acquisition company primarily focused on medical technologies, we have
been operating under our current business plan focused on soil remediation since 2011, and we have not yet proven to be profitable. We
have not yet sold any substantial amount of products or services commercially and have not proven that our business model will allow us
to identify and develop commercially feasible products or technologies.&#160; Likewise, SFD and WCCC have only been in operations for
a few years and subject to similar risks as new business ventures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have historically suffered net losses,
and we may not be able to sustain profitability.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We had an accumulated deficit of $41,237,559 and
$35,731,359 as of June 30, 2022 and December 31, 2021, respectively, and we expect to continue to incur significant development expenses
in the foreseeable future related to the completion of the development and commercialization of our products. As a result, we are incurring
operating and net losses, and it is possible that we may never be able to sustain the revenue levels necessary to achieve and sustain
profitability. If we fail to generate sufficient revenues to operate profitably on a consistent basis, or if we are unable to fund our
continuing losses, you could lose all or part of your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely upon a few, select key employees
who are instrumental in our ability to conduct and grow our business. In the event any of those key employees would no longer be affiliated
with the Company, it may have a material detrimental impact as to our ability to successfully operate our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our future success will depend in large part on
our ability to attract and retain high-quality management, operations, and other personnel who are in high demand, are often subject to
competing employment offers, and are attractive recruiting targets for our competitors. The loss of qualified executives and key employees,
or our inability to attract, retain, and motivate high-quality executives and employees required for the planned expansion of our business,
may harm our operating results and impair our ability to grow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We depend on the continued services of our key
personnel, including Matthew Nicosia, our Chief Executive Officer, Tyler Nelson, our Chief Financial Officer, and Daniel Hashim, our Chief
Scientific Officer. Our work with each of these key personnel are subject to changes and/or termination, and our inability to effectively
retain the services of our key management personnel, could materially and adversely affect our operating results and future prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may have difficulty raising additional
capital, which could deprive us of necessary resources, and you may experience dilution or subordinate stockholder rights, preferences
and privileges as a result of our financing efforts.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to continue to devote significant capital
resources to fund the continued development of our RPCs and related technologies. In order to support the initiatives envisioned in our
business plan, we will need to raise additional funds through the sale of public or private debt or equity financing or other arrangements.
Our ability to raise additional financing depends on many factors beyond our control, including the state of capital markets, the market
price of our common stock and the development or prospects for development of competitive technologies by others. Sufficient additional
financing may not be available to us or may be available only on terms that would result in further dilution to the current owners of
our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to obtain additional capital during
2022 through financing lease structures for our RPCs or other financing structures related to our RPCs. We also expect that our current
cash position, will enable us to fund our operating expenses and capital expenditure requirements for the next twelve months. Thereafter,
unless we can achieve and sustain profitability, we anticipate that we will need to raise additional capital to fund our operations while
we implement and execute our business plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any future equity financing may involve substantial
dilution to our then existing shareholders. Any future debt financing could involve restrictive covenants relating to our capital raising
activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue
business opportunities. There can be no assurance that such additional capital will be available, on a timely basis, or on terms acceptable
to us. If we are unsuccessful in raising additional capital or the terms of raising such capital are unacceptable, then we may have to
modify our business plan and/or curtail our planned activities and other operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we raise additional funds through government
or other third-party funding, collaborations, strategic alliances, licensing arrangements or marketing and distribution arrangements,
we may have to relinquish valuable rights to our technologies, future revenue stream or grant licenses on terms that may not be favorable
to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce
or terminate our product development or future commercialization efforts or grant rights to develop and market products that we would
otherwise prefer to develop and market ourselves.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, we have certain potential dilutive
instruments, of which the conversion of these instruments could result in dilution to shareholders: As of September 9, 2022, the maximum
potential dilution is 2,067,478, and includes convertible notes payable convertible into approximately 14,560 shares of common stock,
stock options granted to employees of 1,872,918 shares of common stock. Stock options granted to Board members or consultants of 100,000
shares of common stock were granted as of September 9, 2022. There were also warrants issued and outstanding to EF Hutton of 80,000 shares
of common stock as of September 9, 2022. These warrants were related to and granted during the close of the underwritten public offering
in February 2022.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The COVID-19 pandemic has had and may continue
to have a negative impact on our business and operations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Kuwait operations were suspended to comply
with the social distancing measures implemented in Kuwait. Our Utah operations were temporarily suspended from March through May 2020,
but have since resumed in full. These suspensions have had a negative impact on our business and there can be no guaranty that we will
not need to suspend operations again in the future as a result of the pandemic. We have also observed supply chain disruptions from the
COVID-19 pandemic that has contributed to delays in the completion of the manufacturing of our RPCs. We are closely monitoring the COVID-19
pandemic and the directives from federal and local authorities in the United States and in Kuwait affecting not only our workforce, but
those of companies with whom we work.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Constraints in the supply of equipment used
in providing services to our customers and replacement parts for our equipment could affect our ability to execute our growth strategies.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Equipment used in providing services to our customers is normally readily
available. Market conditions could trigger constraints in the supply chain of certain equipment or replacement parts for such equipment,
which could have a material adverse effect on our business.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Economic conditions in the current period
of disruption and instability could adversely affect our ability to access the capital markets, in both the near and long term, and thus
adversely affect our business and liquidity. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current economic conditions related to the
COVID-19 pandemic have had, and likely will continue to have for the foreseeable future a negative impact on the capital markets. Even
if we are able to raise capital, it may not be at a price or on terms that are favorable to us. We cannot predict the occurrence of future
disruptions or how long the current conditions may continue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business plan includes operating internationally,
which subjects us to a number of risks.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our strategic plans include international operations,
such as our projects in the Middle East. We intend to use our proprietary RPC technology system and develop, construct and potentially
sell our RPC system in international locations. Risks inherent to international operations include the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">inability to work successfully with third parties having local expertise to co-develop international projects;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">multiple, conflicting and changing laws and regulations, including export and import restrictions, tax laws and regulations, environmental
regulations, labor laws and other government requirements, approvals, permits and licenses;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">difficulties in enforcing agreements in foreign legal systems;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">changes in general economic and political conditions in the countries in which we operate, including changes in government incentives
relating to oil remediation;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">political and economic instability, including wars, acts of terrorism, political unrest, boycotts, curtailments of trade and other
business restrictions;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">difficulties and costs in recruiting and retaining individuals skilled in international business operations;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">international business practices that may conflict with U.S. customs or legal requirements;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">financial risks, such as longer sales and payment cycles and greater difficulty collecting accounts receivable;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">fluctuations in currency exchange rates relative to the U.S. dollar; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">inability to obtain, maintain or enforce intellectual property rights.</td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failure to effectively manage our expected
growth could place strains on our managerial, operational and financial resources and could adversely affect our business and operating
results. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our expected growth could place a strain on our
managerial, operational and financial resources. Further, if our subsidiaries&#8217; businesses grow, then we will be required to manage
multiple relationships. Any further growth by us or our subsidiaries, or any increase in the number of our strategic relationships, will
increase the strain on our managerial, operational and financial resources. This strain may inhibit our ability to achieve the rapid execution
necessary to implement our business plan and could have a material adverse effect on our financial condition, business prospects and operations
and the value of an investment in our company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will need to achieve commercial acceptance
of our RPCs and related products in order to generate revenues from those operations and sustain profitability. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our goal is to ultimately produce asphaltic cement
and/or other petroleum-based products from the hydrocarbons we recover and sell these products to customers; however, we may not be able
to successfully commercialize our products related to those operations, and even if we do, we may not be able to do so on a timely basis.
Superior competitive technologies may be introduced, or customer needs may change, which will diminish or extinguish the commercial uses
for our applications. We cannot predict when significant commercial market acceptance for our RPCs and related products will develop,
if at all, and we cannot reliably estimate the projected size of any such potential market. If the markets fail to accept those products,
then we may not be able to generate revenues from the commercial application of our technologies related to those products. Our revenue
growth and profitability will partially depend on our ability to manufacture and deploy additional RPCs and produce asphaltic cement to
the specifications required by each of our potential customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>We have identified
material weaknesses in our internal control over financial reporting. Failure to maintain effective internal controls could cause our
investors to lose confidence in us and adversely affect the market price of our common stock. If our internal controls are not effective,
we may not be able to accurately report our financial results or prevent fraud. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Section 404 of the Sarbanes-Oxley
Act of 2002 (&#8220;Section 404&#8221;) requires that we maintain internal control over financial reporting that meets applicable standards.
We may err in the design or operation of our controls, and all internal control systems, no matter how well designed and operated, can
provide only reasonable assurance that the objectives of the control system are met. Because there are inherent limitations in all control
systems, there can be no assurance that all control issues have been or will be detected. If we are unable, or are perceived as unable,
to produce reliable financial reports due to internal control deficiencies, investors could lose confidence in our reported financial
information and operating results, which could result in a negative market reaction and a decrease in our stock price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We have identified material
weaknesses in our internal controls related to the segregation of duties and financial reporting process within our internal controls.
We believe that we will have substantially resolved our previously identified material weakness in our internal controls as we continue
to hire personnel to fulfill the duties related to the financial reporting process and growth in our business. There can be no assurances
that weakness in our internal controls will not occur in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If we identify new material
weaknesses in our internal control over financial reporting, if we are unable to comply with the requirements of Section 404 in a timely
manner, if we are unable to assert that our internal control over financial reporting is effective, or if our independent registered public
accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting (if and when
required), we may be late with the filing of our periodic reports, investors may lose confidence in the accuracy and completeness of our
financial reports and the market price of our common stock could be negatively affected. As a result of such failures, we could also become
subject to investigations by the stock exchange on which our securities are listed, the SEC, or other regulatory authorities, and become
subject to litigation from investors and stockholders, which could harm our reputation, financial condition or divert financial and management
resources from our core business, and would have a material adverse effect on our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A major portion of our business is dependent
on the oil industry, which is subject to numerous worldwide variables.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our prospective customers are concentrated in
the oil industry. As a result, we will be subject to the success of the oil industry, which is subject to substantial volatility based
on numerous worldwide factors. A decline in the oil industry may have a material adverse effect on our business, financial condition,
results of operations and cash flows. The oil and gas industry is competitive in all its phases. Competition in the oil and gas industry
is intense. We will compete with other participants in the search for oil sand properties and in the marketing of oil and other hydrocarbon
products. Our customers could include competitors such as oil and gas companies that have substantially greater financial resources, staff
and facilities than those of our customers and lessees. Competitive factors in the distribution and marketing of oil and other hydrocarbon
products include price and methods and reliability of delivery.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Within the oil remediation market, demand for
our services will be limited to a specific customer base and highly correlated to the oil industry. The oil industry&#8217;s demand for
equipment is affected by a number of factors including the volatile nature of the oil industry&#8217;s business, increased use of alternative
types of energy and technological developments in the oil extraction process. A significant reduction in the target market&#8217;s demand
for oil would reduce the demand for the equipment, which would have a material adverse effect upon our business, financial condition,
results of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Low oil prices may substantially impact
our ability to generate revenues.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Low oil prices may negatively impact our ability
to operate. The demand for our products and services depend, in part, on the price of oil and the margins oil producers receive on the
sale of oil. Oil prices are volatile and can fluctuate widely based upon a number of factors beyond our control. Any decline in the prices
of and demand for oil could have a material adverse effect on our business, financial condition, results of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our operations are subject to unforeseen
interruptions and hazards inherent in the oil industry, for which we may not be adequately insured and which could cause us to lose customers
and substantial revenue.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations are exposed to the risks inherent
to our industry, such as equipment defects, vehicle accidents, fires, explosions, blowouts, pipe or pipeline failures, and various environmental
hazards, such as oil spills and releases of, and exposure to, hazardous substances. For example, our operations are subject to risks associated
with storage and handling of oil, including any mishandling or surface spillage. In addition, our operations are exposed to potential
natural disasters, including blizzards, tornadoes, storms, floods, other adverse weather conditions and earthquakes. The occurrence of
any of these events could result in substantial losses to us due to injury or loss of life, severe damage to or destruction of property,
natural resources and equipment, pollution or other environmental damage,&#160;clean-up&#160;responsibilities, regulatory investigations
and penalties or other damage resulting in curtailment or suspension of our operations. The cost of managing such risks may be significant.
The frequency and severity of such incidents will affect operating costs, insurability and relationships with customers, employees and
regulators. In particular, our customers may elect not to purchase our product if they view our environmental or safety record as unacceptable,
which could cause us to lose customers and revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations in the U.S. Gulf of Mexico region
are particularly susceptible to interruption and damage from hurricanes. Any of these operating hazards could cause personal injuries,
fatalities, oil spills, discharge of hazardous substances into the air and water or environmental damage, lost production and revenue,
remediation and clean-up costs and liability for damages, all of which could adversely affect our business, financial condition and results
of operations and may not be fully covered by our insurance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our insurance may not be adequate to cover all
losses or liabilities we may suffer. Furthermore, we may be unable to maintain or obtain insurance of the type and amount we desire at
reasonable rates. As a result of market conditions, premiums and deductibles for certain of our insurance policies have increased and
could escalate further. In addition, sub-limits have been imposed for certain risks. In some instances, certain insurance could become
unavailable or available only for reduced amounts of coverage. If we were to incur a significant liability for which we are not fully
insured, it could have a material adverse effect on our business, results of operations and financial condition. In addition, we may not
be able to secure additional insurance or bonding that might be required by new governmental regulations. This may cause us to restrict
our operations, which might severely impact our financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, we may not have coverage if we
are unaware of the pollution event and unable to report the &#8220;occurrence&#8221; to our insurance company within the time frame required
under our insurance policy. In addition, these policies do not provide coverage for all liabilities, and the insurance coverage may not
be adequate to cover claims that may arise, or we may not be able to maintain adequate insurance at rates we consider reasonable. A loss
not fully covered by insurance could have a material adverse effect on our financial position, results of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We require a variety of permits to operate
our business. If we are not successful in obtaining and/or maintaining those permits it will adversely impact our operations. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business requires permits to operate. Our
inability to obtain permits in a timely manner could result in substantial delays to our business. In addition, our customers may not
receive permitting for our equipment&#8217;s specific use and we may be unable to adjust our equipment to meet our customer&#8217;s permitting
needs. The issuance of permits is dependent on the applicable government agencies and is beyond our control and that of our customers.
There can be no assurance that we and/or our customers will receive the permits necessary to operate, which could substantially and adversely
affect our operations and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are required to pay permit and approval
fees to operate in certain business segments and locations. If we are not able to pay those fees it would adversely impact our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are required to pay various types of permit
and approval fees to the applicable governmental and quasi-governmental agencies to operate our business. These fees are subject to change
at the discretion of the various agencies. Our inability to pay these permit and approval fees could substantially and adversely affect
our operations and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We, and our customers and prospective customers,
are subject to numerous governmental regulations, both domestically and internationally. In order to operate successfully we must be able
comply with these regulations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current and future government laws, regulations
and other legal requirements may increase the costs of doing business or restrict business operations. Laws, regulations and other legal
requirements, such as those relating to the protection of the environment and natural resources, health, business and tax have an effect
on our cost of operation or those of our customers. Such governmental regulation may result in delays, cause us to incur substantial compliance
and other costs and prohibit or severely restrict our business or that of our customers, which could have an adverse effect on our business,
financial condition, results of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>For our operations related to our RPCs we currently depend, and
are likely to continue to depend, on a limited number of customers for a significant portion of our revenues related to those operations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently have two customers in Utah and a
single customer in Kuwait for our RPCs and related products. The failure to obtain additional customers or the loss of all or a portion
of the revenues attributable to any current or future customer as a result of competition, creditworthiness, inability to negotiate extensions
or replacement of contracts or otherwise could have a material adverse effect on our business, financial condition, results of operations
and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If our customers do not enter into, extend or
honor their contracts with us, our profitability could be adversely affected. Our ability to receive payment for production depends on
the continued solvency and creditworthiness of our customers and prospective customers. If any of our customers&#8217; creditworthiness
suffers, we may bear an increased risk with respect to payment defaults. If customers refuse to accept our equipment or make payments
for which they have a contractual obligation, our revenues could be adversely affected. In addition, if a substantial portion of our contracts
are modified or terminated and we are unable to replace the contracts (or if new contracts are priced at lower levels), our results of
operations will be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our primary business is impacted by the
oil industry and the manufacturing industry, which are subject to uncertain economic conditions.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The global economy is subject to fluctuation and
it is unclear how stable the oil industry and the manufacturing industry will be in the future. As a result, there can be no assurance
that the business will achieve anticipated cash flow levels. Further, recent world events evolving out of trade disputes, increased terrorist
activities and political and military action, and the COVID-19 pandemic, among other events, have created an air of uncertainty concerning
the stability of the global economy. Historically, such events have resulted in disturbances in financial markets, and it is impossible
to determine the likelihood of future events. Any negative change in the general economic conditions in the United States and globally
could adversely affect the financial condition and operating results of the business. We plan to expand our level of operations. Slower
economic activity, concerns about inflation or deflation, decreased consumer confidence, reduced corporate profits and capital spending,
adverse business conditions and liquidity concerns in the general economy and recent international conflicts and terrorist and military
activity have resulted in a downturn in worldwide economic conditions, especially in the United States. Political and social turmoil related
to international conflicts and terrorist acts may place further pressure on economic conditions in the United States and worldwide. These
political, social and economic conditions make it extremely difficult for us to accurately forecast and plan future business activities.
If such conditions continue or worsen, then our business, financial condition and results of operations could be materially and adversely
affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will continue to be subject to competition
in our business</i></b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our oil remediation equipment utilizes specific
technology to extract oil from sand. Oil producers are continually investigating alternative oil production technologies with a view to
reduce production costs. In addition, industries that compete with the oil industry, such as the electric power industry, also continue
to innovate and create products that compete with the oil industry. There can be no assurance that superior alternative technologies will
emerge, which could reduce the demand for and price of our product and services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for our products and services is highly
competitive and is becoming more so, which could hinder our ability to successfully market our products and services. We may not have
the resources, expertise or other competitive factors to compete successfully in the future. We expect to face additional competition
from existing competitors and new market entrants in the future. Many of our competitors have greater name recognition and more established
relationships in the industry than we do. As a result, these competitors may be able to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="width: 4%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 95%">develop and expand their product offerings more rapidly;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>adapt to new or emerging changes in customer requirements more quickly;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>take advantage of acquisition and other opportunities more readily; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>devote greater resources to the marketing and sale of their products and adopt more aggressive pricing policies than we can.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Regarding our crude oil gathering, storage
and transportation business, many of our competitors are large tank farm businesses and if one or more of them built storage tanks
and/or facilities near our current facilities they could compete with us for business at our current location. As larger
companies, they have greater resources than we do to compete for business in our area and may be able to price us out of
business.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We carry insurance coverage against liabilities
for personal injury, death and property damage, but there is no guarantee this coverage will be sufficient to cover us against all claims.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although, we maintain insurance coverage against
liability for personal injury, death and property damage. There can be no assurance that this insurance will be sufficient to cover any
such liabilities. We may not be insured or fully insured against the losses or liabilities that could arise from a casualty in the business
operations. In addition, there can be no assurance that particular risks that are currently insurable will continue to be insurable on
an economical basis or that the current levels of coverage will continue to be available. If a loss occurs that is partially or completely
uninsured, we may incur a significant liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>We may be unable to adequately protect our proprietary rights.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to compete partly depends on the superiority,
uniqueness and value of our intellectual property. To protect our proprietary rights, we will rely on a combination of patents, copyrights
and trade secrets, confidentiality agreements with our employees and third parties, and protective contractual provisions. Despite these
efforts, any of the following occurrences may reduce the value of our intellectual property:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="width: 4%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 95%">Our applications for patents relating to our business may not be granted and, if granted, may be challenged or invalidated;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Issued patents may not provide us with any competitive advantages;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Our efforts to protect our intellectual property rights may not be effective in preventing misappropriation of our technology;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Our efforts may not prevent the development and design by others of products or technologies similar to or competitive with, or superior to those we develop; or</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Another party may obtain a blocking patent and we would need to either obtain a license or design around the patent in order to continue to offer the contested feature or service in our products.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become involved in lawsuits to protect
or enforce our patents that would be expensive and time consuming.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to protect or enforce our patent rights,
we may initiate patent litigation against third parties. In addition, we may become subject to interference or opposition proceedings
conducted in patent and trademark offices to determine the priority and patentability of inventions. The defense of intellectual property
rights, including patent rights through lawsuits, interference or opposition proceedings, and other legal and administrative proceedings,
would be costly and divert our technical and management personnel from their normal responsibilities. An adverse determination of any
litigation or defense proceedings could put our pending patent applications at risk of not being issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, because of the substantial amount
of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could
be compromised by disclosure during this type of litigation. For example, during the course of this type of litigation, confidential information
may be inadvertently disclosed in the form of documents or testimony in connection with discovery requests, depositions or trial testimony.
This disclosure could have a material adverse effect on our business and our financial results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our RPC business operations rely on our
ability to transport our equipment to different locations. Any impact on the cost, availability and reliability of transportation could
adversely affect our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The availability and reliability of transportation
and fluctuation in transportation costs could negatively impact our business. Transportation logistics play an important role in the sale
of our RPC products and related services and in the oil industry generally. Delays and interruptions of transportation services because
of accidents, failure to complete construction of infrastructure, infrastructure damage, lack of capacity, weather-related problems, governmental
regulation, terrorism, strikes, lock-outs, third-party actions or other events could impair the operations of our customers and may also
directly impair our ability to commence or complete production or services, which could have a material adverse effect on our business,
financial condition, results of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The lands on which we conduct our business
operations must be properly zoned for our services. If they aren&#8217;t then it could impact our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The lands on which we conduct our business operates
must comply with applicable zoning regulations. Any unknown or future violations could limit or require us to cease operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Data security breaches are increasing worldwide.
If we are the victim of such a breach it will materially impact our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will collect and retain certain personal information
provided by our employees and investors. We intend to implement certain protocols designed to protect the confidentiality of this information
and periodically review and improve our security measures; however, these protocols may not prevent unauthorized access to this information.
Technology and safeguards in this area are consistently changing and there is no assurance that we will be able to maintain sufficient
protocols to protect confidential information. Any breach of our data security measures and disbursement of this information may result
in legal liability and costs (including damages and penalties), as well as damage to our reputation, that could materially and adversely
affect our business and financial performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may indemnify our directors and officers
against liability to us and holders of our securities, and such indemnification could increase our operating costs.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our bylaws allow us to indemnify our directors
and officers against claims associated with carrying out the duties of their offices. Our bylaws also allow us to reimburse them for the
costs of certain legal defenses. Insofar as indemnification for liabilities arising under the Securities Act of 1933 (the &#8220;Securities
Act&#8221;) may be permitted to our directors, officers or control persons, we have been advised by the SEC that such indemnification
is against public policy and is therefore unenforceable. If our officers and directors file a claim against us for indemnification, the
associated expenses could also increase our operating costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>We may be subject to liability if our equipment does not perform
as expected.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be exposed to liability in the event our
equipment does not perform as expected. We intend to enter into contracts with customers, which will grant certain rights with respect
to the condition and use of our products. Certain contractual and legal claims could arise in the event the equipment does not perform
as expected and in the event of personal injury, death or property damage as a result of the use of our equipment. There can be no assurance
that particular risks are insured or, if insured, will continue to be insurable on an economical basis or that current levels of coverage
will continue to be available. We may be liable for any defects in the equipment or its products and services and uninsured or underinsured
personal injury, death or property damage claims.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our RPC business depends on our ability
to manufacture various pieces of equipment, many of which are quite large. Any disruption in our manufacturing ability will adversely
affect our business and operations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our RPC business involves manufacturing and plant
operation risks of delay that may be outside of our control. Production or services may be delayed or prevented by factors such as adverse
weather, strikes, energy shortages, shortages or increased costs of materials, inflation, environmental conditions, legal matters and
other unknown contingencies. Our RPC business also requires certain manufacturing apparatus to manufacture the equipment. If the manufacturing
apparatus were to suffer major damage or are destroyed by fire, abnormal wear, flooding, incorrect operation or otherwise, we may be unable
to replace or repair such apparatus in a timely manner or at a reasonable cost, which would impact the our ability to stay in production
or service. Any significant downtime of the equipment manufacturing could impair our ability to produce for or serve customers and materially
and adversely affect our results of operations. In addition, changes in the equipment plans and specifications, delays due to compliance
with governmental requirements or impositions of fees or other delays could increase production costs beyond those budgeted for the business.
If any cost overruns exceed the funds budgeted for operations, the business would be negatively impacted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Any accident at our manufacturing facilities could subject us
to substantial liability.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The manufacturing and operation of the equipment
involves hazards and risks which could disrupt operations, decrease production and increase costs. The occurrence of a significant accident
or other event that is not fully insured could adversely affect our business, financial condition, results of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If critical components become unavailable
or our suppliers delay their production of our key components, our business will be negatively impacted.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to get key components to build our
RPCs and related equipment is crucial to our ability to manufacture our products. These components are supplied by certain third-party
manufacturers, and we may be unable to acquire necessary amounts of key components at competitive prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are successful in our growth, outsourcing
the production of certain parts and components would be one way to reduce manufacturing costs. We plan to select these particular manufacturers
based on their ability to consistently produce these products according to our requirements in an effort to obtain the best quality product
at the most cost-effective price. However, the loss of all or any one of these suppliers or delays in obtaining shipments would have an
adverse effect on our operations until an alternative supplier could be found, if one may be located at all. If we get to that stage of
growth, such loss of manufacturers could cause us to breach any contracts we have in place at that time and would likely cause us to lose
sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Any shortage of skilled labor would have
a detrimental impact on our ability to provide our products and services.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The manufacturing and operating of our equipment
requires skilled laborers. In the event there is a shortage of labor, including skilled labor, it could have an adverse impact on our
productivity and costs and our ability to expand production in the event there is an increase in demand for our product or services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i></i></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on third party contractors for some
of our operations. If we are unable to find quality contractors, it would severely impact our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We outsource certain aspects of our business to
third party contractors. We are subject to the risks associated with such contractors&#8217; ability to successfully provide the necessary
services to meet the needs of our business. If the contractors are unable to adequately provide the contracted services, and we are unable
to find alternative service providers in a timely manner, our ability to operate the business may be disrupted, which may adversely affect
our business, financial condition, results of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Union activities could adversely impact our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While none of our employees are currently members
of unions, we may become adversely effected by union activities. We are not subject to any collective bargaining or union agreement; however,
it is possible that future employees may join or seek recognition to form a labor union or may be required to become a labor agreement
signatory. If some or all of our employees become unionized, it could adversely affect productivity, increase labor costs and increase
the risk of work stoppages. If a work stoppage were to occur, it could interfere with the business operations and have a material adverse
effect on our business, financial condition, results of operations and cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to make the Threshold Payment,
or otherwise breach the terms of the MIPA, the transaction consummated by the MIPA may be unwound.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the terms of the
MIPA, we agreed with the Sellers that, in the event of a breach of the terms of the MIPA, the Notes, or the Pledge Agreement, the sole
and exclusive remedy of the parties will be to unwind the MIPA transaction (the &#8220;Unwinding&#8221;). In any such Unwinding, the Membership
Interest will be transferred to Sellers and Sellers will assign and transfer to us, the number of shares of our common stock constituting
the Purchaser Stock Consideration and any other amounts (the &#8220;Pre-Payment Amounts&#8221;) paid to Sellers by us above and beyond
the monthly amounts required to be paid to Sellers under the Notes. If the MIPA transaction were to be unwound we would no longer own
SDF and WCCC, which would substantially impact our operations and revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Although our shares
of Common Stock have been approved for listing on The Nasdaq Capital Market, our shares of Common Stock may be subject to potential delisting
if we do not meet or continue to maintain the listing requirements of The Nasdaq Capital Market.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our shares and warrants have been approved for
listing on Nasdaq&#894; however, to keep our listing on Nasdaq, we are required to maintain: (i) a minimum bid price of $1.00 per share,
(ii) a certain public float, (iii) a certain number of round lot shareholders and (iv) one of the following: a net income from continuing
operations (in the latest fiscal year or two of the three last fiscal years) of at least $500,000, a market value of listed securities
of at least $35 million or a stockholders&#8217; equity of at least $2.5 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If our securities are ever delisted from Nasdaq,
trading will most likely take place on the OTC Marketplace operated by OTC Markets Group Inc. An investor is likely to find it less convenient
to sell, or to obtain accurate quotations in seeking to buy, our Common Stock on an over-the-counter market, and many investors may not
buy or sell our Common Stock due to difficulty in accessing over-the-counter markets, or due to policies preventing them from trading
in securities not listed on a national exchange or other reasons, and our ability to issue additional securities for financing or other
purposes, or otherwise to arrange for any financing we may need in the future, may also be materially and adversely affected if our Common
Stock is not traded on a national securities exchange. For these reasons and others, delisting would adversely affect the liquidity, trading
volume and price of our Common Stock, causing the value of an investment in us to decrease and having an adverse effect on our business,
financial condition and results of operations, including our ability to attract and retain qualified executives and employees and to raise
capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to the Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>You may lose all of your investment.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investing in our Common Stock involves a high
degree of risk. As an investor, you might never recoup all, or even part of, your investment and you may never realize any return on your
investment. You must be prepared to lose all your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The market price of our Common Stock may
be highly volatile, you may not be able to resell your shares at or above your purchase price and you could lose all or part of your investment.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading price of our Common Stock may be volatile.
Our stock price could be subject to wide fluctuations in response to a variety of factors, including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">actual or anticipated fluctuations in our revenue and other operating results;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">actions of securities analysts who initiate or maintain coverage of us, changes in financial estimates by any securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">issuance of our equity or debt securities, or disclosure or announcements relating thereto;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the lack of a meaningful, consistent and liquid trading market for our Common Stock;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">additional shares of our Common Stock being sold into the market by us or our stockholders or the anticipation of such sales;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">announcements by us or our competitors of
significant events or features, technical innovations, acquisitions, strategic partnerships, joint ventures or capital commitments;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">changes in operating performance and stock market valuations of companies in our industry;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">price and volume fluctuations in the overall stock market, including as a result of trends in the economy as a whole;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">lawsuits threatened or filed against us;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">regulatory developments in the United States and foreign countries; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">other events or factors, including those
resulting from the impact of COVID-19 pandemic, war or incidents of terrorism, or responses to these events.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the stock market in general has experienced
extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies.
Broad market and industry factors may negatively affect the market price of our Common Stock, regardless of our actual operating performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Under the MIPA, we issued the Sellers shares
of our common stock equal to approximately 19.99% of our then-outstanding common stock. Those shares are being registered for resale in
this prospectus. If the Sellers sell some or all of the shares in the public market it could cause our stock price to fall. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales of a substantial number of shares of our
Common Stock in the public market or the perception that these sales might occur, could depress the market price of our Common Stock and
could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that sales
may have on the prevailing market price of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Risks Related to Our Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>We are an &#8220;emerging
growth company&#8221; and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make
our Common Stock less attractive to investors.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We are an &#8220;emerging
growth company&#8221; as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of
exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including
(1)&#160;not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, (2)&#160;reduced
disclosure obligations regarding executive compensation in this prospectus and our periodic reports and proxy statements, and (3)&#160;exemptions
from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute
payments not previously approved. In addition, as an emerging growth company, we are only required to provide two&#160;years of audited
financial statements and two&#160;years of selected financial data in this prospectus. We could be an emerging growth company until the
fifth anniversary of the first sale of our common stock pursuant to a registration statement occurs, although circumstances could cause
us to lose that status earlier, including if the market value of our common stock held by non-affiliates exceeds $700.0&#160;million as
of June&#160;30 of any&#160;year or if we have total annual gross revenue of $1.07&#160;billion or more during any fiscal&#160;year, in
which cases we would no longer be an emerging growth company as of the following December&#160;31, or if we issue more than $1.0&#160;billion
in nonconvertible debt during any three-year period, in which case we would no longer be an emerging growth company immediately. Even
after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company&#8221; which would
allow us to take advantage of many of the same exemptions from disclosure requirements including not being required to comply with the
auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive
compensation in this prospectus and our periodic reports and proxy statements. We cannot predict if investors will find our Common Stock
less attractive because we may rely on these exemptions. If some investors find our Common Stock less attractive as a result, there may
be a less active trading market for our Common Stock and our share price may be more volatile.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under
the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards
apply to private companies. We have elected to use the extended transition period under the JOBS Act until the earlier of the date we
(i)&#160;are no longer an emerging growth company or (ii)&#160;affirmatively and irrevocably opt out of the extended transition period
provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting
pronouncements as of public company effective dates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>We are a smaller reporting company,
and we cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies will make our Common Stock less
attractive to investors.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We
are currently a &#8220;smaller reporting company&#8221;, meaning that we are not an investment company, an asset-backed issuer, or a majority-owned
subsidiary of a parent company that is not a smaller reporting company and we have a public float of less than $250&#160;million and annual
revenues of less than $100&#160;million during our most recently completed fiscal&#160;year. In the event that we are still considered
a smaller reporting company at such time as we cease being an &#8220;emerging growth company,&#8221; we will be required to provide additional
disclosure in our SEC filings. However, similar to emerging growth companies, smaller reporting companies are able to provide simplified
executive compensation disclosures in their filings; are exempt from the provisions of Section&#160;404(b)&#160;of the Sarbanes-Oxley
Act requiring that independent registered public accounting firms provide an attestation report on the effectiveness of internal control
over financial reporting; and have certain other decreased disclosure obligations in their SEC filings, including, among other things,
only being required to provide two&#160;years of audited financial statements in annual reports and in a registration statement under
the Exchange Act on Form&#160;10. Decreased disclosures in our SEC filings due to our status as a smaller reporting company may make it
harder for investors to analyze our results of operations and financial prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We do not anticipate paying dividends on
our Common Stock, and investors may lose the entire amount of their investment.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash dividends have never been declared or paid
on our Common Stock, and we do not anticipate such a declaration or payment for the foreseeable future. Any future determination about
the payment of dividends will be made at the discretion of our board of directors and will depend upon our earnings, if any, capital requirements,
operating and financial conditions, contractual restrictions, including any loan or debt financing agreements, and on such other factors
as our board of directors deems relevant. In addition, we may enter into agreements in the future that could contain restrictions on payments
of cash dividends. We expect to use future earnings, if any, to fund business growth. Therefore, stockholders will not receive any funds
absent a sale of their shares of our Common Stock. If we do not pay dividends, our Common Stock may be less valuable because a return
on your investment will only occur if our stock price appreciates. We cannot assure stockholders of a positive return on their investment
when they sell their shares of our Common Stock, nor can we assure that stockholders will not lose the entire amount of their investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Provisions in our articles of incorporation
and bylaws and Nevada law might discourage, delay or prevent a change of control of our Company or changes in our management and, therefore,
depress the trading price of our Common Stock.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our articles of incorporation and bylaws contain
provisions that could depress the trading price of our Common Stock by acting to discourage, delay or prevent a change in control of our
company or changes in our management that the stockholders of our Company may deem advantageous. These provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 24px">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; width: 24px"><span style="font-size: 10pt"><span style="font-family: Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">provide that directors may only be removed &#8220;for cause&#8221;;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 24px">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; width: 24px"><span style="font-size: 10pt"><span style="font-family: Symbol">&#183;</span></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">authorize the issuance of &#8220;blank check&#8221;
preferred stock that our board of directors could issue from time to time to increase the number of outstanding shares and discourage
a takeover attempt;</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 24px">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; width: 24px"><span style="font-size: 10pt"><span style="font-family: Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">eliminate the ability of our stockholders to call special meetings of stockholders;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 24px">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; width: 24px"><span style="font-size: 10pt"><span style="font-family: Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">provide that the board of directors is expressly authorized to make, alter or repeal our bylaws;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 24px">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; width: 24px"><span style="font-size: 10pt"><span style="font-family: Symbol">&#183;</span></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">establish advance notice requirements for
nominations for election to our board of directors or for proposing matters that can be acted upon by stockholders at stockholder meetings;
and</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 24px">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; width: 24px"><span style="font-size: 10pt"><span style="font-family: Symbol">&#183;</span></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">require supermajority approvals to remove
the protective provisions in our certificate of incorporation and bylaws listed above or to amend our bylaws.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Such provisions could
impede any merger, consolidation, takeover or other business combination involving the company or discourage a potential acquirer from
making a tender offer or otherwise attempting to obtain control of the company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_303"></span>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains forward-looking statements
that present our current expectations or forecasts of future events. These statements do not relate strictly to historical or current
facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected
revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for
working capital. They are generally identifiable by use of the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;anticipate,&#8221;
&#8220;estimate,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;projects,&#8221; &#8220;continuing,&#8221; &#8220;ongoing,&#8221;
&#8220;expects,&#8221; &#8220;management believes,&#8221; &#8220;we believe,&#8221; &#8220;we intend&#8221; or the negative of these words
or other variations on these words or comparable terminology. These statements may be found under the sections entitled &#8220;<a href="#a_301">Prospectus Summary</a>,&#8221; &#8220;<a href="#a_302">Risk Factors</a>,&#8221; &#8220;<a href="#a_306">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a>&#8221;
and &#8220;<a href="#a_307">Business</a>,&#8221; as well as in this prospectus generally. In particular, these include statements relating to future actions,
prospective products, market acceptance, future performance or results of current and anticipated products, sales efforts, expenses, and
the outcome of contingencies such as legal proceedings and financial results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Examples of forward-looking statements in this
prospectus include, but are not limited to, our expectations regarding our business strategy, business prospects, operating results, operating
expenses, working capital, liquidity and capital expenditure requirements. Important assumptions relating to the forward-looking statements
include, among others, assumptions regarding demand for our products and services, the cost, terms and availability of components, pricing
levels, the timing and cost of capital expenditures, competitive conditions and general economic conditions. These statements are based
on our management&#8217;s expectations, beliefs and assumptions concerning future events affecting us, which in turn are based on currently
available information. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the
forward-looking statements are reasonable, our expectations may prove to be incorrect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Important factors that could cause actual results
to differ materially from the results and events anticipated or implied by such forward-looking statements include, but are not limited
to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td>changes in the market acceptance of our products and services;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td>increased levels of competition;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">changes in political, economic or regulatory conditions generally and in the markets in which we operate;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td>our relationships with our key customers;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td>adverse conditions in the industries in which our customers operate;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td>our ability to retain and attract senior management and other key employees;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td>our ability to quickly and effectively respond to new technological developments;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">our ability to protect our trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on the proprietary rights of the Company; and</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px">&#160;</td>
    <td style="width: 25px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">other risks, including those described in the &#8220;<a href="#a_302">Risk Factors</a>&#8221; discussion of this prospectus.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate in a very competitive and rapidly changing
environment. New risks emerge from time to time. It is not possible for us to predict all of those risks, nor can we assess the impact
of all of those risks on our business or the extent to which any factor may cause actual results to differ materially from those contained
in any forward-looking statement. The forward-looking statements in this prospectus are based on assumptions management believes are reasonable.
However, due to the uncertainties associated with forward-looking statements, you should not place undue reliance on any forward-looking
statements. Further, forward-looking statements speak only as of the date they are made, and unless required by law, we expressly disclaim
any obligation or undertaking to publicly update any of them in light of new information, future events, or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_304"></span>USE OF PROCEEDS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All proceeds from the resale of the shares of
our Common Stock offered by this prospectus will belong to the Selling Stockholders. We will not receive any proceeds from the resale
of the shares of our Common Stock by the Selling Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_305"></span>MARKET FOR OUR COMMON STOCK AND RELATED STOCKHOLDER
MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Market Information</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Common Stock is listed on the Nasdaq Capital Market under the symbol
&#8220;VIVK.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of September 9, 2022,
there were 18,064,838 shares of Common Stock outstanding held by approximately 569 holders of record (not including an indeterminate number
of beneficial holders of stock held in street name).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">There were 80,000
warrants issued and outstanding as of September 9, 2022. The warrants have a five-year term, were issued on February 14, 2022, and
are exercisable for shares of Common Stock at an exercise price of $5.75 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Dividends</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">To date, we have not
paid any dividends on our common stock and do not anticipate paying any dividends in the foreseeable future. The declaration and payment
of dividends on the common stock is at the discretion of our Board of Directors and will depend on, among other things, our operating
results, financial condition, capital requirements, contractual restrictions or such other factors as our Board of Directors may deem
relevant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Securities Authorized
for Issuance under Equity Compensation Plans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14 2022, our 2021 Equity and Incentive
Plan went effective. The plan was approved by our Board of Directors. The Plan&#8217;s number of authorized shares is 2,000,000. As of
September 9, 2022, there were stock options granted to acquire 1,872,918 shares of common stock at a weighted exercise price of $1.75
per share under the plan. As of September 9, 2022, the Plan had 1,083,392 vested shares and 789,526 non-vested shares underlying the stock
options. As of September 9, 2022, no options had been exercised under the Plan. We have not issued any other type of equity awards under
the Plan. The stock options issued under the Plan are held by certain of our executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_306"></span>MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION<br />
AND RESULTS OF OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Note Regarding Forward-Looking Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">This </span>prospectus
<span style="background-color: white">includes a number of forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange
Act&#8221;) that reflect management&#8217;s current views with respect to future events and financial performance. </span>These statements
are based upon beliefs of, and information currently available to, the Company&#8217;s management as well as estimates and assumptions
made by the Company&#8217;s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are
only predictions and speak only as of the date hereof. When used herein, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221;
&#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;future,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221;
&#8220;target,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;continue&#8221;
or the negative of these terms and similar expressions as they relate to the Company or the Company&#8217;s management identify forward-looking
statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties,
assumptions, and other factors, including the risks relating to the Company&#8217;s business, industry, and the Company&#8217;s operations
and results of operations. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove
incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although the Company believes that the expectations
reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance,
or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend
to update any of the forward-looking statements to conform these statements to actual results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial statements are prepared in accordance
with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;). These accounting principles require us to make
certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable
based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments
and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported
amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material
differences between these estimates and actual results. The following discussion should be read in conjunction with our financial statements
and notes thereto appearing elsewhere in this report. The forward-looking statements made in this report are based only on events or information
as of the date on which the statements are made in this report. Except as required by law, we undertake no obligation to update or revise
publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the
statements are made or to reflect the occurrence of unanticipated events. You should read this report and the documents we refer to in
this report and have filed as exhibits to this report completely and with the understanding that our actual future results may be materially
different from what we expect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we believe that the expectations reflected
in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, or performance. Readers are
urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the Securities
and Exchange Commission (&#8220;SEC&#8221;). We undertake no obligation to update or revise forward-looking statements to reflect changed
assumptions, the occurrence of unanticipated events or changes in the future operating results over time except as required by law. We
believe that our assumptions are based upon reasonable data derived from and known about our business and operations. No assurances are
made that actual results of operations or the results of our future activities will not differ materially from our assumptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used in this prospectus and unless otherwise
indicated, the terms &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Vivakor, Inc., its wholly
owned and majority-owned active subsidiaries, or joint ventures (collectively, the &#8220;Company&#8221;). Intercompany balances and transactions
between consolidated entities are eliminated. Vivakor has the following wholly and majority-owned subsidiaries: Vivaventures Management
Company, Inc., Vivaventures Energy Group, Inc. (99%), Vivaventures Oil Sands, Inc., Vivasphere, Inc., and Vivakor Middle East, LLC (49%,
consolidated). Vivakor manages and consolidates RPC Design and Manufacturing LLC, which includes a noncontrolling interest investment
from Vivaopportunity Fund, LLC, which is also managed by Vivaventures Management Company, Inc. Vivakor has common officers with and consolidates
Viva Wealth Fund I, LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Business Overview</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vivakor, Inc. is a socially responsible operator,
acquirer and developer of clean energy technologies and environmental solutions, primarily focused on soil remediation. We specialize
in the remediation of soil and the extraction of hydrocarbons, such as oil, from properties contaminated by or laden with heavy crude
oil and other hydrocarbon-based substances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are focused on the remediation of contaminated
soil and water resulting from either man-made spills or naturally occurring deposits of oil. Our primary focus has been the remediation
of oil spills resulting from the Iraqi invasion of Kuwait and naturally occurring oil sands deposits in the Uinta basin located in Eastern
Utah. We plan to expand into other markets, both domestically and globally, where we believe our technology and services will provide
a distinct competitive advantage over our competition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Recent Developments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Off-Take Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 26, 2022, our
subsidiary Vivaventures Energy Group, Inc., entered into a Product Off-Take Agreement (the &#8220;Off-Take Agreement&#8221;), with Hot
Oil Transport, LLC, a Nevada limited liability company (&#8220;HOT&#8221;). Pursuant to the Off-Take Agreement, the Company plans to produce
asphalt that meets the specifications for PG 64-22 grade, as set forth by the Nevada Department of Transportation and the American Association
of State Highway and Transportation Officials (the &#8220;Product&#8221;) from a to-be-scaled processing plant to be located in Uintah
County, Utah, and as may be relocated from time to time by the Company (the &#8220;Plant&#8221;). HOT will be obligated to purchase from
the Company certain quantities of the Product from the Plant once the Plant begins to produce the Product, on the terms and conditions
set forth in the Off-Take Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The quantity of the Product
to be sold and purchased pursuant to this Agreement will be (i) 1,000 tons of the Product per week, or (ii) the entirety of any lesser
amount that may be produced by the Company during any given week. HOT will also have the first right of refusal to purchase all or any
portion of additional Product that may be produced by the Company within the state of Utah upon the same terms and conditions, except
that the purchase price shall be at market rate as determined in the Company&#8217;s sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the Off-Take
Agreement, the rates for the sale and purchase of up to 1,000 tons of Product per week will be determined on the basis of an average 1,000
tons per week, a price per ton using the &#8220;Argus Rockies Rail Low&#8221; price for asphalt in the Rocky Mountain region as set forth
in the most recent edition of <i>Argus Americas Asphalt</i>&#160;report, produced by Argus Media Group, as of the date of delivery (the
&#8220;Unit Price&#8221;). Once calculated, the weekly purchase price will be reduced by $1,500 in order to compensate Buyer for costs
associated with testing, providing storage tanks for Buyer&#8217;s minimum quantity purchases, and certifying the quality of the Product,
for so long as Buyer is providing the testing facilities for the Product. As noted above, the purchase price for any Product over 1,000
tons per week will be at market rate, as determined by the Company. In the event the Unit Price drops below $250, the Company will have
the right to suspend production of the Product upon written notice to HOT.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Off-Take Agreement
provides for an initial term of ten years. The Off-Take Agreement will automatically renew for two successive ten-year terms, subject
to the Company&#8217;s right to continue operating at the current Plant site, unless either party terminates the Off-Take Agreement by
written notice to the other party not less than three months prior to the expiration of the term. During a term, the Off-Take Agreement
can only be terminated for (i) abandonment or termination of Project by the Company; (ii) default by the other party; or (iii) in connection
with occurrence of a force majeure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Acquisition of Silver
Fuels Delhi, LLC and White Claw Colorado City, LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On June 15, 2022, we
entered into a Membership Interest Purchase Agreement (the &#8220;MIPA&#8221;), with Jorgan Development, LLC, a Louisiana limited liability
company (&#34;Jorgan&#34;) and JBAH Holdings, LLC, a Texas limited liability company (&#8220;JBAH&#8221; and, together with Jorgan,
the &#8220;Sellers&#8221;), as the equity holders of Silver Fuels Delhi, LLC, a Louisiana limited liability company (&#8220;SFD&#8221;)
and White Claw Colorado City, LLC, a Texas limited liability company (&#8220;WCCC&#8221;) whereby, at closing, which occurred on August
1, 2022, the Company acquired all of the issued and outstanding membership interests in each of SFD and WCCC (the &#8220;Membership Interests&#8221;),
making SFD and WCCC wholly owned subsidiaries of the Company (the &#8220;Silver Fuels and White Claw Acquisition&#8221;). The purchase
price for the Membership Interests was approximately $37.4 million, subject to post-closing adjustments, and was paid by the Company to
the Sellers in a combination of 3,009,552 shares of the Common Stock valued at an aggregate of $4,278,655, (the &#8220;Purchaser Stock
Consideration&#8221;), secured three-year promissory notes in the aggregate principal amount of $28,664,284 (the &#8220;Notes&#8221;),
and the assumption of certain liabilities of SFD and WCCC. The shares of Common Stock comprising the Purchaser Stock Consideration represented
19.99% of the number of issued and outstanding shares of the Company&#8217;s Common Stock immediately prior to issuance and were valued
at the volume-weighted average price for the Company&#8217;s Common Stock on Nasdaq during the five trading days immediately preceding
the closing date. In conjunction with the closing, Sellers entered into lock-up agreements for a period of up to 18 months with regard
to the Purchaser Stock Consideration (the &#8220;Lock-up Agreements&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The MIPA contains customary
representations and warranties, pre- and post-closing covenants of each party and customary closing condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The principal amount
of the Notes, together with any and all accrued and unpaid interest thereon, will be paid to the Sellers on a monthly basis in an amount
equal to the Monthly Free Cash Flow beginning on September 20, 2022, and continuing thereafter on the twentieth (20<span style="font-size: 10pt"><sup>th</sup></span>)
calendar day of each calendar month thereafter, as set forth in the MIPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Without in any way limiting
the foregoing, the then outstanding principal amount of the Notes, together with any and all accrued and unpaid interest thereon, will
be due and payable in full in cash or unrestricted common stock of the Company on or prior to the three-year anniversary of the date of
issuance, as set forth in the MIPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The obligations of the
Company under the MIPA are secured by the membership units of SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The timely and full payment
of any and all principal, interest and other amounts due and owing to the Sellers pursuant to the Notes and the other transaction documents
and the payment of any and all other obligations owed to the Sellers by the Company under the Notes or thereunder are guaranteed solely
by, and to the extent set forth in, the Guaranty Agreements between each of the Sellers and SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">SFD owns and operates
a crude oil gathering, storage, and transportation facility located on approximately 9.3 acres near Delhi, Louisiana. Under existing agreements,
a subsidiary of a large NYSE traded energy company (the &#8220;Purchaser&#8221;) is obligated to purchase blended crude oil from SFD in
amounts up to 60,000 barrels per month. With prior approval, SFD is eligible to sell to the Purchaser amounts greater than 60,000 barrels
of crude oil per month. Additionally, for a period of 10 years, SFD is, under existing crude oil supply agreements with WC Crude, guaranteed
a minimum gross margin of $5.00 per barrel on all quantities of blended crude oil sold thereunder. At present, SFD is blending and selling
approximately 1,400 to 1,700 barrels of blended crude oil on a daily basis. Additionally, the acquisition of SFD would provide the Company
with the infrastructure needed to place a Remediation Processing Machine (&#8220;RPC&#8221;) to clean soil which has been contaminated
by hydrocarbons as well as tank bottom sludge. Management believes SFD&#8217;s location in the heart of the Smackover formation would
provide the Company with access to significant amounts of tank bottom sludge and contaminated soil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">WCCC owns a 120,000
barrel crude oil storage tank, in the heart of the Permian Basin, located near Colorado City, Texas. The storage tank is presently
connected to the Lotus pipeline system and the Company intends to further connect the tank to major pipeline
systems. Under the terms of an existing agreement, WC Crude has agreed to lease the oil storage tank for a period of 10 years. As
with SFD, WCCC would provide the Company with the infrastructure to blend and sell oil which has been recovered via a RPC machine
from tank bottom sludge and contaminated soil which exists in the Permian Basin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This disclosure should be read in connection with,
and is subject to, the MIPA, a copy of which is attached hereto as Exhibit 2.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COVID-19</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 11, 2020, the World Health Organization
(&#8220;WHO&#8221;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the
pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets.
Most U.S. states and many countries have issued policies intended to stop or slow the further spread of the disease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Kuwait operations were suspended to comply
with the social distancing measures implemented in Kuwait. Our Utah operations were temporarily suspended from March through May 2020,
but have since resumed in full. Kuwait has allowed for the Company to obtain site personnel visas to recommence operations. These suspensions
have had a negative impact on our business and there can be no guaranty that we will not need to suspend operations again in the future
as a result of the pandemic.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">COVID-19 and the U.S. response to the pandemic
are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may
have in the long-term, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet
know the full extent of the effects on the economy, the markets we serve, our business, or our operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Results of Operations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion and analysis of our financial condition and
results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this prospectus.
Material changes in our Statement of Operations for the three and six months ended June 30, 2022 and 2021, and for the years ended December
31, 2021 and 2020 are discussed below.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended June 30, 2022 and 2021
we realized revenues of none and $22,000, respectively, representing a decrease of $22,000 or 100%. For the six months ended June 30,
2022 and 2021 we realized revenues of none and $117,000, respectively, representing a decrease of $117,000 or 100%. The decrease in revenue
is primarily attributed to our decision to divert our resources away from our precious metals business that we entered into during COVID-19
mandated shutdowns, and back to its primary remediation business and the manufacturing and site preparations for reopening our Remediation
Processing Centers (RPCs) for remediation and production. For the three and six months ended June 30, 2021, approximately 99% of our revenues
were realized from precious metal sales from our business plan of buying and selling precious metal commodities on the open market during
the COVID-19 pandemic while our remediation operations were shut down or delayed. These precious metals were acquired for immediate resale,
with us acting as intermediary and never keeping an inventory of precious metals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020
we realized revenues of $1,088,428 and $1,457,781, respectively, representing a decrease of $369,353 or 25.34%. The decrease in revenue
is primarily attributed to reopening of our Vernal site for quality control operations for the latter course of 2020 and 2021, thereby
the Company diverted its resources to its primary business of manufacturing an operating RPCs for remediation and preparing our Vernal
site for production. 99% of our revenues were realized from precious metal sales from our business plan of buying and selling precious
metal commodities on the open market during the COVID-19 pandemic while our remediation operations were shut down or delayed. These precious
metals having been acquired for immediate resale, with the Company acting as intermediary and never keeping an inventory of precious metals.
We also realized revenues of $54,250 for the sale to a related party of our precious metal concentrate produced from our own precious
metal extraction operations. We also received a payment of $6,000 pursuant to our Kuwait contract for remediation services as described
above, and we sold $7,735 of extracted test material from our second RPC located in Utah.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cost of Revenue </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cost of revenues consisted primarily of costs
associated with selling our precious metals on the open market and precious metal commodity broker fees.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended June 30, 2022 and 2021
costs of revenue were none and $20,530, respectively, representing a decrease of $20,530 or 100%. For the six months ended June 30, 2022
and 2021 costs of revenue were none and $112,450, respectively, representing a decrease of $112,450 or 100%. The decrease in the cost
of revenue directly relates to costs associated with selling our precious metals on the open market and precious metal commodity broker
fees. As the decrease in revenue is primarily attributed to our decision to divert its resources away from our precious metals business
in 2022 that was entered into during COVID-19 mandated shutdowns, and back to our primary remediation business, and the manufacturing
an site preparations for reopening our RPCs for remediation and production, we did not realize costs of revenue from precious metal sales
from buying and selling precious metal commodities for the three and six months ended June 30, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020
costs of revenue were $1,050,676 and $1,356,378, respectively, representing a decrease of $305,702 or 22.54%. The decrease in the cost
of revenue directly relates to costs associated with selling our precious metals on the open market and precious metal commodity broker
fees. In 2021, the Company diverted its resources to its primary business of manufacturing an operating RPCs for remediation and preparing
our Vernal site for production. The Company realized costs of revenue from precious metal sales from our business plan of buying and selling
precious metal commodities on the open market while our remediation operations were shut down or delayed during the COVID-19 pandemic.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Gross Profit and Gross Margin</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended June 30, 2022 and 2021
we realized gross profit of none and $1,470, respectively, representing a decrease of $1,470 or 100%. For the six months ended June 30,
2022 and 2021 we realized gross profit of none and $4,550, respectively, representing a decrease of $4,550 or 100%. The gross profit decreased
in proportion to the revenue and costs of revenue related to the purchase and sale of precious metals as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020
we realized gross profit of $37,752 and $101,403, respectively, representing a decrease of $63,651 or 62.77%. The gross profit decreased
in proportion to the revenue and costs of revenue related to the purchase and sale of precious metals as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our gross margin will continue to be affected by a variety of factors
that include the market prices of precious metals, the volume hydrocarbons produced by our RPC units, the number of RPC units placed into
production, and our ability to raise capital to continue to fund our operations and RPC unit manufacturing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Operating Expenses</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operating expenses consist primarily of marketing,
general and administrative expenses, bad debt expense, and amortization and depreciation expense. Marketing expenses include marketing
fees of company representatives for marketing the business and is products and services as well as investor customer service. General
and administrative expenses include professional services and legal fees associated with the costs for services in finance, accounting,
administrative activities and the formation and compliance of a public company. Bad debt expense includes the expense associated with
assets that management analyses and estimates may be uncollectible. Amortization and depreciation expense uses the useful life of the
asset to calculate the amortization or depreciation expense in accordance with accounting principles generally accepted in the United
States of America (&#34;GAAP&#34;) and management&#8217;s judgment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended June 30, 2022 and 2021,
we realized operating expenses of $3,600,600 and $1,726,096, which represents an increase of $1,618,766, or 108.60%. For the six months
ended June 30, 2022 and 2021, we realized operating expenses of $5,479,964 and $3,865,748, which represents an increase of $1,618,766,
or 41.92%. The increase in our operating expenses were mainly attributed to accrued signing bonuses and employee stock options that were
issued related to the executive employment agreements entered into in June 2022 after the Company&#8217; successful underwritten public
offering of gross proceeds of $8.0 million and uplist to Nasdaq in February 2022. Whereas prior to the underwritten public offering and
uplist to Nasdaq, the executive employment agreements had no signing bonuses, paid the executives $50,000 per year, and only one executive
had a stock option grant. Although the executives are currently accruing substantial portions of their wages and signing bonuses to assist
the Company, the new employment agreements issued stock options to all executives, increased annual wages for all executives, and the
company paid or accrued signing bonuses of $225,000, For the three months ended June 30, 2022 and 2021, we realized employee stock option
expense of $1,229,175 and $111,528, which represents an increase of $1,121,466, or 1,002.1% increase. For the six months ended June 30,
2022 and 2021, we realized employee stock option expense of $1,321,466 and $200,000, which represents an increase of $1,121,466, or 561%
increase.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
we realized operating expenses of $6,963,668 and $4,949,795, which represents an increase of $2,013,873, or 40.69%. Our operating expenses
increased due to increased professional service expenses in regards to audit, tax, and legal expense in relation to our registration statement,
its amendments, and in preparing for an underwritten public offering of our common stock, including our preparations for an uplist of
our common stock to a senior stock exchange. We also organized and commenced operations of VWFI in the fourth quarter of 2020, which contributed
to the approximately $1.4 million in professional service expense, and operations, for startup and management of that entity in 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Other income and expense</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended June 30, 2022 and 2021,
other expense was $1,627,263 and $9,096,785, which represents a decrease of $7,469,522, or 82.11%. The decrease is mainly attributed to
unrealized loss of $1,652,755 and $8,949,169 on marketable securities, which represents a decrease of $7,296,414, or 81.53% in marketable
securities. For the six months ended June 30, 2022 and 2021, other income (expense) was $(473,134) and $3,435,175, which represents a
decrease of $3,908,309, or 113.77%. The decrease in other income is mainly attributed to unrealized gain (loss) of $(413,189) and 3,734,275
on marketable securities, which represents a decrease of $4,147,464, or 111.06% in marketable securities. These securities were accounted
for at a fair value based on the quoted prices in the active markets and fluctuate based on market prices of the securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
we realized interest income of $3,312 and $35,344, which represents a decrease of $32,032, or 90.63%. The decrease in interest income
is mainly attributed to the conversion of the Odyssey note receivable in September 2020, when we converted $809,578 of our note receivable
with Odyssey into 809,578 shares of Odyssey common stock pursuant to the terms of the note. In August 2021, we also converted $81,768
of our note receivable with Scepter into 26,376,882 shares of Scepter common stock pursuant to the terms of the note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
we realized interest expense of $501,598 and $86,162, which represents an increase of $415,436, or 482.16%. The increase in interest expense
is mainly attributable to the Company entering into loans and notes payable to cover operating expenses during the COVID-19 pandemic throughout
2020 and 2021, and our commencement our VWFI $25,000,000 private placement offering to sell convertible promissory notes, which accrue
interest at 12% per annum, and convert to VWFI LLC units after six months. The proceeds of the VWFI offering are used to manufacture RPCs.
VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A, and commenced fundraising for RPC
Series B. Approximately $487,000 in interest has accrued, which is made up of approximately $398,000 capitalized for the construction
RPCs, and $89,000 of interest expense, all of which is related to the VWFI offering for the year ended December 31, 2021. Throughout 2020,
the Company entered into loans and notes payable to cover operating expenses during the COVID-19 pandemic, which temporarily suspended
our operations in Utah and continues to suspend our operations in Kuwait. Interest of approximately $179,000 and amortized loan discounts
of approximately of $194,000 are attributed to these loans for the year ended December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
the company reported an unrealized loss of $1,094,054, and an unrealized gain $2,614,338 on marketable securities, which represents a
decrease of $3,708,392, or 141.85%. Our marketable securities in Odyssey Group International, Inc. (Ticker: ODYY, OTC Markets) and Scepter
Holdings, Inc. (Ticker: BRZL, OTC Markets) were considered to be traded on an active market and were accounted for at a fair value based
on the quoted prices in the active markets resulting in aggregate unrealized gains as noted above. The increase is also attributed to
the fact that our marketable securities holdings in Scepter Holdings, Inc. were accounted for under the equity method of accounting until
the fourth quarter of 2020 when the Company was diluted to an approximate 19% holding of Scepter on a diluted basis, and thereby these
securities were accounted for at a fair value based on the quoted prices in the active markets, which resulted in the Company recording
an unrealized loss on marketable securities of $1,297,594 and an unrealized gain of $2,670,536 for the years ended December 31, 2021 and
2020. In January 2020, the Odyssey securities were considered to be traded on an active market and were accounted for at a fair value
based on the quoted prices in the active markets. <span style="background-color: white">For the years ended December 31, 2021 and 2020
we </span>recorded an unrealized gain of $203,540 and an unrealized loss of $56,198 on these marketable securities for the years ended
December 31, 2020. In December 2021 we sold such shares of Odyssey in a private transaction for a purchase price of $860,491, reflecting
the market price at that time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
we recorded a gain of $87,044 and a loss of $121,428 on the conversion of notes receivable, which represents an increase of $208,472,
or 171.68%. In August 2021 we converted $81,768 of our note receivable with Scepter into 26,376,882 shares of Scepter common stock pursuant
to the terms of the note at $0.0031 per share. On the date of the conversion, the Scepter price per share on OTC Markets was $0.0062 per
share, which resulted in a $87,044 gain on the disposition of the note receivable. In June 2020 we converted $809,578 of our note receivable
with Odyssey into 809,578 shares of Odyssey common stock pursuant to the terms of the note at $1.00 per share. On the date of the conversion,
the Odyssey price per share on OTC Markets was $0.85 per share, which resulted in a $121,428 loss on the disposition of the note receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Provision for income tax</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recorded an income tax provision of
none and $296,477 for the three months ended June 30, 2022 and 2021, respectively, representing a decrease of $296,477 or 100%. The Company
recorded an income tax provision of $800 and $723,911 for the six months ended June 30, 2022 and 2021, respectively, representing a decrease
of $723,111 or 99.89%. The effective tax rate as of June 30, 2022 and 2021 was (0.04)% and 9.18%. The difference in effective tax rate
was primarily due to the decrease in unrealized gains on marketable securities for the six months ended June 30, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company recorded
an income tax benefit of $1,050,207 and a tax provision of $466,964 for the years ended December 31, 2021 and 2020, respectively. The
Company&#8217;s effective tax rate for 2021 and 2020 was 16.48% and -21.96%, which was the result of the benefit of book losses offset
by an additional valuation allowance on the net operating losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash flows</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the primary sources
and uses of cash and cash equivalents for the six months ended June 30, 2022 and 2021 as presented below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Net cash used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(2,808,793</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(2,053,627</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,067,562</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,384,452</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,587,227</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,656,612</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have historically suffered net losses and cumulative
negative cash flows from operations and, as of June 30, 2022 and 2021, we had an accumulated deficit of approximately $41.2 million and
$30.1 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021, we
had cash and cash equivalents of $5,204,591 and $1,493,719, with $296,257 and $199,952 attributed to variable interest entities, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To date we have financed our operations primarily
through debt financing, private equity offerings and our working interest agreements, although on February 14, 2022, the Company closed
an underwritten public offering of 1,600,000 shares of common stock, at a public offering price of&#160;$5.00&#160;per share, for aggregate
gross proceeds of&#160;$8.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. The Company's
Common Stock began trading on the Nasdaq Capital Market under the symbol &#8220;VIVK&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six months ended June 30, 2022 and 2021,
our net cash used in operating activities was driven by the consolidated net loss of $5,953,898 and 1,149,934, which change is mainly
attributed to unfavorable changes in the market which decreased unrealized gains on marketable securities and the increase in stock-based
compensation as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six months ended June 30, 2022 and 2021,
our net cash used in investing activities was mainly attributed to our purchase of equipment of $1,129,515 and $1,334,123 related to the
manufacturing of our RPCs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six months ended June 30, 2022 and 2021,
our net cash provided by our financing activities was mainly attributed to proceeds of $1,968,261 and $6,666,811 related to the issuance
of convertible bridge notes and other loans, and in 2022, proceeds of $6,240,000 from the February 14, 2022 underwritten public offering
of 1,600,000 shares of common stock. We made distributions to noncontrolling interests of $343,889 and none for the six months ended June
30, 2022 and 2021. We also made payments on notes payable of $277,145 and $2,464 for the six months ended June 30, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no further existing firm obligations;
however we anticipate further construction costs of approximately $1.35 million in connection with our construction in process of our
RPCs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to continue to access capital could
be affected adversely by various factors, including general market and other economic conditions, interest rates, the perception of our
potential future earnings and cash distributions, any unwillingness on the part of lenders to make loans to us and any deterioration in
the financial position of lenders that might make them unable to meet their obligations to us. If we cannot generate or raise capital
through scaled up operations of our sites, or from further public or private debt financings, equity offerings, or other means, our ability
to grow our business may be negatively affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe the liquid assets of the Company give
it adequate working capital to finance our day-to-day operations for at least twelve months through August 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Contractual Obligations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our contractual obligations as of June 30, 2022
are for operating lease liabilities for office and warehouse space, which leases end in 2024 and 2025. Operating lease obligations as
of June 30, 2022 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">180,195</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370,902</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">304,892</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,135</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">872,124</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interest Rate and Market Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financing arrangements are not subject to
variable interest rates of the prime rate or LIBOR.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Inflation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inflation generally will cause suppliers to increase
their rates. In connection with such rate increases, we may or may not be able to increase our pricing to consumers. Inflation could cause
both our investment and cost of revenue to increase, thereby lowering our return on investment and depressing our gross margins.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Off Balance Sheet Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Accounting Policies &amp; Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management&#8217;s Discussion and Analysis of
Financial Condition and Results of Operations is based upon our consolidated financial statements included in this report, which have
been prepared in accordance with GAAP. For further information on the critical accounting policies see Note 3 of the Notes to the Consolidated
Financial Statements. The preparation of these financial statements requires management to make estimates and judgments that affect the
reported amounts of assets, liabilities, sales and expenses, and related disclosure of contingent assets and liabilities. Estimates by
their nature are based on judgments and available information. Our estimates are made based upon historical factors, current circumstances
and the experience and judgment of management. Assumptions and estimates are evaluated on an ongoing basis, and we may employ outside
experts to assist in evaluations. Therefore, actual results could materially differ from those estimates under different assumptions and
conditions. We believe our critical accounting estimates relate to the following: Recoverability of current and noncurrent assets, revenue
recognition, stock-based compensation, income taxes, effective interest rates related to long-term debt, marketable securities, lease
assets and liabilities, equity method investments, valuation of stock used to acquire assets, and derivatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_307"></span>BUSINESS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vivakor, Inc. is a socially responsible operator,
acquirer and developer of clean energy technologies and environmental solutions, primarily focused on soil remediation. We specialize
in the remediation of soil and the extraction of hydrocarbons, such as oil, from properties contaminated by or laden with heavy crude
oil and other hydrocarbon-based substances. Our patented process allows us to successfully recover the hydrocarbons which we believe could
then be used to produce asphaltic cement and/or other petroleum-based products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are focused on the remediation of contaminated
soil and water resulting from either man-made spills or naturally occurring deposits of oil. Our primary focus has been the remediation
of oil spills resulting from the Iraqi invasion of Kuwait and naturally occurring oil sands deposits in the Uinta basin located in Eastern
Utah. We plan to expand into other markets, both in Utah and globally, where we believe our technology and services will provide a distinct
competitive advantage over our competition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current focus is on the clean-up of greater
than 7% hydrocarbon contaminated soil located in Kuwait as a result of the Iraqi invasion, and naturally occurring oil sands deposits
in Utah. We have deployed two RPC units to date including one unit to Kuwait (for which operations were temporarily suspended due to COVID-19)
and another to Vernal, Utah (which is presently operating). We expect to deploy two additional RCPs to Vernal, Utah and believe that there
may be an opportunity to deploy additional RPCs in Utah as well as to Kuwait and the Middle East.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Developments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Off-Take Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 26, 2022, our
subsidiary Vivaventures Energy Group, Inc., entered into a Product Off-Take Agreement (the &#8220;Off-Take Agreement&#8221;), with Hot
Oil Transport, LLC, a Nevada limited liability company (&#8220;HOT&#8221;). Pursuant to the Off-Take Agreement, the Company plans to produce
asphalt that meets the specifications for PG 64-22 grade, as set forth by the Nevada Department of Transportation and the American Association
of State Highway and Transportation Officials (the &#8220;Product&#8221;) from a to-be-scaled processing plant to be located in Uintah
County, Utah, and as may be relocated from time to time by the Company (the &#8220;Plant&#8221;). HOT will be obligated to purchase from
the Company certain quantities of the Product from the Plant once the Plant begins to produce the Product, on the terms and conditions
set forth in the Off-Take Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The quantity of the Product
to be sold and purchased pursuant to this Agreement will be (i) 1,000 tons of the Product per week, or (ii) the entirety of any lesser
amount that may be produced by the Company during any given week. HOT will also have the first right of refusal to purchase all or any
portion of additional Product that may be produced by the Company within the state of Utah upon the same terms and conditions, except
that the purchase price shall be at market rate as determined in the Company&#8217;s sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the Off-Take
Agreement, the rates for the sale and purchase of up to 1,000 tons of Product per week will be determined on the basis of an average 1,000
tons per week, a price per ton using the &#8220;Argus Rockies Rail Low&#8221; price for asphalt in the Rocky Mountain region as set forth
in the most recent edition of <i>Argus Americas Asphalt</i>&#160;report, produced by Argus Media Group, as of the date of delivery (the
&#8220;Unit Price&#8221;). Once calculated, the weekly purchase price will be reduced by $1,500 in order to compensate Buyer for costs
associated with testing, providing storage tanks for Buyer&#8217;s minimum quantity purchases, and certifying the quality of the Product,
for so long as Buyer is providing the testing facilities for the Product. As noted above, the purchase price for any Product over 1,000
tons per week will be at market rate, as determined by the Company. In the event the Unit Price drops below $250, the Company will have
the right to suspend production of the Product upon written notice to HOT.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Off-Take Agreement
provides for an initial term of ten years. The Off-Take Agreement will automatically renew for two successive ten-year terms, subject
to the Company&#8217;s right to continue operating at the current Plant site, unless either party terminates the Off-Take Agreement by
written notice to the other party not less than three months prior to the expiration of the term. During a term, the Off-Take Agreement
can only be terminated for (i) abandonment or termination of Project by the Company; (ii) default by the other party; or (iii) in connection
with occurrence of a force majeure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Acquisition of Silver
Fuels Delhi, LLC and White Claw Colorado City, LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1, 2022, the Company, Jorgan Development,
LLC, a Louisiana limited liability company (&#34;Jorgan&#34;) and JBAH Holdings, LLC, a Texas limited liability company (&#34;JBAH&#34;
and, together with Jorgan, the &#34;Sellers&#34;), as the equity holders of Silver Fuels Delhi, LLC, a Louisiana limited liability company
(&#34;SFD&#34;) and White Claw Colorado City, LLC, a Texas limited liability company (&#34;WCCC&#34; ) closed under the Membership
Interest Purchase Agreement among them dated June 15, 2022 (the &#8220;MIPA&#8221;). In accordance with the terms of the MIPA, the Company
acquired all of the issued and outstanding membership interests in each of SFD and WCCC (the &#8220;Membership Interests&#8221;), making
SFD and WCCC wholly owned subsidiaries of the Company. The purchase price for the Membership Interests was approximately $37.4 million,
subject to post-closing adjustments, and was paid by the Company to the Sellers in a combination of 3,009,552 shares of Common Stock valued
at an aggregate of $4,278,655, (the &#34;Purchaser Stock Consideration&#34;), secured three-year promissory notes in the aggregate principal
amount of $28,664,284 (the &#8220;Notes&#8221;), and the assumption of certain liabilities of SFD and WCCC. The Common Stock comprising
the Purchaser Stock Consideration represented 19.99% of the number of issued and outstanding shares of the Company&#8217;s Common Stock
immediately prior to issuance and were valued at the volume-weighted average price for the Company&#8217;s Common Stock on Nasdaq during
the five trading days immediately preceding the closing date. In conjunction with the closing, Sellers entered into lock-up agreements
for a period of up to 18 months with regard to the Purchaser Stock Consideration (the &#8220;Lock-up Agreements&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: normal">The purchase
price was based on the assumption that the net working capital of SFD and WCCC, in the aggregate and as of closing would be equal to One
Hundred Fifty Thousand and No/100s United States Dollars ($150,000.00 USD) (the &#34;Target Working Capital Amount&#34;). If the aggregate
net working capital of SFD and WCCC turns out to be lower than the Target Working Capital Amount (a &#8220;Working Capital Deficit&#8221;)
the purchase price will be decreased by an amount equal to the Working Capital Deficit. If the aggregate net working capital of SFD and
WCCC turns out to be higher than the Target Working Capital Amount (a &#8220;Working Capital Surplus&#8221;) then the then the purchase
price will be increased by an amount equal to the Working Capital Surplus. The amount of any Working Capital Deficit will be payable by
Sellers to the Company by reducing the aggregate principal amount of the Notes and the amount of any Working Capital Surplus will be payable
by the Company to Sellers by increasing the aggregate principal amount of the Notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the MIPA, the Company has committed to make
the Threshold Payment Amount to Sellers on or before the 18-month anniversary of the closing date. &#34;Threshold Payment Amount&#34;
means an amount remitted to Sellers, collectively, equal to Sixteen Million Four Hundred Seventy-One Thousand Four Hundred Sixty -Nine
and 50/100s U.S. Dollars ($16,471,469.50), solely and exclusively as the sum of (a) any payments of principal to Sellers under the Notes,
whether in cash or unrestricted common stock, and (b) the value of any other unrestricted common stock issued to Sellers, including any
Purchaser Stock Consideration which may become unrestricted common stock. The Threshold Payment is subject to adjustment in connection
with any working capital or similar adjustments to the purchase price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: normal">Notwithstanding
any provision to the contrary contained in the MIPA or any other transaction document, prior to Sellers' receipt of the Threshold Payment
Amount, upon a Seller exercising its rights pursuant to a Pledge Agreement among the Company and the Seller in accordance with its terms,
the Company and the Sellers have agreed that the sole and exclusive remedy of the parties will be to unwind the MIPA transaction (the
&#8220;Unwinding&#8221;). In any such Unwinding, the Membership Interests will be transferred to Sellers and Sellers will assign and transfer
to the Company, the number of shares of common stock of the Company constituting the Purchaser Stock Consideration and any other amounts
(the &#8220;Pre-Payment Amounts&#8221;) paid to Sellers by the Company above and beyond the monthly amounts required to be paid to Sellers
under the Notes. Any such Pre-Payment Amounts shall be returned to the Company (i) in cash, if originally remitted to Sellers in cash,
(ii) in Company common stock, if originally remitted to Sellers in Company common stock, or (iii) to the extent Company common stock was
originally remitted to Sellers, but such stock was sold, margined, or hypothecated by Sellers, in cash at the value attributed to such
Purchaser Common Stock at the time of its issuance or transfer to Sellers. Notwithstanding the foregoing, subsequent to the receipt of
the Threshold Payment Amount, no Seller shall have any right to initiate an Unwinding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the MIPA closing, the Company
agreed to file registration statement, of which this prospectus is a part, for the resale of the shares of Common Stock issued to the
Sellers within 45 days of such closing and to use its best efforts to have the registration statement declared effective as soon thereafter
as is practical.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The MIPA contains customary representations and
warranties, pre- and post-closing covenants of each party and customary closing condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal amount of the Notes, together with
any and all accrued and unpaid interest thereon, will be paid to the Sellers on a monthly basis in an amount equal to the Monthly Free
Cash Flow beginning September 20, 2022, and continuing thereafter on the twentieth (20<sup>th</sup>) calendar day of each calendar month
thereafter. Monthly Free Cash Flow means, for any calendar month, an amount equal to the cash proceeds received by SFD and WCCC from the
product of (a) the sum of (i) SFD&#8217;s and WCCC&#8217;s gross revenue (including service revenue, rents, inventory sales and any other
revenues agreed upon in writing by the Company and the Sellers ), in each case determined in accordance with GAAP and derived from SFD&#8217;s
and WCCC&#8217;s monthly unaudited financial statements prepared in the ordinary course of business, <span style="text-decoration: underline">minus</span> (ii) SFD&#8217;s and
WCCC&#8217;s operating expenses (excluding all interest expense, amortization, and depreciation), selling, general and administrative
expenses, capital expenditures (including, but not limited to, maintenance capital expenditures and expenditures for personal protective
equipment, additions to the land/current facilities and pipeline connections) and costs of goods sold, in each case determined in accordance
with GAAP and derived from SFD&#8217;s and WCCC&#8217;s monthly unaudited financial statements prepared in the ordinary course of business,
<span style="text-decoration: underline">plus</span> (iii) the net proceeds of any dispositions of property, plant, equipment or other assets of SFD and WCCC, in each case determined
in accordance with GAAP and derived from SFD&#8217;s and WCCC&#8217;s monthly unaudited financial statements prepared in the ordinary
course of business, <span style="text-decoration: underline">minus</span> (iv) any payments on capital lease obligations of SFD and WCCC, in each case determined in accordance
with GAAP and derived from SFD&#8217;s and WCCC&#8217;s monthly unaudited financial statements prepared in the ordinary course of business,
and <span style="text-decoration: underline">minus</span> (v) any extraordinary expenses incurred by SFD and WCCC (or by the Company for the benefit of SFD and WCCC) that are
approved in writing by the Sellers, <span style="text-decoration: underline">multiplied by</span> (b) ninety-nine percent (99%) in the case of Jorgan and one percent (1%) in the
case of JBAH; provided, however, that the Monthly Free Cash Flow will be calculated so as to eliminate the effect of: (A) premiums and
other payments in excess of principal and accrued interest associated with the retirement of debt (including, without limitation, payments
of income taxes incurred in connection therewith); and (B) tax payments or benefits associated with gains or losses on business divestitures
in calculating net cash from operating activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Without in any way limiting the foregoing, the
then outstanding principal amount of the Notes, together with any and all accrued and unpaid interest thereon, will be due and payable
in full in cash or unrestricted common stock of the Company on or prior to the three-year anniversary of the date of issuance. Subject
to the limitations set forth below, the Company will have the right, but not the obligation, to make payments of principal and interest
under the Notes on any payment date via physical delivery to the Sellers of shares of the Company&#8217;s unrestricted common stock. Any
unrestricted common stock delivered to the Sellers will be valued at the volume weighted average price of the Company&#8217;s common stock
on Nasdaq (or the Company&#8217;s then principal trading market) during the five (5) trading days immediately preceding the applicable
payment date. Notwithstanding the foregoing, (i) the Company may not issue any shares of unrestricted common stock to the Sellers without
first complying with the provisions of Nasdaq Rule 5635(d), (ii) with respect to any payment of Monthly Free Cash Flow, no more than fifty
percent (50%) of the amount of such Monthly Free Cash Flow may be paid to the Sellers via delivery of unrestricted common stock without
the prior written approval of the Sellers and (iii) no more than fifty percent (50%) of the original principal amount of each of the Notes
may be paid to the Sellers via delivery of unrestricted common stock without the prior written approval of the Sellers. Each payment of
Monthly Cash Flow pursuant to the Notes (whether in cash, shares of the Company&#8217;s unrestricted common stock or any combination of
the foregoing) shall be applied to the payment of the obligations of the Company under the Notes as follows: (i) first, to the payment
of any costs, expenses or other amounts (other than principal and interest) owed to the Sellers thereunder; (ii) second, to the payment
of any and all accrued and unpaid interest; and (iii) thereafter, to the payment of the then outstanding principal amount of the Notes.
Subject to the limitations set forth above, the Company may pre-pay the Notes, in whole or in part, in cash or unrestricted common stock
without penalty or premium at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Until such time as the Sellers have received the
indefeasible payment in full of the Threshold Payment Amount, the timely and full payment of any and all principal, interest and other
amounts due and owing to the Sellers pursuant to the Notes and the other transaction documents and the payment of any and all other obligations
owed to the Sellers by the Company under the Notes or thereunder shall be secured solely by, and to the extent set forth in, the Pledge
Agreements between the Company and each of Jorgan and JBAH. The Pledge Agreements will terminate upon the earliest to occur of (A) the
indefeasible payment in full of all of the Company&#8217;s obligations under the Notes and the Pledge Agreements, (B) the indefeasible
payment in full to Jorgan and JBAH of the Threshold Payment Amount or (C) following the occurrence and continuance of an event of default
thereunder or under the Notes and the exercise by Jorgan and JBAH of their right to effect a transfer of the collateral pursuant to the
terms thereof, the execution and/or delivery of the pledged materials by the Company to Jorgan and JBAH in accordance with the Pledge
Agreements and the MIPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The timely and full payment of any and all principal,
interest and other amounts due and owing to the Sellers pursuant to the Notes and the other transaction documents and the payment of any
and all other obligations owed to the Sellers by the Company under the Notes or thereunder are guaranteed solely by, and to the extent
set forth in, the Guaranty Agreements between each of the Sellers and SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conjunction with the August 1, 2022 closing
under the MIPA, SFD, WCCC and the Company entered into a Shared Services Agreement with Endeavor Crude, LLC, a Texas limited liability
company affiliated with the Sellers (&#8220;Endeavor&#8221;), under which Endeavor is providing certain operating and administrative services
to SFD and WCCC. The Shared Services Agreement has a term ending on the earlier of (a) December 31, 2031, (b) an event of default under
the Shared Services Agreement, (c) termination at the sole discretion of SFD and WCCC upon thirty (30) days prior written notice to Endeavor,
or (d) a change in control of SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conjunction with the August 1, 2022 closing
under the MIPA, SFD, WCCC and the Company (collectively, the &#8220;Buyer Group&#8221;) entered into a Master Netting Agreement (the &#8220;Netting
Agreement&#8221;) with Jorgan, JBAH, Endeavor and White Claw Crude, LLC (collectively, the &#8220;Seller Group&#8221;) under which all
amounts owed to the Seller Group by the Buyer Group as a result of all Contracts during a given calendar month (the &#34;Aggregate Amount(s)
Owed Seller Group&#34;) shall be netted against all amounts owed to Buyer Group by Seller Group as a result of all Contracts during the
same calendar month (the &#34;Aggregate Amount(s) Owed Buyer Group&#34;), and the resulting net amount (the &#34;Net Settlement Amount&#34;)
shall be payable either from Seller Group to Buyer Group (if the Aggregate Amount Owed Buyer Group exceeds the Aggregate Amount Owed Seller
Group) or from Buyer Group to Seller Group (if the Aggregate Amount Owed Seller Group exceeds the Aggregate Amount Owed Buyer Group).
For purposes of the foregoing, Contracts means the MIPA, the Notes, the Pledge Agreements, the Shared Services Agreement, the Crude Petroleum
Supply Agreement dated January 1, 2021, by and between White Claw Crude, LLC, and SFD, as amended, and the Oil Storage Agreement dated
January 1, 2021, by and between White Claw Crude, LLC, as Shipper, and WCCC, as Operator, as amended. The Net Settlement Amount shall
be paid by the owing Group to the other Group by wire transfer on or before the 20th day of the month succeeding the invoiced month. The
Netting Agreement will remain in effect until the earlier to occur of (a) an event of default under the Netting Agreement (subject to
the discretion of the non-defaulting Group), or (b) the termination of all the Contracts pursuant to their terms and provision, or (c)
termination by mutual agreement of the parties; provided, however, that any such termination will not cancel the netting arrangement provided
for therein with respect to obligations or transactions which arise prior to the termination date, unless otherwise agreed to in writing
by the parties; provided further, that such termination of the Netting Agreement shall not affect the continuing validity or enforcement
of obligations owed under the Contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January 1, 2021, WCC, in the capacity
of operator, entered into an Oil Storage Agreement with White Claw Crude, LLC ( &#8220;WC Crude&#8221;), in the capacity of shipper, under
which WC Crude has the right, subject to the payment of service and maintenance fees, to store volumes of crude oil and other liquid hydrcarbons
at a certain crude oil and liquid hydrocarbon receipt, storage, blending, throughput and delivery terminal operated by WCCC. Subject to
possible termination upon an event of default, the Oil Storage Agreement expires on December 31, 2031.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January 1, 2021, SFD entered into a
Crude Petroleum Supply Agreement with WC Crude (the &#8220;Supply Agreement&#8221;) under which WC Crude supplies volumes of Crude Petroleum
to SFD. Crude Petroleum means merchantable crude oil, condensate, natural gas liquids, and constituent liquid hydrocarbons acceptable
to SFD, which may be blended by WC Crude from time to time in WC Crude&#8217;s reasonable discretion. WC Crude and SFD will be entering
into a First Amendment to the Supply Agreement in conjunction with the closing under the MIPA. The Supply Agreement, as amended, will
provide for the delivery to SFD of a minimum of 1,000 Sourced Barrels per day. Sourced Barrels means barrels purchased directly from WC
Crude (&#8220;White Claw Barrels&#8221;) or from third parties (the &#8220;Sourced Parties&#8221;) sourced through WC Crude (&#8220;Third
Party Barrels&#8221;). In the event that the price at which SFD resells White Claw Barrels or Third Party Barrels, as applicable, to third
parties (the &#8220;Third Party Sales Price&#8221;) minus the per barrel cost paid by SFD when purchasing barrels from WC Crude or Sourced
Parties (the&#160;&#34;SFD Margin&#34;) is positive, but less than $5.00&#160;per barrel<i>,</i>&#160;WC Crude will pay SFD $5.00 minus
the SFD Margin, which amount will be multiplied by the number of barrels associated with the sale. In the event the SFD Margin is positive,
but greater&#160;than $5.00 per barrel, SFD will pay White Claw a profit sharing payment in the amount equal to 10% of the SFD Margin
minus $5.00 per barrel, which amount will be multiplied by the number of barrels associated with the sale. In the event the SFD Margin
is negative,&#160;WC Crude will pay SFD the sum of the SFD Margin plus $5.00, which amount will be multiplied by the number of barrels
associated with the sale.. For purposes of the foregoing calculation, the SFD Margin shall be treated as a positive number .If the average
Sourced Barrels delivered per month is less than 1,000 Sourced Barrels per day, then WC Crude will pay SFD $5.00 per barrel of the deficient
quantity multiplied by the number of days in the applicable month .Subject to earlier termination in connection with an event of default,
the Supply Agreement, as amended, will remain in effect through and including December 31, 2031.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">SFD owns and operates
a crude oil gathering, storage, and transportation facility located on approximately 9.3 acres near Delhi, Louisiana. Under existing agreements,
a subsidiary of a large NYSE traded energy company (the &#8220;Purchaser&#8221;) is obligated to purchase blended crude oil from SFD in
amounts up to 60,000 barrels per month. With prior approval, SFD is eligible to sell to the Purchaser amounts greater than 60,000 barrels
of crude oil per month. Additionally, for a period of 10 years, SFD is, under existing crude oil supply agreements with WC Crude, guaranteed
a minimum gross margin of $5.00 per barrel on all quantities of blended crude oil sold thereunder. At present, SFD is blending and selling
approximately 1,400 to 1,700 barrels of blended crude oil on a daily basis. Additionally, the acquisition of SFD would provide the Company
with the infrastructure needed to place a Remediation Processing Machine (&#8220;RPC&#8221;) to clean soil which has been contaminated
by hydrocarbons as well as tank bottom sludge. Management believes SFD&#8217;s location in the heart of the Smackover formation would
provide the Company with access to significant amounts of tank bottom sludge and contaminated soil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">WCCC owns a 120,000
barrel crude oil storage tank, in the heart of the Permian Basin, located near Colorado City, Texas. The storage tank is presently
connected to the Lotus pipeline system and the Company intends to further connect the tank to major pipeline
systems. Under the terms of an existing agreement, WC Crude has agreed to lease the oil storage tank for a period of 10 years. As
with SFD, WCCC would provide the Company with the infrastructure to blend and sell oil which has been recovered via a RPC machine
from tank bottom sludge and contaminated soil which exists in the Permian Basin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This disclosure should be read in connection
with, and is subject to, the MIPA, a copy of which is attached hereto as Exhibit 2.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Technologies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own and/or license a number of technologies
that allow us to effectively operate our remediation and recovery business along with other technologies that provide synergies with our
core business. The description of these various technologies follows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Hydrocarbon Extraction Technology</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2015, we acquired and improved technology aimed
at remediating contaminated soil and recovering usable hydrocarbons, which we refer to as RPCs. We presently have two US patents and pending
foreign applications related to our RPCs. Our RPCs each have the potential to clean a minimum of 20 tons of contaminated material per
hour, depending on the oil contamination percentage in the processed material. Each RPC has the capacity to extract on a 24-hour operation
500 tons or more of contaminated material per day. The amount of extracted hydrocarbon recovered depends on the extent to which the material
is contaminated. For example, we estimate that for every 480 tons of contaminated material processed per day that contains at least 10%
oil, we will recover approximately 250 barrels of extracted hydrocarbons. The above example has been calculated as follows: contaminated
material that is 10% oil is comprised of 200 pounds of oil per ton; one gallon of oil weighs 8.44 pounds, resulting in 23.69 gallons of
oil per ton of contaminated material (200/8.44); there are 42 gallons per barrel, resulting in 0.56 barrels of oil per ton of contaminated
material (23.69/42); 20 tons of contaminated material can typically be processed per hour, resulting in 11.2 barrels of oil per hour (0.56*20);
and operations continue 24 hours per day, resulting in 268.8 barrels per day (11.2*24).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We believe our RPCs are
significantly more advanced than other oil remediation technologies or offerings presently available on the market. Our RPCs have successfully
cleaned contaminated soil containing greater than 7% hydrocarbon content, while, to our knowledge, our competitors are limited to projects
containing less than 5% hydrocarbon contamination. We believe our ability to clean soil with higher percentages of hydrocarbon contamination
is a distinctive advantage that will allow us to operate on a global basis in any location that has suffered from oil spills or naturally
occurring oil sands deposits. While our primary focus and mandate will be on the manufacture and deployment of our RPCs, we intend to
continue to develop, acquire or license additional clean energy technologies and environmental solutions that will directly enhance and
expand our current technologies and service offerings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We have designed our
RPCs to provide an environmentally friendly solution to the remediation of hydrocarbon-contaminated soil, as they do not utilize water.
Our RPCs operate by loading contaminated soil onto a feeder and conveyor system that effectively delivers the material prepares the material
into a fully contained, closed-loop system. Physical separation of the hydrocarbons from the contaminated soil does not utilize water
or steam and is instead accomplished using a proprietary extraction fluid to dissolve the hydrocarbon components.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the first stage of the process, hydrocarbon
contaminated soil is mixed with our proprietary solvent which forms a slurry of sand, hydrocarbon and extraction fluid. This slurry moves
from the mixing chamber into a separation chamber where the sand is separated from the hydrocarbon/extraction fluid mix by gravity. The
soil is then dried and transported via a conveyer to a lined pit where extensive testing is performed to ensure the hydrocarbons have
been properly removed. Meanwhile, the extracted hydrocarbon and solvent travels to a separate chamber where the hydrocarbons are separated
from the extraction solvent. The solvent is then reclaimed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The entire extraction process is completed in
a series of sealed chambers. The reclaimed extraction fluid is then recycled back into the process, which ensures that no toxic chemicals
are released into the soil or the environment. Upon completion of our remediation and separation process, the extracted hydrocarbons are
placed into holding tanks to be picked up by our customers, while clean soil is returned to the environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our RPCs are manufactured in Denver, Colorado.
In the future, we expect to finance our RPCs through special purpose vehicles pursuant to 5-year sale/leaseback arrangements. In each
instance, the special purpose vehicle will finance the RPC through third party investors, and we will act as the manager of such special
purpose vehicle and we may hold an approximate 1% ownership interest. Management believes that utilizing this structure provides significant
benefits to our shareholders, as these financings are less dilutive in nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Automation and Machine Learning</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The RPC systems we build are automated and controlled
by software enabling us to maximize efficiencies. We believe that these automations may ultimately allow us to operate the RPCs twenty-four
hours a day, resulting in continuous feed capabilities that will allow us to manage our systems remotely world-wide. Each RPC unit is
designed with a focus on automation to achieve our Key Performance Indicators (KPIs). We have deployed data analytics and machine learning,
to enable operations to be predictive, reduce risk, improve safety, and reduce costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Metallic Separation Technology</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2015, we obtained two metal extraction systems
and a perpetual license to use the proprietary technology and machinery for extracting precious metals from sand-based ore materials for
$7.6 million from Vivaventures Precious Metals, LLC (&#8220;VV Precious Metals&#8221;), pursuant to our loan outstanding to VV Precious
Metals being extinguished. We also received a 75% ownership interest in the concentrated unrefined flakes of precious metals and rare
earth minerals that had already been recovered from soils by VV Precious Metals through a royalty agreement. We divested our 39% interest
in VV Precious Metals in July 2020. Such divestiture has had a de minimis impact on our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our proprietary metallic separation technology
uses a thermal vapor process to extract and process micro particles of precious metals and rare earth minerals, including gold, silver,
platinum, palladium and rhodium from soils. After we complete our soil remediation services, we evaluate the post-remediated soil and,
if we find that the soil contains more than 1% concentration of these metals, we process it through this technology to extract and concentrate
these micro particles of precious metals and rare earth minerals into a concentrated, unrefined flake form.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If contracted to do so, our metal extraction systems
allows us to provide precious metal extraction services on a service fee basis for customers. We also market and sell the precious metals
we have extracted from our own contaminated soil. As we continue our efforts, we anticipate increased opportunities to monetize our precious
metals end product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Hydrocarbon Upgrading Technologies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acquired and/or licensed two separate
technologies described below that will enable us to upgrade the hydrocarbons recovered from our remediation process. These processes have
been proven in laboratory tests, but we have not yet performed this upgrading in a commercial setting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 30, 2020, we entered into an Intellectual
Property License Agreement (&#8220;BGreen License Agreement&#8221;)with BGreen, LLC (&#8220;BGreen&#8221;), pursuant to which we have
been granted a worldwide, exclusive, non-transferable license to the intellectual property embodied in BGreen&#8217;s cavitation technology
to develop, manufacture, have manufactured, use market, import, have imported, offer for sale and sell cavitation devices built from the
licensed intellectual property. The BGreen License Agreement also grants us the first right of refusal to purchase all devices and all
intellectual property associated with the cavitation technology. The BGreen License Agreement extends for the lifetime of the Intellectual
Property. In 2021 we made an initial payment of $5,000 after delivery of the first simple cavitation device. The Company may use these
devices in its own operations or it may sell them to third parties. Upon sale of a cavitation device to a third party we will be obligated
to pay 50% of the net profits to the BGreen. Additionally, under the terms of the BGreen License Agreement, at such time as we successfully
improve and manufacture a cavitation device with a processing rate equal to, or greater than, 30 barrels per hour, we will be required
to issue 33,333 shares of our common stock to BGreen. Third party, independent testing conducted by the University of Utah has shown that
this proprietary technology increases the API gravity of hydrocarbons by elongating the hydrocarbon chains without cutting or cracking
these chains.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in 2017, we acquired from CSS Nanotech
an exclusive right to use their nano-sponge technology for $2,416,572 in Series C Preferred Stock, which has since converted to common
stock. The technology essentially serves as a micro-upgrader, transforming hydrocarbon product into a more useful product, such as petroleum
or gasoline, as an addition to our hydrocarbon extraction technology. The inventor of this technology subsequently joined us as our Chief
Scientific Officer. This patented technology allows for hydrocarbon material to be absorbed by a specialized sponge. Low energy microwaves
are then introduced into the process and the sponge, which is made of a highly thermally conductive material, absorbs this energy causing
an instant thermal effect, which essentially refines the crude by cutting or cracking the carbon chains. We intend to add this system
to our process of upgrading the heavy crude recovered by our RPCs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that each of these technologies has
the ability to upgrade the heavy crude that is recovered from our recovery and remediation process based on our needs and demand, and
we intend to fully integrate these technologies into our process. For example, if there is a high demand for fuels we would process the
extracted crude through the nano-sponge technology to refine and upgrade the product into diesel fuel. If the demand is instead for certain
types of asphaltic cement, where the heavy crude is not refined but processed, we would utilize the CHU technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Market Opportunity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the market for remediating oil
from both soil and water is significant. According to Grandview Research, the market for environmental clean-up of oil spills will reach
$177 billion by 2025. We believe that a large portion of that market will originate from contamination of more than 7% hydrocarbon content
and that our technology is currently the only one that can economically remediate these environmental disasters, while allowing for the
capture and reuse of the crude.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we believe that the heavy crude that
we have been recovering in Utah is ideal for producing asphaltic cement. The demand for asphaltic cement in the United States is presently
estimated to be $93 billion this year according to Transparency Market Research. We provided our material to asphalt companies for testing
to determine what modifications, if any, needed to be made to meet general asphalt specifications. We recently received notification that
our asphaltic cement now meets the general classification of AC20 asphaltic cement and that it passed the specifications of several potential
clients. We are expecting several orders in the near term and we believe that we will be able to offer our product at very competitive
prices and in an environmentally friendly manner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Revenue</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Remediation Processing Centers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We presently have two projects utilizing our first
two manufactured RPCs - our project in Kuwait (which was temporarily suspended due to COVID-19) and our project in Vernal, Utah (which
is currently operating).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In Kuwait, pursuant to an agreement with Al Dali
International Co., a company organized under the laws of Kuwait (&#8220;DIC&#8221;), we will receive $50,000 for the successful remediation
of the first 100 tons ($500 per ton) under its subcontractor services for the Kuwait Oil Company (&#8220;KOC&#8221;) Remediation Contract.
In addition, we will receive $20 per treated ton of soil after the initial 100 tons. The treatment process using the RPC plants is anticipated
to generate a bitumen sub-product. We have agreed with DIC to sell this sub-product and share the net profits equally (50% to the us and
50% to DIC), after allocating 30% of the net profits to DIC in the form of a sales and marketing payment, which will be invoiced on a
monthly basis, in accordance with the Agreement. Pursuant to the Agreement, we will have a stockpile of at least 444,311 tons with at
least 5% oil contamination for us to remediate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our RPC situated in Vernal, Utah has the capacity
to process 500 tons or more of naturally occurring oil sands deposits per day. We estimate that if the extracted material is composed
of at least 10% oil, we will recover approximately 250 barrels of extracted hydrocarbons each day, which could then be sold for energy
or converted to asphaltic cement and sold for use in roads at higher prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide precious metal extraction services
on a service fee basis for customers. We also market and sell the precious metals we have extracted from our own soils. As we continue
our efforts, we anticipate increased opportunities to monetize our precious metals end product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Kuwait Project</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The United Nations (UN) had allocated up to $14.7
billion for post-Iraq war reparations in order to clean up Kuwait. Kuwait suffered extensive contamination as a result of the 1991 Persian
Gulf War. At the close of the Gulf War, Saddam Hussein ordered Kuwaiti oil wells to be blown up, resulting in the destruction of approximately
600 oil wells. The damage resulting from such fires, which burned for seven months, included a layer of hardened &#8220;tarcrete,&#8221;
caused by the sand and gravel on the land's surface combining with oil and soot, forming over almost 5% of the country's area.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We were engaged by a subcontractor, DIC, which
is approved by KOC for the Kuwait Environmental Remediation Program (&#8220;KERP&#8221;) project.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our technology has been successful in reducing
the amount of contaminated material in Kuwait from 20% hydrocarbon contamination to just 0.2% hydrocarbon contamination, based on third
party independent testing performed by ALS Arabia in March 2020. We believe we possess the only technology that has been successful at
remediating such highly contaminated soil (defined as anything above 20% hydrocarbon contamination), while also returning usable hydrocarbons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The KERP project is anticipated to involve approximately
26 million cubic meters of contaminated oil sands requiring remediation. We expect that as much as 20% of the contaminated soil will contain
more than 5% hydrocarbon contamination. Our agreement with DIC is for cleanup of a portion of the KERP project.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The oil recovered from these projects in Kuwait
is considered a sovereign asset, so the ability to reclaim this asset also creates a social value for the country. In order to remediate
all of the contaminated sand exhibiting greater than 7% contamination in the timeframe required by the UN, the Company anticipates obtaining
further agreements through KOC to expand its service contract to deploy 10 RPC units to Kuwait over the next several years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 14, 2021, we, together with our subsidiary,
Vivaventures Energy Group, Inc., entered into a Services Agreement (the &#8220;Services Agreement&#8221;) with Al Dali International Co.,
a company organized under the laws of Kuwait (&#8220;DIC&#8221;). The Government of Kuwait and the United Nations, acting through the
Kuwait Oil Company (&#8220;KOC&#8221;) has awarded to Enshaat Al Sayer rights to remediate contaminated soil under the Kuwait Remediation
Program pursuant to the South Kuwait Excavation, Transportation and Remediation Project (&#8220;KOC Remediation Contract&#8221;). To fulfill
its role, Enshaat Al Sayer has engaged the Company, through the Company&#8217;s agreement with DIC, to perform contaminated soil treatment
for the KOC Remediation Contract using the Company&#8217;s patented technology for extracting hydrocarbons, through the Company&#8217;s
Remediation Processing Center (&#8220;RPC&#8221;) plants. The Services Agreement is subject to DIC and Enshaat Al Sayer entering into
a subcontractor agreement and the Company has received a notice letter from such parties, which confirms that such subcontractor agreement
has been entered into and is in full force and effect. Such subcontractor agreement is subject to termination upon terms substantially
similar to those set forth in the Services Agreement, specifically, providing for a 42-month term with termination upon (i) written consent
of both parties; (ii) bankruptcy, dissolution or similar event; (iii) for material breach that is not cured within 60 days&#8217; notice
thereof (other than non-payment, which is not subject to a cure period); and (iv) non-approval of total optimized study including the
bench scale study and pilot plant commissioning results by KOC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Services Agreement, the Company
and DIC will work together in performing remediation treatment services as subcontractors to Enshaat Al Sayer for the KOC Remediation
Contract. Under the Agreement, the Company will supply one pilot RPC plant already located in Kuwait, one 40-ton per hour RPC plant, and
one technical expert to oversee the hydrocarbons contaminated soil treatment service operations pertaining to this contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will receive $50,000 for the successful
remediation of the first 100 tons ($500 per ton) under its subcontractor services for the KOC Remediation Contract. In addition, the Company
will receive $20 per treated ton of soil after the initial 100 tons. The treatment process using the RPC plants is anticipated to generate
a bitumen sub-product. The Company and DIC have agreed to sell this sub-product and share the net profits equally (50% to the Company
and 50% to DIC), after allocating 30% of the net profits to DIC in the form of a sales and marketing payment, which will be invoiced on
a monthly basis, in accordance with the Agreement. Pursuant to the Agreement, we will have a stockpile of at least 444,311 tons with at
least 5% oil contamination for us to remediate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Agreement, we will provide our
pilot RPC plant (already in Kuwait) within two to four months after retrofitting, and within one year of certain contract milestones,
including the successful testing of the first 100 tons, we will provide a RPC plant capable of processing 40 tons of soil per hour. We
will bear the cost of the related manufacturing, deployment, break-down and spare parts of the RPCs. The RPC plant remediation services
must reduce TPH contamination to less than 1%. DIC will provide all other costs for bonds, infrastructure, and operations of the plant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other International Projects</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to managing the projects in Kuwait,
the UN is overseeing the funds allocated to the remediation and clean-up of the Ogoni Lands in Africa, which is estimated to contain millions
of tons of both contaminated soil and water and has allocated significant funding for its cleanup. Taking into consideration this particular
environmental disaster, plus other global oil contamination projects involving oversight by the UN, together with our successful testing
on the UN-managed SEED Project in Kuwait and our recent agreement with DIC, we believe we will be a contender for significant additional
contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Vernal, Utah Project</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The State of Utah has,
according to the U.S. Geological Survey, approximately 14 billion barrels of measured oil in place with an additional estimated 23
to 28 billion barrels of oil contained in contaminated oil sands that are deposited near the ground surface. We believe that the
crude from these oil sands can be turned into asphaltic cement for making roads, or upgraded for polymers or fuel. Vernal is the
county seat, and largest city in Uintah County, located in northeastern Utah, approximately 175 miles east of Salt Lake City, and 20
miles west of the Colorado border. In June 2021, we entered into an agreement with the owner of such parcel of land that permitted
us to continue to operate on the land on a month-to-month basis. In March 2022, we entered into a land lease with the land owner for
a five year term, with an optional 5 year extension, allowing us to process up to 2,000 tons per day of oil sand material, with a
guarantee by the land owner to deliver material with a minimum of 10% hydrocarbon by weight, which would produce up to 200 tons of
asphalt cement product per day when processed through four of our patented RPCs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Vernal property contains approximately 100
million cubic yards of oil sand material available for processing. The property is located on approximately 600 acres. We believe that
we could ultimately recover as much as 40 million barrels of oil from this property as a whole if we are able to economically scale our
operations and obtain further land leases from the land owner. We believe, based on the number of estimated barrels of oil contained in
oil sands deposits located on SITLA property, that if the State of Utah would allow us to process the oil sand material on these properties
over the next thirty years that we would need as many as 100 RPCs to process the oil sands deposits owned by the State of Utah.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Material extracted from our Vernal, Utah project
can be sold for energy or converted into asphaltic cement, which we believe is less affected by daily changes in oil prices. With our
one RPC unit, assuming full utilization, we anticipate producing approximately 50 tons of asphaltic cement per day. We anticipate that
we will be able to sell our asphaltic cement for, referencing present pricing, approximately $450 per ton.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Crude Oil Gathering, Storage and Transportation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1, 2022, we acquired 100% of the outstanding
ownership interests of Silver Fuels Delhi, LLC, a Louisiana limited liability company (&#8220;SFD&#8221;) and White Claw Colorado City,
LLC, a Texas limited liability company (&#8220;WCCC&#8221;), which are now wholly-owned subsidiaries of ours, and are generating revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SFD owns and operates a crude oil gathering, storage,
and transportation facility located on approximately 9.3 acres near Delhi, Louisiana. Under existing agreements, a subsidiary of a large
NYSE traded energy company (the &#8220;Purchaser&#8221;) is obligated to purchase blended crude oil from SFD in amounts up to 60,000 barrels
per month. With prior approval, SFD is eligible to sell to the Purchaser amounts greater than 60,000 barrels of crude oil per month. Additionally,
for a period of 10 years, SFD is, under existing crude oil supply agreements with WC Crude, guaranteed a minimum gross margin of $5.00
per barrel on all quantities of blended crude oil sold thereunder. At present, SFD is blending and selling approximately 1,400 to 1,700
barrels of blended crude oil on a daily basis. Additionally, the acquisition of SFD provides us with the infrastructure needed to place
a Remediation Processing Machine (&#8220;RPC&#8221;) to clean soil which has been contaminated by hydrocarbons as well as tank bottom
sludge. Management believes SFD&#8217;s location in the heart of the Smackover formation would provide the Company with access to significant
amounts of tank bottom sludge and contaminated soil.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WCCC owns a 120,000 barrel crude oil storage
tank, in the heart of the Permian Basin, located near Colorado City, Texas. The storage tank is presently connected to the Lotus
pipeline system and the Company intends to further connect the tank to major pipeline systems. Under the
terms of an existing agreement, WC Crude has agreed to lease the oil storage tank for a period of 10 years. As with SFD, WCCC would
provide the Company with the infrastructure to blend and sell oil which has been recovered via a RPC machine from tank bottom sludge
and contaminated soil which exists in the Permian Basin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competitive Strengths and Growth Strategy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are focused on the remediation of contaminated
soil and water resulting from either man-made spills or naturally occurring deposits of oil. Our primary focus has been the remediation
of oil spills resulting from the Iraqi invasion of Kuwait and naturally occurring oil sands deposits in the Uinta basin located in Eastern
Utah. We plan to expand into other markets, both in Utah and globally, where we believe our technology and services will provide a distinct
competitive advantage over our competition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Competitive Strengths</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe the following strengths provide us
with a distinct competitive advantage and will enable us to effectively compete on a global basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td>Proprietary patented technology;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Environmental advantages;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Strong relationships with customers and regulatory agencies; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Experienced and highly-skilled management, Board of Directors and Advisory Board.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Proprietary Patented Technology</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In total, we, together with our subsidiaries,
have intellectual property that is in the form of both proprietary knowledge and patents. Our patent portfolio consists of four issued
U.S. patents, one pending international patent application filed through the Paris Cooperation Treaty (PCT), and one pending patent application
in Kuwait. In addition, we have licensed from our partners the right to use additional patented technologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We presently have two US patent and pending foreign
applications related to our RPCs and two issued US patents related to our other remediation technologies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe, based on direct and ongoing conversations
with our customers and third-party independent test results, that our technology is the only commercially available technology that can
not only clean soil that contains greater than 7% hydrocarbon, but also preserves the hydrocarbons extracted from such soil for future
use. We believe that this provides us with a true competitive advantage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our main technology has been tested and validated
for all of its claims by separate, independent expert firms both in the United States and the Middle East, whose reports confirm that
we have reclamation technology, which has been tested and reviewed, that possesses the ability to clean soil with more than 7% hydrocarbon
contamination and still leave the recovered hydrocarbons in a usable state.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Environmental Advantages</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Among our key corporate objectives is to be at
the forefront of social responsibility for its technological impact. We strive for all of our systems to ultimately become closed loop
systems, to minimize adverse impacts on air quality and reduce the need for use of clean water. Our ability to turn waste into value is
in line with this core objective. Our remediation projects in Kuwait are expected to reduce emissions from vaporization of the oil spilled
in the soil. The ability to clean produced water from oil production can eliminate the need for evaporation ponds, improving air quality
and saving on the use of clean water.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe our technology and service offerings
will position us well to conduct our business in any geographical region in which soil or water has been contaminated by hydrocarbons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Strong Relationships with Customers and Regulatory
Agencies</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have developed close relationships with customers
and government agencies, including SITLA and the KOC. We anticipate receiving access to additional oil sands deposits located in Utah
from SITLA, based on our existing relationship with SITLA and our conversations with them. Indeed, our relationships have helped give
rise to our December 2021 agreement with DIC in Kuwait, which will result in our having a stockpile of at least 444,311 tons with at least
5% oil contamination for us to remediate. We also anticipate receiving additional contracts from KOC to remediate contaminated properties
in Kuwait, based on our existing relationship with KOC and conversations with them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Experienced and Highly Skilled Management,
Board of Directors and Advisory Board</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management team has started and successfully
grown numerous technology-based companies and has utilized this experience to develop a strategic vision for the Company. The implementation
of this plan has resulted in the acquisition and in-house development of numerous technologies, which are currently in operation. We have
demonstrated the effectiveness of our technologies in both Vernal, Utah and Kuwait, accomplishing the clean-up of contaminated areas while
also recovering precious metals through our metallic separation technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board of Directors is comprised of accomplished
professionals who bring decades of experience to the Company. Our Board of Directors includes a director who has served as a member of
the Executive Committee of one of the largest global accounting firms and has served on the Board of Directors of two multi-billion dollar
publicly traded companies, a former director of technology investment banking at Goldman Sachs, a successful investor and entrepreneur
who has founded and provided initial financing for numerous life science companies, several of which have grown to multi-billion dollar
publicly traded companies, and the mayor of a city in Utah.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we have an Advisory Board comprised
of former senior members of oil and gas companies, both in the United States and in the Middle East. Our Advisory Board is led by one
member who is an accomplished business professional and a member of a royal family based in the Middle East and another member who is
an experienced health and safety expert operating in the oil and gas industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We rely on our Board of Directors and Advisory
Board to provide it both high level advice and guidance along with using their contacts to help open various markets. Additionally, the
Advisory Board acts as a preliminary informal sounding board for the Board and management for these particular areas in which the Advisory
Board members have expertise. We believe the combination of our management team, Board of Directors and Advisory Board provides us with
a significant competitive advantage over our competitors due to their breadth of experiences and relationships.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Growth Strategies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Remediation Processing Centers</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will strive to grow our RPC business by
pursuing the following strategies:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 2%">&#160;</td>
    <td style="width: 4%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 94%">Expansion of our oil recovery projects in Utah;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Expansion of our remediation projects in Kuwait;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Expansion into new and complementary markets;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Increase of revenue via new service and product offerings;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Strategic acquisitions and licenses targeting complementary technologies; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>Redeployment of the metallic separation technologies.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Expansion of our Oil Recovery Projects in Utah</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The State of Utah has, according to the U.S. Geological
Survey, approximately 14 billion barrels of measured oil in place with an additional estimated 23 to 28 billion barrels of oil contained
in contaminated oil sands that are deposited near the ground surface. The majority of these oil sands deposits are located on land owned
by SITLA. While our current project in Vernal, Utah is not located on SITLA land and we do not yet have a definitive agreement, SITLA
has expressed an interest in providing us leased access to these lands in exchange for a royalty to be paid by us in an amount equal to
8% of all revenue generated from any hydrocarbon-based products produced by us from hydrocarbons extracted from these lands. All royalty
payments to SITLA would result in direct funding to the State&#8217;s school system. We will seek to acquire additional properties and
mineral rights in the vicinity of Vernal, Utah from individual land owners and the State of Utah.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Expansion of our Remediation Projects in Kuwait</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our RPC technology was successfully used in our
initial project for KOC in Kuwait, where we removed hydrocarbons from soil with more than 7% contamination and, following the process,
the hydrocarbon contamination level of the soil was reduced to less than 0.5%, which was lower than the level needed to meet the project
specifications. There is still approximately 26 million cubic meters of soil contaminated by oil from the Iraqi invasion of Kuwait. Pursuant
to our recent agreement with DIC, we will receive $50,000 for the successful remediation of the first 100 tons ($500 per ton) under its
subcontractor services for the KOC Remediation Contract. In addition, we will receive $20 per treated ton of soil after the initial 100
tons. The treatment process using the RPC plants is anticipated to generate a bitumen sub-product. We have agreed with DIC to sell this
sub-product and share the net profits equally (50% to us and 50% to DIC), after allocating 30% of the net profits to DIC in the form of
a sales and marketing payment, which will be invoiced on a monthly basis, in accordance with the Agreement. Pursuant to the Agreement,
we will have a stockpile of at least 444,311 tons with at least 5% oil contamination for us to remediate. Other technologies may also
be used for the less contaminated soils.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Expansion into New and Complementary Markets</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to explore expansion opportunities on
a global basis, including in places with extreme contamination such as the Ogoni Lands region of Nigeria, oil spill lakes located in Saudi
Arabia and Turkmenistan, and naturally occurring oil sands deposits in Kazakhstan, where we believe our technology and service offerings
may provide a distinct competitive advantage. We are currently in discussions with several groups for deploying our RPCs for remediation
projects (primarily for oil spills, tank bottom sludge and drill cuttings) in Saudi Arabia, Qatar and Texas. Saudi Arabia has the objective
to create a circular carbon economy that will ultimately have zero wasted hydrocarbons. Our technology is able to process tank bottom
sludge, drill cuttings, and soils form hydrocarbon spills, returning the sand to less than 0.5% contamination while reclaiming the oil
for waste energy use.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Increase of Revenue via New Service and Product
Offerings</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To date, we have focused on the remediation of
soil contaminated by oil. We intend to target other hydrocarbon remediation businesses that focus on, among other things, the cleaning
of tank bottom sludge, and the cleaning of the water used from drilling oil wells. Oil producers generally pay to dispose of sludge at
the bottom of storage tanks and contaminated water produced from the drilling of oil wells. We believe that our technologies could be
used to clean the contaminated water produced from drilling, while simultaneously recovering the heavy crude. We believe we will be able
to offer these services at a cost that is very competitive with current methods and that our ability to recover the heavy crude for resale
will give us a competitive advantage. We are currently in early stage discussions relating to some of these remediation projects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Strategic Acquisitions and Licenses Targeting
Complementary Technologies</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to seek out opportunities to acquire
or license only specific technologies that are either complementary to our existing product offerings or that will allow us to expand
into the environmental infrastructure markets. We <span style="background-color: white">recently entered into a worldwide, exclusive license
agreement with TBT Group, Inc. to license piezo electric and energy harvesting technologies for creating self-powered sensors for making
smart roadways</span>, which we believe could be embedded directly into the asphaltic cement we intend to produce from the hydrocarbons
we extract, providing the basis for smart roads and infrastructure. We believe that these sensors, which are self-powered, could be used
to provide information about traffic, road conditions and repair needs as well as allowing the roads to communicate directly with autonomous
vehicles enabling these vehicles to sense the road in all weather conditions. By complementing the asphaltic cement we expect to produce
with integrated sensors for automated vehicles, we believe that we will be able to offer a smart road.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Redeployment of the Metallic Separation Technology</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our licensed metallic separation technology has
successfully recovered precious metals including, but not limited to, gold, palladium, platinum, rodium and silver. We intend to redeploy
our metallic separation technology machines to standalone locations to process mine tailings and other soils.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Crude Oil Gathering, Storage and Transportation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WCCC owns a 120,000 barrel crude oil storage
tank, in the heart of the Permian Basin, located near Colorado City, Texas. The Company intends to further connect the tank to major pipeline systems. In doing so, WCCC would provide the Company with the infrastructure to blend and sell oil
which has been recovered via a RPC from tank bottom sludge and contaminated soil which exists in the Permian Basin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SFD owns and operates a crude oil gathering, storage, and
transportation facility, which is presently blending and selling approximately 1,400 to 1,700 barrels of blended crude oil on a daily
basis. We plan to increase operations at the facility to ramp up to the facility daily maximum of blending and selling approximately 4,000
barrels of blended crude oil on a daily basis in the near future. Additionally, this facility may also provide us with the infrastructure
needed to place a RPC to clean soil which has been contaminated by hydrocarbons as well as tank bottom sludge from the area.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Other Holdings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historically, as part of our strategy to find
and invest in technologies that might develop synergies with our existing businesses, we have invested in other companies and/or entities.
Not all of our investments to date have developed into complementary technologies and/or businesses, but with our management&#8217;s assistance,
many of them have still become successful and accretive to our Company&#8217;s value. Over time, we intend to divest our ownership of
companies that are not synergistic with our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Scepter Holdings</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2019, we received 800,000 shares of preferred
stock in Scepter Holdings, Inc. (OTCMarkets: BRZL), a company that manages the sales and development of consumer-packaged goods, to release
Scepter from a secured loan financing that encumbered its assets. In 2019 we entered into a Convertible Master Revolving Note with Scepter
and over the course of approximately two years lent them $71,000, which accrued 7% interest per annum. In August 2021 we exercised our
conversion rights in the note and converted the principal balance and all accrued interest in to 26,376,882 shares of common stock of
Scepter, which represents holdings of 826,376,882 shares of Scepter (approximately 19% of Scepter&#8217;s outstanding stock) and a market
value of approximately $3,553,241 as of April 5, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Odyssey Group International</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2014, we acquired a minority interest in Odyssey
Group International, Inc. (&#8220;Odyssey&#8221;) (OTCQB: ODYY), a trans-disciplinary product development enterprise involved in the discovery,
development and commercialization of a broad range of products applied to targeted segments of the health care industry. We also have
provided a $750,000 secured loan to Odyssey, which they used to acquire a license to use and develop a new technology called CardioMap&#174;,
which is an advanced technology for early non-invasive testing for heart disease. During June 2020, we converted the outstanding secured
loan into 809,578 shares of Odyssey common stock. We owned 3,309,578 shares of Odyssey common stock through December 2021 at which time
we sold such 3,309,578 shares of Odyssey in a private transaction for a purchase price of $860,491, reflecting the market price as of
such time. Such purchase price was paid in the form of $10,000 cash delivered at signing and a note issued in favor of Vivakor in the
amount of $850,491 accruing interest at 3% per annum, with payments due quarterly over a five-year term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Future Products; Research and Acquisition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to identify, develop or acquire, and
bring to market products primarily in the Clean Tech sector with a primary focus on the petroleum, mining and minerals, and alternative
energy industries, as well opportunities that may arise in the natural and formulary products industry. Our general approach is to select
products or processes that are at or near commercial viability, or that we believe can be substantially developed for commercialization.
We then negotiate agreements to either acquire or to provide secured loan financing to these companies to complete their development,
testing and product launches in exchange for control of, or a significant ownership interest in, the products or companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>History</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was originally organized on November
1, 2006 as a limited liability company in the State of Nevada as Genecular Holdings, LLC. The Company&#8217;s name was changed to NGI
Holdings, LLC on November 3, 2006. On April 30, 2008, the Company was converted to a Nevada corporation and changed its name to Vivakor,
Inc. pursuant to Articles of Conversion filed with the Nevada Secretary of State.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have the following direct and indirect wholly-owned
active subsidiaries: VivaVentures Management Company, Inc., a Nevada corporation, VivaSphere, Inc., a Nevada corporation, VivaVentures
Oil Sands, Inc., a Utah corporation, RPC Design and Manufacturing LLC (&#8220;RDM&#8221;), a Utah limited liability company, Silver Fuels
Delhi, LLC, a Louisiana limited liability company, and White Claw Colorado City, LLC, a Texas limited liability company. We have a 99.95%
ownership interest in VivaVentures Energy Group, Inc., a Nevada Corporation; the 0.05% minority interest in VivaVentures Energy Group,
Inc. is held by a private investor unaffiliated with the Company. We also have an approximate 49% ownership interest in Vivakor Middle-East
Limited Liability Company, a Qatar limited liability company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Regulations Affecting our Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is subject to federal, state and
local laws, regulations and policies, including laws regulating the removal of natural resources from the ground and the discharge of
materials into the environment. These regulations mandate, among other things, the maintenance of air and water quality standards and
land reclamation. They also set forth limitations on the generation, transportation, storage and disposal of solid and hazardous waste.
Exploration and exploitation activities are also subject to federal, state and local laws and regulations which seek to maintain health
and safety standards by regulating the design and use of exploration methods and equipment. Environmental and other legal standards imposed
by federal, state or local authorities are constantly evolving, and typically in a manner which will require stricter standards and enforcement,
and increased fines and penalties for noncompliance. Such changes may prevent us from conducting planned activities or increase our costs
of doing so, which would have material adverse effects on our business. Moreover, compliance with such laws may cause substantial delays
or require capital outlays in excess of those anticipated, thus causing an adverse effect on us. Additionally, we may be subject to liability
for pollution or other environmental damages that we may not be able to or elect not to insure against due to prohibitive premium costs
and other reasons. Unknown environmental hazards may exist on our mining claims, or we may acquire properties in the future that have
unknown environmental issues caused by previous owners or operators, or that may have occurred naturally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Failure to comply with applicable federal, state,
local or foreign laws or regulations could subject our company to enforcement action, including product seizures, recalls, withdrawal
of marketing clearances and civil and criminal penalties, any one or more of which could have a material adverse effect on our company&#8217;s
businesses. We believe that our company is in substantial compliance with such governmental regulations. However, federal, state, local
and foreign laws and regulations regarding the manufacture and sale of medical devices are subject to future changes. There can be no
assurance that such changes would not have a material adverse effect on our company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own four issued US patents and two pending
international PCT patent application covering our propriety technology, specifically:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 2%">&#160;</td>
    <td style="width: 4%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 94%">US Patent 7,282,167 for methods for producing nano-scale particles by vaporizing raw material and then cooling the vaporized raw material using a cooling gas, granted October 16, 2007 and expiring July 23, 2025;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">US Patent 9,272,920 for methods for producing ammonia by mixing a first catalyst including a millimeter-sized, granular, ferrous material and a promoter and a second catalyst including discrete nano-sized ferrous catalyst particles that comprise a metallic core with an oxide shell and then reacting hydrogen and nitrogen in the presence of the mixture, granted March 1, 2016 and expiring November 7, 2028; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; background-color: white">&#183;</span></td>
    <td style="text-align: justify"><span style="background-color: white">US Patent 10,913,903 for SYSTEM AND METHOD FOR USING A FLASH EVAPORATOR TO SEPARATE BITUMEN AND HYDROCARBON CONDENSATE granted February 9, 2021 and expiring August 28, 2039;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">US Patent 7,282,167 for U<span style="background-color: white">S Patent 10,947,456 for SYSTEMS FOR THE EXTRACTION OF BITUMEN FROM OIL SAND MATERIAL granted on March 16, 2021 to expire on December 3, 2038</span>;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">Pending US Patent Series Nos. 16/177,210 and 16/554,158, International PCT Application No. PCT Application No. PCT/US2019/048587, and pending Kuwait application KW/P/2020/000111 relating to systems and processes for extracting bitumen from oil sands material which employ a centrifuge and a flash evaporator.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this prospectus , we have <span style="font-size: 10pt">30</span>
full-time or contracted employees, consisting of our CEO, CFO, and additional administrative and direct operations personnel. None of
these employees are represented by a labor union or subject to a collective bargaining agreement. We have never experienced a work stoppage
and our management believes that our relations with employees are satisfactory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Properties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own approximately 9 acres of land near Delhi,
Louisiana where we operate a crude oil gathering, storage, and transportation facility. We also own approximately 7 acres of land near
Colorado City, Texas, where our 120,000 barrel crude oil storage tank is located.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently lease executive office space in Lehi,
Utah, Las Vegas, Nevada, Houston, Texas, and Irvine, California. The Company also leases warehouses in Las Vegas, Nevada and Houston,
Texas, and have paid to be on a land site in Vernal, UT. We believe these facilities are in good condition but that we may need to expand
our leased space and warehouses as business increases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal Proceedings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we may become involved in various
legal actions that arise in the normal course of business. We are not currently involved in any material disputes and do not have any
material litigation matters pending.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_308"></span>MANAGEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth information about our directors,
executive officers and significant employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><b>Name</b></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Age</b></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Position(s)</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td>Matthew Nicosia</td>
    <td>&#160;</td>
    <td style="text-align: center">48</td>
    <td>&#160;</td>
    <td>Chief Executive Officer (Principal Executive Officer) and Director</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>Tyler Nelson</td>
    <td>&#160;</td>
    <td style="text-align: center">42</td>
    <td>&#160;</td>
    <td>Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td>Dr. Daniel Hashim</td>
    <td>&#160;</td>
    <td style="text-align: center">38</td>
    <td>&#160;</td>
    <td>Chief Scientific Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>Al Ferrara</td>
    <td>&#160;</td>
    <td style="text-align: center">70</td>
    <td>&#160;</td>
    <td>Director</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td>Matthew Balk</td>
    <td>&#160;</td>
    <td style="text-align: center">61</td>
    <td>&#160;</td>
    <td>Director</td></tr>
  <tr style="vertical-align: bottom">
    <td>Trent Staggs</td>
    <td>&#160;</td>
    <td style="text-align: center">48</td>
    <td>&#160;</td>
    <td>Director</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Matthew Nicosia </b>joined Vivakor as Chief
Executive Officer and Chairman of the Board in 2011. Prior to joining the Company, Mr. Nicosia co-founded Dermacia Inc. in 1999, a dermatology
product development Company. From December 2012 through December 2015, concurrent with his time serving as Chairman and Chief Executive
Officer of Vivakor, Mr. Nicosia served as the interim Chief Executive Officer of Vivaceuticals, d/b/a Regeneca Worldwide. In February
2019, Mr. Nicosia joined Ridepair Inc., a software development company focused on the transportation market, as Chairman of the Board.
Mr. Nicosia joined the Board of Directors of NarcX Solutions Inc., a developer of onsite drug destruction technologies in June 2019. During
2018, Mr. Nicosia co-founded and has since served as co-Chairman of the Board of Prosperity Utah, a non-profit economic think tank focused
on the State of Utah. From April 2018 until March 2021, Mr. Nicosia has served on the Board of Directors of CannapharmaRx Inc., a public
company which trades on the OTC Markets. Mr. Nicosia received his Bachelor of Arts degree from Brigham Young University and a MBA from
Pepperdine University. <span style="background-color: white">Mr. Nicosia is qualified to serve on our Board of Directors based on his
in depth knowledge of the Company as Chief Executive Officer and because of his </span>extensive experience with thermal vaporization
technologies, business development in the Middle East and U.S. capital markets experience.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 16, 2015, the Consumer Protection
Branch of the Department of Justice of the United States of America initiated an action, on behalf of the Food and Drug Administration,
against Vivaceuticals, d/b/a Regeneca Worldwide, and Mr. Nicosia alleging various violations of the Federal Food, Drug, and Cosmetic Act
in relation to the manufacturing, labeling and distribution of adulterated dietary supplements. The complaint sought a permanent injunction
against Regeneca Worldwide for unlawfully distributing unapproved new drugs, and adulterated and misbranded dietary supplements. A consent
decree of permanent injunction was filed on February 8, 2017. The consent decree prohibits Regeneca from marketing unapproved new drugs,
and adulterated and misbranded dietary supplements. The consent decree also provides that before Regeneca can resume operations, it must,
among other things, hire good manufacturing practice and labeling experts, implement procedures to comply with good manufacturing practice
and labeling requirements and receive written permission from the FDA to resume operations, and Mr. Nicosia is required to notify the
FDA and accept their inspections if he works in the pharmaceutical industry. Regeneca was also required to destroy all remaining products.
Vivaceuticals sold its assets to Scepter Holdings, Inc. in 2018 and is no longer in operation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tyler Nelson</b> joined Vivakor on a part-time
basis as Chief Financial Officer in 2014 and has served as full-time Chief Financial Officer since September 2020. Mr. Nelson is a CPA
who worked from 2006 to 2011 in Audit and Enterprise Risk Services at Deloitte LLP (USA) and later at Withum+Brown, PC. He worked with
clients with assets of more than $100 billion and annual revenues of more than $15 billion, which are considered some of the most respected
financial institutions in the world. In 2011, Mr. Nelson began working for LBL Professional Consulting, Inc. where he provided merger
and acquisition, initial public offering, and interim chief financial officer services to clients. Mr. Nelson continues to sit on the
Board of Directors and remains an officer of LBL Professional Consulting, Inc. Mr. Nelson earned a Master&#8217;s Degree in Accountancy
from the University of Illinois- Urbana-Champaign, and a Bachelor&#8217;s Degree in Economics with a minor in Business Management from
Brigham Young University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dr. Daniel Hashim</b> joined Vivakor as Chief
Scientific Officer in 2017. Dr. Hashim has extensive experience in the areas of nanoscience research, advanced materials synthesis, characterization,
application, innovation and technological entrepreneurship. In addition to leading scientific efforts for Vivakor and its related companies,
Dr. Hashim has served as the Founder, Chairman and CEO of CSS Nanotech, Inc. (&#8220;CSS&#8221;) since 2014. CSS is a nanomaterials research
and development company that designs and commercializes useful structural nanomaterials that exhibit &#8220;safe-to-handle&#8221; nanofunctionality
on a macro-scale, to include carbon filtration media, water purification, oil spill remediation, structural composite materials, electrode
materials, petrochemical refining and thermal management systems. Mr. Hashim holds a Bachelor&#8217;s Degree in Materials Science Engineering
from Rensselaer Polytechnic Institute, with a PhD from Rice University in the field of Materials Science and NanoEngineering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Matthew Nicosia</b>-See &#8220;Executive Officers&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Al Ferrara</b>
joined Vivakor as a director </span>on September 21, 2020. Mr. Ferrara retired as the National Director of Retail &amp; Consumer Products
at BDO USA, LLP in 2016. Mr. Ferrara is a CPA, who worked at BDO USA, LLP in a variety of positions beginning in 1991, and was a member
of its board of directors from 2003 to 2010. Mr. Ferrara served as the Northeast Regional Managing Partner at BDO USA, LLP from 2000 to
2003. Mr. Ferrara was also a director representative at Trenwith Capital, Inc. (now BDO Capital Advisors, LLC) from 2000 to 2015 and a
member of the retail advisory board at Hilco Retail Consulting from 2013 to 2015. Mr. Ferrara was previously on the Board of Directors
for Barnes &amp; Noble, Inc., from August 2016 until the company was sold in August 2019, where he served on its audit committee and compensation
committee, and in July 2019, he joined the Board of Directors of Steven Madden, Ltd., where he serves as Chairman of its audit committee
and a member of its governance committee. Mr. Ferrara is qualified to serve on our Board of Directors because of his extensive experience
in auditing public companies and serving as a director of large public companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Matthew Balk </b>joined Vivakor as a director
on September 21, 2020. Mr. Balk previously spent more than 25 years as an investment banker specializing in technology and biotechnology
where he raised billions of dollars for both public and private companies and dozens of mergers and acquisitions. In 2011, he left investment
banking to start his family office. He has since co-founded several companies including AzurX (Nasdaq: AZRX) and VerifyH20 and invested
in a number of other technology companies. Mr. Balk also works as a consultant to a small number of companies in the areas of Biotech
and technology in general. Mr. Balk received his MBA from New York University Stern School of Business. <span style="background-color: white">Mr.
Balk is qualified to serve on our Board of Directors because of his </span>extensive experience acting as an investment banker supporting
large public companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Trent Staggs</b> joined Vivakor as a director
on September 21, 2020. Mr. Staggs brings a 20-year track record of developing and executing on business strategy, teams and relationships.
Prior to advising the Vivakor team, he was on the corporate leadership team of Unicity International, Inc., a global direct sales company
that operates in over 35 markets, providing strategic direction and leadership of global integrated systems, software and IT infrastructure.
Mr. Staggs has also been directly responsible for financial transactions in excess of 2 billion dollars as a VP at Morgan Stanley and
also running his own nationwide financial company. Mr. Staggs served as a consultant for RDM from January 2019 through March 2020, advising
with respect to obtaining required permitting from State agencies and other regulatory matters. Mr. Staggs received his Bachelor of Arts
degree from the University of Utah and received an MBA from the Marriott School of Management at Brigham Young University. Mr. Staggs
is also the Mayor of Riverton, Utah and serves on many boards, providing needed political guidance and consultation to Vivakor and its
related companies. <span style="background-color: white">Mr. Staggs is qualified to serve on our Board of Directors because of his </span>extensive
experience in capital markets and his understanding of Utah regulatory requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Family Relationships</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no family relationships between any
of our directors and executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporate Governance Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Composition and Director Independence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board of Directors consists of four members.
The directors are elected at each annual meeting to hold office until the next annual meeting and until their successors are duly elected
and qualified. The Company defines &#8220;independent&#8221; as that term is defined in the Nasdaq rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In making the determination of whether a member
of the board is independent, our board considers, in addition to Nasdaq rules, among other things, and transactions and relationships
between each director and his immediate family and the Company, including those reported under the caption &#8220;Related Party Transactions.&#8221;
The purpose of this review is to determine whether any such relationships or transactions are material and, therefore, inconsistent with
a determination that the directors are independent. On the basis of such review and its understanding of such relationships and transactions,
our Board of Directors affirmatively determined that Al Ferrara, Matthew Balk and Trent Staggs are qualified as independent and do not
have any material relationships with us that might interfere with his exercise of independent judgment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Committees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board of Directors has established an Audit
Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Each committee has its own charter, which is
available on our website at www.vivakor.com<i>.</i> Each of the board committees has the composition and responsibilities described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Members will serve on these committees until their
resignation or until otherwise determined by our Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit Committee</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Audit Committee is currently comprised of
Al Ferrara, Matthew Balk and Trent Staggs, each of whom qualify as an independent director under applicable Nasdaq and SEC rules, and
&#8220;financially literate&#8221; under applicable Nasdaq rules. Our board has determined that Al Ferrara, Matthew Balk and Trent Staggs
each qualify as an &#8220;audit committee financial expert&#8221;, as such term is defined in Item 407(d)(5) of Regulation S-K. Al Ferrara
serves as chairman of the Audit Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee oversees our accounting and
financial reporting processes and oversee the audit of our consolidated financial statements and the effectiveness of our internal control
over financial reporting. The responsibilities of this committee include, but are not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="text-align: center; width: 3%"><span style="font-family: Symbol">&#183; </span></td>
    <td style="text-align: justify; width: 94%">selecting and recommending to our Board of Directors the appointment of an independent registered public accounting firm and overseeing the engagement of such firm;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">approving the fees to be paid to the independent registered public accounting firm;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">helping to ensure the independence of the independent registered public accounting firm;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">overseeing the integrity of our financial statements;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">preparing an audit committee report as required by the SEC to be included in our annual proxy statement;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">resolving any disagreements between management and the auditors regarding financial reporting;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">reviewing with management and the independent auditors any correspondence with regulators and any published reports that raise material issues regarding the Company&#8217;s accounting policies;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">reviewing and approving all related-party transactions; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">overseeing compliance with legal and regulatory requirements.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee is authorized to retain independent
legal and other advisors and conduct or authorize investigations into any matter within the scope of its duties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Committee is currently comprised
of Trent Staggs, Al Ferrara and Matthew Balk, each of whom qualify as an independent director under applicable Nasdaq rules. Trent Staggs
serves as chairman of the Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Committee assists the board of
directors in the discharge of its responsibilities relating to the compensation of the board of directors and our executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The responsibilities of this committee include,
but are not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="text-align: center; width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 94%">reviewing and approving on an annual basis the corporate goals and objectives with respect to compensation for our Chief Executive Officer;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">reviewing, approving and recommending to our board of directors on an annual basis the evaluation process and compensation structure for our other executive officers;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">determining the need for and the appropriateness of employment agreements and change in control agreements for each of our executive officers and any other officers recommended by the Chief Executive Officer or Board of Directors;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">providing oversight of management&#8217;s decisions concerning the performance and compensation of other company officers, employees, consultants and advisors;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">reviewing our incentive compensation and other equity-based plans and recommending changes in such plans to our Board of Directors as needed, and exercising all the authority of our Board of Directors with respect to the administration of such plans;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">reviewing and recommending to our Board of Directors the compensation of independent directors, including incentive and equity-based compensation; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">selecting, retaining and terminating such compensation consultants, outside counsel or other advisors as it deems necessary or appropriate.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee may delegate any of
its responsibilities to subcommittees as it deems appropriate. The Compensation Committee is authorized to retain independent legal and
other advisors, and conduct or authorize investigations into any matter within the scope of its duties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nominating and Corporate Governance Committee</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Nominating and Corporate Governance Committee
is currently comprised of Trent Staggs, Matthew Balk and Al Ferrara, each of whom qualify as an independent director under applicable
Nasdaq rules. Trent Staggs serves as chairman of the Nominating and Corporate Governance Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purpose of the Nominating and Corporate Governance
Committee is to recommend to the Board of Directors nominees for election as directors and persons to be elected to fill any vacancies
on the Board of Directors, develop and recommend a set of corporate governance principles and oversee the performance of the Board of
Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The responsibilities of this committee include,
but are not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="text-align: center; width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify; width: 94%">recommending to the Board of Directors nominees for election as directors at any meeting of stockholders and nominees to fill vacancies on the board;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">considering candidates proposed by stockholders in accordance with the requirements in the Committee charter;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">overseeing the administration of the Company&#8217;s code of business conduct and ethics;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">reviewing with the entire Board of Directors, on an annual basis, the requisite skills and criteria for board candidates and the composition of the board as a whole;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">the authority to retain search firms to assist in identifying board candidates, approve the terms of the search firm&#8217;s engagement, and cause the Company to pay the engaged search firm&#8217;s engagement fee;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">recommending to the Board of Directors on an annual basis the directors to be appointed to each committee of the Board of Directors;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">overseeing an annual self-evaluation of the Board of Directors and its committees to determine whether it and its committees are functioning effectively; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">developing and recommending to the board a set of corporate governance guidelines applicable to the Company.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominating and Corporate Governance Committee
may delegate any of its responsibilities to subcommittees as it deems appropriate. The Nominating and Corporate Governance Committee is
authorized to retain independent legal and other advisors and conduct or authorize investigations into any matter within the scope of
its duties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Leadership Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, Mr. Nicosia is our principal executive
officer and chairman of the board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Oversight</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board will oversee a company-wide approach
to risk management. Our Board will determine the appropriate risk level for us generally, assess the specific risks faced by us and review
the steps taken by management to manage those risks. While our Board will have ultimate oversight responsibility for the risk management
process, its committees will oversee risk in certain specified areas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Specifically, our compensation committee will
be responsible for overseeing the management of risks relating to our executive compensation plans and arrangements, and the incentives
created by the compensation awards it administers. Our audit committee will oversee management of enterprise risks and financial risks,
as well as potential conflicts of interests. Our board of directors will be responsible for overseeing the management of risks associated
with the independence of our Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Code of Business Conduct and Ethics</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted a code of business conduct and
ethics applicable to our principal executive, financial and accounting officers and all persons performing similar functions. A copy of
that code is available on our corporate website at <i>www.vivakor.com</i>. We expect that any amendments to such code, or any waivers
of its requirements, will be disclosed on our website.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_309"></span>EXECUTIVE COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Compensation Table</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information concerning
the compensation awarded to, earned by, or paid to, our principal executive officer. No other executive officer received compensation
greater than $100,000 in the last two completed fiscal years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><b>Name and Principal Position</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Year</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Salary</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Total</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td>Matthew Nicosia,</td>
    <td>&#160;</td>
    <td style="text-align: center">2021</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">50,000</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">50,000</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="border-bottom: black 1pt solid"><i>Chief Executive Officer and Chairman</i></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center">2020</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">$</td>
    <td style="border-bottom: black 1pt solid; text-align: right">50,000</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">$</td>
    <td style="border-bottom: black 1pt solid; text-align: right">50,000</td>
    <td style="border-bottom: black 1pt solid">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Tyler Nelson</td>
    <td>&#160;</td>
    <td style="text-align: center">2021</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">49,920</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right">49,920</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><i>Chief Financial Officer</i></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center">2020</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">$</td>
    <td style="border-bottom: black 1pt solid; text-align: right">11,520</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">$</td>
    <td style="border-bottom: black 1pt solid; text-align: right">11,520</td>
    <td style="border-bottom: black 1pt solid">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employment Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 9, 2022 (the &#8220;Effective Date&#8221;),
Vivakor, Inc. (the &#8220;Company&#8221;), pursuant to the approval of its Board of Directors (the &#8220;Board&#8221;), on the recommendation
of the Compensation Committee of the Board, entered into that certain executive employment agreement with each of Matthew Nicosia, Chief
Executive Officer, and Tyler Nelson, Chief Financial Officer (respectively, the &#8220;Nicosia Agreement&#8221; and the &#8220;Nelson
Agreement&#8221;, and collectively, the &#8220;Agreements&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nicosia Agreement provides an annual base
salary of $375,000 (the &#8220;Nicosia Base Salary&#8221;), payable in equal installments and paid every two weeks. The Nicosia Base Salary
will increase by $100,000 upon the Company earning a total of at least $2,000,000 in Earnings before Interest, Taxes, Depreciation and
Amortization (&#8220;EBITDA&#8221;) minus (i) any unrealized gain (add back any unrealized loss) from marketable securities, (ii) stock
based compensation expense, and (iii) stock options issued for services (&#8220;Adjusted EBITDA&#8221;) during any calendar year, and
the Nicosia Base Salary will continue to increase in $100,000 increments for each additional $1,000,000 increase in EBITDA over $2,000,000
during the Term of this Agreement up to $675,000 at which time the Nicosia Base Salary will continue to increase in $20,000 increments
for each additional $1,000,000 increase in Adjusted EBITDA over $4,000,000. As an inducement to continue services going forward, Mr. Nicosia
shall receive a cash signing bonus of $125,000, which shall be paid in a lump sum amount within sixty (60)&#160;days after the Effective
Date. Pursuant to the Nicosia Agreement, Mr. Nicosia may resign at any time with or without Good Reason, as defined in the Nicosia Agreement.
The Company may terminate the Nicosia Agreement for cause (as defined therein) or with 30 days&#8217; prior written notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nelson Agreement provides an annual base salary
of $350,000 (the &#8220;Nelson Base Salary&#8221;), payable in equal installments and paid every two weeks. The Nelson Base Salary will
increase by $100,000 upon the Company earning a total of at least $2,000,000 in Adjusted EBITDA during any calendar year, and the Nelson
Base Salary will continue to increase in $100,000 increments for each additional $1,000,000 increase in EBITDA over $2,000,000 during
the Term of this Agreement up to $650,000 at which time the Nelson Base Salary will continue to increase in $13,500 increments for each
additional $1,000,000 increase in Adjusted EBITDA over $4,000,000. As an inducement to continue services going forward, Mr. Nelson shall
receive a cash signing bonus of $100,000, which shall be paid in a lump sum amount within sixty (60)&#160;days after the Effective Date.
Pursuant to the Nelson Agreement, Mr. Nelson may resign at any time with or without Good Reason, as defined in the Nelson Agreement. The
Company may terminate the Nelson Agreement for cause (as defined therein) or with 30 days&#8217; prior written notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus contains only a brief description
of the material terms of and does not purport to be a complete description of the rights and obligations of the parties to the Nicosia
Agreement and the Nelson Agreement, and such descriptions are qualified in their entirety by reference to the full text of the Nicosia
Agreement and the Nelson Agreement, copies of which are filed herewith as Exhibit 10.4 and 10.5.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stock Incentive Plan </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Equity Incentive Plan</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board of directors approved a new equity incentive
plan in February 2022, which authorizes the issuance of up to 2,000,000 shares of common stock through the grant of stock options (including
incentive stock options qualifying under section 422 of the Code and nonstatutory stock options), restricted stock awards, stock appreciation
rights, restricted stock units, performance awards, other stock-based awards or any combination of the foregoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Outstanding Equity Awards at December 31, 2021</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 there were granted to
Matthew Nicosia non-qualified options to purchase up to 166,667 shares of the Company&#8217;s common stock at an exercise price equal
to 110% of the fair market value of the Company&#8217;s Common Stock on the date of grant. There are no other outstanding equity awards
held by our executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the Company granted stock-based
non-qualified compensation to employees, including a 16,667 share stock award, which vests at the end of four years and a 166,667 stock
options that cliff vests at the end of five years. For the year ended December 31, 2021, stock-based compensation was $446,112. For the
year ended December 31, 2020, stock-based compensation was $146,114.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2020, the Company
also granted non-statutory stock options, including 133,333 stock options to members of the Board of Directors, which vest over one year,
and a 333, 334 stock option to a consultant, which vests over four years. Non-statutory stock-based compensation was $1,585,000 for the
year ended December 31, 2021. Non-statutory stock-based compensation was $555,000 for the year ended December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employee Pension, Profit Sharing or other Retirement Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have a defined benefit, pension plan,
profit sharing or other retirement plan, although we may adopt one or more of such plans in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below shows the compensation paid to
our directors during the years ended December 31, 2021 and 2020. Matthew Nicosia was not compensated for acting as a director during fiscal
year 2021 or 2020. Each of Al Ferrara, Trent Staggs, Matthew Balk and Joseph Spence were appointed to the Board of Directors after January
1, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fees Earned <br /> or<br /> Paid in Cash</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stock<br /> Compensation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 41%">Trent Staggs<span style="font-size: 10pt"><sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 11%; text-align: center">2021</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Al Ferrara</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Joseph Spence <span style="font-size: 10pt"><sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Matthew Balk</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,333</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trent Staggs also received
$48,605 and $84,704 from the Company as payment for consulting services rendered in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Joseph Spence resigned
from the Board of Directors on July 1, 2022.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_310"></span>PRINCIPAL SHAREHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information
regarding our voting shares beneficially owned as of September 9, 2022 by (i) each stockholder known to be the beneficial owner of 5%
or more of the outstanding shares of the particular class of voting stock, (ii) each executive officer, (iii) each director, and (iv)
all executive officers and directors as a group. A person is considered to beneficially own any shares: (i) over which such person, directly
or indirectly, exercises sole or shared voting or investment power, or (ii) of which such person has the right to acquire beneficial ownership
at any time within 60 days through an exercise of stock options, warrants and/or other convertible securities. Unless otherwise indicated,
voting and investment power relating to the shares shown in the tables for each beneficial owner is exercised solely by the beneficial
owner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of computing the percentage of outstanding
shares of our common stock held by each person or group of persons, any shares that such person or persons has the right to acquire within
60 days of September 9, 2022 is deemed to be outstanding, but is not deemed to be outstanding for the purpose of computing the percentage
ownership of any other person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The percentage of beneficial ownership of our
common stock is based on an aggregate of 18,064,838 shares outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as indicated in footnotes to this table,
we believe that the stockholders named in this table have sole voting and investment power with respect to all shares of common stock
shown to be beneficially owned by them, based on information provided to us by such stockholders. Unless otherwise indicated, the address
for each director and executive officer listed is: c/o Vivakor, Inc., 4101 North Thanksgiving Way, Lehi, Utah 84043.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and Address of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares of<br /> Common Stock<br /> Beneficially<br /> Owned</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage<br /> of Common<br /> Stock<br /> Beneficially<br /> Owned</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: left"><span style="font-size: 10pt">Matt Nicosia, Chief Executive Officer and Director <sup>(1)(2)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">4,189,667</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">23.19%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Tyler Nelson, Chief Financial Officer<sup>(10)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">Daniel Hashim, Chief Scientific Officer <sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">166,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Al Ferrara, Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">Trent Staggs, Director <sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.9%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Matthew Balk, Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">All Officers and Directors as a group (seven persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,699,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26.0%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline; text-align: left">5% Beneficial Stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">AKMN Irrevocable Trust <sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,189,405</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23.19%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">Benchmark FBO E.F. Hutton<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.9%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Everett Monroe <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-size: 10pt">Daniel O. Ritt Trust <sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">Peter D'Arruda <sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">James H. Ballengee<sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,009,552</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.66%</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><i>(continued)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and Address of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of<br /> Class B<br /> Units of<br /> VV RII<br /> Beneficially<br /> Owned</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage<br /> of VV RII<br /> Class B<br /> Units<br /> Beneficially<br /> Owned</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">Matt Nicosia, Chief Executive Officer and Director <sup>(1)(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Tyler Nelson, Chief Financial Officer<sup>(12)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">Daniel Hashim, Chief Scientific Officer <sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Al Ferrara, Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">Trent Staggs, Director <sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Matthew Balk, Director</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">All Officers and Directors as a group (seven persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline; text-align: left">5% Beneficial Stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">AKMN Irrevocable Trust <sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">Benchmark FBO E.F. Hutton <sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left"><span style="font-size: 10pt">Everett Monroe <sup>(6)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">90,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">7.88%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-size: 10pt">Daniel O. Ritt Trust <sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.69%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">Peter D'Arruda <sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">60,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.25%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 10pt">James H. Ballengee<sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">______________________</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>*</td>
    <td>Less than 1%</td></tr>
  <tr style="vertical-align: top">
    <td>(1)</td>
    <td style="text-align: justify">The address for these stockholders is: c/o Vivakor, Inc., 4101 North Thanksgiving Way, Lehi, Utah, 84043.</td></tr>
  <tr style="vertical-align: top">
    <td>(2)</td>
    <td style="text-align: justify">The shares of common stock beneficially owned by Matthew Nicosia includes 4,189,405 shares of common stock held by AKMN Irrevocable Trust and 262 shares of common stock held by Nicosia Family Trust. Matthew Nicosia is the trustee of the AKMN Irrevocable Trust, of which Jonathan Nicosia, Matthew Nicosia&#8217;s son, a minor, is the beneficiary. Does not include options to purchase 955,093 shares of common stock.</td></tr>
  <tr style="vertical-align: top">
    <td>(3)</td>
    <td style="text-align: justify">The 166,667 shares of common stock beneficially owned by Dr. Hashim are directly held by CSS Nanotech Ltd. Dr. Hashim is the Chief Executive Officer of CSS Nanotech Ltd.</td></tr>
  <tr style="vertical-align: top">
    <td>(4)</td>
    <td style="text-align: justify">The 336,667 shares of common stock beneficially owned by Trent Staggs are held by TABBS Irrevocable Trust. Trent Staggs is the trustee of TABBS Irrevocable Trust, of which Brennan Trent Staggs and Brecklyn Staggs, Trent Staggs&#8217;s children, are the beneficiaries.</td></tr>
  <tr style="vertical-align: top">
    <td>(5)</td>
    <td style="text-align: justify">Sustainable Fuels, Inc. is owned by Debbie Carpenter, who may be deemed the beneficial owner of these shares. The address for Sustainable Fuels, Inc. is 10124 Marchant Avenue Tustin, CA 92872.</td></tr>
  <tr style="vertical-align: top">
    <td>(6)</td>
    <td style="text-align: justify">Everett Monroe&#8217;s address is 5813 114th Street, Lubbock TX 79424.</td></tr>
  <tr style="vertical-align: top">
    <td>(7)</td>
    <td style="text-align: justify">Daniel O. Ritt Trust&#8217;s address is 168 Dover Pkwy, Stewart Manor, NY 11530.</td></tr>
  <tr style="vertical-align: top">
    <td>(8)</td>
    <td style="text-align: justify">Peter D&#8217;Arruda&#8217;s address is 124 Poppleford Place, Cary, NC 27518.</td></tr>
  <tr style="vertical-align: top">
    <td>(9)</td>
    <td style="text-align: justify">James H. Ballengee&#8217;s address is 5151 Beltline Road, Suite 715 Dallas, Texas 75234. Includes 2,979,456 shares of common
    stock held in the name of Jorgan Development, LLC and 30,096 shares of common stock held in the name of JBAH Holdings,
    LLC. James Ballengee, in his capacity as sole manager, has sole voting and investment power over both Jorgan Development,
    LLC and JBAH Holdings, LLC.</td></tr>
  <tr style="vertical-align: top">
    <td>(10)</td>
    <td style="text-align: justify">Does not include options to purchase 917,825 shares of common stock.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_311"></span>SELLING STOCKHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3,009,552 shares of our Common Stock issued to
the Selling Stockholders pursuant to the MIPA, see &#8220;<i><a href="#a_301">Prospectus Summary</a></i>&#8212;<i>Recent Development</i>&#8221; and &#8220;<i><a href="#a_307">Business</a></i>&#8212;<i>Recent
Development</i>&#8221; above. We are registering the shares of our Common Stock in order to permit the Selling Stockholders to offer the
shares for resale from time to time. Except as otherwise described in the footnotes to the table below and for the ownership of the registered
shares issued pursuant to the Membership Interest Purchase Agreement, neither the Selling Stockholders nor any of the persons that control
them has had any material relationships with us or our affiliates within the past three (3) years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below lists the Selling Stockholders
and other information regarding the beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as
amended (the &#8220;Exchange Act&#8221;) (and the rules and regulations thereunder) of the shares of our Common Stock by each of the Selling
Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The second column lists the number of shares of
our Common Stock beneficially owned by each Selling Stockholder before this Offering (including shares which the Selling Stockholder has
the right to acquire within 60 days, including upon conversion of any convertible securities).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The third column lists the shares of our Common
Stock being offered by this prospectus by each Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fourth and fifth columns list the number of
shares of Common Stock beneficially owned by each Selling Stockholder and their percentage ownership after the Offering (including shares
which the Selling Stockholder has the right to acquire within 60 days), assuming the sale of all of the shares offered by each Selling
Stockholder pursuant to this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amounts and information set forth below are
based upon information provided to us by the Selling Stockholders as of September 15, 2022, except as otherwise noted below. The Selling
Stockholders may sell all or some of the shares of Common Stock it is offering, and may sell, unless indicated otherwise in the footnotes
below, shares of our Common Stock otherwise than pursuant to this prospectus. The tables below assume the Selling Stockholders sell all
of the shares offered by them in offerings pursuant to this prospectus, and do not acquire any additional shares. We are unable to determine
the exact number of shares that will actually be sold or when or if these sales will occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Selling Stockholders</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br /> Owned Before<br /> Offering</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares Offered<br /> Hereby</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares <br /> Owned After <br /> Offering (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage of Shares Beneficially Owned After Offering (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Jorgan Development, LLC (2)(3)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">2,979,456</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">2,979,456</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">0%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">JBAH Holdings, LLC (2)(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,096</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,096</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0%</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">(1)</td>
    <td style="text-align: justify">Assumes that all securities registered within this offering will be sold.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">(2)</td>
    <td style="text-align: justify">Issued pursuant to the MIPA.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px">(3)</td>
    <td style="text-align: justify">James Ballengee, sole manager with sole voting and investment power over Jorgan Development, LLC may be deemed to share voting and voting power with respect to these shares. The address of Jorgan Developmet, LLC is 5151 Beltline Road, Suite 715, Dallas, Texas 75234.</td></tr>
  <tr style="vertical-align: top">
    <td>(4)</td>
    <td style="text-align: justify">James Ballengee, sole manager with sole voting and investment power over JBAH Holdings, LLC may be deemed to share voting and voting power with respect to these shares. The address of JBAH Holdings, LLC is 5151 Beltline Road, Suite 715, Dallas, Texas 75234.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_312"></span>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a description of each transaction
from January 1, 2019 to December 31, 2021 and each currently proposed transaction in which:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="text-align: center; width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 94%">we have been or are to be a participant;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="text-align: center; width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 94%">the amount involved exceeded the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed fiscal years; and</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.4pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
    <td style="text-align: center; width: 3%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 94%">any of our directors, executive officers or holders of more than 5% of our outstanding capital stock, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current policy with regard to related party
transactions is for the Board as a whole to approve any material transactions involving our directors, executive officers or holders of
more than 5% of our outstanding capital stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2020, we entered into a consulting
contract with LBL Professional Consulting, Inc. (&#8220;LBL&#8221;), of which Tyler Nelson is a common officer, which remains in effect.
For the years ended December 31, 2021 and 2020, we paid LBL $188,150 and $191,295, respectively, for serving us. On December 17, 2020
the Company granted non-statutory stock options to LBL to purchase 333,334 shares of common stock. The stock options vest over four years.
The stock option is exercisable up to ten years from the grant date. Mr. Nelson is not the beneficiary of the Company and is not be permitted
to participate in any discussion, including LBL&#8217;s board meetings, regarding any Company stock that LBL may own at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have an existing note payable issued to Triple
T, which is owned by Dr. Khalid Bin Jabor Al Thani, the 51% majority-owner of Vivakor Middle East LLC The note is interest free, has no
fixed maturity date and will be repaid from revenues generated by Vivakor Middle East LLC. As of December 31, 2021 and 2020 the balance
owed was $353,330 and $376,972, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2020, the Company entered into an agreement
with International Metals Exchange, LLC (&#8220;IME&#8221;), giving IME the option to purchase approximately 1,331 ounces of our precious
metal concentrate for approximately $2,800,000. VVMCI, a wholly-owned subsidiary of Vivakor, Inc. owns all of the Class A Units of IME,
which have sole voting power for all material matters except for removal of the manager, and VVMCI serves as a manager of IME. The option
agreement expired on December 31, 2020. For the years ended December 31, 2021 and 2020, the Company has sold none and $54,250 of the precious
metal concentrate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 20, 2021, the Company entered into
a worldwide, exclusive license agreement with TBT Group, Inc. (of which an independent Vivakor Board member is a 7% shareholder) to license
piezo electric and energy harvesting technologies for creating self-powered sensors for making smart roadways. The Company paid $25,000
and 16,667 shares of restricted common stock upon signing and $225,000 as of April 5, 2022. When the licensor delivers to the Company
data showing that the sensor performs based on mutually defined specifications and all designs for the sensor are completed, Company shall
pay an additional $250,000 and 16,667 shares of restricted common stock. Upon the delivery of a mutually agreed working prototype, Company
will pay licensor $250,000 and 16,667 shares of restricted common stock. Upon commercialization of the product, the Company will pay licensor
$250,000 and 33,333 shares of restricted common stock. TBT shall have the option, at its sole discretion, to convert the license to a
non-exclusive license if the Company fails to pay $500,000 to TBT for sensor inventory per year, which will commence after the second
anniversary of product commercialization. The Company shall share in the development costs of the sensor technology to the time of commercialization.
Total costs attributed to the Company are estimated to be $125,000. From May, 2021 through March 3, 2022, the parties amended the license
agreement to extend the terms of the first milestone to March 4, 2022, of which we paid $15,000 as consideration for the extensions and
$225,000 to be paid on March 4, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Policy on Future Related-Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All future transactions between us and our officers,
directors, principal stockholders and their affiliates will be approved by the audit committee, or a similar committee consisting of entirely
independent directors, according to the terms of our Code of Business Conduct and Ethics and our Related-Party Transaction Policies and
Procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><span id="a_313"></span>DIVIDEND POLICY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We have never paid any
cash dividends on our capital stock and do not anticipate paying any cash dividends on our Common Stock in the foreseeable future. We
intend to retain future earnings to fund ongoing operations and future capital requirements. Any future determination to pay cash dividends
will be at the discretion of our board of directors and will be dependent upon financial condition, results of operations, capital requirements
and such other factors as the board of directors deems relevant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><span id="a_314"></span>DETERMINATION OF OFFERING
PRICE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Selling Stockholders
may sell all or a portion of their shares through public or private transactions at prevailing market prices or at privately negotiated
prices. All shares being offered pursuant to this prospectus will be sold by the Selling Stockholders without our involvement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_315"></span>DESCRIPTION OF SECURITIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Introduction</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the discussion that follows, we have summarized
selected provisions of our articles of incorporation, bylaws and the Nevada Revised Statutes relating to our capital stock. This summary
is not complete. This discussion is subject to the relevant provisions of Nevada law and is qualified by reference to our articles of
incorporation and our bylaws. You should read the provisions of our articles of incorporation and our bylaws as currently in effect for
provisions that may be important to you.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Current Amended and Restated Articles of Incorporation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Authorized Capital Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are currently authorized to issue up to 56,666,667
shares of capital stock consisting of: 41,666,667 shares of common stock, par value $0.001 per share, and 15,000,000 shares of preferred
stock, par value of $0.001 per share. As of September 9, 2022, there were 18,064,838 shares of common stock that were issued and outstanding
and held of record by 569 stockholders. As of September 9, 2022, there were no shares of preferred stock outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of our common stock are each entitled
to cast one vote for each share held of record on all matters presented to the shareholders. Cumulative voting is not allowed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of our common stock are entitled to receive
such dividends as may be declared by our Board of Directors out of funds legally available (subject to the rights of holders of all classes
of stock at the time outstanding having prior rights as to dividends) and, in the event of liquidation, to share pro rata in any distribution
of our assets after payment of liabilities (subject to the rights of holders of all classes of stock at the time outstanding having prior
rights as to distributions). Our Board of Directors is not obligated to declare a dividend. It is not anticipated that dividends will
be paid in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of our common stock do not have preemptive
rights to subscribe to additional shares if issued. There is no conversion, redemption, sinking fund or similar provisions regarding the
common stock. All outstanding shares of common stock are fully paid and non-assessable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Preferred Stock </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are authorized to issue 15,000,000 shares of
preferred stock, of which 11,666,667 shares have been designated as follows: (i) 66,667 shares of Series A preferred stock, of which zero
are outstanding as of September <span style="font-size: 10pt">9</span>, 2022; (ii) 3,266,666 shares of Series B preferred stock, of which
zero are outstanding as of September <span style="font-size: 10pt">9</span>, 2022; (iii) 1,666,667 shares of Series B-1 preferred stock,
of which zero are outstanding as of September <span style="font-size: 10pt">9</span>, 2022; (iv) 3,333,333 shares of Series C preferred
stock, of which zero are outstanding as of September <span style="font-size: 10pt">9</span>, 2022; and (v) 3,333,333 shares of Series
C-1 preferred stock, of which zero shares are outstanding as of September <span style="font-size: 10pt">9</span>, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An additional 166,667 shares may be designated
from time to time in one or more series as may be determined by our Board of Directors, subject to the protective rights of any classes
of preferred stock then outstanding, with the voting powers and preferences, the relative rights of each such series and the qualifications,
limitations and restrictions of each such series of undesignated shares to be established by the Board of Directors. Our directors may
issue preferred stock with multiple votes per share and dividend rights which would have priority over any dividends paid with respect
to the holders of our common stock. The issuance of preferred stock with these rights may make the removal of management difficult even
if the removal would be considered beneficial to shareholders generally, and will have the effect of limiting shareholder participation
in transactions such as mergers or tender offers if these transactions are not favored by our management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are currently no shares of Series A preferred
stock outstanding. The Series A Preferred Stock provides holders the right to convert each share into shares of common stock at a conversion
price of $0.60 per share, subject to adjustment. Holders of the Series A preferred stock are not entitled to receive dividends. Holders
of Series A preferred stock have the right to 25 votes for each share of common stock into which such shares of Series A Preferred Stock
may then be converted. Holders of Series A preferred stock are entitled to receive liquidation preference, prior to and in preference
to any distribution of any of the assets of the Company to the holders of common stock, or any other series of preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are currently no shares of Series B preferred
stock outstanding. The Series B Preferred Stock provides holders the right to convert, at any time on or after the date that is one (1)
year after the date of issuance of such share, at a conversion price that is the lesser of (i) the Original Series B Issue Price and (ii)
ninety percent (90%) of the Market Price (as defined in the Company&#8217;s Articles of Incorporation, as amended); provided, however,
upon the earlier to occur of a Qualified Public Offering (as defined in the Company&#8217;s Articles of Incorporation, as amended) or
May 1, 2021, each share of Series B Preferred Stock is convertible into one share of common stock. Holders of Series B preferred stock
are entitled to receive dividends at the rate of $0.75 per share per annum. Each Holder of Series B is entitled to vote upon matters presented
to the Company&#8217;s shareholders on an as converted basis. Holders of Series B preferred stock are entitled to receive liquidation
preference, prior to and in preference to any distribution of any of the assets of the Company to the holders of common stock, Series
A preferred stock or any other series of preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are currently no shares of Series B-1 preferred
stock outstanding. The Series B-1 Preferred Stock provides holders the right to convert at any time on or after the date that is one (1)
year after the date of issuance of such share, at a conversion price that is the lesser of (i) the Original Series B-1 Issue Price and
(ii) ninety percent (90%) of the Market Price; provided, however, upon the earlier to occur of a Qualified Public Offering or May 1, 2021,
each share of Series B-1 Preferred Stock is convertible into one share of common stock. Holders of Series B-1 preferred stock are not
entitled to receive dividends. Holders of Series B-1 preferred stock are not entitled to vote on matters presented to the shareholders
of the Company. Holders of Series B-1 preferred stock are entitled to receive liquidation preference, <i>pari passu</i> with the holders
of Series B preferred stock and prior to and in preference to any distribution of any of the assets of the Company to holders of common
stock, Series A preferred stock, Series C preferred stock, Series C-1 preferred stock, or any other class of preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are currently no shares of Series C preferred
stock outstanding. Holders of the Series C preferred stock would have the right to convert each share into common stock in the number
of fully paid and nonassessable shares of common stock at a conversion price of the lesser of (i) $10.50 per share and (ii) ninety percent
(90%) Market Price (as defined in the Company&#8217;s Articles of Incorporation, as amended); provided, however, upon the earlier to occur
of a Qualified Public Offering (as defined in the Company&#8217;s Articles of Incorporation, as amended) or May 4, 2021, each share of
Series B Preferred Stock is convertible into one share of common stock. Holders of Series C preferred stock would be entitled to receive
dividends at the rate of $1.3125 per share per annum. Holders of Series C preferred stock would be entitled to vote upon matter presented
to the Company&#8217;s shareholders on an as converted basis. Holders of Series C preferred stock are entitled to receive liquidation
preference, prior to and in preference to any distribution of any of the assets of the Company to the holders of common stock, Series
A Preferred Stock or any other series of preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are currently no shares of Series C-1 preferred
stock outstanding, as shares of Series C-1 Preferred Stock were converted to common stock on May 4, 2021. The Series C-1 Preferred Stock
provides holders the right to convert each share into one share of common stock. All Series C-1 Preferred Stock was auto converted to common
stock on May 4, 2021. Holders of Series C-1 preferred stock are not entitled to receive dividends. Holders of Series C-1 preferred stock
shall be entitled to vote on all matters submitted to the shareholders of the Company on an as-converted basis. Holders of Series C-1
Preferred Stock are entitled to receive liquidation preference, <i>pari passu</i> with the holders of Series C Preferred Stock and prior
to and in preference to any distribution of any of the assets of the Company to the holders of common stock, Series A preferred stock
or any other series of preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the Second Amended and
Restated Articles of Incorporation, the holders of common stock will be entitled to one vote per share on all matters to be voted upon
by the shareholders, except on matters relating solely to terms of preferred stock. Subject to preferences that may be applicable to any
outstanding preferred stock, the holders of common stock will be entitled to receive ratably such dividends, if any, as may be declared
from time to time by the board of directors out of funds legally available therefor. See &#8220;<i><a href="#a_313">Dividend Policy</a></i>.&#8221; In the
event of our liquidation, dissolution or winding up, the holders of our common stock will be entitled to share ratably in all assets remaining
after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding. The holders of our common
stock will have no preemptive or conversion rights or other subscription rights. There will be no redemption or sinking fund provisions
applicable to our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Preferred Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the Second Amended and
Restated Articles of Incorporation, our board of directors will have the authority to issue preferred stock in one or more classes or
series and to fix the designations, powers, preferences and rights, and the qualifications, limitations or restrictions thereof, including
dividend rights, conversion right, voting rights, terms of redemption, liquidation preferences and the number of shares constituting any
class or series, without further vote or action by the stockholders. Although we have no present plans to issue any shares of preferred
stock, the issuance of shares of preferred stock, or the issuance of rights to purchase such shares, could decrease the amount of earnings
and assets available for distribution to the holders of common stock, could adversely affect the rights and powers, including voting rights,
of the common stock, and could have the effect of delaying, deterring or preventing a change of control of us or an unsolicited acquisition
proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Limitation on Directors&#8217; Liability</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nevada Revised Statutes limits or eliminates
the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors&#8217; fiduciary
duties as directors. Our bylaws include provisions that require the company to indemnify our directors or officers against monetary damages
for actions taken as a director or officer of our Company. We are also expressly authorized to carry directors&#8217; and officers&#8217;
insurance to protect our directors, officers, employees and agents for certain liabilities. Our Second Amended and Restated Articles of
Incorporation do not contain any limiting language regarding director immunity from liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The limitation of liability and indemnification
provisions under the Nevada Revised Statutes and our bylaws may discourage stockholders from bringing a lawsuit against directors for
breach of their fiduciary duties. These provisions may also have the effect of reducing the likelihood of derivative litigation against
directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. However, these provisions
do not limit or eliminate our rights, or those of any stockholder, to seek non-monetary relief such as injunction or rescission in the
event of a breach of a director&#8217;s fiduciary duties. Moreover, the provisions do not alter the liability of directors under the federal
securities laws. In addition, your investment may be adversely affected to the extent that, in a class action or direct suit, we pay the
costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nevada Anti-Takeover Statute</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be subject to Nevada&#8217;s Combination
with Interested Stockholders Statute (Nevada Corporation Law Sections 78.411-78.444) which prohibits an &#8220;interested stockholder&#8221;
from entering into a &#8220;combination&#8221; with the corporation, unless certain conditions are met. An &#8220;interested stockholder&#8221;
is a person who, together with affiliates and associates, beneficially owns (or within the prior two years, did beneficially own) 10%
or more of the corporation&#8217;s capital stock entitled to vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Forum for Litigation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Second Amended and Restated Articles of Incorporation
provide that, to the fullest extent permitted by law, and unless the Company consents in writing to the selection of an alternative forum,
the Eighth Judicial District Court of Clark County, Nevada, shall, to the fullest extent permitted by law, be the sole and exclusive forum
for state law claims with respect to: (a) any derivative action or proceeding brought in the name or right of the Company or on its behalf,
(b) any action asserting a claim for breach of any fiduciary duty owed by any director, officer, employee or agent of the Company to the
Company or the Company&#8217;s stockholders, (c) any action arising or asserting a claim arising pursuant to any provision of NRS Chapters
78 or 92A or any provision of these Second Amended and Restated Articles of Incorporation or the bylaws or (d) any action asserting a
claim governed by the internal affairs doctrine, including, without limitation, any action to interpret, apply, enforce or determine the
validity of the Second Amended and Restated Articles of Incorporation or the bylaws. The Second Amended and Restated Articles of Incorporation
further provide that, for the avoidance of doubt, this exclusive forum provision shall not be applicable to any action brought under the
Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, and that, unless the Company consents in writing
to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for
the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. Any person or entity
purchasing or otherwise acquiring any interest in shares of capital stock of the Company shall be deemed to have notice of and consented
to the provisions of Article XV of the Second Amended and Restated Articles of Incorporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless the Company consents in writing to the
selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution
of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. There exists uncertainty, however,
as to whether such forum selection provisions of our Second Amended and Restated Articles of Incorporation would be enforced by a court.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Transfer Agent and Registrar</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent and registrar for our common
stock is Empire Stock Transfer with an address at 1859 Whitney Mesa Drive, Henderson, Nevada 89014.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Listing</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is currently listed on the Nasdaq
Capital Market under the symbol &#8220;VIVK&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_316"></span>PLAN OF DISTRIBUTION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Selling Stockholder of the securities and
any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby
on Nasdaq or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These
sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">an exchange distribution in accordance with the rules of the applicable exchange;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">privately negotiated transactions;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">settlement of short sales;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">through the writing or settlement of options or
    other hedging transactions, whether through an option</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">exchange or otherwise;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">a combination of any such methods of sale; or</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify">any other method permitted pursuant to applicable law.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders may also sell securities
under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;),
if available, rather than under this prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broker-dealers engaged by the Selling Stockholders
may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders
(or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except
as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission
in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the sale of the securities
or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions,
which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders
may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers
that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with broker-dealers
or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other
financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may
resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Selling Stockholders and any broker-dealers
or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities
Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale
of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder
has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person
to distribute the securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is required to pay certain fees and
expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders
against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We agreed to keep this prospectus effective until
the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard
to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the
current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have
been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under applicable rules and regulations under the
Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities
with respect to the Common Stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution.
In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder,
including Regulation M, which may limit the timing of purchases and sales of the Common Stock by the Selling Stockholders or any other
person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy
of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_317"></span>LEGAL MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The validity of the securities being offered by
this prospectus has been passed upon for us by Lucosky Brookman LLP, Woodbridge, New Jersey.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_318"></span>EXPERTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated balance sheets of Vivakor, Inc.
for the years ended December 31, 2021 and December 31, 2020, and the related consolidated statements of operations, changes in stockholders&#8217;
deficit, and cash flows for the years then ended, have been audited by Macias Gini &amp; O&#8217;Connell, LLP, an independent registered
public accounting firm, as set forth in its report appearing herein and are included in reliance upon such report given on the authority
of said firms as experts in accounting and auditing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_319"></span>WHERE YOU CAN FIND MORE INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have filed with the SEC a registration statement
on Form S-1 under the Securities Act with respect to the shares offered hereby. This prospectus, which constitutes a part of the registration
statement, does not contain all of the information in the registration statement and the exhibits of the registration statement. For further
information with respect to us and the securities being offered under this prospectus, we refer you to the registration statement, including
the exhibits and schedules thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC maintains a website, which is located
at <i>www.sec.gov</i>, which contains reports, proxy and information statements and other information regarding issuers that file electronically
with the SEC. You may access the registration statement of which this prospectus is a part at the SEC&#8217;s website. We are subject
to the information reporting requirements of the Exchange Act, and we will file reports, proxy statements and other information with the
SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_320"></span>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>Page</b></td></tr>
<tr>
    <td style="width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">Condensed Consolidated Balance Sheets
    as of June 30, 2022 (unaudited) and December 31, 2021</a></span></td>
    <td style="vertical-align: bottom; text-align: center; width: 49px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">Condensed Consolidated Statements of
    Operations for the Three and Six Months ended June 30, 2022 and 2021 (unaudited)</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-3</td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">Condensed Consolidated Statements of
    Changes in Stockholders&#8217; Equity for the Three and Six Months ended June 30, 2022 and 2021 (unaudited)</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-4</td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">Condensed Consolidated Statements of
    Cash Flows for the Six Months ended June 30, 2022 and 2021 (unaudited)</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-5</td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></td>
    <td style="vertical-align: bottom; text-align: center">F-7</td></tr>

<tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><a href="#a_300">Report of Independent Registered Public Accounting Firm</a> (PCAOB Firm ID
    324)</td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">F-21</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt">&#160;</td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><a href="#a22">Audited Consolidated Balance Sheets as of December 31, 2021 and 2020
    (As Restated)</a></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">F-22</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt">&#160;</td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><a href="#a23">Audited Consolidated Statements of Operations for the Years Ended
    December 31, 2021 and 2020 (As Restated)</a></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">F-23</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt">&#160;</td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><a href="#a24">Audited Statement of Consolidated Changes in Stockholders&#8217;
    Equity (Deficit) for the Years Ended December 31, 2021 and 2020 (As Restated)</a></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">F-24</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt">&#160;</td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><a href="#a26">Audited Statements of Consolidated Cash Flows for the Years Ended
    December 31, 2021 and 2020 (As Restated)</a></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">F-25</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt">&#160;</td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><a href="#a27">Notes to the Consolidated Financial Statements (As Restated)</a></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center">F-26</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 76; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_004"></span>CONDENSED CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_306_111_z0WiZjTCGDS2" summary="xdx: Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20220630_zfnMPOFIXLQ" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20211231_zDTFUUZE0Jt" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsAbstract_iB_zXPjkjB4nFad" style="vertical-align: bottom">
    <td style="text-decoration: underline; font-weight: bold; text-align: left">ASSETS</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(As Restated)</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_i01B_zlPvgaJnbn0d" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCzld8_zPLpKKKNdvIa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 66%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,908,334</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,293,767</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--CashAndCashEquivalentsAttributedToVariableInterestEntity_i02I_maCzld8_zdo7fXF5Iwbc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Cash and cash equivalents attributed to variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CashAndCashEquivalentsAttributedToVariableInterestEntity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">296,257</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CashAndCashEquivalentsAttributedToVariableInterestEntity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,952</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccountsNotesAndLoansReceivableNetCurrent_i02I_p0p0_maCzld8_zv4LFky4Q8p6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts Receivable, less allowances of <span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_p0p0_dn_c20220630_z3Rp4ni4ob03" title="Accounts receivable allowance"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">none</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20211231_p0p0_zBemgTNf0JJ" title="Accounts receivable allowance"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,000</ix:nonFraction></span>, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">845</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">845</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_i02I_maCzld8_z3rSjPSsC1K9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,818,029</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,231,218</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryNet_i02I_maCzld8_z6tOj9NHDTJ6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">222,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--PreciousMetalConcentrate_i02I_maCzld8_zsgBLYfHOMyl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Precious metal concentrate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:PreciousMetalConcentrate" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,166,709</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:PreciousMetalConcentrate" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,166,709</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsCurrent_i02I_maCzld8_z0XTwvJOLsi4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">237,422</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,245</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsCurrent_i01TI_mtCzld8_maCzwZZ_z8Em6YvFeg6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,649,596</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,157,736</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherInvestments_i01I_maCzwZZ_zvF8PJtVyTal" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Other investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherInvestments" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherInvestments" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NotesReceivableRelatedParties_i01I_maCzwZZ_z9mYTyYHa2Wf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesReceivableRelatedParties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,150,743</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesReceivableRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,194,235</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzwZZ_zHdmlAVo6hMi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,878,930</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,692,111</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzwZZ_z19XsF0gtxrh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Rights of use assets- operating leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">721,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">663,291</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--LicenseAgreementNet_i01I_maCzwZZ_zcEprFZ2Dvd5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">License agreement, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:LicenseAgreementNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,291,942</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:LicenseAgreementNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,370,835</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--IntellectualPropertyNet_i01I_maCzwZZ_zH8TzSEvOYcd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Intellectual property, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="VIVK:IntellectualPropertyNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,002,504</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="VIVK:IntellectualPropertyNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,662,037</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Assets_iTI_mtCzwZZ_zLH4X4F9u3hf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,699,265</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,744,245</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zP0fZe7EvLGh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline; font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zyioKJK5HUb6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maCzMtr_zJYHrAaJVagj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,061,610</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,023,985</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzMtr_zonHqvqHoWGh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating lease liabilities, current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">364,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">287,769</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--LoansAndNotesPayableCurrent_i02I_maCzMtr_zZsEFJDY9nci" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Loans and notes payable, current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:LoansAndNotesPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">962,405</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:LoansAndNotesPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,511,447</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_i02I_maCzMtr_zR7pbJf9zQLi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Loans and notes payable, current attributed to variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,308,232</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,416,379</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OtherLongTermDebtCurrent_i02I_maCzMtr_zJQWPkRQh3Ae" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Long-term debt (working interest royalty programs), current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLongTermDebtCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,565</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLongTermDebtCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,256</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrent_i01TI_mtCzMtr_maCzmQp_zXI37KOm0sr9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,704,915</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,242,836</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCzmQp_zhWWZbjCb7E4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease liabilities, long term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">414,947</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">434,109</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermNotesAndLoans_i01I_maCzmQp_zjr8z4j7sIh3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loans and notes payable, long term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesAndLoans" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">543,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermNotesAndLoans" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,185,970</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OtherLongTermDebtNoncurrent_i01I_maCzmQp_zqmA6nPz4tY2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long-term debt (working interest royalty programs)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLongTermDebtNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,017,592</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLongTermDebtNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,171,298</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i01I_maCzmQp_zKoWtP9pR9pj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Deferred income tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,156,899</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,156,899</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--Liabilities_iTI_mtCzmQp_maLASEzLBj_zos8BRySQ2a6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,838,222</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,191,112</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockholdersEquityAbstract_iB_zbHxSluUK3S" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stockholders' equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PreferredStockValue_i01I_d0_maCzB74_zNPnbgMVh0fe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Convertible, preferred stock, $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_pdd_z5j2kQBrxt18" title="Preferred stock, par value"><span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_pdd_zfPpPqvobCz3" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zchhZSuNWJN4" title="Preferred stock shares authorized"><span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zfPCJjMfERSg" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,400,000</ix:nonFraction></ix:nonFraction></span></span> shares
    authorized;<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup> Series A- <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zvv3lSZuz3A9" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zP2GBFwjL3Vg" title="Preferred stock, shares outstanding"><span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zkq8byqFlbzg" title="Preferred stock, shares issued"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zZQNBxIA5pA4" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,667</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and
    outstanding<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockValue_i01I_maCzB74_zZgk0DCCdNFj" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Common stock, $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20220630_pdd_zLFeayUc3l44" title="Common stock, par value"><span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231_pdd_zgB22vGMxKZ" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_c20220630_pdd_zQ4VWSGcdfc9" title="Common stock, shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20211231_pdd_zEWVmdAecJYh" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">41,666,667</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_904_eus-gaap--CommonStockSharesIssued_c20220630_pdd_z0nM5jPbaMxf" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_c20220630_pdd_zepAIhkFhy94" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,038,619</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_909_eus-gaap--CommonStockSharesIssued_c20211231_pdd_zEdVGEpYEVf7" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_c20211231_pdd_zVEB5Md5xwrg" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,330,859</ix:nonFraction></ix:nonFraction></span></span> were issued and outstanding as of June 30, 2022 and December 31, 2021<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,039</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,331</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AdditionalPaidInCapital_i01I_maCzB74_zfk1x6S56nB6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,857,646</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,279,590</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--TreasuryStockCarryingBasis_i01NI_di_msCzB74_zsBiyWkGxjVl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Treasury stock, at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockCarryingBasis" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockCarryingBasis" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maCzB74_zrUPYqMcnthb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,237,559</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">35,731,359</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockholdersEquity_i01TI_mtCzB74_maSEIPAz6PR_zhKaB9AUzv01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Vivakor, Inc. stockholders' equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,615,126</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,540,629</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--MinorityInterest_i01I_maSEIPAz6PR_zJd47x8hRmpf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,245,917</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,012,504</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtSEIPAz6PR_maLASEzLBj_zXkso2pmPdnk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total stockholders' equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,861,043</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,553,133</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_p0p0_mtLASEzLBj_zKFUFDxT1X7g" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&#8217; equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,699,265</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,744,245</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%">(1)</td>
    <td style="text-align: justify; width: 96%"> Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 &#8211; Organization and Basis of Presentation for additional information</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to consolidated financial
statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="a_005"></span>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_113_ztk6ssaWM693" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_496_20220401__20220630_zq0QDUvAJIs9" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49A_20210401__20210630_ztnNSMhDmxdk" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_492_20220101__20220630_zHts55pL25ca" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20210630_zgzw4OxMIG4d" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Revenues_d0_maCzXAH_zdNXtThPlueh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CostOfRevenue_d0_msCzXAH_zwRZvJCVtZN9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Cost of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-04-012022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,530</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,450</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GrossProfit_iT_d0_mtCzXAH_maCzXVt_zqzvV3D0tTGh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-04-012022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,470</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,550</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OperatingExpensesAbstract_iB_zhx35cc6YHi5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--SellingAndMarketingExpense_maCzLtc_zBG2o2oJF8J7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">119,252</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,912</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">310,591</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">828,440</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--GeneralAndAdministrativeExpense_maCzLtc_zykblmQUT9Oi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,922,753</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,235,549</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,235,560</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,309,394</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationAndAmortization_maCzLtc_znVjnFDjmrN4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Amortization and depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">558,595</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">364,635</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">933,813</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">727,914</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpenses_iT_mtCzLtc_msCzXVt_zdGHrT6Xrit" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,600,600</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,726,096</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,479,964</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,865,748</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_iT_mtCzXVt_maCzlHF_zKguQe56nnFj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,600,600</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,724,626</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,479,964</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,861,198</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zNAWIOvZu5ai" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other income (expense):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_maCzYdz_zUFtw6LMKQxd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Unrealized gain (loss) on marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,652,755</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,949,169</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">413,189</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,734,275</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InterestAndOtherIncome_maCzYdz_zvHgmiZ6Xs25" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,083</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,461</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,485</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--InterestExpenseOther_iN_di_msCzYdz_zJBx3ASLSlwb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,981</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241,448</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">114,946</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">395,469</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--GainLossOnDispositionOfAssets_d0_maCzYdz_z3Nz5IBQJLaf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Gain on disposition of asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2021-04-012021-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2021-01-012021-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherNonoperatingIncome_maCzYdz_zxnBda1JOeLi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,934</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,590</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,084</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncome" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,884</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NonoperatingIncomeExpense_iT_p0p0_mtCzYdz_maCzlHF_zOaf4LWVJ8E8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,627,263</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,096,785</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">473,134</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,435,175</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProfitLoss_iT_mtCzlHF_maCzIuc_zRh5lNpOrgz9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loss before provision for income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,227,863</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,821,411</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,953,098</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">426,023</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iN_di0_msCzIuc_zXuYnMWDXKye" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Provision for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-04-012022-06-30" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">296,477</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">723,911</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_iT_p0p0_mtCzIuc_maILFCOzSV3_zdml5fZryzSe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Consolidated net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,227,863</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,524,934</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,953,898</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,149,934</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossAttributableToNoncontrollingInterest_msILFCOzSV3_z1lsQAWJ5641" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Net loss attributable to noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">322,546</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,114,003</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">447,698</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,255,844</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzSV3_zu1ZhfC4LPQh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss) attributable to Vivakor, Inc.</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,905,317</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,410,931</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,506,200</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,910</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperations_maNILATzILu_ztKcPshsFbD9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net loss attributable to common shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,905,317</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,410,931</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,506,200</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,910</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PreferredStockDividendsIncomeStatementImpact_d0_msNILATzILu_zyTvOxaB9GN1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dividend on preferred stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2022-04-012022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,196</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,196</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_p0p0_mtNILATzILu_zd6Bz8jBPwxe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="color: rgb(238,238,238); padding-bottom: 2.5pt">Net income loss to parent</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,905,317</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,453,127</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,506,200</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,714</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--EarningsPerShareBasic_z7AkM48sww03" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup id="xdx_F4B_zW3DmNhu06n4">(1)</sup></span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-04-012022-06-30" id="Fact000299" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.33</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-04-012021-06-30" id="Fact000300" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.79</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-06-30" id="Fact000301" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.38</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-06-30" id="Fact000302" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EarningsPerShareDiluted_zprblIOYoBE1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt">Diluted net income per share <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup id="xdx_F41_z1XmpHloW6ea">(1)</sup></span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-04-012022-06-30" id="Fact000304" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.33</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-04-012021-06-30" id="Fact000305" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.79</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-01to2022-06-30" id="Fact000306" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.38</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-06-30" id="Fact000307" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_ztdEHQC9dmTj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: 400; font-style: normal; text-align: left">Basic weighted average common shares outstanding <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup id="xdx_F40_zfouAsGZGlub">(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-04-012022-06-30" id="Fact000309" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,038,619</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-04-012021-06-30" id="Fact000310" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,966,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-06-30" id="Fact000311" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,388,004</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-06-30" id="Fact000312" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,640,306</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_d0_zsTLvhygJqyi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; font-weight: 400; font-style: normal; text-align: left">Effect of dilutive securities <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup id="xdx_F4C_zsSvtEYwCnP9">(1)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2022-04-012022-06-30" id="Fact000314" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-04-012021-06-30" id="Fact000315" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2022-01-01to2022-06-30" id="Fact000316" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-012021-06-30" id="Fact000317" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">910,483</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ProFormaWeightedAverageSharesOutstandingDiluted_zWc2aK6OGNWl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt">Diluted weighted average common shares outstanding <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup id="xdx_F41_zjm5E0i1u6W9">(1)</sup></span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted" contextRef="From2022-04-012022-06-30" id="Fact000319" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,038,619</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted" contextRef="From2021-04-012021-06-30" id="Fact000320" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,966,840</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted" contextRef="From2022-01-01to2022-06-30" id="Fact000321" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,388,004</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted" contextRef="From2021-01-012021-06-30" id="Fact000322" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,550,789</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_F02_zXyb1eSPaJh7" style="vertical-align: top; text-align: left; width: 4%">(1)</td>
    <td id="xdx_F13_zIIPshT3KGRl" style="text-align: justify; width: 96%"><ix:footnote id="Footnote000323" xml:lang="en-US">Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 &#8211; Organization and Basis of Presentation for additional information</ix:footnote></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to consolidated financial
statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="a_006"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_114_zKDP0b6yJsba" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)" style="font: 8pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zO0SuaYE2IKf" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zYFRP2B0uzg4" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_zZld14b9Sqbc" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zCDQlmfJ1Ixb" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zgeYrvgv82tc" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BF_z2ZC3omOg905" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Series A Preferred Stock</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Common Stock</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Additional Paid-in</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Treasury</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Accumulated</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Non-controlling</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Total Stockholders'</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"> Capital</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"> Stock</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"> Deficit</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"> Interest</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"> Equity</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_437_c20220401__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zyaOU2oAtmRf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; width: 28%">March 31, 2022 (unaudited)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_zNf5OujKbfD7" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0332">&#8211;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUJ0LdyKvKTd" title="Beginning balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,038,619</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,039</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,200,971</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,332,242</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,671,402</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,535,170</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockOptionsIssuedForServices_zHFJwaVkhwye" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Stock options issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0336">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">427,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0338">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0339">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0340">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">427,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zyS3sHkt0kil" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0343">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,229,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0345">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0346">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,229,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_p0p0_di_zV8RWo0pw28l" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Distributions by noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0351">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0352">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0353">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,939</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,939</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--IssuanceOfNoncontrollingInterest1_zAMfqyrtGIzf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Issuance of noncontrolling interest for a reduction of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0357">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0358">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0359">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0360">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,105,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,105,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zI4qJdp3ZvY1" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0364">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0365">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0366">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,905,317</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">322,546</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,227,863</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_438_c20220401__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zTNHUUEwqUi6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">June 30, 2022 (unaudited)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_z6UVeI1Y7Xca" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0378">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMyzLpIRcRI3" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,038,619</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,039</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,857,646</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,237,559</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,245,917</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,861,043</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Series A Preferred Stock</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Common Stock</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Additional Paid-in</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Treasury</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Accumulated</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Non-controlling</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Total Stockholders'</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; width: 28%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Capital</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Stock</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Deficit</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Interest</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Equity</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td></tr>

<tr id="xdx_433_c20220101__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zaGYaQaheaZd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; width: 28%"><span style="font-size: 8pt">December 31, 2021 <span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_zpldnXmWOoxa" title="Beginning balance, shares" style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_SeriesAPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,667</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">67</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzsi4GOmanZh" title="Beginning balance, shares" style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,330,859</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,331</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,279,590</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left; width: 1%">)</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">35,731,359</ix:nonFraction></td><td style="text-align: left; width: 1%">)</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,012,504</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,553,133</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--CommonStockIssuedForReductionInLiabilities_iP3us-gaap--SharesOutstanding_zZB7dyLgpkn3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Common Stock issued for a reduction of liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--CommonStockIssuedForReductionInLiabilitiesShares_iP3custom--CommonStockIssuedForReductionInLiabilities_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z80gnnQujD79" title="Common Stock issued for a reduction in liabilities, shares" style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilitiesShares" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">272,156</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">273</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,144,719</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0395">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0396">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0397">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,144,992</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ConversionOfSeriesPreferredStockToCommonStock_iP3custom--CommonStockIssuedForReductionInLiabilitiesShares_za5gEDpsAUwa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Conversion of Series A Preferred Stock to Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ConversionOfSeriesPreferredStockToCommonStockShares_iP3custom--ConversionOfSeriesPreferredStockToCommonStock_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_zWFV2QZpWRga" title="Conversion of Series A Preferred Stock to Common Stock, shares" style="text-align: right">(<ix:nonFraction name="VIVK:ConversionOfSeriesPreferredStockToCommonStockShares" contextRef="From2022-01-012022-06-30_custom_SeriesAPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">66,667</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(67</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--ConversionOfSeriesPreferredStockToCommonStockShares_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVv1ah1RIDKl" title="Conversion of Series A Preferred Stock to Common Stock, shares" style="text-align: right"><ix:nonFraction name="VIVK:ConversionOfSeriesPreferredStockToCommonStockShares" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">833,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:ConversionOfSeriesPreferredStockToCommonStock" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">833</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="VIVK:ConversionOfSeriesPreferredStockToCommonStock" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">766</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0404">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0406">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0407">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_iP3custom--ConversionOfSeriesPreferredStockToCommonStockShares_zQD1tfMRNjd1" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Common Stock issued for cash, net of offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_iP3us-gaap--StockIssuedDuringPeriodValueNewIssues_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8Iujh4B6Qwc" title="Common Stock issued for cash, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,238,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0416">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0417">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,240,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--CommonStockIssuedForFractionalSharesFromReverseStockSplit_iP3us-gaap--StockIssuedDuringPeriodSharesNewIssues_ze8ZuN3CQnZh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Common stock issued for fractional shares from reverse stock split</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--CommonStockIssuedForFractionalSharesFromReverseStockSplitShares_iP3custom--CommonStockIssuedForFractionalSharesFromReverseStockSplit_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdBaPY1JQOq5" title="Common stock issued for fractional shares from reverse stock split, shares" style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplitShares" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,271</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0424">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0426">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--StockOptionsIssuedForServices_zfRhDlCeuXZ2" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Stock options issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0431">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">855,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0433">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0434">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0435">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">855,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_z6SExN7Vg9p" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0438">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,340,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0440">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0441">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0442">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,340,703</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_p0p0_di_zCQ9ayGkGJm8" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Distributions by noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0445">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0446">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0447">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0448">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">343,889</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">343,889</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--IssuanceOfNoncontrollingInterest1_zEr8QibjdFgf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Issuance of noncontrolling interest for a reduction of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0452">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0453">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0454">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,025,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,025,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zZK7PtI4B0E" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0459">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0460">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0461">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,506,200</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">447,698</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,953,898</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20220101__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zoxGkawNimS7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">June 30, 2022 (unaudited)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_zdTG7i5i4CKh" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zB8B16I5YV5k" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,038,619</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,039</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,857,646</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,237,559</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,245,917</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,861,043</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Series A Preferred Stock</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Common Stock</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Additional Paid-in</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Treasury</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Accumulated</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Non-controlling</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Total Stockholders'</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; width: 28%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Capital</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Stock</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Deficit</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Interest</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Equity</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td></tr>

<tr id="xdx_43B_c20210401__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zOhdLc2sxqD8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; width: 28%"><span style="font-size: 8pt">March 31, 2021 <span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_zicuIEhlXdQc" title="Beginning balance, shares" style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_custom_SeriesAPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,667</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">67</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z75LtQJ6pX9d" title="Beginning balance, shares" style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,321,269</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,322</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,818,373</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left; width: 1%">)</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,688,151</ix:nonFraction></td><td style="text-align: left; width: 1%">)</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,137,248</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,258,859</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_409_ecustom--CommonStockIssuedForReductionInLiabilities_zHfE306dB3A1" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt"><span style="font-size: 8pt">Common Stock issued for a reduction of liabilities <span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--CommonStockIssuedForReductionInLiabilitiesShares_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zD52mE4pSPbi" title="Common Stock issued for a reduction in liabilities, shares" style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilitiesShares" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,835</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">228,774</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0491">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0492">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">228,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1_iP3custom--CommonStockIssuedForReductionInLiabilitiesShares_z2DjkZZntVYa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt"><span style="font-size: 8pt">Conversion of temporary equity Series B and B-1 Preferred Stock to Common Stock <span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares_iP3custom--ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfP4F462c50a" title="Conversion of temporary equity Series B and B-1 Preferred Stock to Common Stock (1), shares" style="text-align: right"><ix:nonFraction name="VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">944,312</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">944</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,384,396</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0499">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0500">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0501">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,385,340</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockOptionsIssuedForServices_zvBIxoSqaH3d" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Stock options issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0506">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">427,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0508">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0510">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">427,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zZAGTXgb2nyk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0513">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,528</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0515">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0516">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0517">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">111,528</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--IssuanceOfNoncontrollingInterest1_zo3d184Ic2na" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Issuance of noncontrolling interest for a reduction of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0522">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0523">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DividendsPreferredStock_iNP3custom--IssuanceOfNoncontrollingInterest1_p0p0_di_zJaFOv8c6Tp6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0527">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0528">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0529">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,196</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,196</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zcbwQeTOyJvg" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0534">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0536">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,410,931</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,114,003</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,524,934</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20210401__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_z7RU3yWUcveh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">June 30, 2021 (unaudited)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_z3PG6QXDJGx7" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_SeriesAPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,667</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">67</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeUtfueZ8wte" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,291,416</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,292</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,970,571</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,141,278</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">758,245</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,579,897</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Series A Preferred Stock</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Common Stock</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Additional Paid-in</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Treasury</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Accumulated</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Non-controlling</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Total Stockholders'</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; width: 28%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Capital</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Stock</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Deficit</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Interest</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 1%">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; width: 5%"><span style="font-size: 8pt"> Equity</span></td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td></tr>

<tr id="xdx_438_c20210101__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zKLZEtiCDoHj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; width: 28%"><span style="font-size: 8pt">December 31, 2020<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_zGwaGjLz2kc6" title="Beginning balance, shares" style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_custom_SeriesAPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,667</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">67</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVHixcbpN8Xa" title="Beginning balance, shares" style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,255,967</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,256</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,623,146</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left; width: 1%">)</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,204,992</ix:nonFraction></td><td style="text-align: left; width: 1%">)</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,279,089</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 5%"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,688,566</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_iP3us-gaap--SharesOutstanding_zpcT84Rn1oRh" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt"><span style="font-size: 8pt">Common Stock issued for services<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_iP3us-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8OVR6ypobr2" title="Common Stock issued for services Shares, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,667</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">437,967</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0565">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0566">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0567">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">438,001</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--CommonStockIssuedForReductionInLiabilities_zYq52RNRiQt4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt"><span style="font-size: 8pt">Common Stock issued for a reduction of liabilities<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--CommonStockIssuedForReductionInLiabilitiesShares_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDhFG5LHN8W1" title="Common Stock issued for a reduction in liabilities, shares" style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilitiesShares" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,168</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0574">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0575">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0576">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--CommonStockIssuedForPurchaseOfLicense_iP3custom--CommonStockIssuedForReductionInLiabilitiesShares_zFIgYGgz3kqf" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt"><span style="font-size: 8pt">Common Stock issued for the purchase of a license<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--CommonStockIssuedForPurchaseOfLicenseShares_iP3custom--CommonStockIssuedForPurchaseOfLicense_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2biAmepdJ8b" title="Common Stock issued for the purchase of a license, shares" style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicenseShares" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,667</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicense" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicense" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">224,983</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0583">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0584">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0585">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedForConversionOfTemporaryEquityValue_iP3custom--CommonStockIssuedForPurchaseOfLicenseShares_zm1PH9ZWPLLd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt"><span style="font-size: 8pt">Conversion of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--StockIssuedForConversionOfTemporaryEquityShares_iP3custom--StockIssuedForConversionOfTemporaryEquityValue_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zAn4HRIPmWu3" title="Conversion of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock, shares" style="text-align: right"><ix:nonFraction name="VIVK:StockIssuedForConversionOfTemporaryEquityShares" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">955,947</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockIssuedForConversionOfTemporaryEquityValue" contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">956</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockIssuedForConversionOfTemporaryEquityValue" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,466,648</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0592">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0593">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0594">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockIssuedForConversionOfTemporaryEquityValue" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,467,604</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockOptionsIssuedForServices_zvPRFvP3zKdd" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Stock options issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0599">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">730,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0601">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0602">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0603">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:StockOptionsIssuedForServices" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">730,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zRATTtyZYUwk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0606">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,056</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0608">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0609">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0610">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,056</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IssuanceOfNoncontrollingInterest1_zW0vVKdmrFq" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Issuance of noncontrolling interest for a reduction of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0613">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0614">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0615">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0616">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:IssuanceOfNoncontrollingInterest1" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DividendsPreferredStock_iN_p0p0_di_z6YBfCXFUtaf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0620">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,196</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0624">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,196</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_ztvTuPjLF4Zj" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt">Net income (loss)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0627">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,910</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,255,844</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,149,934</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_430_c20210101__20210630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zisUumrEvu52" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt">June 30, 2021 (unaudited)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPreferredStocksMember_zRLrJqYPcXOa" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_SeriesAPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,667</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">67</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHq1c5A8oBeh" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,291,416</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,292</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,970,571</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,141,278</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">758,245</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,579,897</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_F09_zDzY3dBfAXy7" style="vertical-align: top; text-align: left; width: 4%">(1)</td>
    <td id="xdx_F1F_zwp85WaXwQpc" style="text-align: justify; width: 96%"><ix:footnote id="Footnote000644" xml:lang="en-US">Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 &#8211; Organization and Basis of Presentation for additional information</ix:footnote></td>
    </tr>
  </table>
<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to consolidated financial
statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="a_007"></span>CONDENSED
CONSOLIDATED STATEMENT OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_112_zUiR5RjoK4Pk" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20220101__20220630_zAoyDj8ACKRg" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20210101__20210630_zC8DEPZ22qil" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_z35MMRuWFDff" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">OPERATING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_maCzL2o_z84KPIxUXzgj" style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: left">Consolidated net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,953,898</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,149,934</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zbryOf2D6Lpc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Adjustments to reconcile net income to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DepreciationAndAmortization_i01_maCzL2o_ztb8oj6jCe9e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">933,813</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">727,914</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CommonStockOptionsIssuedForServices_i01_maCzL2o_zIwmavf5HP8b" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Common stock options issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockOptionsIssuedForServices" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">855,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockOptionsIssuedForServices" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">730,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i01_d0_maCzL2o_zVkConIIyOJg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">438,001</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--GainOnDispositionOfAsset_i01N_di_msCzL2o_zsFYwTFJy46g" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Gain on disposal of asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="VIVK:GainOnDispositionOfAsset" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,456</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0665">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_i01N_di_msCzL2o_zVz9z3gBrRT4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unrealized gain (loss) marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">413,189</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,734,275</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInDeferredIncomeTaxes_i01N_di0_msCzL2o_z9dxAq9B9Tjd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Deferred income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">711,070</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ShareBasedCompensation_i01_maCzL2o_zrzo7CQsu022" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,340,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,055</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01_z5ek90x2DZB2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di0_msCzL2o_zJ2yB1BvC8Vi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,515</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInInventories_i01N_di0_msCzL2o_zuVBjlOgg3yc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-01-012021-06-30" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOtherOperatingAssets_i01N_di_msCzL2o_z0WfIlP3lndk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">164,177</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,807</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i01_maCzL2o_zaGW8PaMTSb4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">303,452</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">412,764</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccruedInterestReceivableNet_i01N_di_msCzL2o_zJw7WrdkKVff" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued interest on notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,461</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,485</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInInterestPayableNet_i01_maCzL2o_zL0YRF6J3Zo6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accrued interest on notes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">114,946</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">395,469</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzL2o_maCz1VK_zzk3giLhSNE7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,808,793</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,053,627</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zHBwys4Crdd4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">INVESTING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromCollectionOfNotesReceivable_i01_d0_maCzA2D_zFyxK7ykiJgd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromCollectionOfNotesReceivable" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,953</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromCollectionOfNotesReceivable" contextRef="From2021-01-012021-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PaymentsToAcquireIntangibleAssets_iN_di_msCzA2D_ztRw3dG45j3b" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Payment on costs of patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0706">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,329</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--PaymentsToAcquireIntangibleAssets1_iN_di0_msCzA2D_zDdGlF6h7Rh7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Purchase of a technology license</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:PaymentsToAcquireIntangibleAssets1" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="VIVK:PaymentsToAcquireIntangibleAssets1" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--ProceedsFromSaleOfProductiveAssets_d0_maCzA2D_zwsnBOErSY8b" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from disposal of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2021-01-012021-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_iN_di_msCzA2D_z96SMgeabS8l" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Purchase of equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,129,515</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,334,123</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtCzA2D_maCz1VK_zsFcXKVaAn35" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,067,562</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,384,452</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zrvFEi1luO8j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RepaymentsOfLongTermDebt_i01N_di0_msCzGgM_zuBhsta12Bx9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Payment of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,735</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromNotesPayable_maCzGgM_zKGRaGKi3xh6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Proceeds from loans and notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,968,261</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,666,811</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromIssuanceOfCommonStock_d0_maCzGgM_zpkfauEAoMVd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from sale of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,240,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-012021-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--RepaymentsOfNotesPayable_iN_di_msCzGgM_zc3SKiWisJH2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Payment of notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">277,145</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,464</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsToMinorityShareholders_iN_di0_msCzGgM_zFyphoKYUrSi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Distributions to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">343,889</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" contextRef="From2021-01-012021-06-30" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtCzGgM_maCz1VK_z2frBeqz3Avh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,587,227</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,656,612</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCz1VK_zrZY6gYr4ySg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net increase (decrease) in cash and cash equivalents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,710,872</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,218,533</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zDlRqFqLU83k" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,493,719</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,904</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_ztSfNCogp0Xc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, END OF PERIOD</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,204,591</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,617,437</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zK50Rnn4tVY2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">SUPPLEMENTAL CASHFLOW INFORMATION:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--CashPaidDuringYearForAbstract_iB_zwkkoatDhOeg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Cash paid during the year for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--InterestPaidNet_i01_zziKxSGiuRge" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">46,936</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxesPaidNet_i01_d0_zjJCtIXSvx3d" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-01-012021-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zb03QKAwDWGa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: normal; text-align: left">Noncash transactions<span style="font: normal 700 10pt Times New Roman, Times, Serif">:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ConversionOfSeriesBB1AndC1PreferredStockToCommonStock_i01_z8KBOTvcFSZg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Conversion of Series A, B, B-1, and C-1 Preferred Stock to Common Stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:ConversionOfSeriesBB1AndC1PreferredStockToCommonStock" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:ConversionOfSeriesBB1AndC1PreferredStockToCommonStock" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,467,604</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--CommonStockIssuedForReductionInLiabilitiesCashFlow_i01_zf5mwA1bSNVj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Common stock issued for a reduction in liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilitiesCashFlow" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,144,992</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForReductionInLiabilitiesCashFlow" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--NoncontrollingInterestIssuedForReductionInLiabilities_i01_zUcxYJAQpmL8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Noncontrolling interest issued for a reduction in liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:NoncontrollingInterestIssuedForReductionInLiabilities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,025,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:NoncontrollingInterestIssuedForReductionInLiabilities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--PreferredStockSeriesC1IssuedForReductionInLiabilities_i01_d0_z4eOnhr5Ukg2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Preferred stock Series C-1 issued for a reduction in liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:PreferredStockSeriesC1IssuedForReductionInLiabilities" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:PreferredStockSeriesC1IssuedForReductionInLiabilities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,950</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--CommonStockIssuedForPurchaseOfLicenses_i01_d0_ztF6RR7j8pJ9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Common stock issued for the purchase of a license</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicenses" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:CommonStockIssuedForPurchaseOfLicenses" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--CapitalizedInterestOnConstructionInProcess_i01_z5CjeL0eypNj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Capitalized interest on construction in process</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:CapitalizedInterestOnConstructionInProcess" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,235</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:CapitalizedInterestOnConstructionInProcess" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">822,700</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DividendPaidInSeriesB1PreferredStock_i01_d0_zkR810iP9Iuj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:DividendPaidInSeriesB1PreferredStock" contextRef="From2022-01-01to2022-06-30" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:DividendPaidInSeriesB1PreferredStock" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,196</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to consolidated financial
statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_008"></span>NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80A_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zm8QuDLsXGm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1. <span id="xdx_826_z6AiZ2euZXUb">Basis of Presentation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14, 2022, we effected a <span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20220213__20220214_zYmWYrQCccNd" title="Stockholders&apos; Equity, Reverse Stock Split"><ix:nonNumeric contextRef="From2022-02-132022-02-14" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-30 reverse
split</ix:nonNumeric></span> of our outstanding shares of common stock (the &#8220;Reverse Stock Split&#8221;) via the filing of a certificate of change with
the Nevada Secretary of State which was effective at the commencement of trading of our Common Stock. No fractional shares of the Company&#8217;s
common stock will be issued as a result of the Reverse Stock Split. Any fractional shares resulting from the Reverse Stock Split will
be rounded up to the nearest whole share. All issued and outstanding common stock, preferred stock, and per share amounts in the consolidated
financial statements and footnotes included herein have been retroactively adjusted to reflect this reverse stock split for all periods
presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="VIVK:Covid19PolicyTextBlock"><p id="xdx_846_ecustom--Covid19PolicyTextBlock_zmUb4pmZhvbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_867_zSHu0pmwRcOg">COVID-19</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 11, 2020, the World Health Organization
(&#8220;WHO&#8221;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the
pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets.
Most U.S. states and many countries have issued policies intended to stop or slow the further spread of the disease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">COVID-19 and the U.S. response to the pandemic
are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may
have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent
of the effects on the economy, the markets we serve, our business, or our operations. In March 2020 we temporarily suspended operations
in Kuwait and Utah due to COVID-19 government restrictions, Utah has resumed operations in full. Kuwait has allowed for the Company to
obtain site personnel visas to recommence operations. These suspensions have had a negative impact on our business and there can be no
guaranty that we will not need to suspend operations again in the future as a result of the pandemic.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="VIVK:InterimFinancialInformationPolicyTextBlock"><p id="xdx_849_ecustom--InterimFinancialInformationPolicyTextBlock_zotbl60NRihj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_z9fVd7QJJoZ8">Interim Financial Information</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).
Certain information and disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have
been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the related notes for the year ended December 31, 2021. The unaudited condensed consolidated financial
statements have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and
include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation
of the condensed consolidated financial statements. The operating results for the three and six months ended June 30, 2022 are not necessarily
indicative of the results expected for the full year ending December&#160;31, 2022.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23C_zqgTOh3Fi8zi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zeDN55bSE4ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zuWzZSbJosul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z2kTtpWWcazf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zqnXUeDr7KFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_860_z9df4Z4o31td">Principles of Consolidation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows ASC 810-10-15 guidance with
respect to accounting for Variable Interest Entities (&#8220;VIE&#8221;). A VIE is an entity that does not have sufficient equity at risk
to finance its activities without additional subordinated financial support from other parties, or whose equity investors lack any of
the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will absorb portions
of a VIE&#8217;s expected losses or receive portions of the entity&#8217;s expected residual returns. For the six months ended June 30,
2022 and year ended December 31, 2021 the following entities are considered to be a VIE and are consolidated in our consolidated financial
statements: Viva Wealth Fund I, LLC and RPC Design and Manufacturing, LLC. For the six months ended June 30, 2022 and year ended December
31, 2021 the following entities were considered to be a VIE, but were not consolidated in our consolidated financial statements due to
a lack of the power criterion or the losses/benefits criterion: Vivaventures UTS I, LLC, Vivaventures Royalty II, LLC, Vivaopportunity
Fund, LLC, and International Metals Exchange, LLC. For the six months ended June 30, 2022 and year ended December 31, 2021 the unaudited
financial information for the unconsolidated VIEs is as follows: Vivaventures UTSI, LLC held assets of $<span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z2o3hEUb6w0a" title="Assets"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,383,610</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z6T8semNZ3vi" title="Assets"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,753,296</ix:nonFraction></span> (where
the primary asset represents a receivable from the Company), and liabilities of $<span id="xdx_901_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z8cbapUzlpN2" title="Liabilities"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,049</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_zcgzT2SrUQAa" title="Liabilities"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,608</ix:nonFraction></span>. Vivaventures Royalty II, LLC held
assets of $<span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zFhbvhtZZ4T1" title="Assets"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,939,498</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_z1ZiBuNmonS8" title="Assets"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,648,810</ix:nonFraction></span> (where the primary asset represents a receivable from the Company), and liabilities of $<span id="xdx_908_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zx0CEuhEdJC3" title="Liabilities"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,720</ix:nonFraction></span> and
$<span id="xdx_90B_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zZJUXjRbSsb8" title="Liabilities"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300</ix:nonFraction></span>. Vivaopportunity Fund LLC held assets of $<span id="xdx_905_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zYd31ctlAAW2" title="Assets"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,119,856</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zmk5Cqdjf6Mf" title="Assets"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,119,961</ix:nonFraction></span> (where the primary asset represents a noncontrolling interest
in units of a consolidated entity of the Company) and <span id="xdx_907_eus-gaap--Liabilities_iI_p0p0_do_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_zVdQSlVqDwUe" title="Liabilities"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> liabilities. International Metals Exchange, LLC held assets of $<span id="xdx_901_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zRs8H2qSmrd1" title="Assets"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,938</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zmcLlfgBGRtk" title="Assets"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,461</ix:nonFraction></span>
and liabilities of $<span id="xdx_90E_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zkYw4uKIohil" title="Liabilities"><span id="xdx_907_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zBQtyH2mXEPb" title="Liabilities"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,900</ix:nonFraction></ix:nonFraction></span></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>RPC Design and Manufacturing, LLC: </b>As of
June 30, 2022 and year ended December 31, 2021, investors in RDM have a noncontrolling interest of $<span id="xdx_90A_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zOk4yYA9pdj4" title="Noncontrolling Interest in Variable Interest Entity"><ix:nonFraction name="us-gaap:NoncontrollingInterestInVariableInterestEntity" contextRef="AsOf2022-06-30_custom_RPCDesignAndManufacturingLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">387,049</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zNzqjbbprw72" title="Noncontrolling Interest in Variable Interest Entity"><ix:nonFraction name="us-gaap:NoncontrollingInterestInVariableInterestEntity" contextRef="AsOf2021-12-31_custom_RPCDesignAndManufacturingLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">629,694</ix:nonFraction></span>, respectively.
As of June 30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are not restricted and can be used to settle the
obligations of the reporting entity. As of June 30, 2022 and December 31, 2021 this VIE has an outstanding note payable to the reporting
entity in the amount of $<span id="xdx_90B_eus-gaap--NotesPayable_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zLmmA2qpxP45" title="Notes Payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_RdmMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">628,828</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--NotesPayable_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zW58xCpAuV7a" title="Notes Payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_RdmMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,566</ix:nonFraction></span>, which is eliminated upon consolidation. We have the primary risk (expense) exposure in
financing and operating the assets and are responsible for 100% of the operation, maintenance and any unfunded capital expenditures, which
ultimately could be 100% of a custom machine, and the decisions related to those expenditures including budgeting, financing and dispatch
of power. Based on all these facts, it was determined that we are the primary beneficiary of RDM. Therefore, RDM has been consolidated
by the Company. Any intercompany revenue and expense associated with RDM and its license agreement with the Company has been eliminated
in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Viva Wealth Fund I, LLC:</b> As of June
30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are restricted solely for the use of proceeds of the VWFI
offering (to manufacture RPCs) and cannot be used to settle the obligations of the reporting entity. As of June 30, 2022 and
December 31, 2021, the Company has cash attributed to variable interest entities of $<span id="xdx_90E_ecustom--CashAttributableToVie_c20220630__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zAcm7UDg2Bnj" title="Cash attributable to VIE"><ix:nonFraction name="VIVK:CashAttributableToVie" contextRef="AsOf2022-06-30_custom_VivaWealthFundIMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">296,257</ix:nonFraction></span>
and $<span id="xdx_904_ecustom--CashAttributableToVie_c20211231__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zs0SOaTeO44" title="Cash attributable to VIE"><ix:nonFraction name="VIVK:CashAttributableToVie" contextRef="AsOf2021-12-31_custom_VivaWealthFundIMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,952</ix:nonFraction></span>.
As of June 30, 2022, VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI has
commenced fundraising for RPC Series B. In the event that VWFI does not raise at least $6,250,000 for these RPC Series by the
offering termination date (which date has been extended until November 13, 2022), then the convertible notes and/or units would
convert into Vivakor common stock where the minimum conversion price will be the greater of $13.50 or a 10% discount to market per
share or in the event of a public offering, 200% of the per share price of the Company common stock sold in the underwritten
offering, which was closed on February 14, 2022 at $5.00 per share. As of August 8, 2022, VWFI has raised approximately $4,690,000
for RPC Series B. VWFI unit holders may also sell their units to the Company for their principal investment amount on the
3<sup>rd</sup>, 4<sup>th</sup>, and 5<sup>th</sup> anniversary of the offering termination date, which if this option were
exercised, the Company may elect to pay the amount in either cash or common stock. The Company also has the option to purchase any
LLC units where the members did not exercise their conversion option under the same terms and pricing for cash or common stock. VWFI
has entered into a license agreement with the Company indicating that VWFI will pay the Company a license fee of $1,000,000 per
series of equipment manufactured with the Company&#8217;s proprietary technology, however these transactions are eliminated upon consolidation. All of the operations of VWFI relate to private
placement offering to fund and manufacture proprietary equipment for the Company, as intended in VWFI&#8217;s design and
organization by the Company, so that the Company controls VWFI in its business purpose, use of proceeds, and selling and leasing of
its equipment solely to the Company. Creditors of VWFI have no recourse to the general credit of the Company. We have the primary
risk (expense) exposure in financing and operating the assets and are responsible for 100% of the operation, and any unfunded
capital expenditures, and the expense to the unit holders in conversion to common stock if series of equipment cannot be fully
funded, which ultimately could be 100% of any custom machine. By request of the fund manager, we are responsible for the decisions
related to the expenditures of VWFI proceeds including budgeting, financing and dispatch of power surrounding the series of
equipment. Based on all these facts, it was determined that we are the primary beneficiary of VWFI. Therefore, VWFI has been
consolidated by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_232_zGKRns0o6cVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_z2PGFk0jTOKi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zTH3a1EHQvkb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zOUAySZOKBDk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxp3SdopEgQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86E_z6WL2RG9nXhc">Long Lived Assets</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews the carrying values of
its long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount may not
be recoverable. If the expected future cash flow from the use of the asset and its eventual disposition is less than the carrying
amount of the asset, an impairment loss is recognized and measured using the fair value of the related asset. No impairment charges
were incurred during the six months ended June 30, 2022 or for the year ended December 31, 2021, as the Company was still in the
early phases of our business plan and operating losses were expected in our early phases. On March 11, 2020, the World Health
Organization (&#8220;WHO&#8221;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on
human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the
global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow the further spread of
the disease. We have observed supply chain disruptions from the COVID-19 pandemic that has contributed to delays in the completion
of the manufacturing of our RPCs, although we do not believe that these delays have constituted a triggering event for impairment of
our assets. Our Kuwait operations were suspended to comply with the social distancing measures implemented in Kuwait, but in 2022
has allowed for the Company to obtain site personnel visas to recommence operations. Our Utah operations were temporarily
suspended from March through May 2020, but have since resumed in full in its manufacturing of its RPCs, and construction and implementation of site and infrastructure preparations
in anticipation of commencing operations in 2022. There can be no assurance, however, that market conditions
will not change or demand for the Company&#8217;s services will continue, which could result in impairment of long-lived assets in
the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_846_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zG8Hd8tNjjJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86D_zaOLyLvhpbC3">Intangible Assets</span>:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for intangible assets in accordance
with ASC 350 <i>&#8220;Intangibles-Goodwill and Other&#8221;</i> (&#8220;ASC 350&#8221;). Intangible asset amounts represent the acquisition
date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income
approach, discounting projected future cash flows based on management&#8217;s expectations of the current and future operating environment.
The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure
and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over
their useful lives, which have historically ranged from <span id="xdx_90E_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zGHlcVy4gfxc" title="Amortized useful lives"><ix:nonNumeric contextRef="From2022-01-012022-06-30_srt_MinimumMember" format="ixt-sec:duryear" name="VIVK:AmortizedUsefulLives">10</ix:nonNumeric></span> to <span id="xdx_902_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zudsMyNvjh91" title="Amortized useful lives"><ix:nonNumeric contextRef="From2022-01-012022-06-30_srt_MaximumMember" format="ixt-sec:duryear" name="VIVK:AmortizedUsefulLives">20</ix:nonNumeric></span> years. The carrying amounts of our definite-lived intangible assets are
evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset&#8217;s
carrying amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We assess our intangible assets in accordance
with ASC 360 &#8220;<i>Property, Plant, and Equipment</i>&#8221; (&#8220;ASC 360&#8221;). Impairment testing is required when events occur
that indicate an asset group may not be recoverable (&#8220;triggering events&#8221;). As detailed in ASC 360-10-35-21, the following
are examples of such events or changes in circumstances (sometimes referred to as impairment indicators or triggers): (a) A significant
decrease in the market price of a long-lived asset (asset group) (b) A significant adverse change in the extent or manner in which a long-lived
asset (asset group) is being used or in its physical condition. (c) A significant adverse change in legal factors or in the business climate
that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator (d) An accumulation
of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group)
(e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast
that demonstrates continuing losses associated with the use of a long-lived asset (asset group) (f) A current expectation that, more likely
than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated
useful life. The term more likely than not refers to a level of likelihood that is more than 50 percent. We have evaluated our intangible
assets and found that certain losses and a delay in our business plan may have constituted a triggering event for our intangible assets.
We performed an analysis and assessed that there was no impairment for the six months ended June 30, 2022 or for the year ended December
31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zQFG8YdEw9qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86B_zCouQEPJifTg">Advertising Expense</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising costs are expensed as incurred. The
Company did not incur advertising expense for the six months ended June 30, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_ztPUYJOPyPHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86C_zxSUTsALF6k8">Net Income/Loss Per Share</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net income (loss) per share is
calculated by subtracting any preferred interest distributions from net income (loss), all divided by the weighted-average number of
common shares outstanding for the period, without consideration for common stock equivalents. Diluted net income (loss) per common
share is computed by dividing the net income (loss) by the weighted-average number of common share equivalents outstanding for the
period determined using the treasury stock method if their effect is dilutive. Potential dilutive instruments as of June 30, 2022
and 2021 include the following: convertible notes payable convertible into approximately <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_z230ycvlsUm8" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-06-30_us-gaap_ConvertibleNotesPayableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,560</ix:nonFraction></span>
and <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_zpJ8pjmTnxBd" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-06-30_us-gaap_ConvertibleNotesPayableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,150</ix:nonFraction></span>
shares of common stock, convertible Series A preferred stock convertible into <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dn_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_z2Gg4kwHWWs6" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-06-30_custom_ConvertibleSeriesAPreferredStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></span>
and <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_pdd_zZGsZb1q3Ofl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-06-30_custom_ConvertibleSeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">666,667</ix:nonFraction></span>
shares of common stock (due to the event of a public offering of the Company&#8217;s common stock in February 2022 this will convert
to 833,333 shares), stock options granted to employees of <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_zvfdEGoUbjAh" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-06-30_custom_StockOptionsGrantedToEmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,039,585</ix:nonFraction></span>
and <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_z6K1YxdZvHEl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-06-30_custom_StockOptionsGrantedToEmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">183,333</ix:nonFraction></span>
shares of common stock. Stock options granted to Board members or consultants of <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_pdd_z8arP4CFkbg" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_zgHW5X6Bzx49" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-06-30_custom_StockOptionsGrantedToBoardMembersOrConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-06-30_custom_StockOptionsGrantedToBoardMembersOrConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">466,667</ix:nonFraction></ix:nonFraction></span></span>
shares of common stock were granted as of June 30, 2022 and 2021. There were also warrants issued and outstanding to EF Hutton of <span id="xdx_902_ecustom--WarrantsIssued_c20220630_pdd_zgksOOGqoxB4" title="Warrants issued"><span id="xdx_908_ecustom--WarrantsOutstanding_c20220630_pdd_zZkNi3aJvfQ7" title="Warrants outstanding"><ix:nonFraction name="VIVK:WarrantsIssued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="VIVK:WarrantsOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></ix:nonFraction></span></span>
shares of common stock as of June 30, 2022.  These warrants were related to and granted during the close of the
underwritten public offering in February 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_238_zxgucNwI15q1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zDmzEOHn2F34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zlXGKGJBQ81f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zmUOhxfvVEP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_841_eus-gaap--UseOfEstimates_z8bIuBoo4VGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_868_zyAI2qP3N3lc">Use of Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America requires management to make estimates, judgments, and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes. We believe our critical accounting estimates
relate to the following: Recoverability of current and noncurrent assets, revenue recognition, stock-based compensation, income taxes,
effective interest rates related to long-term debt, marketable securities, cost basis and equity method investments, lease assets and
liabilities, equity method investments, valuation of stock used to acquire assets, and derivatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While our estimates and assumptions are based
on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates
and assumptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWB2ZFyKT0Bc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_860_zQ8hpDlc8Xh2">Fair Value of Financial Instruments</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Accounting Standards Codification
(&#8220;ASC&#8221;) 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;), for assets and liabilities measured
at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value, and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#8217;s financial position
or operating results but did expand certain disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 820 defines fair value as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of
unobservable inputs. These inputs are prioritized below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1: Applies to assets or liabilities for
which there are quoted prices in active markets for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2: Applies to assets or liabilities for
which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3: Applies to assets or liabilities for
which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets
or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board&#8217;s (&#8220;FASB&#8221;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement. The carrying amounts reported in the consolidated balance sheets for marketable
securities are classified as Level 1 assets due to observable quoted prices for identical assets in active markets. The carrying amounts
reported in the consolidated balance sheets for cash, prepaid expenses and other current assets, accounts payable and accrued expenses
approximate their estimated fair market values based on the short-term maturity of these instruments. T<span style="background-color: white">he
recorded values of notes payable approximate their current fair values because of their nature, rates, and respective maturity dates or
durations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23F_zLGcATr4iJ9j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zw0IdQTrtaR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z64IdrTTFLbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zyHI0qODHtdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="VIVK:LiquidityTextBlock"><p id="xdx_80C_ecustom--LiquidityTextBlock_zR2qfSqXzjjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2. <span id="xdx_82A_zpzYYcebaCqg">Liquidity</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have historically suffered net losses and
cumulative negative cash flows from operations, and as of June 30, 2022, we had an accumulated deficit of approximately $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_dixL_c20220630_z54LArkHhmH7" title="::XDX::41237559"><span style="-sec-ix-hidden: xdx2ixbrl0892">41.3</span></span>
million. As of June 30, 2022 we had cash of $<span id="xdx_90A_eus-gaap--Cash_c20220630_p0p0_zr82MY5vHU0c" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,204,591</ix:nonFraction></span>. The
Company closed an underwritten public offering of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_pdd_zThpA8p2eQ6k" title="Stock Issued During Period, Shares, New Issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-06-30_custom_PublicOfferingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,600,000</ix:nonFraction></span>
shares of common stock, at a public offering price of $5.00 per share, for aggregate gross proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn3n3_dm_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_ztKjmbHillFk" title="Proceeds from Issuance or Sale of Equity"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2022-01-012022-06-30_custom_PublicOfferingMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">8</ix:nonFraction></span>
million, prior to deducting underwriting discounts, commissions, and other offering expenses. Prior to the offering, we financed our
operations primarily through debt financing, private equity offerings our working interest agreements. We believe we have other
liquid assets that may be used to assist in financing the operations of the Company if needed, including marketable securities in
Scepter, which hold a fair value $<span id="xdx_902_eus-gaap--MarketableSecurities_c20220630_p0p0_zyaP5djUik16" title="Marketable Securities"><ix:nonFraction name="us-gaap:MarketableSecurities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,818,029</ix:nonFraction></span>
as of June 30, 2022 and have been deposited for trading. We believe the liquid assets from the Company&#8217;s available for sale
investments and funding provided from subsequent fundraising activities (see Note 15) of the Company give it adequate working
capital to finance our day-to-day operations for at least twelve months through August 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"><p id="xdx_804_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zMjYp3admClk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 3. <span id="xdx_82E_zf0w36s7VPKa">Prepaid Expenses and Other Assets</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021, our
other assets mainly consist of various deposits with vendors, professional service agents, or security deposits on office and warehouse
leases. As of June 30, 2022 and December 31, 2021 we had office and warehouse lease deposits in the amount of $<span id="xdx_908_eus-gaap--LeaseDepositLiability_iI_p0p0_c20220630_zgCu3B0RAJu6" title="Office and warehouse lease deposits"><ix:nonFraction name="us-gaap:LeaseDepositLiability" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,676</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--LeaseDepositLiability_iI_p0p0_c20211231_zeIDaGedv2M" title="Office and warehouse lease deposits"><ix:nonFraction name="us-gaap:LeaseDepositLiability" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,245</ix:nonFraction></span>. As
of June 30, 2022 we had deposits in the amounts of $<span id="xdx_903_eus-gaap--Deposits_iI_p0p0_c20220630__srt--CounterpartyNameAxis__custom--VendorMember_z59yXTtEWYg6" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2022-06-30_custom_VendorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,458</ix:nonFraction></span> with vendors, professional service agencies, and a reclamation bond with the
Utah Division of Oil, Gas and Mining in the amount of $<span id="xdx_905_eus-gaap--Deposits_iI_c20220630__dei--LegalEntityAxis__custom--ProfessionalServiceAgenciesMember_zgGHQRNADA14" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2022-06-30_custom_ProfessionalServiceAgenciesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,288</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:MarketableSecuritiesTextBlock"><p id="xdx_803_eus-gaap--MarketableSecuritiesTextBlock_zoyFWqjzhPtd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 4. <span id="xdx_82F_z7EOymzRyjdj">Marketable Securities</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2020, the Company owned <span id="xdx_902_eus-gaap--InvestmentOwnedBalanceShares_iI_c20201231__dei--LegalEntityAxis__custom--OdysseyGroupMember_zUQUUogOiea" title="Investment Owned, Balance, Shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2020-12-31_custom_OdysseyGroupMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,309,758</ix:nonFraction></span>
shares of common stock in Odyssey Group International, Inc. (&#8220;Odyssey&#8221;) ticker: ODYY, OTC Markets. In December 2021 we
sold such shares of Odyssey in a private transaction for a purchase price of $<span id="xdx_905_eus-gaap--ProceedsFromSaleOfOtherInvestments_p0p0_c20210101__20211231__dei--LegalEntityAxis__custom--OdysseyGroupMember_zOF04fy5iek5" title="Proceeds from Sale of Other Investments"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfOtherInvestments" contextRef="From2021-01-012021-12-31_custom_OdysseyGroupMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">860,491</ix:nonFraction></span>,
with $10,000 cash delivered at signing and a note issued in favor of Vivakor in the amount of $850,491, reflecting the market price
at that time. The Company accounted for such securities based on the quoted price from the OTC Markets where the stock is traded,
which resulted in the Company recording an unrealized loss of $<span id="xdx_90B_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220101__20220630__dei--LegalEntityAxis__custom--OdysseyGroupMember_p0p0_z11Taujp06s4" title="Unrealized gain on marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-01-012022-06-30_custom_OdysseyGroupMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">595,392</ix:nonFraction></span>
on these marketable securities for the three months ended June 30, 2021 compared to an unrealized gain of $<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_p0p0_c20210101__20210630__dei--LegalEntityAxis__custom--OdysseyGroupMember_zGLpxUY2yIb7" title="Unrealized gain on marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-01-012021-06-30_custom_OdysseyGroupMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,494,275</ix:nonFraction></span>
for the six months ended June 30, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2019 the Company had an investment of $<span id="xdx_90F_eus-gaap--MarketableSecurities_c20191231__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z4XIBa2qvn6" title="Marketable securities"><ix:nonFraction name="us-gaap:MarketableSecurities" contextRef="AsOf2019-12-31_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800,000</ix:nonFraction></span>
or <span id="xdx_90E_eus-gaap--InvestmentOwnedBalanceShares_c20191231__dei--LegalEntityAxis__custom--OdysseyGroupMember_pdd_zOHqQwlN8p5e" title="Investment Owned, Balance, Shares"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceShares" contextRef="AsOf2019-12-31_custom_OdysseyGroupMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000,000</ix:nonFraction></span> shares of common stock, or a diluted 23% equity holding in Scepter Holdings, Inc. (&#8220;Scepter&#8221;), ticker: BRZL,
OTC Markets. In the fourth quarter of 2020, the Company was diluted to a 19% equity holding in Scepter, and was no longer deemed to have
significant influence and ceased to be an equity investment, and as the stock is traded on an active market, the Company has classified
the investment as marketable securities with the change in unrealized gains and losses on the investment included in the statement of
operations for the three months ended June 30, 2022 and 2021. In August 2021 we converted $<span id="xdx_900_ecustom--NoteReceivableConvertedAmountConverted_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zqKGwnXf3yje" title="Note receivable converted, amount converted"><ix:nonFraction name="VIVK:NoteReceivableConvertedAmountConverted" contextRef="From2021-08-012021-08-31_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,768</ix:nonFraction></span> of our note receivable with Scepter
into <span id="xdx_905_ecustom--NoteReceivableConvertedSharesReceived_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_pdd_z7RIkNvxFcQ2" title="Note receivable converted, shares received"><ix:nonFraction name="VIVK:NoteReceivableConvertedSharesReceived" contextRef="From2021-08-012021-08-31_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,376,882</ix:nonFraction></span> shares of Scepter common stock pursuant to the terms of the note at $0.0031 per share. On the date of the conversion,
the Scepter price per share on OTC Markets was $0.0062 per share, which resulted in a $<span id="xdx_905_ecustom--GainLossOnDispositionOfAsset_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z19EhPiXhivc" title="Gain (Loss) on disposition of asset"><ix:nonFraction name="VIVK:GainLossOnDispositionOfAsset" contextRef="From2021-08-012021-08-31_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,044</ix:nonFraction></span> gain on the disposition of the note receivable.
The Company has accounted for such securities based on the quoted price from the OTC Markets where the stock is traded, which resulted
in the Company recording an unrealized loss on marketable securities of $<span id="xdx_90D_ecustom--MarketableSecuritiesUnrealizedLoss_p0p0_c20220401__20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zoMSoaA6KtC9" title="Unrealized loss on marketable securities"><ix:nonFraction name="VIVK:MarketableSecuritiesUnrealizedLoss" contextRef="From2022-04-012022-06-30_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,652,755</ix:nonFraction></span> and $<span id="xdx_90A_ecustom--MarketableSecuritiesUnrealizedLoss_p0p0_c20210401__20210630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zTTFF3gF594b" title="Unrealized loss on marketable securities"><ix:nonFraction name="VIVK:MarketableSecuritiesUnrealizedLoss" contextRef="From2021-04-012021-06-30_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,353,777</ix:nonFraction></span> for the three months ended June 30,
2022 and 2021 compared to an unrealized gain (loss) of $(<span id="xdx_90C_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220101__20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zDdVifC58Uxb"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-01-012022-06-30_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">413,189</ix:nonFraction></span>) and <span id="xdx_903_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20210101__20210630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z4M10TZFGmgj" title="Unrealized gain on marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-01-012021-06-30_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,240,000</ix:nonFraction></span> for the six months ended June 30, 2022 and 2021. As of
June 30, 2022 and December 31, 2021, the Company&#8217;s Chief Executive Officer has an immediate family member who sits on the board
of directors of Scepter Holdings, Inc. As of June 30, 2022 and December 31, 2021 our Scepter marketable securities were valued at $<span id="xdx_901_eus-gaap--MarketableSecurities_c20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zYtuLO4jk4Qb" title="Marketable securities"><ix:nonFraction name="us-gaap:MarketableSecurities" contextRef="AsOf2022-06-30_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,818,029</ix:nonFraction></span>
and $<span id="xdx_908_eus-gaap--MarketableSecurities_c20211231__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zE7DozMKfY0d" title="Marketable securities"><ix:nonFraction name="us-gaap:MarketableSecurities" contextRef="AsOf2021-12-31_custom_ScepterHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,231,218</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021, marketable
securities were $<span id="xdx_906_eus-gaap--MarketableSecurities_iI_p0p0_c20220630_zJLko8huBQ8g" title="Marketable securities"><ix:nonFraction name="us-gaap:MarketableSecurities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,818,029</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--MarketableSecurities_c20211231_p0p0_zkESzF69woL8" title="Marketable securities"><ix:nonFraction name="us-gaap:MarketableSecurities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,231,218</ix:nonFraction></span>. For the three months ended June 30, 2022 and 2021, the Company recorded a total unrealized
loss of $<span id="xdx_90F_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220401__20220630_zsaHpJY8Egy2" title="Unrealized gain (loss) on marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,652,755</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20210401__20210630_zgL9ZjrxAeCb" title="Unrealized gain (loss) on marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,949,169</ix:nonFraction></span> compared to an unrealized gain (loss) of $(<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220101__20220630_zojWJgTjhH57" title="Unrealized gain (loss) on marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">413,189</ix:nonFraction></span>) and $<span id="xdx_90E_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_p0p0_c20210101__20210630_zGjBsA86hMP4" title="Unrealized gain (loss) on marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,734,275</ix:nonFraction></span> for the six months ended June 30,
2022 and 2021 on marketable securities in the statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_239_zGHHEUIkqeyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zoBGRr3O3Eqj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zVEruIlmlJph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zYAJv9gcnLH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zELX63TQvcx9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 5. <span id="xdx_820_zo4Rm3nSUR82">Inventories</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022, inventories consist primarily
of raw materials (including tar-sand stockpiles) and finished goods (which includes Fenix iron). The tar-sand stockpiles consist of 10,000
tons of tar sand stockpile and are anticipated to be used for our extraction remediation units. The stockpiles were acquired  when the
Company entered into a land lease agreement for located in Vernal, Utah. Under the terms of the lease agreement, we are required to pay
$3 per ton of oil sands processed. As a condition of the lease, we were required to provide $<span id="xdx_907_eus-gaap--InventoryGross_c20220630_p0p0_zClkGJhlsIza" title="Acquisition costs"><ix:nonFraction name="us-gaap:InventoryGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,000</ix:nonFraction></span> toward initial tonnage of oil sands
to be processed at a cost of approximately $3.00 per ton. The nano Fenix Iron are finished goods that have a 20-year shelf life and were
acquired at cost for $<span id="xdx_906_eus-gaap--InventoryGross_c20220630__us-gaap--PublicUtilitiesInventoryAxis__custom--FexixIronMember_p0p0_zHpJndrNfTdb" title="Acquisition costs"><ix:nonFraction name="us-gaap:InventoryGross" contextRef="AsOf2022-06-30_custom_FexixIronMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,000</ix:nonFraction></span>. As of December 31, 2021, inventories consist primarily of the Fenix Iron. Inventories are valued at the
lower of cost or market (net realizable value).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;&#160;<b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ziQG7cPHjXci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6. <span id="xdx_828_zmhcyio93ON6">Property and Equipment</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the components
of the Company&#8217;s property and equipment at June 30, 2022 and December 31, 2021:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2VouumbI78a" summary="xdx: Disclosure - Property and Equipment (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B2_zfpfffVN8IWj"><b style="display: none">Schedule of property and equipment, net</b></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Depreciation</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Depreciation</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; text-align: left">Office furniture and equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zXsTdBFv7A82" title="Gross Carrying Amount" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,998</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_ztsodYoAlDS7" title="Accumulated Depreciation" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,956</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zKDUNcCru1Ae" title="Net Book Value" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,042</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zwZoazTA265c" title="Gross Carrying Amount" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,998</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zZ32mg0fJoph" title="Accumulated Depreciation" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zTEZpDpq3pbg" title="Net Book Value" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,998</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zO3NMe7osB13" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,432</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zzdsjQQI7Yrb" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,466</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJcxKhnqMXI3" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zQ7Atriy3ty5" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,248</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zs4lyMhyDwCl" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,306</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJiDuUxZkWlf" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,942</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Precious metal extraction machine- 1 ton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zDImJSQSDh21" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine1TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,280,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_z73m4qTCp8G4" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine1TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">285,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zM5iBjaCpX2k" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine1TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,995,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zX9vOTirupF5" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine1TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,280,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zAqk24U083Xh" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine1TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">228,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zUMBjG2ealYl" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine1TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,052,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Precious metal extraction machine- 10 ton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjzX9DFslNB4" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine10TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,320,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjJ9QBZL87ki" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine10TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">665,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zNHVOC2qsKt2" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine10TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,655,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziCbgB3CRISh" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine10TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,320,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zGJsbcYm4Brd" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine10TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">532,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziupEQjHeSUc" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine10TonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,788,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Construction in process:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Bioreactors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zJX1X1YDdlw8" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_BioreactorsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,440,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zKd0tIPryxtc" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_BioreactorsMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zFy7Rvv1hcfi" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_custom_BioreactorsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,440,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_z1sLTW6Ec5Ze" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_BioreactorsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,440,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zrBrr6A9lt93" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_BioreactorsMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zM8388fJ0ha4" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_custom_BioreactorsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,440,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nanosponge/Cavitation device</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zmmmxcWILue5" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_NanospongeCavitationDeviceMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zZUGBTB2qjY8" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_NanospongeCavitationDeviceMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zhUHhWKdewvc" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_custom_NanospongeCavitationDeviceMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zrUWkianZiK1" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_NanospongeCavitationDeviceMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zk6VRcYKrGD4" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_NanospongeCavitationDeviceMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_z6yOp7eYdBrl" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_custom_NanospongeCavitationDeviceMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,103</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zeIkaFnaAKR1" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,150,506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zCX1aiNqEGqa" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit1Member" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZMmvd885d8" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,150,506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zsDLMwebAPq4" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,249,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zZsCox1rJwq6" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit1Member" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZxCujJsnja" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit1Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,249,082</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remediation Processing Unit 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zr0N7y1krw3" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,489,760</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_zOByhnGe0ZV7" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit2Member" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zRybXBi4WELc" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,489,760</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zo5UFZhZQLcf" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,201,098</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_z7B01AbNxsp7" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit2Member" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zS3MUtfSXfGk" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit2Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,201,098</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit System A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_z0PNkNXNpk4e" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,127,669</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zeUXjLuOgc23" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemAMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zxDfHTqZr6t6" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,127,669</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_ziBd0YMbc491" title="Gross Carrying Amount" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,561,467</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zIJwLOa1H1kj" title="Accumulated Depreciation" style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemAMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zpJkUOxoJTv3" title="Net Book Value" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,561,467</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Remediation Processing Unit System B</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zOhklpW21nZc" title="Gross Carrying Amount" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,974,884</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zMZNkCzJUfp5" title="Accumulated Depreciation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemBMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zIhvL2LbZjwg" title="Net Book Value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,974,884</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zhiecAo2mir2" title="Gross Carrying Amount" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,345,421</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zxm7PcP0WyYg" title="Accumulated Depreciation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemBMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zRzPCPCaoJJa" title="Net Book Value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,345,421</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total fixed assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_p0p0_zBX0bIt5wCHl" title="Gross Carrying Amount" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,856,352</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_p0p0_zq6uh0KQ3Tg3" title="Accumulated Depreciation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">977,422</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_p0p0_zZRzQLEF55de" title="Net Book Value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,878,930</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_p0p0_zKul4tOLeumh" title="Gross Carrying Amount" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,482,417</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231_p0p0_zRxKJns9Bnxl" title="Accumulated Depreciation" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">790,306</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_p0p0_zAj7QFC1voIk" title="Net Book Value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,692,111</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2021 the
Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__us-gaap--StatementClassOfStockAxis__custom--SeriesC1PreferredStockMember_pdd_zVN7UGsnFFK2"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" contextRef="From2022-01-012022-06-30_us-gaap_EquipmentMember_custom_SeriesC1PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,413</ix:nonFraction> </span>shares
of Series C-1 Preferred Stock value at $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__us-gaap--StatementClassOfStockAxis__custom--SeriesC1PreferredStockMember_p0p0_zVbQq5ShOaNa" title="Prefered stock Series C-1 issued for a reduction in liabilities"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2022-01-012022-06-30_us-gaap_EquipmentMember_custom_SeriesC1PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,950</ix:nonFraction></span>
for equipment, which has been valued based on similar cash purchases of the Series C-1 Preferred Stock at approximately $12.00 per
share. For the six months ended June 30, 2022 and 2021 depreciation expense was $<span id="xdx_90B_eus-gaap--Depreciation_c20220101__20220630_p0p0_zfeAExnfrpL1"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">195,387</ix:nonFraction> </span>and
$<span id="xdx_90D_eus-gaap--Depreciation_c20210101__20210630_p0p0_zcdDqjRUEiO"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,781</ix:nonFraction></span>. For the  six months ended June 30, 2022 and 2021
capitalized interest to equipment from debt financing was $<span id="xdx_90F_eus-gaap--InterestCostsCapitalized_p0p0_c20220101__20220630_zcy0jFqlcZQ4"><ix:nonFraction name="us-gaap:InterestCostsCapitalized" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,235</ix:nonFraction> </span>and
$<span id="xdx_904_eus-gaap--InterestCostsCapitalized_p0p0_c20210101__20210630_z2b9QiBcygvf"><ix:nonFraction name="us-gaap:InterestCostsCapitalized" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">822,700</ix:nonFraction></span>. Equipment that is
currently being manufactured is considered construction in process and is not depreciated until the equipment is placed into
service.<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23B_zBSVX8SH9ls3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_z3X5u49W4kvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zy3O4CbfuQy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_z2XV1MT7ghK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_802_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z8MUZM6C3mx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 7. <span id="xdx_822_zu1RARlcuIc8">Accounts Payable and Accrued Expenses</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts payable and accrued expenses consist
of the following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zCVJ2P9TRvo4" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BF_zoSDtMfhJNb9" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220630_zp7euy5lVgoe" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20211231_zo6XJoLCZP7e" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccountsPayableCurrent_iI_p0p0_z3QU6LDAJ4s4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Accounts payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">851,495</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,450,531</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Deposits_iI_p0p0_zyYEp3MVgCGa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Office access deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_p0p0_zbwpajNChiu3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Accrued compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,798</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">175,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--UnearnedPremiums_iI_p0p0_d0_z9Rkgrlikyzc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnearnedPremiums" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,784</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnearnedPremiums" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--AccruedInterestWorkingInterestRoyaltyPrograms_p0p0_d0_z321N4M3N1Bk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Accrued interest (working interest royalty programs)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:AccruedInterestWorkingInterestRoyaltyPrograms" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,341,079</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="VIVK:AccruedInterestWorkingInterestRoyaltyPrograms" contextRef="AsOf2021-12-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_p0p0_zIRzL7QGsDYa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Accrued tax penalties and interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,114</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,114</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_p0p0_zJfTBbOYm1H5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: justify">Accounts payable and accrued expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,061,610</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,023,985</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of December
31, 2021 the Company accrued $225,000 for a milestone payment to be paid to </span>TBT Group, Inc. (of which an independent Vivakor Board
member is a 7% shareholder) related to our worldwide, exclusive license agreement for the license of piezo electric and energy harvesting
technologies for creating self-powered sensors for making smart roadways. This milestone payment was paid in March 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:MortgageNotesPayableDisclosureTextBlock"><p id="xdx_808_eus-gaap--MortgageNotesPayableDisclosureTextBlock_zbqkSe12fn8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 8. <span id="xdx_82F_zLxdDyTIuxfj">Loans and Notes Payable</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Loans and Notes payable (including accrued interest)
consist of the following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zBt3fjaMI6td" summary="xdx: Disclosure - Loans and Notes Payable (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8B6_zxoRJ43j9WWd" style="display: none">Schedule of loans and notes payable</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Various promissory notes and convertible notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zUNWA1btj3O7" title="Total Notes Payable" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_VariousPromissoryNotesAndConvertibleNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,960</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zN0kYferQQQ" title="Total Notes Payable" style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_VariousPromissoryNotesAndConvertibleNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,960</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Novus Capital Group LLC Note (a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zpSTE0IyGqz" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_NovusCapitalGroupLLCNoteMember" id="Fact001145" format="ixt:numdotdecimal" decimals="0" unitRef="USD">283,612</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zav5q11y8sZc" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_NovusCapitalGroupLLCNoteMember" id="Fact001147" format="ixt:numdotdecimal" decimals="0" unitRef="USD">378,854</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Triple T Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zSZEgoNzwSWe" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_TripleTNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">329,613</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zNBcpGR47NSc" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_TripleTNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">353,330</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">National Buick GMC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zXm3z8AKVpfg" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_NationalBuickGMCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,977</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zTDFdyLHDn2e" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_NationalBuickGMCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,440</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Various Convertible Bridge Notes (b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_d0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zhuPzsIyVhmk" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_VariousConvertibleBridgeNotesMember" id="Fact001157" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zGJauvOtdaY7" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_VariousConvertibleBridgeNotesMember" id="Fact001159" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,075,813</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Blue Ridge Bank</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z12rXJ4a3Yak" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_BlueRidgeBankMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">410,200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z9OrlkdgTtMa" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_BlueRidgeBankMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">410,200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Small Business Administration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zydrssOwAtW6" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_SmallBusinessAdministrationMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">324,267</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zwDAiwwi3E7d" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_SmallBusinessAdministrationMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">318,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">JP Morgan Chase Bank</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zJpORknSSE49" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_JPMorganChaseBankMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,645</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zwVoWi1tUtIf" title="Total Notes Payable" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_JPMorganChaseBankMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,645</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Various Promissory Notes (c)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zYRnUaqpdLkd" title="Total Notes Payable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_VariousPromissoryNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,308,232</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zM2l5gKFENc" title="Total Notes Payable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_VariousPromissoryNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,416,379</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify">Total Notes Payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--NotesPayable_c20220630_p0p0_zONdv7cwV26f" title="Total Notes Payable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,814,506</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--NotesPayable_c20211231_p0p0_zuqD0iN6Vvv6" title="Total Notes Payable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,113,796</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans and notes payable, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesAndLoansPayableCurrent_c20220630_p0p0_zK7D6hbRwb82" title="Loans and notes payable, current" style="text-align: right"><ix:nonFraction name="us-gaap:NotesAndLoansPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">962,405</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--NotesAndLoansPayableCurrent_c20211231_p0p0_zPgxiTmvJqB1" title="Loans and notes payable, current" style="text-align: right"><ix:nonFraction name="us-gaap:NotesAndLoansPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,511,447</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loans and notes payable, current attributed to variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20220630_p0p0_zN30deQcqkfe" title="Loans and notes payable, current attributed to variable interest entity" style="text-align: right"><ix:nonFraction name="VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,308,232</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20211231_p0p0_zDqWaVSwOAE7" title="Loans and notes payable, current attributed to variable interest entity" style="text-align: right"><ix:nonFraction name="VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,416,379</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans and notes payable, long term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--NotesAndLoansPayableNonCurrent_c20220630_p0p0_z00kBjj5Jui6" title="Loans and notes payable, long term" style="text-align: right"><ix:nonFraction name="VIVK:NotesAndLoansPayableNonCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">543,869</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--NotesAndLoansPayableNonCurrent_c20211231_p0p0_zkQigEr6iI1f" title="Loans and notes payable, long term" style="text-align: right"><ix:nonFraction name="VIVK:NotesAndLoansPayableNonCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,185,970</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8A3_z2Wq0BqQ0r3e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="VIVK:ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock_zQNq2SnFcUKa" summary="xdx: Disclosure - Loans and Notes Payable (Details - Maturities of Debt)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zlSGqVJUxfL9" style="display: none">Schedule of maturities of loans and notes payable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zVH8wMM3K2ag" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 34%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,787,944</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_za0wU2dYfCP1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">518,114</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_zTu0ZgExnN5j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72,278</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_zQxnDJ40JULc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">68,878</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zjNSR57lq6Hi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,979</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zftGs1Uv2kf6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">255,313</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NotesAndLoansPayable_iI_p0p0_zJPJWoGa7ce2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,814,506</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">__________________&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><span id="xdx_F02_zrqYTbVasth7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="width: 97%; text-align: justify"><span id="xdx_F13_zbi12mKvg7Ug" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001201" xml:lang="en-US">On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398. As of April 1 2022, the lender agreed to extend the maturity of the note to April 1, 2023 with an initial payment of $52,448 and approximate monthly payment of $29,432 thereafter until the note is fully paid.</ix:footnote></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span id="xdx_F06_z9qYJiM6Aiu8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_z2CxGdiyBuod" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001202" xml:lang="en-US">In 2021 and 2020 the Company entered into various convertible promissory notes as follows:</ix:footnote></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AA_z7hudYkQKocg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_231_zyWSYge3RwWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zn1okuDUkkm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z48fsSD5bWjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zzo9gP11u8xl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify">&#160;</td>
    <td style="width: 97%; text-align: justify">Throughout 2021 and 2020 the Company entered into convertible promissory notes with an aggregate principal of $<span id="xdx_900_eus-gaap--ConvertibleNotesPayable_c20220630_p0p0_z9gn45miNqB8" title="Aggregate principal"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">415,000</ix:nonFraction></span>. The notes accrue interest at <span id="xdx_90A_ecustom--PercentageOfAccrueInterest_dp_c20220101__20220630_zDTVAUVptDHl" title="percentage of accrue interest"><span id="xdx_908_ecustom--PercentageOfAccrueInterest_dp_c20210101__20210630_zui1cKAUtp68" title="percentage of accrue interest"><ix:nonFraction name="VIVK:PercentageOfAccrueInterest" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="VIVK:PercentageOfAccrueInterest" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></ix:nonFraction></span></span>% per annum and have
a maturity of the earlier of 12 months or the consummation of the Company listing its Common Stock on a senior stock exchange. The notes
are convertible at the Company&#8217;s option into shares of the Company&#8217;s common stock at a price equal to 80% of the opening price
of the Company&#8217;s common stock on the national exchange or the offering price paid by the investors in the financing in connection
with the uplist, whichever is lower, or (ii) repaid in cash in an amount equal to the indebtedness being repaid plus a premium payment
equal to 15% of the amount being repaid. If an event of default has occurred and the Company does not convert the amounts due under the
Note into the Company&#8217;s common stock, then the Company will have the option to convert the outstanding indebtedness into shares
of the Company&#8217;s common stock at a price equal to 80% of the weighted average trading price of the Company&#8217;s common stock
on the OTC Markets, or be repaid in cash in an amount equal to all principal and interest due under the Note. All of these notes were
converted to common stock as of June 30, 2022.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="background-color: white">On
October 13, 2020, the Company entered into a convertible promissory note in an amount of $280,500 having an interest rate of 12% per annum.
The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00 or 80% of
the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the note may be
converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in conjunction with
this note, which </span>was recorded as a debt discount in the amount of $44,000, which is amortized to interest expense over the term
of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to state that in no event
shall the conversion price be lower than $3.00 per share. In October 2021 the parties agreed to extend the maturity of this loan to April
13, 2022 in exchange for an increase in principal owed of $30,000. This note has been converted to common stock as of June 30, 2022.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="background-color: white">On
February 4, 2021, the Company entered into a convertible promissory note in an amount of $277,778 having an interest rate of 12% per annum.
The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00 or 80% of
the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the note may be
converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in conjunction with
this note, which </span>was recorded as a debt discount in the amount of $36,000, which is amortized to interest expense over the term
of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to state that in no event
shall the conversion price be lower than $3.00 per share. In February 2022 the parties agreed to extend the maturity of this loan to August
8, 2022 in exchange for an increase in principal owed of $25,000. This note has been converted to common stock as of June 30, 2022.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">(c)</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Viva
Wealth Fund I, LLC is offering up to </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25,000,000 in
convertible notes in a private offering<span style="background-color: white">. As of June 30, 2022, VWFI has raised $10,510,000
and converted $8,575,000 of this debt to VWFI LLC units. A convertible note will </span>automatically <span style="background-color: white">convert
into the LLC units at the earlier of (i) the date that the Equipment is placed into quality control and testing or (ii) six months
from the date of investment. The convertible notes will accrue interest at 12% per annum</span> and are paid quarterly. At the
maturity date, remaining interest will be paid, at which time no further interest payments will accrue. Upon the offering
termination date, all units accepted for any series of equipment will automatically convert to Vivakor common stock if the Company
has not accepted subscriptions for at least $6,250,000 for a series of equipment. The conversion price of the automatic stock
conversion will be the the greater of $13.50 or a 10% discount to market per share or in the event of a public offering, 200% of the
per share price of the Company common stock sold in an underwritten offering, which was closed on February 14, 2022 at $5.00 per
share. <span style="background-color: white">The termination </span>date of the offering has been extended until November 13, 2022
in the sole discretion of the Company. As of April 28, 2021 VWFI has reached $6,250,000 in funding and has released the funding for
construction of RPC Series A. VWFI has commenced fundraising for RPC Series B and has raised approximately $4,690,000 to manufacture
RPC Series B. Subsequent to June 30, 2022 an additional $30,000 of this debt has been converted into units of the LLC.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23A_z32sz9Ojn438" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zNAY7VaZhwS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_z5FTzzCJVd2d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zmvaA8gBeVsd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_ztMUDxYShod4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note
9. <span id="xdx_829_zo8tboMJ3j1g">Commitments and Contingencies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Commencing on September 15, 2019, the Company
entered into a five-year lease with Jamboree Center 1 &amp; 2 LLC covering approximately 6,961 square feet of office space in Irvine,
CA. Under the terms of the lease agreement, we are required to make the following monthly lease payments: Year 1 $<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zdnsfRNK9kwe" title="Lease payments next twelve months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-06-30_custom_JamboreeCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,927</ix:nonFraction></span>, Year 2 $<span id="xdx_90C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_z0DvtGkjWmR6" title="Lease payments next two months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-06-30_custom_JamboreeCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,832</ix:nonFraction></span>,
Year 3 $<span id="xdx_90E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zC76eKBcHTPb" title="Lease payments next three months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-06-30_custom_JamboreeCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,737</ix:nonFraction></span>, Year 4 $<span id="xdx_907_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zUmukQkuhXI5" title="Lease payments next four months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-06-30_custom_JamboreeCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,712</ix:nonFraction></span>, Year 5 $<span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zU0V1PiKrxl8" title="Lessee, Operating Lease, Liability, to be Paid, Year Five"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2022-06-30_custom_JamboreeCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,686</ix:nonFraction></span>. As a condition of the lease, we were required to provide a $<span id="xdx_90E_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zf0EVZ7sEz3e" title="Security deposit"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2019-09-15_custom_JamboreeCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,992</ix:nonFraction></span> security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 1, 2022, the Company entered into
a lease agreement for approximately 2,533 square feet of office and manufacturing space located in Las Vegas, Nevada. Commencing on March
1, 2022, the Company entered into a three-year lease with Speedway Commerce Center, LLC. Under the terms of the lease agreement, we are
required to make the following monthly lease payments: Year 1 $<span id="xdx_90A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zymAhYeuTX7i" title="Lease payments next twelve months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-06-30_custom_SpeedwayCommerceCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,950</ix:nonFraction></span>, Year 2 $<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zDonGQwVedhf" title="Lease payments next two months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-06-30_custom_SpeedwayCommerceCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,028</ix:nonFraction></span>, Year 3 $<span id="xdx_90F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zQTWb4jlVlg2" title="Lease payments next three months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-06-30_custom_SpeedwayCommerceCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,110</ix:nonFraction></span>. As a condition of the lease, we were
required to provide a $<span id="xdx_902_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zMLKWtbCCce6" title="Security deposit"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2019-09-15_custom_SpeedwayCommerceCenterMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,418</ix:nonFraction></span> security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 28, 2022, the Company entered into a
lease agreement for approximately 1,469 square feet of office space located in Lehi, Utah. Commencing on April 1, 2022, the Company entered
into a three-year lease with Victory Holdings, LLC. Under the terms of the lease agreement, we are required to make the following monthly
lease payments: Year 1 is comprised of April to May 2022 $<span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zLqPaRZ7Udbl" title="Lease payments next twelve months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-06-30_custom_VictoryHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">867</ix:nonFraction></span>, June 2022 to March 2023 $<span id="xdx_906_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zix5ICNVP0Aj" title="Lease payments next two and three months"><ix:nonFraction name="VIVK:LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" contextRef="AsOf2022-06-30_custom_VictoryHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,550</ix:nonFraction></span>, Year 2 $<span id="xdx_90F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zRVZpEFDeug" title="Lease payments next three months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-06-30_custom_VictoryHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,657</ix:nonFraction></span>, Year 3 $<span id="xdx_909_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_z658OYxLUFF" title="Lease payments next four months"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-06-30_custom_VictoryHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,766</ix:nonFraction></span>. As a condition
of the lease, we were required to provide a $<span id="xdx_90E_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zAWCi1qng081" title="Security deposit"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2019-09-15_custom_VictoryHoldingsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,766</ix:nonFraction></span> security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2022, the Company entered into a lease
agreement for approximately 2,000 square feet of office and warehouse space located in Houston, Texas. Commencing on April 1, 2022, the
Company entered into a month-to-month lease with JVS Holdings, Inc. The lease may be terminated at any time or for any reason with a 30-day
written notice to terminate. The lease requires a monthly lease payment of $<span id="xdx_905_eus-gaap--OperatingLeasePayments_c20220101__20220630_z7jRn6qWYVWe" title="Lease payment"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000</ix:nonFraction></span> as long as the Company remains in the space.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The right-of-use asset for operating leases as
of June 30, 2022 and December 31, 2021 was $<span id="xdx_90C_eus-gaap--OperatingLeaseRightOfUseAsset_c20220630_p0p0_znoAEiwv99Xj" title="Right-of-use asset for operating leases"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">721,550</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_p0p0_c20211231_zVYNxWCFLV6c" title="Right-of-use asset for operating leases"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">663,291</ix:nonFraction></span>. Rent expense for the six months ended June 30, 2022 and 2021 was $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20220101__20220630_p0p0_zi3WAtVjcQYc" title="Rent expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,170</ix:nonFraction></span>
and $<span id="xdx_900_eus-gaap--OperatingLeaseExpense_c20210101__20210630_p0p0_zV2tAXW27wI7" title="Rent expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">186,086</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table reconciles the undiscounted
cash flows for the leases as of June 30, 2022 to the operating lease liability recorded on the balance sheet:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zqifXTNooFfb" summary="xdx: Disclosure - Commitments (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_zYjrq6de3fO1" style="display: none">Schedule of lessee operating lease liability</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20220630_zadUSdZUWBE2" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_p0p0_zYW4kqHEMVk9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: justify">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,195</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_p0p0_zdXfilqhHpW5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">370,902</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_p0p0_zclp4fjqMg5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">304,892</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_p0p0_zaTLS6ljJFvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,135</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_p0p0_zNnwA4Llgmgg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Total undiscounted lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">872,124</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_p0p0_zKkqEP2TpC8k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,074</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PresentValueOfLeasePayments_iI_p0p0_zhFjN12vDg3j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="VIVK:PresentValueOfLeasePayments" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">779,050</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_p0p0_zpkR0DztXUj2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Operating lease liabilities, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">364,103</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--OperatingLeaseLiability1Noncurrent_iI_p0p0_zsAsIsmBHRTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Operating lease liabilities, long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="VIVK:OperatingLeaseLiability1Noncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">414,946</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zpMy8KS20sR2" title="Weighted-average remaining lease term"><ix:nonNumeric contextRef="AsOf2022-06-30" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.36</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Weighted-average discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z7h5q93x9gTk" title="Weighted-average discount rate"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.0</ix:nonFraction></span>%</td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The discount rate is the Company&#8217;s incremental
borrowing rate, or the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an
amount equal to the lease payments in a similar economic environment. Based on an assessment of the Company&#8217;s borrowings the incremental
borrowing rate was determined to be 7%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Employment Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2022, the Company entered into employment
agreements with its Chief Executive Officer and Chief Financial Officer, which provide for annual base salaries of $375,000 and $350,000,
respectively, and provide for incremental increases in their salaries upon the Company&#8217;s achievement of specific performance metrics.
The Company is currently accruing substantial portions of both executive&#8217;s base salaries (see Note 7). The employment agreements
provide for the grant of stock options to the Chief Executive Officer and Chief Financial Officer to purchase up to 955,093 and 917,825
shares of the Company&#8217;s common stock, respectively, at an exercise price equal to 110% and 100% of the fair market value of the
Company&#8217;s common stock on the date of grant. The stock option will vest after two years of continuous employment, subject to acceleration
if terminated without cause or resignations for good reason. The agreement also provides that it is anticipated that the executives will
receive bonuses for 2022 which will be determined by the Company&#8217;s Compensation Committee and Board of Directors after taking into
account the general business performance of the Company, including any completed financings and or acquisitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p>

<ix:exclude><p id="xdx_23D_zHj8fq0TKOBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_ztQNkbSwqdkg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zcRh0q1S7Ooc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_z3rWQLVqP3Ph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_803_eus-gaap--LongTermDebtTextBlock_z5BZZphgdMKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 10. <span id="xdx_825_zc3OJwZWRKMk">Long-term Debt</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To assist in funding the manufacture of the Company&#8217;s
Remediation Processing Centers, between 2015 and 2017, the Company entered into two agreements which include terms for the purchase of
participation rights for the sale of future revenue of the funded RPCs. The RPCs are estimated to enter scaled up operations in 2022 and
make estimated payments. The Company estimates future payments based on revenue projections for the RPCs. Due to delays in scaled up operations
(see Note 1 <i>Long Lived Assets</i>) the effective interest rate of these agreements increased from approximately 33% to 36%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-term debt consists of the following:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zOV77MkwcL4e" summary="xdx: Disclosure - Long-term Debt (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zzLEroAMHtZi" style="display: none">Schedule Of Long-Term Debt</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220630__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zuAukLD4uUvj" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20211231__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zS8b9c9ISsZ9" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_p0p0_zLfN7oyrf1Hg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%">Principal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,196,233</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,196,233</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_p0p0_zGGHXuiTkjpg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,049,304</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,205,144</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_p0p0_zjy9ZaN5Lxvf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">219,380</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">226,823</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebt_iI_p0p0_zdK2D4HHVXOe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,026,157</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,174,554</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LongTermDebtCurrent_iI_p0p0_zGGJmy4B41D5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long term debt, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,565</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,256</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermDebtNoncurrent_iI_p0p0_znzh3ubHqmQ1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Long term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,017,592</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,171,298</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8AB_zRuxNy5PZzz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the estimated
payment schedule of long-term debt as of June 30, 2022:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zTrvZMAYzY6d" summary="xdx: Disclosure - Long-term Debt (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zBvBSpEAcOpj" style="display: none">Schedule of long-term debt maturities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zZd90qCh3nvk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3,525</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_zGNuNRo4riy7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,795</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_znnugAX2pyMe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,078</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_z6PpCCxR0SSh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,359</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zOau1F6hYCBh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,943</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zV8midIH7ml" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,125,533</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebt_iI_p0p0_ziNLzqwGtbY5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,196,233</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8AA_zB9HULwk0Q1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="VIVK:TemporaryEquityTextBlock"><p id="xdx_804_ecustom--TemporaryEquityTextBlock_zOPa5Whmsouk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11.&#160;<span id="xdx_82D_zVlDTslJPik3">Temporary Equity</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table shows all changes to temporary equity during for
the six months ended June 30, 2021.</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:TemporaryEquityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--TemporaryEquityTableTextBlock_zkj1eVS7qNYb" summary="xdx: Disclosure - Temporary Equity (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span id="xdx_8B7_zuzij8dvxA0i" style="display: none">Schedule of temporary equity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Convertible Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series C-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zKRrSrWKT324" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; font-weight: bold; text-align: left">March 31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zG0XcMv62vu4" title="Beginning balance, shares" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">213,583</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,281,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zO6JJkRUXzS" title="Beginning balance, shares" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesB1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">459,426</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,445,716</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zOYU5NSXkV0k" title="Beginning balance, shares" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesC1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">260,702</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,615,927</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TemporaryEquityDividendsAdjustment_z1XkWG4e7bAj" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--DividendPaidInSeriesB1PreferredStock_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z8FHfogLkTDb" title="Dividend paid in Series B-1 Preferred Stock" style="text-align: right"><ix:nonFraction name="VIVK:DividendPaidInSeriesB1PreferredStock" contextRef="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,196</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ConversionOfStockAmountConverted1_zk6AUfJzvZ4d" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Conversion of Series B and B-1 Preferred Stock to Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zN7NpsVoR004" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">213,583</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,281,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zFpJTwGwHzOk" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesB1Member" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">459,426</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,445,716</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z3AGUCJqXnR8" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">266,328</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,658,123</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zDdXOOdbZdi3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_z1Y9MHFEnHh1" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1341">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_z2oyf7Af0fC3" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1343">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zK0W9oGhcLLg" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1345">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Convertible Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series C-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>

<tr id="xdx_438_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_z3biLnfjToIi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; width: 28%">December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_988_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zfJYQSxfw5g6" title="Beginning balance, shares" style="text-align: right; width: 9%"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">216,916</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">1,301,500</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zRj5DOEhbdIk" title="Beginning balance, shares" style="text-align: right; width: 9%"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesB1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">467,728</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">3,507,981</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_984_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z9lUUVYMRmI" title="Beginning balance, shares" style="text-align: right; width: 9%"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesC1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">255,289</ix:nonFraction></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">4,550,977</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--SerciesC1IssueForReductionInStockPayables_zaia6mKkoECg" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Series C-1 Issue for a reduction in stock payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--SerciesC1IssueForReductionInStockPayable_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zrx0XXgKLpi2" title="Sercies C-1 Issue for a reduction in stock payables, shares" style="text-align: right"><ix:nonFraction name="VIVK:SerciesC1IssueForReductionInStockPayable" contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,413</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,950</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--TemporaryEquityDividendsAdjustment_zM9jXoY9BVo4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--DividendPaidInSeriesB1PreferredStock_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zfllWXEPraYl" title="Dividend paid in Series B-1 Preferred Stock" style="text-align: right"><ix:nonFraction name="VIVK:DividendPaidInSeriesB1PreferredStock" contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,196</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ConversionOfStockAmountConverted1_z51aSSgC3AL4" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Conversion of Series B and B-1 Preferred Stock to Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zWqfszJKZWha" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">216,916</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,301,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zdBJzBBiFtja" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesB1Member" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">467,728</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,507,981</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zbuobMp7Ivfd" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">266,328</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,658,123</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_435_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zpaStK7ArNRe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zMlVoeKrDZIj" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1368">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zDyhxuL7eay8" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1370">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zKyrmU7mQsId" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1372">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8AF_zdanAWU5FfBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ended December 31, 2021, all shares of Series B, B-1,
and C-1 Preferred Stock were converted to common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_235_z73NQ1zpfxCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zVDNWVnspFnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zqYGsvNhcbya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zHoRZLS661V6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>
</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_805_eus-gaap--MinorityInterestDisclosureTextBlock_z17kC2771LC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 12. <span id="xdx_82F_zg5hJXUSXsVi">Noncontrolling Interest</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the six months ended June 30, 2022 and 2021, the Company converted
$<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220101__20220630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zBE7xdKCK3j6"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,025,000</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210101__20210630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zgymMdMJvqQ3"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,000</ix:nonFraction></span> in Viva Wealth Fund I, LLC convertible promissory notes into <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20220630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_ziIdrGSX1lQe"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">605</ix:nonFraction></span> and <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20210630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zy4zphagUTRi"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">147</ix:nonFraction></span> units of noncontrolling interest in Viva
Wealth Fund I, LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six months ended June 30, 2021 and 2020,
the Company paid distributions to Viva Wealth Fund I, LLC unit holders of $<span id="xdx_902_eus-gaap--PaymentsOfDistributionsToAffiliates_c20220101__20220630__dei--LegalEntityAxis__custom--VivaWealthFundILLCMember_zpL2UD5ybnfb"><ix:nonFraction name="us-gaap:PaymentsOfDistributionsToAffiliates" contextRef="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember147106531" format="ixt:numdotdecimal" decimals="0" unitRef="USD">343,889</ix:nonFraction></span> and <span id="xdx_901_eus-gaap--PaymentsOfDistributionsToAffiliates_dn_c20210101__20210630__dei--LegalEntityAxis__custom--VivaWealthFundILLCMember_zxM69rujKWsj"><ix:nonFraction name="us-gaap:PaymentsOfDistributionsToAffiliates" contextRef="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember147106531" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">none</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock"><p id="xdx_806_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zfXdlZyus43e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 13. <span id="xdx_82C_zl7zl2ju1pB8">Share-Based Compensation &amp; Warrants</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally accepted accounting principles require
share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income
statement based on their fair values at the date of grant, net of estimated forfeitures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021,
the Company has granted stock-based compensation to employees, including a <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20180101__20181231__us-gaap--AwardTypeAxis__custom--ShareStockAwardMember__srt--CounterpartyNameAxis__custom--EmployeesMember_pdd_zjDFnAMi6pG1" title="Option granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2018-01-012018-12-31_custom_ShareStockAwardMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,667</ix:nonFraction></span>
share stock award, which was issued in 2018 and vested in May 2022, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210630__us-gaap--AwardTypeAxis__custom--StockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesMember_pdd_zfA20N4ycmE2" title="Option granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2021-01-012021-06-30_custom_StockOptionsMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">166,667</ix:nonFraction></span>
in employee stock options that were issued in 2020 and cliff vest at the end of five years, and <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__srt--CounterpartyNameAxis__custom--EmployeesMember_zgl1FUCJKfRf" title="Option granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-01-012022-06-30_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,872,918</ix:nonFraction></span>
employee stock options granted in June 2022 and vest over a period of two years. For the six months ended June 30, 2022 and 2021,
stock-based compensation was $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__custom--StockOptionsMember_p0p0_z6andRk94JPd" title="Share-based Payment Arrangement, Noncash Expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-06-30_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,340,703</ix:nonFraction></span>
and $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__custom--StockOptionsMember_p0p0_ztWxi0R0PUxk" title="Share-based Payment Arrangement, Noncash Expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-06-30_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,056</ix:nonFraction></span>.
In 2020, the Company also granted non-statutory stock options, including <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember__srt--CounterpartyNameAxis__custom--BoardOfDirectorsMember_pdd_zbhppYpa67me" title="Option granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember_custom_BoardOfDirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,333</ix:nonFraction></span>
stock options to the Board of Directors, which vests over 1 year, and a <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember__srt--CounterpartyNameAxis__custom--ConsultantMember_pdd_zNEPRoHiM775" title="Option granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember_custom_ConsultantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">333,334</ix:nonFraction></span>
stock option to a consultant, which vests over 4 years. Non-statutory stock-based compensation was $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember_p0p0_z7I6JPHa6Cr9" title="Share-based Payment Arrangement, Noncash Expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">855,000</ix:nonFraction></span>
and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember_p0p0_zYGRu1rVeID9" title="Share-based Payment Arrangement, Noncash Expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-06-30_custom_NonStatutoryStockOptionsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">730,000</ix:nonFraction></span>
for the six months ended June 30, 2022 and 2021. In 2022, the Company closed on its underwritten public offering in which the
Company granted the underwriter, EF Hutton, division of Benchmark Investments, LLC (&#34;EF Hutton&#34;), a 45-day option to
purchase up to an additional <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630_pdd_zwSoLkwmr5Cj" title="Option granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">240,000</ix:nonFraction></span>
shares of Common Stock at the public offering price per share, less the underwriting discounts and commissions, to cover
over-allotments, if any. These options were not exercised and expired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no other options granted during the
six months ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The assumptions used in the Black-Scholes option
pricing model to determine the fair value of the options on the date of issuance are as follows:&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="VIVK:ScheduleOWarrantsValuationAssumptionsTableTextBlock"><table cellspacing="0" cellpadding="0" summary="xdx: Disclosure - Share-Based Compensation &amp; Warrants (Details - Assumptions)" id="xdx_893_ecustom--ScheduleOWarrantsValuationAssumptionsTableTextBlock_zQxe2cxJVlX5" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zKgxhekKiKXg" style="display: none">Schedule of warrant assumptions</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 51%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 48%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">December 31, 2020 through June 30, 2022</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zlsfH0sgceil" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-012022-06-30_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.24</ix:nonFraction></span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zkGhwGDXrYqb" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-012022-06-30_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.04</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_c20220101__20220630_zKFJEgzrMNXe" title="Expected dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-01to2022-06-30" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Pure">None</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life of warrants</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zVujzUYtl49d" title="Expected life of warrants"><ix:nonNumeric contextRef="From2022-01-012022-06-30_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3.33</ix:nonNumeric></span>-<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zL0iUs4YQLQf" title="Expected life of warrants"><ix:nonNumeric contextRef="From2022-01-012022-06-30_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">10</ix:nonNumeric></span> years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility rate</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zld1UpQFNTgh" title="Expected volatility rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-012022-06-30_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">169</ix:nonFraction></span> - <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zCJiRY6v3g9k" title="Expected volatility rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-01-012022-06-30_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">273</ix:nonFraction></span>%</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zGFuCeOCsRkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<ix:exclude><p id="xdx_232_z7c7aoPRRPa5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zLootSnchW12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zIwLqDXtMue6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zbCgEoVcJ5mk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes all stock option
activity of the Company for the six months ended June 30, 2022 and 2021:</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEyI1V0pVWfe" summary="xdx: Disclosure - Share-Based Compensation &amp; Warrants (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BE_zg4NRCbjG50l" style="display: none">Schedule of option activity</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">of Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life (Years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; width: 52%; text-align: left">Outstanding, December 31, 2021</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGzyJcHWsoTh" title="Shares outstanding - beginning" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">650,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWH5k9Nj5ET3" title="Weighted average exercise price - beginning" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zepFeL2sKfjc" title="Weighted average contractural term"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.53</ix:nonNumeric></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zpITgqxeEjd9" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,112,919</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zKdW7w1cSeQ5" title="Weighted average exercise price, granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.24</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZoitAmMkGXd" title="Weighted average remaining contractual life (years)"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="VIVK:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2">6.60</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zU3SiJUmuKJd" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,667</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zMVxfEggfAsf" title="Weighted average exercise price, exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zO1xVgNBXkd1" title="Stock Issued During Period, Shares, Restricted Stock Award, Forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">240,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_z6NF080YqpM5" title="Weighted average exercise price, forfeited" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Outstanding, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zq1XgtFHQFL" title="Shares outstanding - ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,506,252</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z4eNEImGgT3e" title="Weighted average exercise price - ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.53</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSJjJT94Y5B7" title="Weighted average contractural term"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.39</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvpCM6SpWLge" title="Shares exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zm0pwFkrSd2i" title="Weighted average exercise price - exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zV5pZP1dANb4" title="Weighted average contractural term"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">7.01</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zVPn5DMyc4F1" title="Shares exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">890,168</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zWWgs4brn9h9" title="Weighted average exercise price - exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2022-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.74</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zw77cQjXXW8i" title="Weighted average contractural term"><ix:nonNumeric contextRef="From2022-01-012022-03-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">7.48</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Outstanding, December 31, 2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9QMEoObEMWe" title="Shares outstanding - beginning" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">650,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zavK7tgH9tIg" title="Weighted average exercise price - beginning" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSYGHhOc5x14" title="Weighted average contractural term"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">6.41</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTcI7KvBhsni" title="Shares outstanding - ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">650,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaV1OFdjkvZe" title="Weighted average exercise price - ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyBOErZ9OBpf" title="Weighted average contractural term"><ix:nonNumeric contextRef="From2021-01-012021-06-30_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">5.91</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7ChZQMefX9d" title="Shares exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,083</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zPRRaCvxnh58" title="Weighted average exercise price - exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNp6f4INXJoc" title="Weighted average contractural term"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">3.38</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTEi1FknJX82" title="Shares exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2021-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">108,333</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zZ80KZsmpbJ8" title="Weighted average exercise price - exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-06-30_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvKBpcjVsmld" title="Weighted average contractural term"><ix:nonNumeric contextRef="From2021-01-012021-06-30_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">5.10</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8A1_zCsd8nAf1O6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021, the
aggregate intrinsic value of the Company&#8217;s outstanding options was approximately none. The aggregate intrinsic value will change
based on the fair market value of the Company&#8217;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021,
the Company had <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightOutstanding_c20220630_pdd_zgJoM7I0zsw1" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></span>
and <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20211231_za9wJkA3JTWg" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span>
warrants outstanding. On February 14, 2022, the Company closed on its underwritten public offering of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_zmIsoCpCise" title="Stock Issued During Period, Shares, New Issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-06-30_custom_PublicOfferingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,600,000</ix:nonFraction></span>
shares of common stock, at a public offering price of $5.00 per share. In addition, the Company has issued the underwriter, EF
Hutton, 5-year warrants to purchase <span id="xdx_906_ecustom--WarrantsIssued_iI_c20220630_zoxolq7QqiN5" title="Warrants issued"><ix:nonFraction name="VIVK:WarrantsIssued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></span>
shares of common stock at an exercise price equal $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20220630_pdd_z9V7vVaikzj7" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.75</ix:nonFraction></span>.
and were valued with a fair market value of $374,000. We used the Black-Scholes option pricing model to determine the fair value of
the warrants, with assumptions of a risk free rate of 1.92%, an expected life of 5 years, and volatility of 167%. The impact of
these warrants has no effect on stockholder&#8217;s equity, as they are considered equity-like instruments, and are considered a
direct expense of the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_235_zDcY0zV1Uk6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zDjkC6T55yId" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zReYkrDwxKa4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_z0pPed75BDK" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zKAIkVVYti8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 14. <span id="xdx_82D_zJt9b1mJ0wic">Income Tax</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculates its quarterly tax provision
pursuant to the guidelines in ASC 740 Income Taxes. ASC 740 requires companies to estimate the annual effective tax rate for current year
ordinary income. In calculating the effective tax rate, permanent differences between financial reporting and taxable income are factored
into the calculation, and temporary differences are not. The estimated annual effective tax rate represents the Company&#8217;s estimate
of the tax provision in relation to the best estimate of pre-tax ordinary income or loss. The estimated annual effective tax rate is then
applied to year-to-date ordinary income or loss to calculate the year-to-date interim tax provision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company recorded a provision for income taxes of $<span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20220630_p0p0_zAPPz3fSvJ3j" title="Provision for income taxes"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--IncomeTaxExpenseBenefit_p0p0_c20210101__20210630_z3nIGzFpfzeh" title="Provision for income taxes"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">723,911</ix:nonFraction></span> for the six months ended June 30, 2022 and 2021, respectively. The
Company is projecting a (0.04)% </span><span style="font-family: Times New Roman, Times, Serif">effective tax rate for the year
ending December 31, 2022, which is primarily the result of projected provision from book loss incurred for the year offset by additional
valuation allowance on the net operating losses. The Company&#8217;s effective tax rate for 2021 was <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210630_z7i5CYECk7m2" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.18</ix:nonFraction></span>% which was the result of the
benefit of book income for the year.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the Company had estimated
federal and state net operating loss (NOL) carryforwards of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_dm_c20211231_zsEAWGy76sfk" title="Net Operating losses"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">14.3</ix:nonFraction></span> million. Federal NOL carryforwards begin to expire in
2028.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zgYUv9GSmJhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 15. <span id="xdx_822_zjeaVTsUkre5">Subsequent Events</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company has evaluated
subsequent events through the date the financial statements were available to issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On August 1, 2022, we
closed a Membership Interest Purchase Agreement, (the &#8220;MIPA&#8221;), with Jorgan Development, LLC, a Louisiana limited liability
company (&#34;Jorgan&#34;) and JBAH Holdings, LLC, a Texas limited liability company (&#34;JBAH&#34; and, together with Jorgan, the
&#34;Sellers&#34;), as the equity holders of Silver Fuels Delhi, LLC, a Louisiana limited liability company (&#34;SFD&#34;) and White
Claw Colorado City, LLC, a Texas limited liability company (&#34;WCCC&#34; ) whereby, the Company acquired all of the issued and outstanding
membership interests in each of SFD and WCCC (the &#8220;Membership Interests&#8221;), making SFD and WCCC wholly owned subsidiaries of
the Company. The purchase price for the Membership Interests is approximately $37.4 million, subject to post-closing adjustments, payable
by the Company in a combination of 3,009,552 shares of the Company&#8217;s common stock, amount equal to 19.99% of the number of issued
and outstanding shares of the Company&#8217;s common stock immediately prior to issuance, a secured three-year promissory notes made by
the Company in favor of the Sellers, and the assumption of certain liabilities of SFD and WCCC. The shares of the Company&#8217;s common
stock and the Notes will have an aggregate value of approximately $32,942,939.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Sellers have entered
into 18-month lock-up agreements at closing with regard to the 3,009,552 common shares issued for consideration for the Membership Interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the MIPA, the
Company has committed to make a payment to the Sellers on or before the 18-month anniversary of the closing date in the amount of
$16,471,469 whether in cash or unrestricted common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:exclude><p id="xdx_238_zsmeMWwWMc42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zyIPuxaNofik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zUhanDNx8UM" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zZQjNyEuFtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the event of a breach
of the terms of the MIPA, the Notes, or the Pledge Agreement, the sole and exclusive remedy of the parties will be to unwind the MIPA
transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The principal amount
of the Notes, together with any and all accrued and unpaid interest thereon, will be paid to the Sellers on a monthly basis in an amount
equal to the Monthly Free Cash Flow continuing thereafter on the twentieth (20<sup>th</sup>) calendar day of each calendar month thereafter.
Monthly Free Cash Flow means cash proceeds received by SFD and WCCC from its operations minus any capital expenditures (including, but
not limited to, maintenance capital expenditures and expenditures for personal protective equipment, additions to the land/current facilities
and pipeline connections) and any payments on capital lease obligations of SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In conjunction with the
closing under the MIPA, SFD, WCCC and the Company will enter into a Shared Services Agreement with Endeavor Crude, LLC, a Texas limited
liability company affiliated with the Sellers (&#8220;Endeavor&#8221;), under which Endeavor will provide certain operating and administrative
services to SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In conjunction with the
closing we entered into a Master Netting Agreement, hereto (the &#8220;Netting Agreement&#8221;), with Jorgan, JBAH, Endeavor and White
Claw Crude, LLC under which all amounts as a result of all Contracts during a given calendar month shall be netted against all amounts
owed as a result of all contracts and the resulting net amount shall be payable. The Netting Agreement includes contracts such as the
MIPA, the Notes, any pledge agreements, the Shared Services Agreement, the Crude Petroleum Supply Agreement dated January 1, 2021, by
and between WC Crude and SFD, as amended, and the Oil Storage Agreement dated January 1, 2021, by and between WC Crude, as Shipper, and
WCCC, as Operator, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the acquisition
of WCCC we also acquired WCC&#8217;s Oil Storage Agreement with WC Crude, under which WC Crude has the right, subject to the payment of
service and maintenance fees, to store volumes of crude oil and other liquid hydrcarbons at a certain crude oil and liquid hydrocarbon
receipt, storage, blending, throughput and delivery terminal operated by WCCC, which expires on December 31, 2031.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the acquisition of
SFD, we acquired a Crude Petroleum Supply Agreement with WC Crude (the &#8220;Supply Agreement&#8221;), under which WC Crude supplies
volumes of Crude Petroleum to SFD. WC Crude and SFD will be entered into an amendment to the Supply Agreement, in conjunction with the
closing under the MIPA, which provides for the delivery to SFD a minimum of 1,000 sourced barrels per day, and includes a guarantee that
when SFD resells these barrels, if SFD does not make at least a $5.00 per barrel margin that WC Crude will pay to SFD the difference between
the sales price and $5.00 per barrel In the event that SFD makes more than $5.00 per barrel, SFD will pay WC Crude a profit sharing payment
in the amount equal to 10% of the excess price over $5.00 per barrel, which amount will be multiplied by the number of barrels associated
with the sale. The Supply Agreement, as amended, will remain in effect through and including December 31,2031.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the acquisition of
SFD, we acquired a crude oil gathering, storage, and transportation facility located on approximately 9.3 acres near Delhi, Louisiana,
along with its existing sales agreements, where a subsidiary of a large NYSE traded energy company is obligated to purchase blended crude
oil from SFD in amounts up to 60,000 barrels per month. With prior approval, SFD is eligible to sell to the Purchaser amounts greater
than 60,000 barrels of crude oil per month. In the acquisition of WCCC, we acquired a 120,000 barrel crude oil storage tank, in the heart
of the Permian Basin, located near Colorado City, Texas. The storage tank is presently connected to the Lotus pipeline system</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to June 30, 2022, VWFI has raised $430,000
in conjunction with the $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC units,
to accredited investors to raise funds to manufacture equipment that manufacture RPC Series B. Subsequent to June 30, 2022, VWFI has also
converted $30,000 of convertible debt into VWFI LLC units.</p>

</ix:nonNumeric><p id="xdx_819_zruSP86Yp392" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><img src="image_004.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="a_300"></span>Report of Independent
Registered Public Accounting Firm</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors and Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vivakor, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Opinion on the Financial Statements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have audited the accompanying consolidated balance sheet of Vivakor,
Inc. (the Company) as of December 31, 2021 and 2020, and the related consolidated statements of operations, stockholders&#8217; equity
(deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the &#8220;consolidated financial
statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position
of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended in conformity
with accounting principles generally accepted in the United States of America.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As discussed in Note 23 to the consolidated financial statements, the
Company filed an incorrect version of the consolidated financial statements and Form 10-K, due to administrative errors, on April 15,
2022. The December 31, 2021, consolidated financial statements have been restated to reflect the correct version of the consolidated financial
statements that we audited. In our opinion, such corrections are appropriate and have now been properly reported.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Basis for Opinion </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These financial statements are the responsibility of the entity&#8217;s
management. Our responsibility is to express an opinion on the entity&#8217;s consolidated financial statements based on our audits. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#34;PCAOB&#34;) and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We conducted our audits in accordance with the standards of the PCAOB.
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free
of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit
of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control
over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity&#8217;s internal control
over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our audits included performing procedures to assess the risks of material
misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Macias Gini &amp; O&#8217;Connell LLP</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Irvine, CA 92816</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company's auditor since
2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Irvine,
California</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 15, 2022, except for Notes 22 and 23 as to which the date is
May 2, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a22"></span><b>CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(As Restated)</b></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; padding-bottom: 1pt; font-weight: bold; text-align: left">ASSETS</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; width: 68%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,293,767</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">309,404</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Cash and cash equivalents attributed to variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199,952</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Accounts Receivable, less allowances of $33,000 and $33,000, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">845</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,735</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,231,218</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,016,951</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">192,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">525,744</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Precious metal concentrate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,166,709</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,166,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">73,245</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">87,052</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 40pt; text-align: left; padding-bottom: 1pt">Total current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,157,736</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,203,095</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Other investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,194,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78,455</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,692,111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,152,699</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Rights of use assets- operating leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">663,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">881,804</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">License agreement, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,370,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,013,810</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Intellectual property, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13,662,037</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,966,627</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 40pt; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">47,744,245</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">42,300,490</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY AND TEMPORARY EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,023,985</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,350,808</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Operating lease liabilities, current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">287,769</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,699</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Loans and notes payable, current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,511,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,196,037</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left">Loans and notes payable, current attributed to variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,416,379</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">735,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Long-term debt, current</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,256</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,020</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 40pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,242,836</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,559,564</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Operating lease liabilities, long term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">434,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">618,696</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Loans and notes payable, long term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,185,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">914,661</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,171,298</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,950,640</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Deferred income tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,156,899</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,207,905</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 40pt; text-align: left; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,191,112</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,251,466</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Redeemable, convertible preferred stock, $.001 par value; 11,600,000 shares authorized;<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-weight: 400; font-style: normal; text-align: left">Series B- 12.5%, cumulative,
none
and 216,916
issued and outstanding as of December 31, 2021 and 2020<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,301,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-weight: 400; font-style: normal; text-align: left">Series B-1- none and 467,728 issued and outstanding as of December 31, 2021 and 2020<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,507,981</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 1pt">Series
    C-1- none
    and 255,290
    issued and outstanding as of December 31, 2021 and 2020<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,550,977</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total temporary equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,360,458</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Stockholders' equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
  <td style="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal">Convertible, preferred stock, $.001 par value;
3,400,000 shares authorized;<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td>
  <td>&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td>&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td style="text-align: left">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
  <td style="text-indent: -10pt; padding-left: 20pt; font-weight: 400; font-style: normal">Series A- 66,667 issued and outstanding
  <sup>(1)</sup></td>
  <td>&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td style="text-align: right">67</td>
  <td style="text-align: left">&#160;</td>
  <td>&#160;</td>
  <td style="text-align: left">&#160;</td>
  <td style="text-align: right">67</td>
  <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: 400; font-style: normal; text-align: left">Common stock, $.001 par value; 41,666,667 shares authorized; 12,330,859 and 11,255,967 were issued and outstanding as of December 31, 2021 and 2020<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,331</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,256</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,279,590</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45,623,146</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Treasury stock, at cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(35,731,359</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,204,992</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Total Vivakor, Inc. stockholders' equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,540,629</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,409,477</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,012,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,279,089</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total stockholders' equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,553,133</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,688,566</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&#8217; equity and temporary equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">47,744,245</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">42,300,490</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="width: 0.5in">(1)</td>
  <td style="text-align: justify">Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 &#8211; Organization and Basis of Presentation for additional information</td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to consolidated financial
statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a23"></span>CONSOLIDATED STATEMENTS OF OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(As Restated)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,088,428</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,457,781</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Cost of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,050,676</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,356,378</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">849,107</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">567,290</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,652,069</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,806,238</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Bad debt expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,645</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Amortization and depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,462,492</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,562,622</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,963,668</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,949,795</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,925,916</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,848,392</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Other income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Equity investment loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,665</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Gain (loss) on disposition of asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">87,044</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(121,428</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Unrealized gain (loss) on marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,094,054</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,614,338</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,312</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,344</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(501,598</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(86,162</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Other income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">125,299</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">39,560</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,379,997</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,443,987</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loss before provision for income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,305,913</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,404,405</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Benefit (provision) for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,050,207</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(466,964</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Consolidated net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,255,706</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,871,369</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Net loss attributable to noncontrolling interests</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,771,535</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(687,672</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss attributable to Vivakor, Inc. </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,484,171</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,183,697</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net loss attributable to common shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5,484,171</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,183,697</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dividend on preferred stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42,196</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">172,795</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt"><b style="display: none">Net income loss to parent</b></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,526,367</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,356,492</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.46</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.23</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: 400; font-style: normal; text-align: left">Basic weighted average common shares outstanding <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,976,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,310,167</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: left; width: 0.5in">(1)</td>
  <td style="text-align: justify">Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 Organization and Basis of Presentation for additional information</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to consolidated financial
statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a24"></span>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217;
EQUITY(DEFICIT)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(As Restated)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>






<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Series A Preferred Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt">Additional Paid-in</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt">Treasury</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt">Accumulated</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt">Non-controlling</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt">Total Stockholders' Equity</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Capital</td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"> Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"> Deficit</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Interest</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"> (Deficit)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 19%; font-weight: 400; font-style: normal; text-indent: -5pt"><span style="font-size: 8pt">December
    31, 2019<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">66,667</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">67</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">9,511,465</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">9,511</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">25,071,709</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">(20,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">(27,848,500</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">1,341,854</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">(1,445,359</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Common
    Stock issued for reduction in stock payable<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">666,667</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">667</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">11,799,333</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">11,800,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Common
    Stock issued for a reduction in liabilities<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">9,164</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">9</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">135,984</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">135,993</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Common
    Stock issued for cash<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">7,600</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">8</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">41,020</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">41,028</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Common
    Stock issued for services<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">23,333</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">23</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">281,208</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">281,231</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Conversion
    of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">1,037,738</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">1,038</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">7,592,778</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">7,593,816</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Stock options issued for services</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">555,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">555,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Stock based compensation</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">146,114</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">146,114</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Issuance of noncontrolling interest</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">624,907</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">624,907</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Dividend paid in Series B-1 Preferred
    Stock</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(172,795</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(172,795</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Net loss</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(2,183,697</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(687,672</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(2,871,369</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-indent: -5pt"><span style="font-size: 8pt">December 31,
    2020<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">66,667</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">67</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">11,255,967</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">11,256</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">45,623,146</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">(20,000</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">(30,204,992</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">1,279,089</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">16,688,566</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Common
    Stock issued for services<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">33,667</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">34</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">437,970</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">438,004</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Common
    Stock issued for a reduction of liabilities<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">68,611</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">68</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">495,731</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">495,799</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Common
    Stock issued for the purchase of a license<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">16,667</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">17</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">224,983</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">225,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-weight: 400; font-style: normal; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Conversion
    of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock<span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: 400"><sup>(1)</sup></span></span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">955,947</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">956</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">9,466,648</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">9,467,604</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Stock options issued for services</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">1,585,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">1,585,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Stock based compensation</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">446,112</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">446,112</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Distributions paid by
    noncontrolling interest</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">&#8211;</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(55,050</span></td><td style="text-align: left"><span style="font-size: 8pt">)&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(55,050</span></td><td style="text-align: left"><span style="font-size: 8pt">)&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Issuance of noncontrolling interest
    for a reduction of debt</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">5,560,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">5,560,000</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Dividend paid in Series B-1 Preferred
    Stock</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(42,196</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(42,196</span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Net  (loss)</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(5,484,171</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(1,771,535</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(7,255,706</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">December 31, 2021</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">66,667</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">67</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">12,330,859</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">12,331</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">58,279,590</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">(20,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">(35,731,359</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">5,012,504</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">27,553,133</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="width: 0.5in">(1)</td>
  <td>Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 &#8211; Organization and Basis of Presentation for additional information</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">See accompanying notes to consolidated financial
statements</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a26"></span>CONSOLIDATED STATEMENT OF CASH FLOWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(As Restated)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>






<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">OPERATING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left">Consolidated net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(7,255,706</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(2,871,369</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Adjustments to reconcile net income to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,462,492</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,562,622</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Bad debt expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,645</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Forgiveness of notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(90,711</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Equity investment loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,665</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss (gain) on disposition of asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(87,044</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">121,428</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Common stock options issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,585,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">555,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">438,004</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">281,231</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Unrealized gain (loss)  marketable securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,094,054</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,614,338</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,051,007</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">466,164</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">146,114</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,890</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,735</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,549</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Precious metal concentrate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,519</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Right of use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">285,345</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(218,513</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(285,345</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">517,931</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accrued interest on notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,313</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,344</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accrued interest on notes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">501,598</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">71,361</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,901,696</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,753,655</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">INVESTING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Issuance of notes receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,441</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payment on costs of patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,366</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,854</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Purchase of a technology license</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(265,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Purchase of equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,236,276</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,197,922</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,514,642</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,227,217</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payment of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,735</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(116,535</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Proceeds from loans and notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,135,984</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,231,796</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from sale of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,028</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Payment of notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(562,046</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,323</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Distributions to noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(55,050</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Issuance of noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">624,907</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,511,153</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,774,873</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net increase (decrease) in cash and cash equivalents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,094,815</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(205,999</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">398,904</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">604,903</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, END OF PERIOD</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,493,719</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">398,904</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">SUPPLEMENTAL CASHFLOW INFORMATION:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Cash paid during the year for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390,843</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: normal; text-align: left">Noncash transactions<span style="font: normal 700 10pt Times New Roman, Times, Serif">:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of Series B, B-1, and C-1 Preferred Stock to Common Stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,467,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,593,816</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Common stock issued for a reduction in liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">495,799</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11,935,993</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of note receivable to equity investment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">81,768</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">809,578</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Noncontrolling interest issued for a reduction in liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,504,950</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred stock Series C-1 issued for a reduction in liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">64,950</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Common stock issued for the purchase of a license</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">225,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized interest on construction in process</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,614,697</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,025,852</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">42,196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">172,795</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sale of marketable securities for note receivable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">860,491</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accounts payable on purchase of equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to consolidated financial
statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VIVAKOR, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a27"></span><b>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(As Restated)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1. Organization and Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vivakor, Inc. (collectively &#8220;we&#8221;,
&#8220;us,&#8221; &#8220;our,&#8221; &#8220;Vivakor&#8221; or the &#8220;Company&#8221;) is a socially responsible operator, acquirer
and developer of clean energy technologies and environmental solutions, which is currently focused on soil remediation in the United States
and Kuwait, and we have corporate offices in Utah, California, and in Qatar. We specialize in the remediation of soil from properties
contaminated by or laden with heavy crude oil and other substances. The Company was originally organized on November 1, 2006 as a limited
liability company in the State of Nevada as Genecular Holdings, LLC. The Company&#8217;s name was changed to NGI Holdings, LLC on November
3, 2006. On April 30, 2008, the Company was converted to a C-corporation and changed its name to Vivakor, Inc. pursuant to Articles of
Conversion filed with the Nevada Secretary of State.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 18, 2020, our Board of Directors
and stockholders holding a majority of our outstanding voting shares, authorized a reverse stock split of each of the
outstanding shares of the Corporation&#8217;s common stock, $0.001
par value per share, as well as each of the outstanding shares of the Corporation&#8217;s preferred stock, at a ratio to be
determined by the Board of within a range of a minimum of a one-for-twelve (1-for-12)
to a maximum of one-for-forty (1-for-40)
(the &#8220;Reverse Stock Split Ratio&#8221;), with the exact ratio to be set at a number within this range as determined by the
Board in its sole discretion, with no change in par value. On February 14, 2022, we effected a 1-for-30
reverse split of our outstanding shares of common stock (the &#8220;Reverse Stock Split&#8221;) via the filing of a certificate of
change with the Nevada Secretary of State which was effective at the commencement of trading of our Common Stock. No fractional
shares of the Company&#8217;s common stock will be issued as a result of the Reverse Stock Split. Any fractional shares resulting
from the Reverse Stock Split will be rounded up to the nearest whole share. All issued and outstanding common stock, preferred
stock, and per share amounts in the consolidated financial statements and footnotes included herein have been retroactively adjusted
to reflect this reverse stock split for all periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COVID-19</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 11, 2020, the World Health Organization
(&#8220;WHO&#8221;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the
pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets.
Most U.S. states and many countries have issued policies intended to stop or slow the further spread of the disease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">COVID-19 and the U.S. response to the pandemic
are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may
have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent
of the effects on the economy, the markets we serve, our business, or our operations. In March 2020 we temporarily suspended operations
in Kuwait and Utah due to COVID-19 government restrictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2. Liquidity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have historically suffered net losses and
cumulative negative cash flows from operations, and as of December 31, 2021, we had an accumulated deficit of approximately $35.7
million. As of December 31, 2021 we had cash of $1,493,719. To date we have financed our operations primarily through debt
financing, private equity offerings and our working interest agreements. For the year ended December 31, 2021 and 2020, we issued
none and $624,907 noncontrolling units of RPC Design and Manufacturing, LLC (&#8220;RDM&#8221;), respectively, made payments on our working interest agreement with RII of $7,735 and
$116,535, respectively, and we also received proceeds of $9,135,984 and $2,231,796 related to the issuance of convertible bridge
notes and other loans. For the years ended December 31, 2021 and 2020, as included in the proceeds above, we obtained two Paycheck
Protection Program loans for $295,745 and $295,745 that may be forgiven <span style="background-color: white">under the CARES Act,
if we can demonstrate that the proceeds from the loan were used for eligible expenses</span>. We also obtained loans from the Small
Business Administration in the amount of $299,900 in May 2020, as included in the proceeds above. In addition, for the years ended
December 31, 2021 and 2020, the Company received debt financing of $8,090,000 and $735,000 through the operations of Viva Wealth
Fund I, LLC, which debt converts into Viva Wealth Fund I units at the earlier of 6 months or the minimum raise of $6,250,000 to
build a Remediation Processing Center (&#8220;RPC&#8221;) system. As of December 31, 2021, $5,560,000 of this debt financing has converted to noncontrolling units in Viva Wealth
Fund I, LLC. We believe we have other liquid assets that may be used to assist in financing the operations of the Company if needed,
including marketable securities in Scepter, which hold a fair value $2,231,218 as of December 31, 2021 and have been deposited for
trading. Subsequent to December 31, 2021, the Company closed its underwritten public offering of 1,600,000 shares of common stock,
at a public offering price of $5.00 per share, for aggregate gross proceeds of $8 million, prior to deducting
underwriting discounts, commissions, and other offering expenses. We believe the liquid assets from the Company&#8217;s available
for sale investments and funding provided from subsequent fundraising activities of the Company give it adequate working capital to
finance our day-to-day operations for at least twelve months through March 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 3. Summary of Significant Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Basis of Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
have been prepared in accordance with the Financial Accounting Standards Board (&#8220;<span style="text-decoration: underline">FASB</span>&#8221;) &#8220;FASB Accounting Standard
Codification&#8482;&#8221; (the &#8220;<span style="text-decoration: underline">Codification</span>&#8221;) which is the source of authoritative accounting principles recognized
by the FASB to be applied by nongovernmental entities in the preparation of consolidated financial statements in conformity with generally
accepted accounting principles (&#8220;<span style="text-decoration: underline">GAAP</span>&#8221;) in the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All figures are in U.S. dollars unless indicated
otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Principles of Consolidation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the accounts of Vivakor, Inc., its wholly owned and majority-owned active subsidiaries, or joint ventures (collectively, the &#8220;Company&#8221;).
Intercompany balances and transactions between consolidated entities are eliminated. Inactive entities have no value, assets or liabilities.
Vivakor has the following wholly and majority-owned subsidiaries: Vivaventures Management Company, Inc., Vivaventures Energy Group, Inc.
(99%), Vivaventures Oil Sands, Inc., Vivasphere, Inc.. Vivakor Middle East, LLC (49%, consolidated). The Company withdrew from VivaVentures
Precious Metal, LLC (39%, equity method investment) in July 2020. Vivakor manages and consolidates RPC Design and Manufacturing LLC, which
includes a noncontrolling interest investment from Vivaopportunity Fund, LLC, which is also managed by Vivaventures Management Company,
Inc. Vivakor has common officers with and consolidates Viva Wealth Fund I, LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows ASC 810-10-15 guidance with
respect to accounting for Variable Interest Entities (&#8220;VIE&#8221;). A VIE is an entity that does not have sufficient equity at risk
to finance its activities without additional subordinated financial support from other parties, or whose equity investors lack any of
the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will absorb portions
of a VIE&#8217;s expected losses or receive portions of the entity&#8217;s expected residual returns. Variable interests are contractual,
ownership, or other pecuniary interests that change with changes in the fair value of the entity&#8217;s net assets. A party is the primary
beneficiary of a VIE and must consolidate it when that party has a variable interest, or combination of variable interests, that provides
the party with a controlling financial interest. A party is deemed to have a controlling financial interest if it meets both of the power
and losses/benefits criteria. The power criterion is the ability to direct the activities of the VIE that most significantly impact its
economic performance. The losses/benefits criterion is the obligation to absorb losses from, or right to receive benefits from, the VIE
that could potentially be significant to the VIE. The VIE model requires an ongoing reconsideration of whether a reporting entity is the
primary beneficiary of a VIE due to changes in facts and circumstances. For the years ended December 31, 2021 and 2020 the following entities
are considered to be a VIE and are consolidated in our consolidated financial statements: Viva Wealth Fund I, LLC (organized in 2020)
and RPC Design and Manufacturing, LLC. For the years ended December 31, 2021 and 2020 the following entities were considered to be a VIE,
but were not consolidated in our consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion:
Vivaventures UTS I, LLC, Vivaventures Royalty II, LLC, Vivaopportunity Fund, LLC, and International Metals Exchange, LLC. For the years
ended December 31, 2021 and 2020 the unaudited financial information for the unconsolidated VIEs is as follows: Vivaventures UTSI, LLC
held assets of $3,753,296 and $3,113,292 (where the primary asset represents a receivable from the Company), and liabilities of $12,608
and $41,894. Vivaventures Royalty II, LLC held assets of $2,648,810 and $2,117,066 (where the primary asset represents a receivable from
the Company), and liabilities of $300. Vivaopportunity Fund LLC held assets of $2,119,961 (where the primary asset represents a noncontrolling
interest in units of a consolidated entity of the Company) and no liabilities. International Metals Exchange, LLC held assets of $30,461
and $82,711 and liabilities of $1,900.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>RPC Design and Manufacturing, LLC:</b>&#160;The
Company established RPC Design and Manufacturing, LLC (&#8220;RDM&#8221;) in December 2018 with a business purpose of manufacturing custom
machinery and selling or leasing the manufactured equipment in long term contracts with financing or leasing activities to the Company.
We own 100% of the voting rights in RDM. We, as the sole general partner of RDM, have the full, exclusive and complete right, power and
discretion to operate, manage and control the affairs of RDM and take certain actions necessary to maintain RDM in good standing without
the consent of the limited partners. RDM has entered into a license agreement with the Company indicating that while RDM builds custom
machinery incorporating the Company&#8217;s hydrocarbon extraction technology, RDM will pay the Company a license fee of $500,000 per
Remediation Processing Center manufactured. RDM has been retained by VWFI to assist in being the plant manager and will manage and direct the manufacturing
of the RPCs. RDM&#8217;s license fee is waived for RPC manufacturing for VWFI. Creditors of RDM have no recourse to the general credit
of the Company. For the years ended December 31, 2021 and 2020, investors in RDM have a noncontrolling interest of $629,694 and $1,343,018,
respectively As of December 31, 2021 and 2020,
the cash and cash equivalents of this VIE are not restricted and can be used to settle the obligations of the reporting entity. As of
December 31, 2021 and 2020 this VIE has an outstanding note payable to the reporting entity in the amount of $354,566 and $335,208, which
is eliminated upon consolidation. We have the primary risk (expense) exposure in financing and operating the assets and are responsible
for 100% of the operation, maintenance and any unfunded capital expenditures, which ultimately could be 100% of a custom machine, and
the decisions related to those expenditures including budgeting, financing and dispatch of power. Based on all these facts, it was determined
that we are the primary beneficiary of RDM. Therefore, RDM has been consolidated by the Company. Any intercompany revenue and expense
associated with RDM and its license agreement with the Company has been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Viva Wealth Fund I, LLC:</b>&#160;The
Company assisted in designing and organizing Viva Wealth Fund I, LLC (&#8220;VWFI&#8221;) in November 2020, as a special purpose
entity, for the purpose of manufacturing, leasing and selling custom equipment solely to the Company. The Company commenced
co-managing VWFI with Wealth Space, LLC, an unaffiliated entity, but as of the date of this report Wealth Space, LLC is the sole
manager. The Company has been retained by the manager and continues to have common officers with VWFI, including our CEO and CFO,
who will assist in the day-to-day operations. VWFI has also retained the Company to act as its sole plant manager, and we will
manage and direct all of the manufacturing, leasing and selling of custom equipment in behalf of VWFI to the Company. In November
2020, VWFI commenced a $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC units,
to accredited investors to raise funds to manufacture equipment that will expand the Company&#8217;s second RPC. As of December 31,
2021 and 2020, the cash and cash equivalents of this VIE are restricted solely for the use of proceeds of the VWFI offering (to
manufacture RPCs) and cannot be used to settle the obligations of the reporting entity. As of December 31, 2021 and 2020, the
Company has cash attributed to variable interest entities of $199,952
and $89,500.
As of December 31, 2021, VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI
has commenced fundraising for RPC Series B. In the event that VWFI does not raise at least $6,250,000 for these RPC Series by the
offering termination date (which date has been extended until November 13, 2022), then the convertible notes and/or units would
convert into Vivakor common stock where the minimum conversion price will be the greater of $13.50 or a 10% discount to
market per share or in the event of a public offering, 200% of the per share price of the Company common stock sold in the
underwritten offering, which was closed on February 14, 2022 at $5.00 per share. As of March 21, 2022, VWFI has raised approximately
$2,740,000 for RPC Series B. VWFI unit holders may also sell their units to the Company for their principal investment amount on the
3<sup>rd</sup>, 4<sup>th</sup>, and 5<sup>th</sup> anniversary of the offering termination date. The Company also has the option to
purchase any LLC units where the members did not exercise their conversion option under the same terms and pricing for cash or
common stock. VWFI has entered into a license agreement with the Company indicating that VWFI will pay the Company a license fee of
$1,000,000 per series of equipment manufactured with the Company&#8217;s proprietary technology. All of the operations of VWFI
relate to private placement offering to fund and manufacture proprietary equipment for the Company, as intended in VWFI&#8217;s
design and organization by the Company, so that the Company controls VWFI in its business purpose, use of proceeds, and selling and
leasing of its equipment solely to the Company. Creditors of VWFI have no recourse to the general credit of the Company. We have the
primary risk (expense) exposure in financing and operating the assets and are responsible for 100% of the operation, and any
unfunded capital expenditures, and the expense to the unit holders in conversion to common stock if series of equipment cannot be
fully funded, which ultimately could be 100% of any custom machine. We are responsible for the decisions related to the expenditures
of VWFI proceeds including budgeting, financing and dispatch of power surrounding the series of equipment. Based on all these facts,
it was determined that we are the primary beneficiary of VWFI. Therefore, VWFI has been consolidated by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid
investments with an original maturity of three months or less when acquired to be cash equivalents. As of December 31, 2021 and
2020, the Company does not have any cash equivalents. The Company places its cash with high credit quality financial institutions.
The Company&#8217;s accounts at these institutions are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up
to $250,000. As of December 31, 2021 and 2020, the Company had bank balances exceeding the FDIC insurance limit. To reduce its risk
associated with the failure of such financial institutions, the Company annually evaluates the rating of the financial institutions
in which it holds deposits. As of December 31, 2021 and 2020, the Company has cash attributed to variable interest entities of
$199,952
and $89,500. The Company has $2,666 in Qatar National Bank, located in Doha Qatar.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accounts Receivable</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are carried at original invoice
amount less an estimated allowance for doubtful accounts, if deemed necessary by management, and based on a review of all outstanding
amounts on a monthly basis. Management determines the allowance for doubtful accounts, if any, by identifying troubled accounts and by
using historical experience applied to an aging of accounts. An allowance for doubtful accounts was considered necessary by management
as of December 31, 2021 and 2020 in the amount of $33,000, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Investments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated net income includes the Company&#8217;s
proportionate net income or loss of equity investments. The carrying value of the Company&#8217;s equity method investments is increased
and decreased by the Company&#8217;s proportionate share of the net income or loss of the investee. The carrying value of our equity method
investment is also decreased by dividends the Company receives from the investee. The Company did not have any equity method investments
as of December 31, 2021. As of December 31, 2020 the equity method investments consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2019 the Company had an investment of
$800,000 or 800,000,000 shares of common stock, or a diluted 23% equity holding in Scepter Holdings, Inc. (ticker: BRZL, OTC
Markets) In the fourth quarter of 2020, the Company was diluted to a 19% equity holding in Scepter Holdings, Inc., and was no longer
deemed to have significant influence and ceased to be an equity investment, and as the stock is traded on an active market, the
Company has classified the investment as trading securities for the years ended December 31, 2021 and 2020 with the change in
unrealized gains and losses on the investment included in the statement of operations (see Note 5). For the year ended December 31,
2020, the Company was attributed a loss on this equity investment in the amount of $37,665.
There were no distributions to the Company in 2021 or 2020 from Scepter Holdings, Inc. As of December 31, 2020, the Company&#8217;s
Chief Executive Officer has an immediate family member who sits on the board of directors of Scepter Holdings, Inc. The
Company&#8217;s 826,376,882
shares of common stock of Scepter Holdings, Inc. have a market value of approximately $3,553,241
as of April 5, 2022 based on the quoted market price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in marketable securities consist of
equity securities recorded at fair value. Fair value is defined as the price that would be received to sell an asset in an orderly transaction
between market participants at the measurement date. We analyze our marketable securities in accordance with Accounting Standard Codification
321 (&#8220;ASC 321&#8221;). Valuations for marketable securities are based on quoted prices for identical assets in active markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2019, the Company held a 39%
interest in Vivaventures Precious Metals, LLC for which the fair value of this investment was none. In July 2020, the Company withdrew
from this LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the Company
owns 1,000 Class A LLC Units in each of the following entities, which are not consolidated: Vivaopportunity Fund LLC, Vivaventures UTSI,
LLC, Vivaventures Royalty II, LLC, and International Metals Exchange, LLC. In aggregate these units amount to $4,000 as of December 31,
2021 and 2020. These Class A Units give the Company&#8217;s management control of the entities but lack the necessary economics criterion,
where the Company lacks the obligation to absorb losses of these entities, as well as the right to receive benefits from the LLCs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Convertible Instruments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews the terms of convertible debt
and preferred stock for indications requiring bifurcation, and separate accounting for the embedded conversion feature. Generally, embedded
conversion features where the ability to physical or net-share settle the conversion option is not within the control of the Company or
the number of shares is variable are bifurcated and accounted for as derivative financial instruments. (See <span style="text-decoration: underline">Derivative Financial Instruments</span>
below). Bifurcation of the embedded derivative instrument requires the allocation of the proceeds first to the fair value of the embedded
derivative instrument with the residual allocated to the host instrument. The resulting discount to the debt instrument or the redemption
value of convertible preferred securities is accreted through periodic charges to interest expense over the term of the agreements or
to dividends over the period to the earliest conversion date using the effective interest rate method, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Derivative Financial Instruments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not use derivative financial
instruments to hedge exposures to cash-flow or market risks. However, certain other financial instruments, such as warrants to purchase
the Company&#8217;s common stock and the embedded conversion features of debt and preferred instruments that are not considered indexed
to the Company&#8217;s common stock are classified as liabilities when either (a) the holder possesses rights to net-cash settlement,
(b) physical or net share settlement is not within the control of the Company, or (c) based on its anti-dilutive provisions. In such instances,
net-cash settlement is assumed for financial accounting and reporting. Such financial instruments are initially recorded at fair value
and subsequently adjusted to fair value at the close of each reporting period. Fair value for embedded conversion features and option-based
derivative financial instruments is determined using the Monte Carlo Simulation or the Black-Scholes Option Pricing Model, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other convertible instruments that are not derivative
financial instruments are accounted for by recording the intrinsic value of the embedded conversion feature as a discount from the initial
value of the instrument and accreting it back to face value over the period to the earliest conversion date using the effective interest
rate method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Leases</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Accounting Standards Codification
842, <i>Leases</i> (&#34;ASC 842&#34;). We determine if an arrangement contains a lease at inception based on whether or not the Company
has the right to control the asset during the contract period and other facts and circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are the lessee in a lease contract when we
obtain the right to control the asset. Operating lease right-of-use (&#34;ROU&#34;) assets represent our right to use an underlying
asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease, both of which
are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Leases with
a lease term of 12 months or less at inception are not recorded on our consolidated balance sheet and are expensed on a straight-line
basis over the lease term in our consolidated statement of operations. We determine the lease term by assuming the exercise of renewal
options that are reasonably certain. As most of our leases do not provide an implicit interest rate, we use our local incremental borrowing
rate based on the information available at the commencement date in determining the present value of future payments. As of December 31,
2021 and 2020, we recorded right-of-use assets of $663,291 and $881,804 and lease obligations of $721,878 and $895,395.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Long Lived Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews the carrying values of its
long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
If the expected future cash flow from the use of the asset and its eventual disposition is less than the carrying amount of the asset,
an impairment loss is recognized and measured using the fair value of the related asset. No impairment charges were incurred during the
years ended December 31, 2021 and 2020, <span style="background-color: white">as the Company was still in the early phases of our business
plan and operating losses were expected in our early phases</span>. On March 11, 2020, the World Health Organization (&#8220;WHO&#8221;)
declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the pandemic is having a
negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets. Most U.S. states
and many countries have issued policies intended to stop or slow the further spread of the disease. Our Kuwait operations were suspended
to comply with the social distancing measures implemented in Kuwait. Our Utah operations were temporarily suspended from March through
May 2020, but have since resumed in full. There can be no assurance, however, that market conditions will not change or demand for the
Company&#8217;s services will continue, which could result in impairment of long-lived assets in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Property and equipment, net</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost or fair
value when acquired. Depreciation is computed by the straight-line method and is charged to the statement of operations over the estimated
useful lives of the assets. Leasehold improvements are depreciated over the shorter of the estimated useful lives of the assets or the
term of the related lease. Impairment losses are recognized for long-lived assets, including definite-lived intangibles, used in operations
when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are not sufficient
to recover the assets' carrying amount. Impairment losses are measured by comparing the fair value of the assets to their carrying amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interest on long-term debt for the development
or manufacturing of Company assets is capitalized to the asset until the asset enters production or use, and thereafter all interest is
charged to expense as incurred. Maintenance and repairs are charged to expense as incurred. Leasehold improvements are depreciated over
the shorter of the estimated useful lives of the assets or the term of the related lease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amount and accumulated depreciation
of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in results
of operations. The estimated useful lives of property and equipment are as follows:&#160;</p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of useful lives for property plant
    and equipment</span></td>
    <td style="vertical-align: top; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 50%; text-align: justify">Computers, software, and office equipment</td>
    <td style="vertical-align: top; width: 50%; text-align: left">1-5 years</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Machinery and equipment</td>
    <td style="vertical-align: top; text-align: left">3-5 years</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Vehicles</td>
    <td style="vertical-align: top; text-align: left">5 years</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture and fixtures</td>
    <td style="vertical-align: top; text-align: left">5 &#8211; 10 years</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Precious metal extraction machinery (heavy extraction equipment)</td>
    <td style="vertical-align: top; text-align: left">10 years</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remediation Processing Centers (heavy extraction and remediation equipment) (&#8220;RPC&#8221;)</td>
    <td style="vertical-align: top; text-align: left">20 years</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Leasehold improvements</td>
    <td style="vertical-align: top; text-align: left">Lesser of the lease term or estimated useful life</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equipment that is currently being manufactured
is considered construction in process and is not depreciated until the equipment is placed into service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Intangible Assets:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for intangible assets in accordance
with ASC 350 <i>&#8220;Intangibles-Goodwill and Other&#8221;</i> (&#8220;ASC 350&#8221;). Intangible asset amounts represent the acquisition
date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income
approach, discounting projected future cash flows based on management&#8217;s expectations of the current and future operating environment.
The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure
and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over
their useful lives, which have historically ranged from 10 to 20 years. The carrying amounts of our definite-lived intangible assets are
evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset&#8217;s
carrying amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We assess our intangible assets in accordance
with ASC 360 &#8220;<i>Property, Plant, and Equipment</i>&#8221; (&#8220;ASC 360&#8221;). Impairment testing is required when events occur
that indicate an asset group may not be recoverable (&#8220;triggering events&#8221;). As detailed in ASC 360-10-35-21, the following
are examples of such events or changes in circumstances (sometimes referred to as impairment indicators or triggers): (a) A significant
decrease in the market price of a long-lived asset (asset group) (b) A significant adverse change in the extent or manner in which a long-lived
asset (asset group) is being used or in its physical condition. (c) A significant adverse change in legal factors or in the business climate
that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator (d) An accumulation
of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group)
(e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast
that demonstrates continuing losses associated with the use of a long-lived asset (asset group) (f) A current expectation that, more likely
than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated
useful life. The term more likely than not refers to a level of likelihood that is more than 50 percent. We have evaluated our intangible
assets and found that certain losses and a delay in our business plan may have constituted a triggering event for our intangible assets.
We performed an analysis and assessed that there to be no impairment for the years ended December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Share-Based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share-based compensation is accounted for based
on the requirements of ASC 718, &#8220;Compensation-Stock Compensation&#8217; (&#8220;ASC 718&#8221;) which requires recognition in the
financial statements of the cost of employee, consultant, or director services received in exchange for an award of equity instruments
over the period the employee, consultant, or director is required to perform the services in exchange for the award (presumptively, the
vesting period). ASC 718 also requires measurement of the cost of employee, consultant, or director services received in exchange for
an award based on the grant-date fair value of the award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Income tax</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred income taxes are provided on the asset
and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax
credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences
between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be
realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our annual effective tax rate is based on our
income and the tax laws in the various jurisdictions in which we operate. Judgment is required in determining our annual tax expense and
in evaluating our tax positions. We establish reserves to remove some or all of the tax benefit of any of our tax positions at the time
we determine that the position becomes uncertain based upon one of the following conditions: (1) the tax position is not &#34;more likely
than not&#34; to be sustained; (2) the tax position is &#34;more likely than not&#34; to be sustained, but for a lesser amount; or
(3) the tax position is &#34;more likely than not&#34; to be sustained, but not in the financial period in which the tax position was
originally taken. For purposes of evaluating whether or not a tax position is uncertain, (1) we presume the tax position will be examined
by the relevant taxing authority that has full knowledge of all relevant information; (2) the technical merits of a tax position are derived
from authorities such as legislation and statutes, legislative intent, regulations, rulings and case law and their applicability to the
facts and circumstances of the tax position; and (3) each tax position is evaluated without considerations of the possibility of offset
or aggregation with other tax positions taken. We adjust these reserves, including any impact on the related interest and penalties, in
light of changing facts and circumstances, such as the progress of a tax audit. See Note 20 for further information on income tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We follow Accounting Standards Codification 606,
Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). For the year ended December 31, 2021 and 2020, approximately 99% and 96%
of our sales consist of the sale of precious metals with a commitment to deliver precious metals&#160;to the customer, and revenue
is recognized on the settlement date, which is defined as the date on which: (1) the quantity, price, and specific items being purchased
have been established, (2) metals have been shipped to the customer, and (3) payment has been received or is covered by the customer&#8217;s
established credit limit with the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The revenue standard contains a five-step approach&#160;that
entities will apply to determine the measurement of revenue and timing of when it is recognized, including (i) identifying the contract(s)
with a customer, (ii) identifying the separate performance obligations in the contract, (iii) determining the transaction price, (iv)
allocating the transaction price to separate performance obligations, and (v)&#160;recognizing revenue when (or as) each performance obligation
is satisfied. The new standard requires a number of disclosures intended to enable users of financial statements to understand the nature,
amount, timing and uncertainty of revenue, and the related cash flows. The disclosures include qualitative and quantitative information
about contracts with customers, significant judgments made in applying the revenue guidance, and assets recognized from the costs to obtain
or fulfill a contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to ensure the revenue recognition in
the proper period, we review material sales contracts for proper cut-off based upon the business practices and legal requirements of each
country.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our performance obligation generally consists
of the promise to sell products or complete services to our customers. Control of the products is transferred upon shipment to our customers'
locations, as determined by the specific terms of the contract. Upon transfer of control to the customer, which completes our performance
obligation, revenue is recognized. Services are completed upon the terms of each contract, specifically in regard to remediation, when
the tonnage of contaminated soil is completed and tested our performance obligation is completed and revenue is recognized. After completion
of our performance obligation, we have an unconditional right to consideration as outlined in the contract. Historically, we have not
accepted returns so there are no sales allowances. Due to the nature of the product we do accept returns. Our receivables will generally
be collected in less than nine months, in accordance with the underlying payment terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Advertising Expense</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Advertising
costs are expensed as incurred. The Company did not incur advertising expense for the years ended December 31, 2021 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent Accounting Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Jumpstart Our Business Startups Act,
or the JOBS Act, we meet the definition of an &#8220;emerging growth company.&#8221; We have irrevocably elected to opt-out of the extended
transition period for complying with new or revised accounting standards pursuant to Section&#160;107(b) of the JOBS Act. As a result,
we will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-
emerging growth companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the Financial Accounting Standards
Board issued Accounting Standards Update 2016-13, or ASU 2016-13. ASU 2016-13 significantly changed how entities measured credit losses
for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaced the
incurred loss model under previous guidance with a current expected credit loss, or&#160;CECL. ASU 2016-13 was effective for fiscal years
beginning after December&#160;15, 2019.&#160; The Company is anticipated to enter into scaled revenue producing activities in 2022 which
will generate accounts receivable which may require an evaluation of potential credit losses under the CECL standard.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, the Financial Accounting Standards
Board (&#34;FASB&#34;) issued Accounting Standards Update (&#34;ASU&#34;) 2019-12,<i>&#160;Simplifying the Accounting for Income Taxes</i>,
which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating taxes during
the quarters and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the
accounting for franchise taxes and changes in tax laws or rates, as well as clarifies the accounting for transactions that result in a
step-up in the tax basis of goodwill. ASU 2019-12 became effective for the Company beginning January 1, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In August
2020, </span>the Financial Accounting Standards Board (&#34;FASB&#34;) issued Accounting Standards Update (&#34;ASU&#34;) 2020-06
<i>Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own
Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity, which</i> improves <span style="background-color: white">Convertible
Instruments and Contracts in an Entity&#8217;s Own Equity and is expected to improve financial reporting associated with accounting for
convertible instruments and contracts in an entity&#8217;s own equity. The ASU simplifies accounting for convertible instruments by removing
major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single
liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion
features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception,
which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (EPS) calculation in
certain areas. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2021, the Financial Accounting Standards
Board (&#34;FASB&#34;) issued Accounting Standards Update (&#34;ASU&#34;) 2021-04 <i>Earnings Per Share (Topic 260), Debt&#8212; Modifications
and Extinguishments (Subtopic 470-50), Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212; Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40), </i>provides a &#8220;principles-based framework to determine whether an issuer should
recognize the modification or exchange as an adjustment to equity or an expense.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Net Income/Loss Per Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net income (loss) per share is
calculated by subtracting any preferred interest distributions from net income (loss), all divided by the weighted-average number of
common shares outstanding for the period, without consideration for common stock equivalents. Diluted net income (loss) per common
share is computed by dividing the net income (loss) by the weighted-average number of common share equivalents outstanding for the
period determined using the treasury stock method if their effect is dilutive. Potential dilutive instruments as of December 31,
2021 and 2020 include the following: convertible notes payable convertible into approximately 192,834 and 35,765 shares of common
stock, convertible Series A preferred stock convertible into none and 666,667 shares of common stock (in the event of a public
offering of the Company&#8217;s common stock this will convert to 833,333 shares), convertible Series B preferred stock convertible
into approximately none and 216,916 shares of common stock, convertible Series B-1 preferred stock convertible into approximately
none and 467,728 shares of common stock, convertible Series C-1 preferred stock convertible into approximately none and 255,290
shares of common stock, stock options granted to employees of 183,333 and 16,667 shares of common stock. Stock options granted to
Board members or consultants of 466,667 shares of common stock were granted as of December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America requires management to make estimates, judgments, and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes. We believe our critical accounting estimates
relate to the following: Recoverability of current and noncurrent Assets, revenue recognition, stock-based compensation, income taxes,
effective interest rates related to long-term debt, marketable securities, cost basis and equity method investments, lease assets and
liabilities, equity method investments, valuation of stock used to acquire assets, and derivatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While our estimates and assumptions are based
on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates
and assumptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fair Value of Financial Instruments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Accounting Standards Codification
(&#8220;ASC&#8221;) 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;), for assets and liabilities measured
at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value, and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#8217;s financial position
or operating results but did expand certain disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 820 defines fair value as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of
unobservable inputs. These inputs are prioritized below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1: Applies to assets or liabilities for
which there are quoted prices in active markets for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2: Applies to assets or liabilities for
which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3: Applies to assets or liabilities for
which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets
or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board&#8217;s (&#8220;FASB&#8221;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement. The carrying amounts reported in the consolidated balance sheets for marketable
securities are classified as Level 1 assets due to observable quoted prices for identical assets in active markets. The carrying amounts
reported in the consolidated balance sheets for cash, prepaid expenses and other current assets, accounts payable and accrued expenses
approximate their estimated fair market values based on the short-term maturity of these instruments. T<span style="background-color: white">he
recorded values of notes payable approximate their current fair values because of their nature, rates, and respective maturity dates or
durations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 4. Prepaid Expenses and Other Assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, our other assets
consist of various deposits with vendors, professional service agents, or security deposits on office and warehouse leases. As of December
31, 2021 and 2020 we had deposits in the amount of $73,245 and $87,052.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company entered into an Option Agreement in
July 2019 for the exclusive right to purchase certain real property commonly known as Asphalt Ridge. The right to purchase the land was
purchased for $200,000, which would be applied as a payment on the land if the option is exercised to purchase the land. The Company amortized
the prepaid over the life of the agreement, 12 months, and the option was completed amortized as of December 31, 2020. For the year ended
December 31, 2020 amortization expense was $117,891. In March 2022, the Company entered into a long term five year lease, with an extension
for an additional five year term, in order to operate on the land.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 5. Marketable Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in marketable securities consist of
equity securities recorded at fair value. Fair value is defined as the price that would be received to sell an asset in an orderly transaction
between market participants at the measurement date. We analyze our marketable securities in accordance with Accounting Standard Codification
321 (&#8220;ASC 32&#8221;). Valuations for marketable securities are based on quoted prices for identical assets in active markets. Where
marketable securities were found not be part of an actively traded market, we made a measurement alternative election and estimate the
fair value at cost of the investment minus impairment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2020, the Company owned 3,309,758
shares of common stock in Odyssey Group International, Inc. (&#8220;Odyssey&#8221;) ticker: ODYY, OTC Markets. In December 2021
we sold such shares of Odyssey in a private transaction for a purchase price of $860,491,
with $10,000 cash delivered at signing and a note issued in favor of Vivakor in the amount of $850,491 (see Note 8), reflecting the market
price at that time. The Company accounted for such securities based on the quoted price from the OTC Markets where the stock is traded
which resulted in the Company recording an unrealized gain of $203,540
and an unrealized loss of $56,198
on these marketable securities for the years ended December 31, 2020. As of December 31, 2020 our Odyssey marketable securities
were valued at $656,951.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2019 the Company had an investment of
$800,000
or 800,000,000
shares of common stock, or a diluted 23% equity holding in Scepter Holdings, Inc. (&#8220;Scepter&#8221;), ticker: BRZL, OTC
Markets. In the fourth quarter of 2020, the Company was diluted to a 19% equity holding in Scepter, and was no longer deemed to have
significant influence and ceased to be an equity investment, and as the stock is traded on an active market, the Company has
classified the investment as marketable securities with the change in unrealized gains and losses on the investment included in the
statement of operations for the years ended December 31, 2021 and 2020. In August 2021 we converted $81,768
of our note receivable with Scepter into 26,376,882
shares of Scepter common stock pursuant to the terms of the note at $0.0031 per share. On the date of the conversion, the Scepter
price per share on OTC Markets was $0.0062 per share, which resulted in a $87,044
gain on the disposition of the note receivable. The Company accounted for such securities based on the quoted price from the OTC
Markets where the stock is traded which resulted in the Company recording an unrealized loss on marketable securities of $1,297,594
and and an unrealized gain of $2,670,536
for the years ended December 31, 2021 and 2020. As of December 31, 2021 and 2020, the Company&#8217;s Chief Executive Officer has an
immediate family member who sits on the board of directors of Scepter Holdings, Inc. As of December 31, 2021 and 2020 our Scepter
marketable securities were valued at $2,231,218
and $3,360,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, marketable securities
were $2,231,218 and $4,016,951. For the years ended December 31, 2021 and 2020, the Company recorded a total unrealized loss of $1,094,054
and an unrealized gain of $2,614,338 on marketable securities in the statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6. Inventories</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2020, inventories consist
primarily of raw materials (including tar-sand stockpiles) and finished goods (which includes Fenix iron). The tar-sand stockpiles
consist of 400,000 tons of tar sand stockpile and are anticipated to be used as test material for our extraction remediation units.
The stockpiles were acquired at a cost of approximately $0.83 per ton or $333,744.
As of December 31, 2021, the parties agreed to have the $333,744 paid for the tar-sand stockpile returned to the Company, and the
amount has been reclassed to notes receivable (see Note 8). The nano Fenix Iron are finished goods that have a 20-year shelf life
and were acquired at cost for $192,000.
As of December 31, 2021, inventories consist primarily of the Fenix Iron. Inventories are valued at the lower of cost or market (net
realizable value).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 7. Precious Metal Concentrate</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Precious metal concentrate includes metal concentrates
located at the Company&#8217;s facilities. Concentrates consist of gold, silver, platinum, palladium, and rhodium. Precious metal concentrate
was acquired from our funding agreements for extraction operations with Vivaventures Precious Metals LLC from 2013 through 2016. Our precious
metal concentrate requires further refining to be sold as a finished product and is valued at the lower of cost or market (net realizable
value).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the Company
carried a refining reserve of $1,166,709 against its
precious metal concentrate asset based on estimates that the Company received if it were to sell the precious metal concentrate in its
current concentrated form to processing refineries. The Company intends to sell our precious metal concentrate in its current state or
refine it into dore bars for sale or monetization and investment purposes. In July 2020, the Company entered into an agreement with International
Metals Exchange, LLC (&#8220;IME&#8221;, a related party) giving IME the option to purchase approximately 1,331 ounces of our precious
metal concentrate for approximately $2,800,000. The option agreement expired on December 31, 2020. For the year ended December 31, 2020,
the Company sold   $54,250
of the precious metal concentrate through this option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020 the net realizable
value of our precious metal concentrate is $1,166,709.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note
8. Notes Receivable&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule Of notes receivable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Scepter Holdings, Inc. note receivable (a)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">78,455</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">PLC International Investments, Inc. (b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">860,491</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">TMC Capital, LLC (c)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">333,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify">Total Notes Receivable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,194,235</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">78,455</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________<b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto; width: 100%">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 3%">(a)</td>
  <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 97%">Master Revolving Note with Scepter Holdings, Inc. (ticker: BRZL, OTC Markets), which the Company entered into in January 2019 to lend
up to $70,000 to the holder. The note accrues interest at a rate of 7% per annum and accrues monthly on the outstanding principal. In
August 2021 we converted the note receivable with Scepter into 26,376,882 shares of Scepter common stock pursuant to the terms of the
note at $0.0031 per share. On the date of the conversion, the Scepter price per share on OTC Markets was $0.0062 per share, which resulted
in a $87,044 gain on the disposition of the note receivable.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 3%">(b)</td>
  <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 97%">In December 2021 we sold such 3,309,578 shares of Odyssey common stock in a private transaction for a purchase price of $860,491, reflecting
the market price as of such time. Such purchase price was paid in the form of $10,000 cash delivered at signing and a note issued in
favor of Vivakor in the amount of $850,491 accruing interest at 3% per annum, with payments due quarterly over a five year term.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 3%">(c)</td>
  <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 97%">The Company entered into an Ore Supply Agreement in December 2016 with TMC Capital, LLC, an affiliate of MCW Energy Group Limited, in
which the Company had the option to purchase 400,000 tons of oil sands from the supplier. The Company paid the supplier $333,744 at the
commencement of the agreement. The parties amended the agreement in December 2021 to return the $333,744 on or before October 1, 2022.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 9. Property and Equipment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the components
of the Company&#8217;s property and equipment at December 31, 2021 and 2020:&#160;</p>






<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule of property and equipment,
    net</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Depreciation</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Depreciation</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Office furniture and equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">14,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">4,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">10,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">14,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">2,088</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">12,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,248</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,306</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,942</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,248</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,657</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,591</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Precious metal extraction machine- 1 ton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,052,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,052,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Precious metal extraction machine- 10 ton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,320,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,788,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,320,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,788,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Construction in process:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Bioreactors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,440,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nanosponge/Cavitation device</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,103</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,249,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,249,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,558,949</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,558,949</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remediation Processing Unit 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,201,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,201,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,149,793</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,149,793</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit System A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,561,467</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,561,467</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,353</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Remediation Processing Unit System B</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,345,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,345,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total fixed assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">25,482,417</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">790,306</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">24,692,111</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,931,444</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">778,745</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,152,699</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2021 the Company
paid $64,950 with 5,413 shares of Series C-1 Preferred Stock for equipment, which has been valued based on similar cash purchases of the
Series C-1 Preferred Stock at approximately $12.00 per share. For the years ended December 31, 2021 and 2020 depreciation expense was
$11,561 and $11,508. For the years ended December 31, 2021 and 2020 capitalized interest to equipment from debt financing was $1,614,697
and $1,025,852. Equipment that is currently being manufactured is considered construction in process and is not depreciated until the
equipment is placed into service. Equipment that is temporarily not in service is not depreciated until placed into service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 10. License Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 17, 2017, the Company purchased rights
to an exclusive license for the applications and implementations involving the Nanosponge Technology and to use and develop the Nanosponge
as we see fit at our sole discretion. The Nanosponge contribution in the Company&#8217;s processes is to facilitate a cracking process
whereby remediated or extracted oil may be further refined from a crude product to a diesel fuel. The license was valued at $2,416,572
and is amortized over its useful life of 20 years. As of December 31, 2021 and 2020 the accumulated amortization of the license was $523,591
and $402,762. For the years ended December 31, 2021 and 2020 amortization expense of the license was $120,829. Amortization expense for
the years 2022 through 2026 is $120,829 in each respective year. As of December 31, 2021 and 2020 the net value of the license is $1,892,981
and $2,013,810.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On January
20, 2021, the Company entered into a worldwide, exclusive license agreement with TBT Group, Inc. (of which an independent Vivakor Board
member is a 7% shareholder) to license piezo electric and energy harvesting technologies for creating self-powered sensors for making
smart roadways. The Company is required to pay $25,000 and 16,667 shares of restricted common stock upon signing. </span>No later than
March 4, 2022, the Company will pay licensor an additional $225,000. When the licensor delivers to the Company data showing that the sensor
performs based on mutually defined specifications and all designs for the sensor are completed, Company shall pay an additional $250,000
and 16,667 shares of restricted common stock. Upon the delivery of a mutually agreed working prototype, Company will pay licensor $250,000
and 16,667 shares of restricted common stock. Upon commercialization of the product, the Company will pay licensor $250,000 and 33,333
shares of restricted common stock. TBT shall have the option, at its sole discretion, to convert the license to a non-exclusive license
if the Company fails to pay $500,000 to TBT for sensor inventory per year, which will commence after the second anniversary of product
commercialization. The Company shall share in the development costs of the sensor technology to the time of commercialization. Total costs
attributed to the Company are estimated to be $125,000. The Company amended the agreement multiple times in 2021 to extend the terms of
the first milestone payment of $225,000 payment to the licensor, and further amended the agreement in March 2022 to finally extend the
payment to be no later than March 4, 2022. The Company paid consideration of $15,000 for these amended extensions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the license is valued
at $490,000 (or each of the initial required payments in milestone one and a $15,000 additional payment) and is amortized over its useful
life of 20 years. As of December 31, 2021 the Company believes that the remaining milestones timelines are undetermined. As of December
31, 2021, the accumulated amortization of the license was $12,146. For the year ended December 31, 2021 amortization expense of the license
was $12,146. Amortization expense for the years 2022 through 2026 is $13,250 in each respective year. As of December 31, 2021 the net
value of the license is $477,854.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 11. Intellectual Property, Net</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company entered into a Contribution Agreement
dated January 5, 2015, where proprietary information and intellectual property related to certain petroleum extraction technology (also
known as hydrocarbon extraction technology) suitable to extract petroleum (or hydrocarbons) from tar sands and other sand-based ore bodies,
and all related concepts and conceptualizations thereof (the &#8220;Extraction Technology&#8221;) was contributed to VivaVentures Energy
Group, Inc., a 99% majority-owned subsidiary of Vivakor, and was assessed a fair market value of $16,385,157, which consists of the consideration
of $11,800,000 and the Company assuming a deferred tax liability in the amount of $4,585,157. All ownership in the Extraction Technology
(including all future enhancements, improvements, modifications, supplements, or additions to the Extraction Technology) was assigned
to the Company and is currently being applied to the Company Remediation Processing Centers, which are the units that remediate material.
The Extraction Technology is amortized over a 20-year life. <span style="background-color: white">For the years ended December 31, 2021
and 2020 the amortization expense of the technology was $819,258. </span>Amortization expense for the years 2022 through 2026 is $819,258
in each respective year. As of December 31, 2021 and 2020 the net value of the Extraction Technology is $10,718,623 and $11,537,881.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2019, the Company began the process of patenting
the Extraction Technology and all of its developments and additions since the acquisition, and we have filed a series of patents and
capitalized the costs of these patents. As of December 31, 2021 and 2020, the capitalized costs of these patents are $113,430 and $100,064.
The patents were placed in service in 2021 and are amortized over the patents&#8217; useful life of twenty years. <span style="background-color: white">For
the year ended December 31, 2021 the amortization expense of the patents was $5,560. </span>Amortization expense for the years 2022 through
2026 is $5,672 in each respective year. As of December 31, 2021 the net value of the patents is $107,870.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company entered into an asset purchase agreement
dated September 5, 2017, where two patents (US patent number 7282167- <span style="background-color: white">Method and apparatus for forming
nano-particles </span>and US patent number 9272920- <span style="background-color: white">System and method for ammonia synthesis</span>)
were purchased and attributed a fair market value of $4,931,380, which consists of the consideration of $3,887,982 and the Company assuming
a deferred tax liability in the amount of $1,043,398. The patents grant the Company ownership of a nano catalyst technology that facilitates
chemical manufacturing, with a focus on the production of ammonia, specifically <span style="background-color: white">for the gas phase
condensation process used to create the iron catalyst.</span> The nano catalyst accelerators <span style="background-color: white">make
the Haber-Bosch process more efficient by increasing the active surface area of standard commercial iron catalysts, thereby lowering the
reaction temperature and pressure required for the Haber-Bosch process to occur. As a result, less energy is needed to complete the reaction
and create ammonia. The patents are amortized over their useful life of 10 years. For the years ended December 31, 2021 and 2020 the amortization
expense of the patents was $369,854. </span>Amortization expense for the years 2022 through 2026 is $493,138 in each respective year.
<span style="background-color: white">As of December 31, 2021 and 2020 the net value of the patents was $2,835,544 and $3,328,682.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the components
of the Company&#8217;s intellectual property at December 31, 2021 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>






<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule Of Intellectual Property</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">December 31, 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">December 31, 2020</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Accumulated Amortization</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Accumulated Amortization</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; text-align: left">Extraction Technology patents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">113,430</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,560</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">107,870</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100,064</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100,064</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Extraction Technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,385,157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,666,534</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,718,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,385,157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,847,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,537,881</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Ammonia synthesis patents</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,931,380</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,095,836</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,835,544</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,931,380</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,602,698</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,328,682</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total Intellectual property</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,429,967</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,767,930</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,662,037</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">21,416,601</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,449,974</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,966,627</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 12. Accounts Payable and Accrued Expenses</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts payable and accrued expenses consist
of the following:&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of accounts payable and accrued expenses</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Accounts payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,450,531</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,003,953</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Office access deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">705</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Accrued compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">175,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,920</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Accrued tax penalties and interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">398,114</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">244,230</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: justify">Accounts payable and accrued expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,023,985</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,350,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 13. Stock Payable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2019, the Company had an outstanding
payable of $11,800,000 payable in common stock to Sustainable Fuels, Inc. (&#8220;SFI&#8221;) for the Extraction Technology (See Note
11). Before the Common Stock was issued, the owner of SFI died and the matters and affairs of his estate were passed to the executor of
his estate. We attempted to contact SFI and the executor of the estate multiple times to issue and send the common stock to the company
or appropriate successor of the estate to no avail. As of December 31, 2021, the Company was able to make contact with the new owner of
SFI and has issued 20,000,000 shares of Common Stock to SFI per the terms of the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 14. Loans and Notes Payable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Loans and Notes payable (including accrued interest)
consist of the following:&#160;</p>






<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of loans and notes payable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Various promissory notes and convertible notes (a)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">50,960</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">50,960</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Novus Capital Group LLC Note (b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">378,854</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">363,231</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Triple T Notes (c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">353,330</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">295,543</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">National Buick GMC (d)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,440</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,643</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Various Convertible Bridge Notes ( e)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,075,813</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">774,522</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Blue Ridge Bank (f)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">410,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,100</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Small Business Administration (g)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">318,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">305,054</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">JP Morgan Chase Bank (h)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,645</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,645</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Various Promissory Notes (i)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,416,379</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">735,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify">Total Notes Payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,113,796</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,845,698</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans and notes payable, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,511,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,196,037</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loans and notes payable, current attributed to variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,416,379</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">735,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans and notes payable, long term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,185,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">914,661</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;_____________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule of maturities of loans and notes payable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 24%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">5,173,946</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin-top: 0; margin-bottom: 0">406,326</p></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,996</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,996</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,996</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Thereafter<br />
</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">374,536</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,113,796</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt">(a)</td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt">From 2013 through 2018 the Company issued a series of promissory notes and convertible notes with various interest rates ranging up to
12% per annum. The convertible notes convert at the holder&#8217;s option after 1 year of issuance and may be converted into shares of
common stock. The conversion price is generally equal to the specified per share conversion rate as noted in the note agreements.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt">(b)</td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt">On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering
debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398.
As of January 1, 2020 the note was amended to accrue interest at 7% per annum commencing January 1, 2020 through July 1, 2020, and 10%
per annum commencing July 2, 2020 and thereafter. In November 2021, the lender agreed to extend the maturity of the note to April 1,
2022. Subsequent to December 31, 2021 the lender agreed to extend the maturity of the note to April 1, 2023 with an approximate monthly
payment of $29,432.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt">(c)</td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt">The balance of this note is due to a related party, a company owned the
51% owner of Vivakor Middle East LLC. The loan was granted to Vivakor Middle East LLC by the majority owner for operational use with only
the agreement of repayment from the net proceeds of such entity&#8217;s operations once it commences scaled up operations. No interest
accrues on the loans, and no specific maturity date had been agreed upon. On March 10, 2021, the Company entered into a master revolving
note with Triple T Trading Company LLC to set forth the relationship of the parties to retain the previous terms of the note payable to
Triple T Trading Company LLC, to include a note maturity of March 10, 2023, and maximum lending amount of 1,481,482 QAR or approximately
$400,000, valued at an exchange rate of approximately $0.27 per QAR on March 10, 2021.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt">(d)</td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt">In May 2019, the Company purchased a vehicle for $36,432 and financed $34,932 over six years with an interest rate of 6.24% per annum.
Monthly payments of $485 are required and commenced in July 2019.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt">(e)</td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt">In 2020 the Company entered into various convertible promissory notes as follows:</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Throughout 2021 and 2020 the Company entered
into convertible promissory notes with an aggregate principal of $415,000.
The notes accrue interest at 10%
per annum and have a maturity of the earlier of 12 months or the consummation of the Company listing its Common Stock on a senior
stock exchange. The notes are convertible at the Company&#8217;s option into shares of the Company&#8217;s common stock at a price
equal to 80% of the opening price of the Company&#8217;s common stock on the national exchange or the offering price paid by the
investors in the financing in connection with the uplist, whichever is lower, or (ii) repaid in cash in an amount equal to the
indebtedness being repaid plus a premium payment equal to 15% of the amount being repaid. If an event of default has occurred and
the Company does not convert the amounts due under the Note into the Company&#8217;s common stock, then the Company will have the
option to convert the outstanding indebtedness into shares of the Company&#8217;s common stock at a price equal to 80% of the
weighted average trading price of the Company&#8217;s common stock on the OTC Markets, or be repaid in cash in an amount equal to
all principal and interest due under the Note. All of these notes were converted to common stock as of April 5, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On
October 13, 2020, the Company entered into a convertible promissory note in an amount of $280,500 having an interest rate of 12% per
annum. The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00
or 80% of the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the
note may be converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in
conjunction with this note, which </span>was recorded as a debt discount in the amount of $44,000, which is amortized to interest
expense over the term of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to
state that in no event shall the conversion price be lower than $3.00 per share. In October 2021 the parties agreed to extend the
maturity of this loan to April 13, 2022 in exchange for an increase in principal owed of $30,000. This note has been converted to
common stock as of March 21, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On
February 4, 2021, the Company entered into a convertible promissory note in an amount of $277,778 having an interest rate of 12% per
annum. The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00
or 80% of the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the
note may be converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in
conjunction with this note, which </span>was recorded as a debt discount in the amount of $36,000, which is amortized to interest
expense over the term of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to
state that in no event shall the conversion price be lower than $3.00 per share. In February 2022 the parties agreed to extend the
maturity of this loan to August 8, 2022 in exchange for an increase in principal owed of $25,000. This note has been converted to
common stock as of April 5, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt"><span style="background-color: white">(f)</span></td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt"><span style="background-color: white">In May 2020, the Company entered into a Paycheck Protection Program (&#8220;PPP&#8221;) loan agreement
for $205,100 with Blue Ridge Bank, subject to the Small Business Administration&#8217;s (&#8220;SBA&#8221;) Paycheck Protection Program.
The loan carries an annual interest rate of one (1) percent per annum with payment beginning in the seventh month with monthly payments
required until maturity in the 18<sup>th </sup>month. The loan may be fully forgivable according to the CARES Act if the Company can
provide proper documentation for the use of the proceeds of the loan. The Company has achieved the milestones for loan forgiveness and
anticipates that this debt will be forgiven in full in 2021. On January 6, 2021 the Company was granted an extension of the PPP and granted
an additional $205,100 from Blue Ridge Bank, subject to the Small Business Administration&#8217;s (&#8220;SBA&#8221;) Paycheck Protection
Program. The loan carries an annual interest rate of one (1) percent per annum with payment beginning in the tenth month with monthly
payments required until maturity in five years. The loan may be fully forgivable according to the CARES Act if the Company can provide
proper documentation for the use of the proceeds of the loan. The Company has achieved the milestones for loan forgiveness, has applied
for loan forgiveness, and anticipates that this debt will be forgiven in full in 2022.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt"><span style="background-color: white">(g)</span></td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt"><span style="background-color: white">From May through August 2020, the Company entered into two loan agreements with the Small Business
Administration for an aggregate loan amount of $299,900. The loans carry an interest rate of 3.75% per annum. The loans shall mature
in 30 years.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt"><span style="background-color: white">(h)</span></td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt"><span style="background-color: white">In April 2021, the Company entered into a Paycheck Protection Program loan agreement with JP Morgan
Chase Bank, subject to the Small Business Administration&#8217;s (&#8220;SBA&#8221;) Paycheck Protection Program. The loan may be fully
forgivable according to the CARES Act if the Company can provide proper documentation for the use of the proceeds of the loan. The Company
has achieved the milestones for loan forgiveness and anticipates that this debt will be forgiven in full in 2022.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt; width: 3pt">(i)</td>
  <td style="text-align: justify; padding-left: 3pt; text-indent: -3pt"><span style="background-color: white">Viva Wealth Fund I, LLC is offering up to </span>$25,000,000 in convertible notes in a private
offering<span style="background-color: white">. As of December 31, 2021, VWFI has raised $8,825,000 and converted $5,560,000 of this
debt to VWFI LLC units. A convertible note will </span>automatically <span style="background-color: white">convert into the LLC units
at the earlier of (i) the date that the Equipment is placed into quality control and testing or (ii) six months from the date of investment.
The convertible notes will accrue interest at 12% per annum</span> and are paid quarterly. At the maturity date, remaining interest will
be paid, at which time no further interest payments will accrue. Upon the offering termination date, all units accepted for any series
of equipment will automatically convert to Vivakor common stock if the Company has not accepted subscriptions for at least $6,250,000
for a series of equipment. The conversion price of the automatic stock conversion will be the the greater of $13.50 or a 10% discount to
market per share or in the event of a public offering, 200% of the per share price of the Company common stock sold in an underwritten
offering, which was closed on February 14, 2022 at $5.00 per share. <span style="background-color: white">The termination </span>date
of the offering has been extended until November 13, 2022 in the sole discretion of the Company. As of March 21, 2021 VWFI has reached
$6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI has commenced fundraising for RPC Series B and
has raised approximately $2,740,000 to manufacture RPC Series B. Subsequent to December 31, 2021 an additional $975,000 of this debt has
been converted into units of the LLC.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 15. Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2019, the Company entered into a Sublease
agreement with US Closer, LLC, whereby we agreed to lease approximately 12,061 square feet of office and manufacturing space located in
South Salt Lake City, Utah. Pursuant to the Sublease, the sublease expired on December 31, 2020 and required a monthly lease payment of
$6,633 plus other pass-through expenses as required under the Primary Lease. The Company renegotiated with the landlord to renew this
lease as the primary tenant in January 2021 to lease this warehouse on a month-to-month basis. The lease may be terminated at any time
or for any reason with a 30-day written notice to terminate. The January 2021 lease requires a monthly lease payment of $6,833 plus other
pass-through expenses as required under the lease as long as the Company remains in the space. As a condition of the lease, we were required
to provide a $6,965 security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Commencing on September 15, 2019, the Company
entered into a five-year lease with Jamboree Center 1 &amp; 2 LLC covering approximately 6,961 square feet of office space in Irvine,
CA. Under the terms of the lease agreement, we are required to make the following monthly lease payments: Year 1 $21,927, Year 2 $22,832,
Year 3 $23,737, Year 4 $24,712, Year 5 $25,686. As a condition of the lease, we were required to provide a $51,992 security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The right-of-use asset for operating leases as
of December 31, 2021 and 2020 was $663,291 and $881,804. Rent expense for the year ended December 31, 2021 and 2020 was $292,410 and $187,343.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table reconciles the undiscounted
cash flows for the leases as of December 31, 2021 to the operating lease liability recorded on the balance sheet:&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of lessee operating lease liability</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: justify">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">287,769</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">299,466</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">231,174</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Total undiscounted lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">818,409</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Less: Abatement of rents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">96,531</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">721,878</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Operating lease liabilities, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">287,769</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Operating lease liabilities, long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">434,109</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Weighted-average remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.0%</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The discount rate is the Company&#8217;s incremental
borrowing rate, or the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an
amount equal to the lease payments in a similar economic environment. Based on an assessment of the Company&#8217;s borrowings the incremental
borrowing rate was determined to be 7%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Employment Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2020, the Company entered into an
employment agreement with the Chief Executive Officer and Chief Financial Officer, which provides for an annual base salary of $50,000
that provides for incremental increases upon the Company&#8217;s achievement of specific performance metrics up to $350,000. The employment
agreement provides for a grant of a stock option to the Chief Executive Officer to purchase up to 166,667 shares of the Company&#8217;s
common stock at an exercise price equal to 110% of the fair market value of the Company&#8217;s common stock on the date of grant. The
stock option will vest after five years of continuous employment, subject to acceleration if terminated without cause or resigns for good
reason. The agreement also provides for an annual bonus of up to 100% of the base salary based upon the achievement of certain performance
goals established and approved by the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 16. Long-term Debt</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To assist in funding the manufacture of the Company&#8217;s
Remediation Processing Centers, between 2015 and 2017, the Company entered into two agreements which include terms for the purchase of
participation rights for the sale of future revenue of the funded RPCs, and which also require working interest budget payments by the
Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for the terms under these
contracts for the sale of future revenue under Accounting Standards Codification 470 (&#8220;ASC 470&#8221;). Accordingly, these contracts
include the receipt of cash from an investor where the Company agrees to pay the investor for a defined period a specified percentage
or amount of the revenue or a measure of income (for example, gross revenue) according to their contractual right, in which the Company
will record the cash as debt and apply the effective interest method to calculate and accrue interest on the contracts. The terms of these
agreements grant the holder a prorated 25% participation in the gross revenue of the assets as defined in the agreements for 20 years
after operations commence for a purchase price of approximately $2,200,000. In the event that the contract is not fully subscribed, it will receive only a prorated participation of the available 25% participation. The Company made its first payment of $7,735
in the second quarter of 2021 and continues its quality control processes. The RPC is estimated to enter scaled up operations early 2022
and make estimated annual payments of $1,957,323. The Company estimates future payments based on revenue projections for the RPCs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In accordance
with ASC 470, the Company records the proceeds from these contracts as debt because</span> the Company has significant continuing involvement
in the generation of the cash flows due to the investor (for example, active involvement in the generation of the operating revenues of
the business segment), which constitutes the presence of a factor that independently creates a rebuttable presumption that debt classification
is appropriate. The Company has determined its effective interest rates to be between 32.6% and 33.76% based on each contract&#8217;s
future revenue streams expected to be paid to the investor. These rates represent the discount rate that equates estimated cash flows
with the initial proceeds received from the investor and is used to compute the amount of interest expense to be recognized each period.
During the development and manufacturing of the assets the effective interest has been capitalized to the assets. As the assets enter
operations or service of their intended use, the effective interest on these contracts will be recognized as interest expense (See Note
9).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2016 and 2017, additional consideration to
investors to enter into these agreements was granted, and the Company issued to these investors 113,000 shares of Series B-1 Preferred
Stock with a relative fair value of $7.50 per share or based on conversion terms and price of the Company&#8217;s Common Stock at the
time of issuance. The Company also issued 106,167 common stock warrants to investors. The relative fair value of the warrants and Series
B-1 preferred stock in aggregate was $1,488,550, and was recorded as a debt discount, which is amortized to interest expense over the
term of the agreements using the effective interest method. During the manufacturing phase of the asset, the interest expense is capitalized
to the asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some holders of these participation rights also
have the option to relinquish ownership and all remaining benefits of their LLC units in exchange for Common Stock in the Company. Depending
on the contract, these options to convert to common stock range from between 1 and 5.5 years. The exercise period ranges from between
1 year to 5.5 years with a step-up discount to market for each year the option is not exercised with a range of between a 5% to a 25%
discount to market. Accordingly, under Accounting Standards Codification 815 (&#8220;ASC 815&#8221;) the Company valued these options
at fair value using a Monte Carlo Simulation by a third-party valuation expert, which found the fair value of the options to be nominal.
Long-term debt related to these participation rights is recorded in &#8220;Long-term debt&#8221; on the consolidated balance sheet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting for the terms under these contracts
that call for working interest budget payments by the Company are recorded in current liabilities on the consolidated balance sheet and
paid down through pass-through expenses or cash according to the contract. Accordingly, the Company records any unpaid balance of budget
payments received in &#8220;Long-term debt, current&#8221; as these liabilities are generally paid within 12 months after proceeds are
received.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-term debt consists of the following:&#160;</p>






<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule Of Long-Term Debt</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%">Principal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,196,233</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,196,233</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,205,144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,997,136</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(226,823</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(241,709</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,174,554</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,951,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long term debt, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,256</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,020</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Long term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,171,298</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,950,640</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the estimated
payment schedule of long-term debt as of December 31, 2021:<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of long-term debt maturities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 24%; text-align: justify">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3,256</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,685</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,572</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,420</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,548</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,136,752</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: justify">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,196,233</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 17. Stockholders' Equity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Series A, Series B, Series B-1, Series C
and Series C-1 Preferred Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Preferred Stock authorized by the Company
may be issued from time to time in one or more series. The Company is authorized to issue 15,000,000 shares of preferred stock. The Company
is authorized to issue 66,667 shares of Series A Preferred Stock, 3,266,667 shares of Series B Preferred Stock, 1,666,667 shares of Series
B-1 Preferred Stock, 3,333,333 shares of Series C Preferred Stock, and 3,333,333 shares of Series C-1 Preferred Stock. The Board of Directors
is authorized to fix or alter the number of shares constituting any series of Preferred Stock and the designation thereof. In 2021, the
Board of Directors authorized, and a majority vote acceptance was received of each voting class of preferred stock, including Series B
Preferred Stock, Series B-1 Preferred Stock, and Series C-1 Preferred Stock, that each class&#8217;s designations be amended that upon
the Company&#8217;s public offering in conjunction with an uplist to a senior stock exchange that these classes of preferred stock will
convert their preferred shares to common shares on a one for one basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has issued 66,667
shares of Series A Preferred Stock, convertible at a current ratio of 10 shares of Common Stock for each outstanding share of
Series A Preferred Stock. The conversion price is subject to adjustment under certain customary circumstances, including as a result
of stock splits and combinations, dividends and distributions, and certain issuances of common stock. Holders of shares of Series A Preferred
Stock will have the right to 25 votes for each share of Common Stock into which such shares of Series A Preferred Stock can then be converted
(with a current conversion ratio of 10 shares of Common Stock for each outstanding share of Series A Preferred Stock) and the right to
a liquidation preference in any distribution of net assets made to the shareowners prior to and in preference to the holders of Common
Stock and any other Preferred Stock holder in the liquidation, dissolution or winding up of our Company. As of December 31, 2021 and
2020 the liquidation preference is $400,000.
Holders of shares of Series A Preferred Stock are not currently entitled to dividends. The Company has the right, but not the obligation,
to redeem shares of Series A Preferred Stock. All of the shares of Series A Preferred Stock were converted to common stock upon the close
of the Company&#8217;s public offering of the Company&#8217;s common stock on February 14, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has issued none and 216,916 of Series
B Preferred Stock as of December 31, 2021 and 2020, respectively. Shares of Series B Preferred Stock are convertible one year after issuance,
at any time at the option of the holder, into shares of Common Stock (with a conversion price at the lesser of the issuance price ($6.00)
or a 10% discount to market on the conversion date). Automatic 1-for-1 conversion of all outstanding shares of Series B Preferred Stock
into shares of Common Stock occurred on May 1, 2021. No other shares have been issued since the conversion of all of the outstanding shares
of this class of stock. The conversion price is subject to adjustment under certain customary circumstances, including as a result of
stock splits and combinations, dividends and distributions, and certain issuances of common stock. The Company has the right, but not
the obligation, to redeem shares of Series B Preferred Stock one year after issuance. Holders of Series B Preferred Stock will have the
right to one vote for each share of Common Stock into which such Series B Preferred Stock is then convertible, and a right to a liquidation
preference in any distribution of net assets made to the shareowners prior to and in preference to the holders of Common Stock and any
Preferred Stockholder, except holders of Series A Preferred Stock, in the liquidation, dissolution or winding up of our Company. As of
December 31, 2021 and 2020 the liquidation preference was none and $1,341,233. Dividends are 12.5% and cumulative and are payable only
when, as, and if declared by the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has issued none and 467,728 of Series
B-1 Preferred Stock as of December 31, 2021 and 2020, respectively. Shares of Series B-1 Preferred Stock are convertible one year after
issuance, at any time at the option of the holder, into shares of Common Stock (with a conversion price at the lesser of the issuance
price ($7.50) or a 10% discount to market on the conversion date). Automatic 1-for-1 conversion of all outstanding shares of Series B-1
Preferred Stock into shares of Common Stock occurred on May 1, 2021. No other shares have been issued since the conversion of all of the
outstanding shares of this class of stock. The conversion price is subject to adjustment under certain customary circumstances, including
as a result of stock splits and combinations, dividends and distributions, and certain issuances of common stock. The Company has the
right, but not the obligation, to redeem shares of Series B-1 Preferred Stock one year after issuance. Holders of Series B-1 Preferred
Stock have no voting or dividend rights, and a right to a liquidation preference in any distribution of net assets made to the shareowners
prior to and in preference to the holders of Common Stock and any Preferred Stockholder, except holders of Series A and Series B Preferred
Stock, in the liquidation, dissolution or winding up of our Company. As of December 31, 2021 and 2020 the liquidation preference was none
and $3,507,981.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has not issued any Series C Preferred
Stock as of December 31, 2021 and 2020, respectively. Shares of Series C Preferred Stock are convertible one year after issuance, at any
time at the option of the holder, into shares of Common Stock (with a conversion price at the lesser of the issuance price ($10.50) or
a 10% discount to the market price on the conversion date). Automatic conversion of shares of Series C Preferred Stock into shares of
Common Stock may occur due to certain qualified public offerings entered into or by written consent of a majority of the holders of Series
C Preferred Stock or upon the four-year anniversary date of the issuance of such shares. The conversion price is subject to adjustment
under certain customary circumstances, including as a result of stock splits and combinations, dividends and distributions, and certain
issuances of common stock. The Company has the right, but not the obligation, to redeem shares of Series C Preferred Stock one year after
issuance. Holders of Series C Preferred Stock will have the right to one vote for each share of Common Stock into which such Series C
Preferred Stock is then convertible, and a right to a liquidation preference in any distribution of net assets made to the shareowners
prior to and in preference to the holders of Common Stock and any Preferred Stockholder, except holders of Series B and B-1 Preferred
Stock, in the liquidation, dissolution or winding up of our Company. Dividends are 12.5% and cumulative and are payable only when, as,
and if declared by the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has issued none and 255,290 of Series
C-1 Preferred Stock as of December 31, 2021 and 2020, respectively. Shares of Series C-1 Preferred Stock are convertible one year after
issuance, at any time at the option of the holder, into shares of Common Stock (with a conversion price at the lesser of the issuance
price ($12.00) or a 10% discount to the market price on the conversion date). Automatic conversion of all outstanding shares of Series
C-1 Preferred Stock into shares of Common Stock occurred on May 4, 2021 by written consent of a majority of the holders of Series C-1
Preferred Stock. No other shares have been issued since the conversion of all of the outstanding shares of this class of stock. The conversion
price is subject to adjustment under certain customary circumstances, including as a result of stock splits and combinations, dividends
and distributions, and certain issuances of common stock. The Company has the right, but not the obligation, to redeem shares of Series
C-1 Preferred Stock one year after issuance. Holders of Series C-1 Preferred Stock have no voting or dividend rights, and a right to a
liquidation preference in any distribution of net assets made to the shareowners prior to and in preference to the holders of Common Stock
and any Preferred Stockholder, except holders of Series A, Series B, Series B-1, and Series C Preferred Stock, in the liquidation, dissolution
or winding up of our Company. As of December 31, 2021 and 2020 the liquidation preference was none and $3,063,472.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
$9,467,604 and $7,593,816 or 950,973 and 996,283 shares of Series B, Series B-1, and Series C-1 Preferred Stock were converted into 955,947
and 1,037,738 shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2021, the Company
issued 5,413 Series C-1 Preferred Stock or $64,950 for a reduction in stock payables.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
the Company issued 5,626 and 23,039 shares of Series B-1 Preferred Stock as a $42,196 and $172,795 stock dividend paid to Series B Preferred
Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is authorized to issue 41,666,667
shares of common stock. As of December 31, 2021 and 2020, there were 12,330,859 and 11,255,967 shares of our common stock issued and outstanding,
respectively. Treasury stock is carried at cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and
2020, $9,467,604 and $7,593,816 or 950,973 and 996,283 shares of Series B, Series B-1, and Series C-1 Preferred Stock were converted
into 955,947 and 1,037,738 shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2020 the Company
issued 666,667 shares of Common Stock for a $11,800,000 reduction in stock payables.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the
Company granted stock-based compensation to employees, including a 16,667 share
stock award, which vests at the end of four years, and a 166,667 stock
options that cliff vests at the end of  five
years. For the years ended December 31, 2021 and 2020, stock-based compensation was $446,112 and
$146,114. As of December 31, 2021 and
2020, the Company also granted non-statutory stock options, including 133,333 stock
options to the Board of Directors, which vests over 1 year,
and a 333,334 stock
option to a consultant, which vests over 4 years.
Non-statutory stock-based compensation was $1,585,000 and
$555,000 for the years ended
December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
the Company issued 68,611 and 9,164 shares for a $495,799 and $135,993 reduction of liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
the Company issued 33,667 and 23,333 shares of Common Stock for $438,004 and $281,231 in services to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2021, the Company
issued 16,667 shares for a $225,000 payment for a technology license (see Note 10).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2020 the Company
issued 7,600 shares of Common Stock in the amount of $41,028 for cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Noncontrolling Interest</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020,
the Company converted $5,560,000 and $2,720,000 in Viva Wealth Fund I, LLC convertible promissory notes into 1,112 and 544 units of noncontrolling
interest in Viva Wealth Fund I, LLC, and paid distributions to unit holders of $55,050 and none.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2020, the Company
issued 124,981 units of noncontrolling interest in RPC Design and Manufacturing LLC for cash of $624,907.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 18.&#160;Temporary Equity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Shares of Series B, B-1,
C and C-1 convertible preferred stock hold conversion features providing that, at the holder&#8217;s election, the holder may convert
the preferred stock into common stock. Upon conversion, the Company may be required to deliver a variable number of equity shares that
is determined by using a formula based on the market price of the Company&#8217;s Common Stock. After four years from the date of issuance,
Series C preferred shareholders are forced to automatically convert to Common Stock. On May 1, 2021, all outstanding shares of Series
B and B-1 converted at 1-for-1 to Common Stock. On May 4, 2021, all outstanding shares of Series C-1 converted at 1-for-1 to Common Stock.
For each respective series, the holder may convert their preferred shares to common shares at the original issue price as defined, which
ranges from between $6.00 per share to $12.00 per share, at the lesser of the original issue price or 90% of the market price on the conversion
date. As of December 31, 2020, the market price of the Company&#8217;s Common Stock was $15.00 per share. There is no contractual cap
on the number of common shares that the Company could be required to deliver on preferred shareholders&#8217; conversions to Common Stock. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Accordingly, under ASC
815-40-25-10 the Company may be forced to settle these conversion features in cash, specifically since it is unknown as to what date the
shareholders&#8217; may convert their preferred stock to common stock and if there will be sufficient authorized and unissued common shares
on that date. As of December 31, 2020 the Company did have sufficient authorized and unissued common shares to satisfy all preferred shareholders
interest if it were converted to Common Stock, although if the stock price were to drop below $0.60 per share and the Company may be forced
to settle such conversions in cash, which may consider them redeemable. Accordingly, Series B, B-1, C and C-1 preferred stock has been
classified in temporary equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table shows all changes to temporary equity
during for the years ended December 31, 2021 and 2020.&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span style="display: none">Schedule Of Temporary Equity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Convertible Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series C-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 40%; font-weight: bold; text-align: left">December 31, 2019</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">708,396</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">4,250,380</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">758,623</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">5,689,690</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">446,159</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">6,841,409</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,039</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">172,795</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Conversion of Series B, B-1, and C-1 Preferred Stock to Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(491,480</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,948,880</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(313,934</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,354,504</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(190,869</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,290,432</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">December 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">216,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,301,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">467,728</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,507,981</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255,290</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,550,977</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Sercies C-1 Issue for a reduction in stock payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,413</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,950</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin-top: 0; margin-bottom: 0">5,626</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Conversion of Series B and B-1 Preferred Stock to Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(216,916</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,301,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(473,354</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,550,177</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(260,703</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,615,927</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 19. Share-Based Compensation &amp; Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally accepted accounting principles require
share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income
statement based on their fair values at the date of grant, net of estimated forfeitures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the Company
has granted stock-based compensation to employees, including a 16,667
share stock award, which was issued in 2018 and vests at the end of four years, and a 166,667
stock options that was issued in 2020 and cliff vests at the end of five years. For the years ended December 31, 2021 and 2020,
stock-based compensation was $446,112
and $146,114.
In 2020, the Company also granted non-statutory stock options, including 133,333
stock options to the Board of Directors, which vests over 1 year, and a 333,334
stock option to a consultant, which vests over 4 years. Non-statutory stock-based compensation was $1,585,000
and $555,000
for the years ended December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no other options granted during the
years ended December 31, 2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The assumptions used in the Black-Scholes option
pricing model to determine the fair value of the options on the date of issuance are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 49%">&#160;</td>
    <td style="width: 3%; text-align: justify">&#160;</td>
    <td style="width: 48%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Year Ended
    December 31, 2020</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27 - 0.38%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life of warrants</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-10 years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility rate</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187 - 273%</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes all stock option
activity of the Company for the years ended December 31, 2021 and 2020:&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="display: none">Schedule of option activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">of Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life (Years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Outstanding, December 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,667</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11.10</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1.42</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Shares outstanding - beginning" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Weighted average exercise price - beginning" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">633,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.71</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Weighted average exercise price - beginning" style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; padding-bottom: 2.5pt">Outstanding, December 31, 2020</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">650,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">12.00</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">8.53</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">650,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">7.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Exercisable, December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">47,083</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6.93</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Exercisable, December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">180,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7.01</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the aggregate
intrinsic value of the Company&#8217;s outstanding options was approximately none. The aggregate intrinsic value will change based on
the fair market value of the Company&#8217;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the Company
had no warrants outstanding. These expired or exercised warrants during the year ended December 31, 2020 relate to the warrants issued
as an incentive to investors with an investment into the Company. The warrants were issued at $12.00 per share of Common Stock. The warrants
were granted for a one-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management uses the Black-Scholes option pricing
model to determine the fair value of warrants on the date of issuance. The fair value of warrants issued pursuant to the issuance of notes
payable was recorded as deferred debt issuance cost and amortized over the remaining term of the associated debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The assumptions used in the Black-Scholes option pricing model to
determine the fair value of the warrants on the date of issuance are as follows:&#160;</p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 52%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule of warrant assumptions</span></td><td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 25%; text-align: left">Risk-free interest rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 25%; text-align: right">1.2%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: right">None</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Expected life of warrants</td><td>&#160;</td>
    <td style="text-align: right">1 years</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility rate</td><td>&#160;</td>
    <td style="text-align: right">119%</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the activity of
the Company&#8217;s share purchase warrants:&#160;</p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="display: none">Schedule of warrant activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 52%; text-align: justify">Balance, December 31, 2019</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">36,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">12.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,333</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(667</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">12.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify">Balance, December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no share purchase warrants outstanding
as of December 31, 2021 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 20. Income Tax</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Provision (benefit) for income taxes is as follows:&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule of components of income tax</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: right"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="text-decoration: underline">Current:</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; padding-bottom: 1pt">State</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">800</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">800</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: White; text-align: left">Total current&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">800</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(718,868</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,124</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(332,139</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">130,040</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="color: White; text-align: left">Total Deferred&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,051,007</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">466,164</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: right; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net provision (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,050,207</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">466,964</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The differences between the expected income tax benefit based on the
statutory Federal United States income tax rates and the Company's effective tax rates are summarized below:&#160;</p>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule reconciliation of income tax</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: left">Tax Computed At The Federal Statutory Rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(1,338,184</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">21.00%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State Tax, Net Of Federal Tax Benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(263,892</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.14%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Nondeductible Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.33%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Flowthrough Entity not Subject to Tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">454,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-7.13%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Foreign Corporation - Minority Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,140</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.05%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Valuation Allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,117</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.14%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Benefit for income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,050,207</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">16.48%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: left">Tax Computed At The Federal Statutory Rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(447,850</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">21.00%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">State Tax, Net Of Federal Tax Benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(77,025</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.54%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Nondeductible Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.03%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Flowthrough Entity not Subject to Tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,948</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-8.81%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Foreign Corporation - Minority Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,996</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-0.42%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Valuation Allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">772,855</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-36.24%</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Provision for income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">466,964</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-21.96%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Significant components of the Company's deferred tax assets and liabilities
are as follows:&#160;</p>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="display: none">Schedule of deferred tax assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: left">Reserves</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">336,875</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,915,092</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,395</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Intangibles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,622,638</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Operating Losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,553,164</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Impairment Losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">598,849</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,905</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(393,154</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Deferred Liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,458,506</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Valuation Allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,698,393</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total deferred tax liability:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,156,899</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: left">Reserves</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">336,875</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,915,021</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Leases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,803</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Intangibles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,964,173</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Operating Losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,544,614</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Impairment Losses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">155,309</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,440</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(699,478</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Deferred Liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,518,629</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Less: Valuation Allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,689,275</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total deferred tax liability:</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(6,207,905</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining the possible future realization
of deferred tax assets, the Company has considered future taxable income from the following sources: (a) reversal of taxable temporary
differences; and (b) tax planning strategies that, if necessary, would be implemented to accelerate taxable income into years in which
net operating losses might otherwise expire.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets are recognized subject to
management&#8217;s judgment that realization is more likely than not. A valuation allowance is recognized for a deferred tax asset if,
based on the weight of the available evidence, it is more likely than not that some portion of the deferred tax asset will not be realized.
In making such judgments, significant weight is given to evidence that can be objectively verified. Based on our review of the deferred
tax assets the Company has concluded that a valuation allowance is necessary on the net operating loss balance, as realization of this
asset does not meet the more likely than not threshold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the
Company had estimated net operating losses for federal and state purposes of $14.3
and 11.7 million, respectively. Federal and state net operating losses will begin to expire in 2028.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize a tax position as a benefit only
if it is &#8220;more likely than not&#8221; that the tax position would be sustained in a tax examination, with a tax examination being
presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For tax positions not meeting the &#8220;more
likely than not&#8221; test, no tax benefit is recorded. We recognize potential interest and penalties related to unrecognized tax benefits
in the general and administrative expense in the statement of operations of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is in the process of filing back income
tax returns from 2010 through the current year and subject to IRS examination for these years. The Company has booked a reserve for potential
penalties associated with non-filing of certain foreign information reports related to its subsidiary in the Middle East. Penalties and
interest have been reported in the general and administrative section of the statement of operations. The reserve balance at December
31, 2021 and 2020 was $289,000 and $238,000, respectively. The Company does not expect this reserve to reverse within the next 12 months,
as they will apply for a penalty waiver when the tax returns are ultimately filed. Due to the non-filing of income tax returns, statutes
of limitations on the potential examination of those income tax periods will continue to run until the returns are filed, at which time
the statutes will begin. The Company expects to file all past due income tax returns within the next 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 21. Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provided secured loan financing and
assistance to the development and commercialization of two bioactive beverages and one weight loss beverage for Vivaceuticals, Inc., which
shared a common officer and board of director member with the Company. Vivaceuticals sold its assets to Scepter Holdings, Inc. in 2018.
In 2019, the Company received 800,000 shares of preferred stock in Scepter Holdings, Inc. to extinguish the loan encumbering the assets.
The Company has converted these preferred shares into 800,000,000 shares of Common Stock of Scepter Holdings, Inc., which is traded on
the OTC Markets (ticker: BRZL) (see Note 3). In 2019 we entered into a Convertible Master Revolving Note with Scepter and over the course
of approximately two years lent them $71,000, which accrued 7% interest per annum (see Note 8). As of December 31, 2021 the principal
balance with all accrued interest was $81,768 and converted into 26,376,882 shares of Scepter common stock pursuant to the terms of the
note at $0.0031 per share. On the date of the conversion, the Scepter price per share on OTC Markets was $0.0062 per share, which resulted
in a $87,044 gain on the disposition of the note receivable. As of December 31, 2021, the Company&#8217;s Chief Executive Officer has
an immediate family member who sits on the board of directors of Scepter Holdings, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has a consulting contract with LBL
Professional Consulting, Inc. (&#8220;LBL&#8221;), which shares a common officer with the Company. For the years ended December 31, 2021
and 2020, LBL was paid $188,150 and $191,295 for services rendered. On December 17, 2020, the Company granted non-statutory stock options
to LBL for 333,334 shares of Common Stock. The stock options vest over four years. The stock options are exercisable for up to ten years
from the grant date. The common officer is not the beneficiary of the Company and is not permitted to participate in any discussion, including
the LBL&#8217;s board meetings, regarding any Company stock that LBL may own at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2020, the Company entered into an
agreement with IME giving IME the option to purchase approximately 1,331 ounces of our precious metal concentrate for approximately
$2,800,000. VVMCI, a wholly owned subsidiary of Vivakor, Inc. owns all of the Class A Units of IME, which have sole voting power for
all material matters except for removal of the manager, and VVMCI serves as a manager of IME. For the year ended December 31, 2021
and 2020, the Company sold none and $54,250, respectively,
of the precious metal concentrate through this option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has a note payable to Triple T, which
is owned by the 51% majority-owner of Vivakor Middle East LLC. As of December 31, 2021 and 2020 the balance owed was $353,330 and $376,972.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On January
20, 2021, the Company entered into a worldwide, exclusive license agreement with TBT Group, Inc. (of which an independent Vivakor Board
member is a 7% shareholder) to license piezo electric and energy harvesting technologies for creating self-powered sensors for making
smart roadways. The Company is required to pay $25,000 and 16,667 shares of restricted common stock  upon signing. </span>Upon
the earlier of (i) 120 days or (ii) the effectiveness of the Company's Registration Statement and receipt of public offering proceeds,
the Company will pay licensor $225,000. When the licensor delivers to the Company data showing
that the sensor performs based on mutually defined specifications and all designs for the sensor are completed, Company shall pay an
additional $250,000 and 16,667 shares of restricted common stock. Upon the delivery of a mutually agreed working prototype, Company will
pay licensor $250,000 and 16,667 shares of restricted common stock. Upon commercialization of the product, the Company will pay licensor
$250,000 and 33,333 shares of restricted common stock. TBT shall have the option, at its sole discretion, to convert the license to a
non-exclusive license if the Company fails to pay $500,000 to TBT for sensor inventory per year, which will commence after the second
anniversary of product commercialization. The Company shall share in the development costs of the sensor technology to the time of commercialization.
Total costs attributed to the Company are estimated to be $125,000. From May, 2021 through March 3, 2022, the parties amended the license
agreement to extend the terms of the first milestone to March 4, 2022, of which we paid $15,000 as consideration for the extensions and
$225,000 to be paid on March 4, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2020, the Company had a common
board of directors member with CannaPharmaRx Inc. The Company has a $33,000 account receivable with CannaPharmaRx Inc. for leasing office
space to this entity. As of December 31, 2020, the Company recorded an allowance for doubtful accounts on these receivables in the amount
of $33,000. As of January 1, 2021 the Company no longer leases office space to this entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 22. Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has evaluated subsequent events through the date the financial statements were available to issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 1, 2022, the Company entered into
a lease agreement for approximately 2,533 square feet of office and manufacturing space located in Las Vegas, Nevada. Commencing on March
1, 2022, the Company entered into a three-year lease with Speedway Commerce Center, LLC. Under the terms of the lease agreement, we are
required to make the following monthly lease payments: Year 1 $1,950, Year 2 $2,028, Year 3 $2,110. As a condition of the lease, we were
required to provide a $2,418 security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14, 2022, the Company closed on its
underwritten public offering of 1,600,000 shares of common stock, at a public offering price of&#160;$5.00&#160;per share, for aggregate
gross proceeds of&#160;$8.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. In addition,
the Company has granted the underwriter, EF Hutton, division of&#160;Benchmark Investments, LLC (&#34;EF Hutton&#34;), a 45-day option
to purchase up to an additional 240,000 shares of Common Stock at the public offering price per share, less the underwriting discounts
and commissions, to cover over-allotments, if any. The Company's Common Stock began trading on the Nasdaq Capital Market on&#160;February
14, 2022, under the symbol &#34;VIVK&#34;. EF Hutton, acted as sole book-running manager for the offering. Simultaneous with the close
of the offering, the Company converted 66,667 shares of Series A Preferred Stock in to 833,333 shares of common stock. The Company effected
a 1-for-30 reverse split of our outstanding shares of common stock (the &#8220;Reverse Stock Split&#8221;) via the filing of a certificate
of change with the Nevada Secretary of State simultaneously with the close of the underwritten public offering, which was effective at
the commencement of trading of our Common Stock. No fractional shares of the Company&#8217;s common stock were issued as a result of the
Reverse Stock Split. Any fractional shares resulting from the Reverse Stock Split were rounded up to the nearest whole share, resulting
in a round up issuance of 2,271 shares of common stock. In conjunction with the offering, approximately $1,228,997 in convertible notes
payable were converted into 272,156 shares of common stock. All issued and outstanding common stock, preferred stock, and per share amounts
in the consolidated financial statements and footnotes included herein have been retroactively adjusted to reflect this reverse stock
split for all periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On March
3, 2022, </span>the Company amended our TBT license agreement to extend the terms of the first milestone to March 4, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 9, 2022, entered into a land lease agreement
for located in Vernal, Utah, which allows&#160;the Company to operate on the land and receive ore supply of 2,000 tons per day of oil
sand material, which is guaranteed by the land owner to be at a minimum of 10% hydrocarbon by weight. Commencing in March 2022, the Company
entered into a five-year lease, with an optional additional five-year extension, with Tar Sands Holdings II, LLC. Under the terms of the
lease agreement, we are required to pay $3 per ton of oil sands processed. As a condition of the lease, we were required to provide a
$30,000 prepayment toward tons of oil sands processed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 28, 2022, the Company entered into a
lease agreement for approximately 1,469 square feet of office space located in Lehi, Utah. Commencing on April 1, 2022, the Company entered
into a three-year lease with Victory Holdings, LLC. Under the terms of the lease agreement, we are required to make the following monthly
lease payments: Year 1 is comprised of April to May 2022 $867, June 2022 to March 2023 $3,550, Year 2 $3,657, Year 3 $3,766. As a condition
of the lease, we were required to provide a $3,766 security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2022, the Company entered into a lease
agreement for approximately 2,000 square feet of office and warehouse space located in Houston, Texas. Commencing on April 1, 2022, the
Company entered into a month-to-month lease with JVS Holdings, Inc. The lease may be terminated at any time or for any reason with a 30-day
written notice to terminate. The lease requires a monthly lease payment of $2,000 as long as the Company remains in the space.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 26, 2022, the Company entered into a 10-year contract with
Hot Oil Transport, LLC, a supplier of asphalt materials. The quantity of product purchased pursuant to the agreement shall be 1,000
tons of product per week, or the entirety of any lesser amount that may be produced by the Company during any given week. Buyer shall
also have the first right of refusal to purchase all or any portion of additional product that may be produced by the Company within the
state of Utah. Subject to the Company&#8217;s right to continue operating at the current plant site in Vernal, the agreement shall automatically
renew for two successive 10-year terms unless either party terminates the agreement by written notice to the other party not less than
three months prior to the expiration of the initial term or any renewal term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to December 31, 2021, VWFI has raised
$295,000 in conjunction with the $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC
units, to accredited investors to raise funds to manufacture equipment that manufacture RPC Series B. Subsequent to December 31, 2021,
VWFI has also converted $1,320,000 of convertible debt into VWFI LLC units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to December 31, 2021, VWFI has raised
$295,000 in conjunction with the $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC
units, to accredited investors to raise funds to manufacture equipment that manufacture RPC Series B. Subsequent to December 31, 2021,
VWFI has also converted $2,235,000 of convertible debt into VWFI LLC units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to December 31, 2021 the Company amended
a note payable with a principal balance of $334,775 to extend the note&#8217;s maturity date to April 1, 2023, with monthly payments of
approximately $29,432 until paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 23. Restatement of Previously Issued Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Subsequent to the filing
of the December 31, 2021 Form&#160;10-K, the Company became aware of scrivener&#8217;s errors in its filing, which led to incorrect financial
information being inadvertently filed in the Form 10-K, including the correction of interest expense to reflect a reduction in the amount
of $398,954 and certain other adjustments. Management determined it should restate its previously reported financial statements. The Company
noted that financial statements were appropriately prepared, but due to these scrivener&#8217;s errors an incorrect version was filed
on April 15, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The impact of the restatement on the Company&#8217;s
financial statements is reflected in the following table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">As Reported</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Adjustment</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">As Restated</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">Consolidated Balance Sheet as of December 31, 2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; text-align: left">Property and equipment, net</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">24,293,157</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">398,954</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">24,692,111</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,345,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,744,245</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,613,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,012,504</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total stockholders' equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27,154,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27,553,133</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total liabilities and stockholders&#8217; equity and temporary equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,345,291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,744,245</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">Consolidated Statement of Operations for the Year Ended December 31, 2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">900,552</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(398,954</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">501,598</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,778,951</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,379,997</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loss before provision for income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(8,704,867</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(8,305,913</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Consolidated net loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,654,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,255,706</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Less: Net loss attributable to noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,170,489</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,771,535</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">Statement of Changes in Stockholders&#8217; Equity (Deficit) December 31, 2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net loss, Noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,170,489</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,771,535</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss, Total Stockholders' Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,654,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,255,706</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Noncontrolling interest as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,613,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,012,504</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total Stockholders' Equity (Deficit) as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27,154,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27,553,133</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">Consolidated Statement of Cash Flows for the Year Ended December 31, 2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Consolidated net loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,654,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,255,706</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accrued interest on notes payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">900,552</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(398,954</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">501,598</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized interest on construction in process</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,215,743</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,614,697</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">Note 9 Property and Equipment</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remediation Processing Unit System A, Gross Carrying Amount</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,253,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">307,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,561,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit System B, Gross Carrying Amount</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,253,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">91,454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,345,421</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Fixed Assets, Gross Carrying Amount</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,083,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,482,417</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit System A, Net Book Value</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,253,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">307,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,561,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remediation Processing Unit System B, Net Book Value</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,253,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">91,454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,345,421</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total Fixed Assets, Net Book Value</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">24,293,157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">24,692,111</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>3,009,552 Shares of Common Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_001.jpg" alt="" style="height: 90px; width: 300px" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Vivakor, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1in">, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INFORMATION NOT REQUIRED IN PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 13. Other Expenses of Issuance and Distribution</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the costs and expenses,
other than underwriting discounts and commissions, to be paid by the Registrant in connection with the issuance and distribution of the
common stock being registered. All amounts other than the SEC registration fee and FINRA fee are estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">SEC Registration Fee</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Legal Fees and Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">*</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Accounting Fees and Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">*</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">*</td>
    </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt">* Estimated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 14. Indemnification of Officers and Directors </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nevada Revised Statutes limits or eliminates
the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors&#8217; fiduciary
duties as directors. Our bylaws include provisions that require the company to indemnify our directors or officers against monetary damages
for actions taken as a director or officer of our Company. We are also expressly authorized to carry directors&#8217; and officers&#8217;
insurance to protect our directors, officers, employees and agents for certain liabilities. Our Amended and Restated Articles of Incorporation
do not contain any limiting language regarding director immunity from liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The limitation of liability and indemnification
provisions under the Nevada Revised Statutes and our bylaws may discourage stockholders from bringing a lawsuit against directors for
breach of their fiduciary duties. These provisions may also have the effect of reducing the likelihood of derivative litigation against
directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. However, these provisions
do not limit or eliminate our rights, or those of any stockholder, to seek non-monetary relief such as injunction or rescission in the
event of a breach of a director&#8217;s fiduciary duties. Moreover, the provisions do not alter the liability of directors under the federal
securities laws. In addition, your investment may be adversely affected to the extent that, in a class action or direct suit, we pay the
costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 15. Recent Sales of Unregistered Securities. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following sets forth information regarding
all unregistered securities sold by us in transactions that were exempt from the requirements of the Securities Act in the last three
years. Except where noted, all of the securities discussed in this Item 15 were all issued in reliance on the exemption under Section
4(a)(2) of the Securities Act. All share and per share price information reflect a proposed reverse stock split at a ratio of 1-for-30.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 128; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">2022</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1 2022, the Company consummated the
transactions under the MIPA including the issuance of an aggregate of 3,009,552 shares of Common Stock to Jorgan Development, LLC and
JBAH Holdings, LLC. The issuances of the foregoing securities were exempt from registration pursuant to Section 4(a)(2) of the Securities
Act promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted herein, in connection with the commencement
of the trading of our Common Stock on Nasdaq Capital Market, we converted 66,667 shares of Series A Preferred Stock in to 833,333 shares
of our common stock. This offering and sales were made in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended. To make
this determination we relied on the representations of the purchasers contained in the securities purchase agreements signed by the purchasers,
which indicated the purchasers were knowledgeable about our management and our operations, were sophisticated investors, and understood
the purchase was part of a private placement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted herein, in connection with the commencement
of the trading of our Common Stock on Nasdaq Capital Market, approximately $1,228,997 in convertible notes payable were converted into
272,156 shares of our common stock. This offering and sales were made in reliance on Section 4(a)(2) of the Securities Act of 1933, as
amended. To make this determination we relied on the representations of the purchasers contained in the securities purchase agreements
signed by the purchasers, which indicated the purchasers were knowledgeable about our management and our operations, were sophisticated
investors, and understood the purchase was part of a private placement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted herein, in connection with underwritten
public offering of 1,600,000 shares of common stock, we issued the underwriter, EF Hutton, a 5-year warrants to purchase 80,000 shares
of common stock at an exercise price equal $5.75. This offering and sales were made in reliance on Section 4(a)(2) of the Securities Act
of 1933, as amended. To make this determination we relied on the representations of the purchasers contained in the securities purchase
agreements signed by the purchasers, which indicated the purchasers were knowledgeable about our management and our operations, were sophisticated
investors, and understood the purchase was part of a private placement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">2021</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 13, 2021, the Company issued 33,667
shares of common stock at approximately $13.05 per share for $438,000 in services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 28, 2021, the Company issued 4,164
shares of common stock for a $36,000 reduction of liabilities pursuant to conversion of a promissory note at approximately $7.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 28, 2021, the Company issued 13,667
shares of common stock at approximately $12.00 per share for $163,000 in services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 2, 2021, the Company issued 1,667
shares of common stock at approximately $14.10 per share pursuant to a convertible promissory note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 16, 2021, the Company issued 24,850 shares
of common stock for a $217,800 reduction of liabilities pursuant to conversion of a promissory note at approximately $8.76 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 22, 2021, the Company issued 16,667 shares
of common stock for a $225,000 payment to purchase a license at approximately $13.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 24, 2021, the Company issued 986 shares
of common stock for a $11,000 reduction of liabilities pursuant to conversion of a promissory note at approximately $11,16 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 5, 2021, the Company issued 19,841 shares
of common stock for an approximate $110,002 reduction of liabilities pursuant to conversion of a promissory note at approximately $5.55
per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 6, 2021, the Company issued 10,784
shares of common stock for an approximate $82,500 reduction of liabilities pursuant to conversion of a promissory note at approximately
$7.65 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 15, 2021, the Company issued 8,818
shares of common stock for a $55,000 reduction of liabilities pursuant to conversion of a promissory note at approximately $6.24 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2021 through December 31, 2021,
the Company issued 218,333 shares of common stock for $1,301,500 for the conversion of 216,916 shares of Series B Preferred Stock, at
an average price of approximately $6.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2021 through December 31, the
Company issued 473,578 shares of common stock for $3,550,176 for the conversion of 467,278 shares of Series B-1 Preferred Stock, at $7.50
per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2021 through December 31, the
Company issued 260,703 shares of common stock for $4,615,927 for the conversion of 266,328 shares of Series C-1 Preferred Stock, at $17.70
per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">2020</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 4, 2020, the Company issued 3,333
shares of common stock at $13.20 per share pursuant to a convertible promissory note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 4, 2020, the Company issued 10,000
shares of common stock at approximately $12.00 per share for $121,230 in services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 21, 2020, the Company issued 666,667
shares of common stock pursuant to a contribution agreement at a price of approximately $17.70.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 13, 2020, the Company issued 2,000 shares
of common stock to investors at $ approximately $9.59 per share for cash proceeds of $19,188.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 27, 2020, the Company issued 5,600
shares of common stock to investors at $3.90 per share for cash proceeds of $21,840.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2020 through December 31, 2020,
the Company issued 23,039 shares of Series B-1 Preferred Stock as a $172,795 stock dividend paid to Series B Preferred Shareholders at
a price of approximately $7.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2020 through December 31, 2020,
the Company issued 523,841 shares of common stock for $2,948,880 for the conversion of 491,480 shares of Series B Preferred Stock, at
an average price of approximately $6.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2020 through December 31, 2020,
the Company issued 321,935 shares of common stock for $2,354,504 for the conversion of 313,934 shares of Series B-1 Preferred Stock, at
an average price of approximately $7.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2020 through December 31, 2020,
the Company issued 191,962 shares of common stock for $2,290,432 for the conversion of 190,869 shares of Series C-1 Preferred Stock, at
an average price of approximately $12.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">2019</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2019, the Company issued 38,526
shares of common stock to a consultant for market services valued at $219,598 at a price of approximately $5.70 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 18, 2019, the Company issued 17,979
shares of Series C-1 Preferred Stock at approximately $12.00 per share for the purchase of equipment valued at $215,749.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 16, 2019 the Company issued 1,098
shares of Series C-1 Preferred Stock at approximately $12.00 per share for the purchase of equipment valued at $13,172.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 11, 2019 the Company issued 23,176 shares
of Series C-1 Preferred Stock at approximately $12.00 per share for the purchase of equipment valued at $278,122.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2019 through December 31, 2019,
the Company issued 66,004 shares of Series B-1 Preferred Stock as a $495,054 stock dividend paid to Series B Preferred Shareholders at
a price of approximately $7.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2019 through December 31, 2019,
the Company issued 1,533,990 shares of common stock for $9,203,875 for the conversion of 1,533,990 shares of Series B Preferred Stock,
at an average price of $6.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2019 through December 31,
2019, the Company issued 249,096 shares of common stock for $1,868,144 for the conversion of 249,096 shares of Series B-1 Preferred
Stock, at an average price of $7.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2019 through December 31, 2019,
the Company issued 6,980 shares for a $53,500 reduction of liabilities pursuant to conversion of promissory notes at an average price
of $7.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From January 1, 2019 through December 31, 2019,
the Company issued 7,667 shares of common stock for $91,982 in cash for the exercise of 7,667 warrants at an average price of $12.00 per
share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 16. Exhibits and Financial Statement Schedules </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following exhibits are filed with this Registration
Statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><b>Incorporated by Reference</b></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Filed or Furnished</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exhibit</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>No.</b></p></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exhibit </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Description</b></p></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Form</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Date</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Number</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Herewith</b></td></tr>
  <tr style="vertical-align: top">
    <td>2.1</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex0201.htm" style="-sec-extract: exhibit">Membership Interest Purchase Agreement, dated as of June 15, 2022, by and among Vivakor, Inc., Jorgan Development, LLC and JBAH Holdings LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">2.1</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>3.1</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822000679/vivakor_ex0305.htm" style="-sec-extract: exhibit">Second Amended and Restated Articles of Incorporation</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">2/4/22</td>
    <td>&#160;</td>
    <td style="text-align: center">3.5</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>3.2</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316820003812/vivakor_ex0302.htm" style="-sec-extract: exhibit">Amended and Restated Bylaws</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">11/10/20</td>
    <td>&#160;</td>
    <td style="text-align: center">3.2</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>3.4</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822000679/vivakor_ex0304.htm">Form of Certificate of Change</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">2/4/22</td>
    <td>&#160;</td>
    <td style="text-align: center">3.4</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>4.3</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex0402.htm">Form of Convertible Promissory Note (2013)</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.2</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>4.4</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex0404.htm">Payroll Protection Program Loan, with Chase Bank</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.4</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>4.5</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex0405.htm">Payroll Protection Program Loan, with Blue Ridge Bank</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.5</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>4.6</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex0406.htm">Small Business Association Loan</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.6</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>4.7</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex0401.htm" style="-sec-extract: exhibit">Form of Secured Promissory Note of Registrant</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">4.1</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>5.1*</td>
    <td>&#160;</td>
    <td>Opinion of Lucosky Brookman LLP</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.1</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316820003812/vivakor_ex1001.htm">Amended Contribution Agreement between Sustainable Fuels Incorporated and Vivakor, Inc. dated as of June 15, 2016</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">11/10/20</td>
    <td>&#160;</td>
    <td style="text-align: center">10.1</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.2</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316820003812/vivakor_ex1004.htm">Intellectual Property License Agreement by and between BGreen, LLC and Vivakor, Inc. dated as of September 30, 2020</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">11/10/20</td>
    <td>&#160;</td>
    <td style="text-align: center">10.4</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.3</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316820003812/vivakor_ex1005.htm">Patent and Intellectual Property License Agreement by and between CSS Nanotech, Inc. and Vivakor, Inc. dated as of July 22, 2020</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">11/10/20</td>
    <td>&#160;</td>
    <td style="text-align: center">10.5</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.4#</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316820003812/vivakor_ex1006.htm">Employment Agreement by and between Vivakor, Inc. and Matthew Nicosia</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">11/10/20</td>
    <td>&#160;</td>
    <td style="text-align: center">10.6</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.5#</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316820003812/vivakor_ex1007.htm">Employment Agreement by and between Vivakor, Inc. and Tyler Nelson</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">11/10/20</td>
    <td>&#160;</td>
    <td style="text-align: center">10.7</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.6#</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822000758/vivakor_ex1008.htm">Vivakor, Inc. 2021 Stock Incentive Plan</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">2/9/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.8</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.7 </td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821001313/vivakor_ex1015.htm">Intellectual Property Agreement by and between VivaVentures Precious Metals, LLC and Vivakor, Inc.</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">4/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.15</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.8 </td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821001313/vivakor_ex1016.htm">Form of Operating Agreement VV UTSI</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">4/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.16</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.9</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1017.htm">Restated Working Interest Agreement by and between VivaVentures Energy Group, Inc. and VivaVentures UTSI, LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.17</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.10</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1018.htm">Amendment No. 1 to Amended and Restated Working Interest Agreement by and between VivaVentures Energy Group, Inc. and VivaVentures UTSI, LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.18</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.11</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1019.htm">Operating Agreement VV RII</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.19</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.12</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1020.htm">Restated Working Interest Agreement by and between VivaVentures Energy Group, Inc. and VivaVentures Royalty II</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.20</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.13</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1021.htm">Articles of Association of Vivakor Company</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.21</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.14 </td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1022.htm">Form of LLC Agreement of IMX</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">4/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.22</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.15 </td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1023.htm">Form of LLC Agreement of RPC Design</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">4/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.23</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.16 </td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1024.htm">Form of LLC Agreement of Viva Wealth</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">4/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.24</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.17 </td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1025.htm">Form of LLC Agreement of VOF</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">4/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.25</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.18</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316821000551/vivakor_ex1026.htm">Agreement Regarding Assets, entered into as of December 3, 2018</a></td>
    <td>&#160;</td>
    <td style="text-align: center">S-1/A</td>
    <td>&#160;</td>
    <td style="text-align: center">2/12/21</td>
    <td>&#160;</td>
    <td style="text-align: center">10.26</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><b>Incorporated by Reference</b></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Filed or Furnished</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exhibit</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>No.</b></p></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exhibit </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Description</b></p></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Form</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Date</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Number</b></td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Herewith</b></td></tr>

<tr style="vertical-align: top">
    <td>10.19</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1001.htm" style="-sec-extract: exhibit">Form of Shared Services Agreement among Endeavor Crude, LLC, Silver Fuels Delhi LLC and White Claw Colorado City, LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.1</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.20</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1002.htm" style="-sec-extract: exhibit">Form of Pledge Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.2</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.21</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1003.htm" style="-sec-extract: exhibit">Form of Master Netting Agreement among Registrant, Silver Fuels Delhi LLC, White Claw Colorado City, LLC, Jorgan Development, LLC, JBAH Holdings, LLC, Endeavor Crude, LLC and White Claw Crude, LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.3</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.22</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1004.htm" style="-sec-extract: exhibit">Form of Guaranty Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.4</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.23</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1005.htm" style="-sec-extract: exhibit">Form of Lock-Up Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.5</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.24</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1006.htm" style="-sec-extract: exhibit">Form of Assignment of Membership Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.6</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.25</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1007.htm" style="-sec-extract: exhibit">Form of Release Agreement</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.7</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.26</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1008.htm" style="-sec-extract: exhibit">Oil Storage Agreement dated January 1,2021 by and between White Claw Colorado City, LLC and White Claw Crude, LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.8</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.27</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1009.htm" style="-sec-extract: exhibit">Crude Petroleum Supply Agreement dated January 1,2021 by and between White Claw Crude, LLC and Silver Fuels Delhi LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.9</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>10.28</td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1450704/000168316822004506/vivakor_ex1010.htm" style="-sec-extract: exhibit">Form of First Amendment to Crude Petroleum Supply Agreement dated January 1,2021 by and between White Claw Crude, LLC and Silver Fuels Delhi LLC</a></td>
    <td>&#160;</td>
    <td style="text-align: center">8-K</td>
    <td>&#160;</td>
    <td style="text-align: center">6/22/22</td>
    <td>&#160;</td>
    <td style="text-align: center">10.10</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>21.1</td>
    <td>&#160;</td>
    <td><a href="vivakor_ex2101.htm">List of Subsidiaries</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>X</td></tr>
  <tr style="vertical-align: top">
    <td>23.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="vivakor_ex2301.htm">Consent of Macias Gini &amp; O&#8217;Connell LLP</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>X</td></tr>
  <tr style="vertical-align: top">
    <td>23.2*</td>
    <td>&#160;</td>
    <td style="text-align: justify">Consent of Lucosky Brookman LLP (included in Exhibit 5.1)</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>24.1</td>
    <td>&#160;</td>
    <td><a href="#a_321">Power of Attorney</a> (included on signature page)</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>X</td></tr>
  <tr style="vertical-align: top">
    <td>101.INS</td>
    <td>&#160;</td>
    <td>Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because iXBRL tags are embedded within the Inline XBRL document)</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>101.SCH</td>
    <td>&#160;</td>
    <td>Inline XBRL Taxonomy Extension Schema Document</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>101.CAL</td>
    <td>&#160;</td>
    <td>Inline XBRL Taxonomy Calculation Linkbase Document</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>101.DEF</td>
    <td>&#160;</td>
    <td>Inline XBRL Taxonomy Calculation Linkbase Document</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>101.LBA</td>
    <td>&#160;</td>
    <td>Inline XBRL Taxonomy Extension Label Linkbase Document</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>101.PRE</td>
    <td>&#160;</td>
    <td>Inline XBRL Taxonomy Extension Label Linkbase Document</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>104</td>
    <td>&#160;</td>
    <td>Cover Page Interactive Data File, formatted in Inline XBRL (included within the Exhibit 101 attachments)</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>107</td>
    <td>&#160;</td>
    <td><a href="vivakor_ex107.htm">Filing Fee Table</a></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>X</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* To be filed by amendment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"># Indicates a management contract or compensatory
plan, contract or arrangement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(b) Financial statement schedules.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All schedules have been omitted because either
they are not required, are not applicable or the information is otherwise set forth in the financial statements and related notes thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 17. Undertakings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned registrant hereby undertakes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 49px">&#160;</td>
    <td style="width: 25px; text-align: justify">(1)</td>
    <td style="text-align: justify">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 73px">&#160;</td>
    <td style="width: 25px; text-align: justify">(i)</td>
    <td style="text-align: justify">To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(ii)</td>
    <td style="text-align: justify">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(iii)</td>
    <td style="text-align: justify">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 49px">&#160;</td>
    <td style="width: 25px; text-align: justify">(2)</td>
    <td style="text-align: justify">That for the purpose of determining any liability under the Securities Act of 1933 each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(3)</td>
    <td style="text-align: justify">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 49px">&#160;</td>
    <td style="width: 25px; text-align: justify">(4)</td>
    <td style="text-align: justify">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(5)</td>
    <td style="text-align: justify">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The undersigned registrant undertakes
that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting
method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to
such purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 73px">&#160;</td>
    <td style="width: 25px; text-align: justify">(i)</td>
    <td style="text-align: justify">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(ii)</td>
    <td style="text-align: justify">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(iii)</td>
    <td style="text-align: justify">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(iv)</td>
    <td style="text-align: justify">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 49px">&#160;</td>
    <td style="width: 25px; text-align: justify">(f)</td>
    <td style="text-align: justify">The undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(h)</td>
    <td style="text-align: justify">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described in Item 14 above, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(i)</td>
    <td style="text-align: justify">The undersigned Registrant hereby undertakes:</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 97px">&#160;</td>
    <td style="width: 25px; text-align: justify">(1)</td>
    <td style="text-align: justify">That for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">(2)</td>
    <td style="text-align: justify">That for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and this offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">*</td>
    <td style="text-align: justify">Paragraph references correspond to those of Regulation S-K, Item 512.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"></p>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized in the City of Lehi, State of Utah, on September 15, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap">&#160;</td>
    <td colspan="3" style="border-top: black 1pt solid; border-bottom: black 1pt solid"><b>Vivakor, Inc.</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 44%">&#160;</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="width: 1%">By:</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 53%"><i>/s/ Matthew Nicosia</i></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>Name: Matthew Nicosia</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>Title: Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">POWER OF ATTORNEY: KNOW ALL PERSONS BY THESE PRESENTS that each individual
whose signature appears below constitutes and appoints Matthew Nicosia, his true and lawful attorneys-in-fact and agents with full power
of substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective
amendments) to this Registration Statement, and to sign any registration statement for the same offering covered by the Registration Statement
that is to be effective upon filing pursuant to Rule 462(b) promulgated under the Securities Act, and all post-effective amendments thereto,
and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person,
hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his, her or their substitute or substitutes,
may lawfully do or cause to be done or by virtue hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed by the following persons in the capacities and on the dates indicated:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 28%; text-align: center"><b>Signature</b></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 49%; text-align: center"><b>Title</b></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 21%; text-align: center"><b>Date</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><i>/s/ Matthew Nicosia</i></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">Chief Executive Officer and Director</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">September 15, 2022. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">Matthew Nicosia</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">(Principal Executive Officer)</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><i>/s/ Tyler Nelson</i></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">Chief Financial Officer</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">September 15, 2022. </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">Tyler Nelson</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">(Principal Accounting Officer and<br />
Principal Financial Officer)</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><i>/s/ Matthew Balk</i></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">Director</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="text-align: center">September 15, 2022. </td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">Matthew Balk</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><i>/s/ Trent Staggs</i></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">Director</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="text-align: center">September 15, 2022. </td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">Trent Staggs</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><i>/s/ Al Ferrara</i></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">Director</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">September 15, 2022.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">Al Ferrara</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">Director</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 136; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
















































































</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>vivakor_ex2101.htm
<DESCRIPTION>SUBSIDIARIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 21.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VivaVentures Management Company, Inc., a Nevada corporation, wholly owned;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VivaSphere, Inc., a Nevada corporation, wholly owned;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VivaVentures Oil Sands, Inc., a Utah corporation, wholly owned;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RPC Design and Manufacturing LLC, a Utah limited liability company, wholly owned;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Silver Fuels Delhi, LLC, a Louisiana limited liability company, wholly owned;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">White Claw Colorado City, LLC, a Texas limited liability company, wholly owned;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VivaVentures Energy Group, Inc., a Nevada Corporation; 99.5% owned; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vivakor Middle East Limited Liability Company, a Qatar limited liability company; approximately 49% ownership.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>vivakor_ex2301.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vivakor, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lehi, Utah</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the use in the Prospectus constituting
a part of this Registration Statement, of our report dated April 15, 2022, except for Notes 22 and 23 as to which the date is May 2, 2022,
relating to the audit of the consolidated financial statement of Vivakor, Inc. which is contained in that Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also consent to the reference to us under the
caption &ldquo;Experts&rdquo; in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Macias Gini &amp; O&rsquo;Connell LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Irvine, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">September 15, 2022</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>vivakor_ex107.htm
<DESCRIPTION>CALCULATION OF FILING FEES TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION OF FILING FEES TABLE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Vivakor, Inc.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="border-top: black 1pt solid; width: 23%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Title of Each</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Class of</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities to be</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Registered</B></P></TD>
    <TD STYLE="border-top: black 1pt solid; width: 9%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amount</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>to be</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Registered</B></P></TD>
    <TD STYLE="border-top: black 1pt solid; width: 9%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proposed</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Maximum</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Offering Price</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Per Unit or Per Share</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="border-top: black 1pt solid; width: 12%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proposed</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Maximum</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aggregate</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Offering Price</B></P></TD>
    <TD STYLE="border-top: black 1pt solid; width: 6%; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fee Rate (per $1 million)</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; width: 10%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amount of</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Registration</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Fee</B></P></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: bottom; width: 7%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Carry Forward Form Type</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: bottom; width: 7%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Carry Forward File Number</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: bottom; width: 7%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Carry Forward Initial Effective Date</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: bottom; width: 10%; border-left: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Filing fee Previously Paid In Connection with
    Unsold Securities to be Carried Forward</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Newly Registered Securities</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="10" STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Fees to Be Paid:</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid"><FONT STYLE="font-size: 10pt">Common Stock held by Selling Securityholders</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3,009,552</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1.62<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$4,875,474</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$92.70</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$451.96</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Fees Previously Paid:</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-0-</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-0-</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-0-</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-0-</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-0-</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD COLSPAN="10" STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Carry Forward Securities</B></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">None</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(238,238,238)">
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Offering Amounts</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$4,875,474</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$451.96</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: White">
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Fees Previously Paid</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(238,238,238)">
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total Fees Offsets</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$0</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: White">
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt"><B>Net Fee Due</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$*</FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&#160;(1)</TD>
    <TD STYLE="text-align: justify">Calculated pursuant to Rule 457(c) under the Securities Act, based on the average of the high and
    low prices of the Registrant&#8217;s common stock as reported on Nasdaq Capital Market on September 14, 2022.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !: 2P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@##USQ?H?AN>*'5KW[-)*N] 8G;<
M,XZ@&C0_%^A>))Y8-)OUN)(EWNOELI SC/S 5R7QHT;[=X4AU)%S)83 L?\
MIF_RG]=M>8?##5_[(\>6!9ML5T3;/_P+[O\ X\%H ^F***9+*D$+RR,%C12S
M,>@ Y)H Y[5?'OAG1-1DL-0U-8;J, O'Y3MC(R.0".A%:.B>(-,\16CW6E7/
MVB!'\MG\ME&[ ./F ]17RUKNIOK6O7VI/G-S,T@![ G@?@,"OI?P/HO]@>#M
M.L67;-Y?F3?[[?,?RSC\* -'6-;T_0+ WVIW'D6X8)OVEN3TX )K,TGQWX;U
MS44L-.U(3W+@E4\IUR ,GD@#I6%\9?\ D0G_ .OJ/^M>7_"/_DHEC_USE_\
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M:H/^_,G_ ,3731N)8UD7(# $;@0?Q!Z5Y/\ #7P7Y[QZ]J47[I3FUB8?>/\
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M\" : /"O@_J_]G>-DM7;$5_$T)';</F7^1'XU]$U\A65U/I.K6]T@*SVLRR
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M]X1.1^1KR%JSZ)NR/G;Q+JKZUXBO;YFRKR$1CT0<*/R KV3X=Z)'I'A6WF*
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M7#4JK4IQNT%0W=K#?6DMK<('AE4HZGN#4U%9)VU1LTFK,X'_ (598=M1N?\
MOE:[:PMGL[&&VDG:=HEV^8XP6 Z9]ZL45K4KU*BM-W,*.%HT6W3C:X5RFL>
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0B@#_V0$!              $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,@ FD# 2(  A$! Q$!_\0
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MC^/M!TGQ=KVG^#/!/C"]U2QN]2LK:T\-^&Y?&LOA[PZ+@W%WI.I:UXFLM/\
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M75]>:F%17_H<_9@^&/AGPY')/IUGY/V);6W@O[B>!9[^-[/RFN9H((D"S/\
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M\7F.9X.GBZ6(P^74:,\C0K/XM?M$>-+/X=?#:PN/MFH075U;Z+::A#8E-)M
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MP\S3(KP+:RSI*Q"?I-'I'Q7\0/X7T;PUXR\1?"WQE!H-E<^,=<EU7P)XNN/
MMMI=@TUQ$/#>M:3>PM87"6(M[BRAO=*$-VT5CI6JZEIP:XN_MSQ[=>)-;36=
M6MS;6M[:65Q;QWFHW1OX;1;9/L\]T\$-U:W&J7 MK82PVEI+#)>BWG6*YB2)
MG;RCPI\+#IR>%]*:]O-$@U/4-(\<>-]6LI[2R\[0_#JC4]!\,Z]J5W)+%_9E
M]K+2:OJ0CGOXY8=/6V>Y2QF#3_QKQYXH<0<>_P!GTLVIX"G0RW%8O%X>&$I3
MISC5Q5*-";K5ZM?$5J]Z48V4Y2=TYRES29_IUX2^ ?!GA(LTQ?#U;-JV,SG
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MWFK#QY\4]8\ ^ H?"_A'Q9X@TSPNK_#0(VE6MQ8:7J_B#7=2U;6=/TKP[[6
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MLM/U_2_#'AU)[[1IX3;:E:^'M=N-,US0[*[U&;39;:PA2T_0+X9_\$_/B/\
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M/IT2ZC;)+91WD%O8RQQZG#+;?97MYK: ^597<\S_ ,M?[9/P;M?A+\9?B?\
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MO<_37Q)\,[/]G[3I=8N=8_9CTWP[K\ND>*M);XH0_#_]G'Q/\.WMH4NVUO\
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M[F66\A_ISZ27%&4\/\'X#@G)JT9PA@,NX;P$%*DY2P.31PD\QQD^64H\DJF
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MW/T%^R>9]-UKXZZQXAUZ_N]=A_9F^.-U-'.;2VM(]-M/",T)86]M<:E;7EQ
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M:_L__P#!.C]J;P18^"?B)9ZN-2T:\O\ XL7=@H75]4M++1_"^D^,O&FH>'-
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MM9:Q91?8+IXK8VNNPZ/;7.FBO8D^,WP_T75[[1KCXB_#7^Q/%GB6S\'ZM?\
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M;VS6=W=W+VC>)-5M[RW5;:UMM2:QT19&DOVM6O\ $=G</I6F>P?#_P (>'_
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M/V<_&_\ P2P^!NO?&K3OA?XU_9KG\6^%OV9OCUXY\?Z=\/O&EK\<?%%O\-/
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M;19/&'A#P5I][XJ\5^$KF'3[ZU\3>&_#MM+JFMZ!+IVI6\NE7J:SIUG=:?\
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M\VG64'Q/\)_$XZ5X\\0>(Y;C1_$>A6.N> 9(K+3+>U;Q+JM]J=W'JWB3C_\
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MVA_:KX8Z_P#M">(/A_HWQ,^ ?_!-O]E+]J+X>>,K#3;WX77\'A33OAAJ^O\
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M=M%HC\?;'XQ?MO>#K+4])\:_"G7]0\0WC6=OH6HZ)J_A;QC;6UWYSM>R:H?
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MH!UWJ!!XR\4#Q+H/[.MF[O\ ;/A;\#M&^'7B%95N%\O4=&^-GQE\6VL%LY@
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M^9IQO%1LWHHI:1M:25E;[4DK:/J9.36EUI\W>VKNM^]_/[OSA_9D_9$_:[^
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M6SMO$^FS:I=_8ETXPZ7>7%]:OI@CG3LOB'^VX/&O@1O%7QL\*7%[JNE?'A?
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M"_P_^'_A+QAX6^%UC\4O'O@?Q5X?UJ3P/X3TGQ?I'C/Q%\/=5DG\'V/BC6?
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M;B*"Q^'%_;W046B&$,98J^M?\$G?%_AG1;[6-"^/WQT_93T2V-U=/XM\&?\
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ME6Y6$ 7)@MC&S*AP[HJK@O\ ,7GPSN5/WFVDU+CPQ8WZ#R+YK%W?S<11S1*
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M#<QVCM##OC$,=W(86(="C"4/#YMJEQJ'AF+3[*Z\-W?B/6/$7C#PY);^*I_
M7B+5=&M[+4+/6M*E\/75TFO7'@+PI;VU[)I=\5U;0X]5U9X(H]/UG3+J&W\.
MWC<I-:MORT]?+6^J>Z>S!)MV77U_34]'M];:*&77].:T>2[:>>:+1O[(M+]C
M.@:.[MM3L;VW-[97L4D*F.:*V 41H\L%PD=D_L_@7XC?##7U\/:)\=[S4_AQ
M_9MW#X=\.?$ZTLY5;6-.2[M8-"\.>.-*N+6:YM/%(U'6$TFU\=S3ZW'XD6[L
M;:[T[2+R"TFOOD^+PE'<6ZW\TD=[JDYEN-/L[K3KS47@4:==_P"DR:C=0RW6
ME&01RW<EG%=&>WMQ?26JQ0Z?/-:<CK6@)IY:ST:7P]>WAM;/3[O29KW2K/5[
M!H5&E:MJCZ1-<WFOP:6;FZDLK**"Z-E;WP^QW<]Q>WEAI$7C9OD639W25+-L
MLP>.4I)J6)H4:M6$HI<LN><)2:6BLYN-EMWTIRG!RM)W5WK=Q:OM9J72[^>O
M=?IKJ'PJ^&>O:%JTWP(^).B?$.33KB]U34/">FO9PZE/!]MO6O[VVFL=\E_=
M-JBM8SW<=L+5M6CDTJZ,6LW'V.YXZ?X5^+[&WCUF;PQXDLK.[M(K>*ZAM;I#
M$VIQQ7$,%Q EL]S!=+-:+YM[(@FL;K[0EU:6[7!8?"MMH=Y;1:IK&I+#I6@W
M]NM@8K ^,-'M;K3H;.QCT6*U,&OV/B+QK9QLMO<7'B;4=/72M1O->MC+%:PZ
MA8VXZWPU\2?B_=:]8>'M+^*7Q*DTZW^T3Q:-<^./&<MWJE@+@7+V1-KK<.MV
M]NVAQ?:"S7&LVMI:.#<W#V]M&X_,\^\$N$LWKO$TZ$L#5Y(Q_P!D<%!N+<>=
MTIJI3YN2RDE4A&T4E"%DWNL3&4DYQ2=TG90M9*VJ26_HTWYW/L?2]&OM*U(Z
M5!H=A>W>G_\ $RN=+$\%O-! LL2M*Y@7SK61&V>9(EO+Y8?S6@4.8T]!N(_!
MT*17DUCK>BZ\NHW2V_V62XU#3X+*9K:2WMXI61=21;<7,Z7TK74T-[YMFL5M
M /*EG^7/V8_VE?B)HE]?)XMU+QGJ<6N6&K-<> OBYK?B'Q0?#MSHNOZW=:+=
MZ7XCNM1U"WA?Q)X8>&_U#PQ::)?3Z!-!Y5W=ZS=:==:]J7U7IW[4'[/FHI;_
M /";_"G3M%,6BZIXFETOX>Q7_B:]_P"$?>1=VN/+:^%_ 6K:M:ZBFL:;/#I%
MMX,N[JXU#6=+.AZCK5I<6]P_Q.<>#=;+<![#)LSIW7->EF."P^+I\LU%1:JT
MXTZE.K'EO&I*4I0DVDEJSNH5*,Y-\B4$M;?$M6K\CBUTNM'M9/<Z_6?%VJW]
MGX5T;P6=6ET>&WN-/U"XOKEHX9;V[D@N6FTVQ@CDCM5L[B:>"*VFU'4I[F&5
M)9;JRE$EM7,^9XK_ .AA;_P80?\ RLKZ8E^$/PZGM-/\4:#+XG\+Z5XITW3/
M%F@7FMZA<^'C/I%Y$NHV6KZ5I'B/1]-U*_\ #]Y#=VS0ZA8:E<6-S<6WGV-[
M;RV5] TW_"G=*_O^*OR;_&OS6OX<^(U2H_9X[!3ITXTZ<4L=&A"*A%1]RE.F
MYPC*RE:3>K=F>A/#X1M/O&+^"5V];MZ)7;U=DEJM$?YMCNC><K%,DOPRMLD+
M,& ("E1@J&._:H,8;>&"Y_IZ_P"#;V"."/\ ;ZU?PYJ6H>&?&\/['7[3&WQ]
MH$<*^*O"%AI_P.\50^&[G2=1EBE2QL8]?\0ZAXBN=.NO,TW6O%?A?P)J%W%]
MI\)Z<K_'7@3_ ((NZ_K5[JS^-_VCO!FF:1H7A#XA>--23P/X+UWQ+K5WI_PZ
M^'WBOQ_J%A91^(]2\%6-M+J5OX7;3$U.>:YBTQ;YM7DL=0&G_P!GWGZ9_P#!
M%?XGZ9XP\:_MB>'M$US4K328?^"9'[5>M:)\-KD>#+2V\ 6-AH7C'0)=.F/P
M^\/>#="U?4M4\/\ _"N;W7_%.I>$/#FL^*-6TI=:O;6=39-9_P"@O"^'P&)S
M"LLUPU"M@Y8'&8>G'$IJ$L=B(Y;'"3BU4A!U**^M.DISU]M448)2G./YQQ-6
MQU#+)SRVI6I8FE5H8J53#M3<<-0J5G7@UR3<O:7HMQ5-WC2?-)7C&?\ .A\0
M=<\2?$S7?"NJ:OK^M_V_X8TJU\.:3//.?$B7%S)K6HZM=O'I.H0"UA_M?Q!K
M5[-#X>TB"RT"TBFM--TW1PD0,WJOPJ_9]\&V%S_:.KNNL>)(O"448\+:;K$E
ME):VWCWPW\1O"^OP>,('TSQ2^F:_IDB^&M0T;2K>WM(+237M1C\0RW%YX?O=
M'DY3XJ^!--T779+'3)=0CM[O7=<TN21[DW1FO(]:>VMDLRT>[S7+)&L-NLN]
MN/*27RU?M/"7PW^*.@OJ6G^"M36ZBTK5[6WU)DTVVO$DU.YT_2M3FOC+J>C1
M2#_1;RS2X7[39W#7$)00D?O#[_'>+\.L=A<UP/#<(</9M2Q>(IX/,<5+,:6#
MPSP688NE5HRPU*MF.'<)T<.HTYJC%QG&#IQ4;3EOD3S6V!Q6-<L9A:V'HUJF
M&IK#^VFJ^#PLZ:4IQPTHVG6?.E)SNI:1::C[C\ O#NM_"?5/ SZ;\0/'Y\/:
M3XV\/:S;>"1XH\':;IVY)K[1M2U/0(KE_B3<ZQ?ZEHNN:SI5_I.B>&OAA8^(
M[>[%G<>)M.G^SO8_3OP8_:"_;)\:WGPL\0?M _&WX+_$_P ,?#R?6]$MO /Q
ML\%>.?%NAW7A;Q>FEZ;X@\S1[KP/J7PSEGFBTO2/$V@)KGAYK*+5=/TZ:6?3
M$GEE3X0T[QO\9O &BZ/;WNDI=Z -5U2WTJ^UK0;ZU_M9](G:VN5AMM+OK.WA
MN[5YX[JWO&M%NH;L((;B\,$N.4T?7$C_ +*TF&"3PZVYX);S2/$&M>$;N.VF
MEAAMT$=DWB2[U.2W0SN\O]CV\L[/_9UK:6Z.UT?P>K+.J%ISKY-G,>6$:=3
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M77X=1ZL5E./QT(+$3I8V=)S4+8R/)&$Z[K\[O&'++VB3G!+FTUDT[+Y2EG7
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MNX!\1_"GAB3X7^([*;5;G5]:T_Q%X?UJ/3I=(U2PM[FQM=0MM01,+0/AA?\
MPQOOB?INM>.OA5J>K^(/BAXL^(R>$] ^*GP^\2^-])T3Q19^&[>"+Q)X1\(^
M)O%%]H-V-7TW4Q'#JLMC<26S6TTMO:R2M;Q\53#8[#NI6A#$TH15_:4ZDXJ,
M+Q:DY4:D4TFEI?JDUKK\/6RJMAKK$4J;Y).FVXQ?.X2E&\5*2E9I75HO1=TU
M'X.^,'[%O[._CWQ5\&/@A>^&=3\.?#?3-"^.?C;1]$\+ZU+"UCXFO;_X9)?W
MD$_B.W\2HUO=0S2O-930S6QE"N$0+@\7H_\ P28^#/A:^EU/X8?''X_?"G56
M4M!J?A34O!UA?0.Q*K)%?>#_  U\/]6VQ)D+MU19<E6$P5BE?7GC.\:W^/GP
M3;C,WA3XVVC$@X(^P> ;U1@G&!]E)+;LC!P.IKWFVG9E+*01]WA1QU&,,>AW
M-D<XW#^Z&.,,RQE."A'%U+)2DN=0J7YG>5W5HU79O=-MWU;;2MQRPU&3UIVE
MY2G%W7?EG&[VWNOQ/B;3_AM^VE:?&#XKV_[,O_!0;XO? 33_  -X:^!7A74O
M#DNK^/M6T+QOJDWPDTEKOQ?JUJ?&&OZ197^MRZ<\^HVDGA77V:]EDN4OWD8J
M_K*?&W_@KA\--"\">#K;]K7P=\1_C!XV^+.MZ-HNL>*_#G@_6_A^WPYT#X5:
M[XTOCK">(?A7X?U6'Q!%J7AS4YQ-%875U=VS6]G;O*[NP[KP!J/D_&O]H.U4
MX\[2_@%J()Y4F;P;XMTWA<D!MND# &. . 22>@\87>/BE^S/(QW$?$SXD6YX
M&,3_ +-GQE8$@<@LUOR0#V!X.X8U,RQ+@U*GAIQC:3]IAJ,9O5M<SC3A*2:D
ME9O5:::H2P<%S2O4C=WUG*RZ>ZFI1BM=DNAQW[4O_!0W_@HW^S+\"/"^O^(_
MB_\  'Q/\0O%OC >%[W5?"'[.UAHFF>'+5] U35F;2+S7?$]];>(]1,MHL9U
M.]\!^%XH(VF6'2)94COF_!GXP?M]?MI_'E;N#XJ?M0_&;6](O4=;CPQHOC/4
M? GA"XBEW![.\\+^ #X9T75+1E!'D:O::@F0<C(&W]3/^"N%S!#^S[X"NKB6
M*"*#XPV ,TKA8T,O@WQ8"-T@5=S+%P!AB%.,X)/\[TFKQRK_ *):WEV"HVLD
M(AA95R6*SW#)#L*;@Q0OR2<DDFOH^':5+%X66)K4,/[95ZBC+V"E&*LO<A%R
MY8QC>+M%)M'F8SFI5E"$I\JBNKUO=N[5KV5ELM]K@DVG6$DD-A:6MM)=RRRW
M/V6VA@:>:5@#<W31J&FE9F8RRR>9*[ N7)(J_-'%<#RI/N.DD,F-R969=I'F
M\LN0%P &!/7;P4Q%CO9F$B0VFGL<')\S4+B$?,K?)";*U#GYGRMTP Y.#G%B
M/3IY2HN+FYD&X[T-Q]EC<*O&(+54P"V#M-P<@$-(2/F^GII)6?LKMNRII1C9
MW225^JNW;U:T.1:IMRU2=KOHMM?OMYG]"?\ P3^D+?#A^@!^'/P1"9(Q\DGQ
M8@VQ@_-M14"%5PK-\Z@[V!_.?_@I!=6MI^U5XKEN;B"&.3P'\+&5I)(H(UQX
M40;<2,I/HBY)(0#DC-??_P#P3GB2/X87L"O*P_X0OX8,/.8,T2CQ#\9D,:,%
M#QQ0NBQVR,TK06BPQB0A<'\^/^"CL,3?M:>*I0L:S0>!/A<L<ZI$MV ?!]HO
ME?:0HG0*8MRKYR[&,Q"*)#G\XP2C'BC&1U24:ME%=?94[)];/7:Y[]2TLKHS
M5DN:"N]K7:U3W=TM&K\VNA\!W-W#>D-!'=W0Z[K>V:.W8.6<@7$Q2(,P= "L
MDBL1P0N#5VT?49$CBBM;.TAC!Q)=7,M[(58-_P NUI&$<[BHP^H1#/.X$;:E
M,EDDZQW5U:6J\NUU?SRB$^2F0=RPW,Q<CA$CA<R$EMQ"$C0TW4+2]'F6MU#,
MF60-;RK, 8Y7BE4KE64++&T3$[2KIM')X^WY9QBI<B?O:N5KI:;Q>M[[)O2S
M32/)IJ+E:4G'TTYF[JW,FK+>_>]NI^U'_!*!+RWL_B$+QK>5!:71MI887MV<
MOJ7AT7$<D333Q101A+4VF)6GD=KII=H6%:\=_P""I2V]U^T%X!:>*VE%I\)-
M*>%WMH)'C,OB_P 6F39+(DC)O\G>RCAFP<@IN'I'_!/3QEH'PJ^&?C7XB_$"
M^U#P]X.U#Q''X*TO7&T?5+NRU+Q3<SZ!<C1;">VMFMKF^@MFMKB^MUFW:?;W
M,-Q>^3#(DAX?]LW1+3]HG6;#XN>"]6\7^'M!T70?#_A&ZNK_ .%MQ>7C1V.M
M^*-3O6T^[U7Q7X>T6YGU"ZU[3M._L]C<7=M"K:E:K?1?:K&+XJAEV/QO$>*Q
M-#"U:F&IN,*F*<8PH4FZ$HU(SE*<%]I64.9V5G9V;]>6*PN'P$*=:JO:SG+V
M=-WE-VDK>ZEUZ7>UFW:Y^?5K>Z;'%//>ZQ9V*VUNDL,>HRW#R7[L1$EG8011
M20,^Y07-U+:P6\>3O=@D;>V?"7X5_$K]HC6;OP%\#O ?B'XH>*8XYX]3T_P;
M9'4;?0(B[6L]]XHU9&CT+PII<,Q2*;5?$>I:7ID<TL<?VMI9HEE]Y^$_A3X2
M>/;_ ,(_#KX;>!K&^\?:WXMB\,ZWXAU3P(/B7X<\%Z1I^I>'(])\27'Q9UWP
MOJ/PWT[6O&NN7FK7=OXM7PEJPTK1= MOAKH?@N36]>U#XJ:3^TOCC]I+]G+]
MB7]E6TMO /QX^ 8T_5+J?QH_PN/QGLO"7Q ^*=Q(X6Z^(UQ9>"_!7C?^T=6U
M-%FG\,Z%J5OI\TNG?\2FQO=!M!;V%QX?&LLSRBBL-PUD-7B7B7$0EB,)@*>)
MIX+ 4:"G[*>,S3,\34IX;"4(5ZE*G2P\)O&8I^T5"DJ=.IB(]F65J6*YI8NO
M]3P47&%2K.+<G+6<:=&C3A.4Y2@Y.4OAA%1OT/I*W^#NK>&_!'AKPYXIU_X?
MZYXXTVUT>SO_  ?.?$<NB>'-)M;-%\03:KXV\%6.J>(KC7M,,+W=GI/AW0&T
M/43:/!JWC'2[-_-?P/PYXMTSP3\2_B[H?Q ^'W@[X;>%_ 'P[U;XO>!O'\/C
M"]_:#\??$O0/#=Q90ZUH'P>^$.I>$M!\":3K&D6_V_Q)X@\7>.+_ ,0S>!_"
M-BWC8:)=6FG>+[+P-\ _ K_@KC\$?BSK_B+1/BIX;\#?"CPSI][H*> ?%TGQ
M.O?'VG_$_6+CQ']ATJW\._#S7?A#\/?'>DG2]4TQM4B\0ZWIMC'IMQ8V3);V
M5^VF7ES^D/Q%\9_"K1_AKJ?B+Q[\%='_ &BOAIHM_H,>O>!+GPGI/B74]*MM
M#UBQEG\5:;>^(K9]:\':S\.+*&3Q/)JNGW,6O?8[-=.N+'6;/6Y-.O?YYS/B
M[Q;RRG/ASQ%R7.,)4XMSBCE6&GPSA<NH9=EF&QCPT\!+)N(<!G&%E7S!UJ5?
M!XS+,XQ6'6*P]7VU'&PJ*.&J_44,NR7$U:.-RK$8?%1P5.564,3)SJUY4W/V
ME*MA:U&4H0LTZ=6G"?*VW*&BY?@7X7_MA?$KQ-\;8T\5W%A\2_ OQB^(-G9:
MQ\(?B/=W_BKP;%!XHO/['MY?"%_=S3ZMX*\0Z/IUT#;^+?!UQIMW/-9M/JEK
MJUG+<Z?/]A?&O]GK5O#>FW_C#X6^(->O_AI=ZG9VT>M63:;!XQ\"W]Y+LLO#
M/C_3Y+.\T]O.N/,L])\3V>W0?%ULD<@M-$UO[1H5MG:M^S]^SEI)\ _M#_!_
MP'X5U_X?S>)I]9\"?$GP#*?!5[IWB&RN;^&^\(?$3P;HMC!X:A\1:/JT5Y82
MNUI#:ZY?V:WNGM;S0W&FV7U+\*/B#'JK7=]HT4EEJ5M:7>CZ]H.MPV=];7NC
MZCMBNM+UC3VDFL-;\.:LB0B6UE4VZS10+LM[^UMI8IS?B_BWP5AE7%O#^$K<
M5>&<:E7 \5TH0K4\;E>.ABE3FL7E];VV)R?,L))588BK5I+#U,3-83&5HSK8
M7%XG3$4<JXE<\+5A'+<WA%+"/DCRUX)62IUH*G3K4[J$>1*51.\HI2@XK\[[
M+5=?TXQ0ZEJ_V.]"QQ7%Y+#'8QZ@Z *91;0WOV%&EW SQ>7$%DSY<(5BL?6R
MO=QN9)VF;[0H=Y/L4TQF=@2"\D$D<H9CN=6612%X!91@_9OQ'^"MI<6&K^.O
M "!-%L(FU3Q/X#CMVN-8\"P/+BZUG0K^%H;G7/ ,$LUOY5T;0:SX6@G6Q\1S
M:A##%KFH?/,2Z%!%)')!KEN6_>B\M%LIK)EDP=B&\%_<LS[=Q,DV#OW$!2?*
M_K'@CQ X:\1,@PG$?#&.HX[!8J,75IPG&6)P&)<4ZV!Q]'F]IAL51ES)TJD8
MNI!1J4I3A),_/,QRW%Y9B)X;%TI4YQ;Y9.W+5C>RG3LW>.EG9MW=I1BTT>70
M6T6K-*+JPE,:<122O<B0HR(?-MKE07+#>2D+JKXB/S8QE[Z4EFJ)%JZE'A=H
MX6*R3QB0@(HNE-G.L:K\K07%I*P;:?M.Q"LO97&F^%)!,DFH:Y+>NC+!-$+2
MPGA(DW%I8B]TERTJ,HD2.>TB!0,C'<I?EY_#\,DC?8==OE14!635+2VF1&9E
M22)C9WEU+$J2"41NTT190IE@B9I$3[).ZNOR:_,\\IR:>VG1E[^YO[A'7,,E
MQN:%?,;<OD8MO*BA8;E1S;RJ-X5Y92Y =#=3QHL-A?V\ 4-YMHPLW#,S $JD
M.H6:%I0HD'F6BS/(X9X(]C**R:9K]K&ZZ:XU%0_GJ;=(8RV</AFM[BXRB+AG
M9Q+(,;F2,JR"J^))U-]X2>X*[6=TU..)%=61I)$CDA-M*5F8%1-!%)GYA<!?
MD+ AM]..J:A-"+*XT]HH9P/+T^-=&N'9\R2RA)Y(8).4DB)61)'?S)'BQ*]<
MSJ^AW(GETN^,ZV\\!,,\5R!#<HDEOM<O ?+2'Y8P%01R,CRH,APR=T9(,>:N
MG:II10?NIXYD$B<H&V36MU*C -\Q?RH@"=H( #4W[68=RWRQZJDNT-'=+'8R
MRK_K,R7)*K&[%0@DFE(<*7=\LRDV \X^PP6%FR:E?ZREJB1RL+/7S:0F?R38
M?:!<QP1217B6EQ/:Y-Y _P!F@C2+RYG2:/R_QSX4\+^"O#VJ>+-+U._ETR:Q
MDFF\%^+;CQ5I.EV>MR7=M=0ZG_PD_AQ/'MAH/AZW5?/E\3:QX76%7>".\N="
MM[>/49?HZ>SM[F2/[/)':2;G39<-)<2;2R%T6;>FZ/8=D<JJK1K&R"*:.X60
M<]=>#+P7/F^1I$$;W"7-O<O':/:PW<"RRP:B8KB.*""\BD8S07,),X:19%N1
M*S-2:NFAQDX[).^FM^_2S7ZGYQ:3\1_$NNVL$7P[T.UN+4Z7IVKZ1=ZS>7 \
M'^$_#;6"*VLC2[ZS\,3^.=4@TR^BBTW08[7PY]NT6'5-:N[Z1HM;T73>OL/A
MMX!_X1"QOM'@^+&M?%6#Q9K6N^._B>]MJ'AKP#\2?%6JWR:IJ\WA^STKQCXH
MT76?AI9ZE;:4WA!?#/A^YU/6YM,LDEUJWL[K4;_2_L/Q-\&OB%J=O!9R>.YK
M8G3+RRT-8(M:LX+<:G97,JK%IVB>)_L>M17MP[:M=/IG]A7QD@*3/>:G(FKV
MGEWB[X0?&_POH=SJ]EXF@\;ZOI5U;2W7@G_A%;[PC>:IXA>&>#Q L7B%_B'X
MKU.TT">]M;>ZU;PCJVFQ?8'GMX=,UB0Z3J%OJ\Q=E9NVKT^Y?+7K^A<DV[I7
M32L_O[LR_"?@CQMXH\(Z!#\6))[2/4M&OM;ET;4-9T36%A\;:I"^IZ7X TR*
MVTW2[JY2262XN=1BT#0]:@U[4K.#Q.VF>'[&QU!#] 6WQ7TW0=/TZ:U^$5EK
M]MJEU#HNL>+8Y_$5_P",?'^J^(/&U_I^G67B"Y^(>F3^")[#P8+*XA\5VUIX
MJTKPMI16_2;3[_5DTB2+YWM_'WB/3O''A71!X#^+EG8"W\+Z3)?:7\ +GPEX
M1GG\8K;V^NZ6MU;?$OXA7V@>$="^VW>E2ZUXAOM46XTK^TX]/\.6MSXC^VVG
MIEXGBS4M8@L&TW7GN=,L[S5-1FU33=2MO 44_AB_TOP=/:+J&LZ-I,CP7MOI
M]A_85U8ZA?2WOA:;3]9EN8M-@N=(L%5I4Z]-TZL5.$NCOHULUYKH.FW&3:;3
M26UN^VS_  =SUK1M1^"DOQ,UD6FB>&]/\1>$]8L(=30_##P]HVJ)JEEINDW7
MA_1[W5K6]U$F^U/2KO4M8MY[36KNQ.G_ &/[=JMCKLNG0ZGZQ_PTE\$O^C-?
MB3_X,M0_^65?/7@_P]>:/97VD>)DTW5_$GB/5-=TO26O+G[5X>TOPGK6IO+9
MP7T)\V_O;22<:-I=W=RZEI*07LUW)JE]K4)B:XK?\)#^RQ_T.?A3_P -GJ7_
M ,C5P_V5@W:\).VB]^2LNBW?_!>MD="KU._X)_FF?B%JG_!2K]IGXD> '^"O
MB[3_ (40>$]0\.6O@*]\2Z3X)\.^%/&EQI=E:V^DZ9J&J^-['1SXE?4;BYTR
MRN/$6L/K(N=3M[K6I-0E>/4[Y9OKG_@EM\?_ !!XYU?]K3P7K'P_^'V@K\(_
M^"-W_!1O1/"GB+PUI,.@>.AHNE? G5KJ/2O$?B?1[32==\3N]S>/<SW_ (@O
M+S4UOQ'J=O)87IE\W\:Y_B5\"-4UZ>^T?X)?$&'PCIVI:C+=0:C\6]*EOK'P
M_+J=Q<:/8MKNF_#6PTY-8>PC2UGU;7- \51W%\=2N;;0K^R6#2+?]&_^"/-W
M8:M\1OVW+G2="O-/GN?^"/7_  4STZX9/-N+35;VV^!5S+!>Z=8C3HI=.:6T
MN;.VGTV*_P!9;SMEW]N6"[CLX^G%5L14P\HUL3&:4D_9*G%2<KI<RE&G!1G!
M/W97NN9J+3=C"G3P\&E2HRC/1N<JDY7:?5.<_=DKIQ?NN]Y1=D?(6J^/]9\,
MV$>@:5#;7NIZE:Z3"]YX?\3>*]3CDU--,TFQNA;VVJ3C6H-26ZN;6U366C@U
M2ZUQ)(8-0NKK2GNZ\GB\<:SHUY/XBO-3^U7SWEM;3S-J,^L>)+VUN+>;S;ZU
M77+?5DNH$ATY;.:^EN!#:W3:5%*XAEAV\?INF^(O#?@3PK<^*_ GB#3-+U)_
M$-KX9U+Q'I%YH^F:Y9075O\ :KKP]<W&D6R>(X+36CK5EJ']GW4R:9>P1P7=
MZMQ<QQI2-^\L9FBVIO+1R)(NU6$>>=TGFR[26.%0@ # W8%?)O*Z=.O7BZ-:
MJZM6JZC]M+EFY3;:7OMP2N[IKF;=[-2N>K]:DX4^6=.#AR**]G"+BJ=DDYM)
MR=HV:C9JRZ+3[-MOV@;K7M"L_ =MH?P=UZV^Q6.H:7IOQ ^!FF6WB2)[^S=]
M1O;+Q[X(N+O6=5U%;E$NM6MM;MTEDFN8K>S_ +72TN9(O!-+\<75II/Q-LGG
MN= UJ?Q1IOBJPBTK4?#ECH6H_P!GZM$\NF/H&K>&-/\ %3V2+)YL-QH/B[3Q
MI]G%;6%WX"U2(S7MCY#+KDUG'87T-RL<D$,]JC&"*92T4TRR"-)@T'[JWO8]
M@EAE"L8QA@L>=/PG\8KOP5X9^)WA*Y\)?#SQ?8_%&PBBU+6/&7A/3=3\8>%-
M4M(=42T\0_#_ ,620?VQX4U&.35[A[V&QF_L_5Q'!'=VY,,,UKVY?E=.G%NG
MA*=-64>63K1=TY)-RE.TK75K6M;FW1A6Q<ZD[RJ3FW)\T[:/F:YENE=J[NWU
M2MW_ %B^/7A'PI\3OV.OA?8>$?V=?'7PP^,G@ZVAU30OB)X+_9JU5-*^,OA&
M+1=-TS1SXC\9?#3PWKVF:E)?,=9U&?4_$]]I5W+*VBZQ<R3W4%[9-^6U[X9U
M)O!W@"P\,:=-XE^-6I_$+XC>&/$O@+1%U#6?$\^CZ-H?PKU7P!JUKX-M(U\0
M6MYJ.J>(?B)IN^RL )Y/#!>:RMI;033?K=^S)_P5E\6^&OV?_"?P)T/]FK2]
M;LOA%X9TSPUJ7QOO/B#J=MX;\(Q:_K>JPZ;XF\0Z-;?##Q7;:9+'<7UO8Z=I
M>G6VJ:SJ\]IJ-UIEV;EC%!E_MI>,/C]\=?AEX5T:Q^,7A[XE?#OQ6^E^*-4\
M#?%GX;?\(WJ7P=U36M.L'T_Q#X,>]\2_$JST'0=6TJ>]OSKFE2:)XIT307.A
M^(KK697U%S]'EW$^?Y:U2>:8_ KVDHX>,<?6KX:<DI6C[.3Q%)IQLVI0T;<4
MUHH\5?+\)5<ITZ%.NH^].4J$822=DY7TE=.RU:=E=-+?\PM/O/$=MX%^/OA3
MQAIGB?P_XVT7Q#\+?$NN:+XPTZ]L?$5CKWA:?QUX16QU6#62NLI=P6?Q"FDG
MMM3M+6:&*S5)%V!%-']E"[76_P!I/X36LK:>L_BG4O$/A*Y%G#);7!;QKX.\
M2>%6>XC9%MII)_[8+;H6V3%Q',T;,2OZ^?L:_P#!&O3?$&FVGQ(^*OQT^%WQ
M%\!^)-"EA3PC\ /&EWXILG1VM;J.3Q9\1-+@LX;"XTN4?:K[PEX;MY+^8-'#
MJOB/PJX9)/MS4O\ @DY^R=\*O%WPH^)/P@L_B38>+_ASXS\+^-;6POOB5HFJ
MQ^,3X4NK#Q%JVDSZ-<:?JW^EM:Q2HMA::Q9+>DBQEU.PM'BNVY<=GM+%8JI6
MQ51UL;/D]M7C0IT[N,XMI<D,/&TE"[?L4DHI7VMM3R[$*"4*35/E]V,I)MI*
M:3<IRN_B=GS:NY_.'\)?&WCJTU_6-#T"7PK>6W@ZRUSXI6.F>-O%^B>&K.V6
MST#3-;\6'PC-XNN)])B\2ZK;Z#I3MI_AZWL_%GB5=(M=-M;BZ1/L4OF<OBJ]
MU'7?$'C:R>SN+L>(]7U>ZTC%YOO-)UJ>Y_M0FYGA^QW-A=6U^VC7%J]P=2DM
M;WS5LQ:Q231?H/X1_8"\2Z-\<-1\%?&'QIHGP<\3)X>\0Z3XEC\1>']3\1Z+
MX1\(^-?A+!HG@KQ3N\*1^([OQ#J.L^+O%RZ8OA^&#2KE$\(:Q'876I^(]9T'
M0)-SX5?\$UIM7T;5=.B^.WP\UMO%GA33CJ-K\/?#_P 0OBSXVLK*YN=*U.PU
MGP;\/KK0_@MXVUQCJ%L+*\OM!T?QMX8MK"=DO+[[5+;D]\,7%QBZ<I3C%1DK
M./NWNTXJ[E)M2;O&\4UJUJCR<5EEIQ<XQI2E&,K.47S)MZIQG4BK*+7*W&3N
M_=VD0:5_P2C\8^-/AGXP_:*^'7[0'P6\=?LV>!]9TR/Q]XD\$3^*/%7Q=^$>
M@:[)<26VK?%OX)'1=)\0>![?1[:TNYM9UGQ#K6F^$X=.T^\\02>*(-"M+N^M
M^O\ C7_P3+^ _P )[CP;?_!O]LGP7\=O$\?P\F^*7C[PG\5OA2? /PIT+1Y?
M[8T3PVFF?%+PC\5/&\OC6X\7>*-.N]-\.:,GA+PZ5M]/N]?\0W^F^%K*_P!6
MMOKG]@WX8_%#]C7]H;XZ?LP>'M0\0^'+OXW^$/'/PB\)>+?%?@9OAKXO\9_%
MKPY\./A5\=/ ?AF+5]0ENIO"MYI4NL0^(?#NDZR^GVOB6"\6ST>36KN34A8V
M/C#_ ,$Z_P!E/Q[X8^(EQX9U+XW?L?>-9K?^TM(L/%OB+PK\4/V0+?4;[5VU
M%+.?6O"7@R+XR_#SX?\ AXG5K>^G\5:-KF@^!$D@TBYU%K.+4=7)/$P5; 2G
M*G'"4JN+JXZC32>-QD)85QP5&EB*M3DPE"CBI*MB53P]6IB:<8T%.,??79A,
M+A,/@<S4J%6MF.(AA:648J-3DP6!J4L4I9C/&82G!UL9.MA/W6%F\5A:.&KW
MK3IU^94H_)G[#OPD^+O[/^HO\:8_AIXET?XD6W@F^\/>%?%,=_XS^&_B'P#H
M/Q6^&GB33!J^GZ?_ ,(+X^DU_4]+EL]/N/!?CK2M(N]-\!WGBG3?'WB#PU\0
M?#L^F^'[']8_@#^Q)\'/^"JO['/PXU'XQ^,OBG\+[GP]XM^,GC?P9J?P^U7P
M!XSN/"NI^//%4?PE\-MXS\-#P'X TCQYI?A/P=^S=H=MI'AI+;X5ZW?>&[F.
M"3Q%:WUXVHS?#7_!/&SBC\/?&S23\9[7XZP:;X@^'/A^V\<Z5:>.[/P[:O%I
M'CZZN-!\,W'Q T;PUXAOH+5-2M]0GUE= TF&:?4XY+%KR%(=2N/HGXM^/_C%
M^R'X5^*O[2GP,UB30M9TY_@UK4VFWJ#5?!OC"VT ^*O!_C'PQXO\.^9')?Z!
M/X7B\#1&_6>SU339Q;W6A:MIUY;"2+^@LL\%,-Q!X=8#C?*<YQ-/&U<JQF-Q
M>58BA2JX>?U2OC>>-&IA_9UL/.5/!15-R]I&%1IMV>GXCC?%^KDGB!C>!<UR
MS#+#SQN4X?+\WI3G&K&KCZ6"Y*.(C4C*E)>WQ\DU1<)>SC[ZJS]Y?C]^T]_P
M1Y_;U_90^(FNZ9%\*_$7Q3\%>']/U7QUX+^/GP:M[W4O WB7PSX:\[4YM:TG
M4&-EK7A[QGH=O9M<ZQX!U"WM_&VAWL),%CJ%@^GZIJ&)\"OVQ]3C2S\/?'&X
M$$S2?\2SXF[HY4N1<&,+;^.=,M8I)+B.<22.?&6C0W-RK83Q!HNKQW4FLZ9_
M9!^QO^VA\)/^"A_[.-U'X@\$Q:5I_P 2=)UOPY\5_@1X@\1WDPFN-$N;C2-5
MU7P;XKT630O$<D>FRD:CH'C+05TKQ?X/%_8Q:B64FXU;^:3_ (*>_P#!#?QU
M^RQIWBC]H3]DZ;Q+\;_V5-,M+O7_ !GHMW9Q7GQE_9NL$D,EVGQ"L-)3R/'/
MPPTZV9)++XS^'+"SM;2V2[3X@^&_!SV=KJ&N_@K4\.W*7-*";C*5E)1Y=&JD
M8VYX=ZDXWA)).R39^S1ESI1DE&;49**3<6VK\U-MN*O'5).S5]6]'[;X7\6S
M:5>:/XET?5)-!U6R:TU_PUKN@7Y$=R;J)DLM<T75K*:YBNX+Z-)(EO+&:YM+
MZ)9K>62YA66VA^E=!\;>#_&VHZIKMIX0\"^&/BGXZ_L;1_B-J]_XCG\*?"WX
MKZ5I'BNQ\2BY\2^%U\-ZKX?T7QIJ4TVM6^I7UL(-$\1:I>VNH>(_#TT3SLOX
M@_#3XN_ ?]G/]D_P))_PEOCCXE?M#^,?'S>(/$OPE3Q'8Z3\.?AK\*-9M_$$
M5G/H4LOA77+F'XAZD-#TKQ%J<BZW:Z-/:>-O#EMJ/AG47T2^N)OKCX7_ !;\
M*?$+2X?$7@G7DU&RM9;>/5$EMUL-3T2ZNEQ#8^+?#K7%Q+:/<M(+$7GG:EHN
MIR1/#IVKZH5DL[?KHS52/+)4W.%Y0H.7/RSG&2YJ,Y75.4DWSP34ES)2B]&=
MV79CC\EQU',LMK+#XO#W]G6Y(SC*$E*G.E6HU%[.I2J0E*$N:,F[N5.49),;
M9^"_BWX"^'_Q^^!'B7P#X$^%WBV+PE^T1?VVJV'AJQE^(]SX*T2\\0>)=2\'
M>(="MM(N/%<?@CXJ:1K\T'PR\<Z<MOX>*>']'E>*;3M'O;_1Y?'OAGX0S?LA
M^#_#O@[0H+33OB;XB_9A\3>,;K2=4NKF2?4()YO"VHPZEY]_=R:'?"XU'Q4X
MDAAC8R:BBE0BVR#[7TSXG6?CKX6>,/V??B-?^+[SX5_$+P<? OB31O!OB*'P
M_P".-%\*2WJ:M:I\//$-W9W]GJ&@Z/KEM!K]O\+_ !'#=>!]5U&T-F!X<N))
M;T_F!\:?V)_&_P"S=X*T?QKH'[2MQ\0/V?M&U2]>#Q_<_"U1X<\&>(9=8COO
M#7@WQ1H4_C36?%'@OQ1JE[::3J>K:1JMMI?AF;5;Z!_"-_XV-I>WD?)*@Z=*
M?)&<X/#<DY3455H2C553WN9KW86<8MM1;<E)JS<OU; ^*N!E0>%SO((U9RPM
M'"2KX7$T:E.K:?/4J4Z%;#TIP52,IIX;VTVWR151\R:]JO?V5M/^)&@_"SP%
M%)=^#/AWX#^+O[0T_C3QKJT#ZSHW@31KZTT74O!][XCOKY(T+^)TU+X8>$=$
MTB.2[\5^+O$5]!IW@W1]<\07UMILGOWCCP%\4=+\>^$O@I^S?<WO@[Q5JG[)
MMKH<OQN\37NN>&OB[\1_ACX;US5/"Z^"O!W@3PF/%<'P)M]?FG)DTNSU_P 7
M?$SQ%82VESJ7BSP#%J,OPTTWYO\ V7?VU_B'\>OCG\ ?AGXY^$EM\>U\->(9
M[G2;GX2W7Q!^!=UH>KZAH5]H.H_$J;3?"&B_$SPKXF\4OH<UGH6H_$7QO\"M
M5\5#PM:V?@O2%ATF*P1?W?UWXG?LW? O_A*?B#X[OO#_ ,,OB[X8^'<?AOP>
M_BCX@?!+XLZM:Z5>:K<37WPPTO6(=;^"WB6PU2^C0WMSJWB3X.:-\/["2Y@G
M\4:CX_MK%? 5UPSA7Q-2I5PW/&G&O"I4G*#<K48\E2-.+2]^4'ROE]W6VEVU
MV8GQ X8J8?'5<1A,PJ/VU\OX?H..%H8^,4G&MGF:8>MST\/!VC]1P\(TH0C>
MI+$U)\E/YRT;]BSX7_ S5OBWX_\ B/<_#RW\&_$OX?> +F[^ >G>$O OA_X9
M:%X>^&?AC0_#VO?$WQOKNLV7]A:3H-WX_&L16>IV^AVGA*RO[N&.S_X65X]U
M2+P)I?Y=_M/?M_C1]8;P)\  (_&VLWA^S>-K,W6@:Q!J6LVR:7'+\.;2Y2WU
MWX>00:=+;6,7Q>\37L/QO\;VB07.A0_ /PO8:?H+^L?'WQ9\8/VK;I[C3/%V
MN:?X'O\ 48M;AM/A-\,?BC\<(1KMG;7%IHFO:MX\\2Z%\%_@YXX\8:#IDPTR
MP^(7BSXGZ%I'@VQ,FG?#?X>_#O0KE[,_,.C_ +(^L^%]*\6:%8Z1\2;"'Q7)
MYGC;5?'7Q@\ ^&(?%VFM836M]I7B?P[\,/!_Q*\7ZUHU_+/=:E=:3:_'6/2)
MM02TO)=)N-1TFPU-/HLOI9I7I3PF"PDZ5*[G*M5J0C4JQDY2DW9U)QA&[NUK
M9V4+O3\6SK,)9_CEFF?8Z%247*&#R["0<L+A*51N5/#82BH4Z<*-.45SNK)\
MR;;YFE!?#H\?6GB#PQX.\&:W\'OAY>_%6)G^'WA67P];ZYH/C_7(O$>H>']5
MT+5-=T6ZBU3P'XHL-0O=0CT[0UC%A>ZS::CJ0LFL+,MX@E['PMXA^'_@?4K'
MQ@JZ=^T!^U+XJN7&DQ:_H&GW'PA^ 7]C3G3M$@TWPAJBOH?Q>^(&E:7IT$EL
MNJZ?9_L]?![PY8:?Y4/Q9OKRZ'PT^X?"/P_^"'P^L=<\$:+XZ^"^B:GXSN],
MTCQ'%H7@?0OBCXLU 7]RVG0^$K/QO\3O%>H>+]%DU^35(K34]$E\)S:%JMO<
MV]CX@T3Q-ITPB&+HWQ2_9%O+SPUX;\%ZO;^)M6\57T6@:=X<U+6M(\%:1!=2
M@2I>^*YH="^#OPZT;3G:,1QZMK&GQP:<2@N)H(1]J7KK86&"A3K9E6P\%2E)
MQA4J<U/F=FI2BDZE5QC9N]&4M%[KTO> RJKC8PJ1K8;!X2I*4E4Q6-HX>5:G
M3DO:?5Z:A7K*-^>G3]E1GSR;C!>Z?.7QM^ >H:#X3UWXP?%/]HOPGXM^/_B?
M5M?N_&7@*Y\6Z-XNUSQ ]UJUY;ZMK$GQ*TWQSXAN?&&MWMO:Z?JMS!K?ASPR
M%E\K2=$?6([2UO3XCX/_ &8O&OCQ+[4;34M%NTT^T:ZU>]OM"\7ZO8V5\ZW=
MQ#HLGC#3=!3PK)K5OHEK9:I-:ZQXITORO[1L;"=5UB4V)_3[XM?"C]H'X)_L
M\Z]^TWX%_9E^$WACP;X%U_0]/\8>)?"GB/P%\6[OPB-?U'2K3PCXJU?Q5\/]
M4M;C0K+5KC4K.QT>[MM=U*#^T;N.T)M9]\K?G!\7/VB?C/K6JZ!J>M^+;C4=
M1,=W;7%P\,\K%M"U%84TLWNK75_KUO;K&TMI?V4%^+(J[FSN$9WN*\O^W<#F
M6&IT*&.AC:.'Q6+Y*M&F[TZLHPE6IRJ2ITERQC"GRQ=.-FY:ZJ_MK+.'<-C>
M;$XBK&,:6'B\!EM'$XIXE7DH.>88RO@J4&TY*;P^%46IQ<(0EK''M/V9=9\(
M:_X?U'Q9K7@K1K6UU+2=<N8=;F4ZK<VR:^T::=I^E:#!XQWR_P!F::=2+W%]
M% T&HPV^97M;C/T;K_QC_: M?C_\7_$G[*'[0/Q*\"^$[_QIH>E:#I?A#XSW
M7P2:]T?5=06Y\-^'1\.[?Q3X-LY]'T/7-5O8[K3X=!;3]"O;F]U2\M+">\NY
MZ^+/ OQ2\5:=\4O#WC#4=>U34I8?%&A27R:M>WNL6@TL>)M,U.:P2#5;F] L
MX'L;0Q1^9N"P)%*\R>9YWZ/_  W^#/A>X\=?M4^"/B'#I'Q?\8:.VA:S8>,?
M$'AFUTW6]1U+5++5-5FO;*VMM3OSI,M]J4MO:7L%KJ4T5VFUV:,3A(_+K5).
MI&5ER\R:EJN:U.?+&3BDW)1C*S=^EVDK+]0X5X:R_/\ "PR_+</4I4:F;13E
MF4\)4=.K'"5ZN'ITZU'#59Q]JL/75.'+55J4W.K)WB]CXO\ [;'[?O@?XQ>.
M=%\0:KX)\8/X;3P1XBUVQ;X.^%_C+X5T]+C1=-U31KZ;QKX]\&Z[\1[*&ZGF
MFO0VL>+()-.U:[U6WTF:T@$<,?K_ ,/?^"JOQ#^'FC:3X.\2? [X;>*-(G^#
MGC_QC86U]\/=1^"$VE>)M'\-:I\1]"NO"\WPG\6Z#H_BCX>:Q8VL^F/;7VB6
MVI#3M4L-9;4)I+6*PN>;O?!!\9_M9?%B>R\??$_X<7UC\,?A+>Z=J?PS\6MX
M5U XT>TT^*VU:-[2^M-8M;..UBC6QO;;8IW@/$TKL<WXK>"?$L_[1'P>@L]>
M\)^*?%M_^S]XUT'4->^*7AJWUBS\5:AH5MJUG9ZIKVFQ0ZI;O<WLNL6"ZJ;2
MSE=M"M=6LPL\6H?94F4I\E2[DX.LZ"]Y6;YZE/6,E)RYHV36UTG>[T^FS'PW
MJ8>CF&+PWMZ7L\RE@L-6HSIN<Y/&PPZ:IX;%8"NY*<FN2K04*L$XJ+C.*/N#
M_@K0OC&+XX_!SXL^#OV<],^-.B^*_P!FOX/>/O%.D3^!]2\>:=IWB,ZYXCTK
M3-2\165AHMY:WD,^D6GAW1T?59M+LM1ATJWANX+Z-&MXOA/6O"/Q3_;6^(7@
M;0/C9^S7\)/V6OASK6GWUQX@^//P6_9T\-ZOXM\$:8VDZW?6=]'\.-!^-_P\
M\*W]_P"*_$#Z/H^I/J^K>'WT23R=;D.G6T5_%J']-]W\+_"GCG_A0?B;QSX5
M\$>(=;LOV7?"&BPO<^%M*U?1=/N;74K)]4AT&UUBQ?['I4TNI7*6UNL-NBV(
M2*:+Y2J\;XE_9!_9S\2/-->? SX.+=38+7.G_#K0?#5Y+(A<H6U'PC!H%^H)
M+1@FX9U^8JS [:\#P]C%\.4U*,FUCLUH7I*$.54<RQ,=U%MS49K63YDU>\;0
M9_-&:\^#S/%8:I"%\-B<1"46FKS]M6A/GBVY*4G!W3E)K6+D[2O^:'[$'[)'
MP@_9=\=VGC23PE\8/V@=7\*^+-6\0^!?'?QC^,?PW^%GPSF6_P#"&C>'H[[4
M_P!E?X:VG[5VC>)M?TZZN/%":?JNO?''2?\ 15\,:C;RZ!K.G1#3OW>UO]K[
M39_"\DVJ>)/BGK>HV,!BTOP5\.?A)\/O"UW<K(!Y6E6WB_XU?'KXO^&HK4$!
M3=V^E>&RI8-#I .8A\;^+OV?]"\,>!?$LW@35?$/@N[T;PKJEQX=CLM4_M?1
M='OM/TNXGLW&B^(K35(;RU2X2-KBTGD/VNW$EN)K>1O.3^<77?C%\<OB/%H]
ME\1_B7KD\NJRW6AWZ^"7O_AQH]S9(UVLB1Z1X7U>WCEDO;;$UW?W=Q+/*DQB
MMK6WAA16^RJ8>A4<FH23>\O:3;;WO+F3;DUIO9;JS2"CG>-H4U2IQPBI0E>%
M.6%IR46_M).?+=6LVX.5GH[VM^Z_QS_X*G_$CX8&[MM1_9\\"?"*X$:1:<_[
M0?[=6K^)_%6NV4Z%K*^B^'G[/6E?LZ7FDV4\D@C331X@\6:0)F;?.]D#,WY6
M>(/^"M?Q5OKO6;NSUWX9_#1I=45[5?@9^S?\);'Q%?Q+I-M%<7>K_$;7O!]S
MXRUNZAUNZO;S2]1O_&-UJMQ;Z;#'=ZY#-(TP_&GXL^!?"?@/X@VZZ7;V=MH^
MJZMX79XAF35-.D-Y%%JUR]]J^HI!)!?I-=W3->WEK##<V]M]JGCMQ-(-;XGV
M7ASP%X\N_"5CK,EQ#'8:?J,4FJ7FGSW4*ZHLDEG;W5]8VVGZ?<.UC':W1G@M
MXHG2Z1HS(C12NO90H*ZH49S2DISJ1G6;NVX751\LGRK1<NEM4VKOZO),XI8R
MI.CC\94P+G_NT<(XX.G*T5[12KMWI)N7*U*3C)6C:[N]KXZ_'[XR_'OQ9?ZK
M\8?C-\8_C!9&75[S0;7XN?$7Q5XT31[9KAI=.M[+2M9UW6=#T:2QMVAB$.BP
M06L;1!H=@QC]:O\ @CMXP_9,TZ+Q9;_&#]LWP3^S+XPOM(L;OQ=;?&3X=_$/
MXA'XE:W=:OXWAT#PM\.=?\*^)-$L/A]I'@WPSHWA;7O$/B#7])^*.N>-=>\9
MZIH.E^&/#-AX:L=2O_Q"GC2YU.T\L^;')87^9$ E1P/)8Y9"T94J2 ,DJ#GG
M (_2S_@EM;PZ7\7OB+J5K%#!JL'PXM8+'58D2/4[&"\\26R7T-AJ"1I>6L=^
MCK%?"SGC%Y"!#.LL8VU\YFV*IY?@<=6G0C6I1IRG*DJDJ:DYV=G))K1N/+IH
MG)VNU;Z?-\"\3ETJ^#Q4:4,)5A/FC"G6]JE[-\SJQ4TYRT;DW=N4KQO)M_J[
M;?'#X6_%OXU_"6[^&_C#3O%D'AZ?XLV-W<6(N(T>TU7P59W&E:G!#<QP726.
MJPZ1>^2EQ##>VT]I<V=];6]S;RPU]H6&H((9,$8"LI(.1G.0#PI!&2!WY^8<
M;C^;EUX9M?#O[:^DWB6GAZ'4?%/ASPUXNOKW0M'?3M0U5_&/PE^)FKRW/B_4
M+B_U"[\0^*XKBQEL[O5BVG6#V-MIMO8:-8);RR7'WM;R#9,<=2R#H,L%'+$D
MY)) 4CI@<=2?S3,:LL!5H4E.4_:8+#XIN2A&RQ:>(C37*M8TX5(TU)R;;@VK
M\USY6FU7G*K&#I4N>453G-UI7BE&4G4<:;?/)2J17)%0C)12ERW?.>"9P?C=
M\:7) %[X(^ UT!DG A'Q8LB0Q)4DFT8@@*0""3N&3TGC:X8?$;]FIH@24^,O
MBBW5L@82Z_9P^/(9QD$[ACJ1N##=D@-7G'@RX9?C1\3'&4$_PU^#6!C#%X/$
M7QF!.[;MPOG#&1G&/E&3CL?&7F-X\_9WDPQ$'QLO)0AR-PN/@'\<[.-OE<J2
MK3(".XZ#)VU-/&PG3A*=3E<X0NY-\O*U=7E+2ZM%*UE9Z%<LGS:-J+LK?:3W
M<EHTUT717O8^?O\ @JO&S?LW^&'1F7ROC!X8AD92-PBF\.>+I@C-@M&6N;6W
ME=@0P$3H3Y4D@?\ GTCT^:[%R]K8WNH&TM+C4KY[2TNM2:TTZS -YJ5R((Y6
MM+"U5HY+O4)S':6FY/M$J!@3_0C_ ,%3([E_V8--N'0K';_%_P $R.Q&U1YV
MA^-(5+L< +(=_) !/)/S8K\'_ ?A#5?$T>O^*X[[Q#X/\(?#^.WU+Q5\3](\
M+:'XCL_A[?W>FZQ<>'FNAXH^(/PJTBVU'6);"ZAM/L/C6#Q'!9B[U#1M$UXP
M&PN?ON%U&M@JO))SA'$2MRM-7G&&JUM9J+;:;_,\',XN-:"TUC96:>VEKJ^N
MFVK[^?GNES+K^H1Z1H,5]K.OS1WES'I&EZ1?:A+;Z5IMM<:CJVN:EJ,2"RTS
M1M,TRVEU74-2N&.EZ;IL,FH:K?Z?:1R3IIZCI>LZ5';'5])U+2UN4=[274-.
MNK2"_C1HS]HTVYE@%MJ-HRR1-]JL);NVD62.2.=XI8R_S9XC\7ZW\2KVUD\4
M:+X8D\47^H65TWB[2?"6E^!O$$=I:6,5XUP+'0&LM U';))"QO!IEQ-=>3;W
M$5\UU-).WT'\3?BQ\9?C,=)O_BM\9/B7\3/$OAOPPG@[PGXE^)7C#7O'E_X9
M\,P7LFHP:#HJZ[J$T.G:(EY-<79TO3TL[5YYY;AT>Y*2+]1).$X\L(>SY5=Z
MJ2J.731[QNFM-=]T><TE=/?75:7>VK[;O;SU6A^]?_!-/1M:UOP(^FZ'I.K:
MQJ.L>%O!$>F:?ING7NI7M_\ 8/$_QK\^2ULK*&:XN8E"2+'*D>UTM;D88V\I
M'Y]?\%/;#4_!_P"V'XNT'Q3IU]X=UV+P/\*4GT/6K2YTK6H))/!4,T-M/IVH
M0PWL-Q):QO<)#+#'.]J/-1?)P]?+?@7XQ?M>_"W]GGXA^&O@]X2?XD? ^\\5
MOXQ^*=SJF@7OC?2O#NIZEYFA02:_X1TWQ FD3:'>VGA^_P!(^T^+O"FKV5NV
MBWSV5U821/(GR!H'BZU\:ZGH>JZ_<MXF^)7B+4K#1[72M T*_O-<231HO["\
M*V46D:-IV^]FATM+;3]-%C'J5]+:0V%C-&);16KY7"9#B*'$&*S2MB(2HU93
MC0P\*?[R;J0A&E"*YFYSNK24;RYK<JZ'KU<70EEM+#Q55585(N<;1<(4U=\W
MM5*,HO[2C.DK1;DZCO[NYXX_M34+,KI%M<M.)5"FVDA#Q*@=M[EG0I$W^K.U
MV8/(@$>#BO=_A?\ %N70/@AXE^$/C+X4_"_Q]/K-O')\._B=JUQXYTSX@_!6
MZGN[:]U*[\.-X.\3^'O"/C?^T84OXI#\0M&UZ20ZHDUY<:E;:3I>D0_2?@[_
M ()Q?M/_ !"@:/6O!^F_";2[VV.V^^+OB#_A"KZXL[@/'+<1>$+:PUWXDVH$
M;-*D5_X(LKRYMY!+96\L<BRG[H^&?_!-[]GGX0V4VI?&;XL:Q\6;?0- DO\
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MDTM]7GTRXU&YO]*LTTU);QVCVC*4HJZ<7W;NE;[G9^@DX\K5O>Z/LM//]#[
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MA=3:C\!?%7B76]"TZ=9?'MK?WUOJEA^LO@[X.?LS?M??L^_"_P"+4WP;\+_
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M[D!(^W_!'X?SE6Y(-MJ]W:'C<V7"QE3RN,E ,*&K8\=+%)^TG^SU<S1AY(O
M/Q:2V(D9'CN([* N2P())M;BX22%PT91Y%/."/.]/O/*_:DUB5MRF;X):*K9
MW#!M/%6H*R;0,-M<'9MVJ0 V<DYZ[Q;>I>?M ?L_R(0_D>'?C#;*VS:6QX5:
M] ?(.&W6S$ .-XX&S;EXIS7OIZWQT6M]5+$)-):7TDUNKZ:J]S^@\TPKCE.<
M245RX;B:<W=748+,\MJIO56O[>]DTV[)<KU/Z9O UQ<WO@7]GG4_M0_L^_\
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M6,KU)QA5Q$G2C4Y;U;1<8TX3E%1@KU';F;DHM?1<-\%91D->AB<OHM8Y86>
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M& 2<J.<.%0%0S \_,[8SDQL2QJYY!8.\Y>0G(RA$<><YV*%7 ' ^5 %)X"*
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MNGW\4EBMW;VDMO;W0M)5WV@O+6X%L[.8F3>Q;1L?BCX@^''B3XD:-X<U^_\
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M36C]_F;C9.TGSI)R<5>R6E]1*G&4DW*5U?>S6M]_=6E^MTV[:*Z/?/$?[/\
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M ++G[)/QH_X*C_$CXY_''XC?&'PM\'/@7\#?"X^(7[47[4WCK3+C4?A[\&/
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M]&\:^%_ASJ5_!LOI+S4=-\*F_P# EQ?1:EF]BU:]\O5K,PO=2:RI:&2'ZO\
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M&HU-J6DGS*#3U>[[6UGAI^T]G4@XRA2G5Y4EJHN',M&[Z6V=VVE9M67Z0_\
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MES<M/K%[-&\=S<&&V\-02W3:_IW*?##QCX)^+GBGQMXA_M#0/AU)\)M:T/\
MM;3O%4VFWOC?QSHL&DZ_IDWB[Q7I$FJVND>*;"^74K.?QSJ%\MEHUM9WNE>$
MK<:[!>)J/B#T#POX2E^*&J:SX>6^T;P1\1E9 MDSZ)%<W8.F3&XBFT764LK*
M[B_LR>VO/['L[75KN^DCBL[NYLDO3J5KYY\5_A[=>&-2TVV^*?A"RM[V_MH-
M,L+^WO/"<=VUQ=SZ%IFFZCJUP=*U:^B2U^P:2NFV=Z]M#<376E0P^=J2:/'-
MZ5K;/N];O=OK_ETT6EB8?#\_3L1^,+'0M>N]4TWP=X2\<^%G\.Z%86MKX;U8
M6O@!/$5ZTUWKGQ&D^)'A:^\/W/Q7\:)XN5-<AT+6]0ALWT[PGHMEX1AT36]/
MT"RU>7S7XC^*==^%VB:OK_BJ+Q'X6O?"UKJ>F>%HM#^Q7B>%M0\30Z?I=MK.
MK:1)X:NM5^'DES:S:>]AK$]CI\"175CX?BT;6-0T_3S=]#?V6O0^(9+J/_A*
M];CCL[?1O"%GX2G\/ZKJ_AV)M5\/2P+9^'VEDNH+40V=I-<:MILWAO3=3B5M
M&EU301+:0:CQ7CKX(^,O&L6H^(=$\5>(?&WBC3--L?'F@:[H?P4\736+^#Q(
M5EUS1_%)TO4_#%BD>I:/JUGX<N]0OOL_C&_T_P 07,>HP>)=#M+:^3O9VWZ7
ML]>E]4]5HDG9/5M,F2C>][MO5+=;>7XZ^A\T>/\ QYXH\;:KHFMZMHNEZ;JN
MN:5I'B36O$FK>(M1U;Q5XNU36/#%I;:?XO\ 'GQ+DEM8M1CTVQNH=3T_2DT3
M3-&\)S7,NB:#:6MI');P=Q\$K^[\0:G_ &-J.N:TMUJ,\UIIL<^FPWYOKUY(
MVT<ZAJCV=GJ1:=X5L;$?8[G6$\^TU2"!;<R7[_0OAOX$?$30D\*ZW\>+'4/A
MG>:KINK^);BQO_#[Z?\ %G7/!.LR)J>K>,];\)W.EV@\7Q:[=7NHZR8)O$O@
M>\%QH^F:?!9-=ZM%?VV;_P (I^SIH&MZ?XD\/Z[XETN3^T-3MM=B\3> K"?P
ME);,6NG76K?7=&\1>'M/@UEYK5FLKK5KV_UE=-O+K6&C&GJ+PM[MMM+=-WJW
MV=WUW;NVV]1J247M>[:5V]-/N\G?;IH==X8FCTR35-'\5>+$\6:]I,ZWT=O/
M->OHT>CW<EA9'2!H>HZ5>PZ=<P);:E=Z3:Q:O+]NL8[*\M]%\.6%K<7%CY';
M^&=-TJUFT5M-UV5(?$_BC5=+LFLX=3U*&[OM6AOXIM"GDMM-6&XTW4)KGS+S
M3[S49;/49;V&RE^S17$L/J3^&-'DN;;7=#\26>M^&]:M-(GN8M7NO$%]?62W
M,,>HVFH>%;_6O&]IX;T;P8;6ZFN/"2Z3H=AJSVM\NIRF]:&WM-4S+Z\@\27]
M];-=KI6I^%M%NH;CP6TIUB\T73F\W5] U"ROI]/L[_7[?3[B./3;:[O]#T6V
M\1V-Y>:U+K!.GZ+X6O"FE!>ZDU>5I65Y)ZJ]M][_ ".:O2E7>C>BU5[+;1*[
M5NJ^;TT."L?#6C#4(-%O]-\0W&IZM;74%QH^JZEKLE[<:5823V4L&D>&_$4M
MO"T=TD5M''J LM,T9M.EDBTJ\?3KT,/1O^$ _9T_Z)+>?^#JZ_\ E[74^&O@
MAJMWX-U*[BM#-I%Z/#\EWX%;1_$6IW^JW=A;FWM]<\3Q7,^JWS21:)K&KP^&
MO"$^@06EO;22^)+NYNH]4;1X_>/^%<^*_P#HF_Q/_P##:^ __E#6GM'V7XK]
M3".!FEJD[N^_IOHM;WZ'TT_BOQ->>,;SP_J7P[^*T=IJ/F:9X@\7MX2TZUTG
M4M/EO?MEU<06^FZEIVL:GH^K:E//<:@/#-D;B_O!<R7>CWXFGG'Z&_\ !/3P
MOJY^)O[3B3>#[D^&+G]@_P#:XMM*\17&J:3X>N-3N+OX=K;ZA;+X*2WG\0V2
MZPD;W4FN7W_".W,=Q=(+\:ZZQ6.B?(>H?%*XT?1#-XFA.C-9ZU_9EII6F2?V
MY:2)##Y<&L3WD*:,NCZ?<SN;*WM]2DOM9NIK?8-&6W=;Y/J7]@G4]0UGX@?M
M-)%;:.4U+_@GY^VC':'3(]7U*;7G?X='?>ZG'JVH>)[[6/)N&M].M].\/Z?X
M;LM,$CV]]H?B:^U*PO++YY5%*#^RVHI6:DKRUBDTVI/SNUTON>URR=Y-KE=H
M*+;UDDY-Z)VT[:_(^>-9O9-$\16=YH7B;PEHFFEM3DT[PUI7B"ZU75&TA;6)
M%L]2>*&:2-Q)=6#WUY*\5I %EOVC>.:>WC]%;4WU+23X@CU2'5+/4T+R7MG<
MQW7VJTB2.(+#/&#-_HHD4!_+D:"&%XGA,D\2/X/X4\.:KJ"ESI'AR?0M2OHM
M9U+P=I4NFZQI]]JML;AEU6.#68="TR>:&YO(6AN]7\+7-U'!>6LUO'ISW;FY
M^F--\+0B$03W4-G/YA9]/S'.ZW<B"[E8! \OE!'N&:18O])MXRDEI$P>-'&G
M**=JCDVI)2?\R;U:5N:TKJ2=E=)QVLVVN9)*U[Z)Z*RT[-WUZ>O0YR'29[77
MX78WTEA=VMI'/XALM:T^*6=&MRB6L5QK%EJ-[IWVF2[-E%;P1W-RH010R6@>
M:WT_L)/[<T"UOSH^HG3K:SNQ=K9^)+ZY\074GVDP"RMI;@G3;BZN;V>.9[-+
M&4IJEO#/#9V7D+'=6N\8M#T>*YT>YL;]=8FMX;J6^BL#>6=RZO*EE':W<-[9
M+9W4-L9S#JL#27%I=230B(E29O"E\&:KIFN3ZI9:=IYL;N:>WN-,@FN;ZZ:2
M^U,2:QK<VI6]\VE^9?MQ#:#0X;VSN--*C5=<M]5=M%J[C\5Y-M)**;:26KM:
M]EUW>J\RET4FTK]+7TM=+SM\M3W'1OB/;:C]GT_3M<NSK$\,3ZU'8#5=(M[J
M=RYN[8_;T16CD9%(=(-2*B5+21I[FSFBDZ+4/M=TL-HL[07+RNEY%=K??:M.
MB@,4FY=/6PM4OY)I!)&'OOM%W;FVN6F6U@GMI1X7JD-U>ZAX8T+PPWASPVCZ
M7J>HZM?SZ_JQURZ\4,=,N--TN&_M=$T31-*>%AJLGFR6GB&SENI \>K2.)9I
M/I/X:>#]?GT"?4_%.L0V237\$%G(-*TF$WJV6FV7G2Q-HUU*-;FAUF*]MWDA
MM+2".X^TR"UC=K3S^:O75.]2,I-1]WV;TBW>S?+;GYHI[)IW:T9O3I\[V4/=
M3ZN25VHJ3NN:ZNT[+1-=%?.T/PUX?AMX$MK1UAD\V^6ZNI)-.FU&[E\^-YFN
MXFD9[US^[6XMS>RJQ90\<: -Z/+_ &,@M9#)8:-+&!+(R6U\\<$9(<74-Y!/
M&C-<>9*[C^S_ -RSF,7DBA+JI1X8TNX<N\LUE:2"2;4=8O[QG%Q=16ZM=6-S
M>Z7&L5Q+9#[*MQ<W-LT\:2(JK;)M4TKC0=%@NHYKI(YX-*B%_=3(+NTG:&6:
M8Q7=I)=7S^9/(YG2W3$QC>V1[PA-06<\TL7%VG>=TK*W-=:MO3FBFWJKZ]+;
M6*E3<+:MQ>S;Y7UUV?*KIZ-7\K.YLZD?!96TA%]'>ZI<1K=*EPCQSSJF+:74
MGM[I&*/'("R0L#<D>6XG1&5GN?V7_P )M>V6BZ;H^I:R(/MOD-/976HI-<+M
MNFL-$%OJOEI>O&A%P$-I8V(F>Y^T%+2[1^:T+3].\0O<:I]ET;P7X0TM;_6-
M:\0:II-GIB0V6BZ9<ZEX@FG\0_9]4DU&*TT^S&HWZ6-XT>G:?I]Y>>(]4\.Z
M=]EN!^9'[5'_  6H\,?##3]5^%/[(.E/+JL]E>6&K?&74;B'4=?G1+B]M;.#
MP7#<0W%O#-JT5BEU;ZM+;1V&BK;3+I%KK\FF_P#";)ZV#P#Q#I5:KJ4J25U*
MK.U1N3NXII[+1VE;6UEV\S$8IP52%.$JM6*2Y(3U]ZZ7+=6]=+69Y7_P6H.D
M_LT_M"?\$XOB<-?\):_\0/AO\3%\8^,_ADGB"[:#PQI/AKQC\.?%GAG2/%>N
MZ;K=M?6,7BRT37+35HK*?2+NQTJVBU*">VL]4TNZ?\U/VAOB!X)^.WQ@U[Q/
M\3]3\!_#&!K#1;;2?$G[,/PQ\*>(O@\5\9VHUC1[;XC>(_"OCV\TB/Q7HMW/
MJ]I/H6G^%8?%OB6U@73?$7BO2CIEKJ,?G?B3P%_P4X^+_@:&3PC:?M%>,/AI
M\6M(UKXH7W@3P5XA\7W^@7_A:37-6T&\^(VO>&CJHO;WPGXAOO[?DUGXEZC8
M+X9\6II&L:IJ.M:K:>&[S4[3Q;]B'P]^UN?C/?\ @_\ 9D\1>*/"OCR^$_AW
MQ)X9\-?%?PEX"O/&D,-X]A<>"YO"?BCQ5HVB_&:*]OHI;*Y^'2Z3XVBU^&0V
MS^']2MKA8YOT;@K,<PP6:QRO#U\93P&95Z%+$0I8G%X>,9-QIPQ&(FZ.(PL8
M4_:*]3$4:M.$;J7+34K?/YO@L%6I1Q^(I4:F,R_#8EX>K4I4*DZ*JI5*].FH
M2]JE-T^6U*492<4DI2:1Z7XC_8LU'5M#N_$?@#5?!WQ?TFVMI9]3;X=W5Y8>
M,]"L(E5OM^O_  _UJWNX=(0>7*Y^SZUJ:_9[662*Z-NLI@\3LO@=X\\(_#_X
MM>*;C0M=F\'V?@J[T'6+JZT[4+:Y\+W\/B+PMK.EQ>+=)$5Y=>$XM;*EO#E_
MX@.B:/XJ_P!-B\(/KS6&HR6_W_XQ63P'XTO?"7[1?[/=]X)^)?AV^6ZU#4/A
MM'<?LN?&?P=?W3[H]3G\#WWA+Q!\*IXF<&]MK-OA/X*N]5A/V30_'?A6VG_M
M"WSOB_)HOC3X2?$5M&^,GA+XO6NC?#SQQ>Z,OQ7^',WPR_:*\,Q6_AZZU.^C
MT*U.I?$3PUJL6HO8;_$\7@SXV^.(]1LD&NZI8VE[;![']/XKX*QD<ES?,71R
M[%+#8*KBEBYT88/%^SHM3O#,N''4RO-;PBITXX_+\+4JRL_K%-74_GLFXEPL
M\9@J-*K4<:U>G14*,IUJ%.=6$Z:C/#8Z#Q6$;DY)RI5ZM/1\\=%;]._V?_V@
M/V(_ G_!.S_@G]\&?VA+)?B]IKWWC+X]:4=<\)1ZAH_PV\<Q>,+_ $G6_!UK
MH]A)%?ZQI6J:WIJ2:C8ZI8^*=%^(^J:/-9W\J7?ARQ\,V?A>L^+/A#^U7X9_
M:0_X*6_M6>$_^$Y^"7P!UP? G]DK]F"Y\::]X4\,:_K^F0:#JDFG^.H]%\,:
MC?6VGZI+XR\+WPL]&OM"N-:U>V\3Q:U<MH7@JP%?,7A7]JK]F#PS_P $]/ 7
MPF\8?!#Q3J'QRTCX3>*;KP3/XD\/+I]OXK\9>(_&_BM/"'Q(^'_BR^@>/2?A
M;X,42GQIX9T'3X-!^,'B!?$>D>+[C6+O2['4-&^'/B'\<O%OC#X8Z9\%[VTT
MP>&_!#Z/XD\,0MX<\*3>)_"MK)9_;]:TZX\=_#6UL/"VO:'J^K:_]OU36+W2
M=-UF\U32=.'B>TTO4=*M4D\CA?-J4,LAEF,H3ITL3"6*IUHX3]UB9SHJE'#U
M\9*,J,()N%2G:K3G*<7'DJ<\Y/ASKAR=;.Z^=83$8FEBE#"8";68UE3P>7O%
MT\3CZF79=&/LZ>,Q>'H1P-7%149O"UJRC4IS@DOTR^.W_!1O6?C!_P $K?$'
M[,%SIOASX=>(8OVP?#GB*;X8_#?2;K1_AKX:_9TLO"-I>?"OP=X=MUN;V!-(
MT[XAZ/KNI75O<:EJ$NH^(99]7N&DO[N20?B5!:^=!?M=7MM 9I;:RE@=IGU*
M."1X[J2^%O''(LEM"(8;9B95E>[N8X%B\M)WC\MM]:\0:!J-U;:=JE]:1+-J
M/F64TAFL+E=3CM5OUO=)N&EL;R/48;.P2Y$\$OVA+*P+,6MK1H<^;596@:T,
MF_+([2I+-&[+&KH+<H)#"8G=A*[-&TX9$6.4('#?BV(P$O[2S;%^Y&>/S2MB
M:K<M83;C2]E"ZYG3IPPU.,.B@GO)MR_1J,Z<,/AZ4(WA2HTX07OI-*-U*=YS
M;D^=M^]=R;DW?0ZS7OLUN/-34;*[9@%,=H\S($*':TEP\"6V[!.88GN)$^1_
M+R=U8%OJMMYL:2LX5C&LTFPR>5&<":54=HGD,*>8ZP@*9R"@EB+;A0U35+?5
MFLV&F6.F26UDEK(U@+O-_)'/-(EY<-=W-V6N1;20V8C@:.$Q6T<OEB>6>1ZU
MK;RR/&L3!69U3$J#:K,P ^8$G.,$C!8 _0'LHT:N(J4X4DZLW+E48)RE)MNR
M2T3;VW75MV1+DTFVTDMW9I)=^O\ GIW/VU_X)SW7A[Q'^R-_P5O\*Z=:7>HQ
MVG[*)\8QS>)H=-=;G_A$CXNO=$U33_#\-GJRZ#K.CQSZ@[:C#KVH3I+=VCV=
MQIJQ3SCX"\-_MO?'/P/X:T;P9X/U/2--TCP^+N'2VU+3)M<O+,7!N]_EQZK?
MW.EPE8)U@$5KIEO;*UK:W26ZWT?VEON?_@E)HVHI\/\ _@IS8/9:C+H^N_\
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M5].L!=?$?X ?$.]\SQCX.26XALYM;T/6]+_L.?Q5X+75+:U_L_QOH5M;Z?\
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MPM+&99"%+%3C3A.-1^TA4<HN/.FFFF[)\JC-)WDVM#];?["\1:AJ$%[JT_\
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MBZ1XOO+ATO;G0?%=_!':W?AQ[J>U-KIVO_$*Q\:^%-;O;K3;G7;^UTC3TO\
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M1Z-X=TO4==U&]6WO;@Q:U9:=8:+:@V*PC5]3UMKB34A;L9#<!HHWLL2+I_\
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M.OQ+P=@,WI*G*G6J8/#XG*,?&2J7^L4IU\-B<IQNL4T\-F%).%G!1E*%OTG
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M)TI=2GG:QTZUM--2\F:#<WY(?\$[O%?C35M2^('B_0FU_2O$_A*Z^%L9\=^
M[W5_#_B2QT_6/$-W%<R/?^&+JQUBPAM]/AN$FU"WN5L[:S8M*MK(BRS>EX5^
M.'%7'7'V+\,JE')LQI4*W]C8S.<13KPQ66YD\@>>M8C"PI^QQ-*5"M@Z=Z%2
ME44\10DHU8PK4X_%<;<-Y9PQD.+XJHU<9/"86=#$O)L7*EC:.)H3Q^'PKA0Q
MV(4,72FI5FO:8B&,ARJ<$XPY(RX'PA\:?@-\1&C\4_%_]E^/P1XX@NKJQO\
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M>)&GN#[%X)^'O[&WQ\^$_P .OC#^R7:_'SX)?!&\_:'C\/?'3QM^T#I%C>^
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MQ.UU<R>)=5LM:\:Z@;ZYAU3Q#J=KY,$&=\'[+P1K_P >?A[\,/C'XGM?A?\
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M!WPJ\*I=0VLB7\E[':7'B37+41O>74UREHT,+([EOJWXQ?MC?"?X8^,'\/\
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MN/&?CC5_$'C/2KKP]I'A[3O#NF;8X-2U6_U*UM;73-;O]+OY[B4!+)VA_?\
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MO)M1U>2XACC>2:&_U*[2W@F2:WM;=H+.XUG[09_[5T]EETH]G8^'O$RRQ?\
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MO[6N+VUO;"69-\(>RU>SAU":.&W$ACMGBU6WNK*1$,-D9DV]]\0O@-K/BKQ
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M&U.[L(KD".[7Q R17>F:7',MQJZD6=WHUBT%S;RW,MS8:>?D7XU?\%(O%?\
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MOB+7/B)X!\:>$M#U+5_&_P#PJCX;_M >#?"&EZ=IGPR^)OQ#GTC0O''B_7_
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M(5CEB6.,(MLCW;:LUR$L_P R1_P=O?\ !1[&6^"W[%BXY./AY\:2>QQ_R7_
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MP^?!XZLUO8%N[G4+X;X[-?M-[>2)$EQJ6HW=Q\<?$_\ X.A/V\O ]G8?V?\
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MKW<=\]S+<W!^+*73PW5Y=+=-/#+%/:LA2VC#;&'Y=M_P=:_\%#@./@Y^QM[
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MO?M7_L\^.M,U_0[30O&.C^-O@'XMUV32D@O)9[V_^'.L6WC71[S0IM2#+/\
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M9)ELG:^GN_5[-[V?,K6NEHD?8+Q4X-B[K'XI.]TUEV+_ %7EHN^UC^AWQ/\
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M3+"53->F>>"TGNKZ6837-RT :R'\]G_$77_P4D_Z(G^Q/_X;WXV__1 4P_\
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MP4UR3]B_9_)QCGXMWO3.>W@_\/ITH?CAX06_Y./PE\LSEV?_ % #7AMQY?\
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M\79.C):=4]]S^>A>K_[P_P#0%JJR!]P.1\\F,$CJ[=1W'3Z_2OZ(1_P;%?\
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M2>_ [9X_HEE_X-;O^"I!(,5E^SIP <-\8+S&[((.1X+R,8]#^/)I5_X-<_\
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MNN)@#G(W$KDGGUY/CVL:SJ.N3FXU"8R L62V0N(8AP!LCR0>2#N968ALEL
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MFK;62(MYCY,C>Q8?* ,8SC+'&[ '3 [+7F/C?XJ6PBE,ZA_O-F*0JYZ@G+*
MOY\X'.!S\(P_$C788@A^8*N-WF.,9]1D[AD'/3(/;D5A:CXHU35WS/.X3!!7
MD$X(SG.>N<X!(YZ'@CU:F:XNK35)NT4FM9)I+711MRI6L]%N[[ZG\X95X%X?
M"9G+&8ET/9\[G.4)6D[2O9>RL[M:>\NM[;GT"/&NB:K<R,]RL3LP407(9?E
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M:2<=?CK\:23_  ]3K1Z8/)].F2*4?%SX98Y_9STSG)X^._QH4@8Z$?VNW4C
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M.M2Q7$KPJJY6H?6U+$O'^Q2A.;I>VA)4:=6,HU7#VE&=;CK2XGPN&Q6+Q%7
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M"-)K@KBUW[3R7M?2^-3_  ]=SW%P+)Z+.\MOOK3QBOMWI*^_1[:['^;M%=%
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MT8C^Q?\ \$<%(_XU5:N!U_Y(%XJVC.3RW_"4[0"?PY([FE/[&O\ P1Q7.?\
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M&3QCG()Q6D5+[OEZN"?0 ;@"2/<^W'''6O\ 1S7]CS_@CFK K_P2JUL=MP^
M'BL88C@9_P"$GZ$9[8X/(X-3_P##('_!'E5++_P2MUP#N?\ A07BM1D# S_Q
M4_.1T)Z],]Z:^D'E49?\D3Q4KJR2Q?#5G9M[RS23V??[MWQU?"[%5)7AG^4K
M2UG0S)6:=VFOJB?GHG?36US_ #B+B !@1N"_/@'L2>1\WL,+R,8/)SQ$Z[UV
M\Y;@X &T9&/F+8))Y)P .G.,U_H]G]D/_@CNZ@M_P2OUYL!B/^+ ^*U(!'!!
M/B<D\XSS@<<@'--'[(/_  1W_P"D5FOCC_H@?BLG@]\>)^AP0 2,D@YQG.T?
MI$97%)?ZD<6-I:_[7PUO=MZ?VI;JNAG'PKQJY>;B#*)..S]CF*MK?2^%3OZI
M/Y'^<59R%'4$?+GJ3@@$'/0+R 5[8.&YSG'21L'4,=QXX"]2&(P<\8X(SD\]
M037^B>?V0O\ @CJ.3_P2JU_Y3@'_ (4!XK..3W'B<YS@GC@]<\@&5?V3O^"/
MB85?^"5_B/H,!?@%XJX4?7Q-T7 R!^"D XW_ .)C,H;UX'XM:[/%\+V_'-;)
M^:M+L[;X8CPCQE=J<<_R>,NKE1S*SUZ6PS]6?YV+1ETQE@>K' QN7YLC(Z'(
M7 QGMT)-)@02O;!!RN1M(QDXV\9 YQ_#U%?Z+I_93_X) J<?\.L?$@+=!_PH
M+Q4,DC QGQ..K?+NX"@9S@<<C+\$?^"'<<TD,_\ P3TT&"Y@D>&>"?X=B">&
M:-V1X9H)/'J2PS1.&26*95D1P4=58$#II_2/RR5U#@/C&JU\2IU^&JEM=VJ>
M93:6EDVDGJEJ<\?"+,*>DN(\D2;?+>AFD=?66$C%[])2Z/II_GFJN!M&[&25
M)X!4@<Y(.,98@<;N/QL*20 ..^ N<#ONR?7))P..HS7^A+_PI7_@AKP!_P $
M^O#G7'/@"-0, ]S\0@#T(ZYR,8SG##\&/^"&:8S_ ,$^?#@#8 Q\/XP3D@#G
M_A8'*Y;UZ],GBM8?22RNE+FEX?\ &]^71.?#B=KVO9Y@OR*EX2XN2_Y*3(^K
M_AYD_-O_ '=[VON?Y\JY 7@LH()Q@')QP>N,,<G..<#TS8 + '+ 'Y=K8)'W
ML]B!D#!(['@U_=K^U[^R1_P2Q\4?\$[_ -O7XK_L[_L9>!OAU\0?@I\ /%/B
M'0?%E[X5ETC6-"\17FC:I/HFL:!-!XIU>,W6GOIEQ,)9(U6*7[/E9D>13_"8
M@^1>!PQ''3^/./;(X]*_7_#GQ%P7B-E^:8[!Y/FN2O)\QI9=7PV;RP,L1.K6
MP"Q\*E-8"K6HJFJ-2*?/-U.9IIN+;7PG%W"6(X3JX&G7QV#QZQ]&K7I5<'&O
M&$8TJWLI1DL1"#OSK1Q5K+7L?O9_P;8C_C:AX-'4'X%?'S(Z_P#,#T48^AST
M/>OUHOX<:CJ9\I6 U/4^68  ?;[GU0CDL??D8/S #\E_^#;$?\;4/!8]?@5\
M?.OOH>BU^O\ ?HW]H:IQ_P Q74L#G@B]F'/RD$$$-RN._.<C\'\69->*V<6D
MU*7"?">S:;:K<1O=-;6OT6G4^YX<BI\&Y.FK_P#"KG?1/[&7];/?MIW.>\J(
MDMM7)).2@! ^7@ =>O.1GWQC#?)BY)"X&?E*DY .0"01D$X.,>QSSG8,8<EF
M\M"!P #\HS][;QDY/)W8 XYZ,AMUZJ"P(Y(W<YXW!@<<G#<*1SC)ZGXR%2<7
M=SJ/HK2FUI+HW+M=?>=4J*?V8S72Z3UMH]5:^^JUUMJC-^-FM:=X;^)7P'UZ
MY\FY3PO\)_V;?$UQIPN;:VN+RW\/2IK<E@CSEDADO([(PQ2S1F%#.LC*T?!S
M]<_:@\9^.=1^+6C_ !5\<_$CXC_!_P"+TGB9IOA[XB^)^I:K/X%NI/$4WB[X
M;Z_X,&KW]UH5MJOP^UZVT<3Z*]K#X?\ $GAV#4-#NHH!+I]Q9>TZ;\6_BAI6
MF:;H]AXQN8M-T>Q@TS2K6YT3PKJ9L=,MRQM;&"ZU7P_=WJVL&^1;>![ETA4E
M8R =HM-\:OBV,C_A,6X!RP\*>!"A7O@#PJ2,9Z9+#!'K7(HTZE+"4\9E.%QE
M?!X5X3#XR>/J4JM&$<SGFE+$87GRNM/!XJ.(=%JM1JNHE!T^:5.3A+DG@\3"
MOBJN$S6K@Z&+Q3Q=?"QP,)T:CG@%EU2CB%',:,,50GAY5(2I5(*#YU)I22DO
MFZ/]HWXD:7\-_A!\-O ?Q3^)?PPTWX<>&?'.C>(8/ OQ3USPGHOC+5_&'Q,\
M4>/8==&F^&M6T]H+K3M+\0PZ$\]Z]S>LEEN@N4M_+C'/>"_B3X<\/^%_$OP[
M\?>&9?B3\.?%OBNU\>7$6F>.U\(?$;P=\1HK5],O?B-X+\8:GI/B_2[S7-<T
M>4Z;XJT7Q;X?U;2O&4-OIKWU_IUUIT%Z?K'_ (79\63POC0@GE5_X13P(<CG
M=C;X4!(P&X^9??' :?C9\6<D+XR);.&!\+> P<#'!7_A%,XSC((XY)))..I3
MP\:->E3R7 T'7Q3QM7$4,UJX;&RQ;Q=;&0Q*QM#*:>*]O2Q%>I+#2=6H\/&<
MZ,8U:,I4Y<G]G8SVU*M//JU6-+#1PD,/7RU5\(L*L-3PL\.\)5S.6&G1JT*=
M*%>'LZ:K.G"HW3K1C./QUXI\1_"F\M]/TSX<>$/$_ARTL+B\N=1\6?$KXEZ-
MXR\=>*_M5O;QVUE<:5X3\*^!_ OAC2-)EBF:VM])TO6-4U&:<W5]KD$:?V<K
MO$OC[3/$?A#X+^%8X(["7X3>"O&WA.[OYM4L98=>D\6_%CQA\2(KZS@BVR64
M=C!XHCTN:.YDDDGN+.2X0K!(F?L,_&_XM 8'C+!/IX6\"\^NYO\ A%<@ 8 Q
MD9 R""<HWQM^+))/_"7[B0&(_P"$6\",>R]3X3Z@#ZG&>3733QM:G]4<L#[>
MI@*V)Q&'KXK/L57K*MBJ%3"UY5*E3*DYIT*LH0IN-.G2M3]E3@HI&%3(U/ZU
MRYE3H0QE&AAZM*ADM&A15+#5J>(I1ITZ68VIOVU-3G/FG.I>7/.;FV? JR:9
M$QE^V6_!7A]05HT(!"[%>4HF 6  4 ;BJD!J]+T3XO7'A71_@I%X5N(-*\7?
M!3XL?$+XIZ3X@N;VRN=+U&X\:6_P]MX=$GTZ.6&YDT]K3P7J>E>)+>XE^RZU
MHOB"?3,"&6Z!^J_^%W_%I>OC.15SP#X5\!XZ$\$>%!R3M &#D8ZDX#'^./Q;
M5ACQH3D[2/\ A&/ @Y) Q_R*A)&>G0@ALG S3Q6/>,IT:6(RC SI4:M6O&BL
MSG"C.I5P^,PE5U:<,HC"I&I2Q^*C4A+^*YIRGS14DL+D=3"U*E6CG=>-6I2I
MT)5?J+G55.C7PN)IJG4GF3E3E3JX+#NE.+;IJ'+&-FXOY=\4_&:?QM9_M'3^
M)K?2I/$?[0-S\-I_M&A7EKIGASP99?#?Q+;:GH_AW2M&GFN;N+PWI/AG3=+\
M'^%=.AO!_8VF:9IT,DLT4 63M/$OQ[^'_CW5_B=I_P 0?!GBB]\ >/\ XCZ1
M\5?#DW@?Q]X4\/\ Q'^&WC#3/!&F^!-4EL)_$?AGQ7X-\5Z+XOT32K"SUS2-
M3T_3;BR.GV&I:3J:WEN\,WMI^.7Q;R-WC(X^7_F5_ AQD@#(_P"$4P.22<'V
M.,@4UOCG\6@#CQD<]R/"_@3C.>?^15()X.,CWR.2.!TL.W3J4LII4)4535"6
M%SS%8=X:5*G@*%.6'E#*INE.E3R["0@_WJY5656%>.*KQEWK"8WWXU,Y6(C6
M=18B.)RBCB%B%6GC*E6->,\PC&I"I4Q^)G.*5*TG1]E*A+#T91\5?]HKP9;:
M9\+O#6@?"E+7X=>#/A9\;_@OXY\!ZS\3K74M5^(G@GXR^/8O'=UK \?6?ABP
M?0?B)I^N6>F^+&\16?@U="M/%EG';:3X:@\-QI9-R.K_ !*^$=G\*_'GPK^'
M/@;QM8IXV\4?#/Q5=?$#XF?$7P;XF\63_P#"O[[6+Q?#3:1X-\(>#?#FCZ!&
MNJ2_8'M%U;5=4U.>74-5O[.UM[#28?I0_'+XN9(7QK*?O<CPMX#8'!&3QX4W
M8+;L9/R\N1CBFGXZ?%X_,/&4AS@Y/A7P(0#P>G_"*YX&%.,>@R<XRA2H4>3V
M>75(05>AB:L5Q'F/L\7B<+BJ^-H8C&*64R6)K4JN*KJ%6I*-J<U&4*CI4/J]
M.AC:O/S9EA7)TJ]"G4_L#!N>&P^)PU'"5Z&%Y,P@\-1J4L/2<J<$VYQ;C*FJ
ME;ZQYY??M;)JFL?%^TNM4^._@3P/\3/C3K/QOT2\_9]_:#D^$GQ)\'^(M;T&
MP\.:MH^MS0Z7J?@[XB^&M<T[1M!%Q8ZS9:9=^'[S2EU+P_J EOM0LKCYQ^(O
MC./XAZYJ^LRZ]X[NX;C3;#2-(_X6S\8M9^-?C:VT_3[-(R-5\>^(K?2YKTZE
MJKZEK[Z9I>DZ-H.BW6LW5AHVGPVD8GN/LP_'3XO$';XW&?O ?\(GX%&,<DY_
MX17<0!W RP('M5=OCK\9&(7_ (35U8<9;PKX$X7!YX\*C"GH 2_<8Y).^7QP
M^68AXG!Y1A:%1T/8-O-ZDTU['#8>57]YD;JNI4I8/#JK)XIQG*DYQHTISFY\
M^.P>-S&C&AC,VG6@JJK*7]F4Z<DE4KU8T^:.;*'LJ<\175%?5TX0FJ;J5(Q2
MCX5\1_'G[)_Q0^('BGXFZ_X!_:/TOQAXOETV_P!370/B7^SP/#UGJ^F>&]'\
M/1S:;'JWP@U/Q$FG/_8UO<O%>:]=WV)9%2^0[/*]#^'G[7>A^#-7^#7B;4K7
MX^37OPDT;P;X3_X5AX'_ &EX/ _[-6OZ9X2L9=,D\9W?PNT_PF=3N/&/B)9Y
MO$'BSPS=:]_PBOB_QS)+XA\0ZK>Z3?7_ (5G[)OCG\85&#XY.#NX/A/P&O P
M0,CPL.N0.#C@].\!^.WQA4?\CS*<C.!X3\!$*0?XPWA1R#D $D@' Y)R3S5,
M'AL1A:6"K8"MB,-AJ<J.'I5>),54CAZ,\-]4G1H/_5^,J=.>'Y*<G[];EHT_
M9XR@W7E7ZJ4<;3Q%3%T<?A*&(KSC5KU*7#]"+K5J>(6)IU9IYQ)2J0K<]:$U
MR454JS=3"UK4_9>!> /C-X*^'7@GQ7H'A_2?BR^H^.O _BGP=XR^'^H?&_PQ
MJ/[,OC+6?%7AV\\/?\+3\2_#*Y^')\2-XN\.S7-GXJT'1].\21-:^)-!T3[%
MX[TO1+<Z57(_$?XB> _'6C>$]3B\/^)M%^).D?#SX?\ P[\8:O>>/_"VK?#S
M6=*^%7@'3?A[H6L>&O#$'@S3?%>D:SXBTG0-&U#7XM6\8:GIFE7T%U9:9!?P
MWC:G%]2#X^?&-22?&\C+@ M_PBO@%L=NWA/N=H'<9//.*A?X\_&)MP7QJY7D
MG/A3X?J,'C#;O"9!'RGG//(ZY+=>'C##8R.84LM@L6JTZ\J\L_Q<I3Y\(\%*
MA5?]BQ53#_5^2FXS4ZTXTZ4:F,G"C3A'EKX+%8K"?4:V84_JOLHT8T5D=%1I
M\F*^N*O2<<UE[/$.NYS4Z<X4X.I4=/"1E6JRJ87QY0/\4M592'1_!7P-(9"&
M1U_X9^^%!5E(;D$@_,I((&0>:\;DA; (W#N <9&",@'Y@P P"#C@Y!XKL_$V
MO:]XPUW4?$OBC4;K6_$.J/;/J6J7@@6XNS9:?::59AUM(;:WACM-+L+&PMHH
M+>..&TM8(DB"H,\Y)#_L< D*,DX89#<9R.JC!//(SD8KJPK=##4*,G%SI4:<
M)N+O#GC&2ER.2B^6\VDW&,N6*ND]#MK1<ZM2<4U&4VXIJTN7W;75Y6;44Y+F
ME9O=Z&(803AG3Y=PQ@@AN1G[PX!7GC! .#Z5WBRQ^4DKG &,@#<F,G&00P^;
MH#A3D@DQ^)_%'A3P99IJ'BOQ3X?\,6,[^1#=>(=8L-'MYYM\<92&2_N(1(8V
MG@$[(2L"RQ-*Z"2,-JK&D\230E9875FCN(76:"90SQ[HIE8QL!)&\3%&)\Q9
M8SEHRBVL0W*45)<T4N:S7NW5U>/,I:ZJ_*UIV5UG[.3V5_);_CI]]CX^_;>\
M077AG]EOXOBW\.7'BF3Q=H,7PT>TCF:UL-+L_B7>Q>#-1\0ZW>1"2XM].TJQ
MU6Y6R2UAEFU#Q/=>']'<VEG?WFJZ?\I>&OB9^U%HNAZ-I'A_XS_!N^LM(TW2
M]&TK1O$?[/,T/V#3-,LH;*UL;O4/#?Q2TV]G-A:0P0?;_LIDNF0W,RI+*4'U
MY^V]?P:7^S'\0O.E,4>KZS\+-" 7<S327GQ7\%WJ6Z( SR&<Z68=J+\^?F'E
M[E'Q-&L,4H#+&);:>1-Q(,C2I(0<,1E@2' .<$$@#D8\*OAZV)S?%U_K^-HR
MIY;@</0CAJSH1IJ>)QV)J<SI^]656JJ=1NLG[-P4*2C3>NF-S2>6Y;E^&IX;
M"3=?&YCBL1]:HPQ/M(PAE^'BX\\E[*5.G[:G:DTVJC<KWLNNL/C_ /MLK\0-
M$TJS\-?LV_$$/KFN>#-'MM%TSXK>$I]0DT[Q%HUKK9LX+KXDZS)H6JA(#K\&
MN2:;JNCZ1X3TGQ#K6O1^7I$L%O\ :OQ8_9D^ ?QPEUW5_BS\%?AEXX\7:_H=
M[I.H>,-5T2&W\47<MS:0".:3X@:;96'BPWEM=V-BFG^+)U?Q'I=E;*;'[-&U
MS83^'_LH^'KY/%_BCQC/+,MAK6K?%30]$@>-O)D@TT_!#4]=N_,*MYD;ZWJ<
MEA&L0\I;C3KV.4M<6S+#]Y"$D9#;ST#  !>Q Z<'. .<<'(.!7+E^!G*ECJ>
M9XNIFT:U:450Q\*.)IT4X24W3]IATU.KS*-2\I1Y80:7,Y<WK2QVN"KX/#T<
MMJTZ<9*M@9UL/4K0E)2@JKCB-8P<9+D:3<:DHM<O*H_S_2?\$N?B5X:_9Q\3
MS>./VAM(TJ+2F\9_$3Q7\)/&GA*'5_A_!HWA"YU6[T.]N_BSX9\4>)=?LM47
MPAI%KKES:S^&/B#HMIJEU:6=S=V]YI5SK47YL_"WQ]XQ_9ZO(M8T'P[?>$K_
M .*FB:+K6E:?\4?#Z7^D>.O"=K&TNE?\(KJVIR:?8>*_#MN]S)<V%]X*\56<
MMMJ$D=O<--%;G2Z_IR_;G:<_LN_$#08)F@D^('B;X*?"J5B!E])^)GQW^&GA
M#Q3:OEUS;ZKX.U+Q%H]P@P3;ZC( 1C=7H'Q*_98^ ?Q#C\5:5KGPU\/Z?!XI
MN0WB.3PE;Q>$E\0W%@6BTO5_%6CZ/!%X6\9Z_I>U?[-\0^-?#OB'7--D5)]/
MU"VE1*_-<Z\/*5;,(/A7'5\GQV4X# KVM3%8FO0Q$ZT\;]6A/#RE/#89PI4:
MLG+#0PL7*O:,81IKF_0\KXWC# 3CQ%@J&88/-<=C)<F'P6#IU*$*=/"?6).<
M%&MB%4G6I1C]8J8B:A1BYRJNI:'X.V_[2'P6^-EK'X.^.7PNL[>YBLTD=)K:
M;X@:/8)\[N\.DW&GVWQ,\,P6087$MSH,7BVQ:[>28"WM(3*/6_#O@?5F\/W6
MJ? SXP:+\2OAK=)'%K_PU^+<UQ\<_@_KMA$P@GT+6M8TW6]*^)7A#0Y[>4Z7
MJ=I+J[I/ T^F0W=C:I*(N]^,7_!(&":)[GX-^-AJ6GV]MYUGX4\4)::7K^D7
MEL5>WDTFZ-W8>"/&K77EFV@L8[_]G>;07E;5[CQ)XZO(_P"Q[W\U_%/P _:=
M^#GCJQL(/#^OW?CJ\M9[K1="A.OM\2]<M--A\O4#X233GT?XC>-8=,LQ//?7
M'@NT^).EZ3IBSZE>-%8 SR^'4S?B_AZK"EQ9D3S"@U['^UL!"525?V:<(J>*
MPOM<0TJ;:]CB<-BXN//>FU*2GW0X=X8SNES\)YVLOJNU5Y5C)0EAJ7-)5)3>
M"S!PI4Y\\(WJ86OA+/DESJ5."CVG[8W[*_PM\(> ['Q1IW[//CW]GKXM>)/#
M?PY\>V.C>#_B'8?&[]E[5?"_CVSM]966\U77=$TWXF?!3Q/?:'?6.N>%_"'B
M)];TT:3?:/:2^(=2.J0W<7I6NW'[='PS_9K_ &7=3_8VU_QAJ/PH^ ?A;Q%>
M>*OBK^SWJNG^/9;/XE_$36+CQ-XV\,^-M#\,W6J^*+7PEX=GO)X]-TCQ-X;_
M +'2SBAU:]TN"ZTN.]B\S^'7[=?B7P[+::?XUM=.U&&W4:>9M8N(O#%_&;$"
MRFLHOB'X7TL>'M0:*&*'2X[#QEX-\-'3(K?;J%_?R1K;)]2^$+KX.>-/%6C^
M.? 3>.O@-\;=8MC-X>\7_#.35O ?B_Q"DI@:\LM \5_#TZ]\.?B5IZO:Q27N
MD&;4;;4[&V?5M6\/62EH(5EV(X9S"G*M@<XIY9F6-H4L-*.'CALHJTJM#$>W
ME/!SY7@I5:DHTH8B-:> J584HI_5Y2G&3S*'%&75H+,LCKYGE6 KU*ZJTHXG
M.*52EB,&\-#Z]0<HYA"G1A*M4H3PZQ\*=3$3YOK4.6</E/X3?MJ^$OCI\0_!
MGAGXU?LYZ3-\9_$6NV_A_P $?M.?L?>+A^SE\9='U_7O-M&U?Q!HFC6-UX,\
M1O//<I'K$EM:^ Y);9]3OM8?Q+./L%Q^MWPG_:+^//A_QCJ_PQ\#_&CX'?MD
M^(?!NLWWA[5?@%\3?&NE?!7]K$M9VL$L2^"_B&-!MO _Q+O$NIFMUMX_"7C/
MQ'=6=N4OO#WAEXKO4;+YFOO#?Q9\-?$W_A>/BOPGX!_:E\<ZE<66NZ3\5=0L
M+'X7_M%+I]YX8U+PL=5TW4K<WGPP^*-O>^']73RY;V#3K[7)-(T6^TSQ;X7B
M:>(?FU^UW^RK\']!TO4/BG\._C#X\D\:>,KS2_&5_P#LY_M(_"^]\$_M!:A9
M?$+6KQ8_%W@GQ=X0?7OAI\6-&FU%=4UB_P!2T^3PW):Z;#<KI\.O&TN[AO>E
MC.(.&L,L3/$O,:OUB=2K7C.GE.*J9?##PE[2,H*KA,VK1F^>I-T\=R4XI\TX
MU5R^/AJ>3<3XJ5'"TX8'"T\-3IQPSC/,J$,?5Q4XRISC/ZOCLGHJC'V=.*^H
M>TKRG3BU4HVJ_P!._@_]N7X(:EXHC^'/Q7D\5?LO_%I9A:W7PU_:3T0?#6[6
M]\XP*FF>-KNXG^'FL:?=RJW]D:N/$FGV^K1M (H(KRX6P'V;);W%KY8GAFA%
MQ##=VQ="JW%I=QB6VN[=S\LUK<PM'+:W$3/#<12)+"\D;*6_E"\*_M0?%#]G
MW]@OP-%\6M(/Q]UCQW\;+[PY\'_!?[2^I^*O%?P]T'X.^ ?#]YH?Q!AB\%ZW
M?V$^CS7OC.&+PWX U;1M<\,^)- LH==.ER6WV9;<]O\ L^?ML_L\65U9:9\)
M_B]\7_\ @FYXKN)Y[ZY^&WC"$_M,_L-ZWJ]Q<I+?QVNB7L-GXX^%-GXCN&DO
M9]0TWP]KD6AQ1):W-YXIN)5U*'Z3+_$/#2E0P^8NG3KUL/2Q,*56V"Q2IUXN
M=*[E%Y=7J3CRS:IU,#>-6FK<[E;Q\;P17:KU\#SNC0Q-?".K3OC,'*MAI1A5
MY7&4L=2H^T<H1J3I9A%NE546XTY2/Z@U&2"VYESDGH..@&3G.[&#@#('(SQ.
MN$&1M^[Q@#)[ G&#UZGD9)R1D5^<_A3]L[XM^$/#=QXA_:(_9XU?6O!&C-;'
M6OVA_P!E6#Q!\0?AG9V%[!)=V&L>,OA?XDL[+X@^ +.?2HDUB?4[#7?&MN(9
M@UWX=\)1+'$_VA\(/C-\(/V@M(N]=^"/Q)\(?$^RTJVCO=;M?"FIK=:]X?M;
M@A4NO%'A6X6V\4>'+9I&$,5]K6C6.G7DX*65U<@$C[C#YO@<4^6E7C&JH\SH
M5U*A7T5WRTZW*JL5_P _*%6O3DKSA-P]Y_)U<JQ6'@ZU2G&KAU*4?K.&G'$X
M;27+:56CS*E*]W[+$1PU96DI4U)<J]+4,RI@Y=@N<9*ABNYERHP,8)!()/3@
MC-."$A2%WG<P(!P 2 "0V#DG V\9!.-S,0:?C<!PK,5!^^ >F>F<^Q/0G.YL
M;C5G9Q@QXP!D,=H P, $G!QD D'GZ&NEXB,5S-M)I:NUK/9K5KYW:Z7.;V,7
MLF[*[22_&U[>OF5!&Q0N 1\VT#<6[@$DD# "G=]UL^W!*^4V<MG' QL!8EE8
M9SD?* W..>O2K>&#XZ8)RN<\ '.,$@X.W!P !D9)Q0Q (SV(89(7GG&"?QX'
MYCNI5[1<N:T6N92;TY6M+63]%:^_EI4</9WM:SV;\N[2[^15_P""PXV_\&].
MG*,_\G7_  \QGC.?B7XC)XYP<<]2.WU_@\K^\/\ X+%8_P"(>K3CG)'[5_P\
M!);/_-2O$8'([<X' (& >17\'E?;>$3OD?$+O>_&W$3OWN\OU/;XE5J>0+MD
M6#7W*2_KYC6S@ '&3U]L$_TQ],TW:_\ >_4U)2<^@_,_X5^JGS%[=ON3_,79
MC)'(P<YX)RI   7 'N3U!YQBO] K_@AU&)?^" FJ(2,']HGXN9SCG_BYNA9
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MV\%Q'\1OB)Y5Q#'*A;QWXN)$<L89<_\ $[7;P^<D#)&2!@Y^AO@0ES<^$/V
M+B7>9YOAU^WG)-(VX/*\_AWQ Y>1SRS,S%F<EB6!8G)R/G'3XO!+>"_#2:;)
M\0O^$U-EI8UF#5M&\)0>!DB:&19O[%U:P\2WGBBZD4"U,"ZCH-FKLUQYLD(C
MA,OK97CH8K%8RA5P>%E2ISA&C[#+\+*5-2S'-\-SXB?L_=BL/@J$9SE'6JFW
M%RFW'R\QPU3"X7"U:6,Q4)U%*51U\?BK5?\ 8<MKN%'FDW*?ML36DM4W!\S?
M*E)]LLOQOF^'UQ\58O%GQ*E^']EXZ7X:WOB2/X@^)VMK/QI)H6G>(XM&NX1K
MYNX#/I.J6$T%W) +&6:Y6U2<7.8F;I-W\;-=\)^//'6D>*_B/?>$_AE%X<E\
M<:R/B'XEBAT0^+=1FTOP_"8Y]>6XO+K4KNUN$2"Q@FEMXHC/<HD3Q;_4_AMX
MKTGPS\%?#/AWQK>SV?PL^+/[1WQW^&'Q*NXXS=2>'-.U[X*?LS7/ACXCV]KO
MA6:\^%GC73O#WC<1!TDN],TG5=.#M'?213:?B6:?P?\ "G]H7]G[3-9TO5=/
M^$?P4TO7/B#K'AN\GO?#_C/]H+QA\:?@W_PF^O6-ZZ0?VAHW@?P]I?AWX8>$
M9W@\R&VT3Q'?1S[=>F@M^%YY*.(Q&#65X!U*6=?5Z%5X2C+#RRBEC\!@L77G
M+ZO"E'%TL1C(X6%!U(\TL3AZ[@J%"NWW0RKFP^'Q;S+'*G5REUZM+ZW65=9I
M4P..QF%HPIO$N3PM6AA'B9UG3DXQP^(IQDZ]7#Q/ M:\5_$70=1NM.G^+'B3
M4&@@T^X:^\.?%G6_$>B,NI:=;:FD<&LZ3XBN=/GN;.&Z2UU*WBN3/I^I07>G
MW2Q75I/%%;U+5?BSIGA3P/XUN_B)XY;0_B%?>/K+PZUO\2/%LMX\_P -M0\/
M:;XE^W6PU@?9(X[CQ1IGV!R[B[0W+*(O* ;Z-\76UWX6LOCIXO\ AEX/\,7O
MCKPU?_LRZ/>WDW@/1/%P^%GPO\4_ FQUO6O'V@^$]0T?5=#M;WQ3X^MK'P_K
MOC.XT.ZE\/1K"1=V5QXDGGN>P@T#7]:T']D4^-?A3X;7XC3_  N_;U\?>!/A
MA-X0@\.Z%\4?B=HT?PKUKX93ZO\ #"TAT^Q:Y\6VEG:>+&\!VMAI6E^/+FPL
M9H]-MK#Q0+=N9<3TEAL'B'EV!E355T<6^7*HXFO5IY//,*JIX+ZK)X7#>TKX
M.:Q\ZTZ,84\37JTZ>%I^U>TL@Q#K8G#_ -H8OGE!5,+%?VG+#T:,\UC@J;EB
MEB8*O64*.*@\'"E&K4G4H4:,Y8J;HOXWT_Q'\3]3\.^-O%5I\2?&TFD> -.T
M34_$<DGQ'\5I<+:>(]=A\.Z<+"%-8D%W*=2G431I*ACAW2DM@J;_ (TU+XL_
M#_Q3KO@[Q%\1O&T6M>';FVL]3%G\1_%MW9+-=:?::I (KUM7C$JFTO8"?W:8
MD$B#<%!KTB74OB-XK_9?_:A\1^/O"6C1I!%\)]!TCQ];_#?0_A9J=S=+\1+:
MYU_P&VG>'-!\,:9XEL=#>'1KZ>2XTN[U+P%<S66BSZC:0>)K?3W]S\<Z9X>L
M]?\ VL?'L6M76@>.O#GQD^&'A[4/$%E^S[I?[2&I>!_AGJWPFL=1A\2V?A#6
MO%?AK3/"\'B3QK;-H.I_$.YM=<&AG1=,T.--+?Q-]JN-)\0>PQ5>%?+\MJ1I
M8F6%CAL)3R_$I8BV24Z#GCZ.7W=+FS*O4JMX;VJ?L\/*G*K&"F+)I5,+0G1S
M',*;JT%B)5\3/,*'[F+S:I52P4\;\;C@:-.C:NJ5E4KQJ1I.I*'PX_C_ .($
M<32M\1_B((HXVE9E\>^+L[%!+$'^V@#\HX;GDDD$#GVBX^'O[0%A]DCU;XMZ
M)X?O;S2M)UI-(\3_ +7W@+PQX@ATW7])M-<TBXOO#VN?%*PUK3Y=0TC4++4+
M:VO;&"XDM[N"18RLB,>)^/1T.XU?2[C1M)US2]0NOA;H=UXVN=7^#1^ 5KXF
M\63W/B*6V\9^'OA:FN^(;7P[I/B7P8_@^XG_ +,ODTG4M=MM8UO3[2SAU/[+
M'ZW\?8_ 4GQ%N+>^_9D^)'C#Q-+\*O@C"/B-I'QF\0:1H%Y>2_ SP"NG:G:>
M [3]G_Q';&#2-]M;SZ9#X]N4U:>PN&?4=.%V8+7JQ6:3J+)Y8/ X;#K,:>,J
MUX3RS*<97I+#5,-25EB<1EM)4KU)R<XU)591=/EP\9>UC3Y,-A.66:QQ.88B
MO_9\\+3I2I9CFF'I5/K-/$596EAZ&8U'-^RA&,9THT^?G3KN/LIU?G#_ (6#
M\0#MW?$CQ_F0DQX^(/BTLX4Y;R_^)VRE0<_,K,& \Q#L=07'Q]X_0JC?$?XA
MHY!*JWQ"\6JS#IP!K.XD\9XYR, Y%?6WP(\(:A#XP_9E^'NNZB=<T_XN2^&?
M%.I> /"O[%_A#XKZ-XJ^&OBGQI?Z'XC?XB?'?Q!XY\)>(?#-WH^E:;K8UG6_
M#.D^(8/@M:0V>L0B_P!<MY-(FXS0-%O?$'A%/A)X:L+SX7>,+7P)\<K^/3O'
M_P"S]X=\7^!OC[X5T6\\=Z[%\3-*^/VL:<_BSX;>)M$\#Z=+X;TG4;ZQO/ %
MAX@\.:)<:/XG\/ZIJNMA,Y<3X"->M1_LO"SA2JTW]:Y\'"@\)+$XC"2Q4O\
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M..!AAJ=2O47L8XS%K!5ZZ5.G4G6=)XBG4]G-J$FU[2:OS1_/3XP_$76_V?\
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MUZ:<7%L)TYY-3J1<9PR;"QG&47"2DN9-.+LXM/1JVC^0^BBBOUT^0' $(WH
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M-,TSQ+X4M85TW6++1K*PL=/C\/>-;3PQH-IKVESZ:C6_]K6UWX9OAJT%U#J
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MTE?0YJF6R5TDW%J[LW9/T6C?G;_(XW^S7"Y(8$YVDX!QC )8@[> 54!0"5X
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M;-/J,FUKY;?KMMY-[=T<(VG-T(PH/3'RD\X/#L#C\1A>Q&:A.G$!F4 @;F
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MZKHXMJ@Z53%5L/3Q%2<U&,I?UE_LN_#+XTZ]^SU^S9XQ'[:'[5?@V[UKX?\
MA?QC?:/I-Y\$+_P_+/JVFVXN+"?2/&?P2\2:A-I=Q+'_ &VT#:KY\MSJ=VQN
M=TEM/%^1W[>>M?%3]G3PC)\2U_:@_:V\87>O^)='\+0Z!\/_  )^SGJ4PO\
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MW68@@J5:WE8AL\<C']/OAK6M1UK_ ()3_P#!8Y]0U/\ M%X?V;[58V:>QG,
ME\/?$1F5EL7:.,R (1O8M*JK(OR@5_$BOR/A6\LA@0<;B&'.5(8$$DMANJLI
M(XQC^\_HM<!X"MP5Q!1P>+QV6XK*^(Z%/ XJAB*LY4HU\H^M3C4]M*5><?:3
MDTU74XIN$5RMG\L>.'$.(EG^75ZU'#XFGC<!4>(P]>E!4Y.AB:48N/LE:G)1
M@M5&HG9.4%-1J+^F[_@@/\(]-\(?\%-/"OB'1[VZ2U3X&_'>W;3;A?."-<:#
MHP5H;H,C!8SP8Y(R<A6#Y8 ?D5XBUK6X_$'B4#5-7"KXB\1!4&HWJ! -;U $
MX$R[5R<@YVJ.QP5K](/^#;/Q=XBOO^"G/@KP]J6L7%]HTGP0^.3/%?N;CRO)
MT/0&5HY7S*L85SO0R;<!L#+9'Z ^)M#_ .";%Q\>)=5'[-'A#2/AS'JL?A[Q
M1X>UNZU5C<(-9\02>)OB7X:F\+ZG=7AFO8H]$?PM!JY&FWUW)JUK>VUK$+:5
M?E_&OCFAX:^(U7#\88K$9GB,SX>X<HX3%X3ZO&<<-AIYM"#K_6Y4+<BQ'+*4
M92J-RL^:+:7F\,< 9EXA\*X2IPW[#+J65X_.J^*HXN6*J1<J\,O48X>6&522
M_P!WK24*R=TFG)-IG\WAUO4E=M^I:J6<%\'4+K+-A>=WFODG^(DD8VLPP,"M
M<:M?3-M=KV5&7EI+IYM_0@#S>7&.@ 'W1A<\5_1=^UIXZ_X(7_LD_&&Y^$GQ
M"_9Q^(?BSQ;'\/\ PWXSBM?A!IFM^(_#>L6'C&UM];\/SZ7XMO?BGX:\.SW+
M:>SP7F=4@MM*OO.L;EQ+$[C\Q_BK^WU_P26U2_T_P_\ "+_@EW^U!J%RE];M
MJ=S=?M _#WX;ZU>P7TB1Z1;:1:V?B#X\02S7M[:RV\EI=VT<EU;32Q!X)I(I
M(?C:7C#PS5U>79N_>LI..6RA._(X5(MXG6G-3B[IS;5TE=-'//P6XGI\LO[3
MRF\HJ7O/,Z<HN/-SPG&5*3C.$H/>R=M&UJ?(7P $VM?&C2-"MM"\/>)+F#XJ
M?L]>)])\-^);*"YTC6-0UOQ9_P (3=Z;J4'G6(GM;R73-'BO_+O+"[^QQR2I
M>VAB-Q%_1MXF_P""@/[0'@#Q%XG\#ZG_ ,$V=4U;QUX7UVV\+Z9H/A#]L[PE
MK]_XGLKQ]8DCETW4YOV<=.L+*2>304>3PA]OU/Q%?&ZCNM'MM9T_3-3O+/\
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M3AR>=99BZL,ORFMB*.#?LXJ.%>'=#!589;2P>,P$94Y+%8F%; ^TACUA</\
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ML_$^NW%A;/<>--"MI;F*.>?2/"=EJ4<*71AB-W"FISZ9'J4"126[_9/[4TJ
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MP_\ X(K^"?&7Q@_;#\2_%*#XFMXW\0?!SX6:MJ^H^(_$XA\:)KVH>,K*_P#
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MOVK9'!&&CME:.-<1_-^\7_!$OX):S\6/^"AW[/7B^R\(:YK_ ,,?A?I?Q/\
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M:=^$\)72K&#3+$20>/M?2416-M%#;0,),K+Y,8CD<&4<O@?Y^2]!]!7]T?\
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M1A(HV0P1+&)7($$4>^4M(4<L]::Z-IR6Z6<D06T@M(+94-S=.T=O:Q>7;DW
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MMB^!N-.O"V>OUR^KM>+_ )TNG4T_UPX3MKG^5+?XL3RQV>\G#0^+?VS&W_\
M!+#_ (*= 8)7]F+Q.K @!@1H>O':5P#C!P-RC!) 4XY_SE@Q+D9/RLP_$>OK
MU!'U&,"O]*G_ (*#?#/Q/\-_^"6/_!29?$L5A&=7_9B\:O9BPOEO@18Z)JHG
M#[$01#-W'Y:DMNQ(?E"G/^:LI(,A(^](6 ![$ <]L_*2>HQCGKC_ &A^@!@,
M9EW@]FN"Q^%KX/&4.)'&MAL33=*M3G/ 5ZL5.$FVN:G4IU(N]G"I&2WT_P \
MOI3XO"X_C?"8K XBCB\+5P,G2KT)JI2GRK!TY\DK*ZC*,HO3>/71O][_ /@V
ML ;_ (*G^"E.<-\"_CRK8SD#^R=%Z$8(//&#GTYK]TO%7A'X,VOC[3I/$7PU
M^*_Q2N9?&*>(=(T7X(6GC+XJWOPZ\3Z-=QQP:_\ $>>V30?"=OI]HFD6MWH7
MCWQ);^$[CPOJDTWAO2=#36](D\:>(?PM_P"#:P#_ (>G^"@<D'X%_'D84\X;
M1]%!X(*D^@;C/Y'^C72O 7A'1=4U&2VUCQ/J6H0:GJ$$Q_X2B]T_5+BSN9KN
M*&UUI=,U.Z5M)MK&^N]-L-&@CTO1;:":]OK'2;75+RZOYOY*_:/RC#Q2X6G;
MVEN%:*]GS2IJ3?UE+WXPG*/*N622C)2MRNRDY0_;OHE1<^#LZC&:@_[44E)I
M.W+4<FN636Z3LTTT[-/1IZFH>*/AOX>\$ZUJ7ASX>^(O$WB'XFQWNA^'/$*Z
MWI>C_$*UO/$/AJ::8:1J^JZU_P )-X;N-$T6VN==FA^&IU'Q1Y&G3:S_ ,(Y
MJ'V7<W\J'_!:+]ECXH_!7XB7?[2=TVA^%/!?QC\2:%-I=CIOQ0\0>)_$>G^(
M/"OA?PKI.O67CGQ%XM\*-%X@TW5&M1-::I92^<\<GV1)])DM+:TN/ZB/&?PM
M^&&JZ5?R^)OAW9^-+'2K'6/$NFZ3XBTW5_B!#HSVNB7=A>V_AWP]J-EK5KIU
M[/I0NM/TN'2[-K^U@U*6UT>&$7*P5\__ !J^ '[ O[5/PG\'_#?5/"7Q \#6
M=IJ,7B+X:V'P]N/'MKXK^'VO:WID>GQ27'A&[TSQ#I.F07&EWB:7K.EZGI6G
M6FD11W]WYFFF"[63^"N$>(WPUG> QU15_J52I6P^8J&">*Y,/.FYQ=%0JPY:
ME*I&C.,N2,M)*'+-W7]-<2Y,\YRK$X>C&,\9"-.KA/W[I?O82Y&JSNX5*<H5
M))QYN5J*;V:?\A'[,NB?LY?%CQ0-$_:0_:(C_9LGU**TDT?QGH_A&#XC> ;/
M5#'+8/IS>%M,O?"<UQ/<&/0]+MKY=4T&_N9%"RW5U';VEFOV7X.A_P""5?P:
MU?QGX7^)4O[1/[;VCZG<:=<^'?C5\!])B^"MEX9UBUBC75/"%UH&O?&2X-U/
M97<EK=S:^9-=6XDN#IL=O:2VL4LGS1^U]^R5X\_9)^.C?#K4TU'Q=X<>W;6=
M+\<#P?-H_A?XJ>!]8L9%ETFYM_$=Y+I%SK>ER&TL_$^C0ZMJUMIFNV1CAU(6
M"6-U>?&>O>/M0T7Q%H5XVGZQX<T^PN[O0HG\8FQ&F:AI^M6MF)6T+3+7Q=IE
M]JQTZPCAO/#5EI%[=R75]:7EA.EC;S0S-_J=X1<=<'T?#S!SS;CW/<'1IXVI
M/"9+D*AA:].EB\1"K0S+#XBCED\PG3PRJ5ZF-PU7'\[G2EA\10JPY*3_ (QX
MQX=SBKQ%7I83AW!5<1]7<:^*S.*J46\)1FY86<'B7!U*L^6EAJM*C5C*#]I"
MM"TK_1'[3.G_  7>X^'OBK]GGPU\6/"G@?7T^(;7&N?%5KF?Q):ZY;WUCIWC
MK1X=$M+;2_!-M=V=K-I^MP_8M1O;O5M*\6:?KGB34KNZM;/3K/X])ATJ?380
M-*M-,L9KN)- _M.:ZMKN[N6N'CF_LNQTN&*]DMW4W^IIJ][]EL+ZX5XA>KYS
MC^J#_@FM\:?V/_BW^SC\#/V3_BAX!3Q!\0TUKQ5X@O/!WQK^']MKWA3QC\0F
MN?$OQ!N-7\-:EJ5NNG7:_P#",03KH]K(C:[;:%HB:-K5ZYM3<7WN7[9?_!,3
MX&_'+X/:Y=?L\?![X8_";XSZ3<#Q'X1U/PCHL/@OPUXY6WNKE=3\#:PMC)#H
M%C9ZW&;U='UN*R:RTWQ!:Z?;7;PZ=)=7-E_(G&7B=@5Q_P 183,<OSZAA,=Q
M#CYY?G6;U<-4KXW*ZF,=' YGCZ=.AAI7Q5.E*K4E3IU/9<T')7]HE^V93P5B
M9\-9=B\#F&6UZE#+,*Z^7X-5N6AC(8>,L5@\-4]I5A)T*C481JU(3GRRC=.,
M6?S8_!+XJ_LR>%?!K6?CG]CX_%SQW%?7EYJ7B:^_:F^)/P]^'FHO-+YNC^7\
M%?AQ\/\ 0#I,&GZ<+73KHQ_$K45\0R64FKF?2);M]-L_"OB1\;M3^*5]=:7;
M?!KX(_#;P=IFJ:K-HLWPC^&D>A^*=!M4M732?".J_$2_U#7_ !AXOTP6\D<L
MVK>+KW6O$NI:E:Z?JVJ:Q?7*;GQO%VA>./@]\6O&/PF^(7A37_#WB_2+Y=,N
M_"TUC ^IV>K6UI EW";>.]:XNYL>3/\ :HK1K&:QFTR\M]0GLKZTN&]D^#G[
M*'[1G[0MU+X?^'7@6_UW5].M4URSTJ.P5;2QT2Z@UJ2"\\4^(9;T:#\.[R:?
M0[JPTR'Q;<6$_B#5;Q+;18I+8->'^H,XXKX*I^%>7*KG?UO'RR*G@ZE.&:5\
M1AL)B:<:,*,IQK8R&!PF%=)1O2HQK2KSY(6E-Q4/YQR?AWC-^)F<589+3PN4
MO,_;QK_V9A,/6Q6#;K2KNG4IX2>,Q6-=7W>:K*E&G&3JUJTJ*E \X^'/A7]F
M"ZT#Q$OBCXX_%ZS^(.B6[ZO??!>/X"Z-J\_BW49=16*P\.Z'\?H/C9IWA[P]
MH?BOSX#=^.=?^$B:GX&AU.,V_@'Q_=Z7)%J/TG\*_AE^SU^T5XA\,? []G?X
M-?'SPG\9_BG#XKT+X?6/QO\ VI/A7>?"SP'XMT+PWK'C.^@DO/"W[*N@>,?B
MB_\ 8/A;4="TJ+7=2^&5I;:S>Z--KM_>:5;:Q&/8_%/_  24^(7PB\)_##XQ
M^._$%RUOXG\1^ ]:^-VF>&? EWK6K_#_ ,%:[XYT'1-7\1:!K@-]8^+K+P3I
M=S:CQ,FDW-A'I=S;2>))]3?P]::E8VG[=_L-?L!?!;X*_M)>//BYX2\96_CC
M6K;X6:%X=\-:'>^*="UCQG\//^$JUO7&\93:S;L9M2T.YUWP_8^&=#L4N/#^
M@F!I?%,-VMW;72:?)\=Q'XR\,\/^'6;RHY[F.8\1PX<KY;E6$PO/_9\,=5H4
M\###XZ4*5.:ITL95^L\CYJ6+P>'F_K5'EPZQ'VF4^%/$&:<;X"4\DRS \.RS
M?#9CFF)Q%.G+,)>RJ5*\ZV#@Z]2"57#PC0^L1DJV$KUXTX8>K.=5TOYNO@9\
M+#\!_'W[5OPA^.Y\5_L[?&K1O@+XBN_#2V.C^)=)^($7CG3UM/%W@[PE;6/@
MZ^LM,U;2/B9<VGAY4TS6M \3Z%XLT:ZM]6TI['5=.L=6DZ#_ ((T_$J:V_X*
M&?#A/$?BC6M8A\=:5\7HY-&N+O4WTC4M1U;P5J\.OR:SX5MWDO-1O-1M(=8T
M;4+:'3(Y9;/4Y;-=.MQ#OM?[%?C]^Q[\&?VE'\#ZE\5](OU\4?#JYF/@[Q=X
M9U.7P_XGTG2KZ21IM D\1Z;-:WLWAFZO9IKT^&IG?1X-7N;G4K6&*^N[R\N?
MR<^&_P"Q!\-?V//V_P#XB?&+X%_"K]IG4]9T+1+.?P'=>)/@5JGQI^%^H^)O
M'VDIK7Q/M?#OCK4/#(MYCJ@G33K?7M0U.T_L35[KQ3X9_M2ST=[:\C_F'(/$
M?*\UPN-6,I9AA,RJ83V^(P]*-*IEM-T*<,/.>&JU<52:C6<Z=:4:B=:GRU(*
M,E!SE_0&.X/QN Q6"^K5<'7P5/$2IPQ%5U(XV<:]256*K^SH54_8QC*C!WA&
M:Y6VI2.?_P"#@NSTCP5^S5^R]\%O!<PTSX9>#OBIXA_X1?3+B]?6KC1-%7PE
MJNJ:;X7M-9O8[S6(O!?A=M6U"W\-6&J7NH+H6FSR:-87BZ990V,/SN_[/?B3
MPE_P0M\/^/;;2O$-^TNG^'/$_CGQ38V<&J>%Q\+O'7Q=\'Z_X,\.:I?:=J5S
M'H_B'P9XV3PKXDN6U.QT2XE7XJ^.&72P%GN[[]*OVC_V"OVE_P!N[X/^(=*_
M:%\5_ _X4_%#1?''Q-U;X/7&E^!A\0?#%IX(\?\ PRT/P;I.G?$2XLM3T2_T
M'QEX1U*VUJ^TKQ-X%LO%=IX5G17T[PS>2!+T?+7A_P#9P_X* :?^QUXB_P""
M=OC+P/\ &C5K*Q\"-\+K?X@^ /$_PL7X':OHOA[Q#I_B'X;^,M)NO&.D6FL:
MU8VK:)X6L_$OA[Q/XA\/7^F:-+XFL]/M8[FSL+:O5PW&G#]6EAH4LQH.KA,S
MD\="5:%&$<-'GG'$TZV)="EB:+=1JJ\/*=2$J<TJ4DE4GC5X=S&&(QU6KAY^
MQQ.7TXX27LYU.:K!N$Z<Z='VLZ%2T$Z?M5&%1--U87<5_/C\'OAK\!M;^'O@
MJ]N?VJM.T+6TL]+MO'?AK5_V?OBU>P^$-8N+B68:6OB'PC/XMT_Q5%';QV=W
MH7B..P\.V>M1ZA'8^5;I;R:A!\ _&>?0O WQ>\7:+X7UQ_%_AG0?'-W<^'_$
MDVE'PCJGB"QLM8CU:RU'4/"T^J>(+CP?+=QM%&^DW^IZS>:>[ RF[>*2V;]=
M/VD_V>/VB_A[XET3QG\9/V,$_9^AT.QT[X?^,?''PPTK4/#_ ,)O&?C>.;59
M[/Q%H,FC7FH^%-&;QY%-I]C=^$_#NHW'@O5M;L)-7\*^&O"EWJ-UX9M>F^#W
M_!('QE^V/X2N_B7\'OBWX)^&WQ:T_4/,U3X1?$KPYXZT#1;+0)M:@M(OB1X:
M^*7AK2M5U77M2UJYM]3L?$GA+6OA3H5EH#%HH/$^KR:E8B7^HN)_$7@O,?#G
MA#.<3Q5"=;*L=E]3$X3VL,7/+94\+]2E46*RW+:F&2IUL/0M5KXQT*E&6'G1
MI^VG6I4?YXX>X.XBR_CKB/+L/PW4AA<SP6*A2QJC+"T\P4L7];C2]CC,R=>7
M/&M64HTL!&K0JNM"M7J0I4ZM;\^_$7Q:^!X/P<U_X:? _P :Q>-]+U+3/%-Y
M:?&3XC>#_COH?B*\L/+6?PYH_P +/#_P%^%^CW.B:AN<[O$VJ>)M1NQ%#9P_
MV5Y-S=R?1_CSXT:C?_!3QOH_A7]G3X!_"KP])I&EZQJ6K?#CPQK<'C'Q"/"N
MLZ-XGT.PN]1^)_BCXC^,/!=M-J^D6DSV?P_\31:?JFHF"WO9;W3$@L)NH^-?
M_!*K]IK]EV.+QS\6_A#;>// -EJFA_#SQ)KOAOXI:19Z7#!XBU&9/#_C'0?&
M5OI#2:+=0:C_ *)X>U#QOX OM(NI+^UT?6?AM+=::LUU@_!?]G/]IK]H*Y\2
M?#'X<_!FW^+FEZ%9WC2_VKIFIZ-I4EOISKK4.E7?BR*[\+:;I_BB*)!<6MS/
MKFCW.N7UHR>'8Y#?BS7.AXH<(YA@.+LUQV,CFV79AEM/#8''5<7#$4L37IY5
M6RZM3S+$1Q-##T)*I5I3H4ZM"2HSE"5.TH*-/>OP+Q%A<1PWE> PM+ 8K!YA
M/$8S#^RK4:N%PSS%8VF\OI1ISJ58RHJM0Q%>%52KQ34XRC-Q/(/V2/CY%X!\
M)>(AJO[.OP$^(^OW_CS7-8EU;XJZ+J^K_$O2K;Q%::*;:/0;76?&GA/P_P",
M-+AO[*]G%EKUOJH2^OM4GN(,7:Q3_LQ^RI^T!J_BG4?&&F_%/X7>&?"?AQ;)
MDT#4O"'P[\)>"OA;X(E;3-0O+?PSJ?@[PGX+T;PIX+\;Z^FEZMKGAOQI=?;-
M?\9^(=.OM$D\1ZM.VCV4'Y2?M"?L[>,/V7+?5=:\<? C]H;]FOQ/)_PCMAX;
M'C*/PQ\6_@SKNIWNO:.VJQVOQ@72_ !\&01Z(-7O?#>BJOQS\0SZA'9:#XAU
MF"RNIO$%G]O_ +#/PE^-_P"T#\//C9\+? /B?P7>?&_Q#'HOB;P5XY\::/%H
MEI9_#CP[)IDOC#PW+XKT:\M]5ME&N26/A]=,O/"WBWPAX@O-8TC5/$.C?\2S
M2M>\.?*\5\=<*9SX0U,IQ>'G'%X.IE_L<SA5IU<NP4<)F$)?VA]=GC,1*-">
M"KS]M3P5'V2:DIR?NM_1\.<+<097XE?VK2K8=X:O0Q;G@V\5''XOVN"G&&$^
MK/#TJ=2I'%1BJ4\55C-QERR]JTFOH?1O^"PMM\=O&WPM\._$SX(>%OAU_8OV
M&RM/CQH/C;Q3XL^(&DZIHNEWGA?PIXHO-)M?!_ACQ:_A>72-0OO#>N^'O#OB
M_6-5LO#WBOQ#/:Q^/_#4>J?"GQ7?_P""Q8L[O]DGX2_$W6I=:EN+/XM6UQ]I
MU+PYK0T72CK?A'5?"&H^#H=3OO#/A.[TJ")O#5CJFCV?BKPEX5U2_LVDAN],
ML[TPWVH?GQ\2OV!?VF_V,;^W\??&SX6^+M \'>&?[/N=&^+/PX_X1SXC?#W0
M/$>JW=OX=\')XKNM-\5^#[_PO::OXKU72--MO%<?B"QU3P_?S07.D^&/&U\%
MT:7M_C)^PK\9OVA?#L>G^ /B#\3?C(NI>&K6]U2Y\%6?QF^,MUJVJ: (-5L-
M2\9:'XRN]-\16FA:CJ-GXEA\.>+VM=9TQA:ZD;'Q!J"I!9:A^&X#+^&XXS*L
M7E&,P^%RJC5YYUJ6)J8C .3E6]M'Z[5Q-2GAJW/5THUJT(7?NT5'4_6*V8YP
M\MS+#9EAJE7,JJ4*&'E3IT<2X))QE#"1H0J8FG3C3YG.DJSC%/GGS:+Y:_X)
M[^+? 'ACXQ2?'?5/B3\.O#%C\*[F!(O!7B&ZUZ/Q1X]MM6TW7]-UZU\ 7=GX
M4F\+1#PWINHKXCU^X\5ZUX9@>Q29=);Q#JMM!8W7]'/QR^+GP)_:4\,> --^
M'O@?4?BP;+P8_@^TN)_#YT;Q;X1UB^\11ZI-J=YX>U'7-'UG0-'\0VEUJI\+
M:OK+C1-9\0V:VDZMI4HO7_G6_8E_8X_:I^&_[1OPH\-^.O@O\4?A7XF\,>,8
M_BC=6OB6VT7X::_JOAC098':#P5J7Q7CL?"?B75]>EMG\-Z?'%'K5C:-J$LN
MI1QFUG5?W_U[XU_##XI?M_\ CV+0_@AX?^-G_"">#?A/\&/C/;^--*\$^&/&
M_P ,/B)K/C'6K*'QQX(N=036]#\71:!X4L=.TWXD_#3PQ!I_@CQGHO\ 9VHW
MHT"+08GO>O/J6'J9G+$8.N\73P^65:].6'GA98>E0C.-&GS5H3<:M+$8F4XQ
MFZKAS0E16T5'')JU>67^RQ5".&E6QRIRC7]LJM:JZ:JO]W6UIN%"$7[L8I4U
M?9MGX8?M]>/O#MC_ ,%./@CXIT/0-!75/@%\+?@?X@\3^&_&=SH'B/PMK7CO
MP[)J?Q9TKP\TW@?Q#=Z#KVAQ:=XH\):-=#1O$05[/3;\23)J$4EHWZ.>!W\?
M_MRZKK?[8&D:9X8T_P"-5W\8? 4>J_#?P%JC^$M(\4#2+;P#\/K;6O VL^)=
M1UBYTSQ+K6HZ9%J&M/<^(=6TR'6=1N&:QTO27MC=?E3\?-=^%/CK]HSX[ZC\
M5?A!J_PN\7^*OB9J]^VJ>%]6U+5/$G@WPTE_=:;X?M/$/PG^(NIKIOQ&T<^'
MXM&CT2X\*^//@K"\$8UBTUOQ)I<MIHTOZ<?\$_\ XP_"#X'?#W4/ /AKQ5;Z
MAXJ?7;KQJX^):V7P5\%QW>H:-I-CKO\ PCWBS3K_ .-$EYJ=[H>MW2:#I%AX
M=TKQAXKT9+^QU/2?#7B30[C1H?2S+#T999@:U'"UZF*RW 4<+3K5&ZK>%Q/[
MW$1=2CB)453EB72FING/$4Y4*<J52FE-S\K UJJS+&TYXBG##XO%5<3*DG."
MCB*5XT)>RJTJ5;VE."F[J\.66B;:D_T:_8Q\=_L3_!;5/^"BNKZQ\0/@UH?Q
MH\3_ !\^/OB?XF0?$"'PW\-_$C>#_"FCR6VB>#=+?Q+=6/AWQ/9Z?X@T+QCX
MON])^&C:IIVCZMXK33)K=]5T>-5_)C]B37/BIIFF?"']HGX53Z78^+_!6B>$
M=3M[91J%Q<:B^O\ AU-+UKP\NFZ=:75SK>G:QI>IZIH^L6<BEY+6ZG^R0&>!
M)(?RS_:+\-^/O"FK_$;XD?$;X7?$#PGH_P </''Q#\:V>J>*?"OB_0/#?C#4
M/$VM:IK%Y/X.O_$NB:?::W90WDIGSHDEQ+'Y(>YBMIXY8E_=S_@FA<?"6Z^'
MO[(^GV^K?"CQ5I.H> O"EW\2=*\)?%;PYX<^/]AJ.BVGB:TNVN_@=XSUW15\
M4ZCX;\3P7T5Q=^!I]6UKQ)\+=(TCQ;86A\2*/#DG!7R3"Y;0S?-XYAC<?7SG
M'X.I6IU.6=/"4,#DKHO"4*F&J3Y80J)QA&I2I1I4H0;;;J<W;ALSJXVO@,O>
M$H8*GEM+$*E.FY1E7GB,?"?MJD:M.#4GRN7N.I*I*<K)I1<?6?\ @LWX2^"W
MPO\ @#^SWXE\-:)=:-XS_:,_:#2\1X?$5UK^B2:1H?PW^('B'Q$EK:1R7%L9
MXO&/CKP?:Z+<F"-K+3]0U&*P5+2]N<?D%\$OAKX*^+-EXS\.>)/&7@SP->GQ
M/\'=(T/Q;\0-=DT#P;IDVI:UXRU+6+37;A$G$L5_9^%+:*UA,,LDDD<L"O91
MS/J$'U-_P5._X*%7FH>._B)^PSJG@SX=6'P:^"'QI\.Z]\-OBSI,'Q!E^(DW
MAVP^&>HMH6G>('O?$6OQV<DNC_$R[T_7YK;PEIM_9IIB:/J<B3Q7XN?A+X&?
M%/2]?B\0_#'PYIZ>.!XBUSP9X\\0>*?#&D3:N]GX4^'FF>/+*T\+:Y#)XNT"
M73Y]8UGQM#K=GKL6OZ+*;O2;33M2M1  R<&!P&+R3@K&5\SPGME0K9AC)^TS
M'E6,P>)S&GB<*WCJ5.+PD%@J].G&"ISKTIWA*=FY/]+\.Z<N)_%W@W)<HS99
M;CL9G65X;#8V.5TL?4R['87"8B4ZRRO$IX?,7#%8>5;V-:5+#5E&3J5(NG3Y
M_P!!OBM^Q)XN^&W@RY^+-UX\^$^M^#OA9X(USQ%XB\1>!?%,^I6<5AX]_MCP
M_:^7Y^F6-I>ZQJS7\%_9V5I-!*[PNNS4@9=9OO"OCW^Q/\2OB9XH3XD?#&QL
MM5\/^-OV<_V;?BK=Z==^(XA=SZ_XU^%/@>R\4;YM26R$^E:CX^T+QO?Z$UO.
MT:1:?:VT8"PHQ;X\T3PIX-\.>'I8M;\/:5XE\97EAX'\*:9J5QIO]HZC:ZO:
MB&Y@-MJ.J>&M)\-:;IEM'8V<FEV$7Q"UK7+F?3-,B\1+8/=.WW__ ,%C?V1M
M,^$'PE_8GN?AIXSTOPEJ'@/X?3? ^VT34IK_ $'Q5XG\.^&;27Q:GQ#L/$-K
M +.;2-(\1Z]XETSQ#"ESHUC9:MXUT<:6ALGO+;2/C<BS3(/JF4UHY9F> P.:
MYQG%*G06<5L7.I/+<-">(K4<;B\K4*=.&85JF%CAW2KQ=1XF5+$RA[T/[ \6
M(<>9)XS9?PM7X\X9XGXFP_ &&PF(Q<. J&5X'"4\]Q<L?EN6YID>1<6SE/%X
MO!Y7A\=_:D<=E[PV&GA*E;+94L17C+WG_@DCX:^,O@7X5>-?A;X^\(>*AXO\
M$?%6W^(>F07'BVWU+3=5T?XC6:VM]KNF&QUU%M=0M_$6BZM%KXNG,&J_V@CW
M/DE9[EOQ[_:!\/'2/B?\7]$N;?\ LZYTKXJ?%2WFM)GCN)!J2^.=?GO(Y9[9
MY(GO5N?,MEN()"CK $B?[.T2#[Y_X-]_#^MZM\6_VE/&WB'X@S^(OL'PQ\%^
M$--T.XUG6]7O+@>)/&4^K1^*V35/M%E#INGWG@>[\-VH!GGN]4U.24-9Z4L>
MH7OR'^WC\0O WB3]L3]J&_T+5/[,T ?%C7;#3[V_N+*ZB\27FCZ3I&@>+?%-
MM:H\=_<VOBKXA:5XIUJV%M$OD0ZE9W#-<B1T/TO#7U?$<:<0X;!4<7'+XY9E
MV.YZ]6-:>&KRE3YH5:E.C0A4=7E7)[.G]IP:YU+E_D/Q0PF.RS&5O[7Q67U\
MUGF=?ZZ\OP^)RW 5:M?#1Q5;ZOAL;BL=BJ,E:G6J.IB9TY2KQE1;C9+/NO%N
MF:S^RC^SEX"71[V35O _CG]IF+5-9D06NF7&CZYX@^'7B/2=/MF,1?5M3LM3
MU7Q ]RXGB6PTR[TP@-=7%TJ^+VNC0?\ "->*+K[1>13VVN^&=+T^)[=)[6YL
M_$NF^++F[U*;49+J.[M9],N?#-A:6EI'8WD.H17&HW-Q=Z;+I5M::KZ7KL/A
M#PK\ /V8]?TCQ;I>O3?$_0_C!XSUF*PEF/\ 8&LCXI7'PYT[P[<6EQ%:WD=W
M]A^'RRM<&VCM;W47U6VTNYU*+3I+B23X7^&_^$V^&7[3UU#?P-JW@#PQ\)?B
M4UE=1LLJ>&8OB<GPIUZ;3(21+97.EWGQ=\*W5U'<12"YT6;5KJ:>&:"T2Y^J
MQ\HJCC<7&HWAO:/"J3BXV^KXF&!4E3FHS@G5H-<T^5.+<W[LH'YGAXWE1H-J
M554OK#BY.3?UBG+%MMZ>ZH5KQY;*R5U=LQ?VT#/8?%'X90Z*HEE\)_"_X,V-
MBD9)*QLEUJMK9R1[F(2YL==ELY 6RT5\&:-MWS>?ZL/^)A"SINMKQ5-RA/R2
M0W"-8SQ2'<&^17!++Y9;RE.0<5G_ !N\07'B[5O&OBV/S+>:].B6.AACO:&#
MP]X>TC1?#X!Q&6F@T?P_ITA0;5C<2 AR@#^J?&73;&U\>>+[?18S%I=UK&E^
M+_#L&WYH/#_Q+T?1/B-H-E&X$9G@MM!\8:=:Q3HJK<06L-T%42L$XG#E>'I6
M:G.G6BI)7LU+FYG?K&<^5=/)VYB%-.%:HFI*$HJRU7+).*?X*UONN?OU_P $
ML/"YU7]B;0]%TOQJ++7O#OQ.^)0TW6H-&N;F?P']EU[2-3TJ#7;2#4M*&MZQ
MY6H274>H?;]+GU30X[.SL-5TN.QO;.'[7\'_  G\8^'-.?0=1^,.E^*8&DNK
MR_U'0OA-??##49-6U>ZGW:A));_%KXC:GDV\5B1:6^MVTE[)&U^][FZ6VA_/
M;_@BW?-<_#O]H30I[V^D_L'XC>"]>MK:"-1%"-9\)SV4EP)$GM98YG?1U@$;
M7)M)9?-EN;>=FBFM_P!KKNRBNX1&VH'>(K.62TO;:=;FY0""W18%N)KB&ZE>
M4PNT*VXAN!-(;:2&"!8Y/Y^XKE6P7$N=T5)-5,:L2^>$&[8JC0Q"2?:U3WFK
M<UK-/5'ZED$*.(R;+JB4ER8?V*M*2THU)TTVKVYGRW;\U:R/Q9_X*<_LS^(/
M'_[)7C77Y/%FMZ_<?!K4K'XD:+I^LP2W<+Z'I-KJFD>*VMXV7[7 UUX/U2YU
M2<ZE<ZQOU+PYHMOI]G:Z5+=ZO%_-G^S-INDCQQ/+K?AVV\16UIJBOJ.A2W^K
M:?J,VGFUCFG?PAK^D2#6O#'C&QN8(O$7@KQ%:YO-)\2:#9065_:_;9;Z+^Z'
MQOX"E^(/A#QCX/LKN.&R\6>!?''A*]T?4]/C:"\O_&^CZOIT5_,T44-U8SQZ
MC?--+L>2&:YNI;R:*ZGGDGE_BTT?X<ZUX>T>_P#%'P_\.Z#X/G^'5SX(NO%'
MB;5/CSX;^(,^GZGJFO#PKH>F^)O#R>&[?1?"MGJ7B&XOM)E_X2>.2UM[BWFT
M+63=-J5SI5[^@^'F+Q6/P&:4(U(N>!J4)P5N2IR8V#B_9SBHQLJ]*2;J5(\L
MI1Y7.3<7\YQ72HX;%X&KRMJO[6+DVI^_0<9N_-=JU.4I2Y5>*5VE>\OZ7OV?
M=6UKPIJ<6D>(/%%SXK.B:KIESI?CR*VLK'Q'XB\."UMO$?AW3_C+X*M/L,=M
MXVM]$8V]K\5_!36WASX@Z-):>+DMK/5;O^S%\;\9_LG:OJ?@B?X:67PZ^'_Q
M U>2UCU[3?BMJFF>%+74-)O])US2+;P5X4TWX-:5\2/A9I^@>%=+\*ZOXLLO
M%?B'1_BAX8MM;M[32+>^\&1^)YXO&.E>J_LX_"&X\:_"/PKXDN]4^$^AW=KX
M?@FT;4=$\6>%-;M_"9&;RS7PK;GQ+=:QI?PZU34=1N[:\^%!\1:[:_"7Q19:
MUIOPX\8>*/!,5K%#^E)TUEAAE@N)+1KF&$2PZ=LGL[>%8%=E4VMU:7ZQ133>
M89#%:QJ/("PNDB,_E<1UL?DE?#.=!T95,56JTO:)QA4GA6I1<71JPG*"=3GE
M!.E2JWO.E.[3]3+OJV94IQI2A7C&@H5%&TK1K+9<\.17Y7[T5.2:5N6US\XO
M^"F/PED^"7_!M[H'PXEU@ZX^D?M<^%KMKL74EW;1R:S\8O%VKSP633W6H7%K
MIYN;R:YLM(N-1UJYT&"YCT.;Q5XX?3F\<>)?X@U3 ?DXRV V"JX.<@<#&>>?
MQ-?WY?\ !</3UTK_ ((-K:(%&/VJOAK*T:6RV@B>;XD>(7:$PB23:\3$K(S2
M,SR!G8DDEOX$1T_S_G^7T%?ZW_12KU<5X/Y1BJS4JN)QE>M4DHJ*E4G@<JE-
MJ*TBKRTBM$K(_ACQGIQH<:8VC"+A"E+$4HPYG/EC3QE:*7,]9-):MI7W*S</
M@E> #G8%SP>AP3['!]N<D4;U]?T/^%6J*_I&R[)^M_TL?DS:=KIZ*VC_ . -
MQD<8P0!SGI_^H^O]<?9_P+_X*,_MX?LP^ ;?X5?L]_M7?%_X0?#>TU76->MO
M!?@K6-*L=#@UG7;@7>LZDD-WHU[.MSJERHN+IC<&/S@3&D8=PWQ>2",J01D9
M/4#ZXSDCC ]<9P*<5C .&XQE>ZX+$-D8);)&.<=21G&*Y\3EF"S6BL/F&"P6
M/P\:D:GL,=AL/BZ2JQBU&K&EB:%>"J1C.48S4.>*E*S2>O1AL=BL#4=3"8BO
MAJLHR@YT)RIS<6U>+E'5IM)VUVOIN_TT7_@LY_P5?(4_\-^?M&$?Q?\ %2:$
M0 "W.1X<STQD Y.0 >]._P"'S?\ P5<R1_PW]^T8/KXDT3'_ *C_ /3ZU^:.
M!Z"C ]!^5<_^J'":VX8X<VW_ +!RB_\ ZK+:66MKO=[Z]7^L>>_]#?,O_"NI
M_G\C],/^'S/_  5=Q_R?]^T7@=_^$CT3MUR?^$>SQW!/ P3VI#_P69_X*N_]
M'_?M%C/&?^$DT08SQU_X1[\O?%?F=U.% SG ; PN ..AY!/MC.,=ZD*;0NXY
M)901QC[V>. >G]3Z8TAPAPI;7ACAMW[Y#E'_ ,ZQ/B//;I/.,QN]O]KJI_<F
ME\W_ ,$_3!?^"S7_  5>('_&?G[11#;>GB30<]]^#_PCN>,#&"#SR.#3U_X+
M,_\ !5WI_P -^?M%D8Z_\))H)(Y[C_A'#]<Y)Z<=A^9H7;M <;06)SCD8!(Y
M[8R2??/3D3Q1))C(/()R#D$J=O!( P<@Y].@-6N$.%-?^,7X:3_[$&4:?^8Q
M?\.92XESY:_VSF26NV*JW[ZIR7;2WH?IC'_P68_X*LL"6_;]_:*R'QQXBT/!
M&%QT\.X&68+SS@CGTE?_ (++?\%6%_YO[_:* SR3XDT+ SG'_,N$GTQ^0Z5^
M9<0C7JW1\],]-IZX)SN4<9'0': ,5,Q1A\I)P1_>'8XZ^G:G'@_A-M)\+\-V
MO_T(<H\_^I7^IE+B3/U+_D<YI97O_M=9=O-'Z6_\/E_^"K)4X_;Z_:*!XR/^
M$DT(]PO7_A'<^_! )!^4')H_X?+_ /!5G.?^&^_VBN1T_P"$CT/'7/'_ !3G
MX9STK\T> ,8&._ ]0>?R'Y4JC))&.<$].<<#  [D8[\\>QV7!_":5EPMPU_X
M8<H=_ORI_A9>5R/]9<_MIG.9KS>+K-=/[S/TN7_@LM_P58X_XSZ_:*P>_P#P
MD>AGC@=_#N.O4^]/'_!93_@JP3@?M]_M%]Q_R,>ACG/_ &+@Z?EZ^_YIKPOX
MGH/4G/ ]_3CTXIZJ&W#D'N1CH1C:1CL5.1^'K3CP?PFVD^%N&K?]B')]?_,4
M3+B7B"S?]LYFNS^N5GU72_;^D?I@O_!9/_@JN1G_ (;Z_:''U\1Z$<<D?]"Z
M/3OD@]3WI1_P62_X*K$'/[??[174CY?$>A'L,G_D7<C!R,9[=.M?FF %_GS[
M #^7Y=.E/4C=C/\ ">,^X&3STQN],\BMEP;PC>RX5X95[ZO(,G=]&[_\BMZ^
MB,7Q/Q KM9UFG_A96_\ DC]+C_P61_X*K_\ 1_'[1'U'B+0C^7_%/X_0>O7F
MIX_^"R'_  54(!/[>_[0Q)QD?\)'H9&>O?P\0,CTQP?I7YG@9ZYYY(('Z\#I
M4D)^]SD!VQP..%XZ=BQ%="X,X0O%+A7AG?\ Z)_)MM?^I5;M_F<\N)N(>5_\
M+F:+EU=L;75^EOC_ ,C]-%_X+'_\%4R"?^&]?VA.,YSXBT(X "DG_D7L=^?K
MU[4]_P#@L;_P51"J1^WK^T-SCIXBT+N,\?\ %.X]..WI7YK0@,K$@'+,.F.,
M $<>H'-2.HVC@<'Z\=,<Y]OR'I71'@SA!-)\)\,6;M_R3V2];O\ Z%)RRXHX
MA4U'^V\UT>O^W5];J]K^TOI=?B?I(?\ @L;_ ,%4@A/_  WK^T-NR" ?$>A9
M_A[?\([CUX/!_.M&V_X+(?\ !4]5.?VZOC_-R03+XBT7(&." /#PP<[E)P#@
M9Z'C\RP%*@8&, $8QSC_ #^9J[ !MZ=\_B2<_P"?<^IKH_U*X.Y6_P#5+A>]
M[+_C'LE]?^A3^)A6XFXAE!J6=YL_>_Z#\4DNVL:T9?C]Y^EDW_!9#_@J<ZG;
M^W5\?8B,G$?B#0Q@ C)R?#WUXZ#'T%(O_!8;_@J=U;]O']H3D8'_ !46AABW
M&>/^$>VKSZ'(].P_-ANA_P!U@/KQBI\;1EF .>3D#/)(&2/3V/0<$#!UCP5P
M<H1?^J7"S;YKWX=R1[-=\I?Y'.^)^(H12CGF;+7_ *&&+?W-UI/IW?H?I,O_
M  6%_P""I1Z?MY?M"$CJ/^$AT/&",@G/AWG(R1@XX[8-/'_!83_@J42H/[=_
M[0F"><>(=#!QACG_ )%\C'&.@X[\5^;D8P,^I_' !P3[[LGJ1D\$\&I%&YN"
M1@,<@ ]]N3QTY;OT.3792X(X-<8N7"/"DF[;\-Y&^BO_ ,R=)ZN^QSRXJXD4
MFEG^<)+73,,3O_X-\S[R^(G_  4]_P""AWQ;\#^*_AC\3OVQ/C7XZ^'WCO1+
MSPQXR\'>(=;TFYT7Q)X>U1?(U'2-2CAT.WG>SO86,4ZPSP2LA*"0*Q#?#8QM
M)SGKU_X%GGN<DC(]?8U Q P?]I2?HK*6)SZ =>W%6!C8V,8[8ST(+9YYYSG]
M*^AR_*,JR>C5H91E>6951K5/:U:.68#"9?2JU5!P56K3P6%PD*E502IJI.$Y
MJFE!3Y$HGD9AF>89FZ=3,<=B\;4IKDISQ6(JUY4X2FG*,'5G+EC*6K4;7:3;
M=D?O9_P;68_X>H^">G_)#/CP/RTC13CG_>/_ -:OZ?9[U)KN[MBMV1%>7J&(
M%U 8W<H$<<*J&^<C)2, R;F8A<L:_F"_X-K>/^"J/@GC_FAOQZ]_^81HGU^G
M/_UC_3<UG;/=7N]9H7;4[X(+2<3SG?<3)(TD;7EL-[E2K6ZS1^<-QD>WCW2+
M_CO^T:C%^*/"[<5=<+85]=+_ %E/2_5)+7LC^_OHE+FX.SK=)YFM4VG\<GO\
MDOO%N+^TANUMY8);>[241^3+"T<T#H0WS33?O%N%E;8L1$;K@P?ZT>4+$FK6
MLT$AN+6Z<*K%F#[4G(W[XF\R21N@BW.(0%4-*JR.I%5X6FB>'[)%<26]JQ*L
M-J,KLL>_9!;WUS!;7+JBIYD,\K[0FZ601*JY5[I$.IN$N+K6K5@RL\.G:KJ%
MJ9M[_/$\UG<Q3R*75=MN'\HSL[L5.!7^=<Z:;NW!0BH\T>:^FM_<3NV[^O2Z
M1_67*M+-W3?*EU>J:;;N^^K>NQY_\6_AE\+OCMX&O_AS\4_"J^)?#%S>1WUM
M:0W3V&H^&=7MK22"#Q/X<\06=VE_X=\1:?9W5S!%JMHJSI;3R6]R)]/NKBV'
M@OP'_8;_ &:?V>?$>J>+/!>D^/=9NM?T'5_#.I:9X\\=OXQT34M'\07EA=ZK
M;ZAH>JV0T+5)KV32=/W3:UIFL3^7 (E/DS.A^R[31]6\VXD.GW;VZK MI-)(
MTMW/$+=9&-RD]M:-;*DQ_P!'6.\U!Y8WWN;>:)5FOI"UOB5VTY)RBD1W5R)\
MR+E@CVX@RCQ%5:8&5E#,I@D9A,J^A2SC,<)@JV7X7'XFA@,4^:O@J&)J4Z%1
MOE3=2A%J,;\L7)QY.>24I<\DI'!4RS 8C$0QE;!4)8NEI2Q-6E2G7@K;0J.+
MDEJTKW<?L\K///#'PN^!?@'6+WQ!\._@1\'O >LWMI-;7_B;PA\*OAMH7B2Y
M@N,R7-K<>)O!_@_PSJ-Q:W*VZ-)ITEPT$XMP)H9#"@KU"'6I96"1VL0D&^1;
M>WW"5&2,&:78TSYE=0S#RXOWBD(I=59!#)>0^40USIT&PJ=RPLZNRR*ZH(V2
M"5XI$3:P::WDA4HWVD11+')#(L5_&5N(DNH_*:Y2:W1V4+&/FN8U<L,KA!]K
M6:3R\H?-=]KMYM3$3JMJMS5G:R=6K5J.UV]95)U':\FU%-)-Z)'7'#TX64;Q
M2?,E!1BDUI>T5'5Z:N[?VFWJ1>*(?#WQ \/#P5X^\,Z-X]\$+))/+X,\=>']
M/^(?A%;J%Y"DTOA7Q=IM_P"'DFMG>8PRMID]Q9RM,ZL'D=UY;P_X*^#_ (3T
M_6-!\#_#GX/>$M'UN58O$NA^!/ _PX\.:1K5Y+8"W-EXFT[P9I&FZ;J=])I]
MREJVF^(K.YO(]/NXH9H/LT\ ;M+33K>69(H28DFF3]W#:6;E)\B7S9(I-1LX
M)Y96;<8YV@(D"2-<,=FU\D,1)>YEE+L%CWLES*SQQ*(T2&5E#-YS2,S1HZQ*
MQ ?=;H)::Q-?V:I\\O9<RM2]K545*"7++V2JJD^6RY4Z+46KJS2%+#TN9U5"
M]1<SBXPIJHE)/G_>.+J>\M9+FUU;<F<AX6\'_#WX>6=]I/PU^&7@#P%HVJE8
M]3TKX?\ @'PKX$T?6$DMTLFBU?1?"7ARPTW442R5+3&IQ2V[VL1M9/*@;9';
M\*Z#X7\$:6=%\ ^#O!O@#P^))IY] \!^"O"_@;0C<;7@6;^RO"NGZ9I#7,R[
M(7NIM+:99 $9=A6=>N;[,T,4915\MU<J)T<2PX=UMYK:..*:/_63,;G[5)YD
M4HC6./R@TB(;8LHFD,9C)!@C-Q]GAV["@B56E+F"U/SR32PE>"Y174+DYS?.
MI3FU4DI5+SE+GE%64IIR:FXK2+DG9*RLM":3AS024ERIJ*;33_NJRBTE92M\
M+:U5]XGE@CW@W+Q;D)?>[/*TIV1-&VU98I7VL#(]W(B[&4;'#&,1I)%'L=)[
M([C&CR-;QS;6019)3*#!P/\ 7)A=T7ERRA40L?1;.*:>[C%[ ]PF'B\RXMX;
MD!I?*>>&ZU&]6V,I2:,2"*3:C2%$S'A;5M#$TMJQ=8XP94W0P>1"9 CR/'%-
M(L\\DJ. @GC9DAD*S2+/ SPKF_92C[MY>\G[\$M5_=?-JKZ.UTWHTU<W7/=W
M<5!W2BEK9VZZ:NVNDNZL9\M_8^=%&TC17%[F*(3+% TS%9$?[-$D<C7,^U21
M';PO(5B)=0@\TCO#(0L<5OJ#IEEBNK:XD$3JVT&3+0-*(Y&(CMU>W3S 8[S!
M5]VR)?,"0PF1%D<".&2^$2AO+)50%B9'7[26,KNP4(SJ!&0P%<^5:A1]I,B,
MXC4BYGL_-D9O+E6.^N97,I2'<SVZ1 E-I@GYC4*322YDGKI=)ZO=^]S?F_3H
M7KK9[JVNNCLM;Z[+UZ&9>1+K6F7FCZC96>L>'M2B^SWVDZKH^DZUX>OK-KB&
M<6FJ:5>V]SI-_9VFI6\<B1W%M)%%<6Z2N[7$<LQ\L^'WP*^#?PLGUF^^$'PB
M^%_PQN/$LEO<>)+[X=_#?0/!]QKLD4UU-81ZS<>'M)CGU&*REGOI;&WN9Y;*
MQ>[8V*Q LK^UW$=M>.!/;6M\'$+^;.6G4B/9)#=1VQ\K[6S>6GE@2P112*)A
M<RL?DL"SFDN&"6\DD2_9G:6_@6ZN8X8Q()?LH9IO+CN851W@*K'"Q60R2!0M
M7&O5HTZE.G4J0IU6G4ITZE2%.HTTTZE.%2%.=FDTYTYM247NDU/)3<X3E3A*
M4&W&4HQE*-U9\LG%RC\I+Y7=_(?''PS\!_$6PL_#_P 2/!NA^.].T[5X=9TG
M3/$^AV>II8:_:VUS96VLZ-+)C4-,U6WM-1U*U34-,EM[N:QU+4;**9+>\NM^
MAX4^'O@OX9:/=Z1X$\":-X'TJ^OQJ.I67A;P]I&BIJVL2DA+S5X[?S=2U36F
M12([_5GGOXX8C:">&*%$/I#^3$NYC;ER4!2?RIW4\M(TK3[5(\LH8T\DQ&(&
M,H08BDB3)&&>/='D.PLK&.()*F\7$4;2*)/*$A^1@ K1C8RB6+:H:Q5>5)4/
M:UY4.9U)8=UZOL.=VO.-)UG24VTFY>RYG9.]U<3I4O:NLJ5-56G'VO)#VJBT
MU95.7G5TVG::W?SXC5=(M_$&@:[X;UOP9?>(_"WB*RN=*\5>$]1\+VVMZ7XE
MT*]MH9+JPUKP_=2:IHNHZ7(S>4MCJT<EN9;1)Y+?S(X&E\A^%'[,?P'^"&L7
M6M_"/X067PTO[S3;C38GL];\47=E:6%]=6M_>Z;9>&]8\:ZUX7\.S7=QIMA-
M?)X<TK2I));46[2O$JPM]-I'M>9+W3EBDDNP\5LID>2V9D@9TU!MA-U*DDTH
M2\A@L(%M$BC6RB3$[OGU>"T!L/+MHFN4$ 6]:.RN[EGF"106U\TNY9G\U&CL
M-\MT]M'YT%N\:+/&XXW%8>C7PU#$8FA0Q45'$T:6*KQHXB-XW5:E"K&E53<(
M\WM(OFY8\U^5(4J%&K4I5)T:,ZM*5Z56=*G*I2>MG3J.#G3:UMR35KNUFVSE
M-:T.UUO2]4T77O#]AK>@^(-/N]%UCP_JVF6.J^&M;TS5('%_I6IZ1?1WFCZA
M87]O(_\ :&G7UE>6=XG[R:W".C'S_P"&WP)^$?P9743\(?@K\-_A)'XJ42^(
M9/AOX2\+>"]/U(68-Y:WFKS:+HEC%>R02/<?8=/4V<#7C.QG$X66?VX131+;
MK$FE>2Z2#SS=P0Q[ 6=L2I:W,:R"8395PA\WRAYCEFJQ%J,>G2Q6*!)#*6)N
MK2U>YB0.AFWW3P64!BAA2)P\DSM$^Y0HF52&YW7K>PJX>%2K"E5:E4HJ56-"
MK)<S3J4E-4*SN]'*C5:_F5DELJ,'4C4J4H3G!/DJ2A&4X7T?)-Q<XN2NI6DK
MWUN]3Y/^-/['?P%^._BK0?'/Q?\ AQ<>+?$FA:-<>%-"U1_&WCCPTPTJ[NH]
M6DT-=/T#Q9INE74,]V(=0D0VDMQ=W"6MY=K=""T2'QCXH?\ !+W]DKXH>,]&
M^(.J^!?&G@'4]'\$:5\-IY?A1X\\1> X-8\(Z#!<Z7I&G>(([.],/B'4=-TZ
M4:,=2O1]JO\ 3\0ZG)J$L3^;^DJSP1*RVTSL9PP6%8XVM_-\Z3RU\N#8THG9
MW,:PV\#()H8Y6D!\V26*]5]P^TO"85,L4K0P!( )3$\$,8G:%WF)G58!$MS<
M,UR989(XIB.K"9YGF"]A]2S?,<-#"TZE'#1H8NM"GAZ55)5:="DFZ5)-KEER
M4EHI<LHW=^>OEF6XEU77R_!U77G"I6=3#TYRK3I_!.I)QYISCHE)RYM(W<N6
M*7QG\;OV./ _[1WA/X?^#_BAJ?C>\\$?#-KW3- \/Z7X@TEGU+2&M[6PTVXO
M]4\0Z%JWC;2O$%K96$1DOO"7B7P\+NXO=4%ZVH'56+^2>&/^"8W[%OP]N]'U
M#2?@CK&HZCH>J6^I:=+XJ^)GC'5&M[^]U%I]\5E<^(=)M5BM+VZ:Z,D!BO;&
M53?64RS10[/TD74M.^TR),3#.\D89([80!(XE6)%BC%_*ZP0J@0I;^45$?EH
M@D"M#!_:%F6GF^U2VLBSO;S74]XD<#6V/+8*)IX9(K>0 B29YH<PJ+>2&2+S
M95Z<'Q-Q+EV&6#P&=YE@\)&I6JQP^&KJC!5<1.52O43A14G4JSG)SFZG,W+1
MI>Z98C)<FQ=98C%93E^(K*G"E[6OAXU9>SIQY:<.64HPM!?"G%[=_>/RE^(O
M_!+/X$^.)M4UCX&ZUX[_ &--:UVZAN_%J?L[ZEIX^&'Q GL3<-'%\4/@MJTK
M_#CQ?<PR-++8ZA=65E);WOE-=27(6\BG_+CQI_P1<_:TUSXNKJ]WXI^!OB&P
M\.W&BZ+\/_BKX0\ ^'?A!_PDVD:#KP\4Z'XL\>Z3\(X]4\9^!_B_8W[O=V^I
M^&O!&L64Y\,6UW_PL^SEL],O-3_J7.IVLDC3QR/=2E"V%N,Q7"6[1Q@SWC+.
MXE";FCCN(V1(?+DB9UE244[O6+6*0@0RPPR/' 6MI1-(^;VV=IIHWMX8G%M<
MI=71>]N,&>TLK*VAD;49KK2?6RCC[BK)9RJ4<7''2="K0A_:5&GC:D(5XN%:
MV)FZ6+ESQD[JMB,5%-1?)I9<>9<,Y%F<80K4:F'?-2G..%JU:-)^Q2]G'V2=
M2A347%2M2A1;<8W;;N_YB_VZ/^""OPPUO3_&GQW^'?B_]I/Q[\5;_6KGQ3J_
M@CQ)I<_Q^OOB7XSU:">]U%Y/$FH:IX.\<^&[G5]6C\W5?''C#7?B)&CWD*:C
MX=B^T"XMOGSX4?\ !-CXI_"N*\'PH_97^,%EK^K65LLVM:QIUIH=O=7D,+W$
MMO>WWB"U\-/:6]OYLL8+OJ>DS:A%9W=M+<NLL=U_8#;ZE%#DPW,B3/( TMQ%
M([+*RE7*0B&%()+F-5APGG-&TOV>*Z=XXGGIOJ%K%?7=^=2N;"YGB7,;L8#=
MO$\-P&EDB_TB2\EMXV9'W0O$0NY&)6:+T<)XF\2T\LJ97CZ.%SJC/VD&\R]M
M52HU+?[/4P]"G2P]2BDN9>VIU9/W4Y+EBXE+A7 8/.<+GN38[,,@S#!U*-7"
M8S)L3+ XW#8FCK3QF%QU*M1Q6#Q"DKJIA:]*<7*5I.,YPG_'#^T;_P $@?VZ
M/CYH7@OQ);_"RU\)ZG\.[S7Y!977Q#\$WVO>*5\5'2+N>;3+:35M(6=-,>S>
MXG$NM^<ZSRW'^G7+27<WYO?$K]GOXT_L[7>A:;\8_A!\0?ACI>@^--*T[4_$
M^N_#7Q#HO@:QOM<TZX+WNG>+]!TK6_ QN-=N+2S%C/HMWJ[7-\JV"&YO8+G[
M/_H=K=V<*-%<S:J+>63;)<W*1SR,1&FR5I;I[>>:$V\,+HDB/AFD^SO"GV:N
M+\;^%/A7\0O#>I>!_B%X:TGQ]X-U\VUQJ?ACQEX9L_%WAR^OM-OK'4-*NFT[
M5?[6LK>6QU6VTW5;)[6"SN-,U*W35;*6"]ABN5]#*O%'%X/#X?*\=P]E5;(J
M3?L\%EE/$8%X:E5J3JUH454JU85&YRYU&4J4.>4_>6B.S-,LS;,.(:G&*XPS
MZKQA4JPQ%7B+,,>LPS3$XBCAX8:C4Q&(G1=2<J6'IPH1DZ=6U%<B@[7?\A7@
M_P#;.^+'[&=UX7UOX0Z5\+ET#XB>'O#_ (4G\-^,O"#WT.L:3X,GU&7PO:6G
MB#3-6\/:Q!I5^VOZY>QC3M1T:(ZC<37-Q!_:27-W7QO^VQ\;O'NN?$/Q=^T!
M\5_AOX;^&&D_&7Q%HDUWHOP]U<>)_"VF>(Y?!>AV&H:]JO@W5---YHT/C'7-
M#UCQ9J>M_P#"0>+[VX\6:AK!U*RO]3NUU%_[1?%G[*?[*^O>"]>^&UY\,[[P
M]X4\0:MHFKZSIW@?Q7\4O"L<]WX8OKJ^\.K<SZ%X\M3-I>E:G+/?:?HDP_L6
M/48[?6(M+LM1TZSN;3Y+^.'_  2G_9.^+OPE\0^ /!>C:3X&\2:SJ>CWNG?$
M[XA> M5^/5YX8GT._,T\ND^'+_XC?")X]5U*W!TF37_^$R$]KILEX9].UR2Z
MB^S_ $G#/B#P5EF-IXBEP[B,IKU9+!5<33BZL:>!J5GB'5JUXXFM\&(JU&J<
M<-4Q/)9TW.%XGS/%F6\;<4U<9C\\XG>?8_$J&(KXG&U6\3B,5AL)0P-"$8_5
M<+=_4\/1H)*=%<L%*<9RYJD_Y;_V@_VDO"7B3X<_LKWL/P^U>ST3X3_LL?"W
MX/>)/'.C> KX?#;4_%-[K7BW6=8:.YU#4;[Q=J^E>*+K4M/OK_Q<NE7WA_6?
M'>KZ_J&F10QZGI6FI^G/[''[,.NZ)_P3]_:J_:A\.:;\.]>\5?&?X(ZOX+\+
M^''\7:%<:#\-O@XGC/2[CX@>-_'.K7^HZ/8>'_%&IV_AJU\6^$_#6MMINJ*W
MA7P=9E_[5\4KHZ_2_P 3?^"/?BWQ+\-O'FBZ_P#'.#Q%/=>!;ZST+3_A)\(+
MZRUGQ)<))"EDMKX,^,/Q]CT*VOY[C[+/?#_A=]DK-%%8Z:UG=-IZV_X]?%K_
M ()^?M3?";X&Z)K/P[_9.^,5YXTTG3[;PKX[MHM \2:_\0K>V\F5HM6T;3?!
MVH7*-8Z7J>GVOG1:)9Z]I9BO+6XF@M8=,MI+O[AYWP[Q!EE+)LEXCPF"C3S7
M#U<<L7"4HXW#_6I9C[%RQM? U%[?$2:KUJ":7)2H.$4YTU\.\LS?*L;/,<SR
M:OBE+ SC26&D[8:K'#4\/&IR86EBH2C"E%.$:T5:ISM2YN69\I>,-=NI(&EO
M;"^TNULK>24Q7ZVDP>7R]\H,VFW5Y:W%Q*D<<%M;P3M/,JPQJD4C&*OT4_;>
M^#FM_ H_LKW7B&_TJ#QQXU_8Y_9H?XB^"+03R:_X6\6?#/X5>!OA!KMUJ44<
M;I+'?P^&K*2TEAMTO9KW0/$\;Q 6RW*_B5IWBKX_>#_'_A75/'7@VYUB+POX
MST2\UC0/$XM_#FHO)X6U.PU'7]%NMK6NN:;J)^P2QZE#-H5[J&DO<[IM)?[#
M#9W?Z2_\%"/VF[WXF_M/>)OC'JWP:UCP7X6^+'ASX?:]X=BU;QAH^NZ_=+X:
M\!>%O!FKWEA=Z+86VB7>EQZKH_V2PTQI-#U5+4?V[JD-GJNH7&@VOT6)P&,Q
M.=Y5##2PM7 K"9OB,56I5</6]O4<<)2P^$M&M&5*<W4JXR$Z*J)_5_8M0C/F
M?S^'QU&EEF83Q7MX8MU\!2H4ZD:E-TX.I7J5,3'GB_:KFC##RC5Y'[_-[KY;
M?M%_P1$U&#5+3]IJUT]?MD%U%\++R1I(UNK211<^/[:<R0^<D DA%I)(RWK@
ML'8?9KG?*H_==WL;V)[>5+$PF5D:..ZMYK5;JS?,T*9CAM;>]62X$IM+B,7$
MT3&ZABGMA+<K^/7_  15'[/'A_X-W'B71_CEX"\2?'[]H'[+=^*OA,^K>&=#
M\:^%='\!ZWXOT3POX.L]%N]0NO$'CKQ!)!+?>+-7U[2(=3MEMM<T_2;?3H!I
M]QJ5_P#N1=A=/NY6O+&]TZZ.%N'O[(Z9=YC2%#+=2!;9V$/V6)(X'AV&!BR>
M7&40_P U>(%:$N+<VE&G7I4XSH4(RQ&'K87VD\)0IX:O.FL33H^TI>V@X4JM
M.52-:G3C5A>$E)_LW"2E_8.!4Y4Y5)1JU6J56%>T*E652"DZ+J1C)4W%RBW>
M+E:5F<&;2WM+19(K5+&:&*T=+6Y>:0V;1>4I_P!(FS:.+5 R%+5H!'-!)<"Z
ME$85OY0O^"B?@G2/AI^UY^TKK5LOAC2O$_C_ ,3Q_$WPS>ZS8?#F35&O?BI!
MX<\3^*;?2KW4/&<WBO6GU34+_P 7:/JMAIWP_P!-BO;;49+[4[J O!--_75<
MI%&EVUQYUDS1(C7T\<D*:; 3:S2I#<7T]VACN=UQ+YRPP*UM- %5#$TTW\W_
M /P4"^#OC2W_ &T_VF-=\'MX-\67/Q#_ &;_  !JNJ^"&TK4]-\0^&QX6\':
M#X7CU_7UDLKYM8NM.N[GPAXBO%TNXUBTMO"OBK0]+\7^#]/T7Q/X0\6VO5X>
MUW'.L1RSY.7+IU;/2,G2Q>#FKRY9JDN64VZDXJ'+>/.^:SKB2*GE\(\CE?$Q
M5DU>/-3J\\N5-.32C"Z^):.U]5E?\$V/VF_$RZ=XH^!MUX*^$V@ZOX@77]4^
M'>HS^!;%?#GBC5_"^CO;>/?"MTXFLTT+Q_X,M6T3XB:WX9O-.AG\=^ /#_BN
M[T\Z5KOA_2-67^AAY;07(@>/1WGCM8[K4(WNKN.YTZ-4V6MU/;WEM%$L%_<%
MHK:62:/RAO"Q72AFB_G8_9V^&/AGQ[_PK?X\>$_$MGH]MJNE>$-.\5^&;+4K
MFUM-4O\ X8?:+;3O&'A?5;BVFU;P3\1OA'#:V_B/P%?ZQ9:M'+X!?6/A;XFS
MI/C/Q)K&H?TB^'+K3AHVBW]^9K2ZG\+Z%.\<5PMC9[+RPTJ264I*TMTLOFF&
MUATZRU1],@!B6&.ZD6&:/TO$7$U*]; U'4GI+$4WA[4U[&7)#5RIT,/)Q<8*
M4%-U/B4X2:FF<O"]"%"C74*2BGR_O;S?M(J4G'2=:KRM2G/11A;K?8^0?^"Z
ML;1?\$)$B:%K;9^U!\*4$32&1D5?'VN*,LUO;D' Y7;($.56YNE N)/X >0<
M8YY.#P<$GIUST]NV<<X_T$/^"]0@7_@AH5ME98?^&H?A*5!:9U(?QWKCAHC.
MSN(F!#1@$*%("JO('^?CY;98LV0!QP.1DYZ@Y*]>@R>O4$?Z[_1#@ZG@AP\_
MM>VG9W>O_";D[:?2UVK/>_6Q_#'C>[<=YC>W\;&O6]W_ ,*%=:+O\T'6BH7Q
M\Q&1WW-UP.N%^[DG@9(],@\4_8O]T_\ ?QO_ (FOZ6E[KM)6?HW^2^X_(M+7
MO:_EZ=K]PY;E1NZ D$ '!P5!Y)RI8Y'3D?,*GPKC!&0#@C)&TX)QCCH"!G/U
M'3#3* V-I)SM'(ZGV&2.V>.!C/:I0 "<#DG)]S@?TQ7=&*BK):?J8R;TT:M\
M+Z]-_1=K:L:&XRV%/<9SCK@GTS@TX?,1SP2!Z'DXQSQGT../0Y-(0#_#D\=.
MI_$=ADGTI1D%05VC<O4_[0_P)_ UM!--W5M/U(O_ ,-_6I*%*CD@G=GV' ]<
MXZ=?<COD*2#C/'.1G'4=\9[$_G[4W<2<@_*K;2,@<]CGD$'(!4X ZYR,4_=M
M(=EXVL!@@Y/RGMQT4\^O''-:&;NW=ZO5V37;16>FUOZO94(#Y'W0,$YZ=&QP
M>G&"!P <YYXN)\H(;@Y8X/7'J,9ST_\ K]!4:(6PP"@97(ZY7"L.0"#U.1T/
M!SP<N *!DW$\Y#9R>H)Z^W'?I[FG9O;7_@&-1K:^UE9^3>]M+W?W6\Q7^]^
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M[<Y' SM/0C=UYP=N>Z\].]6D&%(YZJ.>O"D9ZGT]3]:AC/S-C&>GU("$D^N
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M*4B#%."TCRE0@+*R J/#_P#A\[_P0[8J9/%/QHEVD%1+\(_C!(%.4(V@V9V
MLB XP2/DS@\2S?\ !9S_ ((@7#%G\6?&G>1&JLOPE^,:&-(P?+1&>T+*J]54
M,4R%.TA:Q7T/O'QR<O\ 4'.'"[NHY1Q%IV3_ .$EJZ?=_>+_ (F \,K)O/:*
MTUMBLJW[+_;[_@SW2.ZFA#>2)X6G#>3-#%B2!MK9:.9%41, G^MPOS^6H(#_
M "N5FD93=+=2+\[227D\;$29*-YN^$R*[EV8NQ0")E8,(Y S>$-_P6:_X(@R
M'][XQ^-TF=N=_P +/C&S'8590";4@+E2Q4+@DD\<Y+7_ (+%?\$0;NYBLK#Q
M!\:[B[O;I4M[.T^#_P 8GGO+N?8J10PQ66^XFFD"D11 EI,84/N)UE]$+QW]
MZ4^ <X2BI2DY93Q E%*+E*4Y/*X1C&,8MRDY1BDG)M)-B7T@?#2__(]P_)=Z
M1Q>6.3Z7Y5C-[Z65W9Z(]TV?)(ZRW.$W;)C<H>(YB_R0PVZIL8,,.UZ&,&U7
MMCN8F8-*3#<VZZB;A%C/F)J,,-NZ6]R8Y9VQ +JZN'E$J/Y<T*0M"4W-R(?H
MGX7?%3]A_P",6E6NM>#_  3\>%L[PB[@F\0> OBCX?N&\Y=P+Q7PBGC7:P=4
MFX3(8A6R:]3U+3/V4=)MWU"\\&_%5XX(]VZ#1O'MU<1QE=A5$C_>*FWJBNI(
M;IR6/Y5CO#7&97C*F6YCQ#P7E^8T*KI5<#B^(*5'%4JR?(Z52A5CS1FI+E<'
M)-2T;31]C0X\P.-PT,7A,FXGKX6M!5*.*HY/[6C5@[.,Z<XUHJ<6FFI**333
MV/BNVEC@21)M-DF42,(8);Z>*!&E\R1FE@@MD0W$LQ59(\,_F9$DSO$MPQ<:
MS,JG;:-!$<HMM;7,DD"1^8N2(;E+A 45U\QI)'B=?,G93*Q5.=^,7_!1K_@E
M!\ ]930OBO9?M">$KH_N[.>Y^$?QDGTVY<;BT5GJ=O!+:2S88AXQ,)&7Y2I"
ML*\</_!97_@AZ N_Q5\:&P=P+_";XP,5)X)!:U)  ^4 $;1G80#S^CY9]%3Q
MHSG!4,SRCA/%YMEV+@JF%S#+<!FV.P6*INUIT,3A<'B:%2-K*].I>SUL]'\?
MB_'#P^R[%5<+C<W>"QE"<H5L/BIY?A\11FOBC4HUL7"I3E9K1Q\TY*S/=X=5
MGF+,[61S(2XB+SJ%1S"GF^7!'"LC1(7VQRED/EE225(6>\50LH5(RCS^;*-.
MBMK2)-D(25IQ>B0SM*F1');10QHB21N]S>W")X0?^"R__!#S !\4_&@A59%
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M?,N[BV$;-&^&V*KB -E9$*!25:.-P%:/8/*5FF"J?E\_\%K?^"%L0V_\)?\
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MB^ENIFBU*.%[:1[F<W$MU &E9/WDB7*(\4MU"]G"MQ*T?YU_!;_@I5_P;F_
M06T?P_\ &?[3C6>F^"7^'&A:=XM\+?M#^-+/PWX%EUK2O$+^%] 7Q&+^XL-)
M&LZ+97L=K]HFCM_W\%L(;>=HA[O'_P %NO\ @@Q"T;0>-/CK;F%9%A\CX5_'
M&'R/-B6%FA$<2B,B-0B;1\BM(J\/Q\%Q']&OQQSG%0FN$ZO)1E7:JTLIX@P\
MJRJ5ZLJ'MJ4L!4_?4J'LJ=2ISKVDXR:BHJ%OM.&O%WA#+\MC3S7,XU,P<YJK
M+!U\#/#.G&3]E*"K8NG.DYQ495*4%[*-13E#2HTN._X+KPP1?\$)XWM95N+>
M[_:B^%.IPW$>-ETNJ>/]=U WJ, %9+]KI[]65GCQ<[87:!8@/X 7D* $ ,"6
M/7MP>..I!Z5_8K_P6A_X*[_\$Z/VLO\ @G5J?[+W[*'C?XCZQXVE^-/PS\?6
M.D>,?AG\0O#]M+IVB^)M0UGQ3>2^*/%=FMJUPIO6NEMY[SSKB1G2!)'9RO\
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M#Z__ "6W"W_AZPOZI?F0^%.(^F2YA\L/4\^FM_P/Q 4 X &.<;<8(7(SU/\
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M#BAVMD&::+_H#JZ.[MLGMYGXI0DDODD<^@SP% !YXSGGC.3QQUG0!OO\X X
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MFW^IO%Z_YD&<J_\ U!5G^/(S\3F5>"./0 N#C&>N<YSVQZC/K^E/_!'/:/\
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MTG@< _&/X5<\X'_,T 'C)QD$#T[PC_@W<_X*X8(/[-.DC@'_ )+)\*>/H/\
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M'?RR]QM+'/!'WBW SQG@>W -?MO_ ,0ZW_!74$$?LT:.>_S?&7X5'!P<'/\
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M#FESP1QR,<C-9NDKMI)-N^WY6?Z"YM5>]U;5V[W_ )?F"QJPRRM]"S $8R"
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M"A5.WC!)!R< XQD$GI@G/.>HSP*_M2&S]=?N/YXJR2E'TZ=+OO\ C^@H!<\
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M/C:Q%UJ4DZ->6<^I1:>S2K'H&HE$MS[!X=TK2+6Z9X]&TJ&6%90DD.EV$,@
M8J!'(MNCJ!DDKD*22VT&MOQ;<7#Z<T7GR%$11L:5V5&)C4!4+-M 0J !Q@#
M.!D _"#5?A[X.T?5]0TB3PKX,NYM*U/5-)DN;;PM;P6UX^EWL]B+NTAUK0-(
MUF*SNS";JU&JZ3I6H+;RQ_;=-LYQ+;)6'@SP6RDMX+\)(1Q_R+NCD\%3@#[
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MF1P#G#%F/3J!DY'9@,9&3_59^WDNS_@V1_X)NJ4C0K^WE\2LI"Q>-3_PDO\
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M&"NTGD$8Y(.1@@$@<\=3IW@6=Y%ACCD9W C6*&.1GDW@XC2-3O8OOY55<D8
M !Y\7U[]M+X>VRO!X(\)WVLSF&YNH]:\6:E#I'AZ.PLS')<:@EEX>37M6U1)
M(&+VFGF^\/7$@WSSWMK' $F^*O'_ ,>OB%\2K$Z;>^)?&VI^';R2:UNX-#L+
M?PGX<U>22.2"+1/[+T^W)US2M0FFELY9[ZZO+?6<16EOI\ETJ1W7Y7Q!](W@
M;)8R64+%<28RTH1A@:,J."YF^5.KF&+ITZ?+=^^L/A\3-PO&,7-Q3^_R3P;X
MTS:I3>8TZ7#^%G:?M<RDYUW"3:<J>!PM2=:ZL]:]?"Q@[2EH?HEXC\8_#7X<
MO<0>(/&.E6NK6=I_:"^&]*O%U'Q"P4R&W0:5ISW,EG<75Q"8[%]5^P6\\V%\
MX*K31_"WQ@^.'C/Q_9ZI9S7NG>$/#\2WMHVB'3FU#5)+;RWGL;_Q$;Z:WM]0
MNX+5!<:GHILM5TB"Y6U6X/E17-O/X-X3TRX2::&XB&@:?8VS7:00);6LL<4E
MK'-#<02V\MLNF6R+))%!:VT<<=R$S#>NGG1P>X^#M'L+'RH_#]Q:QW-C]BGN
M]8B8W/BF.2YMFGMS]FLI'TK2M/6RE:&6XOM-UJX@LX;76M-TQ62SF;^:>/\
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MI6I^)HI]6O/BEX=\$>$?!NCZ;J.B'PKX5N+B[T;6-1@NH[O0]?US7_'/PV\
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M<N65CAOM#$8X1LBJ22V5@/T.OH)9,M]HNTDY^Y-+N?@GYBTI9>A5@HS\HY(
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MV3L#N;';Q[E2RE@N)]X\N1_,MIG?C;'!;W$<:I(22(XWD>25@,%"-AL3->6
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M?3. 3^')J/:6!)Z@G@#L.1^//;C'/))Q)SE@>S$9Z'*^W/<9Y/U':D(P"1@
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M>5[[B#)78%.3D#E>F#G@*,]^?EY![ @_9/\ P3UQ_P -_P#["/J/VS_V6/Q
M^.7@;'?')P1Z_C7R"3@$COC   Y8@ X^O3CU[=/KO_@GJ3_P\ _815@<C]M#
M]ED$GO\ \7Q\"'/7U(_#CM7B\7IOA'BUJ.BX5XF\U_R3^=O6[_3H=F2R<\ZR
M:RLEFV6)]]<PP-_DMDO/J?6__!7,?\;-OVUCW_X71<8SSR/"_AD@8QR,KDC/
M3=7T]^PWK9\3_LO1Z%/,))_ WCGQ;X=BC&5EATW41IWC+3PV26:(S^(M4BMR
M/+7; 55/D-?,'_!7(.?^"FO[:[(@;_B]%T,EMN"/"WA@?3H3U/&< <UU?_!-
MWQ 2_P 9?!3L UYI_A7Q7;1I(S_O=/N-4T6[D7&_YFCU*S\S!4;(XQ\H(8_X
MG6M.3N_>L[=%I3VZ]#_1;^ON<E_PY]>:O%MAE^7<RR G(&0#(=HSU ;.Y0/F
M!/7I7EEU"LDEQ9E \5RL\&6.5*7(:%@RD#*[GY4Y!R,Y^_7L>M1&*.]C=<X<
M$#'JVQ3CD\,H/)!/?OGR6_C,5Z6^9#Y@ 55&"OF!E(R3R68%L@$')&>%# \7
MM;.SU'4- L[6+2/!=GI7@;2_$-[K.A^'?#MOXJU._NM4OO#MGH^EZM=Z5/\
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MRSZYI>D-J\OC&2ZM;VRL_"X^+?$?POU']J#P!XKD^$7A+X,Z/X)LM1N+:Z\
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MRPC.,'J"<_GG^1S_ $'2OZH?VZRO_$,C_P $WRB31*?V[OB40)FC>7)\1_\
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M>VCGOQ:)I^KZC=61V37$^GF^N[F(?$WA^]AL9=;L=.\BV@\13FW@UUKZ>3Q
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MO^)I>WM[J4KQO<3N\9D/PWX!_:TU[P'I6DS?$S3;G7[#5-=U3PY>:A8QZ/\
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M_+3@=#@D 9_($?SK_0GZ-T6_#"A)/1<2<3W\W]8RO]$_+[S^9/%237%D[?\
M0NRYM>3A7^[:WS*W)Z$8X_H>#_)@>.PSS3-F6//8'IW.1^I&>_<<<4X$;F&0
M"';CN?3\ N!C'4#FDD.T9 Y.!GIT/(/M@L<]L'N1C]VE>SMH]'=W\O)O;LC\
M]5[V3M=::>C(CSGZD9]<$C]1GGMDXJL^"_8'@C.22=H Z8XZ'GKR<@\"R/\
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M::5:VBV6LAKC1I-%NM"N-)L[](T2'45@L["5(I\K-*;MO0Y[K1_#VAZ]I?\
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M_P"EJ_\ @#0%9N "!N5LY/S94X.??) Z>E?7W_!/@*/V_OV%/E _XS-_9<Z
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M*N!Y:G 4  8)FA-JT?V"^O8HH'=VM[F&"6[EL+AV1BZH%MEFM)RB)?0"965
M+R'?<Q""=U[IL2^5>6TMM;V-P=C0>>;@Z?>A!)/8 V_VD/"3FYL9>LUFVUT6
MY@N M(06J#YKJ1SG!$-IE"IVAE\V>>WD0E !S9.HR ,C&,W*::7*E?9\R;^Y
M)?GU\BFHZVE?R))X(;.=[>=+V:2,H659;6S5A)"DT4BX2_,D4\+I+!,DJK-"
MR,A.<A;;4!:O*;>V@>*91'<6UP9I[:YCR=J3EIAAXV&Z*>+9+;2X:$J0RM;@
MELYT33KB H$#'3KN[NFFCM99&=S:W7V>&R"Z;<SR2MA0WV*[E^U9EADNHC5D
M>6WEFMY+:VMI8&>&>,6MN75T;+(YF64K][>LB/\ ,A21"R.#5WDTDVVM^73E
M6_F]M'M>_P"%<UHI*S?7R_JY^M7_  3CT_3/'&B>,O#%H[SW7ASQGX;\=Q:9
M9%[?58K+R["WOTB6S4R22H=,,5M=V^)+U9XE5+:Z<11?J/H?Q)T[X@6D%G!+
M-8Q>*]4ODT2]FM;RUOM"O-$\3ZYX:7Q18V]T;*\TZ>PT:SM[]9=\#W6G&6WN
MF>PU"Y27^=O]D[X_Z]^SQ\9_#WQ L8K[5M(6&XT/Q+H\ N+A;C0=21X93Y40
M8QG3YGCU"((D69;=?+9),-7Z(7'[6FB?&;]KKP;X6\(V]_+I?BNR\;V>J:M!
M'<)IFBZAK/AS6+RU^TS7%M"(_-U9UTT)#YTL,UY;K=;5W-3,]]_R2_(_4'0?
M$FFV=JOB3P!XIT7QUX.O=5OM.N=1TV[L(-!U#Q']L/VZPUXV$<EIX \<W-]=
MQWCZNMG'X7\:WMR]U?:7I.H>((+S2_5H?&_A8:9=ZOJ6N:9X:M]-N([76!XL
MU#3?#%QHEZX\V*SU<:K>V\5G/-%MDLI1=2VNI1CS]-N;F'++\R_#?1?#/PG\
M)-X>MM-TZ#6M?O\ QC>ZF3I5G"^KIX<-U?0Z?K&$-WJ\-EH-I+# NJ3W2'3/
M$5Q%9P6NFRP6LG*_$/P;X5\3^-/#VI-XAU;3=(M-!%CI]E81:3=7FEP74EU>
MM;:=KFL6&J7D&FM+%%''ITL5TUNCO]FOX8%AM+6HR<;M?C?UZ-?ULT]2N9VM
MIM;^O/MIH]3/^,MI\%+I[CQ1X$\:Q6_BN*_AUR#2O"=OK-[:7NK6X81ZSX=U
M;3+>.VT;6H89KN2UGT_4!;7;RR:?;7_AZWO+B\6UH'[8">&O"5FWBW38O$6H
MI$CV_B/4?$6D>"-'FLWD2&"W\0:K>6>I2IK(>2/['/8^'#'J]K-!'>16NL6N
MH7%]^(7[3OC[XD^%?C7\2/ VD?$+Q=8^$=*UV(>'(K+4AI4TVB7NFZ?J5JYU
M+2+;3KZ>6&2[:TENX;E&:>%U<"3Y5Q?BAJ6IZ;\*/V;]?FOC<:W%I:ZE#J5]
M=/?W$\T&C^'=1CNFN+WS;AI6N9895O6N!<.QWHP"%J_,L9EM/ASCKAO&9#".
M7X7C+&\2X3BK*<.W3RS,<7@.&I9_@<_IX%+ZK@\\IXS#RPV89C@J>$J9O@\8
MHYI#&XC#4,9#ZRCCIYMP[F]#,W]9KY#0RJMDF,G%/%X2AB,VAEV)RN6):]K6
MRR6&K*IAL+6E4IX#$4+X-T*5:K1E^\=U^T=\7O$<$MSX0\ VNE:;&L4MQ>IX
M?\0:W+%!.P2WG3Q!XE'AKP[/92X(AN4\.R+,0WD3HH,CX&JZA^T7K,-Y+J_B
MV3P_;P26"7%I+XFL?#$,D>J>1]DD@_X0C1-8U RL+V(^7))IJ%L![E'.U>J^
M$/Q)^%G[4'[//AO5O$/B#4_"OB>T@TI_%]AIUW-:WVI7OA_4K?4&T?48'2&2
M?2[Z_L+6]>WD:![BSDBN5:XTR\,4_P ??&']I70]"^(%WX3M-1V06MKI6IWT
MIN4B2ST7PFEK?7^H:A(ZB.",PVB6L3L4CFU&]L[6)-\\43?ICW:\VO6S:_&Q
M\C_DOR/ OVT_&7C#X/Z]X4T&&_\ "GCH>-O"L^O7GB+Q%H.LZCK^FW]AJS6P
ML;74=8\8ZS))':J(+VSU*2VL[V"ZPUNMLT:.>9_9Z_;BGT^]T#0/B_=WUK>Z
M$\\7A/XMZ'=C3O$'AE[K$-S%=NEO(L5E>0B.#5HI4O/#VN6X$?B#2L#[4?DW
MXR?&O3OC;XBTO6YX;V71]*T9M+T'4+6X54875X]Y=7C6DMLLE]93.((86CO+
M"0^6]U;R7$0CBO/&[B.6UC6X@MK%K:1_+BOHD>[A>4(\C1NUX\KP3[=SB*XC
MC<JK/!$Z 24U&3=K6\WL_)>8W%K5IG]=_P -OVC--OK73(_&M_ID5I>I:Q:7
M\3--VVW@G7GNF1-.C\3V8EN5^'FN7#RQ6:237^H>#-8O&AETK6-&EU"U\,VG
MOOCOP!X+^)_AK5_ GQ!\+Z5XE\.:PBPZOX=\16*WEA=-#^\BE:WF&ZWO;*4B
M:QOK<P7]C<JD]I<Q2HIK^0;X'_M*^/?@;J:IIDR:]X0N?M$&J>#;YH4T^6SN
MXWBOH],5H)K6R:6*1UFT^2SFTB^1Y(+FVA%R]U%^UOP#_;=\#167@-M$U:]O
M? &O>)HO!GB3P3=R75[JOPB$WA7Q/KNGZWX8,2W>HVFAVFI:!;:++X%NX)=!
MEM-6%UX5U;0QI<.E:E,VJ:<IOEC%-N3V26[;2>B3NWT5WLG9)7=EN]CY:_:I
M_P""4/B;P4VK>-_V=;O4O&/A0&6[O/A;J0CO/&>AQ!LM_P (AK5Q>VT7C"Q&
M3LTC4A8^(+.(>1;7GB"0*K_D9-.+>:[T[4--N_[0TRZET[4;36I)K76-,O;-
MO)N-+O+-;2SU#3;NV*^7+::G)=/!M0-!M;G^V[2?%OAS6]!D\366OZ'JGA2&
MTN+V[\2VNJ6,ND:?:6-J+V_N-5OQ)Y&F+IUF#=:F-0>UDT^!))+I(E7<W\H_
M[<'Q[\"?M#_M)^+O&_A*QE/@;1+'3? ?A+7=+L]/TS4/&=EH G:]\=:E/-"]
MQJ5MK6JW=Y'X>M=0MDU(>$[#07;5+,S26$*34DFFFFDTTTTTU=---IIIIIIM
M-=0::=FFFMTU9KU3/D3/F9%M)#"5)98)4@BN!R% CO6B,<S$ ;0DEK*[')@5
MMK/&\MWYIM)_M$TZ@XT^\2:YE4LN[]W;2%I8V8'>KVXB;C>2P;+3.A$4DUK;
M6<T$>'EF4S74\$:C"M<PW+YMU+%%>8VL=L'.PON*J6"^NO*$1D62T8<63_)9
ME6RW[N& 1+ ?XBT*[G.=X8A75@.^S(-HE":=*,!H[J4&,?*2O[H&34+9L C8
M\%P&8L0T*R!%3R_LBR2I=R2))A)386[R6[%L$)=/=-!&IR0J*UO>%_O"%001
M L=L2D<+F"5B%%K,YE21I"J@V]RBHV2QP(+BW+(I ^VS-]ZR]C?V;AIX3IK$
M$)+>2QV@D4,5)B#NLES#\F"T44T&<[F(& GM]_\ Z3,/Z_%'[C?MNR++_P &
MQ_\ P3:D6-8U/[=_Q+RJLC*"OB;_ (*#!F!BA@0;V4OL2)%3)3G;N;^6J088
MX_V3@>AP3C.3SSBOZEOVW6)_X-C_ /@FX6DBE8_MX_$LL\*!(V/_  E'_!0<
M-L58XE^4G!VQJC%2RY4AC_+2X?<25;&T8XZ+DD=>,8;U)'?K7^AGT;%?PPI)
MW5^).);?^%&6)_F?S%XJW?%U3_L69?:[6KY:^FKMM=E:0*5RW7(//0J&R,^P
M&>#],=J8<$ ]0,,.3CZ\=<#D<?EUJPQQCZX'?[P*@]1W/J/8YJN.01D9!8-C
MKNSR1Z9.3R,\@_7]UM;3MHO-*UG\_P!#\\@_=3UT??H]_2VWWD+]?EXY8,#D
M8;.>.,Y/S X.!@D=.4QQ^7/N.:D,>3Z98-GG.<$'@YZY/?H<8XYB*E7(SD!0
M1ZG<3C<<XR"#R .#^64XZWZ/?RTLOO\ T-TXM))W:5]?\^O^1"<@D$$9+$>X
MSV_,4U@2H P>5)[9 ()Q_GI[U)*#C=Z YP<'DKT./:HU.5!P1D \\GIWQQFN
M>2MKY_DD;P;:O9:/\?ZU(F!SGU+?ED@$?7'\Z5'FC;? [(Z[2I4[3G/3/;(.
M3TZ 9P32-U/U;^?&/3OG\^^ @R,XQR,$XZ]?RZ^O]#6;5TT::7::BTU9IJZ=
M[733T:?4U6\0ZP(VB-Y*J8 V'D@$@;LC!_W0#QP#T)JC_:VI?\_]S_WS4 B4
M@ L>0"RC&-PP20<9'(]?PIODK_TT_7_&L&K;HB.'P<+I8;#J[;=L/2U??6GK
MMOU')RH;/4J.#P/G7KQU/4<\#'K7]9?[!3:&O_!KO_P5$;Q-87FJ: OQE\8G
M5].T\1_;KVR%E^S09;:V>74=*2*693L6<7T<EOGSX8KN6-+2?^38D A0N/F0
M<8QD.,X  ZGO@9P.G2OZQ?V#RR?\&N?_  5%F33[[56MOC-XOO!I^FW!M;^Z
M-E:?LSW7EVMR+6]%O*!#N65K2XCCV[I(GC# _A_TAO\ DV]3_LI.&NET_P#:
M\<MNJ_,_1_#+7B.5M/\ A/QR6NWN4[:I_P"3/Y4=1@\+W=OJ<^A?#+PI\-M!
M70(O$,FJQ7^H_$O7;#48TG%EX?N-2UZQ2WTCPK%J_P#9EI?ZIIWVR>'^TUU"
M2/Q-<7ZV.B^"R:58W$UY'IMVL,%A(=!L;-8;ZXUO4(]5OM<O= M;6X.FV5S<
M7T0BM(K:]U,Z/XD\327%Q:VV@64L4UOI?UCIFB?#G3M,L--\07.MVFAV]VS:
MOXDAL]"U*>S@U/2IK/1[73=#N/'NG?VK'I-\H58SK6E7/BR,D6\V@W)TH)DV
M?AG5?$,MOJ>IK]GBUC3-'DN_"WB-O$]EH?A?2-0M]2L;O5KZ'PX=5M;ZPO\
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M5E8R1QPW EC#32;Q\YO'W#Y6+(H#QF2,011,D@&Z.1LO^T98IP&0F1+AX48
M@C,D2.#(A##EK>78"A8, LA5=Q]##U/:RQ$8M1E1<9Q;CI*2;=2$6_BE%<R?
MNIN-EK>YQU5[-4;J353FYGIH[V4M.[;6D>E[);>IV^KM<0[<"5&0LH+D@PRB
M2-T#QJ6!1B9 &16".I56&%&9=ZC+&UO"K)))"D9AF,CM&S&65_D,N2%:-BLT
M;,9)MD?DH'+&7C4NDM9A%:/#(DZ(5,;RI%+;S@1ACY@>6(13,L!5(VC$P6-6
M<DD07EU+"TD<FT*Z-)B6WPL9Q'%<8,4ID"JX24',>XAB6,@;$O#1E552G&FH
M^Q:C&<6[3M;FLGR\O*ZL'?FM&2:CS6E&N>I&GR2G+E]HG>G)QC+6U[/F3>B:
M=UJFGI[IULFH274DOE[;>1UB0VJ@QPF0D8<';N$Q$DL3AEC'[Y%$@!(&5=7-
MP/M-K$$^UW5E=+:B:X"#S%B #-,B2/;1!WC,\PC=(XW61X7\ORI<2YN8FN8U
M255FE*[6@826[$/))O@*,IBA7<,O([@-]^%3\C> ?%?XF^*;S6'\$> VU"/Q
M!:W-A;:HB1M]KNYKIV,,R2A)I+?35@AF:\N($DO979O(6"5K:=LJU=4:4J<H
M>Y5C*'LN9N:JR;5J6W,H33G%-WDG9)N20J=*56K&I";C*G*%64W\*A3O=MO5
M7ORK17TNSZ7_ &*XIK7X'_\ !0RTOY;^/58?@3XNFU'2-0MKN!M(EE\%?$.&
M#[%+=VEG)=V=]IMMISR7$4$=LM_;7:69N+=EGK_/8TI6;3-/W< V%H!WS_H\
M>3G/ [ <\<].G^C'^R[X+MO#/P'_ &Y=4B'B*VNM?_9O\2)<Z=KJ6Z-9#3O!
M/Q%VAA%)=3R732W<LLD]S=/,ZS@-""?,D_SH=,4G3=. 4$"PL@2>B_Z-$2<D
MC/9B.O QDXQ_>7T)J,Z>4>(,:JM..9<.-IN^D\!FLXVY7)=4[7=FVF[W2_F;
MZ1M6-;%\-5(7<9T\SLVE=.$\)!]M>:+U:O:VI=C7(Y <8QDKTP,X(R<MG!/(
M!XP0PS4F&,F2NT1CY,=&R",$]!P<@=LCWS*3QQD<CJ".,C/)'IFCA03VQG\!
MD\?J?Q^E?W3!=6K._I_6[/YAE-MW756]+[VMIJM-NNEG8=Q^/4_X_I^E)U95
M!ZL0<#)&%+<#N>!Z]?6GI%DON 8@^YQPA"]!QDEAQQ]:D$:Y^50".>.#G&WK
MUZ'!_,]*U4&U>Z,7-)VU?W!'$2,Y!^;=T .=NWGJ< '@9^N:^P/^"?*E?V^_
MV%LG_F\O]E[IW_XO=X(&.<<9(]?SP:^10-N%&./4@8Z8^8G ! ]_0G)%?7?_
M  3Z_P"3_/V%R<8/[9?[+O 96Y/QP\# 'Y3P!WX[=Z\#C&*_U.XO25O^,4XH
M?7IP[GEW\SOR*3>>Y*]_^%C*K:+;^TL!9?.Y]*_\%=%@_P"'F_[;!9IF)^,]
MS\B1)M#?\(KX8'+O(.,*<D1..HVDC-?G4DD:*Q2!B2"S--<R/\P&,JL$=HO0
M])/,Y!&0,;?T4_X*ZBW3_@IM^VNTEQ("?C/< QP6Q=AGPKX9;YI))[>,'YBR
M[?-R>,+G!_.W_1P& @DE; "O-<[%'][_ $>WB0X(Z WAYQGH=W^'CW?R_P#;
M+G^E]*',OF[IO31RL_1]-=-;]C]5?^"<OB$7OA;XS^!93'&MEJ/ASQE91JN
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MP)'"DRV[(MO<>89( J%4F=WA5I60JORO<PVT=K<>;?H2MO.RQ6=O+=L7$,F
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M8/#;137UVL"W5UJ5W+-'XAU']GF#PK-X>TK]GKXZ:=IMS]H0V&G?MTZ'X32
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MFA^!7Q*G@L(Q;1QO^U%X?G>2-(R8L'_ADR!9YEE1K>&);B(&*4L<F..**O\
M4SB"FU4AE=:TK2=\3@.:$DUSRC.>+3E=JSDDFUHE9$0XVX<MRO-J2>JLL-CF
MFFFHWA]3C;ECHEM??7;Z)O-0=77:D1,8NF 41JGEW"P%E9P6@\J,PM(\XD58
M$FFW&,(<Y,/B?1I+6=VU2P;R=C7$ZWMNJV\H#MF9Y'01'R;?#I<&)X61V#,V
MT+Y9!^T%\)[RTO1)\"OBBT=PT<WE3?M*^'8S'<!S(%@CA_9=C2*5!'%/%)*C
M;_,B$DB1;6'0Z)X'^$OQ#\$V'Q3L/"GC/3]0N/'_ (B\$:EHWCWXE67C]KZ#
MP[X3\*>(K2^T[4?#O@'X4BR@67QO=:;=:=/I6I>?#IMI=_VA$R):IRX[AC/\
M'AZ.(J86>'HPG2]M7E5PTN:K4G*,5)4,15J2C)1DK*FV]VUN=V7\5<.8W%/"
MT<9'%5YPJ.E3C2Q<+QIP4I2?M<-"$7&+UYYZ+EY;MI'2:QXSM?#BOJ&KZG:V
M2PRB*&=;BV>>1_.24O;[&:8F,'RY;R-"T!CB)<3':<-OB[X*G\/:K?OXD3RM
M'U6QT_47CMIWN8[Z]FCM8I6L;:.61=[:A#<F[M]]L]L\C-<QQVMP8,O4/AA\
M,(;_ $L7/@C3BMII%Q:+MTK4Y;67[*Z"**ZOOM%O$DA=VB\N]AO%U%;B[G*3
M/'-:-T$/@[PAKUS<ZG-IUUY=YI4<::<T073(84N9$ED-E%;:7=Q7QN[NX,D]
MPH^U0S3-)OA6WMSY\<)C:=25:$Z#ERTH1@J,W2C*G!P]I)>UBZ;5US*.E5OG
M:BURKTO;8:<%3M--2G*<_:I2E!WDZ<;PY6FK).R>MK/=\-K'CVX\1WVGZ3X3
MGOO[&G,?V;7](AU&XL-2UJ*XMDDM+N\L;"X>VTV'8!:ZC93.D]Q+/;RM&H)I
M?!7A?PK=^+&UKX6_$3Q5!LBBTSQIHWB33#9^+K07*!K(G5H94BN(KJ]L;>*>
MWDL)$M?[.O7_ +:E>:?36FL?#%CK8\5^%M<\/7F@7<5WIMO8>)-,N=5E_MC1
M[:_EEM-3G>&"!-.ENUNEM[VSL-?U"37+(W5MJ]G&+.4W'4?#SP+I?A"X:]L=
M.L+R71HETNVO-(DEAN[ZV=C>W?GV4U])/>7"-Y#WMW=R7%W-*%X=8(84XJ6!
MJU*LZ]2O"JWS\]ZE6+A6IRC%4:=XTY.3DE!)\M.,8\L9)*-^JICH0@J-*G**
M48N/(E+FIRBYNK4TE#79I2]JI73IJ*1^COPNBEM/@!^V/IS)(T=A^SCXR@%U
M,MN);R9? WCK[1/+]EAM[?=,VR4A+>WB^?,<0!PO^:?II']FZ?TXL+3\ +>/
MIZXXZ?7N*_TD?@OJTVK?!+]MV9C%);?\,Y^+);>2-V,FV3P7\0E>">%\O&\3
MHP1PXCDC*KL26.5:_P VS303IUAC(']GVG.TG/\ H\>T= ,')P>22>@Q7^@G
MT*:<X9;XB0E%QDLRX:;C[S:4LNS=J_.V[V>MY-]=C^5_I%2C.MPM*-K.EFEM
M$KVGA+[66_S[MV- *S,H*L!G)/ XVMW!SUQ4JQ*,X7=]?F_GG\^O/6G@<_4]
M^W0?Y_*I%&"22 .A(YQT]C[#H>2/P_N:,4NEWTV;^1_,,IOH[::)7UU_KKT!
M5P21SD'. /7GG/88S_O?B9/Z$_@1P?ZCBF@D<Y Z?>_/!QCIG(Z'(]*=C<02
M=H8Y)QD=,\=CV .?2M(Q<KZ/2^RZWM9[_A?U,7J[]=KZ]+WZ?UL( ,X&3W '
M/7//3/KWQS]*^N_^"?:L?V^_V%^.!^V5^RX>N.GQP\#GOUZ9P!SS]1\E+&#S
MN .=O;)& <9SS@D#&.^>N ?L#_@GVH_X;X_894;<K^V1^R^S%0.WQN\$AL@8
MY)(SG_:YXQ7B<84E'@[C![?\8GQ0_=2L_P#C&\]UM:_];GJ9#)+/<D6[_MC*
M5KYYEEZTT7E:[Z]7H?1O_!7FWD3_ (*<_MJDM BO\9)&3S+F-6(?P=X5D8^6
MGF2* #P61=Q(522"*_.61+7"K)>@YR2MI927+QD<;2UY-ID1;G $+RCC(<[L
M#]'_ /@L1#Y/_!4#]M,DA1_PMFSDYX&;CP!X-<,>!U\S@[L@ @#D&OS<BM9[
MHR/:Q7$\:D[Y;>$RP1L!NQ--&K10A02Q::1-HP3MR*_PQE\<O2+_  I+\MC_
M $TC3<HJ4=6VW:Z6CYM=WK_74]A_9\\66?@OX\?![Q*EM<);6'Q#\-VM_-<7
MR,YTG7;Q?#FL2"."UMXX1_96JWI,<TEYR !*QV,/W<\<V?V?5KU&Y"Q2Q%1G
M<'5G5R"H('SC( 4 @J,9.:_G'6S>)E8WEK:,CI*DBW:R31M&0T,D?V);EC-$
MVUHRF75D4X&TFOTT\&?MR:;J'AC28?BWIFI3:OIUU!HMWXV\,6C75IJA%J+B
M'4-;T&=HM1M;]HHW6\O=*EO8=3N(9KA-+TG>8Y$)PDM'%K^O4^C=:MRFTD9(
M98R" I!WR+R#T/))')/S#GJ(?)-WI]]:'YA=6UY;[-Q.X7%N\(& R\L7*C."
M..AYK@['XV?"_P >S2:=X2\51:MJK03Z@=+BTO6EU3[+;R1B6?[++IJL\5NU
MS LSQNPB\U21M(SS]S\?_A)X7O;VPU;Q=!%J.GR_9K[3H-)UNZO;>YMG;S+>
M:&/3@!/&059"P;<N2 IS0DK^]JFU=>6EU]U_^ )73[-?G9V_&S.P\'S7,D5I
M#=(RNVG7*3!L[4N#!HUPX&6(9RZW4AD 3<K(I4[2RP:WLM[F"X=UAB@,DL[R
M.L<4<$2&:6:::1ECB@CB#22RR%(T16D9D0%J\AE^*\&D?#*;XH>$M,'BBPBO
M-6@TW3=7O;CPZ;E8;_Q)I%U>2O'I6J7%HUK'HDDQL'MA/J&8;%+RQENHY3XC
M^T/K.K>*?AC\//%HU>[?0_%=\CZCI%C,L7AZ<7.D'5=.@DA@9A?1V4EE/-&=
M1N+XK<>7.Q9T@:+\Z\*[T>#J&5.Z?#V>\7\-\LDERT\EXMX@HX>,4FUR+"8S
M!\FBM#E^)/G?T_&/OY[/%V5LRRW(\U3BFE*6/R7+9U9:MZNMAZ[F^DW)-73.
M"_:&^)_A_P"(_BK28=#AEU'0_"-A=Z79ZK'<Q06FLWNI7,%UJEU;1"S>ZDTF
M+[+;6-E,+RV:\:VO+V./[-/92-XQ?7:7EG#J\%I9K=))#I^L,\;7+27,<933
M]35KF68J+^SMFANHY(W#:AI\UV\C'4EAMLFVM+J\0RVMI/<1+DO<QQN;:/9C
M)FO65+6 *%8LT\\8"J<$@+B]8+;V<SC4;FVCT^YMWL-2ABE-U.+6<J_G0_9(
M;I1<6%Q'!?6KC]V;BV6*5O)FF5OT77[+<7W5F_N>GX'S"=FGV[[&;/=WERIB
M:ZG-N>#!&3;VV2#\HL[<0VH  5B1!\Q.2>6S25-A/[L;1G.Q<8#@KZ@[0"20
M2"'(&2 <[%Y:Z?IEQ<64[W^H302!7:$VFE63'RXY4EB=FUR:\MKB-TFADV:>
M6A>-P"'#BK]NVG,%A80!<[6\J6[<<%3\U]-<IN!Y)92IQE8D&<9\T8)\T[V=
MKRLM=$UI9=F]=+KO&+VJ<KV<4K7OKII=WN]DEJ]+7NVDB^Z2Z_$]W;P2W.KV
M2PC5H;='N)KZS+0VMMK2PQHS"6*5X++564,)'-IJ$AWW%ZXHBQG&?M$EK; A
MHR+BZB61 2 Y>"$7%Q&RX VRQHQ)R54"J[^(9K&YM%N=4\N5YFDM--N)@(;U
MY(WMI([?1E*Q7BW-M)+:S6EK:.;FVGEML%961O3M+^#?Q)\4O%=>$_A[XHDT
MF_@CNX)]:L?^$8M--9@6GLKF?Q/+I4LD5LRLUG>+ PN].>WN76&=KBWA\_-,
MZRC(\/\ 6\\S3+LDPS3:KYQCL'E=*:35_92Q^(P7MFKK2C'$MMV46[I=&#P&
M,S*HL/E^$Q>/K+>G@<-7Q<U>WQ1P]*OR*S3_ 'DZ-X^]=1M)^<-%81MB2[GO
M 6'R65K]E1N,'%[?D30G(('_ !*IUX,@8Y7&T9;?6 9+334;741G9+IWOI];
MB5 [2QI$MG;2:Y F]IA%8QR:M GG1(VH+<R7G>W'PCT+P[<&W^)/QK^&_@VZ
MA(-QH'A:#4_BKXOB*D--;76EZ/<>'[+P]<1QDD7=U=ZW:1,5:2WD1U%7K4_
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M7T]-)U;Q!!I&J>:?"OX-^$/B5X\^#=KX7_:1^&GQ!^&7BW]HCX1?!/XO>*O
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MLBH95'/\E>7N\G/%.HU7G.3IO+*KM7IU;RIUXUG6@N51@Z<%>+;52?J6F_\
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MJUU-I^C2^(_&WBOQCIFBVUUXDU=6TSP]X82YN-=\4ZD9[;P_IMQ<1RW%NJW
M.,P\'4KYKE]&FMZE6ABX05VE%7;ZR:C%+F;<HI*4FHNZ/B)@L145*AE.8U:L
MN91A3JX2<GRIN7PMVM%.4F^51BI2<HJ,G'\';CQKX9O)7N;OQGH5U<R &6YO
M/$NGW5S(%Z;[BXOI9F R -SG&22.H;V?X1_M&^&/ADFI6A\3:3>6>M7MD+Q!
MXDT:/3],MHD\N;5X(5-SJ%WJ,!6-_P"S[>;3X;RVB:W:]C=TD3]9/B3^TM^V
MU\*M0TBS\3_MF_%O4[#Q'I\>K>&/$_@C]J_5_'?A#Q/I\EY/IKS:-K_AKQO?
M6YN;?5K.\TJ]TC48]/URQU2SNK.ZTV-XF8<,_P"VW^UG#!;W=W^V1^T!86ER
M ]O<7GQ_\>Q1S*[K$LD2CQ*TTBM*RQH/+W3.R)&'=@IPK>&E;-,*H3Q^ Q&%
MKZJ4*6-<:G(VO=E%*2<9*6W).,HM<J5T#\2L)A*TE++,PI5J>DH5*V"BU=)W
MDFVE&2DG&2YX33C*$I)IN'2O'OP_U6SL=0TSQ7X)UJ5ET^"XOTUKPX;BSGGL
MV(NI;E+ZX^S2W<DJ6K:8UQI]P]M<M;@R8,<_2RZUX4DBCN]-\5Z1<R3R0J#>
MZA8K>FV>=?LVF6JG4(_L4ANSYRL8GNA@QF( >>\>F_MB_M?S>%]>\9Z;^UG^
MT9J?A;P;>^#AK^NO\?/%MCX?TB[\?:CJND^"A/!=>+;BYU-_%.I:%J]EICVT
M,!,VG7,=S&%0%NXT#_@HG^TS>27FG:C^U5\8;76+6%H8+&U^,GC*;4KR^C"R
M92QFUP@+!:[4OK>]E:8I<6ETDC1%X1\-7\"LSA[1T,^P>(C"<HSA'!8EU:3M
M&<82C[>[E&%2#=TFH\LI631ZL?%?+W&+GD^.ASQC*$GB<%%5$W.'/%RA;E<Z
M=2*:TE*,DCR^TU;2=38I]OT^&Z:XEA@TY[BPO[R&.*YNXWD0;II(S.,O_:D<
M2"XAB1KM;0SO+#IP_9X;6YOBUI9PRNUS80VM@)+NY#/&1=JEO<:?I\MF9#+<
M"XO\W)6 ZA)'-/&]R?J#P5^V3\0?B;\-_P!J71/B'\??B+XW\.Z1^SO+K.I>
M'?&'C?Q7XKTJRU6S_:'_ &9K#3=631[[4;P6^J0-KT]O9LT,-[;1:A+)&K6<
MTRW/PZWQ;\)7>I?V=HWBS1A.]KK6I+>?VI!:6]S9Z382&%9-82TN)YUNYG>8
M-=9:QALY?*,*6\4X_->*>$,QX7Q]/ 575QLI82.*G5HX+$4H0<IU(^S?,JG,
MTJ3E>ZB[JVES[?A[B'#\08&6.HTIX:,<35PRIUJM*<Y2IQA+F4J246I<]DK7
M33NVMO30T5G ;[4IP(7F:.".6=X5@OHF:>6,_:;^]O[J0O;2&U1)MR6,"QA6
MAB>Z;Y^^.^@6OB;PYK-]=W%I'-IX_P"$@O=+ETRWU#6CID,RV$6O:=>:?>PQ
MZ1<7^E))8SZC>V/B-6;0+&TGAC6U+UEZG^U-X(T_5M;MX-%U?4)I82O]HP?9
MIM/.IVBP:?;16EG-(8I+<V1N9$UB.0YEA^QB"_M[O[4/'O%'[0WBW66.H:)I
MVGQ>&[6SCM9=&NY;W5#;6LD=I%<-XHLY9TCD#SP(MKJF@MI-DAE%I<RS#4)]
M,?GRS)LXCB:6(AAIT52E";E5<(<T+J;C&-W4;G!RLW"*TN[):>M5Q%%QE!SO
M=2C[NK3TM>W1O2^VY\\W-U9)=3V<"W&IZ':7-U;Z1)>/';ZM#I:W,GV1X[V*
M(I;S& B>6SDMI]/$SOMLE&%,3VW[E[FTN$O+2-/,F*QK'=V:8!=[RS665HH4
M9@K7<+W%D-R,\Z%U0U[2TNM2DEBLK.XO'M_WTZVT3RQVL#2!%GNY$'E6%J6;
MFXNC#;QE@OG 8S>6PMM.ECFGUF.SN89 \*:'G5M1BD&1^[GBN;'2X&Y9'<:Q
M(P1B\-O>(Q1OTNFYI)5%-^XI.^JLZ<FOF]_OO97/*G3T;2CY63;7O+HE_7H?
MN%^VF-W_  ;'_P#!-KH?^,[?B9T]_%G_  4$+=/3;C';D'IFOY>9.<Q]E)ZG
M)) (P.!@=?P]#G']2O[;\\-W_P &S?\ P3AN+:WEMXG_ &[?B85AFGM;B<%/
M%/\ P4!1Y)9K+3M(M'DF</,ZV^FVD*&1HTCVKO;^6^1!AFV\X9@3G.1EOIUY
M/\L$U_HY]&7WO"Z@ULN)>)FK^>(RNVW;0_E+Q9=N,*B=[O+,M];N.(U:>NVC
M*C+@C )Z$9&>Y]O3!QP1T/7A6C#8P3@X&[M\H(!(QDY#'(X/0GN&<W*Y[D C
M^?Z<\]AGWIJ;N>X&>,\YZXYZ=?7\,5^]U8VUZK>U]4]E\M3\XYG9-.SBVM>I
M4=0"R,01^7IC^G'KQFJI4(P(P0PY)^\"S #GN"2 >XX&2 ,7Y >1@#H2,]]V
M[CUSD#@<]21@U Z @Y7(P<9[="/IT!X^M<TXMZ]D[[W\K?._WG1"5DKWM+1I
M;7LE?[]?D5V&X$?0_D0?Z5#ZY[$C\B1[5," 2,C[S@#V5B,#Z 5'(JJI8##%
MDR<GNX![]\FL9I--O=)V?:]C>#L^7N]/U^^WWD4B[E()Q@AL_P"Z<_TJ#)R?
M0 $$=3RPXSGJ "..,]ZGDSM( R3@8'IGG\QQ^-0 >HQNYZ\E1N)_#+K@^QZ=
M^>2NO,Z(.V^VNGW?/]",ON&-I&>>HZ^_0]OY?@VI&"*IQ@ ?3K^/3U]CS461
MZC\Q6)L_).VO1_UV 'E<[OE9#VQ@,<G\>^!7]N?_  0[_9P\9?M8_P#!!O\
M;3_9Z\#MH5GXK^*O[2OC/1O#E]XOU#5]$\++J6E>'?V>/$);5M7T?0/$NH6U
MFBZ.Z2FRT347EE>.V=84EDN(?XCT7(+$ [EXXR?I]<@$'L0.#5"ZT71[^43Z
MAI.E7\VU(EFO=.L[F<1;LK&)IX99%C4DE4'R@EB%'.[X/Q(X*GQ]PS+A^EF5
M/*9O,\LS!8NI@YXZ*_LZMB*OLG0IXC"R?M?;6]I[:U-PO*$E-6^FX4SZEP[F
MCQ];#5<5!X7$8?V5&K2I3YJ\8+FYJL)P<8\LKII-MKE=T[_VR_#/_@VB_;#\
M%W=SJ^J^./V4M1\0ZM>V]QJ.HVOB?XJ16=I! \MK';VUO)\(FEN/*T8VUH\:
MK964\\,WF6LD%Q.;GVV+_@WW_:QG\0W?BS5O%7[/=YXA70(-&TJ:7Q]\1M3T
M[3W$RW$MQ#8ZE\&]L:&<3,4LFT^Z^UKIFIO<7+6EU;7W\%*^%?#./F\->'\]
M.-'TW&.QYLNO..@Z<YIZ^%O#(9?^*<T #.-O]C:81R"/^?09Z@].,9Z\U^'K
MZ,N8S=UQS@4VG[T.&<3&2OHWIGT+=4VF[Z;[K]&CXMY;!6628UI+6^-P4KV6
MR_<:+3I9']^NA_\ !"?]MKP=XR\-^*/!7C;]FO09_"VM:/XC\-WL7CKXF74G
MA76?#VK6&LZ++H^EWOP3DM;BTL;[1[&\CCDGL))+JZG68B"PC.H_6-C_ ,$S
M/V]U+W>M:Q^PEJFI7UR;[5WLO@EX#T^.[NGC+SF:YG_9PN[B]%Q?M-<3321P
M22"52J@PGS?\V >%?#&5!\-^'^6Q_P @33/0X)/V7/U XSC&.<RIX3\+@@GP
MUX?/'.=%TSO[&S(R.F/7OZ]%+Z-&:T6O9\?86,K.*MPUC+ROK=N/$D>9J[4>
M>ZB[N*N[G#B/%7)*[4J_#V+J)2<HPGBLLG&+M9\BJ8&:IJ5ES<BBY:*3:5C_
M $JM)_X)I?MV1ZA$E[JO["UCH?VAC<P:=\#?A_-<R13R*SW$<'_#.UC!'?6J
MH&5Q=;+^=M\WV5%^?2O?^";G[<202)IFJ_L4R9$[_9]0^$/@9A+)=W!FN(WN
M5_9SG"QQQ+%;VQ%L-RQ0FXC*Q!1_FE0^$_"Q8C_A&/#I'.=VBZ7D@ 9Y%F,#
MYATY//(QDS?\(GX6\PA?#'AT+NX']B:6<+@<?\>9S@Y.#WR.E=5/Z-F>.,J;
M\0Z%FU.[X;Q[FN71153_ %JC)1LWHN5.^BN<LO%#AUU5)\+5[PCI&-;)XP>S
MU@LO2<GO=Z]#_1R\1?\ !,K_ (*'^([.[TQY_P#@G_I=G*)+=5M?A9X%OK:6
M R6Q2[:VU?\ 9+U"%=2)6>\@$UI<:=87DC(]IJ'DVU[7 :-_P2?_ ."E6@6$
M-A::]_P3GN%FN&:_S\#_  '!;+%)>6SQO;6=I^R;I]K+-I5M]HETUWBAE.HE
M6O&N8U:>7_/-7PAX6X'_  C/AWDXR-%TP=>Y_P!$//0# ]^.UJ+P?X6#'=X8
M\-L,=#H>F==P/_/IP,<=S]*3^C#G3BE_Q$B.RNUP[F">G>W%24FDKWE&3Z+9
M6;\6.'(_\TI-O=6EDBO9OJLNMUUNC_0LMO\ @E7_ ,%.8]0D9_%/_!/>'3<V
MUS L/P7^'LES;W"JAO$$9_9/@:5KDM+:M-<:E.YMHH?WJR74[VWE'Q&_X(R_
M\%2OBEX:U#P'XD^*/[$6C^#M2\8:#XWOH/AEI$_PFGU?6_":ZQ;>'9/$\'@#
M]E[P_<>)X],L]>UE=,_M#7HH],NM4GODM;F2W-M?_P &(\)>$@PSX4\-XW!?
M^0%I7\7?_CTZ<@^O;' S.?"7A+DMX6\->I_XD.F<?7_1>W;@9[8J*GT5<RJ+
MEJ>(\*L96DX3X<QTXWNI)N$^)YP=KW2<))/6S>HEXP9'1E"=+A7$4YJ_+.G7
MR:$NSBI0R^$TM5?EE![+FT/[0;C_ (-Q/VZYHA+#X_\ V5;;4+:)K6SD/Q"^
M+L]O)9"5[F..^1?@A:?:[HS^6SWE^FHSB7S[EI)I[DM%GWW_  ;:_MX3 -;?
M%7]EMKE[F.[N)[OQ1\4D9VC2&(1L]M\)C]L"VEM;:;;K/'%)96\$;07:VXAL
MK7^-5?"'A+H?"OAOKR!H6E#TX)^QD XZ':<Y&0,C,Z>$/"@!/_"*^&2>V="T
MKICDY%GG[V<#&, <]<;T/HDXZ#4H^(&%B^SX4K3T6JT_UC2LG9I/KKY%3\<L
MMDFGP[F$E:UO[0RY73Z_[K;I?Y']E7P^_P"#;K]NW1&OF\8_%']E_5);+4-0
M'A>>P\<_%NZAMM,U+4+?6#<W%E-\&M'^Q:Q%J,3/>K'/JEA=R%;T)-=+'*GT
M+-_P0<_;;NTO7NOBA\ VNKN+8+H>./B<]W%)_I1647EY\+-0FEQ(UB1'+MBA
MM;4V=E#91S3"3^%E/"/A3'R^%?#0S@G_ (DFE'DA3QFQ[ ^PST'<N_X1+PKR
M1X8\-]><Z#I7;C'%I[>@/ X&:I?1#Q<I-_\ $0</=N[?^J=;5W;OIQ+^FESD
M?C;E2NO]7,Q5GO\ VKE]];O5O!MO>ZNW\NG^@C\._P#@DE_P4,^'OA^\\*:=
M\3?V2KGP[J/B*X\73Z9XE\+)\1K.R\27&@:9X;_MW28/B)\ _$=Q87QTG1M/
MTZ\@M-1M(KVUMXV><2\1^JI_P32_;RA?<FL?L)SQ@/YT,_P1\#0+>/)L9706
M_P"SG+]D\AT:&-'ENU:*>69V$B1Q-_G,CPGX4) 'A?PURQ4?\2+2^,=22+3D
M=1VR?3M<'A3PDL:X\*>&B!P/^)'I04<XQ@V9Q@]#Z=!VKKI_1(S7E=.GXF*C
M"_PTN%\;2CS2;OI#BR"?2_-MH[NR2YJOC/D,IJ=3A'%5JDG_ !*F-RBI-J*L
MDZE7+9S:27+%2G/E244TDDO]'B7_ ()R_MRPM#'8:G^Q-<6<*AP-0^#7@:PD
MDGCQ+'+);6G[/FK6\3K.\JHT%PS16PBR9K@-([)O^"<7[<CVV+?4OV(+"]#V
M?DSP?!?P==0VRP7BN6:WE^ -H+QXK;S'M_)FTOS+F0QRM;PPQ2W'^<8/"/A(
M@'_A%?#*E@ ,:#I>?F(P3BT S][ ZX4'D5;A\'^%%+;O"GAEL@8_XD6F ?*>
M<D6F=Q)'3WZ8 -KZ'^;R:_XVG53332_U<QUFUKK?B^2:ZV=EIHS*?C7P[9WX
M-K.ST3Q62IW_ ,7]EO[[IZ;G^D?9_P#!/C]LNTDA1O\ ABJ:V33+.V9%^%'A
M&U9K^&6\-S= Q_L]3QQ6T\<L+?88XV7SY;Q4ECCD\UI/$?\ P3G_ &L?$>D^
M#M&N]=_9YL;+PWK6K:[=VWA32Y?!.F7>HZ[I^EZ?J5Z^E>&/A+IMI>WMU:Z3
MIUA/=7BM<-8:=;I#/;2R*;;_ #=T\)>%1EO^$8\-@<G:-#TL').WK]DQ@8 &
M#G!SCBK,?A'PHV2?"WAO"\ '0M+/.,YS]DP.O/7/<>NR^AYF=2\:GB>ZL=+Q
MJ<+XZI#1NSY)\83IJ2NTGRMZM/96RCXY9!0?-2X-Q%*25O:4L?E%.HD[*454
MIY3":B].:*ERRLF[V/\ 10O/^"6/[3DIC,7BGX07*1J[+%-XH\>:>!.5N(XI
M4%M\/[R.V:,S"??"6E;#0/( JRNEM_P2N_:92?[3=>)?@M=2^3+;0QGQ!XWM
MX+."=_,8QQI\.ITN5MY"TEO:31Q@X6.2[8RR.O\ G<+X2\*@8/A?PZ>A&-#T
MK[IXY)M./NDXZ =\G%._X1+PF<@>&/#I(XXT/2#CKUQ:^N>N/2FOH88MIM^(
M]#WEJ_\ 5"NGO>]UQ6K/3[AOZ0&5)O\ XQ;,7W:SG *_G_R+[[]_,_T,=-_X
M)0_M0VFIWVIWWB7X!ZE<W9O(X99[[QO,]E:(MDFCV,7VCP&P:SMMFH2S1DJ\
M<UV&1KD/.TF])_P2X_:;1K'[+XF^"WD6EGJ%G]GGU;QJR.NH7$%V[SM'X(2Y
MG1+I99Q:+>6Z"7R6%T0JK!_G<)X/\*'#+X7\.#C(']AZ63AAC_GT[9SC';KS
M5A/"'A0=?"_AO(5BW_$@TH\#)Z?9!C@J,9Z]_7I?T+\;4<6_$K"IW7+;@W$;
MI6NO^,L:3LG?OVU1S+Z063TTXKA;,Y)[IYSE^]V]O[,6JTL_)'^E[\+_ -D3
MXF?LS_!']LF?Q;J'AG4-)\:_L\>,K#1]+\+:IXAUMK35-*\%^.9;^9SK7AW1
M#:P7D=]9Q6UI =0E-RDVZ9HVA%?YK6EJ7T_3<'"G3[,ASSNS:Q$;3R,DG)]<
M=<C%9D7A/PNKAH_#7AZ-T<2(R:'IB/&Z,&25'6U#+(K<HRE64@,K C ZG#;@
MY^8\L<;B22IZC!]1GD[1CMBOZ%\#_!>MX08?B6C6XDCQ&^(<3E>)56&43RGZ
MI_9F'QF&]FXSS/,O;^V6*YN?FI*'L^51FGSK\I\3/$3"<>/)OJN4XC*UE<,;
M%K$8VCC/:O%SI5%R>PP^'5.-/V33C+F7O7CU%1"#C).<X[]\[6'K@L>W)R.^
M9A%S\W.!P, #D]B#GUZCW([%$1MRL0 %/')R1M8 XVCKNSR1^?!L5^^Q2=]7
M:^W<_(YU&GI:_5JSL[V[6V$&<<G)]>GY=?K^-."DD =\]?H>GXXH1"[$;@N%
M!P1GJ2#SD>U6 ICYX/!&3D'*J6)(.3G:I&,]3R>.=80;TLXJVCTUU^=NK.>4
MK.]TY.VFW3TMT6W^9$(01DG@$'G/(."""/7)'4GCN0:^OO\ @G\@'[>G[#V/
M^CQ?V8FR>I/_  NSP/GKV_KQCCGY)/*DXR,$\-[!N@&&.3G.0&SC VDGZV_X
M)_HW_#>?[#G?;^V)^R^20>[_ !N\#8&."2Q."><Y8<XKP>,:27!?&4M;KA#B
MMI^7^K.?MO>UN^RM;U/4R"3EGV17=O\ A<RA*/37-,N_&[2M9WOML?KA_P %
M3?VW/^%9_P#!0#]IGP-_PQS^P7\0QH'C2RMO^$T^*?[.W_"7^/\ 7\Z#IC&Y
M\3>(_P#A,=/&JWD9S%'<&RMRMO'!%M)3<?@/_AXPV,#]@?\ X)F$ 9X_93;G
M//&/'PSVZ<#(K[#_ ."K?[#?[9?Q,_X*#_M-^/\ X?\ [+7QX\9>!_$GC@7.
M@^+?#7PR\5:YH6M6D=I%;O<Z3>Z5IMXM];IY0/G1 H<@1LV-H_/,_P#!.K]N
MR%LO^Q=^UKJ+*1NCL_@;XSTVW<$<A-2OM(O+H[?^6B/X>B.<I'.!B2O\'G/;
ME<4DE9J2>G[JV]1WT5TU\6U['^H;2LO=UZZ._P!K?33]+]3])/@3^TOX)^(W
MPU\&?$?XB?!OX"_!SPAI%U_P4\^'&H^!/V>=&MOV>O#OC^Z\4_\ !/CP+I^B
MZ4VL7EO\2;?1_B3X[UGQ=I_@'0_%\OASQ*+1F\-Q+X3UM[%=/O[?P*^,?[,_
MA5O@#J.A^!8/AG\.1\;/%>N_'_P%\1?BG-\9/B%HWQ6\-?"+XB^'OV4?BRGB
MZU^$7AO0M4^ ?@[Q%X]M/%6N2Z5^S[>>(? WCS0O$EQXGT3XB:+%X.M=>^??
MA1\"?VQ? /PEB^$GC;_@D]^U#\4-.L/BIXN^*>B:[9'XN?#/4=-O?&O@SX<^
M"]6T:\L;;X6>.++5[:&W^&NDZG::B)-,GBN+Z]MA9B*.&5NKE^#/[0LX$<W_
M  1@_;%DC 8",_%?XTF! W#+'"O[.B1(N>=JH![$<G[C*\YR2CEM##XW%9G3
MQ$:;A5IX:FY8>REF*A)6Q4(SJJ&.]I"I*'/0J1Y(-QE4<O@<VR7/:^9XG$8+
M"996PU2JJM*IBJL(XB[CESG%WP\YPHN6!Y*E.,^6M";E)7C32^J8/VD)_#'Q
M!\$3^.?%^B^(/%W@WP5^VKXE\._$WXG_ +<NG?MX>*].N/&'[&_QA\(^$_AK
M>Z]>_ SX?Z?IG@/Q_P#$S4O#EYX=^'&N^)_$\,GB*-K6T\$^&X?$-RFJ?/&H
M?MI_M!6_[,O@S5;;]I_XFW_[1>G?'WXCZ?=?$4>-[Z#]H"V^"C?#?X4>*_#_
M (+N/B#*;SQP?@S=?%>+Q/J]OX.;4+?PO=ZY%J.EG3&TFUBT^'*U/X'?'=/[
M/G@_X(Q_M>W*W^CZ==W2Q_%/XR*]G?P&?3;RRGC7]G=]LD<NF_:8RX#3VEW:
M7)4><I&:/@?\?PP;_ARY^V"#MP3_ ,+6^-!8Y)+ Y_9V .23G.<DG)%>C2S[
MA.'*ZGUFLXSIS2EEF'Y(JC]::IPA/$UE3I5)8MRG2BU2E.E"4J4U='F5,@XO
MG=06%HJ4:D&XYO5<W*K]47M:DUAZ3G5A#"<D*TU.K&%::C5@^64?M^Z_:(^'
MNF:K\2?^%#^/[#P3XLD_:J^)?Q-^(NK?#_\ ;6TK]BC2OB'X4\1Z'\-]2\ >
M(I+J/X!?%+2/C/\ #;P_J4/Q'T;5/A7;ZI#8>&]:N]<OH_AIXBB\9I=V7F>D
M_'O4_$2_!W5/@3^T+\+?V4/A1I'CGXF7?[0_P$_X6O=:1X:;Q5XJ_:*\;>*%
M\8:[X&OO"OAL?M5_"?Q'\#=9^&G@+PCX>;P1JZ:3H'@_6O"%UX%\&^?;R3_-
M;?!#X_-M#?\ !%O]K\!.5)^*GQFPN.@!'[.WRG/).?3C(5J&^"7Q\RK'_@BY
M^V S+]UA\5?C-E2"""N/V=3LYY...,=,URQSSA>$91^MXV4I+EYL1EN&KN2]
ME*E*5:%3&<E:4$^;"5)Q<\)))T6E=/:61\4S<+X3+Z<(/F5.AFU:A9JLJT8T
MI4<,IT85&FL7&G-0QBE-5HN34E]'W'Q1^'.I>.KJZTCXX?\ "'ZIH_[:_P#P
M4E^*_P /KOPC\4M,^%-]K%[XW^&?P7TKX0V7_"Z-0\->.++X(>'/BU=6'B70
M]-^,_P#PBFK76CS:3<6^AW_AO6;JP\9^&^ZF_:%O+/5_"5IX*_:>MO /QI\=
M?L(?M&_!WQ#\1(?VQ?%'Q(NK+XR:1^T?:>.?@9HGQ0_:MU6P\(WNM>)M(^&,
M?BG2O _C/Q.USIWAVRU2#P7HGC+5=(%GJ,_R;?? 7X_WEQ;36_\ P1E_:UFC
MU+3X=3G,OQ>^+]JMC=/+<6VJ6EU')^SV1&8+^UN9;90'DO-,GL;U8A]J,4=0
M_ ?XVPATN/\ @C=^V#*P(7[-I7Q*^--RK8^<B2\O/V>["UC7<-R2V\>I.)#N
M:#C)TEGW#,N64L9C914*E.*J99A9Q:J*#;O/$6J0YZ4*E2$G*-2<;2?)[JRA
MD/%5.,DL'@(R=2$W.&;5X-<KJ:QM3;A4C"I.E"<4G"$I.-ZCYCUK1?B_#_P@
M7@?0? W[07AGP#^TRO[)OA_P7X;^-E[\17\.7VCZS;_MS?M9>+_C-\/]&^.0
MQ)\*?B%\2/A[XT\#>+[7QM=ZKX;D\4>!UO\ PY%XFT]_&EI'JG2ZM^TKKGA?
MX<_&"#PW\?-)\4_M8_\ #-/[/W@_Q]\=? WB,ZQXC^(/Q"T_]KSQ7XOGD\#^
M.?L$%[X^^*GPB_9LOO!G@GQ=\;]$-UK$MSI&K7OAWQ9?:II%OXIF^=E^#/Q\
M42%?^"*G[8#*S847'Q8^-,[Q*2,8"_LZ00RN#EBYMX^/E 50")/^%1?M$J83
M'_P1A_;%C$$J311Q_%;XSQ6Z2QD%9/LT7[.<4(8D#>0F]AU<CBJ7$7"JGSSQ
M.,J1]JZLZ<LLPO+-2J0J2P\JGUERE@6H6C@;?5X5&JR3J;2N'^*N3EC0P,)Q
MI.E"HLVK/D?)*G'$0C[!06.7->6.?^T2II4KJF<)^TIX^O/BWI_[.WC;Q/XW
M@\=_%.Y_9JL-%^-GB_5=4CUCQMK'CKPE\>_CUX<\,R_$C4H5FU+6/&UK\$=-
M^%%G-K&NO<Z_?^&+;PU/J5Y<!89C[-^T;^T/\&=(^/O[27CGX'?!>^U/XE>*
M-1^,OA71/VA]:_:.D\;>"#I_Q6\'>(OAIX^\<_#?X.Z#\%/ T6F:AXA\"^+?
M%.D^%G\2_%CQUIO@]]8DOA:>)+^TM;N/F]0^!GQWB>VGL_\ @C'^U_):ZA9P
M7HB3XJ_&2&6QN2SPW^F7-O'^SPXB-EJ$%P+*12BWVEMI^IJEL]XUG:T/^%*?
MM 9R/^"+O[80.,8'Q7^- 7'H%'[.P 4< *,# %;?ZT\,.-"$JN8.E0HXB@J4
M,.Z%*I2Q&*6*]G4A0Q5-3HTG&$(T%*-)PA!34N6,3E?#/%,9XFI"AEOM<35P
M]65:IBXUZD*E#"?5G5I3K86HHUJEYSJ5W&55RG)1E'F<CZ;^(?[3WB?XA?%G
M]JW2/ 7[2>C?#KQK_;W@S1/V5OB7'X[A^&?A;0_A)I^K3O\ &OP;\*/BI8I;
M:9\*/'OQ;NY/#?C[QKX^.K^&-6^+ \/>,M#UCQI+JFNP:9J3-6^,UWJWA/5O
M#_PS_:>\'^%/VW'\"?!'2OCE^U/H_P 2G^%[?&O3/#_B'XU:GXB\%^$OVF6C
MT!I/&GA/POKW[.WAWXK>-H]<T"'XYZK\-;FVM/$WBA-)A?Q-\SGX*?'\JRM_
MP1;_ &P74_PM\6/C05."&'RG]G4CAAD?[6&SG.5A^#/[0<$B.G_!%G]K\E%<
M*C?%7XS&)E>-XI8'C;]G5D-O/'(\4\8 $D4DBE3GCECGW"T.14Z^*C&G&%D\
MJPDE4G"C1HM8A^WA+%8>HJ,:M3 SY<.\14JUU^]DG'K>1\52<W4P^#G*HZO-
M-9QB(2I*I6JUHSPR5%K#XFE[7V5/&0O7^KPA0;Y(N_TG\,_CO<:7X.\3Z?9?
M'::\_:'?]H7Q/XX^-GQ8\#_MU0?L?K\8?#EQX.^'=OX#\27/CZX_9Z\;VGQ\
M\(>#M9M/B!I'B3P.]UID5UX@O-4\5S>$/B OBO\ MR#&N/C9I_CKX4^/='E^
M(?P^_9Z^&4NK_M">-O _A3X3?M4:[>>"[GQ'XL^+&O>/M ^"7[2G['][\//#
M]K^T1X8\<>(%TO0/!_QQ\.^'/AWJ_P ,_@Y>^#S?6&H^&_!=WX+T[Q#4?@5\
M>(C:O:_\$8OVOKFSN[:.XA!^*WQE%Q:2 M%<6%[;?\,[L(9[6XB>*.56>WOK
M-K>_AE"3^3#*O[/_ ,>HV66__P""-?[6=H_EJYC@^+'QJU2] *DI'Y%G^SQ]
MD$I7&V.YU2RB .)+F)OEI2SSAF<YU'B<=&;K1JJ<<LPUX6<9/DC];]FH0<>2
MA"5.<:%"4J,$DHSC4,BXHC3A2^J9?*$:4J4H/-JW)434H_O']74W*IS*IB*D
M90G7KPC6K.H^>E5^A?B;\;[;Q)<?$7QIX]^/<MS\0/%G[-'[?WA&'X36W[5.
MH?M0_!;2YOB1\!5M/"NI_!;7M8LK76O@MI/Q3\837OA#1/V9=6U?Q5_8EEHF
MCRZ)J6FZ=(NC669\0?VH_$_C/X\?$GX?7/QSN=>_97\3_L@:Q\/G^'B>(HY/
MA!JOCO0_^":^GW7@R?4=+\A]-U/XL:;^T_X6\,6?A[XC7-O<^.[#QGX?TKPQ
MH^KVECH=EHMIX*?@M\<H) UI_P $5/VQIH ,EM0^*_QC22:0[29Y+.T_9X:.
M C'%N][J)W*LCW3.$17GX1_M$!'@'_!%W]KYK69'AGL!\4?C(EA<1DJ-ES G
M[.<:3\*C1SS!YHVB1XW0@%=*>?\ #"C)2KXV;C"4:4EEM"+PDI2IRI5:#CB7
M.%2C&DHT)J7MH<S_ '\YVG*99!Q4YJ4:& @N:FZL?[3JS6)Y(SC4IUTZ2C4I
MUW-RK4%&-"IRPO3A'W(_3WA#XR:EXX\=_M!P^"OVJ-)N_@"/V'OVGK_P'^R9
M!JGBFXNO@IH>E_LG>+-(T_PQ?_!0:3)X1^!GB'X:ZAJLVA^*?C5IU]9S_%2_
M\36^BKK_ (DO/C;<Z;%\5_#V?P9\0O@9K7P%O_'7A/X?^-=/^,>@_&GP9/\
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MTAST'?C\^GZ_7Z>G/).*5KW:UB^FVW?=]>B-UT>W>W0K#A01R=O ]>*;N?\
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M4\]LA5.>1SQD^Y)-*<JA)P2 Q]L\G';CM[BCJQ&3@!3CMDENOKT%-;.,')W
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M(&"#CK.#GCIBD_X>5_\ !0G''[;'[2A('/\ Q=;Q%^F+CGIWZ_B:^+<,.2&
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KZ ]AWQ_BW8_^S_WT?_B:YW!M[W]?^ ;1DDDO\C__V0$!              $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !) .4# 2(  A$! Q$!_\0
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MJTU>4="*6*I57:$KLW**3K2,=JY^E8G0.HI*8SJA 8@$G SWH DHIH(I"PH
M?159[NVB4L\\2*&"$LX #'M]?:I(Y8Y4#QLKJ>A4Y![=:!7):*C>5(UW.P49
M R3@<T\4#%HHHH **** $KQ'XK_\C@G_ %Z)_P"A-7MU>(_%;_D<4_Z\T_\
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-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>vivk-20220630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOayFaaPty552qYkxvmR5fUnq3yIpYIvc/i/lp9+GcYQC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:VIVK="http://vivakor.com/20220630" elementFormDefault="qualified" targetNamespace="http://vivakor.com/20220630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://vivakor.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" id="CondensedConsolidatedStatementsOfChangesInStockholdersEquity">
	  <link:definition>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows" id="CondensedConsolidatedStatementOfCashFlows">
	  <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/BasisOfPresentation" id="BasisOfPresentation">
	  <link:definition>00000007 - Disclosure - Basis of Presentation</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Liquidity" id="Liquidity">
	  <link:definition>00000008 - Disclosure - Liquidity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/PrepaidExpensesAndOtherAssets" id="PrepaidExpensesAndOtherAssets">
	  <link:definition>00000009 - Disclosure - Prepaid Expenses and Other Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/MarketableSecurities" id="MarketableSecurities">
	  <link:definition>00000010 - Disclosure - Marketable Securities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Inventories" id="Inventories">
	  <link:definition>00000011 - Disclosure - Inventories</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000012 - Disclosure - Property and Equipment</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpenses" id="AccountsPayableAndAccruedExpenses">
	  <link:definition>00000013 - Disclosure - Accounts Payable and Accrued Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/LoansAndNotesPayable" id="LoansAndNotesPayable">
	  <link:definition>00000014 - Disclosure - Loans and Notes Payable</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000015 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Long-termDebt" id="Long-termDebt">
	  <link:definition>00000016 - Disclosure - Long-term Debt</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/TemporaryEquity" id="TemporaryEquity">
	  <link:definition>00000017 - Disclosure - Temporary Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/NoncontrollingInterest" id="NoncontrollingInterest">
	  <link:definition>00000018 - Disclosure - Noncontrolling Interest</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Share-basedCompensationWarrants" id="Share-basedCompensationWarrants">
	  <link:definition>00000019 - Disclosure - Share-Based Compensation &amp; Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/IncomeTax" id="IncomeTax">
	  <link:definition>00000020 - Disclosure - Income Tax</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000021 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/BasisOfPresentationPolicies" id="BasisOfPresentationPolicies">
	  <link:definition>00000022 - Disclosure - Basis of Presentation (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000023 - Disclosure - Property and Equipment (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables" id="AccountsPayableAndAccruedExpensesTables">
	  <link:definition>00000024 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/LoansAndNotesPayableTables" id="LoansAndNotesPayableTables">
	  <link:definition>00000025 - Disclosure - Loans and Notes Payable (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000026 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Long-termDebtTables" id="Long-termDebtTables">
	  <link:definition>00000027 - Disclosure - Long-term Debt (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/TemporaryEquityTables" id="TemporaryEquityTables">
	  <link:definition>00000028 - Disclosure - Temporary Equity (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsTables" id="Share-basedCompensationWarrantsTables">
	  <link:definition>00000029 - Disclosure - Share-Based Compensation &amp; Warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/BasisOfPresentationDetailsNarrative" id="BasisOfPresentationDetailsNarrative">
	  <link:definition>00000030 - Disclosure - Basis of Presentation (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/LiquidityDetailsNarrative" id="LiquidityDetailsNarrative">
	  <link:definition>00000031 - Disclosure - Liquidity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative" id="PrepaidExpensesAndOtherAssetsDetailsNarrative">
	  <link:definition>00000032 - Disclosure - Prepaid Expenses and Other Assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/MarketableSecuritiesDetailsNarrative" id="MarketableSecuritiesDetailsNarrative">
	  <link:definition>00000033 - Disclosure - Marketable Securities (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/InventoriesDetailsNarrative" id="InventoriesDetailsNarrative">
	  <link:definition>00000034 - Disclosure - Inventories (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
	  <link:definition>00000035 - Disclosure - Property and Equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000036 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails" id="AccountsPayableAndAccruedExpensesDetails">
	  <link:definition>00000037 - Disclosure - Accounts Payable and Accrued Expenses (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/LoansAndNotesPayableDetails" id="LoansAndNotesPayableDetails">
	  <link:definition>00000038 - Disclosure - Loans and Notes Payable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt" id="LoansAndNotesPayableDetails-MaturitiesOfDebt">
	  <link:definition>00000039 - Disclosure - Loans and Notes Payable (Details - Maturities of Debt)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative" id="LoansAndNotesPayableDetailsNarrative">
	  <link:definition>00000040 - Disclosure - Loans and Notes Payable (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CommitmentsDetails" id="CommitmentsDetails">
	  <link:definition>00000041 - Disclosure - Commitments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000042 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Long-termDebtDetails" id="Long-termDebtDetails">
	  <link:definition>00000043 - Disclosure - Long-term Debt (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Long-termDebtDetails1" id="Long-termDebtDetails1">
	  <link:definition>00000044 - Disclosure - Long-term Debt (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/TemporaryEquityDetails" id="TemporaryEquityDetails">
	  <link:definition>00000045 - Disclosure - Temporary Equity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/NoncontrollingInterestDetailsNarrative" id="NoncontrollingInterestDetailsNarrative">
	  <link:definition>00000046 - Disclosure - Noncontrolling Interest (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions" id="Share-basedCompensationWarrantsDetails-Assumptions">
	  <link:definition>00000047 - Disclosure - Share-Based Compensation &amp; Warrants (Details - Assumptions)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetails" id="Share-basedCompensationWarrantsDetails">
	  <link:definition>00000048 - Disclosure - Share-Based Compensation &amp; Warrants (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative" id="Share-basedCompensationWarrantsDetailsNarrative">
	  <link:definition>00000049 - Disclosure - Share-Based Compensation &amp; Warrants (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://vivakor.com/role/IncomeTaxDetailsNarrative" id="IncomeTaxDetailsNarrative">
	  <link:definition>00000050 - Disclosure - Income Tax (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="vivk-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vivk-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vivk-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vivk-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="VIVK_SeriesAPreferredStocksMember" name="SeriesAPreferredStocksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VivaventuresUtsiMember" name="VivaventuresUtsiMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VivaventuresRoyaltyMember" name="VivaventuresRoyaltyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VivaopportunityFundMember" name="VivaopportunityFundMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_InternationalMetalsExchangeMember" name="InternationalMetalsExchangeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_RPCDesignAndManufacturingLLCMember" name="RPCDesignAndManufacturingLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_RdmMember" name="RdmMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VivaWealthFundIMember" name="VivaWealthFundIMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConvertibleSeriesAPreferredStockMember" name="ConvertibleSeriesAPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_StockOptionsGrantedToEmployeesMember" name="StockOptionsGrantedToEmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember" name="StockOptionsGrantedToBoardMembersOrConsultantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_PublicOfferingMember" name="PublicOfferingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VendorMember" name="VendorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ProfessionalServiceAgenciesMember" name="ProfessionalServiceAgenciesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_OdysseyGroupMember" name="OdysseyGroupMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ScepterHoldingsMember" name="ScepterHoldingsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_FexixIronMember" name="FexixIronMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_PreciousMetalExtractionMachine1TonMember" name="PreciousMetalExtractionMachine1TonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_PreciousMetalExtractionMachine10TonMember" name="PreciousMetalExtractionMachine10TonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_BioreactorsMember" name="BioreactorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_NanospongeCavitationDeviceMember" name="NanospongeCavitationDeviceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_RemediationProcessingUnit1Member" name="RemediationProcessingUnit1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_RemediationProcessingUnit2Member" name="RemediationProcessingUnit2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_RemediationProcessingUnitSystemAMember" name="RemediationProcessingUnitSystemAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_RemediationProcessingUnitSystemBMember" name="RemediationProcessingUnitSystemBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_SeriesC1PreferredStockMember" name="SeriesC1PreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VariousPromissoryNotesAndConvertibleNotesMember" name="VariousPromissoryNotesAndConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_NovusCapitalGroupLLCNoteMember" name="NovusCapitalGroupLLCNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_TripleTNotesMember" name="TripleTNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_NationalBuickGMCMember" name="NationalBuickGMCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VariousConvertibleBridgeNotesMember" name="VariousConvertibleBridgeNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_BlueRidgeBankMember" name="BlueRidgeBankMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_SmallBusinessAdministrationMember" name="SmallBusinessAdministrationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_JPMorganChaseBankMember" name="JPMorganChaseBankMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VariousPromissoryNotesMember" name="VariousPromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_JamboreeCenterMember" name="JamboreeCenterMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_SpeedwayCommerceCenterMember" name="SpeedwayCommerceCenterMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VictoryHoldingsMember" name="VictoryHoldingsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConvertiblePreferredStockSeriesBMember" name="ConvertiblePreferredStockSeriesBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConvertiblePreferredStockSeriesB1Member" name="ConvertiblePreferredStockSeriesB1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConvertiblePreferredStockSeriesC1Member" name="ConvertiblePreferredStockSeriesC1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_VivaWealthFundILLCMember" name="VivaWealthFundILLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ShareStockAwardMember" name="ShareStockAwardMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_StockOptionsMember" name="StockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_NonStatutoryStockOptionsMember" name="NonStatutoryStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_BoardOfDirectorsMember" name="BoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConsultantMember" name="ConsultantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity" name="CashAndCashEquivalentsAttributedToVariableInterestEntity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_PreciousMetalConcentrate" name="PreciousMetalConcentrate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_LicenseAgreementNet" name="LicenseAgreementNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_IntellectualPropertyNet" name="IntellectualPropertyNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_LoansAndNotesPayableCurrent" name="LoansAndNotesPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" name="LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockIssuedForReductionInLiabilities" name="CommonStockIssuedForReductionInLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockIssuedForReductionInLiabilitiesShares" name="CommonStockIssuedForReductionInLiabilitiesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockIssuedForPurchaseOfLicense" name="CommonStockIssuedForPurchaseOfLicense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockIssuedForPurchaseOfLicenseShares" name="CommonStockIssuedForPurchaseOfLicenseShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_StockIssuedForConversionOfTemporaryEquityValue" name="StockIssuedForConversionOfTemporaryEquityValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_StockIssuedForConversionOfTemporaryEquityShares" name="StockIssuedForConversionOfTemporaryEquityShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" name="ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" name="ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConversionOfSeriesPreferredStockToCommonStock" name="ConversionOfSeriesPreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConversionOfSeriesPreferredStockToCommonStockShares" name="ConversionOfSeriesPreferredStockToCommonStockShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit" name="CommonStockIssuedForFractionalSharesFromReverseStockSplit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares" name="CommonStockIssuedForFractionalSharesFromReverseStockSplitShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_StockOptionsIssuedForServices" name="StockOptionsIssuedForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_IssuanceOfNoncontrollingInterest1" name="IssuanceOfNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockOptionsIssuedForServices" name="CommonStockOptionsIssuedForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_GainOnDispositionOfAsset" name="GainOnDispositionOfAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_PaymentsToAcquireIntangibleAssets1" name="PaymentsToAcquireIntangibleAssets1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CashPaidDuringYearForAbstract" name="CashPaidDuringYearForAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock" name="ConversionOfSeriesBB1AndC1PreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow" name="CommonStockIssuedForReductionInLiabilitiesCashFlow" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_NoncontrollingInterestIssuedForReductionInLiabilities" name="NoncontrollingInterestIssuedForReductionInLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities" name="PreferredStockSeriesC1IssuedForReductionInLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CommonStockIssuedForPurchaseOfLicenses" name="CommonStockIssuedForPurchaseOfLicenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CapitalizedInterestOnConstructionInProcess" name="CapitalizedInterestOnConstructionInProcess" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_DividendPaidInSeriesB1PreferredStock" name="DividendPaidInSeriesB1PreferredStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_DisclosureLiquidityAbstract" name="DisclosureLiquidityAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_LiquidityTextBlock" name="LiquidityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_DisclosureTemporaryEquityAbstract" name="DisclosureTemporaryEquityAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_TemporaryEquityTextBlock" name="TemporaryEquityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_Covid19PolicyTextBlock" name="Covid19PolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_InterimFinancialInformationPolicyTextBlock" name="InterimFinancialInformationPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock" name="ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock" name="ScheduleOWarrantsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_CashAttributableToVie" name="CashAttributableToVie" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_AmortizedUsefulLives" name="AmortizedUsefulLives" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_WarrantsIssued" name="WarrantsIssued" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_WarrantsOutstanding" name="WarrantsOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_NoteReceivableConvertedAmountConverted" name="NoteReceivableConvertedAmountConverted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_NoteReceivableConvertedSharesReceived" name="NoteReceivableConvertedSharesReceived" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_GainLossOnDispositionOfAsset" name="GainLossOnDispositionOfAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_MarketableSecuritiesUnrealizedLoss" name="MarketableSecuritiesUnrealizedLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_AccruedInterestWorkingInterestRoyaltyPrograms" name="AccruedInterestWorkingInterestRoyaltyPrograms" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_NotesAndLoansPayableNonCurrent" name="NotesAndLoansPayableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_PercentageOfAccrueInterest" name="PercentageOfAccrueInterest" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_PresentValueOfLeasePayments" name="PresentValueOfLeasePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_OperatingLeaseLiability1Noncurrent" name="OperatingLeaseLiability1Noncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" name="LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_SerciesC1IssueForReductionInStockPayables" name="SerciesC1IssueForReductionInStockPayables" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_SerciesC1IssueForReductionInStockPayable" name="SerciesC1IssueForReductionInStockPayable" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>vivk-20220630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://vivakor.com/role/Cover" xlink:href="vivk-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedBalanceSheets" xlink:href="vivk-20220630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="vivk-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentation" xlink:href="vivk-20220630.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Liquidity" xlink:href="vivk-20220630.xsd#Liquidity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PrepaidExpensesAndOtherAssets" xlink:href="vivk-20220630.xsd#PrepaidExpensesAndOtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/MarketableSecurities" xlink:href="vivk-20220630.xsd#MarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Inventories" xlink:href="vivk-20220630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipment" xlink:href="vivk-20220630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpenses" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayable" xlink:href="vivk-20220630.xsd#LoansAndNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingencies" xlink:href="vivk-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebt" xlink:href="vivk-20220630.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquity" xlink:href="vivk-20220630.xsd#TemporaryEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/NoncontrollingInterest" xlink:href="vivk-20220630.xsd#NoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrants" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/IncomeTax" xlink:href="vivk-20220630.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/SubsequentEvents" xlink:href="vivk-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentationPolicies" xlink:href="vivk-20220630.xsd#BasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentTables" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableTables" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingenciesTables" xlink:href="vivk-20220630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtTables" xlink:href="vivk-20220630.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquityTables" xlink:href="vivk-20220630.xsd#TemporaryEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsTables" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentationDetailsNarrative" xlink:href="vivk-20220630.xsd#BasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LiquidityDetailsNarrative" xlink:href="vivk-20220630.xsd#LiquidityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:href="vivk-20220630.xsd#PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/MarketableSecuritiesDetailsNarrative" xlink:href="vivk-20220630.xsd#MarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/InventoriesDetailsNarrative" xlink:href="vivk-20220630.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentDetails" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetails" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsDetails" xlink:href="vivk-20220630.xsd#CommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="vivk-20220630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtDetails" xlink:href="vivk-20220630.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtDetails1" xlink:href="vivk-20220630.xsd#Long-termDebtDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquityDetails" xlink:href="vivk-20220630.xsd#TemporaryEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/NoncontrollingInterestDetailsNarrative" xlink:href="vivk-20220630.xsd#NoncontrollingInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetails-Assumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetails" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/IncomeTaxDetailsNarrative" xlink:href="vivk-20220630.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity" xlink:label="loc_VIVKCashAndCashEquivalentsAttributedToVariableInterestEntity" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_VIVKCashAndCashEquivalentsAttributedToVariableInterestEntity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalConcentrate" xlink:label="loc_VIVKPreciousMetalConcentrate" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_VIVKPreciousMetalConcentrate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments" xlink:label="loc_us-gaapOtherInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedParties" xlink:label="loc_us-gaapNotesReceivableRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapNotesReceivableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LicenseAgreementNet" xlink:label="loc_VIVKLicenseAgreementNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_VIVKLicenseAgreementNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_IntellectualPropertyNet" xlink:label="loc_VIVKIntellectualPropertyNet" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_VIVKIntellectualPropertyNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LoansAndNotesPayableCurrent" xlink:label="loc_VIVKLoansAndNotesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_VIVKLoansAndNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:label="loc_VIVKLoansAndNotesPayableCurrentAttributedToVariableInterestEntity" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_VIVKLoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="loc_us-gaapOtherLongTermDebtCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesAndLoans" xlink:label="loc_us-gaapLongTermNotesAndLoans" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermNotesAndLoans" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="loc_us-gaapOtherLongTermDebtNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCarryingBasis" xlink:label="loc_us-gaapTreasuryStockCarryingBasis" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockCarryingBasis" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockOptionsIssuedForServices" xlink:label="loc_VIVKCommonStockOptionsIssuedForServices" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_VIVKCommonStockOptionsIssuedForServices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_GainOnDispositionOfAsset" xlink:label="loc_VIVKGainOnDispositionOfAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_VIVKGainOnDispositionOfAsset" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedInterestReceivableNet" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="loc_us-gaapProceedsFromCollectionOfNotesReceivable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromCollectionOfNotesReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PaymentsToAcquireIntangibleAssets1" xlink:label="loc_VIVKPaymentsToAcquireIntangibleAssets1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_VIVKPaymentsToAcquireIntangibleAssets1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentation" xlink:title="00000007 - Disclosure - Basis of Presentation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Liquidity" xlink:title="00000008 - Disclosure - Liquidity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PrepaidExpensesAndOtherAssets" xlink:title="00000009 - Disclosure - Prepaid Expenses and Other Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/MarketableSecurities" xlink:title="00000010 - Disclosure - Marketable Securities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000013 - Disclosure - Accounts Payable and Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayable" xlink:title="00000014 - Disclosure - Loans and Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebt" xlink:title="00000016 - Disclosure - Long-term Debt" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquity" xlink:title="00000017 - Disclosure - Temporary Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/NoncontrollingInterest" xlink:title="00000018 - Disclosure - Noncontrolling Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrants" xlink:title="00000019 - Disclosure - Share-Based Compensation &amp; Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/IncomeTax" xlink:title="00000020 - Disclosure - Income Tax" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentationPolicies" xlink:title="00000022 - Disclosure - Basis of Presentation (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables" xlink:title="00000024 - Disclosure - Accounts Payable and Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableTables" xlink:title="00000025 - Disclosure - Loans and Notes Payable (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingenciesTables" xlink:title="00000026 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtTables" xlink:title="00000027 - Disclosure - Long-term Debt (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquityTables" xlink:title="00000028 - Disclosure - Temporary Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsTables" xlink:title="00000029 - Disclosure - Share-Based Compensation &amp; Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentationDetailsNarrative" xlink:title="00000030 - Disclosure - Basis of Presentation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LiquidityDetailsNarrative" xlink:title="00000031 - Disclosure - Liquidity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:title="00000032 - Disclosure - Prepaid Expenses and Other Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/MarketableSecuritiesDetailsNarrative" xlink:title="00000033 - Disclosure - Marketable Securities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/InventoriesDetailsNarrative" xlink:title="00000034 - Disclosure - Inventories (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentDetails" xlink:title="00000035 - Disclosure - Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000036 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:title="00000037 - Disclosure - Accounts Payable and Accrued Expenses (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetails" xlink:title="00000038 - Disclosure - Loans and Notes Payable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:title="00000039 - Disclosure - Loans and Notes Payable (Details - Maturities of Debt)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative" xlink:title="00000040 - Disclosure - Loans and Notes Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsDetails" xlink:title="00000041 - Disclosure - Commitments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtDetails" xlink:title="00000043 - Disclosure - Long-term Debt (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtDetails1" xlink:title="00000044 - Disclosure - Long-term Debt (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquityDetails" xlink:title="00000045 - Disclosure - Temporary Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/NoncontrollingInterestDetailsNarrative" xlink:title="00000046 - Disclosure - Noncontrolling Interest (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions" xlink:title="00000047 - Disclosure - Share-Based Compensation &amp; Warrants (Details - Assumptions)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetails" xlink:title="00000048 - Disclosure - Share-Based Compensation &amp; Warrants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative" xlink:title="00000049 - Disclosure - Share-Based Compensation &amp; Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://vivakor.com/role/IncomeTaxDetailsNarrative" xlink:title="00000050 - Disclosure - Income Tax (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>vivk-20220630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://vivakor.com/role/Cover" xlink:href="vivk-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedBalanceSheets" xlink:href="vivk-20220630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="vivk-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentation" xlink:href="vivk-20220630.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Liquidity" xlink:href="vivk-20220630.xsd#Liquidity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PrepaidExpensesAndOtherAssets" xlink:href="vivk-20220630.xsd#PrepaidExpensesAndOtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/MarketableSecurities" xlink:href="vivk-20220630.xsd#MarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Inventories" xlink:href="vivk-20220630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipment" xlink:href="vivk-20220630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpenses" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayable" xlink:href="vivk-20220630.xsd#LoansAndNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingencies" xlink:href="vivk-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebt" xlink:href="vivk-20220630.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquity" xlink:href="vivk-20220630.xsd#TemporaryEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/NoncontrollingInterest" xlink:href="vivk-20220630.xsd#NoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrants" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/IncomeTax" xlink:href="vivk-20220630.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/SubsequentEvents" xlink:href="vivk-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentationPolicies" xlink:href="vivk-20220630.xsd#BasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentTables" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableTables" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingenciesTables" xlink:href="vivk-20220630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtTables" xlink:href="vivk-20220630.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquityTables" xlink:href="vivk-20220630.xsd#TemporaryEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsTables" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentationDetailsNarrative" xlink:href="vivk-20220630.xsd#BasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LiquidityDetailsNarrative" xlink:href="vivk-20220630.xsd#LiquidityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:href="vivk-20220630.xsd#PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/MarketableSecuritiesDetailsNarrative" xlink:href="vivk-20220630.xsd#MarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/InventoriesDetailsNarrative" xlink:href="vivk-20220630.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentDetails" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetails" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsDetails" xlink:href="vivk-20220630.xsd#CommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="vivk-20220630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtDetails" xlink:href="vivk-20220630.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtDetails1" xlink:href="vivk-20220630.xsd#Long-termDebtDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquityDetails" xlink:href="vivk-20220630.xsd#TemporaryEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/NoncontrollingInterestDetailsNarrative" xlink:href="vivk-20220630.xsd#NoncontrollingInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetails-Assumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetails" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/IncomeTaxDetailsNarrative" xlink:href="vivk-20220630.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SeriesAPreferredStocksMember" xlink:label="loc_VIVKSeriesAPreferredStocksMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VIVKSeriesAPreferredStocksMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForReductionInLiabilities" xlink:label="loc_VIVKCommonStockIssuedForReductionInLiabilities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForReductionInLiabilities_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForReductionInLiabilitiesShares" xlink:label="loc_VIVKCommonStockIssuedForReductionInLiabilitiesShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForReductionInLiabilitiesShares_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForPurchaseOfLicense" xlink:label="loc_VIVKCommonStockIssuedForPurchaseOfLicense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForPurchaseOfLicense_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForPurchaseOfLicenseShares" xlink:label="loc_VIVKCommonStockIssuedForPurchaseOfLicenseShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForPurchaseOfLicenseShares_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockIssuedForConversionOfTemporaryEquityValue" xlink:label="loc_VIVKStockIssuedForConversionOfTemporaryEquityValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKStockIssuedForConversionOfTemporaryEquityValue_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockIssuedForConversionOfTemporaryEquityShares" xlink:label="loc_VIVKStockIssuedForConversionOfTemporaryEquityShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKStockIssuedForConversionOfTemporaryEquityShares_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" xlink:label="loc_VIVKConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" xlink:label="loc_VIVKConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfSeriesPreferredStockToCommonStock" xlink:label="loc_VIVKConversionOfSeriesPreferredStockToCommonStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKConversionOfSeriesPreferredStockToCommonStock_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfSeriesPreferredStockToCommonStockShares" xlink:label="loc_VIVKConversionOfSeriesPreferredStockToCommonStockShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKConversionOfSeriesPreferredStockToCommonStockShares_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit" xlink:label="loc_VIVKCommonStockIssuedForFractionalSharesFromReverseStockSplit_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForFractionalSharesFromReverseStockSplit_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares" xlink:label="loc_VIVKCommonStockIssuedForFractionalSharesFromReverseStockSplitShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForFractionalSharesFromReverseStockSplitShares_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsIssuedForServices" xlink:label="loc_VIVKStockOptionsIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKStockOptionsIssuedForServices_80" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_80" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_IssuanceOfNoncontrollingInterest1" xlink:label="loc_VIVKIssuanceOfNoncontrollingInterest1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKIssuanceOfNoncontrollingInterest1_80" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStock_80" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_80" xlink:type="arc" order="24" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentation" xlink:title="00000007 - Disclosure - Basis of Presentation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Liquidity" xlink:title="00000008 - Disclosure - Liquidity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/PrepaidExpensesAndOtherAssets" xlink:title="00000009 - Disclosure - Prepaid Expenses and Other Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/MarketableSecurities" xlink:title="00000010 - Disclosure - Marketable Securities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000013 - Disclosure - Accounts Payable and Accrued Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayable" xlink:title="00000014 - Disclosure - Loans and Notes Payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebt" xlink:title="00000016 - Disclosure - Long-term Debt" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquity" xlink:title="00000017 - Disclosure - Temporary Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/NoncontrollingInterest" xlink:title="00000018 - Disclosure - Noncontrolling Interest" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrants" xlink:title="00000019 - Disclosure - Share-Based Compensation &amp; Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/IncomeTax" xlink:title="00000020 - Disclosure - Income Tax" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentationPolicies" xlink:title="00000022 - Disclosure - Basis of Presentation (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables" xlink:title="00000024 - Disclosure - Accounts Payable and Accrued Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableTables" xlink:title="00000025 - Disclosure - Loans and Notes Payable (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingenciesTables" xlink:title="00000026 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtTables" xlink:title="00000027 - Disclosure - Long-term Debt (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquityTables" xlink:title="00000028 - Disclosure - Temporary Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsTables" xlink:title="00000029 - Disclosure - Share-Based Compensation &amp; Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentationDetailsNarrative" xlink:title="00000030 - Disclosure - Basis of Presentation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="loc_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_us-gaapVariableInterestEntityPrimaryBeneficiaryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaventuresUtsiMember" xlink:label="loc_VIVKVivaventuresUtsiMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaventuresUtsiMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaventuresRoyaltyMember" xlink:label="loc_VIVKVivaventuresRoyaltyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaventuresRoyaltyMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaopportunityFundMember" xlink:label="loc_VIVKVivaopportunityFundMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaopportunityFundMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_InternationalMetalsExchangeMember" xlink:label="loc_VIVKInternationalMetalsExchangeMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKInternationalMetalsExchangeMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaWealthFundIMember" xlink:label="loc_VIVKVivaWealthFundIMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaWealthFundIMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RPCDesignAndManufacturingLLCMember" xlink:label="loc_VIVKRPCDesignAndManufacturingLLCMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_VIVKRPCDesignAndManufacturingLLCMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RdmMember" xlink:label="loc_VIVKRdmMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_VIVKRdmMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertibleSeriesAPreferredStockMember" xlink:label="loc_VIVKConvertibleSeriesAPreferredStockMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_VIVKConvertibleSeriesAPreferredStockMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsGrantedToEmployeesMember" xlink:label="loc_VIVKStockOptionsGrantedToEmployeesMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_VIVKStockOptionsGrantedToEmployeesMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember" xlink:label="loc_VIVKStockOptionsGrantedToBoardMembersOrConsultantsMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_VIVKStockOptionsGrantedToBoardMembersOrConsultantsMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapAssets_270" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapLiabilities_270" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:label="loc_us-gaapNoncontrollingInterestInVariableInterestEntity_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapNoncontrollingInterestInVariableInterestEntity_270" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapNotesPayable_270" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CashAttributableToVie" xlink:label="loc_VIVKCashAttributableToVie_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_VIVKCashAttributableToVie_270" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_AmortizedUsefulLives" xlink:label="loc_VIVKAmortizedUsefulLives_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_VIVKAmortizedUsefulLives_270" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_270" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_WarrantsIssued" xlink:label="loc_VIVKWarrantsIssued_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_VIVKWarrantsIssued_270" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_WarrantsOutstanding" xlink:label="loc_VIVKWarrantsOutstanding_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_VIVKWarrantsOutstanding_270" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/LiquidityDetailsNarrative" xlink:title="00000031 - Disclosure - Liquidity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PublicOfferingMember" xlink:label="loc_VIVKPublicOfferingMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="loc_VIVKPublicOfferingMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapCash_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaapMarketableSecurities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapMarketableSecurities_30" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:title="00000032 - Disclosure - Prepaid Expenses and Other Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VendorMember" xlink:label="loc_VIVKVendorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_VIVKVendorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ProfessionalServiceAgenciesMember" xlink:label="loc_VIVKProfessionalServiceAgenciesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKProfessionalServiceAgenciesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseDepositLiability" xlink:label="loc_us-gaapLeaseDepositLiability_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLeaseDepositLiability_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Deposits" xlink:label="loc_us-gaapDeposits_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeposits_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/MarketableSecuritiesDetailsNarrative" xlink:title="00000033 - Disclosure - Marketable Securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_OdysseyGroupMember" xlink:label="loc_VIVKOdysseyGroupMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKOdysseyGroupMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ScepterHoldingsMember" xlink:label="loc_VIVKScepterHoldingsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKScepterHoldingsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfOtherInvestments_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfOtherInvestments_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaapMarketableSecurities_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecurities_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NoteReceivableConvertedAmountConverted" xlink:label="loc_VIVKNoteReceivableConvertedAmountConverted_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKNoteReceivableConvertedAmountConverted_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NoteReceivableConvertedSharesReceived" xlink:label="loc_VIVKNoteReceivableConvertedSharesReceived_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKNoteReceivableConvertedSharesReceived_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_GainLossOnDispositionOfAsset" xlink:label="loc_VIVKGainLossOnDispositionOfAsset_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKGainLossOnDispositionOfAsset_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_MarketableSecuritiesUnrealizedLoss" xlink:label="loc_VIVKMarketableSecuritiesUnrealizedLoss_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKMarketableSecuritiesUnrealizedLoss_200" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/InventoriesDetailsNarrative" xlink:title="00000034 - Disclosure - Inventories (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems" xlink:label="loc_us-gaapInventoryLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable" xlink:label="loc_us-gaapInventoryCurrentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInventoryLineItems" xlink:to="loc_us-gaapInventoryCurrentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="loc_us-gaapPublicUtilitiesInventoryAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapInventoryCurrentTable" xlink:to="loc_us-gaapPublicUtilitiesInventoryAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="loc_us-gaapPublicUtilitiesInventoryTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPublicUtilitiesInventoryAxis" xlink:to="loc_us-gaapPublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="loc_us-gaapPublicUtilitiesInventoryTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPublicUtilitiesInventoryAxis" xlink:to="loc_us-gaapPublicUtilitiesInventoryTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_FexixIronMember" xlink:label="loc_VIVKFexixIronMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPublicUtilitiesInventoryTypeDomain" xlink:to="loc_VIVKFexixIronMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInventoryLineItems" xlink:to="loc_us-gaapInventoryGross_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentDetails" xlink:title="00000035 - Disclosure - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalExtractionMachine1TonMember" xlink:label="loc_VIVKPreciousMetalExtractionMachine1TonMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKPreciousMetalExtractionMachine1TonMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalExtractionMachine10TonMember" xlink:label="loc_VIVKPreciousMetalExtractionMachine10TonMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKPreciousMetalExtractionMachine10TonMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BioreactorsMember" xlink:label="loc_VIVKBioreactorsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKBioreactorsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NanospongeCavitationDeviceMember" xlink:label="loc_VIVKNanospongeCavitationDeviceMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKNanospongeCavitationDeviceMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnit1Member" xlink:label="loc_VIVKRemediationProcessingUnit1Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKRemediationProcessingUnit1Member_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnit2Member" xlink:label="loc_VIVKRemediationProcessingUnit2Member_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKRemediationProcessingUnit2Member_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnitSystemAMember" xlink:label="loc_VIVKRemediationProcessingUnitSystemAMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKRemediationProcessingUnitSystemAMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnitSystemBMember" xlink:label="loc_VIVKRemediationProcessingUnitSystemBMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKRemediationProcessingUnitSystemBMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_230" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_230" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_230" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000036 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SeriesC1PreferredStockMember" xlink:label="loc_VIVKSeriesC1PreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_VIVKSeriesC1PreferredStockMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized" xlink:label="loc_us-gaapInterestCostsCapitalized_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapInterestCostsCapitalized_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:title="00000037 - Disclosure - Accounts Payable and Accrued Expenses (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetails" xlink:title="00000038 - Disclosure - Loans and Notes Payable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousPromissoryNotesAndConvertibleNotesMember" xlink:label="loc_VIVKVariousPromissoryNotesAndConvertibleNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKVariousPromissoryNotesAndConvertibleNotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NovusCapitalGroupLLCNoteMember" xlink:label="loc_VIVKNovusCapitalGroupLLCNoteMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKNovusCapitalGroupLLCNoteMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_TripleTNotesMember" xlink:label="loc_VIVKTripleTNotesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKTripleTNotesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NationalBuickGMCMember" xlink:label="loc_VIVKNationalBuickGMCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKNationalBuickGMCMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousConvertibleBridgeNotesMember" xlink:label="loc_VIVKVariousConvertibleBridgeNotesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKVariousConvertibleBridgeNotesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BlueRidgeBankMember" xlink:label="loc_VIVKBlueRidgeBankMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKBlueRidgeBankMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SmallBusinessAdministrationMember" xlink:label="loc_VIVKSmallBusinessAdministrationMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKSmallBusinessAdministrationMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_JPMorganChaseBankMember" xlink:label="loc_VIVKJPMorganChaseBankMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKJPMorganChaseBankMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousPromissoryNotesMember" xlink:label="loc_VIVKVariousPromissoryNotesMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKVariousPromissoryNotesMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapNotesPayable_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:label="loc_VIVKLoansAndNotesPayableCurrentAttributedToVariableInterestEntity_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_VIVKLoansAndNotesPayableCurrentAttributedToVariableInterestEntity_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NotesAndLoansPayableNonCurrent" xlink:label="loc_VIVKNotesAndLoansPayableNonCurrent_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_VIVKNotesAndLoansPayableNonCurrent_210" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:title="00000039 - Disclosure - Loans and Notes Payable (Details - Maturities of Debt)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative" xlink:title="00000040 - Disclosure - Loans and Notes Payable (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsDetails" xlink:title="00000041 - Disclosure - Commitments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_JamboreeCenterMember" xlink:label="loc_VIVKJamboreeCenterMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_VIVKJamboreeCenterMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SpeedwayCommerceCenterMember" xlink:label="loc_VIVKSpeedwayCommerceCenterMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_VIVKSpeedwayCommerceCenterMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VictoryHoldingsMember" xlink:label="loc_VIVKVictoryHoldingsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_VIVKVictoryHoldingsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSecurityDeposit_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:label="loc_VIVKLesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKLesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasePayments_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_110" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtDetails" xlink:title="00000043 - Disclosure - Long-term Debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems" xlink:label="loc_us-gaapExtinguishmentOfDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:label="loc_us-gaapScheduleOfExtinguishmentOfDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapScheduleOfExtinguishmentOfDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis" xlink:label="loc_us-gaapExtinguishmentOfDebtAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfExtinguishmentOfDebtTable" xlink:to="loc_us-gaapExtinguishmentOfDebtAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:label="loc_us-gaapExtinguishmentOfDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapExtinguishmentOfDebtAxis" xlink:to="loc_us-gaapExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:label="loc_us-gaapExtinguishmentOfDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapExtinguishmentOfDebtAxis" xlink:to="loc_us-gaapExtinguishmentOfDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember" xlink:label="loc_us-gaapLongTermDebtMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapExtinguishmentOfDebtTypeDomain" xlink:to="loc_us-gaapLongTermDebtMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountPremiumNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountPremiumNet_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapLongTermDebt_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtDetails1" xlink:title="00000044 - Disclosure - Long-term Debt (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquityDetails" xlink:title="00000045 - Disclosure - Temporary Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesBMember" xlink:label="loc_VIVKConvertiblePreferredStockSeriesBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_VIVKConvertiblePreferredStockSeriesBMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesB1Member" xlink:label="loc_VIVKConvertiblePreferredStockSeriesB1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_VIVKConvertiblePreferredStockSeriesB1Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesC1Member" xlink:label="loc_VIVKConvertiblePreferredStockSeriesC1Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_VIVKConvertiblePreferredStockSeriesC1Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="loc_us-gaapTemporaryEquityDividendsAdjustment_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityDividendsAdjustment_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DividendPaidInSeriesB1PreferredStock" xlink:label="loc_VIVKDividendPaidInSeriesB1PreferredStock_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKDividendPaidInSeriesB1PreferredStock_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SerciesC1IssueForReductionInStockPayables" xlink:label="loc_VIVKSerciesC1IssueForReductionInStockPayables_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKSerciesC1IssueForReductionInStockPayables_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SerciesC1IssueForReductionInStockPayable" xlink:label="loc_VIVKSerciesC1IssueForReductionInStockPayable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKSerciesC1IssueForReductionInStockPayable_160" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/NoncontrollingInterestDetailsNarrative" xlink:title="00000046 - Disclosure - Noncontrolling Interest (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapMinorityInterestTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaWealthFundILLCMember" xlink:label="loc_VIVKVivaWealthFundILLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKVivaWealthFundILLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaWealthFundILLCMember" xlink:label="loc_VIVKVivaWealthFundILLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaWealthFundILLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates" xlink:label="loc_us-gaapPaymentsOfDistributionsToAffiliates_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapPaymentsOfDistributionsToAffiliates_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions" xlink:title="00000047 - Disclosure - Share-Based Compensation &amp; Warrants (Details - Assumptions)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetails" xlink:title="00000048 - Disclosure - Share-Based Compensation &amp; Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:label="loc_VIVKSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_VIVKSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_100" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_100" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_100" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative" xlink:title="00000049 - Disclosure - Share-Based Compensation &amp; Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ShareStockAwardMember" xlink:label="loc_VIVKShareStockAwardMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_VIVKShareStockAwardMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsMember" xlink:label="loc_VIVKStockOptionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_VIVKStockOptionsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NonStatutoryStockOptionsMember" xlink:label="loc_VIVKNonStatutoryStockOptionsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_VIVKNonStatutoryStockOptionsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_EmployeesMember" xlink:label="loc_VIVKEmployeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_VIVKEmployeesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BoardOfDirectorsMember" xlink:label="loc_VIVKBoardOfDirectorsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_VIVKBoardOfDirectorsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConsultantMember" xlink:label="loc_VIVKConsultantMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_VIVKConsultantMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PublicOfferingMember" xlink:label="loc_VIVKPublicOfferingMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="loc_VIVKPublicOfferingMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_WarrantsIssued" xlink:label="loc_VIVKWarrantsIssued_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_VIVKWarrantsIssued_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_140" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://vivakor.com/role/IncomeTaxDetailsNarrative" xlink:title="00000050 - Disclosure - Income Tax (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>vivk-20220630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SeriesAPreferredStocksMember" xlink:label="VIVK_SeriesAPreferredStocksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_SeriesAPreferredStocksMember" xlink:to="VIVK_SeriesAPreferredStocksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_SeriesAPreferredStocksMember_lbl" xml:lang="en-US">Series A Preferred Stocks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaventuresUtsiMember" xlink:label="VIVK_VivaventuresUtsiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VivaventuresUtsiMember" xlink:to="VIVK_VivaventuresUtsiMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VivaventuresUtsiMember_lbl" xml:lang="en-US">Vivaventures UTSI, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaventuresRoyaltyMember" xlink:label="VIVK_VivaventuresRoyaltyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VivaventuresRoyaltyMember" xlink:to="VIVK_VivaventuresRoyaltyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VivaventuresRoyaltyMember_lbl" xml:lang="en-US">Vivaventures Royalty II, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaopportunityFundMember" xlink:label="VIVK_VivaopportunityFundMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VivaopportunityFundMember" xlink:to="VIVK_VivaopportunityFundMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VivaopportunityFundMember_lbl" xml:lang="en-US">Vivaopportunity Fund LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_InternationalMetalsExchangeMember" xlink:label="VIVK_InternationalMetalsExchangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_InternationalMetalsExchangeMember" xlink:to="VIVK_InternationalMetalsExchangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_InternationalMetalsExchangeMember_lbl" xml:lang="en-US">International Metals Exchange, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_lbl" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RPCDesignAndManufacturingLLCMember" xlink:label="VIVK_RPCDesignAndManufacturingLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_RPCDesignAndManufacturingLLCMember" xlink:to="VIVK_RPCDesignAndManufacturingLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_RPCDesignAndManufacturingLLCMember_lbl" xml:lang="en-US">R P C Design And Manufacturing L L C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RdmMember" xlink:label="VIVK_RdmMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_RdmMember" xlink:to="VIVK_RdmMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_RdmMember_lbl" xml:lang="en-US">RDM [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaWealthFundIMember" xlink:label="VIVK_VivaWealthFundIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VivaWealthFundIMember" xlink:to="VIVK_VivaWealthFundIMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VivaWealthFundIMember_lbl" xml:lang="en-US">Viva Wealth Fund I [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertibleSeriesAPreferredStockMember" xlink:label="VIVK_ConvertibleSeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConvertibleSeriesAPreferredStockMember" xlink:to="VIVK_ConvertibleSeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConvertibleSeriesAPreferredStockMember_lbl" xml:lang="en-US">Convertible Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsGrantedToEmployeesMember" xlink:label="VIVK_StockOptionsGrantedToEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_StockOptionsGrantedToEmployeesMember" xlink:to="VIVK_StockOptionsGrantedToEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_StockOptionsGrantedToEmployeesMember_lbl" xml:lang="en-US">Stock Options Granted To Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember" xlink:label="VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember" xlink:to="VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember_lbl" xml:lang="en-US">Stock Options Granted To Board Members Or Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis_lbl" xml:lang="en-US">Security Owned and Sold, Not yet Purchased, at Fair Value [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PublicOfferingMember" xlink:label="VIVK_PublicOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PublicOfferingMember" xlink:to="VIVK_PublicOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_PublicOfferingMember_lbl" xml:lang="en-US">Public Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VendorMember" xlink:label="VIVK_VendorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VendorMember" xlink:to="VIVK_VendorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VendorMember_lbl" xml:lang="en-US">Vendor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ProfessionalServiceAgenciesMember" xlink:label="VIVK_ProfessionalServiceAgenciesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ProfessionalServiceAgenciesMember" xlink:to="VIVK_ProfessionalServiceAgenciesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ProfessionalServiceAgenciesMember_lbl" xml:lang="en-US">Professional Service Agencies [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_OdysseyGroupMember" xlink:label="VIVK_OdysseyGroupMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_OdysseyGroupMember" xlink:to="VIVK_OdysseyGroupMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_OdysseyGroupMember_lbl" xml:lang="en-US">Odyssey Group [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ScepterHoldingsMember" xlink:label="VIVK_ScepterHoldingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ScepterHoldingsMember" xlink:to="VIVK_ScepterHoldingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ScepterHoldingsMember_lbl" xml:lang="en-US">Scepter Holdings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilitiesInventoryAxis_lbl" xml:lang="en-US">Inventory [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_FexixIronMember" xlink:label="VIVK_FexixIronMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_FexixIronMember" xlink:to="VIVK_FexixIronMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_FexixIronMember_lbl" xml:lang="en-US">Fexix Iron [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalExtractionMachine1TonMember" xlink:label="VIVK_PreciousMetalExtractionMachine1TonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PreciousMetalExtractionMachine1TonMember" xlink:to="VIVK_PreciousMetalExtractionMachine1TonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_PreciousMetalExtractionMachine1TonMember_lbl" xml:lang="en-US">Precious Metal Extraction Machine- 1 Ton [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalExtractionMachine10TonMember" xlink:label="VIVK_PreciousMetalExtractionMachine10TonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PreciousMetalExtractionMachine10TonMember" xlink:to="VIVK_PreciousMetalExtractionMachine10TonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_PreciousMetalExtractionMachine10TonMember_lbl" xml:lang="en-US">Precious Metal Extraction Machine- 10 Ton [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BioreactorsMember" xlink:label="VIVK_BioreactorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_BioreactorsMember" xlink:to="VIVK_BioreactorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_BioreactorsMember_lbl" xml:lang="en-US">Bioreactors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NanospongeCavitationDeviceMember" xlink:label="VIVK_NanospongeCavitationDeviceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NanospongeCavitationDeviceMember" xlink:to="VIVK_NanospongeCavitationDeviceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_NanospongeCavitationDeviceMember_lbl" xml:lang="en-US">Nanosponge/Cavitation Device [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnit1Member" xlink:label="VIVK_RemediationProcessingUnit1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_RemediationProcessingUnit1Member" xlink:to="VIVK_RemediationProcessingUnit1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_RemediationProcessingUnit1Member_lbl" xml:lang="en-US">Remediation Processing Unit 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnit2Member" xlink:label="VIVK_RemediationProcessingUnit2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_RemediationProcessingUnit2Member" xlink:to="VIVK_RemediationProcessingUnit2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_RemediationProcessingUnit2Member_lbl" xml:lang="en-US">Remediation Processing Unit 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnitSystemAMember" xlink:label="VIVK_RemediationProcessingUnitSystemAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_RemediationProcessingUnitSystemAMember" xlink:to="VIVK_RemediationProcessingUnitSystemAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_RemediationProcessingUnitSystemAMember_lbl" xml:lang="en-US">Remediation Processing Unit System A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnitSystemBMember" xlink:label="VIVK_RemediationProcessingUnitSystemBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_RemediationProcessingUnitSystemBMember" xlink:to="VIVK_RemediationProcessingUnitSystemBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_RemediationProcessingUnitSystemBMember_lbl" xml:lang="en-US">Remediation Processing Unit System B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SeriesC1PreferredStockMember" xlink:label="VIVK_SeriesC1PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_SeriesC1PreferredStockMember" xlink:to="VIVK_SeriesC1PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_SeriesC1PreferredStockMember_lbl" xml:lang="en-US">Series C-1 Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousPromissoryNotesAndConvertibleNotesMember" xlink:label="VIVK_VariousPromissoryNotesAndConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VariousPromissoryNotesAndConvertibleNotesMember" xlink:to="VIVK_VariousPromissoryNotesAndConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VariousPromissoryNotesAndConvertibleNotesMember_lbl" xml:lang="en-US">Various Promissory Notes And Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NovusCapitalGroupLLCNoteMember" xlink:label="VIVK_NovusCapitalGroupLLCNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NovusCapitalGroupLLCNoteMember" xlink:to="VIVK_NovusCapitalGroupLLCNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_NovusCapitalGroupLLCNoteMember_lbl" xml:lang="en-US">Novus Capital Group L L C Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_TripleTNotesMember" xlink:label="VIVK_TripleTNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_TripleTNotesMember" xlink:to="VIVK_TripleTNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_TripleTNotesMember_lbl" xml:lang="en-US">Triple T Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NationalBuickGMCMember" xlink:label="VIVK_NationalBuickGMCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NationalBuickGMCMember" xlink:to="VIVK_NationalBuickGMCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_NationalBuickGMCMember_lbl" xml:lang="en-US">National Buick G M C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousConvertibleBridgeNotesMember" xlink:label="VIVK_VariousConvertibleBridgeNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VariousConvertibleBridgeNotesMember" xlink:to="VIVK_VariousConvertibleBridgeNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VariousConvertibleBridgeNotesMember_lbl" xml:lang="en-US">Various Convertible Bridge Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BlueRidgeBankMember" xlink:label="VIVK_BlueRidgeBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_BlueRidgeBankMember" xlink:to="VIVK_BlueRidgeBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_BlueRidgeBankMember_lbl" xml:lang="en-US">Blue Ridge Bank [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SmallBusinessAdministrationMember" xlink:label="VIVK_SmallBusinessAdministrationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_SmallBusinessAdministrationMember" xlink:to="VIVK_SmallBusinessAdministrationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_SmallBusinessAdministrationMember_lbl" xml:lang="en-US">Small Business Administration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_JPMorganChaseBankMember" xlink:label="VIVK_JPMorganChaseBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_JPMorganChaseBankMember" xlink:to="VIVK_JPMorganChaseBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_JPMorganChaseBankMember_lbl" xml:lang="en-US">J P Morgan Chase Bank [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousPromissoryNotesMember" xlink:label="VIVK_VariousPromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VariousPromissoryNotesMember" xlink:to="VIVK_VariousPromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VariousPromissoryNotesMember_lbl" xml:lang="en-US">Various Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_JamboreeCenterMember" xlink:label="VIVK_JamboreeCenterMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_JamboreeCenterMember" xlink:to="VIVK_JamboreeCenterMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_JamboreeCenterMember_lbl" xml:lang="en-US">Jamboree Center [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SpeedwayCommerceCenterMember" xlink:label="VIVK_SpeedwayCommerceCenterMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_SpeedwayCommerceCenterMember" xlink:to="VIVK_SpeedwayCommerceCenterMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_SpeedwayCommerceCenterMember_lbl" xml:lang="en-US">Speedway Commerce Center [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VictoryHoldingsMember" xlink:label="VIVK_VictoryHoldingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VictoryHoldingsMember" xlink:to="VIVK_VictoryHoldingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VictoryHoldingsMember_lbl" xml:lang="en-US">Victory Holdings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis" xlink:label="us-gaap_ExtinguishmentOfDebtAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtAxis_lbl" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember" xlink:label="us-gaap_LongTermDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMember" xlink:to="us-gaap_LongTermDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMember_lbl" xml:lang="en-US">Long-Term Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesBMember" xlink:label="VIVK_ConvertiblePreferredStockSeriesBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConvertiblePreferredStockSeriesBMember" xlink:to="VIVK_ConvertiblePreferredStockSeriesBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConvertiblePreferredStockSeriesBMember_lbl" xml:lang="en-US">Convertible Preferred Stock Series B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesB1Member" xlink:label="VIVK_ConvertiblePreferredStockSeriesB1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConvertiblePreferredStockSeriesB1Member" xlink:to="VIVK_ConvertiblePreferredStockSeriesB1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConvertiblePreferredStockSeriesB1Member_lbl" xml:lang="en-US">Convertible Preferred Stock Series B 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesC1Member" xlink:label="VIVK_ConvertiblePreferredStockSeriesC1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConvertiblePreferredStockSeriesC1Member" xlink:to="VIVK_ConvertiblePreferredStockSeriesC1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConvertiblePreferredStockSeriesC1Member_lbl" xml:lang="en-US">Convertible Preferred Stock Series C 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaWealthFundILLCMember" xlink:label="VIVK_VivaWealthFundILLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_VivaWealthFundILLCMember" xlink:to="VIVK_VivaWealthFundILLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_VivaWealthFundILLCMember_lbl" xml:lang="en-US">Viva Wealth Fund I L L C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ShareStockAwardMember" xlink:label="VIVK_ShareStockAwardMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ShareStockAwardMember" xlink:to="VIVK_ShareStockAwardMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ShareStockAwardMember_lbl" xml:lang="en-US">Share Stock Award [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_EmployeesMember" xlink:label="VIVK_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_EmployeesMember" xlink:to="VIVK_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsMember" xlink:label="VIVK_StockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_StockOptionsMember" xlink:to="VIVK_StockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_StockOptionsMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NonStatutoryStockOptionsMember" xlink:label="VIVK_NonStatutoryStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NonStatutoryStockOptionsMember" xlink:to="VIVK_NonStatutoryStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_NonStatutoryStockOptionsMember_lbl" xml:lang="en-US">Non Statutory Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BoardOfDirectorsMember" xlink:label="VIVK_BoardOfDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_BoardOfDirectorsMember" xlink:to="VIVK_BoardOfDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_BoardOfDirectorsMember_lbl" xml:lang="en-US">Board Of Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConsultantMember" xlink:label="VIVK_ConsultantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConsultantMember" xlink:to="VIVK_ConsultantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConsultantMember_lbl" xml:lang="en-US">Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity" xlink:label="VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity" xlink:to="VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity_lbl" xml:lang="en-US">Cash and cash equivalents attributed to variable interest entity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_AccountsNotesAndLoansReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:to="us-gaap_AccountsNotesAndLoansReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableNetCurrent_lbl" xml:lang="en-US">Accounts Receivable, less allowances of none and $33,000, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_lbl" xml:lang="en-US">Marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalConcentrate" xlink:label="VIVK_PreciousMetalConcentrate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PreciousMetalConcentrate" xlink:to="VIVK_PreciousMetalConcentrate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_PreciousMetalConcentrate_lbl" xml:lang="en-US">Precious metal concentrate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments" xlink:label="us-gaap_OtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestments" xlink:to="us-gaap_OtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvestments_lbl" xml:lang="en-US">Other investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedParties" xlink:label="us-gaap_NotesReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableRelatedParties" xlink:to="us-gaap_NotesReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableRelatedParties_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Rights of use assets- operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LicenseAgreementNet" xlink:label="VIVK_LicenseAgreementNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_LicenseAgreementNet" xlink:to="VIVK_LicenseAgreementNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_LicenseAgreementNet_lbl" xml:lang="en-US">License agreement, net</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_IntellectualPropertyNet" xlink:label="VIVK_IntellectualPropertyNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_IntellectualPropertyNet" xlink:to="VIVK_IntellectualPropertyNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_IntellectualPropertyNet_lbl" xml:lang="en-US">Intellectual property, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities, current</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LoansAndNotesPayableCurrent" xlink:label="VIVK_LoansAndNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_LoansAndNotesPayableCurrent" xlink:to="VIVK_LoansAndNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_LoansAndNotesPayableCurrent_lbl" xml:lang="en-US">Loans and notes payable, current</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:label="VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:to="VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_lbl" xml:lang="en-US">Loans and notes payable, current attributed to variable interest entity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="us-gaap_OtherLongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebtCurrent" xlink:to="us-gaap_OtherLongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebtCurrent_lbl" xml:lang="en-US">Long-term debt (working interest royalty programs), current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities, long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesAndLoans" xlink:label="us-gaap_LongTermNotesAndLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesAndLoans" xlink:to="us-gaap_LongTermNotesAndLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesAndLoans_lbl" xml:lang="en-US">Loans and notes payable, long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="us-gaap_OtherLongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebtNoncurrent" xlink:to="us-gaap_OtherLongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term debt (working interest royalty programs)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred income tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Convertible, preferred stock, $.001 par value; 3,400,000 shares authorized;(1) Series A- 66,667 issued and outstanding(1)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.001 par value; 41,666,667 shares authorized; 15,038,619 and 12,330,859 were issued and outstanding as of June 30, 2022 and December 31, 2021(1)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCarryingBasis" xlink:label="us-gaap_TreasuryStockCarryingBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCarryingBasis" xlink:to="us-gaap_TreasuryStockCarryingBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockCarryingBasis_lbl" xml:lang="en-US">Treasury stock, at cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Vivakor, Inc. stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Amortization and depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseOther" xlink:label="us-gaap_InterestExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseOther_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Gain on disposition of asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Consolidated net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Less: Net loss attributable to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Net income (loss) attributable to Vivakor, Inc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xml:lang="en-US">Net loss attributable to common shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xml:lang="en-US">Dividend on preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net income loss to parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic and diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net income per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic weighted average common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Effect of dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:label="us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:to="us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_lbl" xml:lang="en-US">Diluted weighted average common shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Common Stock issued for services(1)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Common Stock issued for services Shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForReductionInLiabilities" xlink:label="VIVK_CommonStockIssuedForReductionInLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockIssuedForReductionInLiabilities" xlink:to="VIVK_CommonStockIssuedForReductionInLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockIssuedForReductionInLiabilities_lbl" xml:lang="en-US">Common Stock issued for a reduction of liabilities(1)</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForReductionInLiabilitiesShares" xlink:label="VIVK_CommonStockIssuedForReductionInLiabilitiesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockIssuedForReductionInLiabilitiesShares" xlink:to="VIVK_CommonStockIssuedForReductionInLiabilitiesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockIssuedForReductionInLiabilitiesShares_lbl" xml:lang="en-US">Common Stock issued for a reduction in liabilities, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForPurchaseOfLicense" xlink:label="VIVK_CommonStockIssuedForPurchaseOfLicense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockIssuedForPurchaseOfLicense" xlink:to="VIVK_CommonStockIssuedForPurchaseOfLicense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockIssuedForPurchaseOfLicense_lbl" xml:lang="en-US">Common Stock issued for the purchase of a license(1)</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForPurchaseOfLicenseShares" xlink:label="VIVK_CommonStockIssuedForPurchaseOfLicenseShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockIssuedForPurchaseOfLicenseShares" xlink:to="VIVK_CommonStockIssuedForPurchaseOfLicenseShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockIssuedForPurchaseOfLicenseShares_lbl" xml:lang="en-US">Common Stock issued for the purchase of a license, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockIssuedForConversionOfTemporaryEquityValue" xlink:label="VIVK_StockIssuedForConversionOfTemporaryEquityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_StockIssuedForConversionOfTemporaryEquityValue" xlink:to="VIVK_StockIssuedForConversionOfTemporaryEquityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_StockIssuedForConversionOfTemporaryEquityValue_lbl" xml:lang="en-US">Conversion of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock(1)</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockIssuedForConversionOfTemporaryEquityShares" xlink:label="VIVK_StockIssuedForConversionOfTemporaryEquityShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_StockIssuedForConversionOfTemporaryEquityShares" xlink:to="VIVK_StockIssuedForConversionOfTemporaryEquityShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_StockIssuedForConversionOfTemporaryEquityShares_lbl" xml:lang="en-US">Conversion of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" xlink:label="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" xlink:to="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1_lbl" xml:lang="en-US">Conversion of temporary equity Series B and B-1 Preferred Stock to Common Stock (1)</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" xlink:label="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" xlink:to="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares_lbl" xml:lang="en-US">Conversion of temporary equity Series B and B-1 Preferred Stock to Common Stock (1), shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfSeriesPreferredStockToCommonStock" xlink:label="VIVK_ConversionOfSeriesPreferredStockToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConversionOfSeriesPreferredStockToCommonStock" xlink:to="VIVK_ConversionOfSeriesPreferredStockToCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConversionOfSeriesPreferredStockToCommonStock_lbl" xml:lang="en-US">Conversion of Series A Preferred Stock to Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfSeriesPreferredStockToCommonStockShares" xlink:label="VIVK_ConversionOfSeriesPreferredStockToCommonStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConversionOfSeriesPreferredStockToCommonStockShares" xlink:to="VIVK_ConversionOfSeriesPreferredStockToCommonStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConversionOfSeriesPreferredStockToCommonStockShares_lbl" xml:lang="en-US">Conversion of Series A Preferred Stock to Common Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Common Stock issued for cash, net of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Common Stock issued for cash, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit" xlink:label="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit" xlink:to="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit_lbl" xml:lang="en-US">Common stock issued for fractional shares from reverse stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares" xlink:label="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares" xlink:to="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares_lbl" xml:lang="en-US">Common stock issued for fractional shares from reverse stock split, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsIssuedForServices" xlink:label="VIVK_StockOptionsIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_StockOptionsIssuedForServices" xlink:to="VIVK_StockOptionsIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_StockOptionsIssuedForServices_lbl" xml:lang="en-US">Stock options issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions by noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_IssuanceOfNoncontrollingInterest1" xlink:label="VIVK_IssuanceOfNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_IssuanceOfNoncontrollingInterest1" xlink:to="VIVK_IssuanceOfNoncontrollingInterest1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_IssuanceOfNoncontrollingInterest1_lbl" xml:lang="en-US">Issuance of noncontrolling interest for a reduction of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock" xlink:label="us-gaap_DividendsPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStock_lbl" xml:lang="en-US">Dividend paid in Series B-1 Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">OPERATING ACTIVITIES:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Consolidated net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationAndAmortization_2_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockOptionsIssuedForServices" xlink:label="VIVK_CommonStockOptionsIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockOptionsIssuedForServices" xlink:to="VIVK_CommonStockOptionsIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockOptionsIssuedForServices_lbl" xml:lang="en-US">Common stock options issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Common stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_GainOnDispositionOfAsset" xlink:label="VIVK_GainOnDispositionOfAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_GainOnDispositionOfAsset" xlink:to="VIVK_GainOnDispositionOfAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="VIVK_GainOnDispositionOfAsset_lbl" xml:lang="en-US">Gain on disposal of asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xml:lang="en-US">Unrealized gain (loss) marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl" xml:lang="en-US">Accrued interest on notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Accrued interest on notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable_lbl" xml:lang="en-US">Proceeds from notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Payment on costs of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PaymentsToAcquireIntangibleAssets1" xlink:label="VIVK_PaymentsToAcquireIntangibleAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PaymentsToAcquireIntangibleAssets1" xlink:to="VIVK_PaymentsToAcquireIntangibleAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="VIVK_PaymentsToAcquireIntangibleAssets1_lbl" xml:lang="en-US">Purchase of a technology license</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xml:lang="en-US">Proceeds from disposal of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Payment of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from loans and notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Payment of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="us-gaap_PaymentsToMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xml:lang="en-US">Distributions to noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS, END OF PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL CASHFLOW INFORMATION:</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CashPaidDuringYearForAbstract" xlink:label="VIVK_CashPaidDuringYearForAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CashPaidDuringYearForAbstract" xlink:to="VIVK_CashPaidDuringYearForAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CashPaidDuringYearForAbstract_lbl" xml:lang="en-US">Cash paid during the year for:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Noncash transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock" xlink:label="VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock" xlink:to="VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock_lbl" xml:lang="en-US">Conversion of Series A, B, B-1, and C-1 Preferred Stock to Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow" xlink:label="VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow" xlink:to="VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow_lbl" xml:lang="en-US">Common stock issued for a reduction in liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NoncontrollingInterestIssuedForReductionInLiabilities" xlink:label="VIVK_NoncontrollingInterestIssuedForReductionInLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NoncontrollingInterestIssuedForReductionInLiabilities" xlink:to="VIVK_NoncontrollingInterestIssuedForReductionInLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_NoncontrollingInterestIssuedForReductionInLiabilities_lbl" xml:lang="en-US">Noncontrolling interest issued for a reduction in liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities" xlink:label="VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities" xlink:to="VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities_lbl" xml:lang="en-US">Preferred stock Series C-1 issued for a reduction in liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForPurchaseOfLicenses" xlink:label="VIVK_CommonStockIssuedForPurchaseOfLicenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CommonStockIssuedForPurchaseOfLicenses" xlink:to="VIVK_CommonStockIssuedForPurchaseOfLicenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CommonStockIssuedForPurchaseOfLicenses_lbl" xml:lang="en-US">Common stock issued for the purchase of a license</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CapitalizedInterestOnConstructionInProcess" xlink:label="VIVK_CapitalizedInterestOnConstructionInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CapitalizedInterestOnConstructionInProcess" xlink:to="VIVK_CapitalizedInterestOnConstructionInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CapitalizedInterestOnConstructionInProcess_lbl" xml:lang="en-US">Capitalized interest on construction in process</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DividendPaidInSeriesB1PreferredStock" xlink:label="VIVK_DividendPaidInSeriesB1PreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_DividendPaidInSeriesB1PreferredStock" xlink:to="VIVK_DividendPaidInSeriesB1PreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_DividendPaidInSeriesB1PreferredStock_lbl" xml:lang="en-US">Dividend paid in Series B-1 Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DisclosureLiquidityAbstract" xlink:label="VIVK_DisclosureLiquidityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_DisclosureLiquidityAbstract" xlink:to="VIVK_DisclosureLiquidityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_DisclosureLiquidityAbstract_lbl" xml:lang="en-US">Liquidity</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LiquidityTextBlock" xlink:label="VIVK_LiquidityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_LiquidityTextBlock" xlink:to="VIVK_LiquidityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="VIVK_LiquidityTextBlock_lbl" xml:lang="en-US">Liquidity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Prepaid Expenses and Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US">Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageNotesPayableDisclosureTextBlock" xlink:label="us-gaap_MortgageNotesPayableDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MortgageNotesPayableDisclosureTextBlock" xlink:to="us-gaap_MortgageNotesPayableDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MortgageNotesPayableDisclosureTextBlock_lbl" xml:lang="en-US">Loans and Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Long-term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DisclosureTemporaryEquityAbstract" xlink:label="VIVK_DisclosureTemporaryEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_DisclosureTemporaryEquityAbstract" xlink:to="VIVK_DisclosureTemporaryEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_DisclosureTemporaryEquityAbstract_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_TemporaryEquityTextBlock" xlink:label="VIVK_TemporaryEquityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_TemporaryEquityTextBlock" xlink:to="VIVK_TemporaryEquityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="VIVK_TemporaryEquityTextBlock_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">Noncontrolling Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Share-Based Compensation &amp; Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_Covid19PolicyTextBlock" xlink:label="VIVK_Covid19PolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_Covid19PolicyTextBlock" xlink:to="VIVK_Covid19PolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_Covid19PolicyTextBlock_lbl" xml:lang="en-US">COVID-19</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_InterimFinancialInformationPolicyTextBlock" xlink:label="VIVK_InterimFinancialInformationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_InterimFinancialInformationPolicyTextBlock" xlink:to="VIVK_InterimFinancialInformationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_InterimFinancialInformationPolicyTextBlock_lbl" xml:lang="en-US">Interim Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income/Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">Schedule of loans and notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock" xlink:label="VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock" xlink:to="VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock_lbl" xml:lang="en-US">Schedule of maturities of loans and notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of lessee operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule Of Long-Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of long-term debt maturities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xml:lang="en-US">Schedule of temporary equity</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock" xlink:label="VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock" xlink:to="VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of warrant assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of option activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Stockholders' Equity, Reverse Stock Split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:label="us-gaap_NoncontrollingInterestInVariableInterestEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:to="us-gaap_NoncontrollingInterestInVariableInterestEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestInVariableInterestEntity_lbl" xml:lang="en-US">Noncontrolling Interest in Variable Interest Entity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CashAttributableToVie" xlink:label="VIVK_CashAttributableToVie" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_CashAttributableToVie" xlink:to="VIVK_CashAttributableToVie_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_CashAttributableToVie_lbl" xml:lang="en-US">Cash attributable to VIE</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_AmortizedUsefulLives" xlink:label="VIVK_AmortizedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_AmortizedUsefulLives" xlink:to="VIVK_AmortizedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_AmortizedUsefulLives_lbl" xml:lang="en-US">Amortized useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_WarrantsIssued" xlink:label="VIVK_WarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_WarrantsIssued" xlink:to="VIVK_WarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_WarrantsIssued_lbl" xml:lang="en-US">Warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_WarrantsOutstanding" xlink:label="VIVK_WarrantsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_WarrantsOutstanding" xlink:to="VIVK_WarrantsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_WarrantsOutstanding_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable_lbl" xml:lang="en-US">Security Owned and Sold, Not yet Purchased, at Fair Value [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems_lbl" xml:lang="en-US">Security Owned and Sold, Not yet Purchased, at Fair Value [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MarketableSecurities_lbl" xml:lang="en-US">Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseDepositLiability" xlink:label="us-gaap_LeaseDepositLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseDepositLiability" xlink:to="us-gaap_LeaseDepositLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseDepositLiability_lbl" xml:lang="en-US">Office and warehouse lease deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Deposits" xlink:label="us-gaap_Deposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="us-gaap_Deposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Deposits_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="us-gaap_InvestmentOwnedBalanceShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceShares" xlink:to="us-gaap_InvestmentOwnedBalanceShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalanceShares_lbl" xml:lang="en-US">Investment Owned, Balance, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:label="us-gaap_ProceedsFromSaleOfOtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:to="us-gaap_ProceedsFromSaleOfOtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfOtherInvestments_lbl" xml:lang="en-US">Proceeds from Sale of Other Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecurities_2_lbl" xml:lang="en-US">Marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NoteReceivableConvertedAmountConverted" xlink:label="VIVK_NoteReceivableConvertedAmountConverted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NoteReceivableConvertedAmountConverted" xlink:to="VIVK_NoteReceivableConvertedAmountConverted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_NoteReceivableConvertedAmountConverted_lbl" xml:lang="en-US">Note receivable converted, amount converted</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NoteReceivableConvertedSharesReceived" xlink:label="VIVK_NoteReceivableConvertedSharesReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NoteReceivableConvertedSharesReceived" xlink:to="VIVK_NoteReceivableConvertedSharesReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_NoteReceivableConvertedSharesReceived_lbl" xml:lang="en-US">Note receivable converted, shares received</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_GainLossOnDispositionOfAsset" xlink:label="VIVK_GainLossOnDispositionOfAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_GainLossOnDispositionOfAsset" xlink:to="VIVK_GainLossOnDispositionOfAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_GainLossOnDispositionOfAsset_lbl" xml:lang="en-US">Gain (Loss) on disposition of asset</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_MarketableSecuritiesUnrealizedLoss" xlink:label="VIVK_MarketableSecuritiesUnrealizedLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_MarketableSecuritiesUnrealizedLoss" xlink:to="VIVK_MarketableSecuritiesUnrealizedLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_MarketableSecuritiesUnrealizedLoss_lbl" xml:lang="en-US">Unrealized loss on marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_3_lbl" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryCurrentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryCurrentTable_lbl" xml:lang="en-US">Inventory, Current [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLineItems_lbl" xml:lang="en-US">Inventory [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Acquisition costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Gross Carrying Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated Depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Net Book Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xml:lang="en-US">Prefered stock Series C-1 issued for a reduction in liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized" xlink:label="us-gaap_InterestCostsCapitalized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestCostsCapitalized" xlink:to="us-gaap_InterestCostsCapitalized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestCostsCapitalized_lbl" xml:lang="en-US">Interest Costs Capitalized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="us-gaap_Deposits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Deposits_2_lbl" xml:lang="en-US">Office access deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums" xlink:label="us-gaap_UnearnedPremiums" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnearnedPremiums" xlink:to="us-gaap_UnearnedPremiums_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnearnedPremiums_lbl" xml:lang="en-US">Unearned revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_AccruedInterestWorkingInterestRoyaltyPrograms" xlink:label="VIVK_AccruedInterestWorkingInterestRoyaltyPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_AccruedInterestWorkingInterestRoyaltyPrograms" xlink:to="VIVK_AccruedInterestWorkingInterestRoyaltyPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_AccruedInterestWorkingInterestRoyaltyPrograms_lbl" xml:lang="en-US">Accrued interest (working interest royalty programs)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Accrued tax penalties and interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Total Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="us-gaap_NotesAndLoansPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayableCurrent" xlink:to="us-gaap_NotesAndLoansPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesAndLoansPayableCurrent_lbl" xml:lang="en-US">Loans and notes payable, current</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NotesAndLoansPayableNonCurrent" xlink:label="VIVK_NotesAndLoansPayableNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NotesAndLoansPayableNonCurrent" xlink:to="VIVK_NotesAndLoansPayableNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="VIVK_NotesAndLoansPayableNonCurrent_lbl" xml:lang="en-US">Loans and notes payable, long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansPayable" xlink:label="us-gaap_NotesAndLoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayable" xlink:to="us-gaap_NotesAndLoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansPayable_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Aggregate principal</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PercentageOfAccrueInterest" xlink:label="VIVK_PercentageOfAccrueInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PercentageOfAccrueInterest" xlink:to="VIVK_PercentageOfAccrueInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_PercentageOfAccrueInterest_lbl" xml:lang="en-US">percentage of accrue interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total undiscounted lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: Imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PresentValueOfLeasePayments" xlink:label="VIVK_PresentValueOfLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PresentValueOfLeasePayments" xlink:to="VIVK_PresentValueOfLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_PresentValueOfLeasePayments_lbl" xml:lang="en-US">Present value of lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_OperatingLeaseLiability1Noncurrent" xlink:label="VIVK_OperatingLeaseLiability1Noncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_OperatingLeaseLiability1Noncurrent" xlink:to="VIVK_OperatingLeaseLiability1Noncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_OperatingLeaseLiability1Noncurrent_lbl" xml:lang="en-US">Operating lease liabilities, long-term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted-average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted-average discount rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Lease payments next twelve months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lease payments next two months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lease payments next three months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lease payments next four months</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:label="VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:to="VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_lbl" xml:lang="en-US">Lease payments next two and three months</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Lease payment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Right-of-use asset for operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:label="us-gaap_ScheduleOfExtinguishmentOfDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:to="us-gaap_ScheduleOfExtinguishmentOfDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfExtinguishmentOfDebtTable_lbl" xml:lang="en-US">Schedule of Extinguishment of Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems" xlink:label="us-gaap_ExtinguishmentOfDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtLineItems" xlink:to="us-gaap_ExtinguishmentOfDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtLineItems_lbl" xml:lang="en-US">Extinguishment of Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Principal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl" xml:lang="en-US">Debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Total long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Long term debt, current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long term debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDividendsAdjustment" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment_lbl" xml:lang="en-US">Dividend paid in Series B-1 Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Conversion of Series B and B-1 Preferred Stock to Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Conversion of Series B and B-1 Preferred Stock to Common Stock, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xml:lang="en-US">June 30, 2021</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SerciesC1IssueForReductionInStockPayables" xlink:label="VIVK_SerciesC1IssueForReductionInStockPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_SerciesC1IssueForReductionInStockPayables" xlink:to="VIVK_SerciesC1IssueForReductionInStockPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_SerciesC1IssueForReductionInStockPayables_lbl" xml:lang="en-US">Series C-1 Issue for a reduction in stock payables</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SerciesC1IssueForReductionInStockPayable" xlink:label="VIVK_SerciesC1IssueForReductionInStockPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_SerciesC1IssueForReductionInStockPayable" xlink:to="VIVK_SerciesC1IssueForReductionInStockPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_SerciesC1IssueForReductionInStockPayable_lbl" xml:lang="en-US">Sercies C-1 Issue for a reduction in stock payables, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestTable_lbl" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestLineItems_lbl" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates" xlink:label="us-gaap_PaymentsOfDistributionsToAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDistributionsToAffiliates" xlink:to="us-gaap_PaymentsOfDistributionsToAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDistributionsToAffiliates_lbl" xml:lang="en-US">Payments of Distributions to Affiliates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Shares outstanding - beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price - beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average contractural term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:label="VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:to="VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Shares outstanding - ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price - ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Shares exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price - exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average contractural term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_lbl" xml:lang="en-US">Option granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrants exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net Operating losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NoteReceivableConvertedSharesReceived" xlink:to="VIVK_NoteReceivableConvertedSharesReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VIVK_NoteReceivableConvertedSharesReceived_doc" xml:lang="en-US">Note receivable converted, shares received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NoteReceivableConvertedAmountConverted" xlink:to="VIVK_NoteReceivableConvertedAmountConverted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VIVK_NoteReceivableConvertedAmountConverted_doc" xml:lang="en-US">Note receivable converted, amount converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCarryingBasis" xlink:to="us-gaap_TreasuryStockCarryingBasis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCarryingBasis_2_lbl" xml:lang="en-US">Treasury Stock, Carrying Basis</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseOther_2_lbl" xml:lang="en-US">Interest Expense, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStock_2_lbl" xml:lang="en-US">Dividends, Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_GainOnDispositionOfAsset" xlink:to="VIVK_GainOnDispositionOfAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_GainOnDispositionOfAsset_2_lbl" xml:lang="en-US">GainOnDispositionOfAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Interest Receivable, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_PaymentsToAcquireIntangibleAssets1" xlink:to="VIVK_PaymentsToAcquireIntangibleAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_PaymentsToAcquireIntangibleAssets1_2_lbl" xml:lang="en-US">PaymentsToAcquireIntangibleAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToMinorityShareholders_2_lbl" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_LiquidityTextBlock" xlink:to="VIVK_LiquidityTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_LiquidityTextBlock_2_lbl" xml:lang="en-US">LiquidityTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_2_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_TemporaryEquityTextBlock" xlink:to="VIVK_TemporaryEquityTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_TemporaryEquityTextBlock_2_lbl" xml:lang="en-US">TemporaryEquityTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecurities_3_lbl" xml:lang="en-US">Marketable Securities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayableCurrent" xlink:to="us-gaap_NotesAndLoansPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansPayableCurrent_2_lbl" xml:lang="en-US">Notes and Loans Payable, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VIVK_NotesAndLoansPayableNonCurrent" xlink:to="VIVK_NotesAndLoansPayableNonCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VIVK_NotesAndLoansPayableNonCurrent_2_lbl" xml:lang="en-US">NotesAndLoansPayableNonCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3_lbl" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_3_lbl" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDividendsAdjustment" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment_2_lbl" xml:lang="en-US">Temporary Equity, Dividends, Adjustment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>vivk-20220630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://vivakor.com/role/Cover" xlink:href="vivk-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedBalanceSheets" xlink:href="vivk-20220630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="vivk-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows" xlink:href="vivk-20220630.xsd#CondensedConsolidatedStatementOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentation" xlink:href="vivk-20220630.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Liquidity" xlink:href="vivk-20220630.xsd#Liquidity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PrepaidExpensesAndOtherAssets" xlink:href="vivk-20220630.xsd#PrepaidExpensesAndOtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/MarketableSecurities" xlink:href="vivk-20220630.xsd#MarketableSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Inventories" xlink:href="vivk-20220630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipment" xlink:href="vivk-20220630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpenses" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayable" xlink:href="vivk-20220630.xsd#LoansAndNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingencies" xlink:href="vivk-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebt" xlink:href="vivk-20220630.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquity" xlink:href="vivk-20220630.xsd#TemporaryEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/NoncontrollingInterest" xlink:href="vivk-20220630.xsd#NoncontrollingInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrants" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/IncomeTax" xlink:href="vivk-20220630.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/SubsequentEvents" xlink:href="vivk-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentationPolicies" xlink:href="vivk-20220630.xsd#BasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentTables" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableTables" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingenciesTables" xlink:href="vivk-20220630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtTables" xlink:href="vivk-20220630.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquityTables" xlink:href="vivk-20220630.xsd#TemporaryEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsTables" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/BasisOfPresentationDetailsNarrative" xlink:href="vivk-20220630.xsd#BasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LiquidityDetailsNarrative" xlink:href="vivk-20220630.xsd#LiquidityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:href="vivk-20220630.xsd#PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/MarketableSecuritiesDetailsNarrative" xlink:href="vivk-20220630.xsd#MarketableSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/InventoriesDetailsNarrative" xlink:href="vivk-20220630.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentDetails" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="vivk-20220630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:href="vivk-20220630.xsd#AccountsPayableAndAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetails" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative" xlink:href="vivk-20220630.xsd#LoansAndNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsDetails" xlink:href="vivk-20220630.xsd#CommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="vivk-20220630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtDetails" xlink:href="vivk-20220630.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Long-termDebtDetails1" xlink:href="vivk-20220630.xsd#Long-termDebtDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/TemporaryEquityDetails" xlink:href="vivk-20220630.xsd#TemporaryEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/NoncontrollingInterestDetailsNarrative" xlink:href="vivk-20220630.xsd#NoncontrollingInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetails-Assumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetails" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative" xlink:href="vivk-20220630.xsd#Share-basedCompensationWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://vivakor.com/role/IncomeTaxDetailsNarrative" xlink:href="vivk-20220630.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity" xlink:label="loc_VIVKCashAndCashEquivalentsAttributedToVariableInterestEntity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_VIVKCashAndCashEquivalentsAttributedToVariableInterestEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalConcentrate" xlink:label="loc_VIVKPreciousMetalConcentrate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_VIVKPreciousMetalConcentrate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments" xlink:label="loc_us-gaapOtherInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableRelatedParties" xlink:label="loc_us-gaapNotesReceivableRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapNotesReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LicenseAgreementNet" xlink:label="loc_VIVKLicenseAgreementNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_VIVKLicenseAgreementNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_IntellectualPropertyNet" xlink:label="loc_VIVKIntellectualPropertyNet" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_VIVKIntellectualPropertyNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LoansAndNotesPayableCurrent" xlink:label="loc_VIVKLoansAndNotesPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_VIVKLoansAndNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:label="loc_VIVKLoansAndNotesPayableCurrentAttributedToVariableInterestEntity" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_VIVKLoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="loc_us-gaapOtherLongTermDebtCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesAndLoans" xlink:label="loc_us-gaapLongTermNotesAndLoans" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermNotesAndLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="loc_us-gaapOtherLongTermDebtNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCarryingBasis" xlink:label="loc_us-gaapTreasuryStockCarryingBasis" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockCarryingBasis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:label="loc_us-gaapProFormaWeightedAverageSharesOutstandingDiluted" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProFormaWeightedAverageSharesOutstandingDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; EQUITY (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SeriesAPreferredStocksMember" xlink:label="loc_VIVKSeriesAPreferredStocksMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_VIVKSeriesAPreferredStocksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForReductionInLiabilities" xlink:label="loc_VIVKCommonStockIssuedForReductionInLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForReductionInLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForReductionInLiabilitiesShares" xlink:label="loc_VIVKCommonStockIssuedForReductionInLiabilitiesShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForReductionInLiabilitiesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForPurchaseOfLicense" xlink:label="loc_VIVKCommonStockIssuedForPurchaseOfLicense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForPurchaseOfLicense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForPurchaseOfLicenseShares" xlink:label="loc_VIVKCommonStockIssuedForPurchaseOfLicenseShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForPurchaseOfLicenseShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockIssuedForConversionOfTemporaryEquityValue" xlink:label="loc_VIVKStockIssuedForConversionOfTemporaryEquityValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKStockIssuedForConversionOfTemporaryEquityValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockIssuedForConversionOfTemporaryEquityShares" xlink:label="loc_VIVKStockIssuedForConversionOfTemporaryEquityShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKStockIssuedForConversionOfTemporaryEquityShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" xlink:label="loc_VIVKConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" xlink:label="loc_VIVKConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfSeriesPreferredStockToCommonStock" xlink:label="loc_VIVKConversionOfSeriesPreferredStockToCommonStock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKConversionOfSeriesPreferredStockToCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfSeriesPreferredStockToCommonStockShares" xlink:label="loc_VIVKConversionOfSeriesPreferredStockToCommonStockShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKConversionOfSeriesPreferredStockToCommonStockShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit" xlink:label="loc_VIVKCommonStockIssuedForFractionalSharesFromReverseStockSplit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForFractionalSharesFromReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares" xlink:label="loc_VIVKCommonStockIssuedForFractionalSharesFromReverseStockSplitShares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKCommonStockIssuedForFractionalSharesFromReverseStockSplitShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsIssuedForServices" xlink:label="loc_VIVKStockOptionsIssuedForServices" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKStockOptionsIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_IssuanceOfNoncontrollingInterest1" xlink:label="loc_VIVKIssuanceOfNoncontrollingInterest1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKIssuanceOfNoncontrollingInterest1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockOptionsIssuedForServices" xlink:label="loc_VIVKCommonStockOptionsIssuedForServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_VIVKCommonStockOptionsIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_GainOnDispositionOfAsset" xlink:label="loc_VIVKGainOnDispositionOfAsset" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_VIVKGainOnDispositionOfAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedInterestReceivableNet" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="loc_us-gaapProceedsFromCollectionOfNotesReceivable" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromCollectionOfNotesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PaymentsToAcquireIntangibleAssets1" xlink:label="loc_VIVKPaymentsToAcquireIntangibleAssets1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_VIVKPaymentsToAcquireIntangibleAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CashPaidDuringYearForAbstract" xlink:label="loc_VIVKCashPaidDuringYearForAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_VIVKCashPaidDuringYearForAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VIVKCashPaidDuringYearForAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VIVKCashPaidDuringYearForAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock" xlink:label="loc_VIVKConversionOfSeriesBB1AndC1PreferredStockToCommonStock" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VIVKConversionOfSeriesBB1AndC1PreferredStockToCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow" xlink:label="loc_VIVKCommonStockIssuedForReductionInLiabilitiesCashFlow" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VIVKCommonStockIssuedForReductionInLiabilitiesCashFlow" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NoncontrollingInterestIssuedForReductionInLiabilities" xlink:label="loc_VIVKNoncontrollingInterestIssuedForReductionInLiabilities" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VIVKNoncontrollingInterestIssuedForReductionInLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities" xlink:label="loc_VIVKPreferredStockSeriesC1IssuedForReductionInLiabilities" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VIVKPreferredStockSeriesC1IssuedForReductionInLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CommonStockIssuedForPurchaseOfLicenses" xlink:label="loc_VIVKCommonStockIssuedForPurchaseOfLicenses" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VIVKCommonStockIssuedForPurchaseOfLicenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CapitalizedInterestOnConstructionInProcess" xlink:label="loc_VIVKCapitalizedInterestOnConstructionInProcess" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VIVKCapitalizedInterestOnConstructionInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DividendPaidInSeriesB1PreferredStock" xlink:label="loc_VIVKDividendPaidInSeriesB1PreferredStock" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VIVKDividendPaidInSeriesB1PreferredStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentation" xlink:title="00000007 - Disclosure - Basis of Presentation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Liquidity" xlink:title="00000008 - Disclosure - Liquidity">
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DisclosureLiquidityAbstract" xlink:label="loc_VIVKDisclosureLiquidityAbstract" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LiquidityTextBlock" xlink:label="loc_VIVKLiquidityTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VIVKDisclosureLiquidityAbstract" xlink:to="loc_VIVKLiquidityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PrepaidExpensesAndOtherAssets" xlink:title="00000009 - Disclosure - Prepaid Expenses and Other Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/MarketableSecurities" xlink:title="00000010 - Disclosure - Marketable Securities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="loc_us-gaapMarketableSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Inventories" xlink:title="00000011 - Disclosure - Inventories">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000013 - Disclosure - Accounts Payable and Accrued Expenses">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayable" xlink:title="00000014 - Disclosure - Loans and Notes Payable">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageNotesPayableDisclosureTextBlock" xlink:label="loc_us-gaapMortgageNotesPayableDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapMortgageNotesPayableDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebt" xlink:title="00000016 - Disclosure - Long-term Debt">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquity" xlink:title="00000017 - Disclosure - Temporary Equity">
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DisclosureTemporaryEquityAbstract" xlink:label="loc_VIVKDisclosureTemporaryEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_TemporaryEquityTextBlock" xlink:label="loc_VIVKTemporaryEquityTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VIVKDisclosureTemporaryEquityAbstract" xlink:to="loc_VIVKTemporaryEquityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/NoncontrollingInterest" xlink:title="00000018 - Disclosure - Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrants" xlink:title="00000019 - Disclosure - Share-Based Compensation &amp; Warrants">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/IncomeTax" xlink:title="00000020 - Disclosure - Income Tax">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentationPolicies" xlink:title="00000022 - Disclosure - Basis of Presentation (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_Covid19PolicyTextBlock" xlink:label="loc_VIVKCovid19PolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_VIVKCovid19PolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_InterimFinancialInformationPolicyTextBlock" xlink:label="loc_VIVKInterimFinancialInformationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_VIVKInterimFinancialInformationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables" xlink:title="00000024 - Disclosure - Accounts Payable and Accrued Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableTables" xlink:title="00000025 - Disclosure - Loans and Notes Payable (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock" xlink:label="loc_VIVKScheduleOfMaturitiesOfLongTermDebtsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_VIVKScheduleOfMaturitiesOfLongTermDebtsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingenciesTables" xlink:title="00000026 - Disclosure - Commitments and Contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtTables" xlink:title="00000027 - Disclosure - Long-term Debt (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquityTables" xlink:title="00000028 - Disclosure - Temporary Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DisclosureTemporaryEquityAbstract" xlink:label="loc_VIVKDisclosureTemporaryEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="loc_us-gaapTemporaryEquityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VIVKDisclosureTemporaryEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsTables" xlink:title="00000029 - Disclosure - Share-Based Compensation &amp; Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock" xlink:label="loc_VIVKScheduleOWarrantsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_VIVKScheduleOWarrantsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/BasisOfPresentationDetailsNarrative" xlink:title="00000030 - Disclosure - Basis of Presentation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="loc_us-gaapVariableInterestEntityPrimaryBeneficiaryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_us-gaapVariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaventuresUtsiMember" xlink:label="loc_VIVKVivaventuresUtsiMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaventuresUtsiMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaventuresRoyaltyMember" xlink:label="loc_VIVKVivaventuresRoyaltyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaventuresRoyaltyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaopportunityFundMember" xlink:label="loc_VIVKVivaopportunityFundMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaopportunityFundMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_InternationalMetalsExchangeMember" xlink:label="loc_VIVKInternationalMetalsExchangeMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKInternationalMetalsExchangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaWealthFundIMember" xlink:label="loc_VIVKVivaWealthFundIMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaWealthFundIMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:label="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RPCDesignAndManufacturingLLCMember" xlink:label="loc_VIVKRPCDesignAndManufacturingLLCMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_VIVKRPCDesignAndManufacturingLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RdmMember" xlink:label="loc_VIVKRdmMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="loc_VIVKRdmMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertibleSeriesAPreferredStockMember" xlink:label="loc_VIVKConvertibleSeriesAPreferredStockMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_VIVKConvertibleSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsGrantedToEmployeesMember" xlink:label="loc_VIVKStockOptionsGrantedToEmployeesMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_VIVKStockOptionsGrantedToEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember" xlink:label="loc_VIVKStockOptionsGrantedToBoardMembersOrConsultantsMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_VIVKStockOptionsGrantedToBoardMembersOrConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestInVariableInterestEntity" xlink:label="loc_us-gaapNoncontrollingInterestInVariableInterestEntity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapNoncontrollingInterestInVariableInterestEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_CashAttributableToVie" xlink:label="loc_VIVKCashAttributableToVie" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_VIVKCashAttributableToVie" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_AmortizedUsefulLives" xlink:label="loc_VIVKAmortizedUsefulLives" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_VIVKAmortizedUsefulLives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_WarrantsIssued" xlink:label="loc_VIVKWarrantsIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_VIVKWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_WarrantsOutstanding" xlink:label="loc_VIVKWarrantsOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_VIVKWarrantsOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LiquidityDetailsNarrative" xlink:title="00000031 - Disclosure - Liquidity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DisclosureLiquidityAbstract" xlink:label="loc_VIVKDisclosureLiquidityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VIVKDisclosureLiquidityAbstract" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueTable" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PublicOfferingMember" xlink:label="loc_VIVKPublicOfferingMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="loc_VIVKPublicOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaapMarketableSecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems" xlink:to="loc_us-gaapMarketableSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative" xlink:title="00000032 - Disclosure - Prepaid Expenses and Other Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VendorMember" xlink:label="loc_VIVKVendorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_VIVKVendorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ProfessionalServiceAgenciesMember" xlink:label="loc_VIVKProfessionalServiceAgenciesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKProfessionalServiceAgenciesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseDepositLiability" xlink:label="loc_us-gaapLeaseDepositLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLeaseDepositLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Deposits" xlink:label="loc_us-gaapDeposits" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeposits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/MarketableSecuritiesDetailsNarrative" xlink:title="00000033 - Disclosure - Marketable Securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_OdysseyGroupMember" xlink:label="loc_VIVKOdysseyGroupMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKOdysseyGroupMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ScepterHoldingsMember" xlink:label="loc_VIVKScepterHoldingsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKScepterHoldingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfOtherInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfOtherInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaapMarketableSecurities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NoteReceivableConvertedAmountConverted" xlink:label="loc_VIVKNoteReceivableConvertedAmountConverted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKNoteReceivableConvertedAmountConverted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NoteReceivableConvertedSharesReceived" xlink:label="loc_VIVKNoteReceivableConvertedSharesReceived" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKNoteReceivableConvertedSharesReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_GainLossOnDispositionOfAsset" xlink:label="loc_VIVKGainLossOnDispositionOfAsset" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKGainLossOnDispositionOfAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_MarketableSecuritiesUnrealizedLoss" xlink:label="loc_VIVKMarketableSecuritiesUnrealizedLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKMarketableSecuritiesUnrealizedLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/InventoriesDetailsNarrative" xlink:title="00000034 - Disclosure - Inventories (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable" xlink:label="loc_us-gaapInventoryCurrentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryCurrentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems" xlink:label="loc_us-gaapInventoryLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryCurrentTable" xlink:to="loc_us-gaapInventoryLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="loc_us-gaapPublicUtilitiesInventoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryCurrentTable" xlink:to="loc_us-gaapPublicUtilitiesInventoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="loc_us-gaapPublicUtilitiesInventoryTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPublicUtilitiesInventoryAxis" xlink:to="loc_us-gaapPublicUtilitiesInventoryTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_FexixIronMember" xlink:label="loc_VIVKFexixIronMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPublicUtilitiesInventoryTypeDomain" xlink:to="loc_VIVKFexixIronMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryLineItems" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentDetails" xlink:title="00000035 - Disclosure - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalExtractionMachine1TonMember" xlink:label="loc_VIVKPreciousMetalExtractionMachine1TonMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKPreciousMetalExtractionMachine1TonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PreciousMetalExtractionMachine10TonMember" xlink:label="loc_VIVKPreciousMetalExtractionMachine10TonMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKPreciousMetalExtractionMachine10TonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BioreactorsMember" xlink:label="loc_VIVKBioreactorsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKBioreactorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NanospongeCavitationDeviceMember" xlink:label="loc_VIVKNanospongeCavitationDeviceMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKNanospongeCavitationDeviceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnit1Member" xlink:label="loc_VIVKRemediationProcessingUnit1Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKRemediationProcessingUnit1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnit2Member" xlink:label="loc_VIVKRemediationProcessingUnit2Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKRemediationProcessingUnit2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnitSystemAMember" xlink:label="loc_VIVKRemediationProcessingUnitSystemAMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKRemediationProcessingUnitSystemAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_RemediationProcessingUnitSystemBMember" xlink:label="loc_VIVKRemediationProcessingUnitSystemBMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_VIVKRemediationProcessingUnitSystemBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000036 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SeriesC1PreferredStockMember" xlink:label="loc_VIVKSeriesC1PreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_VIVKSeriesC1PreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCostsCapitalized" xlink:label="loc_us-gaapInterestCostsCapitalized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapInterestCostsCapitalized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails" xlink:title="00000037 - Disclosure - Accounts Payable and Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Deposits" xlink:label="loc_us-gaapDeposits" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapDeposits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnearnedPremiums" xlink:label="loc_us-gaapUnearnedPremiums" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapUnearnedPremiums" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_AccruedInterestWorkingInterestRoyaltyPrograms" xlink:label="loc_VIVKAccruedInterestWorkingInterestRoyaltyPrograms" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_VIVKAccruedInterestWorkingInterestRoyaltyPrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetails" xlink:title="00000038 - Disclosure - Loans and Notes Payable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousPromissoryNotesAndConvertibleNotesMember" xlink:label="loc_VIVKVariousPromissoryNotesAndConvertibleNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKVariousPromissoryNotesAndConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NovusCapitalGroupLLCNoteMember" xlink:label="loc_VIVKNovusCapitalGroupLLCNoteMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKNovusCapitalGroupLLCNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_TripleTNotesMember" xlink:label="loc_VIVKTripleTNotesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKTripleTNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NationalBuickGMCMember" xlink:label="loc_VIVKNationalBuickGMCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKNationalBuickGMCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousConvertibleBridgeNotesMember" xlink:label="loc_VIVKVariousConvertibleBridgeNotesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKVariousConvertibleBridgeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BlueRidgeBankMember" xlink:label="loc_VIVKBlueRidgeBankMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKBlueRidgeBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SmallBusinessAdministrationMember" xlink:label="loc_VIVKSmallBusinessAdministrationMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKSmallBusinessAdministrationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_JPMorganChaseBankMember" xlink:label="loc_VIVKJPMorganChaseBankMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKJPMorganChaseBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VariousPromissoryNotesMember" xlink:label="loc_VIVKVariousPromissoryNotesMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKVariousPromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:label="loc_VIVKLoansAndNotesPayableCurrentAttributedToVariableInterestEntity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_VIVKLoansAndNotesPayableCurrentAttributedToVariableInterestEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NotesAndLoansPayableNonCurrent" xlink:label="loc_VIVKNotesAndLoansPayableNonCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_VIVKNotesAndLoansPayableNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt" xlink:title="00000039 - Disclosure - Loans and Notes Payable (Details - Maturities of Debt)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansPayable" xlink:label="loc_us-gaapNotesAndLoansPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapNotesAndLoansPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative" xlink:title="00000040 - Disclosure - Loans and Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PercentageOfAccrueInterest" xlink:label="loc_VIVKPercentageOfAccrueInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_VIVKPercentageOfAccrueInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsDetails" xlink:title="00000041 - Disclosure - Commitments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PresentValueOfLeasePayments" xlink:label="loc_VIVKPresentValueOfLeasePayments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_VIVKPresentValueOfLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_OperatingLeaseLiability1Noncurrent" xlink:label="loc_VIVKOperatingLeaseLiability1Noncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_VIVKOperatingLeaseLiability1Noncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_JamboreeCenterMember" xlink:label="loc_VIVKJamboreeCenterMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_VIVKJamboreeCenterMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SpeedwayCommerceCenterMember" xlink:label="loc_VIVKSpeedwayCommerceCenterMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_VIVKSpeedwayCommerceCenterMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VictoryHoldingsMember" xlink:label="loc_VIVKVictoryHoldingsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="loc_VIVKVictoryHoldingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:label="loc_VIVKLesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKLesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtDetails" xlink:title="00000043 - Disclosure - Long-term Debt (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExtinguishmentOfDebtTable" xlink:label="loc_us-gaapScheduleOfExtinguishmentOfDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfExtinguishmentOfDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtLineItems" xlink:label="loc_us-gaapExtinguishmentOfDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfExtinguishmentOfDebtTable" xlink:to="loc_us-gaapExtinguishmentOfDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis" xlink:label="loc_us-gaapExtinguishmentOfDebtAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfExtinguishmentOfDebtTable" xlink:to="loc_us-gaapExtinguishmentOfDebtAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:label="loc_us-gaapExtinguishmentOfDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtAxis" xlink:to="loc_us-gaapExtinguishmentOfDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember" xlink:label="loc_us-gaapLongTermDebtMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtTypeDomain" xlink:to="loc_us-gaapLongTermDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountPremiumNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapExtinguishmentOfDebtLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Long-termDebtDetails1" xlink:title="00000044 - Disclosure - Long-term Debt (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/TemporaryEquityDetails" xlink:title="00000045 - Disclosure - Temporary Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DisclosureTemporaryEquityAbstract" xlink:label="loc_VIVKDisclosureTemporaryEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VIVKDisclosureTemporaryEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesBMember" xlink:label="loc_VIVKConvertiblePreferredStockSeriesBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_VIVKConvertiblePreferredStockSeriesBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesB1Member" xlink:label="loc_VIVKConvertiblePreferredStockSeriesB1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_VIVKConvertiblePreferredStockSeriesB1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConvertiblePreferredStockSeriesC1Member" xlink:label="loc_VIVKConvertiblePreferredStockSeriesC1Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_VIVKConvertiblePreferredStockSeriesC1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="loc_us-gaapTemporaryEquityDividendsAdjustment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityDividendsAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_DividendPaidInSeriesB1PreferredStock" xlink:label="loc_VIVKDividendPaidInSeriesB1PreferredStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKDividendPaidInSeriesB1PreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SerciesC1IssueForReductionInStockPayables" xlink:label="loc_VIVKSerciesC1IssueForReductionInStockPayables" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKSerciesC1IssueForReductionInStockPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SerciesC1IssueForReductionInStockPayable" xlink:label="loc_VIVKSerciesC1IssueForReductionInStockPayable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VIVKSerciesC1IssueForReductionInStockPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/NoncontrollingInterestDetailsNarrative" xlink:title="00000046 - Disclosure - Noncontrolling Interest (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapMinorityInterestLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaWealthFundILLCMember" xlink:label="loc_VIVKVivaWealthFundILLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_VIVKVivaWealthFundILLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_VivaWealthFundILLCMember" xlink:label="loc_VIVKVivaWealthFundILLCMember_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_VIVKVivaWealthFundILLCMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates" xlink:label="loc_us-gaapPaymentsOfDistributionsToAffiliates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapPaymentsOfDistributionsToAffiliates" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions" xlink:title="00000047 - Disclosure - Share-Based Compensation &amp; Warrants (Details - Assumptions)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetails" xlink:title="00000048 - Disclosure - Share-Based Compensation &amp; Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:label="loc_VIVKSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_VIVKSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative" xlink:title="00000049 - Disclosure - Share-Based Compensation &amp; Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ShareStockAwardMember" xlink:label="loc_VIVKShareStockAwardMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_VIVKShareStockAwardMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_StockOptionsMember" xlink:label="loc_VIVKStockOptionsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_VIVKStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_NonStatutoryStockOptionsMember" xlink:label="loc_VIVKNonStatutoryStockOptionsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_VIVKNonStatutoryStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_EmployeesMember" xlink:label="loc_VIVKEmployeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_VIVKEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_BoardOfDirectorsMember" xlink:label="loc_VIVKBoardOfDirectorsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_VIVKBoardOfDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_ConsultantMember" xlink:label="loc_VIVKConsultantMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_VIVKConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:label="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_PublicOfferingMember" xlink:label="loc_VIVKPublicOfferingMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="loc_VIVKPublicOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="vivk-20220630.xsd#VIVK_WarrantsIssued" xlink:label="loc_VIVKWarrantsIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_VIVKWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://vivakor.com/role/IncomeTaxDetailsNarrative" xlink:title="00000050 - Disclosure - Income Tax (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300135014032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIVAKOR, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001450704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2178141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4101 North Thanksgiving Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">Lehi,
UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300127161552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,908,334<span></span>
</td>
<td class="nump">$ 1,293,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity', window );">Cash and cash equivalents attributed to variable interest entity</a></td>
<td class="nump">296,257<span></span>
</td>
<td class="nump">199,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Accounts Receivable, less allowances of none and $33,000, respectively</a></td>
<td class="nump">845<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">1,818,029<span></span>
</td>
<td class="nump">2,231,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">222,000<span></span>
</td>
<td class="nump">192,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_PreciousMetalConcentrate', window );">Precious metal concentrate</a></td>
<td class="nump">1,166,709<span></span>
</td>
<td class="nump">1,166,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other assets</a></td>
<td class="nump">237,422<span></span>
</td>
<td class="nump">73,245<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">8,649,596<span></span>
</td>
<td class="nump">5,157,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investments</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableRelatedParties', window );">Notes receivable</a></td>
<td class="nump">1,150,743<span></span>
</td>
<td class="nump">1,194,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">25,878,930<span></span>
</td>
<td class="nump">24,692,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Rights of use assets- operating leases</a></td>
<td class="nump">721,550<span></span>
</td>
<td class="nump">663,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_LicenseAgreementNet', window );">License agreement, net</a></td>
<td class="nump">2,291,942<span></span>
</td>
<td class="nump">2,370,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_IntellectualPropertyNet', window );">Intellectual property, net</a></td>
<td class="nump">13,002,504<span></span>
</td>
<td class="nump">13,662,037<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">51,699,265<span></span>
</td>
<td class="nump">47,744,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">3,061,610<span></span>
</td>
<td class="nump">2,023,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">364,103<span></span>
</td>
<td class="nump">287,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_LoansAndNotesPayableCurrent', window );">Loans and notes payable, current</a></td>
<td class="nump">962,405<span></span>
</td>
<td class="nump">1,511,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity', window );">Loans and notes payable, current attributed to variable interest entity</a></td>
<td class="nump">2,308,232<span></span>
</td>
<td class="nump">3,416,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtCurrent', window );">Long-term debt (working interest royalty programs), current</a></td>
<td class="nump">8,565<span></span>
</td>
<td class="nump">3,256<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,704,915<span></span>
</td>
<td class="nump">7,242,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, long term</a></td>
<td class="nump">414,947<span></span>
</td>
<td class="nump">434,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesAndLoans', window );">Loans and notes payable, long term</a></td>
<td class="nump">543,869<span></span>
</td>
<td class="nump">1,185,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Long-term debt (working interest royalty programs)</a></td>
<td class="nump">5,017,592<span></span>
</td>
<td class="nump">6,171,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">5,156,899<span></span>
</td>
<td class="nump">5,156,899<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">17,838,222<span></span>
</td>
<td class="nump">20,191,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Convertible, preferred stock, $.001 par value; 3,400,000 shares authorized;(1) Series A- 66,667 issued and outstanding(1)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value; 41,666,667 shares authorized; 15,038,619 and 12,330,859 were issued and outstanding as of June 30, 2022 and December 31, 2021(1)</a></td>
<td class="nump">15,039<span></span>
</td>
<td class="nump">12,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">67,857,646<span></span>
</td>
<td class="nump">58,279,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCarryingBasis', window );">Treasury stock, at cost</a></td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(41,237,559)<span></span>
</td>
<td class="num">(35,731,359)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Vivakor, Inc. stockholders' equity</a></td>
<td class="nump">26,615,126<span></span>
</td>
<td class="nump">22,540,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">7,245,917<span></span>
</td>
<td class="nump">5,012,504<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">33,861,043<span></span>
</td>
<td class="nump">27,553,133<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 51,699,265<span></span>
</td>
<td class="nump">$ 47,744,245<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_IntellectualPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_IntellectualPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_LicenseAgreementNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_LicenseAgreementNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_LoansAndNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_LoansAndNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_PreciousMetalConcentrate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_PreciousMetalConcentrate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesAndLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesAndLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from parties associated with the reporting entity as evidenced by a written promise to pay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCarryingBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost basis for treasury stock acquired for purposes other than retirement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCarryingBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300133802272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts receivable allowance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">41,666,667<span></span>
</td>
<td class="nump">41,666,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">15,038,619<span></span>
</td>
<td class="nump">12,330,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">15,038,619<span></span>
</td>
<td class="nump">12,330,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">3,400,000<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">66,667<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">66,667<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300134571056">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 117,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,530<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">112,450<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">119,252<span></span>
</td>
<td class="nump">125,912<span></span>
</td>
<td class="nump">310,591<span></span>
</td>
<td class="nump">828,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,922,753<span></span>
</td>
<td class="nump">1,235,549<span></span>
</td>
<td class="nump">4,235,560<span></span>
</td>
<td class="nump">2,309,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Amortization and depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">558,595<span></span>
</td>
<td class="nump">364,635<span></span>
</td>
<td class="nump">933,813<span></span>
</td>
<td class="nump">727,914<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,600,600<span></span>
</td>
<td class="nump">1,726,096<span></span>
</td>
<td class="nump">5,479,964<span></span>
</td>
<td class="nump">3,865,748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,600,600)<span></span>
</td>
<td class="num">(1,724,626)<span></span>
</td>
<td class="num">(5,479,964)<span></span>
</td>
<td class="num">(3,861,198)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,652,755)<span></span>
</td>
<td class="num">(8,949,169)<span></span>
</td>
<td class="num">(413,189)<span></span>
</td>
<td class="nump">3,734,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,083<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
<td class="nump">12,461<span></span>
</td>
<td class="nump">2,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,981)<span></span>
</td>
<td class="num">(241,448)<span></span>
</td>
<td class="num">(114,946)<span></span>
</td>
<td class="num">(395,469)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gain on disposition of asset</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,456<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,456<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">39,934<span></span>
</td>
<td class="nump">92,590<span></span>
</td>
<td class="nump">40,084<span></span>
</td>
<td class="nump">93,884<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,627,263)<span></span>
</td>
<td class="num">(9,096,785)<span></span>
</td>
<td class="num">(473,134)<span></span>
</td>
<td class="nump">3,435,175<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss before provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,227,863)<span></span>
</td>
<td class="num">(10,821,411)<span></span>
</td>
<td class="num">(5,953,098)<span></span>
</td>
<td class="num">(426,023)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">296,477<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="num">(723,911)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Consolidated net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,227,863)<span></span>
</td>
<td class="num">(10,524,934)<span></span>
</td>
<td class="num">(5,953,898)<span></span>
</td>
<td class="num">(1,149,934)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(322,546)<span></span>
</td>
<td class="num">(1,114,003)<span></span>
</td>
<td class="num">(447,698)<span></span>
</td>
<td class="num">(1,255,844)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net income (loss) attributable to Vivakor, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,905,317)<span></span>
</td>
<td class="num">(9,410,931)<span></span>
</td>
<td class="num">(5,506,200)<span></span>
</td>
<td class="nump">105,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net loss attributable to common shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,905,317)<span></span>
</td>
<td class="num">(9,410,931)<span></span>
</td>
<td class="num">(5,506,200)<span></span>
</td>
<td class="nump">105,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Dividend on preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,196<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,196<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income loss to parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (4,905,317)<span></span>
</td>
<td class="num">$ (9,453,127)<span></span>
</td>
<td class="num">$ (5,506,200)<span></span>
</td>
<td class="nump">$ 63,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15,038,619<span></span>
</td>
<td class="nump">11,966,840<span></span>
</td>
<td class="nump">14,388,004<span></span>
</td>
<td class="nump">11,640,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">910,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted', window );">Diluted weighted average common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15,038,619<span></span>
</td>
<td class="nump">11,966,840<span></span>
</td>
<td class="nump">14,388,004<span></span>
</td>
<td class="nump">12,550,789<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 &#8211; Organization and Basis of Presentation for additional information</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300126602384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A Preferred Stocks [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 11,256<span></span>
</td>
<td class="nump">$ 45,623,146<span></span>
</td>
<td class="num">$ (20,000)<span></span>
</td>
<td class="num">$ (30,204,992)<span></span>
</td>
<td class="nump">$ 1,279,089<span></span>
</td>
<td class="nump">$ 16,688,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="nump">11,255,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common Stock issued for services(1)</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">437,967<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">438,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common Stock issued for services Shares, shares</a></td>
<td class="nump">33,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForReductionInLiabilities', window );">Common Stock issued for a reduction of liabilities(1)</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">264,771<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">264,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForReductionInLiabilitiesShares', window );">Common Stock issued for a reduction in liabilities, shares</a></td>
<td class="nump">29,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForPurchaseOfLicense', window );">Common Stock issued for the purchase of a license(1)</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">224,983<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForPurchaseOfLicenseShares', window );">Common Stock issued for the purchase of a license, shares</a></td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_StockIssuedForConversionOfTemporaryEquityValue', window );">Conversion of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock(1)</a></td>
<td class="nump">$ 956<span></span>
</td>
<td class="nump">9,466,648<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,467,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_StockIssuedForConversionOfTemporaryEquityShares', window );">Conversion of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock, shares</a></td>
<td class="nump">955,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_StockOptionsIssuedForServices', window );">Stock options issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">730,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">730,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">223,056<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">223,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_IssuanceOfNoncontrollingInterest1', window );">Issuance of noncontrolling interest for a reduction of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">735,000<span></span>
</td>
<td class="nump">735,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividend paid in Series B-1 Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(42,196)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(42,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">105,910<span></span>
</td>
<td class="num">(1,255,844)<span></span>
</td>
<td class="num">(1,149,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 12,292<span></span>
</td>
<td class="nump">56,970,571<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(30,141,278)<span></span>
</td>
<td class="nump">758,245<span></span>
</td>
<td class="nump">27,579,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="nump">12,291,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Mar. 31, 2021</a></td>
<td class="nump">$ 11,322<span></span>
</td>
<td class="nump">46,818,373<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(20,688,151)<span></span>
</td>
<td class="nump">1,137,248<span></span>
</td>
<td class="nump">27,258,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2021</a></td>
<td class="nump">11,321,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForReductionInLiabilities', window );">Common Stock issued for a reduction of liabilities(1)</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">228,774<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">228,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForReductionInLiabilitiesShares', window );">Common Stock issued for a reduction in liabilities, shares</a></td>
<td class="nump">25,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1', window );">Conversion of temporary equity Series B and B-1 Preferred Stock to Common Stock (1)</a></td>
<td class="nump">$ 944<span></span>
</td>
<td class="nump">9,384,396<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,385,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares', window );">Conversion of temporary equity Series B and B-1 Preferred Stock to Common Stock (1), shares</a></td>
<td class="nump">944,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_StockOptionsIssuedForServices', window );">Stock options issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">427,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">427,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">111,528<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">111,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_IssuanceOfNoncontrollingInterest1', window );">Issuance of noncontrolling interest for a reduction of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">735,000<span></span>
</td>
<td class="nump">735,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividend paid in Series B-1 Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(42,196)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(42,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(9,410,931)<span></span>
</td>
<td class="num">(1,114,003)<span></span>
</td>
<td class="num">(10,524,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 12,292<span></span>
</td>
<td class="nump">56,970,571<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(30,141,278)<span></span>
</td>
<td class="nump">758,245<span></span>
</td>
<td class="nump">27,579,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="nump">12,291,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 12,331<span></span>
</td>
<td class="nump">58,279,590<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(35,731,359)<span></span>
</td>
<td class="nump">5,012,504<span></span>
</td>
<td class="nump">27,553,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="nump">12,330,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForReductionInLiabilities', window );">Common Stock issued for a reduction of liabilities(1)</a></td>
<td class="nump">$ 273<span></span>
</td>
<td class="nump">1,144,719<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,144,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForReductionInLiabilitiesShares', window );">Common Stock issued for a reduction in liabilities, shares</a></td>
<td class="nump">272,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_ConversionOfSeriesPreferredStockToCommonStock', window );">Conversion of Series A Preferred Stock to Common Stock</a></td>
<td class="nump">$ 833<span></span>
</td>
<td class="num">(766)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_ConversionOfSeriesPreferredStockToCommonStockShares', window );">Conversion of Series A Preferred Stock to Common Stock, shares</a></td>
<td class="nump">833,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66,667)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock issued for cash, net of offering costs</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">6,238,400<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock issued for cash, shares</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit', window );">Common stock issued for fractional shares from reverse stock split</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares', window );">Common stock issued for fractional shares from reverse stock split, shares</a></td>
<td class="nump">2,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_StockOptionsIssuedForServices', window );">Stock options issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">855,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">855,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,340,703<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,340,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions by noncontrolling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(343,889)<span></span>
</td>
<td class="num">(343,889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_IssuanceOfNoncontrollingInterest1', window );">Issuance of noncontrolling interest for a reduction of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,025,000<span></span>
</td>
<td class="nump">3,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,506,200)<span></span>
</td>
<td class="num">(447,698)<span></span>
</td>
<td class="num">(5,953,898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 15,039<span></span>
</td>
<td class="nump">67,857,646<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(41,237,559)<span></span>
</td>
<td class="nump">7,245,917<span></span>
</td>
<td class="nump">33,861,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2022</a></td>
<td class="nump">15,038,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 15,039<span></span>
</td>
<td class="nump">66,200,971<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(36,332,242)<span></span>
</td>
<td class="nump">6,671,402<span></span>
</td>
<td class="nump">36,535,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2022</a></td>
<td class="nump">15,038,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_StockOptionsIssuedForServices', window );">Stock options issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">427,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">427,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,229,175<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,229,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions by noncontrolling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(207,939)<span></span>
</td>
<td class="num">(207,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_IssuanceOfNoncontrollingInterest1', window );">Issuance of noncontrolling interest for a reduction of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,105,000<span></span>
</td>
<td class="nump">1,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,905,317)<span></span>
</td>
<td class="num">(322,546)<span></span>
</td>
<td class="num">(5,227,863)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 15,039<span></span>
</td>
<td class="nump">$ 67,857,646<span></span>
</td>
<td class="num">$ (20,000)<span></span>
</td>
<td class="num">$ (41,237,559)<span></span>
</td>
<td class="nump">$ 7,245,917<span></span>
</td>
<td class="nump">$ 33,861,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2022</a></td>
<td class="nump">15,038,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockIssuedForPurchaseOfLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockIssuedForPurchaseOfLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockIssuedForPurchaseOfLicenseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockIssuedForPurchaseOfLicenseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockIssuedForReductionInLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockIssuedForReductionInLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockIssuedForReductionInLiabilitiesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockIssuedForReductionInLiabilitiesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_ConversionOfSeriesPreferredStockToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_ConversionOfSeriesPreferredStockToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_ConversionOfSeriesPreferredStockToCommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_ConversionOfSeriesPreferredStockToCommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_IssuanceOfNoncontrollingInterest1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_IssuanceOfNoncontrollingInterest1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_StockIssuedForConversionOfTemporaryEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_StockIssuedForConversionOfTemporaryEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_StockIssuedForConversionOfTemporaryEquityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_StockIssuedForConversionOfTemporaryEquityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_StockOptionsIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_StockOptionsIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300122110240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Consolidated net loss</a></td>
<td class="num">$ (5,953,898)<span></span>
</td>
<td class="num">$ (1,149,934)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">933,813<span></span>
</td>
<td class="nump">727,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockOptionsIssuedForServices', window );">Common stock options issued for services</a></td>
<td class="nump">855,000<span></span>
</td>
<td class="nump">730,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Common stock issued for services</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">438,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_GainOnDispositionOfAsset', window );">Gain on disposal of asset</a></td>
<td class="num">(2,456)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) marketable securities</a></td>
<td class="nump">413,189<span></span>
</td>
<td class="num">(3,734,275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">711,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,340,703<span></span>
</td>
<td class="nump">223,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(30,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(164,177)<span></span>
</td>
<td class="nump">13,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(303,452)<span></span>
</td>
<td class="num">(412,764)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Accrued interest on notes receivable</a></td>
<td class="num">(12,461)<span></span>
</td>
<td class="num">(2,485)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest on notes payable</a></td>
<td class="nump">114,946<span></span>
</td>
<td class="nump">395,469<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(2,808,793)<span></span>
</td>
<td class="num">(2,053,627)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from notes receivable</a></td>
<td class="nump">55,953<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payment on costs of patents</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,329)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_PaymentsToAcquireIntangibleAssets1', window );">Purchase of a technology license</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from disposal of equipment</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of equipment</a></td>
<td class="num">(1,129,515)<span></span>
</td>
<td class="num">(1,334,123)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,067,562)<span></span>
</td>
<td class="num">(1,384,452)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payment of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,735)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from loans and notes payable</a></td>
<td class="nump">1,968,261<span></span>
</td>
<td class="nump">6,666,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="nump">6,240,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payment of notes payable</a></td>
<td class="num">(277,145)<span></span>
</td>
<td class="num">(2,464)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to noncontrolling interest</a></td>
<td class="num">(343,889)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">7,587,227<span></span>
</td>
<td class="nump">6,656,612<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">3,710,872<span></span>
</td>
<td class="nump">3,218,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD</a></td>
<td class="nump">1,493,719<span></span>
</td>
<td class="nump">398,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, END OF PERIOD</a></td>
<td class="nump">5,204,591<span></span>
</td>
<td class="nump">3,617,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CashPaidDuringYearForAbstract', window );"><strong>Cash paid during the year for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">223,639<span></span>
</td>
<td class="nump">46,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Noncash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock', window );">Conversion of Series A, B, B-1, and C-1 Preferred Stock to Common Stock</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">9,467,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow', window );">Common stock issued for a reduction in liabilities</a></td>
<td class="nump">1,144,992<span></span>
</td>
<td class="nump">264,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_NoncontrollingInterestIssuedForReductionInLiabilities', window );">Noncontrolling interest issued for a reduction in liabilities</a></td>
<td class="nump">3,025,000<span></span>
</td>
<td class="nump">735,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities', window );">Preferred stock Series C-1 issued for a reduction in liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CommonStockIssuedForPurchaseOfLicenses', window );">Common stock issued for the purchase of a license</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CapitalizedInterestOnConstructionInProcess', window );">Capitalized interest on construction in process</a></td>
<td class="nump">$ 256,235<span></span>
</td>
<td class="nump">$ 822,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_DividendPaidInSeriesB1PreferredStock', window );">Dividend paid in Series B-1 Preferred Stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,196<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CapitalizedInterestOnConstructionInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CapitalizedInterestOnConstructionInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CashPaidDuringYearForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CashPaidDuringYearForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockIssuedForPurchaseOfLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockIssuedForPurchaseOfLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CommonStockOptionsIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CommonStockOptionsIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_DividendPaidInSeriesB1PreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_DividendPaidInSeriesB1PreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_GainOnDispositionOfAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_GainOnDispositionOfAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_NoncontrollingInterestIssuedForReductionInLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_NoncontrollingInterestIssuedForReductionInLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_PaymentsToAcquireIntangibleAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_PaymentsToAcquireIntangibleAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300133914336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zm8QuDLsXGm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1. <span id="xdx_826_z6AiZ2euZXUb">Basis of Presentation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14, 2022, we effected a <span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20220213__20220214_zYmWYrQCccNd" title="Stockholders' Equity, Reverse Stock Split">1-for-30 reverse
split</span> of our outstanding shares of common stock (the &#8220;Reverse Stock Split&#8221;) via the filing of a certificate of change with
the Nevada Secretary of State which was effective at the commencement of trading of our Common Stock. No fractional shares of the Company&#8217;s
common stock will be issued as a result of the Reverse Stock Split. Any fractional shares resulting from the Reverse Stock Split will
be rounded up to the nearest whole share. All issued and outstanding common stock, preferred stock, and per share amounts in the consolidated
financial statements and footnotes included herein have been retroactively adjusted to reflect this reverse stock split for all periods
presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_846_ecustom--Covid19PolicyTextBlock_zmUb4pmZhvbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_867_zSHu0pmwRcOg">COVID-19</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 11, 2020, the World Health Organization
(&#8220;WHO&#8221;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the
pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets.
Most U.S. states and many countries have issued policies intended to stop or slow the further spread of the disease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">COVID-19 and the U.S. response to the pandemic
are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may
have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent
of the effects on the economy, the markets we serve, our business, or our operations. In March 2020 we temporarily suspended operations
in Kuwait and Utah due to COVID-19 government restrictions, Utah has resumed operations in full. Kuwait has allowed for the Company to
obtain site personnel visas to recommence operations. These suspensions have had a negative impact on our business and there can be no
guaranty that we will not need to suspend operations again in the future as a result of the pandemic.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_849_ecustom--InterimFinancialInformationPolicyTextBlock_zotbl60NRihj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_z9fVd7QJJoZ8">Interim Financial Information</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).
Certain information and disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have
been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the related notes for the year ended December 31, 2021. The unaudited condensed consolidated financial
statements have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and
include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation
of the condensed consolidated financial statements. The operating results for the three and six months ended June 30, 2022 are not necessarily
indicative of the results expected for the full year ending December&#160;31, 2022.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zqnXUeDr7KFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_860_z9df4Z4o31td">Principles of Consolidation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows ASC 810-10-15 guidance with
respect to accounting for Variable Interest Entities (&#8220;VIE&#8221;). A VIE is an entity that does not have sufficient equity at risk
to finance its activities without additional subordinated financial support from other parties, or whose equity investors lack any of
the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will absorb portions
of a VIE&#8217;s expected losses or receive portions of the entity&#8217;s expected residual returns. For the six months ended June 30,
2022 and year ended December 31, 2021 the following entities are considered to be a VIE and are consolidated in our consolidated financial
statements: Viva Wealth Fund I, LLC and RPC Design and Manufacturing, LLC. For the six months ended June 30, 2022 and year ended December
31, 2021 the following entities were considered to be a VIE, but were not consolidated in our consolidated financial statements due to
a lack of the power criterion or the losses/benefits criterion: Vivaventures UTS I, LLC, Vivaventures Royalty II, LLC, Vivaopportunity
Fund, LLC, and International Metals Exchange, LLC. For the six months ended June 30, 2022 and year ended December 31, 2021 the unaudited
financial information for the unconsolidated VIEs is as follows: Vivaventures UTSI, LLC held assets of $<span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z2o3hEUb6w0a" title="Assets">3,383,610</span> and $<span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z6T8semNZ3vi" title="Assets">3,753,296</span> (where
the primary asset represents a receivable from the Company), and liabilities of $<span id="xdx_901_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z8cbapUzlpN2" title="Liabilities">47,049</span> and $<span id="xdx_909_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_zcgzT2SrUQAa" title="Liabilities">12,608</span>. Vivaventures Royalty II, LLC held
assets of $<span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zFhbvhtZZ4T1" title="Assets">2,939,498</span> and $<span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_z1ZiBuNmonS8" title="Assets">2,648,810</span> (where the primary asset represents a receivable from the Company), and liabilities of $<span id="xdx_908_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zx0CEuhEdJC3" title="Liabilities">1,720</span> and
$<span id="xdx_90B_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zZJUXjRbSsb8" title="Liabilities">300</span>. Vivaopportunity Fund LLC held assets of $<span id="xdx_905_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zYd31ctlAAW2" title="Assets">2,119,856</span> and $<span id="xdx_90B_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zmk5Cqdjf6Mf" title="Assets">2,119,961</span> (where the primary asset represents a noncontrolling interest
in units of a consolidated entity of the Company) and <span id="xdx_907_eus-gaap--Liabilities_iI_p0p0_do_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_zVdQSlVqDwUe" title="Liabilities">no</span> liabilities. International Metals Exchange, LLC held assets of $<span id="xdx_901_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zRs8H2qSmrd1" title="Assets">29,938</span> and $<span id="xdx_90F_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zmcLlfgBGRtk" title="Assets">30,461</span>
and liabilities of $<span id="xdx_90E_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zkYw4uKIohil" title="Liabilities"><span id="xdx_907_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zBQtyH2mXEPb" title="Liabilities">1,900</span></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>RPC Design and Manufacturing, LLC: </b>As of
June 30, 2022 and year ended December 31, 2021, investors in RDM have a noncontrolling interest of $<span id="xdx_90A_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zOk4yYA9pdj4" title="Noncontrolling Interest in Variable Interest Entity">387,049</span> and $<span id="xdx_907_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zNzqjbbprw72" title="Noncontrolling Interest in Variable Interest Entity">629,694</span>, respectively.
As of June 30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are not restricted and can be used to settle the
obligations of the reporting entity. As of June 30, 2022 and December 31, 2021 this VIE has an outstanding note payable to the reporting
entity in the amount of $<span id="xdx_90B_eus-gaap--NotesPayable_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zLmmA2qpxP45" title="Notes Payable">628,828</span> and $<span id="xdx_90C_eus-gaap--NotesPayable_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zW58xCpAuV7a" title="Notes Payable">354,566</span>, which is eliminated upon consolidation. We have the primary risk (expense) exposure in
financing and operating the assets and are responsible for 100% of the operation, maintenance and any unfunded capital expenditures, which
ultimately could be 100% of a custom machine, and the decisions related to those expenditures including budgeting, financing and dispatch
of power. Based on all these facts, it was determined that we are the primary beneficiary of RDM. Therefore, RDM has been consolidated
by the Company. Any intercompany revenue and expense associated with RDM and its license agreement with the Company has been eliminated
in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Viva Wealth Fund I, LLC:</b> As of June
30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are restricted solely for the use of proceeds of the VWFI
offering (to manufacture RPCs) and cannot be used to settle the obligations of the reporting entity. As of June 30, 2022 and
December 31, 2021, the Company has cash attributed to variable interest entities of $<span id="xdx_90E_ecustom--CashAttributableToVie_c20220630__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zAcm7UDg2Bnj" title="Cash attributable to VIE">296,257</span>
and $<span id="xdx_904_ecustom--CashAttributableToVie_c20211231__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zs0SOaTeO44" title="Cash attributable to VIE">199,952</span>.
As of June 30, 2022, VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI has
commenced fundraising for RPC Series B. In the event that VWFI does not raise at least $6,250,000 for these RPC Series by the
offering termination date (which date has been extended until November 13, 2022), then the convertible notes and/or units would
convert into Vivakor common stock where the minimum conversion price will be the greater of $13.50 or a 10% discount to market per
share or in the event of a public offering, 200% of the per share price of the Company common stock sold in the underwritten
offering, which was closed on February 14, 2022 at $5.00 per share. As of August 8, 2022, VWFI has raised approximately $4,690,000
for RPC Series B. VWFI unit holders may also sell their units to the Company for their principal investment amount on the
3<sup>rd</sup>, 4<sup>th</sup>, and 5<sup>th</sup> anniversary of the offering termination date, which if this option were
exercised, the Company may elect to pay the amount in either cash or common stock. The Company also has the option to purchase any
LLC units where the members did not exercise their conversion option under the same terms and pricing for cash or common stock. VWFI
has entered into a license agreement with the Company indicating that VWFI will pay the Company a license fee of $1,000,000 per
series of equipment manufactured with the Company&#8217;s proprietary technology, however these transactions are eliminated upon consolidation. All of the operations of VWFI relate to private
placement offering to fund and manufacture proprietary equipment for the Company, as intended in VWFI&#8217;s design and
organization by the Company, so that the Company controls VWFI in its business purpose, use of proceeds, and selling and leasing of
its equipment solely to the Company. Creditors of VWFI have no recourse to the general credit of the Company. We have the primary
risk (expense) exposure in financing and operating the assets and are responsible for 100% of the operation, and any unfunded
capital expenditures, and the expense to the unit holders in conversion to common stock if series of equipment cannot be fully
funded, which ultimately could be 100% of any custom machine. By request of the fund manager, we are responsible for the decisions
related to the expenditures of VWFI proceeds including budgeting, financing and dispatch of power surrounding the series of
equipment. Based on all these facts, it was determined that we are the primary beneficiary of VWFI. Therefore, VWFI has been
consolidated by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxp3SdopEgQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86E_z6WL2RG9nXhc">Long Lived Assets</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews the carrying values of
its long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount may not
be recoverable. If the expected future cash flow from the use of the asset and its eventual disposition is less than the carrying
amount of the asset, an impairment loss is recognized and measured using the fair value of the related asset. No impairment charges
were incurred during the six months ended June 30, 2022 or for the year ended December 31, 2021, as the Company was still in the
early phases of our business plan and operating losses were expected in our early phases. On March 11, 2020, the World Health
Organization (&#8220;WHO&#8221;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on
human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the
global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow the further spread of
the disease. We have observed supply chain disruptions from the COVID-19 pandemic that has contributed to delays in the completion
of the manufacturing of our RPCs, although we do not believe that these delays have constituted a triggering event for impairment of
our assets. Our Kuwait operations were suspended to comply with the social distancing measures implemented in Kuwait, but in 2022
has allowed for the Company to obtain site personnel visas to recommence operations. Our Utah operations were temporarily
suspended from March through May 2020, but have since resumed in full in its manufacturing of its RPCs, and construction and implementation of site and infrastructure preparations
in anticipation of commencing operations in 2022. There can be no assurance, however, that market conditions
will not change or demand for the Company&#8217;s services will continue, which could result in impairment of long-lived assets in
the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_846_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zG8Hd8tNjjJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86D_zaOLyLvhpbC3">Intangible Assets</span>:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for intangible assets in accordance
with ASC 350 <i>&#8220;Intangibles-Goodwill and Other&#8221;</i> (&#8220;ASC 350&#8221;). Intangible asset amounts represent the acquisition
date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income
approach, discounting projected future cash flows based on management&#8217;s expectations of the current and future operating environment.
The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure
and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over
their useful lives, which have historically ranged from <span id="xdx_90E_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zGHlcVy4gfxc" title="Amortized useful lives">10</span> to <span id="xdx_902_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zudsMyNvjh91" title="Amortized useful lives">20</span> years. The carrying amounts of our definite-lived intangible assets are
evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset&#8217;s
carrying amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We assess our intangible assets in accordance
with ASC 360 &#8220;<i>Property, Plant, and Equipment</i>&#8221; (&#8220;ASC 360&#8221;). Impairment testing is required when events occur
that indicate an asset group may not be recoverable (&#8220;triggering events&#8221;). As detailed in ASC 360-10-35-21, the following
are examples of such events or changes in circumstances (sometimes referred to as impairment indicators or triggers): (a) A significant
decrease in the market price of a long-lived asset (asset group) (b) A significant adverse change in the extent or manner in which a long-lived
asset (asset group) is being used or in its physical condition. (c) A significant adverse change in legal factors or in the business climate
that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator (d) An accumulation
of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group)
(e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast
that demonstrates continuing losses associated with the use of a long-lived asset (asset group) (f) A current expectation that, more likely
than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated
useful life. The term more likely than not refers to a level of likelihood that is more than 50 percent. We have evaluated our intangible
assets and found that certain losses and a delay in our business plan may have constituted a triggering event for our intangible assets.
We performed an analysis and assessed that there was no impairment for the six months ended June 30, 2022 or for the year ended December
31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zQFG8YdEw9qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86B_zCouQEPJifTg">Advertising Expense</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising costs are expensed as incurred. The
Company did not incur advertising expense for the six months ended June 30, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_ztPUYJOPyPHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86C_zxSUTsALF6k8">Net Income/Loss Per Share</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net income (loss) per share is
calculated by subtracting any preferred interest distributions from net income (loss), all divided by the weighted-average number of
common shares outstanding for the period, without consideration for common stock equivalents. Diluted net income (loss) per common
share is computed by dividing the net income (loss) by the weighted-average number of common share equivalents outstanding for the
period determined using the treasury stock method if their effect is dilutive. Potential dilutive instruments as of June 30, 2022
and 2021 include the following: convertible notes payable convertible into approximately <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_z230ycvlsUm8" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">14,560</span>
and <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_zpJ8pjmTnxBd" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">227,150</span>
shares of common stock, convertible Series A preferred stock convertible into <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dn_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_z2Gg4kwHWWs6" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">none</span>
and <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_pdd_zZGsZb1q3Ofl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">666,667</span>
shares of common stock (due to the event of a public offering of the Company&#8217;s common stock in February 2022 this will convert
to 833,333 shares), stock options granted to employees of <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_zvfdEGoUbjAh" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">2,039,585</span>
and <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_z6K1YxdZvHEl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">183,333</span>
shares of common stock. Stock options granted to Board members or consultants of <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_pdd_z8arP4CFkbg" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_zgHW5X6Bzx49" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">466,667</span></span>
shares of common stock were granted as of June 30, 2022 and 2021. There were also warrants issued and outstanding to EF Hutton of <span id="xdx_902_ecustom--WarrantsIssued_c20220630_pdd_zgksOOGqoxB4" title="Warrants issued"><span id="xdx_908_ecustom--WarrantsOutstanding_c20220630_pdd_zZkNi3aJvfQ7" title="Warrants outstanding">80,000</span></span>
shares of common stock as of June 30, 2022.  These warrants were related to and granted during the close of the
underwritten public offering in February 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p id="xdx_841_eus-gaap--UseOfEstimates_z8bIuBoo4VGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_868_zyAI2qP3N3lc">Use of Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America requires management to make estimates, judgments, and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes. We believe our critical accounting estimates
relate to the following: Recoverability of current and noncurrent assets, revenue recognition, stock-based compensation, income taxes,
effective interest rates related to long-term debt, marketable securities, cost basis and equity method investments, lease assets and
liabilities, equity method investments, valuation of stock used to acquire assets, and derivatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While our estimates and assumptions are based
on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates
and assumptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWB2ZFyKT0Bc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_860_zQ8hpDlc8Xh2">Fair Value of Financial Instruments</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Accounting Standards Codification
(&#8220;ASC&#8221;) 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;), for assets and liabilities measured
at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value, and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#8217;s financial position
or operating results but did expand certain disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 820 defines fair value as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of
unobservable inputs. These inputs are prioritized below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1: Applies to assets or liabilities for
which there are quoted prices in active markets for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2: Applies to assets or liabilities for
which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3: Applies to assets or liabilities for
which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets
or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board&#8217;s (&#8220;FASB&#8221;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement. The carrying amounts reported in the consolidated balance sheets for marketable
securities are classified as Level 1 assets due to observable quoted prices for identical assets in active markets. The carrying amounts
reported in the consolidated balance sheets for cash, prepaid expenses and other current assets, accounts payable and accrued expenses
approximate their estimated fair market values based on the short-term maturity of these instruments. T<span style="background-color: white">he
recorded values of notes payable approximate their current fair values because of their nature, rates, and respective maturity dates or
durations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300129407872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_DisclosureLiquidityAbstract', window );"><strong>Liquidity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_LiquidityTextBlock', window );">Liquidity</a></td>
<td class="text"><p id="xdx_80C_ecustom--LiquidityTextBlock_zR2qfSqXzjjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2. <span id="xdx_82A_zpzYYcebaCqg">Liquidity</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have historically suffered net losses and
cumulative negative cash flows from operations, and as of June 30, 2022, we had an accumulated deficit of approximately $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_dixL_c20220630_z54LArkHhmH7" title="::XDX::41237559"><span style="-sec-ix-hidden: xdx2ixbrl0892">41.3</span></span>
million. As of June 30, 2022 we had cash of $<span id="xdx_90A_eus-gaap--Cash_c20220630_p0p0_zr82MY5vHU0c" title="Cash">5,204,591</span>. The
Company closed an underwritten public offering of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_pdd_zThpA8p2eQ6k" title="Stock Issued During Period, Shares, New Issues">1,600,000</span>
shares of common stock, at a public offering price of $5.00 per share, for aggregate gross proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn3n3_dm_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_ztKjmbHillFk" title="Proceeds from Issuance or Sale of Equity">8</span>
million, prior to deducting underwriting discounts, commissions, and other offering expenses. Prior to the offering, we financed our
operations primarily through debt financing, private equity offerings our working interest agreements. We believe we have other
liquid assets that may be used to assist in financing the operations of the Company if needed, including marketable securities in
Scepter, which hold a fair value $<span id="xdx_902_eus-gaap--MarketableSecurities_c20220630_p0p0_zyaP5djUik16" title="Marketable Securities">1,818,029</span>
as of June 30, 2022 and have been deposited for trading. We believe the liquid assets from the Company&#8217;s available for sale
investments and funding provided from subsequent fundraising activities (see Note 15) of the Company give it adequate working
capital to finance our day-to-day operations for at least twelve months through August 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_DisclosureLiquidityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_DisclosureLiquidityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_LiquidityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_LiquidityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300132397968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Assets</a></td>
<td class="text"><p id="xdx_804_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zMjYp3admClk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 3. <span id="xdx_82E_zf0w36s7VPKa">Prepaid Expenses and Other Assets</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021, our
other assets mainly consist of various deposits with vendors, professional service agents, or security deposits on office and warehouse
leases. As of June 30, 2022 and December 31, 2021 we had office and warehouse lease deposits in the amount of $<span id="xdx_908_eus-gaap--LeaseDepositLiability_iI_p0p0_c20220630_zgCu3B0RAJu6" title="Office and warehouse lease deposits">61,676</span> and $<span id="xdx_903_eus-gaap--LeaseDepositLiability_iI_p0p0_c20211231_zeIDaGedv2M" title="Office and warehouse lease deposits">73,245</span>. As
of June 30, 2022 we had deposits in the amounts of $<span id="xdx_903_eus-gaap--Deposits_iI_p0p0_c20220630__srt--CounterpartyNameAxis__custom--VendorMember_z59yXTtEWYg6" title="Deposits">161,458</span> with vendors, professional service agencies, and a reclamation bond with the
Utah Division of Oil, Gas and Mining in the amount of $<span id="xdx_905_eus-gaap--Deposits_iI_c20220630__dei--LegalEntityAxis__custom--ProfessionalServiceAgenciesMember_zgGHQRNADA14" title="Deposits">14,288</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300132391328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text"><p id="xdx_803_eus-gaap--MarketableSecuritiesTextBlock_zoyFWqjzhPtd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 4. <span id="xdx_82F_z7EOymzRyjdj">Marketable Securities</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2020, the Company owned <span id="xdx_902_eus-gaap--InvestmentOwnedBalanceShares_iI_c20201231__dei--LegalEntityAxis__custom--OdysseyGroupMember_zUQUUogOiea" title="Investment Owned, Balance, Shares">3,309,758</span>
shares of common stock in Odyssey Group International, Inc. (&#8220;Odyssey&#8221;) ticker: ODYY, OTC Markets. In December 2021 we
sold such shares of Odyssey in a private transaction for a purchase price of $<span id="xdx_905_eus-gaap--ProceedsFromSaleOfOtherInvestments_p0p0_c20210101__20211231__dei--LegalEntityAxis__custom--OdysseyGroupMember_zOF04fy5iek5" title="Proceeds from Sale of Other Investments">860,491</span>,
with $10,000 cash delivered at signing and a note issued in favor of Vivakor in the amount of $850,491, reflecting the market price
at that time. The Company accounted for such securities based on the quoted price from the OTC Markets where the stock is traded,
which resulted in the Company recording an unrealized loss of $<span id="xdx_90B_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220101__20220630__dei--LegalEntityAxis__custom--OdysseyGroupMember_p0p0_z11Taujp06s4" title="Unrealized gain on marketable securities">595,392</span>
on these marketable securities for the three months ended June 30, 2021 compared to an unrealized gain of $<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_p0p0_c20210101__20210630__dei--LegalEntityAxis__custom--OdysseyGroupMember_zGLpxUY2yIb7" title="Unrealized gain on marketable securities">1,494,275</span>
for the six months ended June 30, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2019 the Company had an investment of $<span id="xdx_90F_eus-gaap--MarketableSecurities_c20191231__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z4XIBa2qvn6" title="Marketable securities">800,000</span>
or <span id="xdx_90E_eus-gaap--InvestmentOwnedBalanceShares_c20191231__dei--LegalEntityAxis__custom--OdysseyGroupMember_pdd_zOHqQwlN8p5e" title="Investment Owned, Balance, Shares">800,000,000</span> shares of common stock, or a diluted 23% equity holding in Scepter Holdings, Inc. (&#8220;Scepter&#8221;), ticker: BRZL,
OTC Markets. In the fourth quarter of 2020, the Company was diluted to a 19% equity holding in Scepter, and was no longer deemed to have
significant influence and ceased to be an equity investment, and as the stock is traded on an active market, the Company has classified
the investment as marketable securities with the change in unrealized gains and losses on the investment included in the statement of
operations for the three months ended June 30, 2022 and 2021. In August 2021 we converted $<span id="xdx_900_ecustom--NoteReceivableConvertedAmountConverted_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zqKGwnXf3yje" title="Note receivable converted, amount converted">81,768</span> of our note receivable with Scepter
into <span id="xdx_905_ecustom--NoteReceivableConvertedSharesReceived_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_pdd_z7RIkNvxFcQ2" title="Note receivable converted, shares received">26,376,882</span> shares of Scepter common stock pursuant to the terms of the note at $0.0031 per share. On the date of the conversion,
the Scepter price per share on OTC Markets was $0.0062 per share, which resulted in a $<span id="xdx_905_ecustom--GainLossOnDispositionOfAsset_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z19EhPiXhivc" title="Gain (Loss) on disposition of asset">87,044</span> gain on the disposition of the note receivable.
The Company has accounted for such securities based on the quoted price from the OTC Markets where the stock is traded, which resulted
in the Company recording an unrealized loss on marketable securities of $<span id="xdx_90D_ecustom--MarketableSecuritiesUnrealizedLoss_p0p0_c20220401__20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zoMSoaA6KtC9" title="Unrealized loss on marketable securities">1,652,755</span> and $<span id="xdx_90A_ecustom--MarketableSecuritiesUnrealizedLoss_p0p0_c20210401__20210630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zTTFF3gF594b" title="Unrealized loss on marketable securities">8,353,777</span> for the three months ended June 30,
2022 and 2021 compared to an unrealized gain (loss) of $(<span id="xdx_90C_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220101__20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zDdVifC58Uxb">413,189</span>) and <span id="xdx_903_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20210101__20210630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z4M10TZFGmgj" title="Unrealized gain on marketable securities">2,240,000</span> for the six months ended June 30, 2022 and 2021. As of
June 30, 2022 and December 31, 2021, the Company&#8217;s Chief Executive Officer has an immediate family member who sits on the board
of directors of Scepter Holdings, Inc. As of June 30, 2022 and December 31, 2021 our Scepter marketable securities were valued at $<span id="xdx_901_eus-gaap--MarketableSecurities_c20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zYtuLO4jk4Qb" title="Marketable securities">1,818,029</span>
and $<span id="xdx_908_eus-gaap--MarketableSecurities_c20211231__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zE7DozMKfY0d" title="Marketable securities">2,231,218</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021, marketable
securities were $<span id="xdx_906_eus-gaap--MarketableSecurities_iI_p0p0_c20220630_zJLko8huBQ8g" title="Marketable securities">1,818,029</span> and $<span id="xdx_909_eus-gaap--MarketableSecurities_c20211231_p0p0_zkESzF69woL8" title="Marketable securities">2,231,218</span>. For the three months ended June 30, 2022 and 2021, the Company recorded a total unrealized
loss of $<span id="xdx_90F_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220401__20220630_zsaHpJY8Egy2" title="Unrealized gain (loss) on marketable securities">1,652,755</span> and $<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20210401__20210630_zgL9ZjrxAeCb" title="Unrealized gain (loss) on marketable securities">8,949,169</span> compared to an unrealized gain (loss) of $(<span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220101__20220630_zojWJgTjhH57" title="Unrealized gain (loss) on marketable securities">413,189</span>) and $<span id="xdx_90E_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_p0p0_c20210101__20210630_zGjBsA86hMP4" title="Unrealized gain (loss) on marketable securities">3,734,275</span> for the six months ended June 30,
2022 and 2021 on marketable securities in the statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300129281520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zELX63TQvcx9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 5. <span id="xdx_820_zo4Rm3nSUR82">Inventories</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022, inventories consist primarily
of raw materials (including tar-sand stockpiles) and finished goods (which includes Fenix iron). The tar-sand stockpiles consist of 10,000
tons of tar sand stockpile and are anticipated to be used for our extraction remediation units. The stockpiles were acquired  when the
Company entered into a land lease agreement for located in Vernal, Utah. Under the terms of the lease agreement, we are required to pay
$3 per ton of oil sands processed. As a condition of the lease, we were required to provide $<span id="xdx_907_eus-gaap--InventoryGross_c20220630_p0p0_zClkGJhlsIza" title="Acquisition costs">30,000</span> toward initial tonnage of oil sands
to be processed at a cost of approximately $3.00 per ton. The nano Fenix Iron are finished goods that have a 20-year shelf life and were
acquired at cost for $<span id="xdx_906_eus-gaap--InventoryGross_c20220630__us-gaap--PublicUtilitiesInventoryAxis__custom--FexixIronMember_p0p0_zHpJndrNfTdb" title="Acquisition costs">192,000</span>. As of December 31, 2021, inventories consist primarily of the Fenix Iron. Inventories are valued at the
lower of cost or market (net realizable value).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;&#160;<b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128502608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ziQG7cPHjXci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6. <span id="xdx_828_zmhcyio93ON6">Property and Equipment</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the components
of the Company&#8217;s property and equipment at June 30, 2022 and December 31, 2021:</p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2VouumbI78a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B2_zfpfffVN8IWj"><b style="display: none">Schedule of property and equipment, net</b></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Depreciation</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Depreciation</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; text-align: left">Office furniture and equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zXsTdBFv7A82" style="width: 9%; text-align: right" title="Gross Carrying Amount">14,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_ztsodYoAlDS7" style="width: 9%; text-align: right" title="Accumulated Depreciation">4,956</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zKDUNcCru1Ae" style="width: 9%; text-align: right" title="Net Book Value">10,042</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zwZoazTA265c" style="width: 9%; text-align: right" title="Gross Carrying Amount">14,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zZ32mg0fJoph" style="width: 9%; text-align: right" title="Accumulated Depreciation">4,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zTEZpDpq3pbg" style="width: 9%; text-align: right" title="Net Book Value">10,998</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zO3NMe7osB13" style="text-align: right" title="Gross Carrying Amount">36,432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zzdsjQQI7Yrb" style="text-align: right" title="Accumulated Depreciation">22,466</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJcxKhnqMXI3" style="text-align: right" title="Net Book Value">13,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zQ7Atriy3ty5" style="text-align: right" title="Gross Carrying Amount">48,248</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zs4lyMhyDwCl" style="text-align: right" title="Accumulated Depreciation">26,306</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJiDuUxZkWlf" style="text-align: right" title="Net Book Value">21,942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Precious metal extraction machine- 1 ton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zDImJSQSDh21" style="text-align: right" title="Gross Carrying Amount">2,280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_z73m4qTCp8G4" style="text-align: right" title="Accumulated Depreciation">285,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zM5iBjaCpX2k" style="text-align: right" title="Net Book Value">1,995,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zX9vOTirupF5" style="text-align: right" title="Gross Carrying Amount">2,280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zAqk24U083Xh" style="text-align: right" title="Accumulated Depreciation">228,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zUMBjG2ealYl" style="text-align: right" title="Net Book Value">2,052,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Precious metal extraction machine- 10 ton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjzX9DFslNB4" style="text-align: right" title="Gross Carrying Amount">5,320,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjJ9QBZL87ki" style="text-align: right" title="Accumulated Depreciation">665,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zNHVOC2qsKt2" style="text-align: right" title="Net Book Value">4,655,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziCbgB3CRISh" style="text-align: right" title="Gross Carrying Amount">5,320,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zGJsbcYm4Brd" style="text-align: right" title="Accumulated Depreciation">532,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziupEQjHeSUc" style="text-align: right" title="Net Book Value">4,788,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Construction in process:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Bioreactors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zJX1X1YDdlw8" style="text-align: right" title="Gross Carrying Amount">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zKd0tIPryxtc" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zFy7Rvv1hcfi" style="text-align: right" title="Net Book Value">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_z1sLTW6Ec5Ze" style="text-align: right" title="Gross Carrying Amount">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zrBrr6A9lt93" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zM8388fJ0ha4" style="text-align: right" title="Net Book Value">1,440,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nanosponge/Cavitation device</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zmmmxcWILue5" style="text-align: right" title="Gross Carrying Amount">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zZUGBTB2qjY8" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zhUHhWKdewvc" style="text-align: right" title="Net Book Value">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zrUWkianZiK1" style="text-align: right" title="Gross Carrying Amount">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zk6VRcYKrGD4" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_z6yOp7eYdBrl" style="text-align: right" title="Net Book Value">22,103</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zeIkaFnaAKR1" style="text-align: right" title="Gross Carrying Amount">6,150,506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zCX1aiNqEGqa" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZMmvd885d8" style="text-align: right" title="Net Book Value">6,150,506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zsDLMwebAPq4" style="text-align: right" title="Gross Carrying Amount">6,249,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zZsCox1rJwq6" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZxCujJsnja" style="text-align: right" title="Net Book Value">6,249,082</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remediation Processing Unit 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zr0N7y1krw3" style="text-align: right" title="Gross Carrying Amount">5,489,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_zOByhnGe0ZV7" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zRybXBi4WELc" style="text-align: right" title="Net Book Value">5,489,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zo5UFZhZQLcf" style="text-align: right" title="Gross Carrying Amount">5,201,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_z7B01AbNxsp7" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zS3MUtfSXfGk" style="text-align: right" title="Net Book Value">5,201,098</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit System A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_z0PNkNXNpk4e" style="text-align: right" title="Gross Carrying Amount">3,127,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zeUXjLuOgc23" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zxDfHTqZr6t6" style="text-align: right" title="Net Book Value">3,127,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_ziBd0YMbc491" style="text-align: right" title="Gross Carrying Amount">2,561,467</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zIJwLOa1H1kj" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zpJkUOxoJTv3" style="text-align: right" title="Net Book Value">2,561,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Remediation Processing Unit System B</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zOhklpW21nZc" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">2,974,884</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zMZNkCzJUfp5" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zIhvL2LbZjwg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Book Value">2,974,884</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zhiecAo2mir2" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">2,345,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zxm7PcP0WyYg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zRzPCPCaoJJa" style="border-bottom: Black 1pt solid; text-align: right" title="Net Book Value">2,345,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total fixed assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_p0p0_zBX0bIt5wCHl" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">26,856,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_p0p0_zq6uh0KQ3Tg3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation">977,422</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_p0p0_zZRzQLEF55de" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value">25,878,930</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_p0p0_zKul4tOLeumh" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">25,482,417</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231_p0p0_zRxKJns9Bnxl" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation">790,306</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_p0p0_zAj7QFC1voIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value">24,692,111</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2021 the
Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__us-gaap--StatementClassOfStockAxis__custom--SeriesC1PreferredStockMember_pdd_zVN7UGsnFFK2">5,413 </span>shares
of Series C-1 Preferred Stock value at $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__us-gaap--StatementClassOfStockAxis__custom--SeriesC1PreferredStockMember_p0p0_zVbQq5ShOaNa" title="Prefered stock Series C-1 issued for a reduction in liabilities">64,950</span>
for equipment, which has been valued based on similar cash purchases of the Series C-1 Preferred Stock at approximately $12.00 per
share. For the six months ended June 30, 2022 and 2021 depreciation expense was $<span id="xdx_90B_eus-gaap--Depreciation_c20220101__20220630_p0p0_zfeAExnfrpL1">195,387 </span>and
$<span id="xdx_90D_eus-gaap--Depreciation_c20210101__20210630_p0p0_zcdDqjRUEiO">5,781</span>. For the  six months ended June 30, 2022 and 2021
capitalized interest to equipment from debt financing was $<span id="xdx_90F_eus-gaap--InterestCostsCapitalized_p0p0_c20220101__20220630_zcy0jFqlcZQ4">256,235 </span>and
$<span id="xdx_904_eus-gaap--InterestCostsCapitalized_p0p0_c20210101__20210630_z2b9QiBcygvf">822,700</span>. Equipment that is
currently being manufactured is considered construction in process and is not depreciated until the equipment is placed into
service.<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128446384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="text"><p id="xdx_802_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z8MUZM6C3mx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 7. <span id="xdx_822_zu1RARlcuIc8">Accounts Payable and Accrued Expenses</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts payable and accrued expenses consist
of the following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zCVJ2P9TRvo4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BF_zoSDtMfhJNb9" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220630_zp7euy5lVgoe" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20211231_zo6XJoLCZP7e" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccountsPayableCurrent_iI_p0p0_z3QU6LDAJ4s4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Accounts payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">851,495</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,450,531</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Deposits_iI_p0p0_zyYEp3MVgCGa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Office access deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_p0p0_zbwpajNChiu3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Accrued compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,798</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">175,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--UnearnedPremiums_iI_p0p0_d0_z9Rkgrlikyzc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69,784</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--AccruedInterestWorkingInterestRoyaltyPrograms_p0p0_d0_z321N4M3N1Bk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Accrued interest (working interest royalty programs)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,341,079</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_p0p0_zIRzL7QGsDYa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Accrued tax penalties and interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">398,114</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">398,114</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_p0p0_zJfTBbOYm1H5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: justify">Accounts payable and accrued expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,061,610</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,023,985</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As of December
31, 2021 the Company accrued $225,000 for a milestone payment to be paid to </span>TBT Group, Inc. (of which an independent Vivakor Board
member is a 7% shareholder) related to our worldwide, exclusive license agreement for the license of piezo electric and energy harvesting
technologies for creating self-powered sensors for making smart roadways. This milestone payment was paid in March 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128479728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans and Notes Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageNotesPayableDisclosureTextBlock', window );">Loans and Notes Payable</a></td>
<td class="text"><p id="xdx_808_eus-gaap--MortgageNotesPayableDisclosureTextBlock_zbqkSe12fn8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 8. <span id="xdx_82F_zLxdDyTIuxfj">Loans and Notes Payable</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Loans and Notes payable (including accrued interest)
consist of the following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zBt3fjaMI6td" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans and Notes Payable (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8B6_zxoRJ43j9WWd" style="display: none">Schedule of loans and notes payable</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Various promissory notes and convertible notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zUNWA1btj3O7" style="width: 13%; text-align: right" title="Total Notes Payable">50,960</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zN0kYferQQQ" style="width: 13%; text-align: right" title="Total Notes Payable">50,960</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Novus Capital Group LLC Note (a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zpSTE0IyGqz" style="text-align: right" title="Total Notes Payable">283,612</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zav5q11y8sZc" style="text-align: right" title="Total Notes Payable">378,854</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Triple T Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zSZEgoNzwSWe" style="text-align: right" title="Total Notes Payable">329,613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zNBcpGR47NSc" style="text-align: right" title="Total Notes Payable">353,330</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">National Buick GMC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zXm3z8AKVpfg" style="text-align: right" title="Total Notes Payable">16,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zTDFdyLHDn2e" style="text-align: right" title="Total Notes Payable">19,440</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Various Convertible Bridge Notes (b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_d0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zhuPzsIyVhmk" style="text-align: right" title="Total Notes Payable">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zGJauvOtdaY7" style="text-align: right" title="Total Notes Payable">1,075,813</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Blue Ridge Bank</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z12rXJ4a3Yak" style="text-align: right" title="Total Notes Payable">410,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z9OrlkdgTtMa" style="text-align: right" title="Total Notes Payable">410,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Small Business Administration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zydrssOwAtW6" style="text-align: right" title="Total Notes Payable">324,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zwDAiwwi3E7d" style="text-align: right" title="Total Notes Payable">318,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">JP Morgan Chase Bank</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zJpORknSSE49" style="text-align: right" title="Total Notes Payable">90,645</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zwVoWi1tUtIf" style="text-align: right" title="Total Notes Payable">90,645</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Various Promissory Notes (c)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zYRnUaqpdLkd" style="border-bottom: Black 1pt solid; text-align: right" title="Total Notes Payable">2,308,232</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zM2l5gKFENc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Notes Payable">3,416,379</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify">Total Notes Payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--NotesPayable_c20220630_p0p0_zONdv7cwV26f" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Notes Payable">3,814,506</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--NotesPayable_c20211231_p0p0_zuqD0iN6Vvv6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Notes Payable">6,113,796</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans and notes payable, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesAndLoansPayableCurrent_c20220630_p0p0_zK7D6hbRwb82" style="text-align: right" title="Loans and notes payable, current">962,405</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--NotesAndLoansPayableCurrent_c20211231_p0p0_zPgxiTmvJqB1" style="text-align: right" title="Loans and notes payable, current">1,511,447</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loans and notes payable, current attributed to variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20220630_p0p0_zN30deQcqkfe" style="text-align: right" title="Loans and notes payable, current attributed to variable interest entity">2,308,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20211231_p0p0_zDqWaVSwOAE7" style="text-align: right" title="Loans and notes payable, current attributed to variable interest entity">3,416,379</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans and notes payable, long term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--NotesAndLoansPayableNonCurrent_c20220630_p0p0_z00kBjj5Jui6" style="text-align: right" title="Loans and notes payable, long term">543,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--NotesAndLoansPayableNonCurrent_c20211231_p0p0_zkQigEr6iI1f" style="text-align: right" title="Loans and notes payable, long term">1,185,970</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8A3_z2Wq0BqQ0r3e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock_zQNq2SnFcUKa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Loans and Notes Payable (Details - Maturities of Debt)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zlSGqVJUxfL9" style="display: none">Schedule of maturities of loans and notes payable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zVH8wMM3K2ag" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 34%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,787,944</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_za0wU2dYfCP1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">518,114</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_zTu0ZgExnN5j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72,278</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_zQxnDJ40JULc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">68,878</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zjNSR57lq6Hi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,979</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zftGs1Uv2kf6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">255,313</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NotesAndLoansPayable_iI_p0p0_zJPJWoGa7ce2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,814,506</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">__________________&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><span id="xdx_F02_zrqYTbVasth7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="width: 97%; text-align: justify"><span id="xdx_F13_zbi12mKvg7Ug" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398. As of April 1 2022, the lender agreed to extend the maturity of the note to April 1, 2023 with an initial payment of $52,448 and approximate monthly payment of $29,432 thereafter until the note is fully paid.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span id="xdx_F06_z9qYJiM6Aiu8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_z2CxGdiyBuod" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021 and 2020 the Company entered into various convertible promissory notes as follows:</span></td></tr>
  </table>
<p id="xdx_8AA_z7hudYkQKocg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify">&#160;</td>
    <td style="width: 97%; text-align: justify">Throughout 2021 and 2020 the Company entered into convertible promissory notes with an aggregate principal of $<span id="xdx_900_eus-gaap--ConvertibleNotesPayable_c20220630_p0p0_z9gn45miNqB8" title="Aggregate principal">415,000</span>. The notes accrue interest at <span id="xdx_90A_ecustom--PercentageOfAccrueInterest_dp_c20220101__20220630_zDTVAUVptDHl" title="percentage of accrue interest"><span id="xdx_908_ecustom--PercentageOfAccrueInterest_dp_c20210101__20210630_zui1cKAUtp68" title="percentage of accrue interest">10</span></span>% per annum and have
a maturity of the earlier of 12 months or the consummation of the Company listing its Common Stock on a senior stock exchange. The notes
are convertible at the Company&#8217;s option into shares of the Company&#8217;s common stock at a price equal to 80% of the opening price
of the Company&#8217;s common stock on the national exchange or the offering price paid by the investors in the financing in connection
with the uplist, whichever is lower, or (ii) repaid in cash in an amount equal to the indebtedness being repaid plus a premium payment
equal to 15% of the amount being repaid. If an event of default has occurred and the Company does not convert the amounts due under the
Note into the Company&#8217;s common stock, then the Company will have the option to convert the outstanding indebtedness into shares
of the Company&#8217;s common stock at a price equal to 80% of the weighted average trading price of the Company&#8217;s common stock
on the OTC Markets, or be repaid in cash in an amount equal to all principal and interest due under the Note. All of these notes were
converted to common stock as of June 30, 2022.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="background-color: white">On
October 13, 2020, the Company entered into a convertible promissory note in an amount of $280,500 having an interest rate of 12% per annum.
The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00 or 80% of
the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the note may be
converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in conjunction with
this note, which </span>was recorded as a debt discount in the amount of $44,000, which is amortized to interest expense over the term
of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to state that in no event
shall the conversion price be lower than $3.00 per share. In October 2021 the parties agreed to extend the maturity of this loan to April
13, 2022 in exchange for an increase in principal owed of $30,000. This note has been converted to common stock as of June 30, 2022.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="background-color: white">On
February 4, 2021, the Company entered into a convertible promissory note in an amount of $277,778 having an interest rate of 12% per annum.
The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00 or 80% of
the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the note may be
converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in conjunction with
this note, which </span>was recorded as a debt discount in the amount of $36,000, which is amortized to interest expense over the term
of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to state that in no event
shall the conversion price be lower than $3.00 per share. In February 2022 the parties agreed to extend the maturity of this loan to August
8, 2022 in exchange for an increase in principal owed of $25,000. This note has been converted to common stock as of June 30, 2022.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">(c)</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Viva
Wealth Fund I, LLC is offering up to </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25,000,000 in
convertible notes in a private offering<span style="background-color: white">. As of June 30, 2022, VWFI has raised $10,510,000
and converted $8,575,000 of this debt to VWFI LLC units. A convertible note will </span>automatically <span style="background-color: white">convert
into the LLC units at the earlier of (i) the date that the Equipment is placed into quality control and testing or (ii) six months
from the date of investment. The convertible notes will accrue interest at 12% per annum</span> and are paid quarterly. At the
maturity date, remaining interest will be paid, at which time no further interest payments will accrue. Upon the offering
termination date, all units accepted for any series of equipment will automatically convert to Vivakor common stock if the Company
has not accepted subscriptions for at least $6,250,000 for a series of equipment. The conversion price of the automatic stock
conversion will be the the greater of $13.50 or a 10% discount to market per share or in the event of a public offering, 200% of the
per share price of the Company common stock sold in an underwritten offering, which was closed on February 14, 2022 at $5.00 per
share. <span style="background-color: white">The termination </span>date of the offering has been extended until November 13, 2022
in the sole discretion of the Company. As of April 28, 2021 VWFI has reached $6,250,000 in funding and has released the funding for
construction of RPC Series A. VWFI has commenced fundraising for RPC Series B and has raised approximately $4,690,000 to manufacture
RPC Series B. Subsequent to June 30, 2022 an additional $30,000 of this debt has been converted into units of the LLC.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageNotesPayableDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for mortgage notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageNotesPayableDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300129355696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_ztMUDxYShod4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note
9. <span id="xdx_829_zo8tboMJ3j1g">Commitments and Contingencies</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Commencing on September 15, 2019, the Company
entered into a five-year lease with Jamboree Center 1 &amp; 2 LLC covering approximately 6,961 square feet of office space in Irvine,
CA. Under the terms of the lease agreement, we are required to make the following monthly lease payments: Year 1 $<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zdnsfRNK9kwe" title="Lease payments next twelve months">21,927</span>, Year 2 $<span id="xdx_90C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_z0DvtGkjWmR6" title="Lease payments next two months">22,832</span>,
Year 3 $<span id="xdx_90E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zC76eKBcHTPb" title="Lease payments next three months">23,737</span>, Year 4 $<span id="xdx_907_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zUmukQkuhXI5" title="Lease payments next four months">24,712</span>, Year 5 $<span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zU0V1PiKrxl8" title="Lessee, Operating Lease, Liability, to be Paid, Year Five">25,686</span>. As a condition of the lease, we were required to provide a $<span id="xdx_90E_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zf0EVZ7sEz3e" title="Security deposit">51,992</span> security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 1, 2022, the Company entered into
a lease agreement for approximately 2,533 square feet of office and manufacturing space located in Las Vegas, Nevada. Commencing on March
1, 2022, the Company entered into a three-year lease with Speedway Commerce Center, LLC. Under the terms of the lease agreement, we are
required to make the following monthly lease payments: Year 1 $<span id="xdx_90A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zymAhYeuTX7i" title="Lease payments next twelve months">1,950</span>, Year 2 $<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zDonGQwVedhf" title="Lease payments next two months">2,028</span>, Year 3 $<span id="xdx_90F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zQTWb4jlVlg2" title="Lease payments next three months">2,110</span>. As a condition of the lease, we were
required to provide a $<span id="xdx_902_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zMLKWtbCCce6" title="Security deposit">2,418</span> security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 28, 2022, the Company entered into a
lease agreement for approximately 1,469 square feet of office space located in Lehi, Utah. Commencing on April 1, 2022, the Company entered
into a three-year lease with Victory Holdings, LLC. Under the terms of the lease agreement, we are required to make the following monthly
lease payments: Year 1 is comprised of April to May 2022 $<span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zLqPaRZ7Udbl" title="Lease payments next twelve months">867</span>, June 2022 to March 2023 $<span id="xdx_906_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zix5ICNVP0Aj" title="Lease payments next two and three months">3,550</span>, Year 2 $<span id="xdx_90F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zRVZpEFDeug" title="Lease payments next three months">3,657</span>, Year 3 $<span id="xdx_909_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_z658OYxLUFF" title="Lease payments next four months">3,766</span>. As a condition
of the lease, we were required to provide a $<span id="xdx_90E_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zAWCi1qng081" title="Security deposit">3,766</span> security deposit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2022, the Company entered into a lease
agreement for approximately 2,000 square feet of office and warehouse space located in Houston, Texas. Commencing on April 1, 2022, the
Company entered into a month-to-month lease with JVS Holdings, Inc. The lease may be terminated at any time or for any reason with a 30-day
written notice to terminate. The lease requires a monthly lease payment of $<span id="xdx_905_eus-gaap--OperatingLeasePayments_c20220101__20220630_z7jRn6qWYVWe" title="Lease payment">2,000</span> as long as the Company remains in the space.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The right-of-use asset for operating leases as
of June 30, 2022 and December 31, 2021 was $<span id="xdx_90C_eus-gaap--OperatingLeaseRightOfUseAsset_c20220630_p0p0_znoAEiwv99Xj" title="Right-of-use asset for operating leases">721,550</span> and $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_p0p0_c20211231_zVYNxWCFLV6c" title="Right-of-use asset for operating leases">663,291</span>. Rent expense for the six months ended June 30, 2022 and 2021 was $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20220101__20220630_p0p0_zi3WAtVjcQYc" title="Rent expense">199,170</span>
and $<span id="xdx_900_eus-gaap--OperatingLeaseExpense_c20210101__20210630_p0p0_zV2tAXW27wI7" title="Rent expense">186,086</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table reconciles the undiscounted
cash flows for the leases as of June 30, 2022 to the operating lease liability recorded on the balance sheet:</p>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zqifXTNooFfb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_zYjrq6de3fO1" style="display: none">Schedule of lessee operating lease liability</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20220630_zadUSdZUWBE2" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_p0p0_zYW4kqHEMVk9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: justify">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">180,195</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_p0p0_zdXfilqhHpW5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370,902</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_p0p0_zclp4fjqMg5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">304,892</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_p0p0_zaTLS6ljJFvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,135</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_p0p0_zNnwA4Llgmgg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Total undiscounted lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">872,124</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_p0p0_zKkqEP2TpC8k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">93,074</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PresentValueOfLeasePayments_iI_p0p0_zhFjN12vDg3j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">779,050</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_p0p0_zpkR0DztXUj2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Operating lease liabilities, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">364,103</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--OperatingLeaseLiability1Noncurrent_iI_p0p0_zsAsIsmBHRTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Operating lease liabilities, long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">414,946</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zpMy8KS20sR2" title="Weighted-average remaining lease term">2.36</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Weighted-average discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z7h5q93x9gTk" title="Weighted-average discount rate">7.0</span>%</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The discount rate is the Company&#8217;s incremental
borrowing rate, or the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an
amount equal to the lease payments in a similar economic environment. Based on an assessment of the Company&#8217;s borrowings the incremental
borrowing rate was determined to be 7%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Employment Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2022, the Company entered into employment
agreements with its Chief Executive Officer and Chief Financial Officer, which provide for annual base salaries of $375,000 and $350,000,
respectively, and provide for incremental increases in their salaries upon the Company&#8217;s achievement of specific performance metrics.
The Company is currently accruing substantial portions of both executive&#8217;s base salaries (see Note 7). The employment agreements
provide for the grant of stock options to the Chief Executive Officer and Chief Financial Officer to purchase up to 955,093 and 917,825
shares of the Company&#8217;s common stock, respectively, at an exercise price equal to 110% and 100% of the fair market value of the
Company&#8217;s common stock on the date of grant. The stock option will vest after two years of continuous employment, subject to acceleration
if terminated without cause or resignations for good reason. The agreement also provides that it is anticipated that the executives will
receive bonuses for 2022 which will be determined by the Company&#8217;s Compensation Committee and Board of Directors after taking into
account the general business performance of the Company, including any completed financings and or acquisitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128446384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt</a></td>
<td class="text"><p id="xdx_803_eus-gaap--LongTermDebtTextBlock_z5BZZphgdMKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 10. <span id="xdx_825_zc3OJwZWRKMk">Long-term Debt</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To assist in funding the manufacture of the Company&#8217;s
Remediation Processing Centers, between 2015 and 2017, the Company entered into two agreements which include terms for the purchase of
participation rights for the sale of future revenue of the funded RPCs. The RPCs are estimated to enter scaled up operations in 2022 and
make estimated payments. The Company estimates future payments based on revenue projections for the RPCs. Due to delays in scaled up operations
(see Note 1 <i>Long Lived Assets</i>) the effective interest rate of these agreements increased from approximately 33% to 36%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-term debt consists of the following:</p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zOV77MkwcL4e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-term Debt (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zzLEroAMHtZi" style="display: none">Schedule Of Long-Term Debt</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220630__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zuAukLD4uUvj" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20211231__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zS8b9c9ISsZ9" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_p0p0_zLfN7oyrf1Hg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%">Principal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,196,233</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,196,233</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_p0p0_zGGHXuiTkjpg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,049,304</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,205,144</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_p0p0_zjy9ZaN5Lxvf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(219,380</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(226,823</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebt_iI_p0p0_zdK2D4HHVXOe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,026,157</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,174,554</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LongTermDebtCurrent_iI_p0p0_zGGJmy4B41D5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long term debt, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,565</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,256</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermDebtNoncurrent_iI_p0p0_znzh3ubHqmQ1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Long term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,017,592</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,171,298</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8AB_zRuxNy5PZzz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the estimated
payment schedule of long-term debt as of June 30, 2022:</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zTrvZMAYzY6d" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-term Debt (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zBvBSpEAcOpj" style="display: none">Schedule of long-term debt maturities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zZd90qCh3nvk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3,525</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_zGNuNRo4riy7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,795</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_znnugAX2pyMe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,078</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_z6PpCCxR0SSh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,359</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zOau1F6hYCBh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,943</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zV8midIH7ml" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,125,533</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebt_iI_p0p0_ziNLzqwGtbY5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,196,233</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8AA_zB9HULwk0Q1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128502608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Temporary Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_DisclosureTemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_TemporaryEquityTextBlock', window );">Temporary Equity</a></td>
<td class="text"><p id="xdx_804_ecustom--TemporaryEquityTextBlock_zOPa5Whmsouk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11.&#160;<span id="xdx_82D_zVlDTslJPik3">Temporary Equity</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table shows all changes to temporary equity during for
the six months ended June 30, 2021.</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--TemporaryEquityTableTextBlock_zkj1eVS7qNYb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Temporary Equity (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span id="xdx_8B7_zuzij8dvxA0i" style="display: none">Schedule of temporary equity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Convertible Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series C-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zKRrSrWKT324" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; font-weight: bold; text-align: left">March 31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zG0XcMv62vu4" style="width: 9%; text-align: right" title="Beginning balance, shares">213,583</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,281,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zO6JJkRUXzS" style="width: 9%; text-align: right" title="Beginning balance, shares">459,426</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,445,716</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zOYU5NSXkV0k" style="width: 9%; text-align: right" title="Beginning balance, shares">260,702</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,615,927</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TemporaryEquityDividendsAdjustment_z1XkWG4e7bAj" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--DividendPaidInSeriesB1PreferredStock_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z8FHfogLkTDb" style="text-align: right" title="Dividend paid in Series B-1 Preferred Stock">5,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,196</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ConversionOfStockAmountConverted1_zk6AUfJzvZ4d" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Conversion of Series B and B-1 Preferred Stock to Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zN7NpsVoR004" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(213,583</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,281,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zFpJTwGwHzOk" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(459,426</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,445,716</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z3AGUCJqXnR8" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(266,328</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,658,123</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zDdXOOdbZdi3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_z1Y9MHFEnHh1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1341">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_z2oyf7Af0fC3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1343">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zK0W9oGhcLLg" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1345">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Convertible Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series C-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>

<tr id="xdx_438_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_z3biLnfjToIi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; width: 28%">December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_988_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zfJYQSxfw5g6" style="text-align: right; width: 9%" title="Beginning balance, shares">216,916</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">1,301,500</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zRj5DOEhbdIk" style="text-align: right; width: 9%" title="Beginning balance, shares">467,728</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">3,507,981</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_984_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z9lUUVYMRmI" style="text-align: right; width: 9%" title="Beginning balance, shares">255,289</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">4,550,977</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--SerciesC1IssueForReductionInStockPayables_zaia6mKkoECg" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Series C-1 Issue for a reduction in stock payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--SerciesC1IssueForReductionInStockPayable_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zrx0XXgKLpi2" style="text-align: right" title="Sercies C-1 Issue for a reduction in stock payables, shares">5,413</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,950</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--TemporaryEquityDividendsAdjustment_zM9jXoY9BVo4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--DividendPaidInSeriesB1PreferredStock_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zfllWXEPraYl" style="text-align: right" title="Dividend paid in Series B-1 Preferred Stock">5,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,196</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ConversionOfStockAmountConverted1_z51aSSgC3AL4" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Conversion of Series B and B-1 Preferred Stock to Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zWqfszJKZWha" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(216,916</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,301,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zdBJzBBiFtja" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(467,728</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,507,981</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zbuobMp7Ivfd" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(266,328</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,658,123</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_435_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zpaStK7ArNRe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zMlVoeKrDZIj" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1368">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zDyhxuL7eay8" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1370">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zKyrmU7mQsId" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1372">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8AF_zdanAWU5FfBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ended December 31, 2021, all shares of Series B, B-1,
and C-1 Preferred Stock were converted to common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>










<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_DisclosureTemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_DisclosureTemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_TemporaryEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_TemporaryEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128482160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Noncontrolling Interest<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Noncontrolling Interest</a></td>
<td class="text"><p id="xdx_805_eus-gaap--MinorityInterestDisclosureTextBlock_z17kC2771LC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 12. <span id="xdx_82F_zg5hJXUSXsVi">Noncontrolling Interest</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the six months ended June 30, 2022 and 2021, the Company converted
$<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220101__20220630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zBE7xdKCK3j6">3,025,000</span> and $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210101__20210630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zgymMdMJvqQ3">735,000</span> in Viva Wealth Fund I, LLC convertible promissory notes into <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20220630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_ziIdrGSX1lQe">605</span> and <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20210630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zy4zphagUTRi">147</span> units of noncontrolling interest in Viva
Wealth Fund I, LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the six months ended June 30, 2021 and 2020,
the Company paid distributions to Viva Wealth Fund I, LLC unit holders of $<span id="xdx_902_eus-gaap--PaymentsOfDistributionsToAffiliates_c20220101__20220630__dei--LegalEntityAxis__custom--VivaWealthFundILLCMember_zpL2UD5ybnfb">343,889</span> and <span id="xdx_901_eus-gaap--PaymentsOfDistributionsToAffiliates_dn_c20210101__20210630__dei--LegalEntityAxis__custom--VivaWealthFundILLCMember_zxM69rujKWsj">none</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128479728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation &amp; Warrants<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Share-Based Compensation &amp; Warrants</a></td>
<td class="text"><p id="xdx_806_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zfXdlZyus43e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 13. <span id="xdx_82C_zl7zl2ju1pB8">Share-Based Compensation &amp; Warrants</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally accepted accounting principles require
share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income
statement based on their fair values at the date of grant, net of estimated forfeitures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021,
the Company has granted stock-based compensation to employees, including a <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20180101__20181231__us-gaap--AwardTypeAxis__custom--ShareStockAwardMember__srt--CounterpartyNameAxis__custom--EmployeesMember_pdd_zjDFnAMi6pG1" title="Option granted">16,667</span>
share stock award, which was issued in 2018 and vested in May 2022, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210630__us-gaap--AwardTypeAxis__custom--StockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesMember_pdd_zfA20N4ycmE2" title="Option granted">166,667</span>
in employee stock options that were issued in 2020 and cliff vest at the end of five years, and <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__srt--CounterpartyNameAxis__custom--EmployeesMember_zgl1FUCJKfRf" title="Option granted">1,872,918</span>
employee stock options granted in June 2022 and vest over a period of two years. For the six months ended June 30, 2022 and 2021,
stock-based compensation was $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__custom--StockOptionsMember_p0p0_z6andRk94JPd" title="Share-based Payment Arrangement, Noncash Expense">1,340,703</span>
and $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__custom--StockOptionsMember_p0p0_ztWxi0R0PUxk" title="Share-based Payment Arrangement, Noncash Expense">223,056</span>.
In 2020, the Company also granted non-statutory stock options, including <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember__srt--CounterpartyNameAxis__custom--BoardOfDirectorsMember_pdd_zbhppYpa67me" title="Option granted">133,333</span>
stock options to the Board of Directors, which vests over 1 year, and a <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember__srt--CounterpartyNameAxis__custom--ConsultantMember_pdd_zNEPRoHiM775" title="Option granted">333,334</span>
stock option to a consultant, which vests over 4 years. Non-statutory stock-based compensation was $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember_p0p0_z7I6JPHa6Cr9" title="Share-based Payment Arrangement, Noncash Expense">855,000</span>
and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember_p0p0_zYGRu1rVeID9" title="Share-based Payment Arrangement, Noncash Expense">730,000</span>
for the six months ended June 30, 2022 and 2021. In 2022, the Company closed on its underwritten public offering in which the
Company granted the underwriter, EF Hutton, division of Benchmark Investments, LLC ("EF Hutton"), a 45-day option to
purchase up to an additional <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630_pdd_zwSoLkwmr5Cj" title="Option granted">240,000</span>
shares of Common Stock at the public offering price per share, less the underwriting discounts and commissions, to cover
over-allotments, if any. These options were not exercised and expired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no other options granted during the
six months ended June 30, 2022 and 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The assumptions used in the Black-Scholes option
pricing model to determine the fair value of the options on the date of issuance are as follows:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOWarrantsValuationAssumptionsTableTextBlock_zQxe2cxJVlX5" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share-Based Compensation &amp; Warrants (Details - Assumptions)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zKgxhekKiKXg" style="display: none">Schedule of warrant assumptions</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 51%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 48%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">December 31, 2020 through June 30, 2022</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zlsfH0sgceil" title="Risk-free interest rate">0.24</span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zkGhwGDXrYqb" title="Risk-free interest rate">3.04</span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_c20220101__20220630_zKFJEgzrMNXe" title="Expected dividend yield">None</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life of warrants</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zVujzUYtl49d" title="Expected life of warrants">3.33</span>-<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zL0iUs4YQLQf" title="Expected life of warrants">10</span> years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility rate</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zld1UpQFNTgh" title="Expected volatility rate">169</span> - <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zCJiRY6v3g9k" title="Expected volatility rate">273</span>%</span></td></tr>
  </table>
<p id="xdx_8A0_zGFuCeOCsRkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes all stock option
activity of the Company for the six months ended June 30, 2022 and 2021:</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEyI1V0pVWfe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-Based Compensation &amp; Warrants (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BE_zg4NRCbjG50l" style="display: none">Schedule of option activity</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">of Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life (Years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; width: 52%; text-align: left">Outstanding, December 31, 2021</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGzyJcHWsoTh" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Shares outstanding - beginning">650,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWH5k9Nj5ET3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Weighted average exercise price - beginning">12.00</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zepFeL2sKfjc" title="Weighted average contractural term">7.53</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zpITgqxeEjd9" style="text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures">2,112,919</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zKdW7w1cSeQ5" style="text-align: right" title="Weighted average exercise price, granted">2.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZoitAmMkGXd" title="Weighted average remaining contractual life (years)">6.60</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zU3SiJUmuKJd" style="text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period">(16,667</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zMVxfEggfAsf" style="text-align: right" title="Weighted average exercise price, exercised">11.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zO1xVgNBXkd1" style="border-bottom: Black 1pt solid; text-align: right" title="Stock Issued During Period, Shares, Restricted Stock Award, Forfeited">(240,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_z6NF080YqpM5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited">5.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Outstanding, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zq1XgtFHQFL" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares outstanding - ending">2,506,252</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z4eNEImGgT3e" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - ending">4.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSJjJT94Y5B7" title="Weighted average contractural term">7.39</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvpCM6SpWLge" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable">180,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zm0pwFkrSd2i" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zV5pZP1dANb4" title="Weighted average contractural term">7.01</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zVPn5DMyc4F1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable">890,168</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zWWgs4brn9h9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable">4.74</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zw77cQjXXW8i" title="Weighted average contractural term">7.48</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Outstanding, December 31, 2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9QMEoObEMWe" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding - beginning">650,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zavK7tgH9tIg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price - beginning">12.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSYGHhOc5x14" title="Weighted average contractural term">6.41</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTcI7KvBhsni" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares outstanding - ending">650,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaV1OFdjkvZe" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - ending">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyBOErZ9OBpf" title="Weighted average contractural term">5.91</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7ChZQMefX9d" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable">47,083</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zPRRaCvxnh58" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNp6f4INXJoc" title="Weighted average contractural term">3.38</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTEi1FknJX82" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable">108,333</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zZ80KZsmpbJ8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvKBpcjVsmld" title="Weighted average contractural term">5.10</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8A1_zCsd8nAf1O6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021, the
aggregate intrinsic value of the Company&#8217;s outstanding options was approximately none. The aggregate intrinsic value will change
based on the fair market value of the Company&#8217;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2022 and December 31, 2021,
the Company had <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightOutstanding_c20220630_pdd_zgJoM7I0zsw1" title="Warrants outstanding">80,000</span>
and <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20211231_za9wJkA3JTWg" title="Warrants outstanding">no</span>
warrants outstanding. On February 14, 2022, the Company closed on its underwritten public offering of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_zmIsoCpCise" title="Stock Issued During Period, Shares, New Issues">1,600,000</span>
shares of common stock, at a public offering price of $5.00 per share. In addition, the Company has issued the underwriter, EF
Hutton, 5-year warrants to purchase <span id="xdx_906_ecustom--WarrantsIssued_iI_c20220630_zoxolq7QqiN5" title="Warrants issued">80,000</span>
shares of common stock at an exercise price equal $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20220630_pdd_z9V7vVaikzj7" title="Warrants exercise price">5.75</span>.
and were valued with a fair market value of $374,000. We used the Black-Scholes option pricing model to determine the fair value of
the warrants, with assumptions of a risk free rate of 1.92%, an expected life of 5 years, and volatility of 167%. The impact of
these warrants has no effect on stockholder&#8217;s equity, as they are considered equity-like instruments, and are considered a
direct expense of the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128462784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text"><p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zKAIkVVYti8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 14. <span id="xdx_82D_zJt9b1mJ0wic">Income Tax</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company calculates its quarterly tax provision
pursuant to the guidelines in ASC 740 Income Taxes. ASC 740 requires companies to estimate the annual effective tax rate for current year
ordinary income. In calculating the effective tax rate, permanent differences between financial reporting and taxable income are factored
into the calculation, and temporary differences are not. The estimated annual effective tax rate represents the Company&#8217;s estimate
of the tax provision in relation to the best estimate of pre-tax ordinary income or loss. The estimated annual effective tax rate is then
applied to year-to-date ordinary income or loss to calculate the year-to-date interim tax provision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company recorded a provision for income taxes of $<span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20220630_p0p0_zAPPz3fSvJ3j" title="Provision for income taxes">800</span> and $<span id="xdx_90C_eus-gaap--IncomeTaxExpenseBenefit_p0p0_c20210101__20210630_z3nIGzFpfzeh" title="Provision for income taxes">723,911</span> for the six months ended June 30, 2022 and 2021, respectively. The
Company is projecting a (0.04)% </span><span style="font-family: Times New Roman, Times, Serif">effective tax rate for the year
ending December 31, 2022, which is primarily the result of projected provision from book loss incurred for the year offset by additional
valuation allowance on the net operating losses. The Company&#8217;s effective tax rate for 2021 was <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210630_z7i5CYECk7m2" title="Effective tax rate">9.18</span>% which was the result of the
benefit of book income for the year.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the Company had estimated
federal and state net operating loss (NOL) carryforwards of approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_dm_c20211231_zsEAWGy76sfk" title="Net Operating losses">14.3</span> million. Federal NOL carryforwards begin to expire in
2028.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128446384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zgYUv9GSmJhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 15. <span id="xdx_822_zjeaVTsUkre5">Subsequent Events</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company has evaluated
subsequent events through the date the financial statements were available to issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On August 1, 2022, we
closed a Membership Interest Purchase Agreement, (the &#8220;MIPA&#8221;), with Jorgan Development, LLC, a Louisiana limited liability
company ("Jorgan") and JBAH Holdings, LLC, a Texas limited liability company ("JBAH" and, together with Jorgan, the
"Sellers"), as the equity holders of Silver Fuels Delhi, LLC, a Louisiana limited liability company ("SFD") and White
Claw Colorado City, LLC, a Texas limited liability company ("WCCC" ) whereby, the Company acquired all of the issued and outstanding
membership interests in each of SFD and WCCC (the &#8220;Membership Interests&#8221;), making SFD and WCCC wholly owned subsidiaries of
the Company. The purchase price for the Membership Interests is approximately $37.4 million, subject to post-closing adjustments, payable
by the Company in a combination of 3,009,552 shares of the Company&#8217;s common stock, amount equal to 19.99% of the number of issued
and outstanding shares of the Company&#8217;s common stock immediately prior to issuance, a secured three-year promissory notes made by
the Company in favor of the Sellers, and the assumption of certain liabilities of SFD and WCCC. The shares of the Company&#8217;s common
stock and the Notes will have an aggregate value of approximately $32,942,939.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Sellers have entered
into 18-month lock-up agreements at closing with regard to the 3,009,552 common shares issued for consideration for the Membership Interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the MIPA, the
Company has committed to make a payment to the Sellers on or before the 18-month anniversary of the closing date in the amount of
$16,471,469 whether in cash or unrestricted common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the event of a breach
of the terms of the MIPA, the Notes, or the Pledge Agreement, the sole and exclusive remedy of the parties will be to unwind the MIPA
transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The principal amount
of the Notes, together with any and all accrued and unpaid interest thereon, will be paid to the Sellers on a monthly basis in an amount
equal to the Monthly Free Cash Flow continuing thereafter on the twentieth (20<sup>th</sup>) calendar day of each calendar month thereafter.
Monthly Free Cash Flow means cash proceeds received by SFD and WCCC from its operations minus any capital expenditures (including, but
not limited to, maintenance capital expenditures and expenditures for personal protective equipment, additions to the land/current facilities
and pipeline connections) and any payments on capital lease obligations of SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In conjunction with the
closing under the MIPA, SFD, WCCC and the Company will enter into a Shared Services Agreement with Endeavor Crude, LLC, a Texas limited
liability company affiliated with the Sellers (&#8220;Endeavor&#8221;), under which Endeavor will provide certain operating and administrative
services to SFD and WCCC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In conjunction with the
closing we entered into a Master Netting Agreement, hereto (the &#8220;Netting Agreement&#8221;), with Jorgan, JBAH, Endeavor and White
Claw Crude, LLC under which all amounts as a result of all Contracts during a given calendar month shall be netted against all amounts
owed as a result of all contracts and the resulting net amount shall be payable. The Netting Agreement includes contracts such as the
MIPA, the Notes, any pledge agreements, the Shared Services Agreement, the Crude Petroleum Supply Agreement dated January 1, 2021, by
and between WC Crude and SFD, as amended, and the Oil Storage Agreement dated January 1, 2021, by and between WC Crude, as Shipper, and
WCCC, as Operator, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the acquisition
of WCCC we also acquired WCC&#8217;s Oil Storage Agreement with WC Crude, under which WC Crude has the right, subject to the payment of
service and maintenance fees, to store volumes of crude oil and other liquid hydrcarbons at a certain crude oil and liquid hydrocarbon
receipt, storage, blending, throughput and delivery terminal operated by WCCC, which expires on December 31, 2031.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the acquisition of
SFD, we acquired a Crude Petroleum Supply Agreement with WC Crude (the &#8220;Supply Agreement&#8221;), under which WC Crude supplies
volumes of Crude Petroleum to SFD. WC Crude and SFD will be entered into an amendment to the Supply Agreement, in conjunction with the
closing under the MIPA, which provides for the delivery to SFD a minimum of 1,000 sourced barrels per day, and includes a guarantee that
when SFD resells these barrels, if SFD does not make at least a $5.00 per barrel margin that WC Crude will pay to SFD the difference between
the sales price and $5.00 per barrel In the event that SFD makes more than $5.00 per barrel, SFD will pay WC Crude a profit sharing payment
in the amount equal to 10% of the excess price over $5.00 per barrel, which amount will be multiplied by the number of barrels associated
with the sale. The Supply Agreement, as amended, will remain in effect through and including December 31,2031.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the acquisition of
SFD, we acquired a crude oil gathering, storage, and transportation facility located on approximately 9.3 acres near Delhi, Louisiana,
along with its existing sales agreements, where a subsidiary of a large NYSE traded energy company is obligated to purchase blended crude
oil from SFD in amounts up to 60,000 barrels per month. With prior approval, SFD is eligible to sell to the Purchaser amounts greater
than 60,000 barrels of crude oil per month. In the acquisition of WCCC, we acquired a 120,000 barrel crude oil storage tank, in the heart
of the Permian Basin, located near Colorado City, Texas. The storage tank is presently connected to the Lotus pipeline system</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to June 30, 2022, VWFI has raised $430,000
in conjunction with the $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC units,
to accredited investors to raise funds to manufacture equipment that manufacture RPC Series B. Subsequent to June 30, 2022, VWFI has also
converted $30,000 of convertible debt into VWFI LLC units.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300127028400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_Covid19PolicyTextBlock', window );">COVID-19</a></td>
<td class="text"><p id="xdx_846_ecustom--Covid19PolicyTextBlock_zmUb4pmZhvbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_867_zSHu0pmwRcOg">COVID-19</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 11, 2020, the World Health Organization
(&#8220;WHO&#8221;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the
pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets.
Most U.S. states and many countries have issued policies intended to stop or slow the further spread of the disease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">COVID-19 and the U.S. response to the pandemic
are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may
have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent
of the effects on the economy, the markets we serve, our business, or our operations. In March 2020 we temporarily suspended operations
in Kuwait and Utah due to COVID-19 government restrictions, Utah has resumed operations in full. Kuwait has allowed for the Company to
obtain site personnel visas to recommence operations. These suspensions have had a negative impact on our business and there can be no
guaranty that we will not need to suspend operations again in the future as a result of the pandemic.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_InterimFinancialInformationPolicyTextBlock', window );">Interim Financial Information</a></td>
<td class="text"><p id="xdx_849_ecustom--InterimFinancialInformationPolicyTextBlock_zotbl60NRihj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_z9fVd7QJJoZ8">Interim Financial Information</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).
Certain information and disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have
been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the related notes for the year ended December 31, 2021. The unaudited condensed consolidated financial
statements have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and
include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation
of the condensed consolidated financial statements. The operating results for the three and six months ended June 30, 2022 are not necessarily
indicative of the results expected for the full year ending December&#160;31, 2022.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zqnXUeDr7KFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_860_z9df4Z4o31td">Principles of Consolidation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows ASC 810-10-15 guidance with
respect to accounting for Variable Interest Entities (&#8220;VIE&#8221;). A VIE is an entity that does not have sufficient equity at risk
to finance its activities without additional subordinated financial support from other parties, or whose equity investors lack any of
the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will absorb portions
of a VIE&#8217;s expected losses or receive portions of the entity&#8217;s expected residual returns. For the six months ended June 30,
2022 and year ended December 31, 2021 the following entities are considered to be a VIE and are consolidated in our consolidated financial
statements: Viva Wealth Fund I, LLC and RPC Design and Manufacturing, LLC. For the six months ended June 30, 2022 and year ended December
31, 2021 the following entities were considered to be a VIE, but were not consolidated in our consolidated financial statements due to
a lack of the power criterion or the losses/benefits criterion: Vivaventures UTS I, LLC, Vivaventures Royalty II, LLC, Vivaopportunity
Fund, LLC, and International Metals Exchange, LLC. For the six months ended June 30, 2022 and year ended December 31, 2021 the unaudited
financial information for the unconsolidated VIEs is as follows: Vivaventures UTSI, LLC held assets of $<span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z2o3hEUb6w0a" title="Assets">3,383,610</span> and $<span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z6T8semNZ3vi" title="Assets">3,753,296</span> (where
the primary asset represents a receivable from the Company), and liabilities of $<span id="xdx_901_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z8cbapUzlpN2" title="Liabilities">47,049</span> and $<span id="xdx_909_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_zcgzT2SrUQAa" title="Liabilities">12,608</span>. Vivaventures Royalty II, LLC held
assets of $<span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zFhbvhtZZ4T1" title="Assets">2,939,498</span> and $<span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_z1ZiBuNmonS8" title="Assets">2,648,810</span> (where the primary asset represents a receivable from the Company), and liabilities of $<span id="xdx_908_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zx0CEuhEdJC3" title="Liabilities">1,720</span> and
$<span id="xdx_90B_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zZJUXjRbSsb8" title="Liabilities">300</span>. Vivaopportunity Fund LLC held assets of $<span id="xdx_905_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zYd31ctlAAW2" title="Assets">2,119,856</span> and $<span id="xdx_90B_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zmk5Cqdjf6Mf" title="Assets">2,119,961</span> (where the primary asset represents a noncontrolling interest
in units of a consolidated entity of the Company) and <span id="xdx_907_eus-gaap--Liabilities_iI_p0p0_do_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_zVdQSlVqDwUe" title="Liabilities">no</span> liabilities. International Metals Exchange, LLC held assets of $<span id="xdx_901_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zRs8H2qSmrd1" title="Assets">29,938</span> and $<span id="xdx_90F_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zmcLlfgBGRtk" title="Assets">30,461</span>
and liabilities of $<span id="xdx_90E_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zkYw4uKIohil" title="Liabilities"><span id="xdx_907_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zBQtyH2mXEPb" title="Liabilities">1,900</span></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>RPC Design and Manufacturing, LLC: </b>As of
June 30, 2022 and year ended December 31, 2021, investors in RDM have a noncontrolling interest of $<span id="xdx_90A_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zOk4yYA9pdj4" title="Noncontrolling Interest in Variable Interest Entity">387,049</span> and $<span id="xdx_907_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zNzqjbbprw72" title="Noncontrolling Interest in Variable Interest Entity">629,694</span>, respectively.
As of June 30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are not restricted and can be used to settle the
obligations of the reporting entity. As of June 30, 2022 and December 31, 2021 this VIE has an outstanding note payable to the reporting
entity in the amount of $<span id="xdx_90B_eus-gaap--NotesPayable_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zLmmA2qpxP45" title="Notes Payable">628,828</span> and $<span id="xdx_90C_eus-gaap--NotesPayable_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zW58xCpAuV7a" title="Notes Payable">354,566</span>, which is eliminated upon consolidation. We have the primary risk (expense) exposure in
financing and operating the assets and are responsible for 100% of the operation, maintenance and any unfunded capital expenditures, which
ultimately could be 100% of a custom machine, and the decisions related to those expenditures including budgeting, financing and dispatch
of power. Based on all these facts, it was determined that we are the primary beneficiary of RDM. Therefore, RDM has been consolidated
by the Company. Any intercompany revenue and expense associated with RDM and its license agreement with the Company has been eliminated
in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Viva Wealth Fund I, LLC:</b> As of June
30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are restricted solely for the use of proceeds of the VWFI
offering (to manufacture RPCs) and cannot be used to settle the obligations of the reporting entity. As of June 30, 2022 and
December 31, 2021, the Company has cash attributed to variable interest entities of $<span id="xdx_90E_ecustom--CashAttributableToVie_c20220630__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zAcm7UDg2Bnj" title="Cash attributable to VIE">296,257</span>
and $<span id="xdx_904_ecustom--CashAttributableToVie_c20211231__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zs0SOaTeO44" title="Cash attributable to VIE">199,952</span>.
As of June 30, 2022, VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI has
commenced fundraising for RPC Series B. In the event that VWFI does not raise at least $6,250,000 for these RPC Series by the
offering termination date (which date has been extended until November 13, 2022), then the convertible notes and/or units would
convert into Vivakor common stock where the minimum conversion price will be the greater of $13.50 or a 10% discount to market per
share or in the event of a public offering, 200% of the per share price of the Company common stock sold in the underwritten
offering, which was closed on February 14, 2022 at $5.00 per share. As of August 8, 2022, VWFI has raised approximately $4,690,000
for RPC Series B. VWFI unit holders may also sell their units to the Company for their principal investment amount on the
3<sup>rd</sup>, 4<sup>th</sup>, and 5<sup>th</sup> anniversary of the offering termination date, which if this option were
exercised, the Company may elect to pay the amount in either cash or common stock. The Company also has the option to purchase any
LLC units where the members did not exercise their conversion option under the same terms and pricing for cash or common stock. VWFI
has entered into a license agreement with the Company indicating that VWFI will pay the Company a license fee of $1,000,000 per
series of equipment manufactured with the Company&#8217;s proprietary technology, however these transactions are eliminated upon consolidation. All of the operations of VWFI relate to private
placement offering to fund and manufacture proprietary equipment for the Company, as intended in VWFI&#8217;s design and
organization by the Company, so that the Company controls VWFI in its business purpose, use of proceeds, and selling and leasing of
its equipment solely to the Company. Creditors of VWFI have no recourse to the general credit of the Company. We have the primary
risk (expense) exposure in financing and operating the assets and are responsible for 100% of the operation, and any unfunded
capital expenditures, and the expense to the unit holders in conversion to common stock if series of equipment cannot be fully
funded, which ultimately could be 100% of any custom machine. By request of the fund manager, we are responsible for the decisions
related to the expenditures of VWFI proceeds including budgeting, financing and dispatch of power surrounding the series of
equipment. Based on all these facts, it was determined that we are the primary beneficiary of VWFI. Therefore, VWFI has been
consolidated by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long Lived Assets</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxp3SdopEgQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86E_z6WL2RG9nXhc">Long Lived Assets</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews the carrying values of
its long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount may not
be recoverable. If the expected future cash flow from the use of the asset and its eventual disposition is less than the carrying
amount of the asset, an impairment loss is recognized and measured using the fair value of the related asset. No impairment charges
were incurred during the six months ended June 30, 2022 or for the year ended December 31, 2021, as the Company was still in the
early phases of our business plan and operating losses were expected in our early phases. On March 11, 2020, the World Health
Organization (&#8220;WHO&#8221;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on
human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the
global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow the further spread of
the disease. We have observed supply chain disruptions from the COVID-19 pandemic that has contributed to delays in the completion
of the manufacturing of our RPCs, although we do not believe that these delays have constituted a triggering event for impairment of
our assets. Our Kuwait operations were suspended to comply with the social distancing measures implemented in Kuwait, but in 2022
has allowed for the Company to obtain site personnel visas to recommence operations. Our Utah operations were temporarily
suspended from March through May 2020, but have since resumed in full in its manufacturing of its RPCs, and construction and implementation of site and infrastructure preparations
in anticipation of commencing operations in 2022. There can be no assurance, however, that market conditions
will not change or demand for the Company&#8217;s services will continue, which could result in impairment of long-lived assets in
the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_846_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zG8Hd8tNjjJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86D_zaOLyLvhpbC3">Intangible Assets</span>:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for intangible assets in accordance
with ASC 350 <i>&#8220;Intangibles-Goodwill and Other&#8221;</i> (&#8220;ASC 350&#8221;). Intangible asset amounts represent the acquisition
date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income
approach, discounting projected future cash flows based on management&#8217;s expectations of the current and future operating environment.
The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure
and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over
their useful lives, which have historically ranged from <span id="xdx_90E_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zGHlcVy4gfxc" title="Amortized useful lives">10</span> to <span id="xdx_902_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zudsMyNvjh91" title="Amortized useful lives">20</span> years. The carrying amounts of our definite-lived intangible assets are
evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset&#8217;s
carrying amount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We assess our intangible assets in accordance
with ASC 360 &#8220;<i>Property, Plant, and Equipment</i>&#8221; (&#8220;ASC 360&#8221;). Impairment testing is required when events occur
that indicate an asset group may not be recoverable (&#8220;triggering events&#8221;). As detailed in ASC 360-10-35-21, the following
are examples of such events or changes in circumstances (sometimes referred to as impairment indicators or triggers): (a) A significant
decrease in the market price of a long-lived asset (asset group) (b) A significant adverse change in the extent or manner in which a long-lived
asset (asset group) is being used or in its physical condition. (c) A significant adverse change in legal factors or in the business climate
that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator (d) An accumulation
of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group)
(e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast
that demonstrates continuing losses associated with the use of a long-lived asset (asset group) (f) A current expectation that, more likely
than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated
useful life. The term more likely than not refers to a level of likelihood that is more than 50 percent. We have evaluated our intangible
assets and found that certain losses and a delay in our business plan may have constituted a triggering event for our intangible assets.
We performed an analysis and assessed that there was no impairment for the six months ended June 30, 2022 or for the year ended December
31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Expense</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zQFG8YdEw9qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86B_zCouQEPJifTg">Advertising Expense</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising costs are expensed as incurred. The
Company did not incur advertising expense for the six months ended June 30, 2022 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income/Loss Per Share</a></td>
<td class="text"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_ztPUYJOPyPHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86C_zxSUTsALF6k8">Net Income/Loss Per Share</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net income (loss) per share is
calculated by subtracting any preferred interest distributions from net income (loss), all divided by the weighted-average number of
common shares outstanding for the period, without consideration for common stock equivalents. Diluted net income (loss) per common
share is computed by dividing the net income (loss) by the weighted-average number of common share equivalents outstanding for the
period determined using the treasury stock method if their effect is dilutive. Potential dilutive instruments as of June 30, 2022
and 2021 include the following: convertible notes payable convertible into approximately <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_z230ycvlsUm8" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">14,560</span>
and <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_zpJ8pjmTnxBd" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">227,150</span>
shares of common stock, convertible Series A preferred stock convertible into <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dn_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_z2Gg4kwHWWs6" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">none</span>
and <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_pdd_zZGsZb1q3Ofl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">666,667</span>
shares of common stock (due to the event of a public offering of the Company&#8217;s common stock in February 2022 this will convert
to 833,333 shares), stock options granted to employees of <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_zvfdEGoUbjAh" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">2,039,585</span>
and <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_z6K1YxdZvHEl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">183,333</span>
shares of common stock. Stock options granted to Board members or consultants of <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_pdd_z8arP4CFkbg" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"><span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_zgHW5X6Bzx49" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount">466,667</span></span>
shares of common stock were granted as of June 30, 2022 and 2021. There were also warrants issued and outstanding to EF Hutton of <span id="xdx_902_ecustom--WarrantsIssued_c20220630_pdd_zgksOOGqoxB4" title="Warrants issued"><span id="xdx_908_ecustom--WarrantsOutstanding_c20220630_pdd_zZkNi3aJvfQ7" title="Warrants outstanding">80,000</span></span>
shares of common stock as of June 30, 2022.  These warrants were related to and granted during the close of the
underwritten public offering in February 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_841_eus-gaap--UseOfEstimates_z8bIuBoo4VGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_868_zyAI2qP3N3lc">Use of Estimates</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America requires management to make estimates, judgments, and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes. We believe our critical accounting estimates
relate to the following: Recoverability of current and noncurrent assets, revenue recognition, stock-based compensation, income taxes,
effective interest rates related to long-term debt, marketable securities, cost basis and equity method investments, lease assets and
liabilities, equity method investments, valuation of stock used to acquire assets, and derivatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While our estimates and assumptions are based
on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates
and assumptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWB2ZFyKT0Bc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_860_zQ8hpDlc8Xh2">Fair Value of Financial Instruments</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Accounting Standards Codification
(&#8220;ASC&#8221;) 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;), for assets and liabilities measured
at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value, and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#8217;s financial position
or operating results but did expand certain disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 820 defines fair value as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of
unobservable inputs. These inputs are prioritized below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1: Applies to assets or liabilities for
which there are quoted prices in active markets for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2: Applies to assets or liabilities for
which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3: Applies to assets or liabilities for
which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets
or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board&#8217;s (&#8220;FASB&#8221;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement. The carrying amounts reported in the consolidated balance sheets for marketable
securities are classified as Level 1 assets due to observable quoted prices for identical assets in active markets. The carrying amounts
reported in the consolidated balance sheets for cash, prepaid expenses and other current assets, accounts payable and accrued expenses
approximate their estimated fair market values based on the short-term maturity of these instruments. T<span style="background-color: white">he
recorded values of notes payable approximate their current fair values because of their nature, rates, and respective maturity dates or
durations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_Covid19PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_Covid19PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_InterimFinancialInformationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_InterimFinancialInformationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300127972640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2VouumbI78a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B2_zfpfffVN8IWj"><b style="display: none">Schedule of property and equipment, net</b></span></td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Depreciation</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Depreciation</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Book Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; text-align: left">Office furniture and equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zXsTdBFv7A82" style="width: 9%; text-align: right" title="Gross Carrying Amount">14,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_ztsodYoAlDS7" style="width: 9%; text-align: right" title="Accumulated Depreciation">4,956</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zKDUNcCru1Ae" style="width: 9%; text-align: right" title="Net Book Value">10,042</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zwZoazTA265c" style="width: 9%; text-align: right" title="Gross Carrying Amount">14,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zZ32mg0fJoph" style="width: 9%; text-align: right" title="Accumulated Depreciation">4,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zTEZpDpq3pbg" style="width: 9%; text-align: right" title="Net Book Value">10,998</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zO3NMe7osB13" style="text-align: right" title="Gross Carrying Amount">36,432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zzdsjQQI7Yrb" style="text-align: right" title="Accumulated Depreciation">22,466</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJcxKhnqMXI3" style="text-align: right" title="Net Book Value">13,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zQ7Atriy3ty5" style="text-align: right" title="Gross Carrying Amount">48,248</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zs4lyMhyDwCl" style="text-align: right" title="Accumulated Depreciation">26,306</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJiDuUxZkWlf" style="text-align: right" title="Net Book Value">21,942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Precious metal extraction machine- 1 ton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zDImJSQSDh21" style="text-align: right" title="Gross Carrying Amount">2,280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_z73m4qTCp8G4" style="text-align: right" title="Accumulated Depreciation">285,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zM5iBjaCpX2k" style="text-align: right" title="Net Book Value">1,995,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zX9vOTirupF5" style="text-align: right" title="Gross Carrying Amount">2,280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zAqk24U083Xh" style="text-align: right" title="Accumulated Depreciation">228,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zUMBjG2ealYl" style="text-align: right" title="Net Book Value">2,052,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Precious metal extraction machine- 10 ton</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjzX9DFslNB4" style="text-align: right" title="Gross Carrying Amount">5,320,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjJ9QBZL87ki" style="text-align: right" title="Accumulated Depreciation">665,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zNHVOC2qsKt2" style="text-align: right" title="Net Book Value">4,655,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziCbgB3CRISh" style="text-align: right" title="Gross Carrying Amount">5,320,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zGJsbcYm4Brd" style="text-align: right" title="Accumulated Depreciation">532,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziupEQjHeSUc" style="text-align: right" title="Net Book Value">4,788,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Construction in process:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Bioreactors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zJX1X1YDdlw8" style="text-align: right" title="Gross Carrying Amount">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zKd0tIPryxtc" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zFy7Rvv1hcfi" style="text-align: right" title="Net Book Value">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_z1sLTW6Ec5Ze" style="text-align: right" title="Gross Carrying Amount">1,440,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zrBrr6A9lt93" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zM8388fJ0ha4" style="text-align: right" title="Net Book Value">1,440,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Nanosponge/Cavitation device</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zmmmxcWILue5" style="text-align: right" title="Gross Carrying Amount">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zZUGBTB2qjY8" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zhUHhWKdewvc" style="text-align: right" title="Net Book Value">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zrUWkianZiK1" style="text-align: right" title="Gross Carrying Amount">22,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zk6VRcYKrGD4" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_z6yOp7eYdBrl" style="text-align: right" title="Net Book Value">22,103</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zeIkaFnaAKR1" style="text-align: right" title="Gross Carrying Amount">6,150,506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zCX1aiNqEGqa" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZMmvd885d8" style="text-align: right" title="Net Book Value">6,150,506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zsDLMwebAPq4" style="text-align: right" title="Gross Carrying Amount">6,249,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zZsCox1rJwq6" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZxCujJsnja" style="text-align: right" title="Net Book Value">6,249,082</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Remediation Processing Unit 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zr0N7y1krw3" style="text-align: right" title="Gross Carrying Amount">5,489,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_zOByhnGe0ZV7" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zRybXBi4WELc" style="text-align: right" title="Net Book Value">5,489,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zo5UFZhZQLcf" style="text-align: right" title="Gross Carrying Amount">5,201,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_z7B01AbNxsp7" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zS3MUtfSXfGk" style="text-align: right" title="Net Book Value">5,201,098</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Remediation Processing Unit System A</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_z0PNkNXNpk4e" style="text-align: right" title="Gross Carrying Amount">3,127,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zeUXjLuOgc23" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zxDfHTqZr6t6" style="text-align: right" title="Net Book Value">3,127,669</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_ziBd0YMbc491" style="text-align: right" title="Gross Carrying Amount">2,561,467</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zIJwLOa1H1kj" style="text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zpJkUOxoJTv3" style="text-align: right" title="Net Book Value">2,561,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Remediation Processing Unit System B</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zOhklpW21nZc" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">2,974,884</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zMZNkCzJUfp5" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zIhvL2LbZjwg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Book Value">2,974,884</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zhiecAo2mir2" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">2,345,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zxm7PcP0WyYg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zRzPCPCaoJJa" style="border-bottom: Black 1pt solid; text-align: right" title="Net Book Value">2,345,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total fixed assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_p0p0_zBX0bIt5wCHl" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">26,856,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_p0p0_zq6uh0KQ3Tg3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation">977,422</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_p0p0_zZRzQLEF55de" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value">25,878,930</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_p0p0_zKul4tOLeumh" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">25,482,417</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231_p0p0_zRxKJns9Bnxl" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation">790,306</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_p0p0_zAj7QFC1voIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value">24,692,111</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128527936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accounts payable and accrued expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zCVJ2P9TRvo4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BF_zoSDtMfhJNb9" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220630_zp7euy5lVgoe" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20211231_zo6XJoLCZP7e" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AccountsPayableCurrent_iI_p0p0_z3QU6LDAJ4s4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Accounts payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">851,495</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,450,531</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Deposits_iI_p0p0_zyYEp3MVgCGa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Office access deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_p0p0_zbwpajNChiu3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Accrued compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,798</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">175,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--UnearnedPremiums_iI_p0p0_d0_z9Rkgrlikyzc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Unearned revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69,784</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--AccruedInterestWorkingInterestRoyaltyPrograms_p0p0_d0_z321N4M3N1Bk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Accrued interest (working interest royalty programs)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,341,079</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_p0p0_zIRzL7QGsDYa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Accrued tax penalties and interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">398,114</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">398,114</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_p0p0_zJfTBbOYm1H5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: justify">Accounts payable and accrued expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,061,610</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,023,985</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300127144032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans and Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of loans and notes payable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zBt3fjaMI6td" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans and Notes Payable (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8B6_zxoRJ43j9WWd" style="display: none">Schedule of loans and notes payable</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Various promissory notes and convertible notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zUNWA1btj3O7" style="width: 13%; text-align: right" title="Total Notes Payable">50,960</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zN0kYferQQQ" style="width: 13%; text-align: right" title="Total Notes Payable">50,960</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Novus Capital Group LLC Note (a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zpSTE0IyGqz" style="text-align: right" title="Total Notes Payable">283,612</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zav5q11y8sZc" style="text-align: right" title="Total Notes Payable">378,854</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Triple T Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zSZEgoNzwSWe" style="text-align: right" title="Total Notes Payable">329,613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zNBcpGR47NSc" style="text-align: right" title="Total Notes Payable">353,330</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">National Buick GMC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zXm3z8AKVpfg" style="text-align: right" title="Total Notes Payable">16,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zTDFdyLHDn2e" style="text-align: right" title="Total Notes Payable">19,440</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Various Convertible Bridge Notes (b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_d0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zhuPzsIyVhmk" style="text-align: right" title="Total Notes Payable">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zGJauvOtdaY7" style="text-align: right" title="Total Notes Payable">1,075,813</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Blue Ridge Bank</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z12rXJ4a3Yak" style="text-align: right" title="Total Notes Payable">410,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z9OrlkdgTtMa" style="text-align: right" title="Total Notes Payable">410,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Small Business Administration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zydrssOwAtW6" style="text-align: right" title="Total Notes Payable">324,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zwDAiwwi3E7d" style="text-align: right" title="Total Notes Payable">318,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">JP Morgan Chase Bank</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zJpORknSSE49" style="text-align: right" title="Total Notes Payable">90,645</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zwVoWi1tUtIf" style="text-align: right" title="Total Notes Payable">90,645</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Various Promissory Notes (c)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zYRnUaqpdLkd" style="border-bottom: Black 1pt solid; text-align: right" title="Total Notes Payable">2,308,232</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zM2l5gKFENc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Notes Payable">3,416,379</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: justify">Total Notes Payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--NotesPayable_c20220630_p0p0_zONdv7cwV26f" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Notes Payable">3,814,506</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--NotesPayable_c20211231_p0p0_zuqD0iN6Vvv6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Notes Payable">6,113,796</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans and notes payable, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--NotesAndLoansPayableCurrent_c20220630_p0p0_zK7D6hbRwb82" style="text-align: right" title="Loans and notes payable, current">962,405</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--NotesAndLoansPayableCurrent_c20211231_p0p0_zPgxiTmvJqB1" style="text-align: right" title="Loans and notes payable, current">1,511,447</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Loans and notes payable, current attributed to variable interest entity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20220630_p0p0_zN30deQcqkfe" style="text-align: right" title="Loans and notes payable, current attributed to variable interest entity">2,308,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20211231_p0p0_zDqWaVSwOAE7" style="text-align: right" title="Loans and notes payable, current attributed to variable interest entity">3,416,379</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans and notes payable, long term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_ecustom--NotesAndLoansPayableNonCurrent_c20220630_p0p0_z00kBjj5Jui6" style="text-align: right" title="Loans and notes payable, long term">543,869</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--NotesAndLoansPayableNonCurrent_c20211231_p0p0_zkQigEr6iI1f" style="text-align: right" title="Loans and notes payable, long term">1,185,970</td><td style="text-align: left">&#160;</td></tr>
  </table>



<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock', window );">Schedule of maturities of loans and notes payable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock_zQNq2SnFcUKa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Loans and Notes Payable (Details - Maturities of Debt)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zlSGqVJUxfL9" style="display: none">Schedule of maturities of loans and notes payable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zVH8wMM3K2ag" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 34%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,787,944</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_za0wU2dYfCP1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">518,114</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_zTu0ZgExnN5j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72,278</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_zQxnDJ40JULc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">68,878</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zjNSR57lq6Hi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,979</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zftGs1Uv2kf6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">255,313</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NotesAndLoansPayable_iI_p0p0_zJPJWoGa7ce2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,814,506</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">__________________&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify"><span id="xdx_F02_zrqYTbVasth7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="width: 97%; text-align: justify"><span id="xdx_F13_zbi12mKvg7Ug" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398. As of April 1 2022, the lender agreed to extend the maturity of the note to April 1, 2023 with an initial payment of $52,448 and approximate monthly payment of $29,432 thereafter until the note is fully paid.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span id="xdx_F06_z9qYJiM6Aiu8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify"><span id="xdx_F1A_z2CxGdiyBuod" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021 and 2020 the Company entered into various convertible promissory notes as follows:</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128473872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of lessee operating lease liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zqifXTNooFfb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_zYjrq6de3fO1" style="display: none">Schedule of lessee operating lease liability</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20220630_zadUSdZUWBE2" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_p0p0_zYW4kqHEMVk9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: justify">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">180,195</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_p0p0_zdXfilqhHpW5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370,902</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_p0p0_zclp4fjqMg5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">304,892</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_p0p0_zaTLS6ljJFvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,135</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_p0p0_zNnwA4Llgmgg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Total undiscounted lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">872,124</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_p0p0_zKkqEP2TpC8k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Imputed interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">93,074</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PresentValueOfLeasePayments_iI_p0p0_zhFjN12vDg3j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">779,050</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_p0p0_zpkR0DztXUj2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Operating lease liabilities, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">364,103</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--OperatingLeaseLiability1Noncurrent_iI_p0p0_zsAsIsmBHRTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Operating lease liabilities, long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">414,946</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zpMy8KS20sR2" title="Weighted-average remaining lease term">2.36</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Weighted-average discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z7h5q93x9gTk" title="Weighted-average discount rate">7.0</span>%</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300128554432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule Of Long-Term Debt</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zOV77MkwcL4e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-term Debt (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zzLEroAMHtZi" style="display: none">Schedule Of Long-Term Debt</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220630__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zuAukLD4uUvj" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20211231__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zS8b9c9ISsZ9" style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_p0p0_zLfN7oyrf1Hg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%">Principal</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,196,233</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,196,233</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_p0p0_zGGHXuiTkjpg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,049,304</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,205,144</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_p0p0_zjy9ZaN5Lxvf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(219,380</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(226,823</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebt_iI_p0p0_zdK2D4HHVXOe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total long term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,026,157</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,174,554</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LongTermDebtCurrent_iI_p0p0_zGGJmy4B41D5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long term debt, current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,565</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,256</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LongTermDebtNoncurrent_iI_p0p0_znzh3ubHqmQ1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Long term debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,017,592</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,171,298</td><td style="text-align: left">&#160;</td></tr>
  </table>



<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of long-term debt maturities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zTrvZMAYzY6d" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-term Debt (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zBvBSpEAcOpj" style="display: none">Schedule of long-term debt maturities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zZd90qCh3nvk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 84%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">3,525</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_zGNuNRo4riy7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,795</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_znnugAX2pyMe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,078</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_z6PpCCxR0SSh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,359</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zOau1F6hYCBh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,943</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zV8midIH7ml" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,125,533</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebt_iI_p0p0_ziNLzqwGtbY5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,196,233</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300133849936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Temporary Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_DisclosureTemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of temporary equity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--TemporaryEquityTableTextBlock_zkj1eVS7qNYb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Temporary Equity (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left"><span id="xdx_8B7_zuzij8dvxA0i" style="display: none">Schedule of temporary equity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Convertible Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series C-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zKRrSrWKT324" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; font-weight: bold; text-align: left">March 31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zG0XcMv62vu4" style="width: 9%; text-align: right" title="Beginning balance, shares">213,583</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,281,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zO6JJkRUXzS" style="width: 9%; text-align: right" title="Beginning balance, shares">459,426</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,445,716</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zOYU5NSXkV0k" style="width: 9%; text-align: right" title="Beginning balance, shares">260,702</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,615,927</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TemporaryEquityDividendsAdjustment_z1XkWG4e7bAj" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--DividendPaidInSeriesB1PreferredStock_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z8FHfogLkTDb" style="text-align: right" title="Dividend paid in Series B-1 Preferred Stock">5,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,196</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ConversionOfStockAmountConverted1_zk6AUfJzvZ4d" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Conversion of Series B and B-1 Preferred Stock to Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zN7NpsVoR004" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(213,583</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,281,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zFpJTwGwHzOk" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(459,426</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,445,716</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z3AGUCJqXnR8" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(266,328</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,658,123</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zDdXOOdbZdi3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_z1Y9MHFEnHh1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1341">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_z2oyf7Af0fC3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1343">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zK0W9oGhcLLg" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1345">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Convertible Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series B-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Series C-1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>

<tr id="xdx_438_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_z3biLnfjToIi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; width: 28%">December 31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_988_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zfJYQSxfw5g6" style="text-align: right; width: 9%" title="Beginning balance, shares">216,916</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">1,301,500</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zRj5DOEhbdIk" style="text-align: right; width: 9%" title="Beginning balance, shares">467,728</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">3,507,981</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td id="xdx_984_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z9lUUVYMRmI" style="text-align: right; width: 9%" title="Beginning balance, shares">255,289</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 9%">4,550,977</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--SerciesC1IssueForReductionInStockPayables_zaia6mKkoECg" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Series C-1 Issue for a reduction in stock payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--SerciesC1IssueForReductionInStockPayable_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zrx0XXgKLpi2" style="text-align: right" title="Sercies C-1 Issue for a reduction in stock payables, shares">5,413</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,950</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--TemporaryEquityDividendsAdjustment_zM9jXoY9BVo4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Dividend paid in Series B-1 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--DividendPaidInSeriesB1PreferredStock_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zfllWXEPraYl" style="text-align: right" title="Dividend paid in Series B-1 Preferred Stock">5,626</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,196</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ConversionOfStockAmountConverted1_z51aSSgC3AL4" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Conversion of Series B and B-1 Preferred Stock to Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zWqfszJKZWha" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(216,916</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,301,500</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zdBJzBBiFtja" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(467,728</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,507,981</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zbuobMp7Ivfd" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares">(266,328</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,658,123</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_435_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zpaStK7ArNRe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zMlVoeKrDZIj" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1368">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zDyhxuL7eay8" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1370">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zKyrmU7mQsId" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl1372">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_DisclosureTemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_DisclosureTemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300134980752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation &amp; Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock', window );">Schedule of warrant assumptions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOWarrantsValuationAssumptionsTableTextBlock_zQxe2cxJVlX5" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share-Based Compensation &amp; Warrants (Details - Assumptions)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zKgxhekKiKXg" style="display: none">Schedule of warrant assumptions</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 51%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 48%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">December 31, 2020 through June 30, 2022</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zlsfH0sgceil" title="Risk-free interest rate">0.24</span> &#8211; <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zkGhwGDXrYqb" title="Risk-free interest rate">3.04</span>%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_c20220101__20220630_zKFJEgzrMNXe" title="Expected dividend yield">None</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life of warrants</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zVujzUYtl49d" title="Expected life of warrants">3.33</span>-<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zL0iUs4YQLQf" title="Expected life of warrants">10</span> years</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility rate</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zld1UpQFNTgh" title="Expected volatility rate">169</span> - <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zCJiRY6v3g9k" title="Expected volatility rate">273</span>%</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of option activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEyI1V0pVWfe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-Based Compensation &amp; Warrants (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BE_zg4NRCbjG50l" style="display: none">Schedule of option activity</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Contractual</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">of Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Life (Years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; width: 52%; text-align: left">Outstanding, December 31, 2021</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGzyJcHWsoTh" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Shares outstanding - beginning">650,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWH5k9Nj5ET3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Weighted average exercise price - beginning">12.00</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zepFeL2sKfjc" title="Weighted average contractural term">7.53</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zpITgqxeEjd9" style="text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures">2,112,919</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zKdW7w1cSeQ5" style="text-align: right" title="Weighted average exercise price, granted">2.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZoitAmMkGXd" title="Weighted average remaining contractual life (years)">6.60</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zU3SiJUmuKJd" style="text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period">(16,667</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zMVxfEggfAsf" style="text-align: right" title="Weighted average exercise price, exercised">11.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zO1xVgNBXkd1" style="border-bottom: Black 1pt solid; text-align: right" title="Stock Issued During Period, Shares, Restricted Stock Award, Forfeited">(240,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_z6NF080YqpM5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited">5.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Outstanding, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zq1XgtFHQFL" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares outstanding - ending">2,506,252</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z4eNEImGgT3e" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - ending">4.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSJjJT94Y5B7" title="Weighted average contractural term">7.39</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvpCM6SpWLge" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable">180,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zm0pwFkrSd2i" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zV5pZP1dANb4" title="Weighted average contractural term">7.01</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zVPn5DMyc4F1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable">890,168</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zWWgs4brn9h9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable">4.74</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zw77cQjXXW8i" title="Weighted average contractural term">7.48</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">Outstanding, December 31, 2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9QMEoObEMWe" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding - beginning">650,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zavK7tgH9tIg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price - beginning">12.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSYGHhOc5x14" title="Weighted average contractural term">6.41</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Outstanding, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTcI7KvBhsni" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares outstanding - ending">650,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaV1OFdjkvZe" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - ending">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyBOErZ9OBpf" title="Weighted average contractural term">5.91</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7ChZQMefX9d" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable">47,083</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zPRRaCvxnh58" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNp6f4INXJoc" title="Weighted average contractural term">3.38</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Exercisable, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTEi1FknJX82" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable">108,333</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zZ80KZsmpbJ8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable">12.00</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvKBpcjVsmld" title="Weighted average contractural term">5.10</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300126616304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 14, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
<td class="text">1-for-30 reverse
split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,699,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,744,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,838,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,191,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,814,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,113,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_WarrantsIssued', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_WarrantsOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,560<span></span>
</td>
<td class="nump">227,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_ConvertibleSeriesAPreferredStockMember', window );">Convertible Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_StockOptionsGrantedToEmployeesMember', window );">Stock Options Granted To Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,039,585<span></span>
</td>
<td class="nump">183,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember', window );">Stock Options Granted To Board Members Or Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466,667<span></span>
</td>
<td class="nump">466,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_AmortizedUsefulLives', window );">Amortized useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_AmortizedUsefulLives', window );">Amortized useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=VIVK_RPCDesignAndManufacturingLLCMember', window );">R P C Design And Manufacturing L L C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInVariableInterestEntity', window );">Noncontrolling Interest in Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=VIVK_RdmMember', window );">RDM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=VIVK_VivaWealthFundIMember', window );">Viva Wealth Fund I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_CashAttributableToVie', window );">Cash attributable to VIE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary [Member] | Vivaventures UTSI, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,383,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,753,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary [Member] | Vivaventures Royalty II, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,939,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,648,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary [Member] | Vivaopportunity Fund LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,119,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,119,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary [Member] | International Metals Exchange, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_AmortizedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_AmortizedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_CashAttributableToVie">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_CashAttributableToVie</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_WarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_WarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of equity (net assets) in a variable interest entity (VIE) not attributable, directly or indirectly, to the parent entity. That is, this is the portion of equity in a VIE that is attributable to the noncontrolling interest (previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_ConvertibleSeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_ConvertibleSeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_StockOptionsGrantedToEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_StockOptionsGrantedToEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=VIVK_RPCDesignAndManufacturingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=VIVK_RPCDesignAndManufacturingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=VIVK_RdmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=VIVK_RdmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_VivaWealthFundIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_VivaWealthFundIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_VivaventuresUtsiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_VivaventuresUtsiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_VivaventuresRoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_VivaventuresRoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_VivaopportunityFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_VivaopportunityFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_InternationalMetalsExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_InternationalMetalsExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300133863152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems', window );"><strong>Security Owned and Sold, Not yet Purchased, at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">$ 41,237,559<span></span>
</td>
<td class="nump">$ 35,731,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">5,204,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">$ 1,818,029<span></span>
</td>
<td class="nump">$ 2,231,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=VIVK_PublicOfferingMember', window );">Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems', window );"><strong>Security Owned and Sold, Not yet Purchased, at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance or Sale of Equity</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=VIVK_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=VIVK_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300129652112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseDepositLiability', window );">Office and warehouse lease deposits</a></td>
<td class="nump">$ 61,676<span></span>
</td>
<td class="nump">$ 73,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposits</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">$ 340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=VIVK_ProfessionalServiceAgenciesMember', window );">Professional Service Agencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposits</a></td>
<td class="nump">14,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=VIVK_VendorMember', window );">Vendor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposits</a></td>
<td class="nump">$ 161,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Deposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Deposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseDepositLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for lease payments received, including variable lease payments, when collectability is not probable at commencement date for sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123408481&amp;loc=SL77919106-209958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseDepositLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_ProfessionalServiceAgenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_ProfessionalServiceAgenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=VIVK_VendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=VIVK_VendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300124952656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,652,755)<span></span>
</td>
<td class="num">$ (8,949,169)<span></span>
</td>
<td class="num">$ (413,189)<span></span>
</td>
<td class="nump">$ 3,734,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,818,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,818,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,231,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,652,755<span></span>
</td>
<td class="nump">8,949,169<span></span>
</td>
<td class="nump">413,189<span></span>
</td>
<td class="num">(3,734,275)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=VIVK_OdysseyGroupMember', window );">Odyssey Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment Owned, Balance, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,309,758<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherInvestments', window );">Proceeds from Sale of Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">595,392<span></span>
</td>
<td class="nump">1,494,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(595,392)<span></span>
</td>
<td class="num">(1,494,275)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=VIVK_ScepterHoldingsMember', window );">Scepter Holdings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(413,189)<span></span>
</td>
<td class="nump">2,240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,818,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,818,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,231,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_NoteReceivableConvertedAmountConverted', window );">Note receivable converted, amount converted</a></td>
<td class="nump">$ 81,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_NoteReceivableConvertedSharesReceived', window );">Note receivable converted, shares received</a></td>
<td class="nump">26,376,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_GainLossOnDispositionOfAsset', window );">Gain (Loss) on disposition of asset</a></td>
<td class="nump">$ 87,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_MarketableSecuritiesUnrealizedLoss', window );">Unrealized loss on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,652,755<span></span>
</td>
<td class="nump">$ 8,353,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 413,189<span></span>
</td>
<td class="num">$ (2,240,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_GainLossOnDispositionOfAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_GainLossOnDispositionOfAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_MarketableSecuritiesUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_MarketableSecuritiesUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_NoteReceivableConvertedAmountConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note receivable converted, amount converted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_NoteReceivableConvertedAmountConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_NoteReceivableConvertedSharesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note receivable converted, shares received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_NoteReceivableConvertedSharesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_OdysseyGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_OdysseyGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_ScepterHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_ScepterHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300133727216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details Narrative)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Acquisition costs</a></td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=VIVK_FexixIronMember', window );">Fexix Iron [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Acquisition costs</a></td>
<td class="nump">$ 192,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=VIVK_FexixIronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=VIVK_FexixIronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300125680256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 26,856,352<span></span>
</td>
<td class="nump">$ 25,482,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">977,422<span></span>
</td>
<td class="nump">790,306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">25,878,930<span></span>
</td>
<td class="nump">24,692,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">14,998<span></span>
</td>
<td class="nump">14,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">4,956<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">10,042<span></span>
</td>
<td class="nump">10,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">36,432<span></span>
</td>
<td class="nump">48,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">22,466<span></span>
</td>
<td class="nump">26,306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">13,966<span></span>
</td>
<td class="nump">21,942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_PreciousMetalExtractionMachine1TonMember', window );">Precious Metal Extraction Machine- 1 Ton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">2,280,000<span></span>
</td>
<td class="nump">2,280,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">285,000<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">1,995,000<span></span>
</td>
<td class="nump">2,052,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_PreciousMetalExtractionMachine10TonMember', window );">Precious Metal Extraction Machine- 10 Ton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">5,320,000<span></span>
</td>
<td class="nump">5,320,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">665,000<span></span>
</td>
<td class="nump">532,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">4,655,000<span></span>
</td>
<td class="nump">4,788,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_BioreactorsMember', window );">Bioreactors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,440,000<span></span>
</td>
<td class="nump">1,440,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">1,440,000<span></span>
</td>
<td class="nump">1,440,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_NanospongeCavitationDeviceMember', window );">Nanosponge/Cavitation Device [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">22,103<span></span>
</td>
<td class="nump">22,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">22,103<span></span>
</td>
<td class="nump">22,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnit1Member', window );">Remediation Processing Unit 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">6,150,506<span></span>
</td>
<td class="nump">6,249,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">6,150,506<span></span>
</td>
<td class="nump">6,249,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnit2Member', window );">Remediation Processing Unit 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">5,489,760<span></span>
</td>
<td class="nump">5,201,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">5,489,760<span></span>
</td>
<td class="nump">5,201,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnitSystemAMember', window );">Remediation Processing Unit System A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">3,127,669<span></span>
</td>
<td class="nump">2,561,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">3,127,669<span></span>
</td>
<td class="nump">2,561,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnitSystemBMember', window );">Remediation Processing Unit System B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Carrying Amount</a></td>
<td class="nump">2,974,884<span></span>
</td>
<td class="nump">2,345,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">$ 2,974,884<span></span>
</td>
<td class="nump">$ 2,345,421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_PreciousMetalExtractionMachine1TonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_PreciousMetalExtractionMachine1TonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_PreciousMetalExtractionMachine10TonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_PreciousMetalExtractionMachine10TonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_BioreactorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_BioreactorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_NanospongeCavitationDeviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_NanospongeCavitationDeviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnit1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnit1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnit2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnit2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnitSystemAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnitSystemAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnitSystemBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=VIVK_RemediationProcessingUnitSystemBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300133824768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 195,387<span></span>
</td>
<td class="nump">$ 5,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Interest Costs Capitalized</a></td>
<td class="nump">$ 256,235<span></span>
</td>
<td class="nump">$ 822,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member] | Series C-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Stock Issued During Period, Shares, Purchase of Assets</a></td>
<td class="nump">5,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Prefered stock Series C-1 issued for a reduction in liabilities</a></td>
<td class="nump">$ 64,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=VIVK_SeriesC1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=VIVK_SeriesC1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300133830064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 851,495<span></span>
</td>
<td class="nump">$ 1,450,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Office access deposits</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">400,798<span></span>
</td>
<td class="nump">175,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnearnedPremiums', window );">Unearned revenue</a></td>
<td class="nump">69,784<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_AccruedInterestWorkingInterestRoyaltyPrograms', window );">Accrued interest (working interest royalty programs)</a></td>
<td class="nump">1,341,079<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued tax penalties and interest</a></td>
<td class="nump">398,114<span></span>
</td>
<td class="nump">398,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">$ 3,061,610<span></span>
</td>
<td class="nump">$ 2,023,985<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_AccruedInterestWorkingInterestRoyaltyPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_AccruedInterestWorkingInterestRoyaltyPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Deposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Deposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300125778928">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Loans and Notes Payable (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,814,506<span></span>
</td>
<td class="nump">$ 6,113,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Loans and notes payable, current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">962,405<span></span>
</td>
<td class="nump">1,511,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity', window );">Loans and notes payable, current attributed to variable interest entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,308,232<span></span>
</td>
<td class="nump">3,416,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_NotesAndLoansPayableNonCurrent', window );">Loans and notes payable, long term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">543,869<span></span>
</td>
<td class="nump">1,185,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_VariousPromissoryNotesAndConvertibleNotesMember', window );">Various Promissory Notes And Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,960<span></span>
</td>
<td class="nump">50,960<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_NovusCapitalGroupLLCNoteMember', window );">Novus Capital Group L L C Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">283,612<span></span>
</td>
<td class="nump">378,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_TripleTNotesMember', window );">Triple T Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">329,613<span></span>
</td>
<td class="nump">353,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_NationalBuickGMCMember', window );">National Buick G M C [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,977<span></span>
</td>
<td class="nump">19,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_VariousConvertibleBridgeNotesMember', window );">Various Convertible Bridge Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,075,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_BlueRidgeBankMember', window );">Blue Ridge Bank [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">410,200<span></span>
</td>
<td class="nump">410,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_SmallBusinessAdministrationMember', window );">Small Business Administration [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">324,267<span></span>
</td>
<td class="nump">318,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_JPMorganChaseBankMember', window );">J P Morgan Chase Bank [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">90,645<span></span>
</td>
<td class="nump">90,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_VariousPromissoryNotesMember', window );">Various Promissory Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total Notes Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,308,232<span></span>
</td>
<td class="nump">$ 3,416,379<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398. As of April 1 2022, the lender agreed to extend the maturity of the note to April 1, 2023 with an initial payment of $52,448 and approximate monthly payment of $29,432 thereafter until the note is fully paid.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">In 2021 and 2020 the Company entered into various convertible promissory notes as follows:</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_NotesAndLoansPayableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_NotesAndLoansPayableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_VariousPromissoryNotesAndConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_VariousPromissoryNotesAndConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_NovusCapitalGroupLLCNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_NovusCapitalGroupLLCNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_TripleTNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_TripleTNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_NationalBuickGMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_NationalBuickGMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_VariousConvertibleBridgeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_VariousConvertibleBridgeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_BlueRidgeBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_BlueRidgeBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_SmallBusinessAdministrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_SmallBusinessAdministrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_JPMorganChaseBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_JPMorganChaseBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_VariousPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_VariousPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300122838976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans and Notes Payable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Aggregate principal</a></td>
<td class="nump">$ 415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_PercentageOfAccrueInterest', window );">percentage of accrue interest</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_PercentageOfAccrueInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_PercentageOfAccrueInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300125841808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 180,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">370,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">304,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">16,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">872,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">93,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_PresentValueOfLeasePayments', window );">Present value of lease payments</a></td>
<td class="nump">779,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">364,103<span></span>
</td>
<td class="nump">$ 287,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_OperatingLeaseLiability1Noncurrent', window );">Operating lease liabilities, long-term</a></td>
<td class="nump">$ 414,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">2 years 4 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_OperatingLeaseLiability1Noncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_OperatingLeaseLiability1Noncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_PresentValueOfLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_PresentValueOfLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300127131184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lease payments next twelve months</a></td>
<td class="nump">$ 180,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lease payments next two months</a></td>
<td class="nump">370,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lease payments next three months</a></td>
<td class="nump">304,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lease payments next four months</a></td>
<td class="nump">16,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Lease payment</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset for operating leases</a></td>
<td class="nump">721,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 663,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense</a></td>
<td class="nump">199,170<span></span>
</td>
<td class="nump">$ 186,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_JamboreeCenterMember', window );">Jamboree Center [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lease payments next twelve months</a></td>
<td class="nump">21,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lease payments next two months</a></td>
<td class="nump">22,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lease payments next three months</a></td>
<td class="nump">23,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lease payments next four months</a></td>
<td class="nump">24,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, to be Paid, Year Five</a></td>
<td class="nump">25,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_SpeedwayCommerceCenterMember', window );">Speedway Commerce Center [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lease payments next twelve months</a></td>
<td class="nump">1,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lease payments next two months</a></td>
<td class="nump">2,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lease payments next three months</a></td>
<td class="nump">2,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_VictoryHoldingsMember', window );">Victory Holdings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lease payments next twelve months</a></td>
<td class="nump">867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lease payments next three months</a></td>
<td class="nump">3,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lease payments next four months</a></td>
<td class="nump">3,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree', window );">Lease payments next two and three months</a></td>
<td class="nump">$ 3,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_JamboreeCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_JamboreeCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_SpeedwayCommerceCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_SpeedwayCommerceCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_VictoryHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=VIVK_VictoryHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300125841712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-term Debt (Details) - Long-Term Debt [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtLineItems', window );"><strong>Extinguishment of Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal</a></td>
<td class="nump">$ 2,196,233<span></span>
</td>
<td class="nump">$ 2,196,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued interest</a></td>
<td class="nump">3,049,304<span></span>
</td>
<td class="nump">4,205,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Debt discount</a></td>
<td class="num">(219,380)<span></span>
</td>
<td class="num">(226,823)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long term debt</a></td>
<td class="nump">5,026,157<span></span>
</td>
<td class="nump">6,174,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long term debt, current</a></td>
<td class="nump">8,565<span></span>
</td>
<td class="nump">3,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt</a></td>
<td class="nump">$ 5,017,592<span></span>
</td>
<td class="nump">$ 6,171,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300134602112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Temporary Equity (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_DividendPaidInSeriesB1PreferredStock', window );">Dividend paid in Series B-1 Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesBMember', window );">Convertible Preferred Stock Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares</a></td>
<td class="nump">213,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Series B and B-1 Preferred Stock to Common Stock, shares</a></td>
<td class="num">(213,583)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(216,916)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesB1Member', window );">Convertible Preferred Stock Series B 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares</a></td>
<td class="nump">459,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Series B and B-1 Preferred Stock to Common Stock, shares</a></td>
<td class="num">(459,426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(467,728)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesC1Member', window );">Convertible Preferred Stock Series C 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, shares</a></td>
<td class="nump">260,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_DividendPaidInSeriesB1PreferredStock', window );">Dividend paid in Series B-1 Preferred Stock</a></td>
<td class="nump">5,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Series B and B-1 Preferred Stock to Common Stock, shares</a></td>
<td class="num">(266,328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(266,328)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_SerciesC1IssueForReductionInStockPayable', window );">Sercies C-1 Issue for a reduction in stock payables, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_DividendPaidInSeriesB1PreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_DividendPaidInSeriesB1PreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_SerciesC1IssueForReductionInStockPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_SerciesC1IssueForReductionInStockPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesC1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=VIVK_ConvertiblePreferredStockSeriesC1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300133834928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Noncontrolling Interest (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=VIVK_VivaWealthFundILLCMember', window );">Viva Wealth Fund I L L C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDistributionsToAffiliates', window );">Payments of Distributions to Affiliates</a></td>
<td class="nump">$ 343,889<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=VIVK_VivaWealthFundILLCMember', window );">Viva Wealth Fund I L L C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt Conversion, Converted Instrument, Amount</a></td>
<td class="nump">$ 3,025,000<span></span>
</td>
<td class="nump">$ 735,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued</a></td>
<td class="nump">605<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDistributionsToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDistributionsToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=VIVK_VivaWealthFundILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=VIVK_VivaWealthFundILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=VIVK_VivaWealthFundILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=VIVK_VivaWealthFundILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300127102032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation &amp; Warrants (Details - Assumptions)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.24%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of warrants</a></td>
<td class="text">3 years 3 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility rate</a></td>
<td class="nump">169.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.04%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of warrants</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility rate</a></td>
<td class="nump">273.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300122121056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation &amp; Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares outstanding - beginning</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price - beginning</a></td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average contractural term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 4 months 20 days<span></span>
</td>
<td class="text">5 years 10 months 28 days<span></span>
</td>
<td class="text">7 years 6 months 10 days<span></span>
</td>
<td class="text">6 years 4 months 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,112,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,667)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(240,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares outstanding - ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,506,252<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price - ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.53<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Shares exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">890,168<span></span>
</td>
<td class="nump">108,333<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="nump">47,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price - exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.74<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted average contractural term</a></td>
<td class="text">7 years 5 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">7 years 3 days<span></span>
</td>
<td class="text">3 years 4 months 17 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300125860000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation &amp; Warrants (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Option granted</a></td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="nump">$ 1,340,703<span></span>
</td>
<td class="nump">$ 223,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_VIVK_WarrantsIssued', window );">Warrants issued</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=VIVK_PublicOfferingMember', window );">Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=VIVK_EmployeesMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Option granted</a></td>
<td class="nump">1,872,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=VIVK_ShareStockAwardMember', window );">Share Stock Award [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Option granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=VIVK_StockOptionsMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="nump">$ 1,340,703<span></span>
</td>
<td class="nump">$ 223,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=VIVK_StockOptionsMember', window );">Stock Options [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Option granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=VIVK_NonStatutoryStockOptionsMember', window );">Non Statutory Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="nump">$ 855,000<span></span>
</td>
<td class="nump">$ 730,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=VIVK_NonStatutoryStockOptionsMember', window );">Non Statutory Stock Options [Member] | Board Of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Option granted</a></td>
<td class="nump">133,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=VIVK_NonStatutoryStockOptionsMember', window );">Non Statutory Stock Options [Member] | Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Option granted</a></td>
<td class="nump">333,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VIVK_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VIVK_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VIVK_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=VIVK_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=VIVK_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=VIVK_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=VIVK_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=VIVK_ShareStockAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=VIVK_ShareStockAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=VIVK_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=VIVK_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=VIVK_NonStatutoryStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=VIVK_NonStatutoryStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=VIVK_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=VIVK_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=VIVK_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=VIVK_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140300127104976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ (0)<span></span>
</td>
<td class="num">$ (296,477)<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 723,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net Operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>vivakor_s1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:VIVK="http://vivakor.com/20220630"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="vivk-20220630.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VIVK:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2022-02-132022-02-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
        </entity>
        <period>
            <startDate>2022-02-13</startDate>
            <endDate>2022-02-14</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaventuresUtsiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaventuresUtsiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaventuresRoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaventuresRoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaopportunityFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaopportunityFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:InternationalMetalsExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:InternationalMetalsExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RPCDesignAndManufacturingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">VIVK:RPCDesignAndManufacturingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RPCDesignAndManufacturingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">VIVK:RPCDesignAndManufacturingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RdmMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">VIVK:RdmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RdmMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">VIVK:RdmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_VivaWealthFundIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaWealthFundIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VivaWealthFundIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaWealthFundIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_ConvertibleSeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:ConvertibleSeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_ConvertibleSeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:ConvertibleSeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_StockOptionsGrantedToEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:StockOptionsGrantedToEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_StockOptionsGrantedToEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:StockOptionsGrantedToEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_StockOptionsGrantedToBoardMembersOrConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:StockOptionsGrantedToBoardMembersOrConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_StockOptionsGrantedToBoardMembersOrConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">VIVK:StockOptionsGrantedToBoardMembersOrConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">VIVK:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_VendorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:VendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ProfessionalServiceAgenciesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ProfessionalServiceAgenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_OdysseyGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OdysseyGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_OdysseyGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_OdysseyGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_ScepterHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_OdysseyGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:OdysseyGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2021-08-012021-08-31_custom_ScepterHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_ScepterHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_ScepterHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_ScepterHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_ScepterHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ScepterHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ScepterHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:ScepterHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_FexixIronMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">VIVK:FexixIronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PreciousMetalExtractionMachine1TonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:PreciousMetalExtractionMachine1TonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PreciousMetalExtractionMachine1TonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:PreciousMetalExtractionMachine1TonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PreciousMetalExtractionMachine10TonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:PreciousMetalExtractionMachine10TonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PreciousMetalExtractionMachine10TonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:PreciousMetalExtractionMachine10TonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BioreactorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:BioreactorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_BioreactorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:BioreactorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NanospongeCavitationDeviceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:NanospongeCavitationDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NanospongeCavitationDeviceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:NanospongeCavitationDeviceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RemediationProcessingUnit1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnit1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RemediationProcessingUnit1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnit1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RemediationProcessingUnit2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnit2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RemediationProcessingUnit2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnit2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RemediationProcessingUnitSystemAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnitSystemAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RemediationProcessingUnitSystemAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnitSystemAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RemediationProcessingUnitSystemBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnitSystemBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RemediationProcessingUnitSystemBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">VIVK:RemediationProcessingUnitSystemBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_EquipmentMember_custom_SeriesC1PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:SeriesC1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_VariousPromissoryNotesAndConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousPromissoryNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VariousPromissoryNotesAndConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousPromissoryNotesAndConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NovusCapitalGroupLLCNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:NovusCapitalGroupLLCNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NovusCapitalGroupLLCNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:NovusCapitalGroupLLCNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_TripleTNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:TripleTNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TripleTNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:TripleTNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NationalBuickGMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:NationalBuickGMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NationalBuickGMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:NationalBuickGMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_VariousConvertibleBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousConvertibleBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VariousConvertibleBridgeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousConvertibleBridgeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BlueRidgeBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:BlueRidgeBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_BlueRidgeBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:BlueRidgeBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SmallBusinessAdministrationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:SmallBusinessAdministrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SmallBusinessAdministrationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:SmallBusinessAdministrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_JPMorganChaseBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:JPMorganChaseBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_JPMorganChaseBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:JPMorganChaseBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_VariousPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VariousPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VariousPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_JamboreeCenterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:JamboreeCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-15_custom_JamboreeCenterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:JamboreeCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-15</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SpeedwayCommerceCenterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:SpeedwayCommerceCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-15_custom_SpeedwayCommerceCenterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:SpeedwayCommerceCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-15</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_VictoryHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:VictoryHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-15_custom_VictoryHoldingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">VIVK:VictoryHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-15</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_LongTermDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_LongTermDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesC1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesC1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesC1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesB1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">VIVK:ConvertiblePreferredStockSeriesB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VivaWealthFundILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">VIVK:VivaWealthFundILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember147106531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaWealthFundILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember147106531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">VIVK:VivaWealthFundILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2018-01-012018-12-31_custom_ShareStockAwardMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:ShareStockAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_StockOptionsMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember_custom_BoardOfDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:NonStatutoryStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">VIVK:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:NonStatutoryStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:NonStatutoryStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_NonStatutoryStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">VIVK:NonStatutoryStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001450704</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-06-30">0001450704</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-06-30">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-06-30">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_custom_SeriesAPreferredStocksMember"
      id="xdx2ixbrl0332"
      unitRef="Shares"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0339"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0340"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0347"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0352"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0359"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_custom_SeriesAPreferredStocksMember"
      id="xdx2ixbrl0378"
      unitRef="Shares"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:ConversionOfSeriesPreferredStockToCommonStock
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:ConversionOfSeriesPreferredStockToCommonStock
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:ConversionOfSeriesPreferredStockToCommonStock
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0406"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:ConversionOfSeriesPreferredStockToCommonStock
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0424"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0426"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0438"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0445"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0446"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0447"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0453"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0459"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_custom_SeriesAPreferredStocksMember"
      id="xdx2ixbrl0473"
      unitRef="Shares"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0492"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1
      contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1
      contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0501"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0506"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0517"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0527"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0534"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0536"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0566"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0567"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0575"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForPurchaseOfLicense
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForPurchaseOfLicense
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0584"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:CommonStockIssuedForPurchaseOfLicense
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockIssuedForConversionOfTemporaryEquityValue
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0592"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockIssuedForConversionOfTemporaryEquityValue
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0593"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockIssuedForConversionOfTemporaryEquityValue
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0594"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0599"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0601"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0602"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0603"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0606"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0608"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0609"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0610"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0614"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0616"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0620"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0627"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0628"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0629"
      unitRef="USD"
      xsi:nil="true"/>
    <VIVK:GainOnDispositionOfAsset
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0665"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0706"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-06-30"
      decimals="0"
      id="xdx2ixbrl0892"
      unitRef="USD">-41237559</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesBMember"
      id="xdx2ixbrl1341"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesB1Member"
      id="xdx2ixbrl1343"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesC1Member"
      id="xdx2ixbrl1345"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesBMember"
      id="xdx2ixbrl1368"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesB1Member"
      id="xdx2ixbrl1370"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-06-30_custom_ConvertiblePreferredStockSeriesC1Member"
      id="xdx2ixbrl1372"
      unitRef="Shares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-01-01to2022-06-30">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-06-30">VIVAKOR, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-06-30">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-06-30">26-2178141</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-06-30">4101 North Thanksgiving Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-06-30">Lehi, UT</dei:EntityAddressPostalZipCode>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-06-30">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-01-01to2022-06-30">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4908334</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1293767</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <VIVK:CashAndCashEquivalentsAttributedToVariableInterestEntity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">296257</VIVK:CashAndCashEquivalentsAttributedToVariableInterestEntity>
    <VIVK:CashAndCashEquivalentsAttributedToVariableInterestEntity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">199952</VIVK:CashAndCashEquivalentsAttributedToVariableInterestEntity>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">33000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">845</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">845</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1818029</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2231218</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:InventoryNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">222000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">192000</us-gaap:InventoryNet>
    <VIVK:PreciousMetalConcentrate contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1166709</VIVK:PreciousMetalConcentrate>
    <VIVK:PreciousMetalConcentrate contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1166709</VIVK:PreciousMetalConcentrate>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">237422</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">73245</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">8649596</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">5157736</us-gaap:AssetsCurrent>
    <us-gaap:OtherInvestments contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4000</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4000</us-gaap:OtherInvestments>
    <us-gaap:NotesReceivableRelatedParties contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1150743</us-gaap:NotesReceivableRelatedParties>
    <us-gaap:NotesReceivableRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1194235</us-gaap:NotesReceivableRelatedParties>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">25878930</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24692111</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">721550</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">663291</us-gaap:OperatingLeaseRightOfUseAsset>
    <VIVK:LicenseAgreementNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2291942</VIVK:LicenseAgreementNet>
    <VIVK:LicenseAgreementNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2370835</VIVK:LicenseAgreementNet>
    <VIVK:IntellectualPropertyNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">13002504</VIVK:IntellectualPropertyNet>
    <VIVK:IntellectualPropertyNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">13662037</VIVK:IntellectualPropertyNet>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">51699265</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">47744245</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3061610</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2023985</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">364103</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">287769</us-gaap:OperatingLeaseLiabilityCurrent>
    <VIVK:LoansAndNotesPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">962405</VIVK:LoansAndNotesPayableCurrent>
    <VIVK:LoansAndNotesPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1511447</VIVK:LoansAndNotesPayableCurrent>
    <VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2308232</VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity>
    <VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3416379</VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity>
    <us-gaap:OtherLongTermDebtCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">8565</us-gaap:OtherLongTermDebtCurrent>
    <us-gaap:OtherLongTermDebtCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3256</us-gaap:OtherLongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">6704915</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7242836</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">414947</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">434109</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesAndLoans contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">543869</us-gaap:LongTermNotesAndLoans>
    <us-gaap:LongTermNotesAndLoans contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1185970</us-gaap:LongTermNotesAndLoans>
    <us-gaap:OtherLongTermDebtNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">5017592</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">6171298</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">5156899</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">5156899</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">17838222</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">20191112</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_ConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">3400000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_ConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">3400000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">67</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">41666667</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">41666667</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">15038619</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">15038619</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">12330859</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">12330859</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">15039</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">12331</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">67857646</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">58279590</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockCarryingBasis contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">20000</us-gaap:TreasuryStockCarryingBasis>
    <us-gaap:TreasuryStockCarryingBasis contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">20000</us-gaap:TreasuryStockCarryingBasis>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-41237559</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-35731359</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">26615126</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">22540629</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">7245917</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">5012504</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33861043</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">27553133</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">51699265</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">47744245</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">22000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">117000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">20530</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">112450</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1470</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">4550</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">119252</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">125912</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">310591</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">828440</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">2922753</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1235549</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">4235560</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2309394</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">558595</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">364635</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">933813</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">727914</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">3600600</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1726096</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">5479964</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">3865748</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-3600600</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1724626</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5479964</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-3861198</us-gaap:OperatingIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-1652755</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-8949169</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-413189</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">3734275</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">6083</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1242</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">12461</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2485</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestExpenseOther
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">22981</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">241448</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">114946</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">395469</us-gaap:InterestExpenseOther>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">2456</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2456</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">39934</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">92590</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">40084</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">93884</us-gaap:OtherNonoperatingIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-1627263</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-9096785</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-473134</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">3435175</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-5227863</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-10821411</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5953098</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-426023</us-gaap:ProfitLoss>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-296477</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">800</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">723911</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-5227863</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-10524934</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5953898</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1149934</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-322546</us-gaap:IncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1114003</us-gaap:IncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-447698</us-gaap:IncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1255844</us-gaap:IncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-4905317</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-9410931</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5506200</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">105910</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-4905317</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-9410931</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5506200</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">105910</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">42196</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">42196</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-4905317</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-9453127</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5506200</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">63714</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      id="Fact000299"
      unitRef="USDPShares">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      id="Fact000300"
      unitRef="USDPShares">-0.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      id="Fact000301"
      unitRef="USDPShares">-0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      id="Fact000302"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      id="Fact000304"
      unitRef="USDPShares">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      id="Fact000305"
      unitRef="USDPShares">-0.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      id="Fact000306"
      unitRef="USDPShares">-0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      id="Fact000307"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      id="Fact000309"
      unitRef="Shares">15038619</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      id="Fact000310"
      unitRef="Shares">11966840</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      id="Fact000311"
      unitRef="Shares">14388004</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      id="Fact000312"
      unitRef="Shares">11640306</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      id="Fact000314"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      id="Fact000315"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      id="Fact000316"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      id="Fact000317"
      unitRef="Shares">910483</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      id="Fact000319"
      unitRef="Shares">15038619</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      id="Fact000320"
      unitRef="Shares">11966840</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      id="Fact000321"
      unitRef="Shares">14388004</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      id="Fact000322"
      unitRef="Shares">12550789</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15038619</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15039</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">66200971</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-20000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-36332242</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">6671402</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">36535170</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">427500</VIVK:StockOptionsIssuedForServices>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">427500</VIVK:StockOptionsIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1229175</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">1229175</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">207939</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">207939</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">1105000</VIVK:IssuanceOfNoncontrollingInterest1>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">1105000</VIVK:IssuanceOfNoncontrollingInterest1>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-4905317</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-322546</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-5227863</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15038619</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15039</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">67857646</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-20000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-41237559</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">7245917</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33861043</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">12330859</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">12331</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">58279590</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-20000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-35731359</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">5012504</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">27553133</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <VIVK:CommonStockIssuedForReductionInLiabilitiesShares
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">272156</VIVK:CommonStockIssuedForReductionInLiabilitiesShares>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">273</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1144719</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1144992</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:ConversionOfSeriesPreferredStockToCommonStockShares
      contextRef="From2022-01-012022-06-30_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      unitRef="Shares">-66667</VIVK:ConversionOfSeriesPreferredStockToCommonStockShares>
    <VIVK:ConversionOfSeriesPreferredStockToCommonStockShares
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">833333</VIVK:ConversionOfSeriesPreferredStockToCommonStockShares>
    <VIVK:ConversionOfSeriesPreferredStockToCommonStock
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">833</VIVK:ConversionOfSeriesPreferredStockToCommonStock>
    <VIVK:ConversionOfSeriesPreferredStockToCommonStock
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-766</VIVK:ConversionOfSeriesPreferredStockToCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">6238400</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">6240000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplitShares
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">2271</VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplitShares>
    <VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2</VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit>
    <VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2</VIVK:CommonStockIssuedForFractionalSharesFromReverseStockSplit>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">855000</VIVK:StockOptionsIssuedForServices>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">855000</VIVK:StockOptionsIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1340703</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1340703</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">343889</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">343889</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">3025000</VIVK:IssuanceOfNoncontrollingInterest1>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">3025000</VIVK:IssuanceOfNoncontrollingInterest1>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-5506200</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-447698</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5953898</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15038619</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15039</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">67857646</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-20000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-41237559</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">7245917</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33861043</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">11321269</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">11322</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">46818373</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-20000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-20688151</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">1137248</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">27258859</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <VIVK:CommonStockIssuedForReductionInLiabilitiesShares
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">25835</VIVK:CommonStockIssuedForReductionInLiabilitiesShares>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">26</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">228774</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">228800</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">944312</VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares>
    <VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">944</VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1>
    <VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">9384396</VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1>
    <VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">9385340</VIVK:ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">427500</VIVK:StockOptionsIssuedForServices>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">427500</VIVK:StockOptionsIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">111528</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">111528</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">735000</VIVK:IssuanceOfNoncontrollingInterest1>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">735000</VIVK:IssuanceOfNoncontrollingInterest1>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">42196</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">42196</us-gaap:DividendsPreferredStock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-9410931</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-1114003</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-10524934</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">12291416</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">12292</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">56970571</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-20000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-30141278</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">758245</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">27579897</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">11255967</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">11256</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">45623146</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-20000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-30204992</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">1279089</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">16688566</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">33667</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">34</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">437967</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">438001</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <VIVK:CommonStockIssuedForReductionInLiabilitiesShares
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">29168</VIVK:CommonStockIssuedForReductionInLiabilitiesShares>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">29</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">264771</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:CommonStockIssuedForReductionInLiabilities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">264800</VIVK:CommonStockIssuedForReductionInLiabilities>
    <VIVK:CommonStockIssuedForPurchaseOfLicenseShares
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">16667</VIVK:CommonStockIssuedForPurchaseOfLicenseShares>
    <VIVK:CommonStockIssuedForPurchaseOfLicense
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">17</VIVK:CommonStockIssuedForPurchaseOfLicense>
    <VIVK:CommonStockIssuedForPurchaseOfLicense
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">224983</VIVK:CommonStockIssuedForPurchaseOfLicense>
    <VIVK:CommonStockIssuedForPurchaseOfLicense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">225000</VIVK:CommonStockIssuedForPurchaseOfLicense>
    <VIVK:StockIssuedForConversionOfTemporaryEquityShares
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">955947</VIVK:StockIssuedForConversionOfTemporaryEquityShares>
    <VIVK:StockIssuedForConversionOfTemporaryEquityValue
      contextRef="From2021-01-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">956</VIVK:StockIssuedForConversionOfTemporaryEquityValue>
    <VIVK:StockIssuedForConversionOfTemporaryEquityValue
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">9466648</VIVK:StockIssuedForConversionOfTemporaryEquityValue>
    <VIVK:StockIssuedForConversionOfTemporaryEquityValue
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">9467604</VIVK:StockIssuedForConversionOfTemporaryEquityValue>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">730000</VIVK:StockOptionsIssuedForServices>
    <VIVK:StockOptionsIssuedForServices
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">730000</VIVK:StockOptionsIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-01-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">223056</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">223056</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">735000</VIVK:IssuanceOfNoncontrollingInterest1>
    <VIVK:IssuanceOfNoncontrollingInterest1
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">735000</VIVK:IssuanceOfNoncontrollingInterest1>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">42196</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">42196</us-gaap:DividendsPreferredStock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">105910</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-1255844</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1149934</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      unitRef="Shares">66667</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">12291416</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">12292</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">56970571</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="0"
      unitRef="USD">-20000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-30141278</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">758245</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">27579897</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5953898</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1149934</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">933813</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">727914</us-gaap:DepreciationAndAmortization>
    <VIVK:CommonStockOptionsIssuedForServices
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">855000</VIVK:CommonStockOptionsIssuedForServices>
    <VIVK:CommonStockOptionsIssuedForServices
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">730000</VIVK:CommonStockOptionsIssuedForServices>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">438001</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <VIVK:GainOnDispositionOfAsset
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2456</VIVK:GainOnDispositionOfAsset>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-413189</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">3734275</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-0</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-711070</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1340703</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">223055</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-6515</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">30000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">164177</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-13807</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-303452</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-412764</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">12461</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2485</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">114946</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">395469</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-2808793</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-2053627</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">55953</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">10329</us-gaap:PaymentsToAcquireIntangibleAssets>
    <VIVK:PaymentsToAcquireIntangibleAssets1
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-0</VIVK:PaymentsToAcquireIntangibleAssets1>
    <VIVK:PaymentsToAcquireIntangibleAssets1
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">40000</VIVK:PaymentsToAcquireIntangibleAssets1>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">6000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1129515</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1334123</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-1067562</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1384452</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">7735</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1968261</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">6666811</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">6240000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">277145</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2464</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">343889</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">7587227</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">6656612</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">3710872</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">3218533</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1493719</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">398904</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">5204591</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">3617437</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">223639</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">46936</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <VIVK:ConversionOfSeriesBB1AndC1PreferredStockToCommonStock
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1200000</VIVK:ConversionOfSeriesBB1AndC1PreferredStockToCommonStock>
    <VIVK:ConversionOfSeriesBB1AndC1PreferredStockToCommonStock
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">9467604</VIVK:ConversionOfSeriesBB1AndC1PreferredStockToCommonStock>
    <VIVK:CommonStockIssuedForReductionInLiabilitiesCashFlow
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1144992</VIVK:CommonStockIssuedForReductionInLiabilitiesCashFlow>
    <VIVK:CommonStockIssuedForReductionInLiabilitiesCashFlow
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">264800</VIVK:CommonStockIssuedForReductionInLiabilitiesCashFlow>
    <VIVK:NoncontrollingInterestIssuedForReductionInLiabilities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">3025000</VIVK:NoncontrollingInterestIssuedForReductionInLiabilities>
    <VIVK:NoncontrollingInterestIssuedForReductionInLiabilities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">735000</VIVK:NoncontrollingInterestIssuedForReductionInLiabilities>
    <VIVK:PreferredStockSeriesC1IssuedForReductionInLiabilities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</VIVK:PreferredStockSeriesC1IssuedForReductionInLiabilities>
    <VIVK:PreferredStockSeriesC1IssuedForReductionInLiabilities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">64950</VIVK:PreferredStockSeriesC1IssuedForReductionInLiabilities>
    <VIVK:CommonStockIssuedForPurchaseOfLicenses
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">0</VIVK:CommonStockIssuedForPurchaseOfLicenses>
    <VIVK:CommonStockIssuedForPurchaseOfLicenses
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">225000</VIVK:CommonStockIssuedForPurchaseOfLicenses>
    <VIVK:CapitalizedInterestOnConstructionInProcess
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">256235</VIVK:CapitalizedInterestOnConstructionInProcess>
    <VIVK:CapitalizedInterestOnConstructionInProcess
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">822700</VIVK:CapitalizedInterestOnConstructionInProcess>
    <VIVK:DividendPaidInSeriesB1PreferredStock
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">0</VIVK:DividendPaidInSeriesB1PreferredStock>
    <VIVK:DividendPaidInSeriesB1PreferredStock
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Shares">42196</VIVK:DividendPaidInSeriesB1PreferredStock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80A_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zm8QuDLsXGm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 1. &lt;span id="xdx_826_z6AiZ2euZXUb"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 14, 2022, we effected a &lt;span id="xdx_903_eus-gaap--StockholdersEquityReverseStockSplit_c20220213__20220214_zYmWYrQCccNd" title="Stockholders' Equity, Reverse Stock Split"&gt;1-for-30 reverse
split&lt;/span&gt; of our outstanding shares of common stock (the &#x201c;Reverse Stock Split&#x201d;) via the filing of a certificate of change with
the Nevada Secretary of State which was effective at the commencement of trading of our Common Stock. No fractional shares of the Company&#x2019;s
common stock will be issued as a result of the Reverse Stock Split. Any fractional shares resulting from the Reverse Stock Split will
be rounded up to the nearest whole share. All issued and outstanding common stock, preferred stock, and per share amounts in the consolidated
financial statements and footnotes included herein have been retroactively adjusted to reflect this reverse stock split for all periods
presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--Covid19PolicyTextBlock_zmUb4pmZhvbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zSHu0pmwRcOg"&gt;COVID-19&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 11, 2020, the World Health Organization
(&#x201c;WHO&#x201d;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the
pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets.
Most U.S. states and many countries have issued policies intended to stop or slow the further spread of the disease.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;COVID-19 and the U.S. response to the pandemic
are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may
have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent
of the effects on the economy, the markets we serve, our business, or our operations. In March 2020 we temporarily suspended operations
in Kuwait and Utah due to COVID-19 government restrictions, Utah has resumed operations in full. Kuwait has allowed for the Company to
obtain site personnel visas to recommence operations. These suspensions have had a negative impact on our business and there can be no
guaranty that we will not need to suspend operations again in the future as a result of the pandemic.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--InterimFinancialInformationPolicyTextBlock_zotbl60NRihj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z9fVd7QJJoZ8"&gt;Interim Financial Information&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated
financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;).
Certain information and disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have
been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the related notes for the year ended December 31, 2021. The unaudited condensed consolidated financial
statements have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and
include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation
of the condensed consolidated financial statements. The operating results for the three and six months ended June 30, 2022 are not necessarily
indicative of the results expected for the full year ending December&#160;31, 2022.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zqnXUeDr7KFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_z9df4Z4o31td"&gt;Principles of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company follows ASC 810-10-15 guidance with
respect to accounting for Variable Interest Entities (&#x201c;VIE&#x201d;). A VIE is an entity that does not have sufficient equity at risk
to finance its activities without additional subordinated financial support from other parties, or whose equity investors lack any of
the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will absorb portions
of a VIE&#x2019;s expected losses or receive portions of the entity&#x2019;s expected residual returns. For the six months ended June 30,
2022 and year ended December 31, 2021 the following entities are considered to be a VIE and are consolidated in our consolidated financial
statements: Viva Wealth Fund I, LLC and RPC Design and Manufacturing, LLC. For the six months ended June 30, 2022 and year ended December
31, 2021 the following entities were considered to be a VIE, but were not consolidated in our consolidated financial statements due to
a lack of the power criterion or the losses/benefits criterion: Vivaventures UTS I, LLC, Vivaventures Royalty II, LLC, Vivaopportunity
Fund, LLC, and International Metals Exchange, LLC. For the six months ended June 30, 2022 and year ended December 31, 2021 the unaudited
financial information for the unconsolidated VIEs is as follows: Vivaventures UTSI, LLC held assets of $&lt;span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z2o3hEUb6w0a" title="Assets"&gt;3,383,610&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z6T8semNZ3vi" title="Assets"&gt;3,753,296&lt;/span&gt; (where
the primary asset represents a receivable from the Company), and liabilities of $&lt;span id="xdx_901_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z8cbapUzlpN2" title="Liabilities"&gt;47,049&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_zcgzT2SrUQAa" title="Liabilities"&gt;12,608&lt;/span&gt;. Vivaventures Royalty II, LLC held
assets of $&lt;span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zFhbvhtZZ4T1" title="Assets"&gt;2,939,498&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_z1ZiBuNmonS8" title="Assets"&gt;2,648,810&lt;/span&gt; (where the primary asset represents a receivable from the Company), and liabilities of $&lt;span id="xdx_908_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zx0CEuhEdJC3" title="Liabilities"&gt;1,720&lt;/span&gt; and
$&lt;span id="xdx_90B_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zZJUXjRbSsb8" title="Liabilities"&gt;300&lt;/span&gt;. Vivaopportunity Fund LLC held assets of $&lt;span id="xdx_905_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zYd31ctlAAW2" title="Assets"&gt;2,119,856&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zmk5Cqdjf6Mf" title="Assets"&gt;2,119,961&lt;/span&gt; (where the primary asset represents a noncontrolling interest
in units of a consolidated entity of the Company) and &lt;span id="xdx_907_eus-gaap--Liabilities_iI_p0p0_do_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_zVdQSlVqDwUe" title="Liabilities"&gt;no&lt;/span&gt; liabilities. International Metals Exchange, LLC held assets of $&lt;span id="xdx_901_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zRs8H2qSmrd1" title="Assets"&gt;29,938&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zmcLlfgBGRtk" title="Assets"&gt;30,461&lt;/span&gt;
and liabilities of $&lt;span id="xdx_90E_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zkYw4uKIohil" title="Liabilities"&gt;&lt;span id="xdx_907_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zBQtyH2mXEPb" title="Liabilities"&gt;1,900&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;RPC Design and Manufacturing, LLC: &lt;/b&gt;As of
June 30, 2022 and year ended December 31, 2021, investors in RDM have a noncontrolling interest of $&lt;span id="xdx_90A_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zOk4yYA9pdj4" title="Noncontrolling Interest in Variable Interest Entity"&gt;387,049&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zNzqjbbprw72" title="Noncontrolling Interest in Variable Interest Entity"&gt;629,694&lt;/span&gt;, respectively.
As of June 30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are not restricted and can be used to settle the
obligations of the reporting entity. As of June 30, 2022 and December 31, 2021 this VIE has an outstanding note payable to the reporting
entity in the amount of $&lt;span id="xdx_90B_eus-gaap--NotesPayable_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zLmmA2qpxP45" title="Notes Payable"&gt;628,828&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--NotesPayable_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zW58xCpAuV7a" title="Notes Payable"&gt;354,566&lt;/span&gt;, which is eliminated upon consolidation. We have the primary risk (expense) exposure in
financing and operating the assets and are responsible for 100% of the operation, maintenance and any unfunded capital expenditures, which
ultimately could be 100% of a custom machine, and the decisions related to those expenditures including budgeting, financing and dispatch
of power. Based on all these facts, it was determined that we are the primary beneficiary of RDM. Therefore, RDM has been consolidated
by the Company. Any intercompany revenue and expense associated with RDM and its license agreement with the Company has been eliminated
in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Viva Wealth Fund I, LLC:&lt;/b&gt; As of June
30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are restricted solely for the use of proceeds of the VWFI
offering (to manufacture RPCs) and cannot be used to settle the obligations of the reporting entity. As of June 30, 2022 and
December 31, 2021, the Company has cash attributed to variable interest entities of $&lt;span id="xdx_90E_ecustom--CashAttributableToVie_c20220630__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zAcm7UDg2Bnj" title="Cash attributable to VIE"&gt;296,257&lt;/span&gt;
and $&lt;span id="xdx_904_ecustom--CashAttributableToVie_c20211231__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zs0SOaTeO44" title="Cash attributable to VIE"&gt;199,952&lt;/span&gt;.
As of June 30, 2022, VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI has
commenced fundraising for RPC Series B. In the event that VWFI does not raise at least $6,250,000 for these RPC Series by the
offering termination date (which date has been extended until November 13, 2022), then the convertible notes and/or units would
convert into Vivakor common stock where the minimum conversion price will be the greater of $13.50 or a 10% discount to market per
share or in the event of a public offering, 200% of the per share price of the Company common stock sold in the underwritten
offering, which was closed on February 14, 2022 at $5.00 per share. As of August 8, 2022, VWFI has raised approximately $4,690,000
for RPC Series B. VWFI unit holders may also sell their units to the Company for their principal investment amount on the
3&lt;sup&gt;rd&lt;/sup&gt;, 4&lt;sup&gt;th&lt;/sup&gt;, and 5&lt;sup&gt;th&lt;/sup&gt; anniversary of the offering termination date, which if this option were
exercised, the Company may elect to pay the amount in either cash or common stock. The Company also has the option to purchase any
LLC units where the members did not exercise their conversion option under the same terms and pricing for cash or common stock. VWFI
has entered into a license agreement with the Company indicating that VWFI will pay the Company a license fee of $1,000,000 per
series of equipment manufactured with the Company&#x2019;s proprietary technology, however these transactions are eliminated upon consolidation. All of the operations of VWFI relate to private
placement offering to fund and manufacture proprietary equipment for the Company, as intended in VWFI&#x2019;s design and
organization by the Company, so that the Company controls VWFI in its business purpose, use of proceeds, and selling and leasing of
its equipment solely to the Company. Creditors of VWFI have no recourse to the general credit of the Company. We have the primary
risk (expense) exposure in financing and operating the assets and are responsible for 100% of the operation, and any unfunded
capital expenditures, and the expense to the unit holders in conversion to common stock if series of equipment cannot be fully
funded, which ultimately could be 100% of any custom machine. By request of the fund manager, we are responsible for the decisions
related to the expenditures of VWFI proceeds including budgeting, financing and dispatch of power surrounding the series of
equipment. Based on all these facts, it was determined that we are the primary beneficiary of VWFI. Therefore, VWFI has been
consolidated by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxp3SdopEgQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_z6WL2RG9nXhc"&gt;Long Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company reviews the carrying values of
its long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount may not
be recoverable. If the expected future cash flow from the use of the asset and its eventual disposition is less than the carrying
amount of the asset, an impairment loss is recognized and measured using the fair value of the related asset. No impairment charges
were incurred during the six months ended June 30, 2022 or for the year ended December 31, 2021, as the Company was still in the
early phases of our business plan and operating losses were expected in our early phases. On March 11, 2020, the World Health
Organization (&#x201c;WHO&#x201d;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on
human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the
global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow the further spread of
the disease. We have observed supply chain disruptions from the COVID-19 pandemic that has contributed to delays in the completion
of the manufacturing of our RPCs, although we do not believe that these delays have constituted a triggering event for impairment of
our assets. Our Kuwait operations were suspended to comply with the social distancing measures implemented in Kuwait, but in 2022
has allowed for the Company to obtain site personnel visas to recommence operations. Our Utah operations were temporarily
suspended from March through May 2020, but have since resumed in full in its manufacturing of its RPCs, and construction and implementation of site and infrastructure preparations
in anticipation of commencing operations in 2022. There can be no assurance, however, that market conditions
will not change or demand for the Company&#x2019;s services will continue, which could result in impairment of long-lived assets in
the future.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zG8Hd8tNjjJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zaOLyLvhpbC3"&gt;Intangible Assets&lt;/span&gt;:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We account for intangible assets in accordance
with ASC 350 &lt;i&gt;&#x201c;Intangibles-Goodwill and Other&#x201d;&lt;/i&gt; (&#x201c;ASC 350&#x201d;). Intangible asset amounts represent the acquisition
date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income
approach, discounting projected future cash flows based on management&#x2019;s expectations of the current and future operating environment.
The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure
and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over
their useful lives, which have historically ranged from &lt;span id="xdx_90E_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zGHlcVy4gfxc" title="Amortized useful lives"&gt;10&lt;/span&gt; to &lt;span id="xdx_902_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zudsMyNvjh91" title="Amortized useful lives"&gt;20&lt;/span&gt; years. The carrying amounts of our definite-lived intangible assets are
evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset&#x2019;s
carrying amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We assess our intangible assets in accordance
with ASC 360 &#x201c;&lt;i&gt;Property, Plant, and Equipment&lt;/i&gt;&#x201d; (&#x201c;ASC 360&#x201d;). Impairment testing is required when events occur
that indicate an asset group may not be recoverable (&#x201c;triggering events&#x201d;). As detailed in ASC 360-10-35-21, the following
are examples of such events or changes in circumstances (sometimes referred to as impairment indicators or triggers): (a) A significant
decrease in the market price of a long-lived asset (asset group) (b) A significant adverse change in the extent or manner in which a long-lived
asset (asset group) is being used or in its physical condition. (c) A significant adverse change in legal factors or in the business climate
that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator (d) An accumulation
of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group)
(e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast
that demonstrates continuing losses associated with the use of a long-lived asset (asset group) (f) A current expectation that, more likely
than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated
useful life. The term more likely than not refers to a level of likelihood that is more than 50 percent. We have evaluated our intangible
assets and found that certain losses and a delay in our business plan may have constituted a triggering event for our intangible assets.
We performed an analysis and assessed that there was no impairment for the six months ended June 30, 2022 or for the year ended December
31, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zQFG8YdEw9qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zCouQEPJifTg"&gt;Advertising Expense&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Advertising costs are expensed as incurred. The
Company did not incur advertising expense for the six months ended June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_ztPUYJOPyPHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zxSUTsALF6k8"&gt;Net Income/Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Basic net income (loss) per share is
calculated by subtracting any preferred interest distributions from net income (loss), all divided by the weighted-average number of
common shares outstanding for the period, without consideration for common stock equivalents. Diluted net income (loss) per common
share is computed by dividing the net income (loss) by the weighted-average number of common share equivalents outstanding for the
period determined using the treasury stock method if their effect is dilutive. Potential dilutive instruments as of June 30, 2022
and 2021 include the following: convertible notes payable convertible into approximately &lt;span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_z230ycvlsUm8" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;14,560&lt;/span&gt;
and &lt;span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_zpJ8pjmTnxBd" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;227,150&lt;/span&gt;
shares of common stock, convertible Series A preferred stock convertible into &lt;span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dn_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_z2Gg4kwHWWs6" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;none&lt;/span&gt;
and &lt;span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_pdd_zZGsZb1q3Ofl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;666,667&lt;/span&gt;
shares of common stock (due to the event of a public offering of the Company&#x2019;s common stock in February 2022 this will convert
to 833,333 shares), stock options granted to employees of &lt;span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_zvfdEGoUbjAh" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;2,039,585&lt;/span&gt;
and &lt;span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_z6K1YxdZvHEl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;183,333&lt;/span&gt;
shares of common stock. Stock options granted to Board members or consultants of &lt;span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_pdd_z8arP4CFkbg" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;&lt;span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_zgHW5X6Bzx49" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;466,667&lt;/span&gt;&lt;/span&gt;
shares of common stock were granted as of June 30, 2022 and 2021. There were also warrants issued and outstanding to EF Hutton of &lt;span id="xdx_902_ecustom--WarrantsIssued_c20220630_pdd_zgksOOGqoxB4" title="Warrants issued"&gt;&lt;span id="xdx_908_ecustom--WarrantsOutstanding_c20220630_pdd_zZkNi3aJvfQ7" title="Warrants outstanding"&gt;80,000&lt;/span&gt;&lt;/span&gt;
shares of common stock as of June 30, 2022.  These warrants were related to and granted during the close of the
underwritten public offering in February 2022&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_841_eus-gaap--UseOfEstimates_z8bIuBoo4VGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zyAI2qP3N3lc"&gt;Use of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America requires management to make estimates, judgments, and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes. We believe our critical accounting estimates
relate to the following: Recoverability of current and noncurrent assets, revenue recognition, stock-based compensation, income taxes,
effective interest rates related to long-term debt, marketable securities, cost basis and equity method investments, lease assets and
liabilities, equity method investments, valuation of stock used to acquire assets, and derivatives.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;While our estimates and assumptions are based
on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates
and assumptions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWB2ZFyKT0Bc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zQ8hpDlc8Xh2"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company follows Accounting Standards Codification
(&#x201c;ASC&#x201d;) 820, &#x201c;Fair Value Measurements and Disclosures&#x201d; (&#x201c;ASC 820&#x201d;), for assets and liabilities measured
at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value, and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#x2019;s financial position
or operating results but did expand certain disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 820 defines fair value as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of
unobservable inputs. These inputs are prioritized below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 1: Applies to assets or liabilities for
which there are quoted prices in active markets for identical assets or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 2: Applies to assets or liabilities for
which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 3: Applies to assets or liabilities for
which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets
or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board&#x2019;s (&#x201c;FASB&#x201d;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement. The carrying amounts reported in the consolidated balance sheets for marketable
securities are classified as Level 1 assets due to observable quoted prices for identical assets in active markets. The carrying amounts
reported in the consolidated balance sheets for cash, prepaid expenses and other current assets, accounts payable and accrued expenses
approximate their estimated fair market values based on the short-term maturity of these instruments. T&lt;span style="background-color: white"&gt;he
recorded values of notes payable approximate their current fair values because of their nature, rates, and respective maturity dates or
durations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2022-02-132022-02-14">1-for-30 reverse
split</us-gaap:StockholdersEquityReverseStockSplit>
    <VIVK:Covid19PolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_846_ecustom--Covid19PolicyTextBlock_zmUb4pmZhvbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zSHu0pmwRcOg"&gt;COVID-19&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 11, 2020, the World Health Organization
(&#x201c;WHO&#x201d;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the
pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets.
Most U.S. states and many countries have issued policies intended to stop or slow the further spread of the disease.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;COVID-19 and the U.S. response to the pandemic
are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may
have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent
of the effects on the economy, the markets we serve, our business, or our operations. In March 2020 we temporarily suspended operations
in Kuwait and Utah due to COVID-19 government restrictions, Utah has resumed operations in full. Kuwait has allowed for the Company to
obtain site personnel visas to recommence operations. These suspensions have had a negative impact on our business and there can be no
guaranty that we will not need to suspend operations again in the future as a result of the pandemic.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</VIVK:Covid19PolicyTextBlock>
    <VIVK:InterimFinancialInformationPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_849_ecustom--InterimFinancialInformationPolicyTextBlock_zotbl60NRihj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z9fVd7QJJoZ8"&gt;Interim Financial Information&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated
financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;).
Certain information and disclosures normally included in consolidated financial statements prepared in accordance with U.S. GAAP have
been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the related notes for the year ended December 31, 2021. The unaudited condensed consolidated financial
statements have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and
include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation
of the condensed consolidated financial statements. The operating results for the three and six months ended June 30, 2022 are not necessarily
indicative of the results expected for the full year ending December&#160;31, 2022.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</VIVK:InterimFinancialInformationPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zqnXUeDr7KFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_z9df4Z4o31td"&gt;Principles of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company follows ASC 810-10-15 guidance with
respect to accounting for Variable Interest Entities (&#x201c;VIE&#x201d;). A VIE is an entity that does not have sufficient equity at risk
to finance its activities without additional subordinated financial support from other parties, or whose equity investors lack any of
the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will absorb portions
of a VIE&#x2019;s expected losses or receive portions of the entity&#x2019;s expected residual returns. For the six months ended June 30,
2022 and year ended December 31, 2021 the following entities are considered to be a VIE and are consolidated in our consolidated financial
statements: Viva Wealth Fund I, LLC and RPC Design and Manufacturing, LLC. For the six months ended June 30, 2022 and year ended December
31, 2021 the following entities were considered to be a VIE, but were not consolidated in our consolidated financial statements due to
a lack of the power criterion or the losses/benefits criterion: Vivaventures UTS I, LLC, Vivaventures Royalty II, LLC, Vivaopportunity
Fund, LLC, and International Metals Exchange, LLC. For the six months ended June 30, 2022 and year ended December 31, 2021 the unaudited
financial information for the unconsolidated VIEs is as follows: Vivaventures UTSI, LLC held assets of $&lt;span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z2o3hEUb6w0a" title="Assets"&gt;3,383,610&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z6T8semNZ3vi" title="Assets"&gt;3,753,296&lt;/span&gt; (where
the primary asset represents a receivable from the Company), and liabilities of $&lt;span id="xdx_901_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_z8cbapUzlpN2" title="Liabilities"&gt;47,049&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresUtsiMember_p0p0_zcgzT2SrUQAa" title="Liabilities"&gt;12,608&lt;/span&gt;. Vivaventures Royalty II, LLC held
assets of $&lt;span id="xdx_906_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zFhbvhtZZ4T1" title="Assets"&gt;2,939,498&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_z1ZiBuNmonS8" title="Assets"&gt;2,648,810&lt;/span&gt; (where the primary asset represents a receivable from the Company), and liabilities of $&lt;span id="xdx_908_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zx0CEuhEdJC3" title="Liabilities"&gt;1,720&lt;/span&gt; and
$&lt;span id="xdx_90B_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaventuresRoyaltyMember_p0p0_zZJUXjRbSsb8" title="Liabilities"&gt;300&lt;/span&gt;. Vivaopportunity Fund LLC held assets of $&lt;span id="xdx_905_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zYd31ctlAAW2" title="Assets"&gt;2,119,856&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_p0p0_zmk5Cqdjf6Mf" title="Assets"&gt;2,119,961&lt;/span&gt; (where the primary asset represents a noncontrolling interest
in units of a consolidated entity of the Company) and &lt;span id="xdx_907_eus-gaap--Liabilities_iI_p0p0_do_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--VivaopportunityFundMember_zVdQSlVqDwUe" title="Liabilities"&gt;no&lt;/span&gt; liabilities. International Metals Exchange, LLC held assets of $&lt;span id="xdx_901_eus-gaap--Assets_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zRs8H2qSmrd1" title="Assets"&gt;29,938&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--Assets_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zmcLlfgBGRtk" title="Assets"&gt;30,461&lt;/span&gt;
and liabilities of $&lt;span id="xdx_90E_eus-gaap--Liabilities_c20220630__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zkYw4uKIohil" title="Liabilities"&gt;&lt;span id="xdx_907_eus-gaap--Liabilities_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember__dei--LegalEntityAxis__custom--InternationalMetalsExchangeMember_p0p0_zBQtyH2mXEPb" title="Liabilities"&gt;1,900&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;RPC Design and Manufacturing, LLC: &lt;/b&gt;As of
June 30, 2022 and year ended December 31, 2021, investors in RDM have a noncontrolling interest of $&lt;span id="xdx_90A_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zOk4yYA9pdj4" title="Noncontrolling Interest in Variable Interest Entity"&gt;387,049&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--NoncontrollingInterestInVariableInterestEntity_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RPCDesignAndManufacturingLLCMember_p0p0_zNzqjbbprw72" title="Noncontrolling Interest in Variable Interest Entity"&gt;629,694&lt;/span&gt;, respectively.
As of June 30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are not restricted and can be used to settle the
obligations of the reporting entity. As of June 30, 2022 and December 31, 2021 this VIE has an outstanding note payable to the reporting
entity in the amount of $&lt;span id="xdx_90B_eus-gaap--NotesPayable_c20220630__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zLmmA2qpxP45" title="Notes Payable"&gt;628,828&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--NotesPayable_c20211231__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--RdmMember_p0p0_zW58xCpAuV7a" title="Notes Payable"&gt;354,566&lt;/span&gt;, which is eliminated upon consolidation. We have the primary risk (expense) exposure in
financing and operating the assets and are responsible for 100% of the operation, maintenance and any unfunded capital expenditures, which
ultimately could be 100% of a custom machine, and the decisions related to those expenditures including budgeting, financing and dispatch
of power. Based on all these facts, it was determined that we are the primary beneficiary of RDM. Therefore, RDM has been consolidated
by the Company. Any intercompany revenue and expense associated with RDM and its license agreement with the Company has been eliminated
in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Viva Wealth Fund I, LLC:&lt;/b&gt; As of June
30, 2022 and December 31, 2021, the cash and cash equivalents of this VIE are restricted solely for the use of proceeds of the VWFI
offering (to manufacture RPCs) and cannot be used to settle the obligations of the reporting entity. As of June 30, 2022 and
December 31, 2021, the Company has cash attributed to variable interest entities of $&lt;span id="xdx_90E_ecustom--CashAttributableToVie_c20220630__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zAcm7UDg2Bnj" title="Cash attributable to VIE"&gt;296,257&lt;/span&gt;
and $&lt;span id="xdx_904_ecustom--CashAttributableToVie_c20211231__dei--LegalEntityAxis__custom--VivaWealthFundIMember_p0p0_zs0SOaTeO44" title="Cash attributable to VIE"&gt;199,952&lt;/span&gt;.
As of June 30, 2022, VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI has
commenced fundraising for RPC Series B. In the event that VWFI does not raise at least $6,250,000 for these RPC Series by the
offering termination date (which date has been extended until November 13, 2022), then the convertible notes and/or units would
convert into Vivakor common stock where the minimum conversion price will be the greater of $13.50 or a 10% discount to market per
share or in the event of a public offering, 200% of the per share price of the Company common stock sold in the underwritten
offering, which was closed on February 14, 2022 at $5.00 per share. As of August 8, 2022, VWFI has raised approximately $4,690,000
for RPC Series B. VWFI unit holders may also sell their units to the Company for their principal investment amount on the
3&lt;sup&gt;rd&lt;/sup&gt;, 4&lt;sup&gt;th&lt;/sup&gt;, and 5&lt;sup&gt;th&lt;/sup&gt; anniversary of the offering termination date, which if this option were
exercised, the Company may elect to pay the amount in either cash or common stock. The Company also has the option to purchase any
LLC units where the members did not exercise their conversion option under the same terms and pricing for cash or common stock. VWFI
has entered into a license agreement with the Company indicating that VWFI will pay the Company a license fee of $1,000,000 per
series of equipment manufactured with the Company&#x2019;s proprietary technology, however these transactions are eliminated upon consolidation. All of the operations of VWFI relate to private
placement offering to fund and manufacture proprietary equipment for the Company, as intended in VWFI&#x2019;s design and
organization by the Company, so that the Company controls VWFI in its business purpose, use of proceeds, and selling and leasing of
its equipment solely to the Company. Creditors of VWFI have no recourse to the general credit of the Company. We have the primary
risk (expense) exposure in financing and operating the assets and are responsible for 100% of the operation, and any unfunded
capital expenditures, and the expense to the unit holders in conversion to common stock if series of equipment cannot be fully
funded, which ultimately could be 100% of any custom machine. By request of the fund manager, we are responsible for the decisions
related to the expenditures of VWFI proceeds including budgeting, financing and dispatch of power surrounding the series of
equipment. Based on all these facts, it was determined that we are the primary beneficiary of VWFI. Therefore, VWFI has been
consolidated by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:Assets
      contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember"
      decimals="0"
      unitRef="USD">3383610</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember"
      decimals="0"
      unitRef="USD">3753296</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember"
      decimals="0"
      unitRef="USD">47049</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresUtsiMember"
      decimals="0"
      unitRef="USD">12608</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember"
      decimals="0"
      unitRef="USD">2939498</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember"
      decimals="0"
      unitRef="USD">2648810</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember"
      decimals="0"
      unitRef="USD">1720</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaventuresRoyaltyMember"
      decimals="0"
      unitRef="USD">300</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember"
      decimals="0"
      unitRef="USD">2119856</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember"
      decimals="0"
      unitRef="USD">2119961</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_VivaopportunityFundMember"
      decimals="0"
      unitRef="USD">0</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember"
      decimals="0"
      unitRef="USD">29938</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember"
      decimals="0"
      unitRef="USD">30461</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="AsOf2022-06-30_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember"
      decimals="0"
      unitRef="USD">1900</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2021-12-31_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_custom_InternationalMetalsExchangeMember"
      decimals="0"
      unitRef="USD">1900</us-gaap:Liabilities>
    <us-gaap:NoncontrollingInterestInVariableInterestEntity
      contextRef="AsOf2022-06-30_custom_RPCDesignAndManufacturingLLCMember"
      decimals="0"
      unitRef="USD">387049</us-gaap:NoncontrollingInterestInVariableInterestEntity>
    <us-gaap:NoncontrollingInterestInVariableInterestEntity
      contextRef="AsOf2021-12-31_custom_RPCDesignAndManufacturingLLCMember"
      decimals="0"
      unitRef="USD">629694</us-gaap:NoncontrollingInterestInVariableInterestEntity>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_RdmMember"
      decimals="0"
      unitRef="USD">628828</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_RdmMember"
      decimals="0"
      unitRef="USD">354566</us-gaap:NotesPayable>
    <VIVK:CashAttributableToVie
      contextRef="AsOf2022-06-30_custom_VivaWealthFundIMember"
      decimals="0"
      unitRef="USD">296257</VIVK:CashAttributableToVie>
    <VIVK:CashAttributableToVie
      contextRef="AsOf2021-12-31_custom_VivaWealthFundIMember"
      decimals="0"
      unitRef="USD">199952</VIVK:CashAttributableToVie>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_84B_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zxp3SdopEgQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_z6WL2RG9nXhc"&gt;Long Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company reviews the carrying values of
its long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount may not
be recoverable. If the expected future cash flow from the use of the asset and its eventual disposition is less than the carrying
amount of the asset, an impairment loss is recognized and measured using the fair value of the related asset. No impairment charges
were incurred during the six months ended June 30, 2022 or for the year ended December 31, 2021, as the Company was still in the
early phases of our business plan and operating losses were expected in our early phases. On March 11, 2020, the World Health
Organization (&#x201c;WHO&#x201d;) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on
human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the
global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow the further spread of
the disease. We have observed supply chain disruptions from the COVID-19 pandemic that has contributed to delays in the completion
of the manufacturing of our RPCs, although we do not believe that these delays have constituted a triggering event for impairment of
our assets. Our Kuwait operations were suspended to comply with the social distancing measures implemented in Kuwait, but in 2022
has allowed for the Company to obtain site personnel visas to recommence operations. Our Utah operations were temporarily
suspended from March through May 2020, but have since resumed in full in its manufacturing of its RPCs, and construction and implementation of site and infrastructure preparations
in anticipation of commencing operations in 2022. There can be no assurance, however, that market conditions
will not change or demand for the Company&#x2019;s services will continue, which could result in impairment of long-lived assets in
the future.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_846_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zG8Hd8tNjjJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zaOLyLvhpbC3"&gt;Intangible Assets&lt;/span&gt;:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We account for intangible assets in accordance
with ASC 350 &lt;i&gt;&#x201c;Intangibles-Goodwill and Other&#x201d;&lt;/i&gt; (&#x201c;ASC 350&#x201d;). Intangible asset amounts represent the acquisition
date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income
approach, discounting projected future cash flows based on management&#x2019;s expectations of the current and future operating environment.
The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure
and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over
their useful lives, which have historically ranged from &lt;span id="xdx_90E_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zGHlcVy4gfxc" title="Amortized useful lives"&gt;10&lt;/span&gt; to &lt;span id="xdx_902_ecustom--AmortizedUsefulLives_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zudsMyNvjh91" title="Amortized useful lives"&gt;20&lt;/span&gt; years. The carrying amounts of our definite-lived intangible assets are
evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset&#x2019;s
carrying amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We assess our intangible assets in accordance
with ASC 360 &#x201c;&lt;i&gt;Property, Plant, and Equipment&lt;/i&gt;&#x201d; (&#x201c;ASC 360&#x201d;). Impairment testing is required when events occur
that indicate an asset group may not be recoverable (&#x201c;triggering events&#x201d;). As detailed in ASC 360-10-35-21, the following
are examples of such events or changes in circumstances (sometimes referred to as impairment indicators or triggers): (a) A significant
decrease in the market price of a long-lived asset (asset group) (b) A significant adverse change in the extent or manner in which a long-lived
asset (asset group) is being used or in its physical condition. (c) A significant adverse change in legal factors or in the business climate
that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator (d) An accumulation
of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group)
(e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast
that demonstrates continuing losses associated with the use of a long-lived asset (asset group) (f) A current expectation that, more likely
than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated
useful life. The term more likely than not refers to a level of likelihood that is more than 50 percent. We have evaluated our intangible
assets and found that certain losses and a delay in our business plan may have constituted a triggering event for our intangible assets.
We performed an analysis and assessed that there was no impairment for the six months ended June 30, 2022 or for the year ended December
31, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <VIVK:AmortizedUsefulLives contextRef="From2022-01-012022-06-30_srt_MinimumMember">P10Y</VIVK:AmortizedUsefulLives>
    <VIVK:AmortizedUsefulLives contextRef="From2022-01-012022-06-30_srt_MaximumMember">P20Y</VIVK:AmortizedUsefulLives>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_84B_eus-gaap--AdvertisingCostsPolicyTextBlock_zQFG8YdEw9qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zCouQEPJifTg"&gt;Advertising Expense&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Advertising costs are expensed as incurred. The
Company did not incur advertising expense for the six months ended June 30, 2022 and 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_ztPUYJOPyPHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zxSUTsALF6k8"&gt;Net Income/Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Basic net income (loss) per share is
calculated by subtracting any preferred interest distributions from net income (loss), all divided by the weighted-average number of
common shares outstanding for the period, without consideration for common stock equivalents. Diluted net income (loss) per common
share is computed by dividing the net income (loss) by the weighted-average number of common share equivalents outstanding for the
period determined using the treasury stock method if their effect is dilutive. Potential dilutive instruments as of June 30, 2022
and 2021 include the following: convertible notes payable convertible into approximately &lt;span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_z230ycvlsUm8" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;14,560&lt;/span&gt;
and &lt;span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd_zpJ8pjmTnxBd" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;227,150&lt;/span&gt;
shares of common stock, convertible Series A preferred stock convertible into &lt;span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dn_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_z2Gg4kwHWWs6" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;none&lt;/span&gt;
and &lt;span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleSeriesAPreferredStockMember_pdd_zZGsZb1q3Ofl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;666,667&lt;/span&gt;
shares of common stock (due to the event of a public offering of the Company&#x2019;s common stock in February 2022 this will convert
to 833,333 shares), stock options granted to employees of &lt;span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_zvfdEGoUbjAh" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;2,039,585&lt;/span&gt;
and &lt;span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToEmployeesMember_pdd_z6K1YxdZvHEl" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;183,333&lt;/span&gt;
shares of common stock. Stock options granted to Board members or consultants of &lt;span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_pdd_z8arP4CFkbg" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;&lt;span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsGrantedToBoardMembersOrConsultantsMember_zgHW5X6Bzx49" title="Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"&gt;466,667&lt;/span&gt;&lt;/span&gt;
shares of common stock were granted as of June 30, 2022 and 2021. There were also warrants issued and outstanding to EF Hutton of &lt;span id="xdx_902_ecustom--WarrantsIssued_c20220630_pdd_zgksOOGqoxB4" title="Warrants issued"&gt;&lt;span id="xdx_908_ecustom--WarrantsOutstanding_c20220630_pdd_zZkNi3aJvfQ7" title="Warrants outstanding"&gt;80,000&lt;/span&gt;&lt;/span&gt;
shares of common stock as of June 30, 2022.  These warrants were related to and granted during the close of the
underwritten public offering in February 2022&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      unitRef="Shares">14560</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-06-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="INF"
      unitRef="Shares">227150</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-06-30_custom_ConvertibleSeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-06-30_custom_ConvertibleSeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">666667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-06-30_custom_StockOptionsGrantedToEmployeesMember"
      decimals="INF"
      unitRef="Shares">2039585</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-06-30_custom_StockOptionsGrantedToEmployeesMember"
      decimals="INF"
      unitRef="Shares">183333</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-06-30_custom_StockOptionsGrantedToBoardMembersOrConsultantsMember"
      decimals="INF"
      unitRef="Shares">466667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-06-30_custom_StockOptionsGrantedToBoardMembersOrConsultantsMember"
      decimals="INF"
      unitRef="Shares">466667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <VIVK:WarrantsIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">80000</VIVK:WarrantsIssued>
    <VIVK:WarrantsOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">80000</VIVK:WarrantsOutstanding>
    <us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_841_eus-gaap--UseOfEstimates_z8bIuBoo4VGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zyAI2qP3N3lc"&gt;Use of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America requires management to make estimates, judgments, and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes. We believe our critical accounting estimates
relate to the following: Recoverability of current and noncurrent assets, revenue recognition, stock-based compensation, income taxes,
effective interest rates related to long-term debt, marketable securities, cost basis and equity method investments, lease assets and
liabilities, equity method investments, valuation of stock used to acquire assets, and derivatives.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;While our estimates and assumptions are based
on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates
and assumptions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zWB2ZFyKT0Bc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zQ8hpDlc8Xh2"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company follows Accounting Standards Codification
(&#x201c;ASC&#x201d;) 820, &#x201c;Fair Value Measurements and Disclosures&#x201d; (&#x201c;ASC 820&#x201d;), for assets and liabilities measured
at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value, and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company&#x2019;s financial position
or operating results but did expand certain disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 820 defines fair value as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of
unobservable inputs. These inputs are prioritized below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 1: Applies to assets or liabilities for
which there are quoted prices in active markets for identical assets or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 2: Applies to assets or liabilities for
which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 3: Applies to assets or liabilities for
which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets
or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board&#x2019;s (&#x201c;FASB&#x201d;) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement. The carrying amounts reported in the consolidated balance sheets for marketable
securities are classified as Level 1 assets due to observable quoted prices for identical assets in active markets. The carrying amounts
reported in the consolidated balance sheets for cash, prepaid expenses and other current assets, accounts payable and accrued expenses
approximate their estimated fair market values based on the short-term maturity of these instruments. T&lt;span style="background-color: white"&gt;he
recorded values of notes payable approximate their current fair values because of their nature, rates, and respective maturity dates or
durations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <VIVK:LiquidityTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80C_ecustom--LiquidityTextBlock_zR2qfSqXzjjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 2. &lt;span id="xdx_82A_zpzYYcebaCqg"&gt;Liquidity&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We have historically suffered net losses and
cumulative negative cash flows from operations, and as of June 30, 2022, we had an accumulated deficit of approximately $&lt;span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_dixL_c20220630_z54LArkHhmH7" title="::XDX::41237559"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0892"&gt;41.3&lt;/span&gt;&lt;/span&gt;
million. As of June 30, 2022 we had cash of $&lt;span id="xdx_90A_eus-gaap--Cash_c20220630_p0p0_zr82MY5vHU0c" title="Cash"&gt;5,204,591&lt;/span&gt;. The
Company closed an underwritten public offering of &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_pdd_zThpA8p2eQ6k" title="Stock Issued During Period, Shares, New Issues"&gt;1,600,000&lt;/span&gt;
shares of common stock, at a public offering price of $5.00 per share, for aggregate gross proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn3n3_dm_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_ztKjmbHillFk" title="Proceeds from Issuance or Sale of Equity"&gt;8&lt;/span&gt;
million, prior to deducting underwriting discounts, commissions, and other offering expenses. Prior to the offering, we financed our
operations primarily through debt financing, private equity offerings our working interest agreements. We believe we have other
liquid assets that may be used to assist in financing the operations of the Company if needed, including marketable securities in
Scepter, which hold a fair value $&lt;span id="xdx_902_eus-gaap--MarketableSecurities_c20220630_p0p0_zyaP5djUik16" title="Marketable Securities"&gt;1,818,029&lt;/span&gt;
as of June 30, 2022 and have been deposited for trading. We believe the liquid assets from the Company&#x2019;s available for sale
investments and funding provided from subsequent fundraising activities (see Note 15) of the Company give it adequate working
capital to finance our day-to-day operations for at least twelve months through August 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</VIVK:LiquidityTextBlock>
    <us-gaap:Cash contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">5204591</us-gaap:Cash>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-06-30_custom_PublicOfferingMember"
      decimals="INF"
      unitRef="Shares">1600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2022-01-012022-06-30_custom_PublicOfferingMember"
      decimals="-3"
      unitRef="USD">8000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:MarketableSecurities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1818029</us-gaap:MarketableSecurities>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_804_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zMjYp3admClk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 3. &lt;span id="xdx_82E_zf0w36s7VPKa"&gt;Prepaid Expenses and Other Assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2022 and December 31, 2021, our
other assets mainly consist of various deposits with vendors, professional service agents, or security deposits on office and warehouse
leases. As of June 30, 2022 and December 31, 2021 we had office and warehouse lease deposits in the amount of $&lt;span id="xdx_908_eus-gaap--LeaseDepositLiability_iI_p0p0_c20220630_zgCu3B0RAJu6" title="Office and warehouse lease deposits"&gt;61,676&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--LeaseDepositLiability_iI_p0p0_c20211231_zeIDaGedv2M" title="Office and warehouse lease deposits"&gt;73,245&lt;/span&gt;. As
of June 30, 2022 we had deposits in the amounts of $&lt;span id="xdx_903_eus-gaap--Deposits_iI_p0p0_c20220630__srt--CounterpartyNameAxis__custom--VendorMember_z59yXTtEWYg6" title="Deposits"&gt;161,458&lt;/span&gt; with vendors, professional service agencies, and a reclamation bond with the
Utah Division of Oil, Gas and Mining in the amount of $&lt;span id="xdx_905_eus-gaap--Deposits_iI_c20220630__dei--LegalEntityAxis__custom--ProfessionalServiceAgenciesMember_zgGHQRNADA14" title="Deposits"&gt;14,288&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:LeaseDepositLiability contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">61676</us-gaap:LeaseDepositLiability>
    <us-gaap:LeaseDepositLiability contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">73245</us-gaap:LeaseDepositLiability>
    <us-gaap:Deposits
      contextRef="AsOf2022-06-30_custom_VendorMember"
      decimals="0"
      unitRef="USD">161458</us-gaap:Deposits>
    <us-gaap:Deposits
      contextRef="AsOf2022-06-30_custom_ProfessionalServiceAgenciesMember"
      decimals="0"
      unitRef="USD">14288</us-gaap:Deposits>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_803_eus-gaap--MarketableSecuritiesTextBlock_zoyFWqjzhPtd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 4. &lt;span id="xdx_82F_z7EOymzRyjdj"&gt;Marketable Securities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2020, the Company owned &lt;span id="xdx_902_eus-gaap--InvestmentOwnedBalanceShares_iI_c20201231__dei--LegalEntityAxis__custom--OdysseyGroupMember_zUQUUogOiea" title="Investment Owned, Balance, Shares"&gt;3,309,758&lt;/span&gt;
shares of common stock in Odyssey Group International, Inc. (&#x201c;Odyssey&#x201d;) ticker: ODYY, OTC Markets. In December 2021 we
sold such shares of Odyssey in a private transaction for a purchase price of $&lt;span id="xdx_905_eus-gaap--ProceedsFromSaleOfOtherInvestments_p0p0_c20210101__20211231__dei--LegalEntityAxis__custom--OdysseyGroupMember_zOF04fy5iek5" title="Proceeds from Sale of Other Investments"&gt;860,491&lt;/span&gt;,
with $10,000 cash delivered at signing and a note issued in favor of Vivakor in the amount of $850,491, reflecting the market price
at that time. The Company accounted for such securities based on the quoted price from the OTC Markets where the stock is traded,
which resulted in the Company recording an unrealized loss of $&lt;span id="xdx_90B_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220101__20220630__dei--LegalEntityAxis__custom--OdysseyGroupMember_p0p0_z11Taujp06s4" title="Unrealized gain on marketable securities"&gt;595,392&lt;/span&gt;
on these marketable securities for the three months ended June 30, 2021 compared to an unrealized gain of $&lt;span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_p0p0_c20210101__20210630__dei--LegalEntityAxis__custom--OdysseyGroupMember_zGLpxUY2yIb7" title="Unrealized gain on marketable securities"&gt;1,494,275&lt;/span&gt;
for the six months ended June 30, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In 2019 the Company had an investment of $&lt;span id="xdx_90F_eus-gaap--MarketableSecurities_c20191231__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z4XIBa2qvn6" title="Marketable securities"&gt;800,000&lt;/span&gt;
or &lt;span id="xdx_90E_eus-gaap--InvestmentOwnedBalanceShares_c20191231__dei--LegalEntityAxis__custom--OdysseyGroupMember_pdd_zOHqQwlN8p5e" title="Investment Owned, Balance, Shares"&gt;800,000,000&lt;/span&gt; shares of common stock, or a diluted 23% equity holding in Scepter Holdings, Inc. (&#x201c;Scepter&#x201d;), ticker: BRZL,
OTC Markets. In the fourth quarter of 2020, the Company was diluted to a 19% equity holding in Scepter, and was no longer deemed to have
significant influence and ceased to be an equity investment, and as the stock is traded on an active market, the Company has classified
the investment as marketable securities with the change in unrealized gains and losses on the investment included in the statement of
operations for the three months ended June 30, 2022 and 2021. In August 2021 we converted $&lt;span id="xdx_900_ecustom--NoteReceivableConvertedAmountConverted_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zqKGwnXf3yje" title="Note receivable converted, amount converted"&gt;81,768&lt;/span&gt; of our note receivable with Scepter
into &lt;span id="xdx_905_ecustom--NoteReceivableConvertedSharesReceived_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_pdd_z7RIkNvxFcQ2" title="Note receivable converted, shares received"&gt;26,376,882&lt;/span&gt; shares of Scepter common stock pursuant to the terms of the note at $0.0031 per share. On the date of the conversion,
the Scepter price per share on OTC Markets was $0.0062 per share, which resulted in a $&lt;span id="xdx_905_ecustom--GainLossOnDispositionOfAsset_c20210801__20210831__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z19EhPiXhivc" title="Gain (Loss) on disposition of asset"&gt;87,044&lt;/span&gt; gain on the disposition of the note receivable.
The Company has accounted for such securities based on the quoted price from the OTC Markets where the stock is traded, which resulted
in the Company recording an unrealized loss on marketable securities of $&lt;span id="xdx_90D_ecustom--MarketableSecuritiesUnrealizedLoss_p0p0_c20220401__20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zoMSoaA6KtC9" title="Unrealized loss on marketable securities"&gt;1,652,755&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--MarketableSecuritiesUnrealizedLoss_p0p0_c20210401__20210630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zTTFF3gF594b" title="Unrealized loss on marketable securities"&gt;8,353,777&lt;/span&gt; for the three months ended June 30,
2022 and 2021 compared to an unrealized gain (loss) of $(&lt;span id="xdx_90C_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220101__20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_zDdVifC58Uxb"&gt;413,189&lt;/span&gt;) and &lt;span id="xdx_903_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20210101__20210630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_z4M10TZFGmgj" title="Unrealized gain on marketable securities"&gt;2,240,000&lt;/span&gt; for the six months ended June 30, 2022 and 2021. As of
June 30, 2022 and December 31, 2021, the Company&#x2019;s Chief Executive Officer has an immediate family member who sits on the board
of directors of Scepter Holdings, Inc. As of June 30, 2022 and December 31, 2021 our Scepter marketable securities were valued at $&lt;span id="xdx_901_eus-gaap--MarketableSecurities_c20220630__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zYtuLO4jk4Qb" title="Marketable securities"&gt;1,818,029&lt;/span&gt;
and $&lt;span id="xdx_908_eus-gaap--MarketableSecurities_c20211231__dei--LegalEntityAxis__custom--ScepterHoldingsMember_p0p0_zE7DozMKfY0d" title="Marketable securities"&gt;2,231,218&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2022 and December 31, 2021, marketable
securities were $&lt;span id="xdx_906_eus-gaap--MarketableSecurities_iI_p0p0_c20220630_zJLko8huBQ8g" title="Marketable securities"&gt;1,818,029&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--MarketableSecurities_c20211231_p0p0_zkESzF69woL8" title="Marketable securities"&gt;2,231,218&lt;/span&gt;. For the three months ended June 30, 2022 and 2021, the Company recorded a total unrealized
loss of $&lt;span id="xdx_90F_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220401__20220630_zsaHpJY8Egy2" title="Unrealized gain (loss) on marketable securities"&gt;1,652,755&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20210401__20210630_zgL9ZjrxAeCb" title="Unrealized gain (loss) on marketable securities"&gt;8,949,169&lt;/span&gt; compared to an unrealized gain (loss) of $(&lt;span id="xdx_906_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_iN_p0p0_di_c20220101__20220630_zojWJgTjhH57" title="Unrealized gain (loss) on marketable securities"&gt;413,189&lt;/span&gt;) and $&lt;span id="xdx_90E_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_p0p0_c20210101__20210630_zGjBsA86hMP4" title="Unrealized gain (loss) on marketable securities"&gt;3,734,275&lt;/span&gt; for the six months ended June 30,
2022 and 2021 on marketable securities in the statement of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2020-12-31_custom_OdysseyGroupMember"
      decimals="INF"
      unitRef="Shares">3309758</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:ProceedsFromSaleOfOtherInvestments
      contextRef="From2021-01-012021-12-31_custom_OdysseyGroupMember"
      decimals="0"
      unitRef="USD">860491</us-gaap:ProceedsFromSaleOfOtherInvestments>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-01-012022-06-30_custom_OdysseyGroupMember"
      decimals="0"
      unitRef="USD">595392</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-01-012021-06-30_custom_OdysseyGroupMember"
      decimals="0"
      unitRef="USD">1494275</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2019-12-31_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">800000</us-gaap:MarketableSecurities>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="AsOf2019-12-31_custom_OdysseyGroupMember"
      decimals="INF"
      unitRef="Shares">800000000</us-gaap:InvestmentOwnedBalanceShares>
    <VIVK:NoteReceivableConvertedAmountConverted
      contextRef="From2021-08-012021-08-31_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">81768</VIVK:NoteReceivableConvertedAmountConverted>
    <VIVK:NoteReceivableConvertedSharesReceived
      contextRef="From2021-08-012021-08-31_custom_ScepterHoldingsMember"
      decimals="INF"
      unitRef="Shares">26376882</VIVK:NoteReceivableConvertedSharesReceived>
    <VIVK:GainLossOnDispositionOfAsset
      contextRef="From2021-08-012021-08-31_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">87044</VIVK:GainLossOnDispositionOfAsset>
    <VIVK:MarketableSecuritiesUnrealizedLoss
      contextRef="From2022-04-012022-06-30_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">1652755</VIVK:MarketableSecuritiesUnrealizedLoss>
    <VIVK:MarketableSecuritiesUnrealizedLoss
      contextRef="From2021-04-012021-06-30_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">8353777</VIVK:MarketableSecuritiesUnrealizedLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-01-012022-06-30_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">-413189</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-01-012021-06-30_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">2240000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2022-06-30_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">1818029</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="AsOf2021-12-31_custom_ScepterHoldingsMember"
      decimals="0"
      unitRef="USD">2231218</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1818029</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2231218</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-1652755</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-8949169</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-413189</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">3734275</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zELX63TQvcx9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 5. &lt;span id="xdx_820_zo4Rm3nSUR82"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2022, inventories consist primarily
of raw materials (including tar-sand stockpiles) and finished goods (which includes Fenix iron). The tar-sand stockpiles consist of 10,000
tons of tar sand stockpile and are anticipated to be used for our extraction remediation units. The stockpiles were acquired  when the
Company entered into a land lease agreement for located in Vernal, Utah. Under the terms of the lease agreement, we are required to pay
$3 per ton of oil sands processed. As a condition of the lease, we were required to provide $&lt;span id="xdx_907_eus-gaap--InventoryGross_c20220630_p0p0_zClkGJhlsIza" title="Acquisition costs"&gt;30,000&lt;/span&gt; toward initial tonnage of oil sands
to be processed at a cost of approximately $3.00 per ton. The nano Fenix Iron are finished goods that have a 20-year shelf life and were
acquired at cost for $&lt;span id="xdx_906_eus-gaap--InventoryGross_c20220630__us-gaap--PublicUtilitiesInventoryAxis__custom--FexixIronMember_p0p0_zHpJndrNfTdb" title="Acquisition costs"&gt;192,000&lt;/span&gt;. As of December 31, 2021, inventories consist primarily of the Fenix Iron. Inventories are valued at the
lower of cost or market (net realizable value).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:InventoryGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">30000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="AsOf2022-06-30_custom_FexixIronMember"
      decimals="0"
      unitRef="USD">192000</us-gaap:InventoryGross>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_ziQG7cPHjXci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 6. &lt;span id="xdx_828_zmhcyio93ON6"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth the components
of the Company&#x2019;s property and equipment at June 30, 2022 and December 31, 2021:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2VouumbI78a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B2_zfpfffVN8IWj"&gt;&lt;b style="display: none"&gt;Schedule of property and equipment, net&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Gross Carrying Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Book Value&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Gross Carrying Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Book Value&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zXsTdBFv7A82" style="width: 9%; text-align: right" title="Gross Carrying Amount"&gt;14,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_ztsodYoAlDS7" style="width: 9%; text-align: right" title="Accumulated Depreciation"&gt;4,956&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zKDUNcCru1Ae" style="width: 9%; text-align: right" title="Net Book Value"&gt;10,042&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zwZoazTA265c" style="width: 9%; text-align: right" title="Gross Carrying Amount"&gt;14,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zZ32mg0fJoph" style="width: 9%; text-align: right" title="Accumulated Depreciation"&gt;4,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zTEZpDpq3pbg" style="width: 9%; text-align: right" title="Net Book Value"&gt;10,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zO3NMe7osB13" style="text-align: right" title="Gross Carrying Amount"&gt;36,432&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zzdsjQQI7Yrb" style="text-align: right" title="Accumulated Depreciation"&gt;22,466&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJcxKhnqMXI3" style="text-align: right" title="Net Book Value"&gt;13,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zQ7Atriy3ty5" style="text-align: right" title="Gross Carrying Amount"&gt;48,248&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zs4lyMhyDwCl" style="text-align: right" title="Accumulated Depreciation"&gt;26,306&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJiDuUxZkWlf" style="text-align: right" title="Net Book Value"&gt;21,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Precious metal extraction machine- 1 ton&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zDImJSQSDh21" style="text-align: right" title="Gross Carrying Amount"&gt;2,280,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_z73m4qTCp8G4" style="text-align: right" title="Accumulated Depreciation"&gt;285,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zM5iBjaCpX2k" style="text-align: right" title="Net Book Value"&gt;1,995,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zX9vOTirupF5" style="text-align: right" title="Gross Carrying Amount"&gt;2,280,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zAqk24U083Xh" style="text-align: right" title="Accumulated Depreciation"&gt;228,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zUMBjG2ealYl" style="text-align: right" title="Net Book Value"&gt;2,052,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Precious metal extraction machine- 10 ton&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjzX9DFslNB4" style="text-align: right" title="Gross Carrying Amount"&gt;5,320,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjJ9QBZL87ki" style="text-align: right" title="Accumulated Depreciation"&gt;665,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zNHVOC2qsKt2" style="text-align: right" title="Net Book Value"&gt;4,655,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziCbgB3CRISh" style="text-align: right" title="Gross Carrying Amount"&gt;5,320,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zGJsbcYm4Brd" style="text-align: right" title="Accumulated Depreciation"&gt;532,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziupEQjHeSUc" style="text-align: right" title="Net Book Value"&gt;4,788,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Construction in process:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Bioreactors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zJX1X1YDdlw8" style="text-align: right" title="Gross Carrying Amount"&gt;1,440,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zKd0tIPryxtc" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zFy7Rvv1hcfi" style="text-align: right" title="Net Book Value"&gt;1,440,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_z1sLTW6Ec5Ze" style="text-align: right" title="Gross Carrying Amount"&gt;1,440,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zrBrr6A9lt93" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zM8388fJ0ha4" style="text-align: right" title="Net Book Value"&gt;1,440,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Nanosponge/Cavitation device&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zmmmxcWILue5" style="text-align: right" title="Gross Carrying Amount"&gt;22,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zZUGBTB2qjY8" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zhUHhWKdewvc" style="text-align: right" title="Net Book Value"&gt;22,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zrUWkianZiK1" style="text-align: right" title="Gross Carrying Amount"&gt;22,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zk6VRcYKrGD4" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_z6yOp7eYdBrl" style="text-align: right" title="Net Book Value"&gt;22,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Remediation Processing Unit 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zeIkaFnaAKR1" style="text-align: right" title="Gross Carrying Amount"&gt;6,150,506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zCX1aiNqEGqa" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZMmvd885d8" style="text-align: right" title="Net Book Value"&gt;6,150,506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zsDLMwebAPq4" style="text-align: right" title="Gross Carrying Amount"&gt;6,249,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zZsCox1rJwq6" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZxCujJsnja" style="text-align: right" title="Net Book Value"&gt;6,249,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Remediation Processing Unit 2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zr0N7y1krw3" style="text-align: right" title="Gross Carrying Amount"&gt;5,489,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_zOByhnGe0ZV7" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zRybXBi4WELc" style="text-align: right" title="Net Book Value"&gt;5,489,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zo5UFZhZQLcf" style="text-align: right" title="Gross Carrying Amount"&gt;5,201,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_z7B01AbNxsp7" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zS3MUtfSXfGk" style="text-align: right" title="Net Book Value"&gt;5,201,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Remediation Processing Unit System A&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_z0PNkNXNpk4e" style="text-align: right" title="Gross Carrying Amount"&gt;3,127,669&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zeUXjLuOgc23" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zxDfHTqZr6t6" style="text-align: right" title="Net Book Value"&gt;3,127,669&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_ziBd0YMbc491" style="text-align: right" title="Gross Carrying Amount"&gt;2,561,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zIJwLOa1H1kj" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zpJkUOxoJTv3" style="text-align: right" title="Net Book Value"&gt;2,561,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Remediation Processing Unit System B&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zOhklpW21nZc" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;2,974,884&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zMZNkCzJUfp5" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zIhvL2LbZjwg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Book Value"&gt;2,974,884&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zhiecAo2mir2" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;2,345,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zxm7PcP0WyYg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zRzPCPCaoJJa" style="border-bottom: Black 1pt solid; text-align: right" title="Net Book Value"&gt;2,345,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total fixed assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_p0p0_zBX0bIt5wCHl" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;26,856,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_p0p0_zq6uh0KQ3Tg3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation"&gt;977,422&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_p0p0_zZRzQLEF55de" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value"&gt;25,878,930&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_p0p0_zKul4tOLeumh" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;25,482,417&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231_p0p0_zRxKJns9Bnxl" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation"&gt;790,306&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_p0p0_zAj7QFC1voIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value"&gt;24,692,111&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the year ended December 31, 2021 the
Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__us-gaap--StatementClassOfStockAxis__custom--SeriesC1PreferredStockMember_pdd_zVN7UGsnFFK2"&gt;5,413 &lt;/span&gt;shares
of Series C-1 Preferred Stock value at $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_c20220101__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember__us-gaap--StatementClassOfStockAxis__custom--SeriesC1PreferredStockMember_p0p0_zVbQq5ShOaNa" title="Prefered stock Series C-1 issued for a reduction in liabilities"&gt;64,950&lt;/span&gt;
for equipment, which has been valued based on similar cash purchases of the Series C-1 Preferred Stock at approximately $12.00 per
share. For the six months ended June 30, 2022 and 2021 depreciation expense was $&lt;span id="xdx_90B_eus-gaap--Depreciation_c20220101__20220630_p0p0_zfeAExnfrpL1"&gt;195,387 &lt;/span&gt;and
$&lt;span id="xdx_90D_eus-gaap--Depreciation_c20210101__20210630_p0p0_zcdDqjRUEiO"&gt;5,781&lt;/span&gt;. For the  six months ended June 30, 2022 and 2021
capitalized interest to equipment from debt financing was $&lt;span id="xdx_90F_eus-gaap--InterestCostsCapitalized_p0p0_c20220101__20220630_zcy0jFqlcZQ4"&gt;256,235 &lt;/span&gt;and
$&lt;span id="xdx_904_eus-gaap--InterestCostsCapitalized_p0p0_c20210101__20210630_z2b9QiBcygvf"&gt;822,700&lt;/span&gt;. Equipment that is
currently being manufactured is considered construction in process and is not depreciated until the equipment is placed into
service.&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2VouumbI78a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B2_zfpfffVN8IWj"&gt;&lt;b style="display: none"&gt;Schedule of property and equipment, net&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Gross Carrying Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Book Value&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Gross Carrying Amount&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Book Value&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zXsTdBFv7A82" style="width: 9%; text-align: right" title="Gross Carrying Amount"&gt;14,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_ztsodYoAlDS7" style="width: 9%; text-align: right" title="Accumulated Depreciation"&gt;4,956&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zKDUNcCru1Ae" style="width: 9%; text-align: right" title="Net Book Value"&gt;10,042&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zwZoazTA265c" style="width: 9%; text-align: right" title="Gross Carrying Amount"&gt;14,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zZ32mg0fJoph" style="width: 9%; text-align: right" title="Accumulated Depreciation"&gt;4,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_p0p0_zTEZpDpq3pbg" style="width: 9%; text-align: right" title="Net Book Value"&gt;10,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zO3NMe7osB13" style="text-align: right" title="Gross Carrying Amount"&gt;36,432&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zzdsjQQI7Yrb" style="text-align: right" title="Accumulated Depreciation"&gt;22,466&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJcxKhnqMXI3" style="text-align: right" title="Net Book Value"&gt;13,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zQ7Atriy3ty5" style="text-align: right" title="Gross Carrying Amount"&gt;48,248&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zs4lyMhyDwCl" style="text-align: right" title="Accumulated Depreciation"&gt;26,306&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_p0p0_zJiDuUxZkWlf" style="text-align: right" title="Net Book Value"&gt;21,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Precious metal extraction machine- 1 ton&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zDImJSQSDh21" style="text-align: right" title="Gross Carrying Amount"&gt;2,280,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_z73m4qTCp8G4" style="text-align: right" title="Accumulated Depreciation"&gt;285,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zM5iBjaCpX2k" style="text-align: right" title="Net Book Value"&gt;1,995,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zX9vOTirupF5" style="text-align: right" title="Gross Carrying Amount"&gt;2,280,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zAqk24U083Xh" style="text-align: right" title="Accumulated Depreciation"&gt;228,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine1TonMember_p0p0_zUMBjG2ealYl" style="text-align: right" title="Net Book Value"&gt;2,052,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Precious metal extraction machine- 10 ton&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjzX9DFslNB4" style="text-align: right" title="Gross Carrying Amount"&gt;5,320,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zjJ9QBZL87ki" style="text-align: right" title="Accumulated Depreciation"&gt;665,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zNHVOC2qsKt2" style="text-align: right" title="Net Book Value"&gt;4,655,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziCbgB3CRISh" style="text-align: right" title="Gross Carrying Amount"&gt;5,320,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_zGJsbcYm4Brd" style="text-align: right" title="Accumulated Depreciation"&gt;532,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PreciousMetalExtractionMachine10TonMember_p0p0_ziupEQjHeSUc" style="text-align: right" title="Net Book Value"&gt;4,788,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Construction in process:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Bioreactors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zJX1X1YDdlw8" style="text-align: right" title="Gross Carrying Amount"&gt;1,440,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zKd0tIPryxtc" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zFy7Rvv1hcfi" style="text-align: right" title="Net Book Value"&gt;1,440,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_z1sLTW6Ec5Ze" style="text-align: right" title="Gross Carrying Amount"&gt;1,440,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_zrBrr6A9lt93" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BioreactorsMember_p0p0_zM8388fJ0ha4" style="text-align: right" title="Net Book Value"&gt;1,440,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Nanosponge/Cavitation device&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zmmmxcWILue5" style="text-align: right" title="Gross Carrying Amount"&gt;22,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zZUGBTB2qjY8" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zhUHhWKdewvc" style="text-align: right" title="Net Book Value"&gt;22,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_zrUWkianZiK1" style="text-align: right" title="Gross Carrying Amount"&gt;22,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_zk6VRcYKrGD4" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--NanospongeCavitationDeviceMember_p0p0_z6yOp7eYdBrl" style="text-align: right" title="Net Book Value"&gt;22,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Remediation Processing Unit 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zeIkaFnaAKR1" style="text-align: right" title="Gross Carrying Amount"&gt;6,150,506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zCX1aiNqEGqa" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZMmvd885d8" style="text-align: right" title="Net Book Value"&gt;6,150,506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zsDLMwebAPq4" style="text-align: right" title="Gross Carrying Amount"&gt;6,249,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_zZsCox1rJwq6" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit1Member_p0p0_zYZxCujJsnja" style="text-align: right" title="Net Book Value"&gt;6,249,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Remediation Processing Unit 2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zr0N7y1krw3" style="text-align: right" title="Gross Carrying Amount"&gt;5,489,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_zOByhnGe0ZV7" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zRybXBi4WELc" style="text-align: right" title="Net Book Value"&gt;5,489,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zo5UFZhZQLcf" style="text-align: right" title="Gross Carrying Amount"&gt;5,201,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_z7B01AbNxsp7" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnit2Member_p0p0_zS3MUtfSXfGk" style="text-align: right" title="Net Book Value"&gt;5,201,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Remediation Processing Unit System A&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_z0PNkNXNpk4e" style="text-align: right" title="Gross Carrying Amount"&gt;3,127,669&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zeUXjLuOgc23" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zxDfHTqZr6t6" style="text-align: right" title="Net Book Value"&gt;3,127,669&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_ziBd0YMbc491" style="text-align: right" title="Gross Carrying Amount"&gt;2,561,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_zIJwLOa1H1kj" style="text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemAMember_p0p0_zpJkUOxoJTv3" style="text-align: right" title="Net Book Value"&gt;2,561,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Remediation Processing Unit System B&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zOhklpW21nZc" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;2,974,884&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zMZNkCzJUfp5" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zIhvL2LbZjwg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Book Value"&gt;2,974,884&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zhiecAo2mir2" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount"&gt;2,345,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_p0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_zxm7PcP0WyYg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Depreciation"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RemediationProcessingUnitSystemBMember_p0p0_zRzPCPCaoJJa" style="border-bottom: Black 1pt solid; text-align: right" title="Net Book Value"&gt;2,345,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total fixed assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20220630_p0p0_zBX0bIt5wCHl" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;26,856,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20220630_p0p0_zq6uh0KQ3Tg3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation"&gt;977,422&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20220630_p0p0_zZRzQLEF55de" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value"&gt;25,878,930&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_p0p0_zKul4tOLeumh" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount"&gt;25,482,417&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231_p0p0_zRxKJns9Bnxl" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Depreciation"&gt;790,306&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_p0p0_zAj7QFC1voIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value"&gt;24,692,111&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">14998</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">4956</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">10042</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">14998</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">4000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">10998</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">36432</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">22466</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">13966</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">48248</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">26306</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">21942</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine1TonMember"
      decimals="0"
      unitRef="USD">2280000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine1TonMember"
      decimals="0"
      unitRef="USD">285000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine1TonMember"
      decimals="0"
      unitRef="USD">1995000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine1TonMember"
      decimals="0"
      unitRef="USD">2280000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine1TonMember"
      decimals="0"
      unitRef="USD">228000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine1TonMember"
      decimals="0"
      unitRef="USD">2052000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine10TonMember"
      decimals="0"
      unitRef="USD">5320000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine10TonMember"
      decimals="0"
      unitRef="USD">665000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_custom_PreciousMetalExtractionMachine10TonMember"
      decimals="0"
      unitRef="USD">4655000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine10TonMember"
      decimals="0"
      unitRef="USD">5320000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine10TonMember"
      decimals="0"
      unitRef="USD">532000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_custom_PreciousMetalExtractionMachine10TonMember"
      decimals="0"
      unitRef="USD">4788000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_BioreactorsMember"
      decimals="0"
      unitRef="USD">1440000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_BioreactorsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_custom_BioreactorsMember"
      decimals="0"
      unitRef="USD">1440000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_BioreactorsMember"
      decimals="0"
      unitRef="USD">1440000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_BioreactorsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_custom_BioreactorsMember"
      decimals="0"
      unitRef="USD">1440000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_NanospongeCavitationDeviceMember"
      decimals="0"
      unitRef="USD">22103</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_NanospongeCavitationDeviceMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_custom_NanospongeCavitationDeviceMember"
      decimals="0"
      unitRef="USD">22103</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_NanospongeCavitationDeviceMember"
      decimals="0"
      unitRef="USD">22103</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_NanospongeCavitationDeviceMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_custom_NanospongeCavitationDeviceMember"
      decimals="0"
      unitRef="USD">22103</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit1Member"
      decimals="0"
      unitRef="USD">6150506</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit1Member"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit1Member"
      decimals="0"
      unitRef="USD">6150506</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit1Member"
      decimals="0"
      unitRef="USD">6249082</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit1Member"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit1Member"
      decimals="0"
      unitRef="USD">6249082</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit2Member"
      decimals="0"
      unitRef="USD">5489760</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit2Member"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnit2Member"
      decimals="0"
      unitRef="USD">5489760</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit2Member"
      decimals="0"
      unitRef="USD">5201098</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit2Member"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnit2Member"
      decimals="0"
      unitRef="USD">5201098</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemAMember"
      decimals="0"
      unitRef="USD">3127669</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemAMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemAMember"
      decimals="0"
      unitRef="USD">3127669</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemAMember"
      decimals="0"
      unitRef="USD">2561467</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemAMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemAMember"
      decimals="0"
      unitRef="USD">2561467</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemBMember"
      decimals="0"
      unitRef="USD">2974884</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemBMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-06-30_custom_RemediationProcessingUnitSystemBMember"
      decimals="0"
      unitRef="USD">2974884</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemBMember"
      decimals="0"
      unitRef="USD">2345421</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemBMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2021-12-31_custom_RemediationProcessingUnitSystemBMember"
      decimals="0"
      unitRef="USD">2345421</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">26856352</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">977422</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">25878930</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">25482417</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">790306</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24692111</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="From2022-01-012022-06-30_us-gaap_EquipmentMember_custom_SeriesC1PreferredStockMember"
      decimals="INF"
      unitRef="Shares">5413</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2022-01-012022-06-30_us-gaap_EquipmentMember_custom_SeriesC1PreferredStockMember"
      decimals="0"
      unitRef="USD">64950</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:Depreciation
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">195387</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">5781</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">256235</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">822700</us-gaap:InterestCostsCapitalized>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_802_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z8MUZM6C3mx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 7. &lt;span id="xdx_822_zu1RARlcuIc8"&gt;Accounts Payable and Accrued Expenses&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accounts payable and accrued expenses consist
of the following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zCVJ2P9TRvo4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zoSDtMfhJNb9" style="display: none"&gt;Schedule of accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220630_zp7euy5lVgoe" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20211231_zo6XJoLCZP7e" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AccountsPayableCurrent_iI_p0p0_z3QU6LDAJ4s4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 68%; text-align: justify"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;851,495&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;1,450,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--Deposits_iI_p0p0_zyYEp3MVgCGa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Office access deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_p0p0_zbwpajNChiu3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Accrued compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;400,798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;175,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--UnearnedPremiums_iI_p0p0_d0_z9Rkgrlikyzc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;69,784&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccruedInterestWorkingInterestRoyaltyPrograms_p0p0_d0_z321N4M3N1Bk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Accrued interest (working interest royalty programs)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,341,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_p0p0_zIRzL7QGsDYa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Accrued tax penalties and interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;398,114&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;398,114&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_p0p0_zJfTBbOYm1H5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,061,610&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,023,985&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;As of December
31, 2021 the Company accrued $225,000 for a milestone payment to be paid to &lt;/span&gt;TBT Group, Inc. (of which an independent Vivakor Board
member is a 7% shareholder) related to our worldwide, exclusive license agreement for the license of piezo electric and energy harvesting
technologies for creating self-powered sensors for making smart roadways. This milestone payment was paid in March 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zCVJ2P9TRvo4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zoSDtMfhJNb9" style="display: none"&gt;Schedule of accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220630_zp7euy5lVgoe" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20211231_zo6XJoLCZP7e" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AccountsPayableCurrent_iI_p0p0_z3QU6LDAJ4s4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 68%; text-align: justify"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;851,495&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;1,450,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--Deposits_iI_p0p0_zyYEp3MVgCGa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Office access deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_p0p0_zbwpajNChiu3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Accrued compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;400,798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;175,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--UnearnedPremiums_iI_p0p0_d0_z9Rkgrlikyzc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;69,784&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccruedInterestWorkingInterestRoyaltyPrograms_p0p0_d0_z321N4M3N1Bk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Accrued interest (working interest royalty programs)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,341,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_p0p0_zIRzL7QGsDYa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Accrued tax penalties and interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;398,114&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;398,114&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_p0p0_zJfTBbOYm1H5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;Accounts payable and accrued expenses&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,061,610&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,023,985&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">851495</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1450531</us-gaap:AccountsPayableCurrent>
    <us-gaap:Deposits contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">340</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">340</us-gaap:Deposits>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">400798</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">175000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:UnearnedPremiums contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">69784</us-gaap:UnearnedPremiums>
    <us-gaap:UnearnedPremiums contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:UnearnedPremiums>
    <VIVK:AccruedInterestWorkingInterestRoyaltyPrograms contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1341079</VIVK:AccruedInterestWorkingInterestRoyaltyPrograms>
    <VIVK:AccruedInterestWorkingInterestRoyaltyPrograms contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</VIVK:AccruedInterestWorkingInterestRoyaltyPrograms>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">398114</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">398114</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3061610</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2023985</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:MortgageNotesPayableDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_808_eus-gaap--MortgageNotesPayableDisclosureTextBlock_zbqkSe12fn8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 8. &lt;span id="xdx_82F_zLxdDyTIuxfj"&gt;Loans and Notes Payable&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Loans and Notes payable (including accrued interest)
consist of the following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zBt3fjaMI6td" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans and Notes Payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zxoRJ43j9WWd" style="display: none"&gt;Schedule of loans and notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 68%; text-align: justify"&gt;Various promissory notes and convertible notes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zUNWA1btj3O7" style="width: 13%; text-align: right" title="Total Notes Payable"&gt;50,960&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zN0kYferQQQ" style="width: 13%; text-align: right" title="Total Notes Payable"&gt;50,960&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Novus Capital Group LLC Note (a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zpSTE0IyGqz" style="text-align: right" title="Total Notes Payable"&gt;283,612&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zav5q11y8sZc" style="text-align: right" title="Total Notes Payable"&gt;378,854&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Triple T Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zSZEgoNzwSWe" style="text-align: right" title="Total Notes Payable"&gt;329,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zNBcpGR47NSc" style="text-align: right" title="Total Notes Payable"&gt;353,330&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;National Buick GMC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zXm3z8AKVpfg" style="text-align: right" title="Total Notes Payable"&gt;16,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zTDFdyLHDn2e" style="text-align: right" title="Total Notes Payable"&gt;19,440&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Various Convertible Bridge Notes (b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_d0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zhuPzsIyVhmk" style="text-align: right" title="Total Notes Payable"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zGJauvOtdaY7" style="text-align: right" title="Total Notes Payable"&gt;1,075,813&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Blue Ridge Bank&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z12rXJ4a3Yak" style="text-align: right" title="Total Notes Payable"&gt;410,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z9OrlkdgTtMa" style="text-align: right" title="Total Notes Payable"&gt;410,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Small Business Administration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zydrssOwAtW6" style="text-align: right" title="Total Notes Payable"&gt;324,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zwDAiwwi3E7d" style="text-align: right" title="Total Notes Payable"&gt;318,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;JP Morgan Chase Bank&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zJpORknSSE49" style="text-align: right" title="Total Notes Payable"&gt;90,645&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zwVoWi1tUtIf" style="text-align: right" title="Total Notes Payable"&gt;90,645&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Various Promissory Notes (c)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zYRnUaqpdLkd" style="border-bottom: Black 1pt solid; text-align: right" title="Total Notes Payable"&gt;2,308,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zM2l5gKFENc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Notes Payable"&gt;3,416,379&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;Total Notes Payable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_c20220630_p0p0_zONdv7cwV26f" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Notes Payable"&gt;3,814,506&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NotesPayable_c20211231_p0p0_zuqD0iN6Vvv6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Notes Payable"&gt;6,113,796&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loans and notes payable, current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NotesAndLoansPayableCurrent_c20220630_p0p0_zK7D6hbRwb82" style="text-align: right" title="Loans and notes payable, current"&gt;962,405&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NotesAndLoansPayableCurrent_c20211231_p0p0_zPgxiTmvJqB1" style="text-align: right" title="Loans and notes payable, current"&gt;1,511,447&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Loans and notes payable, current attributed to variable interest entity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20220630_p0p0_zN30deQcqkfe" style="text-align: right" title="Loans and notes payable, current attributed to variable interest entity"&gt;2,308,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20211231_p0p0_zDqWaVSwOAE7" style="text-align: right" title="Loans and notes payable, current attributed to variable interest entity"&gt;3,416,379&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loans and notes payable, long term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NotesAndLoansPayableNonCurrent_c20220630_p0p0_z00kBjj5Jui6" style="text-align: right" title="Loans and notes payable, long term"&gt;543,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NotesAndLoansPayableNonCurrent_c20211231_p0p0_zkQigEr6iI1f" style="text-align: right" title="Loans and notes payable, long term"&gt;1,185,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A3_z2Wq0BqQ0r3e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock_zQNq2SnFcUKa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Loans and Notes Payable (Details - Maturities of Debt)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zlSGqVJUxfL9" style="display: none"&gt;Schedule of maturities of loans and notes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zVH8wMM3K2ag" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,787,944&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_za0wU2dYfCP1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;518,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_zTu0ZgExnN5j" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72,278&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_zQxnDJ40JULc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;68,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zjNSR57lq6Hi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,979&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zftGs1Uv2kf6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;255,313&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NotesAndLoansPayable_iI_p0p0_zJPJWoGa7ce2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,814,506&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;__________________&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 3%; text-align: justify"&gt;&lt;span id="xdx_F02_zrqYTbVasth7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 97%; text-align: justify"&gt;&lt;span id="xdx_F13_zbi12mKvg7Ug" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398. As of April 1 2022, the lender agreed to extend the maturity of the note to April 1, 2023 with an initial payment of $52,448 and approximate monthly payment of $29,432 thereafter until the note is fully paid.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F06_z9qYJiM6Aiu8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_z2CxGdiyBuod" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In 2021 and 2020 the Company entered into various convertible promissory notes as follows:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_z7hudYkQKocg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 3%; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 97%; text-align: justify"&gt;Throughout 2021 and 2020 the Company entered into convertible promissory notes with an aggregate principal of $&lt;span id="xdx_900_eus-gaap--ConvertibleNotesPayable_c20220630_p0p0_z9gn45miNqB8" title="Aggregate principal"&gt;415,000&lt;/span&gt;. The notes accrue interest at &lt;span id="xdx_90A_ecustom--PercentageOfAccrueInterest_dp_c20220101__20220630_zDTVAUVptDHl" title="percentage of accrue interest"&gt;&lt;span id="xdx_908_ecustom--PercentageOfAccrueInterest_dp_c20210101__20210630_zui1cKAUtp68" title="percentage of accrue interest"&gt;10&lt;/span&gt;&lt;/span&gt;% per annum and have
a maturity of the earlier of 12 months or the consummation of the Company listing its Common Stock on a senior stock exchange. The notes
are convertible at the Company&#x2019;s option into shares of the Company&#x2019;s common stock at a price equal to 80% of the opening price
of the Company&#x2019;s common stock on the national exchange or the offering price paid by the investors in the financing in connection
with the uplist, whichever is lower, or (ii) repaid in cash in an amount equal to the indebtedness being repaid plus a premium payment
equal to 15% of the amount being repaid. If an event of default has occurred and the Company does not convert the amounts due under the
Note into the Company&#x2019;s common stock, then the Company will have the option to convert the outstanding indebtedness into shares
of the Company&#x2019;s common stock at a price equal to 80% of the weighted average trading price of the Company&#x2019;s common stock
on the OTC Markets, or be repaid in cash in an amount equal to all principal and interest due under the Note. All of these notes were
converted to common stock as of June 30, 2022.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="background-color: white"&gt;On
October 13, 2020, the Company entered into a convertible promissory note in an amount of $280,500 having an interest rate of 12% per annum.
The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00 or 80% of
the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the note may be
converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in conjunction with
this note, which &lt;/span&gt;was recorded as a debt discount in the amount of $44,000, which is amortized to interest expense over the term
of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to state that in no event
shall the conversion price be lower than $3.00 per share. In October 2021 the parties agreed to extend the maturity of this loan to April
13, 2022 in exchange for an increase in principal owed of $30,000. This note has been converted to common stock as of June 30, 2022.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="background-color: white"&gt;On
February 4, 2021, the Company entered into a convertible promissory note in an amount of $277,778 having an interest rate of 12% per annum.
The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00 or 80% of
the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the note may be
converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in conjunction with
this note, which &lt;/span&gt;was recorded as a debt discount in the amount of $36,000, which is amortized to interest expense over the term
of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to state that in no event
shall the conversion price be lower than $3.00 per share. In February 2022 the parties agreed to extend the maturity of this loan to August
8, 2022 in exchange for an increase in principal owed of $25,000. This note has been converted to common stock as of June 30, 2022.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;(c)&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Viva
Wealth Fund I, LLC is offering up to &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$25,000,000 in
convertible notes in a private offering&lt;span style="background-color: white"&gt;. As of June 30, 2022, VWFI has raised $10,510,000
and converted $8,575,000 of this debt to VWFI LLC units. A convertible note will &lt;/span&gt;automatically &lt;span style="background-color: white"&gt;convert
into the LLC units at the earlier of (i) the date that the Equipment is placed into quality control and testing or (ii) six months
from the date of investment. The convertible notes will accrue interest at 12% per annum&lt;/span&gt; and are paid quarterly. At the
maturity date, remaining interest will be paid, at which time no further interest payments will accrue. Upon the offering
termination date, all units accepted for any series of equipment will automatically convert to Vivakor common stock if the Company
has not accepted subscriptions for at least $6,250,000 for a series of equipment. The conversion price of the automatic stock
conversion will be the the greater of $13.50 or a 10% discount to market per share or in the event of a public offering, 200% of the
per share price of the Company common stock sold in an underwritten offering, which was closed on February 14, 2022 at $5.00 per
share. &lt;span style="background-color: white"&gt;The termination &lt;/span&gt;date of the offering has been extended until November 13, 2022
in the sole discretion of the Company. As of April 28, 2021 VWFI has reached $6,250,000 in funding and has released the funding for
construction of RPC Series A. VWFI has commenced fundraising for RPC Series B and has raised approximately $4,690,000 to manufacture
RPC Series B. Subsequent to June 30, 2022 an additional $30,000 of this debt has been converted into units of the LLC.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"/&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:MortgageNotesPayableDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zBt3fjaMI6td" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Loans and Notes Payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zxoRJ43j9WWd" style="display: none"&gt;Schedule of loans and notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 68%; text-align: justify"&gt;Various promissory notes and convertible notes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zUNWA1btj3O7" style="width: 13%; text-align: right" title="Total Notes Payable"&gt;50,960&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesAndConvertibleNotesMember_zN0kYferQQQ" style="width: 13%; text-align: right" title="Total Notes Payable"&gt;50,960&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Novus Capital Group LLC Note (a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zpSTE0IyGqz" style="text-align: right" title="Total Notes Payable"&gt;283,612&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NovusCapitalGroupLLCNoteMember_fKGEp_zav5q11y8sZc" style="text-align: right" title="Total Notes Payable"&gt;378,854&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Triple T Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zSZEgoNzwSWe" style="text-align: right" title="Total Notes Payable"&gt;329,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--TripleTNotesMember_zNBcpGR47NSc" style="text-align: right" title="Total Notes Payable"&gt;353,330&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;National Buick GMC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zXm3z8AKVpfg" style="text-align: right" title="Total Notes Payable"&gt;16,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NationalBuickGMCMember_zTDFdyLHDn2e" style="text-align: right" title="Total Notes Payable"&gt;19,440&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Various Convertible Bridge Notes (b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_d0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zhuPzsIyVhmk" style="text-align: right" title="Total Notes Payable"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousConvertibleBridgeNotesMember_fKGIp_zGJauvOtdaY7" style="text-align: right" title="Total Notes Payable"&gt;1,075,813&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Blue Ridge Bank&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z12rXJ4a3Yak" style="text-align: right" title="Total Notes Payable"&gt;410,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--BlueRidgeBankMember_z9OrlkdgTtMa" style="text-align: right" title="Total Notes Payable"&gt;410,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Small Business Administration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zydrssOwAtW6" style="text-align: right" title="Total Notes Payable"&gt;324,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zwDAiwwi3E7d" style="text-align: right" title="Total Notes Payable"&gt;318,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;JP Morgan Chase Bank&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zJpORknSSE49" style="text-align: right" title="Total Notes Payable"&gt;90,645&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--JPMorganChaseBankMember_zwVoWi1tUtIf" style="text-align: right" title="Total Notes Payable"&gt;90,645&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Various Promissory Notes (c)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NotesPayable_iI_p0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zYRnUaqpdLkd" style="border-bottom: Black 1pt solid; text-align: right" title="Total Notes Payable"&gt;2,308,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NotesPayable_iI_p0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--VariousPromissoryNotesMember_zM2l5gKFENc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Notes Payable"&gt;3,416,379&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;Total Notes Payable&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_c20220630_p0p0_zONdv7cwV26f" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Notes Payable"&gt;3,814,506&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NotesPayable_c20211231_p0p0_zuqD0iN6Vvv6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Notes Payable"&gt;6,113,796&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loans and notes payable, current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NotesAndLoansPayableCurrent_c20220630_p0p0_zK7D6hbRwb82" style="text-align: right" title="Loans and notes payable, current"&gt;962,405&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NotesAndLoansPayableCurrent_c20211231_p0p0_zPgxiTmvJqB1" style="text-align: right" title="Loans and notes payable, current"&gt;1,511,447&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Loans and notes payable, current attributed to variable interest entity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20220630_p0p0_zN30deQcqkfe" style="text-align: right" title="Loans and notes payable, current attributed to variable interest entity"&gt;2,308,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--LoansAndNotesPayableCurrentAttributedToVariableInterestEntity_c20211231_p0p0_zDqWaVSwOAE7" style="text-align: right" title="Loans and notes payable, current attributed to variable interest entity"&gt;3,416,379&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loans and notes payable, long term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--NotesAndLoansPayableNonCurrent_c20220630_p0p0_z00kBjj5Jui6" style="text-align: right" title="Loans and notes payable, long term"&gt;543,869&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NotesAndLoansPayableNonCurrent_c20211231_p0p0_zkQigEr6iI1f" style="text-align: right" title="Loans and notes payable, long term"&gt;1,185,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_VariousPromissoryNotesAndConvertibleNotesMember"
      decimals="0"
      unitRef="USD">50960</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_VariousPromissoryNotesAndConvertibleNotesMember"
      decimals="0"
      unitRef="USD">50960</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_NovusCapitalGroupLLCNoteMember"
      decimals="0"
      id="Fact001145"
      unitRef="USD">283612</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_NovusCapitalGroupLLCNoteMember"
      decimals="0"
      id="Fact001147"
      unitRef="USD">378854</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_TripleTNotesMember"
      decimals="0"
      unitRef="USD">329613</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_TripleTNotesMember"
      decimals="0"
      unitRef="USD">353330</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_NationalBuickGMCMember"
      decimals="0"
      unitRef="USD">16977</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_NationalBuickGMCMember"
      decimals="0"
      unitRef="USD">19440</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_VariousConvertibleBridgeNotesMember"
      decimals="0"
      id="Fact001157"
      unitRef="USD">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_VariousConvertibleBridgeNotesMember"
      decimals="0"
      id="Fact001159"
      unitRef="USD">1075813</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_BlueRidgeBankMember"
      decimals="0"
      unitRef="USD">410200</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_BlueRidgeBankMember"
      decimals="0"
      unitRef="USD">410200</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_SmallBusinessAdministrationMember"
      decimals="0"
      unitRef="USD">324267</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_SmallBusinessAdministrationMember"
      decimals="0"
      unitRef="USD">318175</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_JPMorganChaseBankMember"
      decimals="0"
      unitRef="USD">90645</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_JPMorganChaseBankMember"
      decimals="0"
      unitRef="USD">90645</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_VariousPromissoryNotesMember"
      decimals="0"
      unitRef="USD">2308232</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_VariousPromissoryNotesMember"
      decimals="0"
      unitRef="USD">3416379</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3814506</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">6113796</us-gaap:NotesPayable>
    <us-gaap:NotesAndLoansPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">962405</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:NotesAndLoansPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1511447</us-gaap:NotesAndLoansPayableCurrent>
    <VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2308232</VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity>
    <VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3416379</VIVK:LoansAndNotesPayableCurrentAttributedToVariableInterestEntity>
    <VIVK:NotesAndLoansPayableNonCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">543869</VIVK:NotesAndLoansPayableNonCurrent>
    <VIVK:NotesAndLoansPayableNonCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1185970</VIVK:NotesAndLoansPayableNonCurrent>
    <VIVK:ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock_zQNq2SnFcUKa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%" summary="xdx: Disclosure - Loans and Notes Payable (Details - Maturities of Debt)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zlSGqVJUxfL9" style="display: none"&gt;Schedule of maturities of loans and notes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zVH8wMM3K2ag" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 34%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,787,944&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_za0wU2dYfCP1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;518,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_zTu0ZgExnN5j" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72,278&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_zQxnDJ40JULc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;68,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zjNSR57lq6Hi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,979&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zftGs1Uv2kf6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;255,313&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NotesAndLoansPayable_iI_p0p0_zJPJWoGa7ce2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,814,506&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;__________________&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 3%; text-align: justify"&gt;&lt;span id="xdx_F02_zrqYTbVasth7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 97%; text-align: justify"&gt;&lt;span id="xdx_F13_zbi12mKvg7Ug" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398. As of April 1 2022, the lender agreed to extend the maturity of the note to April 1, 2023 with an initial payment of $52,448 and approximate monthly payment of $29,432 thereafter until the note is fully paid.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F06_z9qYJiM6Aiu8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_z2CxGdiyBuod" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In 2021 and 2020 the Company entered into various convertible promissory notes as follows:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</VIVK:ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">415000</us-gaap:ConvertibleNotesPayable>
    <VIVK:PercentageOfAccrueInterest
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0.10</VIVK:PercentageOfAccrueInterest>
    <VIVK:PercentageOfAccrueInterest
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.10</VIVK:PercentageOfAccrueInterest>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_ztMUDxYShod4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note
9. &lt;span id="xdx_829_zo8tboMJ3j1g"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Commencing on September 15, 2019, the Company
entered into a five-year lease with Jamboree Center 1 &amp;amp; 2 LLC covering approximately 6,961 square feet of office space in Irvine,
CA. Under the terms of the lease agreement, we are required to make the following monthly lease payments: Year 1 $&lt;span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zdnsfRNK9kwe" title="Lease payments next twelve months"&gt;21,927&lt;/span&gt;, Year 2 $&lt;span id="xdx_90C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_z0DvtGkjWmR6" title="Lease payments next two months"&gt;22,832&lt;/span&gt;,
Year 3 $&lt;span id="xdx_90E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zC76eKBcHTPb" title="Lease payments next three months"&gt;23,737&lt;/span&gt;, Year 4 $&lt;span id="xdx_907_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zUmukQkuhXI5" title="Lease payments next four months"&gt;24,712&lt;/span&gt;, Year 5 $&lt;span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zU0V1PiKrxl8" title="Lessee, Operating Lease, Liability, to be Paid, Year Five"&gt;25,686&lt;/span&gt;. As a condition of the lease, we were required to provide a $&lt;span id="xdx_90E_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--JamboreeCenterMember_p0p0_zf0EVZ7sEz3e" title="Security deposit"&gt;51,992&lt;/span&gt; security deposit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 1, 2022, the Company entered into
a lease agreement for approximately 2,533 square feet of office and manufacturing space located in Las Vegas, Nevada. Commencing on March
1, 2022, the Company entered into a three-year lease with Speedway Commerce Center, LLC. Under the terms of the lease agreement, we are
required to make the following monthly lease payments: Year 1 $&lt;span id="xdx_90A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zymAhYeuTX7i" title="Lease payments next twelve months"&gt;1,950&lt;/span&gt;, Year 2 $&lt;span id="xdx_90D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zDonGQwVedhf" title="Lease payments next two months"&gt;2,028&lt;/span&gt;, Year 3 $&lt;span id="xdx_90F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zQTWb4jlVlg2" title="Lease payments next three months"&gt;2,110&lt;/span&gt;. As a condition of the lease, we were
required to provide a $&lt;span id="xdx_902_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--SpeedwayCommerceCenterMember_p0p0_zMLKWtbCCce6" title="Security deposit"&gt;2,418&lt;/span&gt; security deposit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 28, 2022, the Company entered into a
lease agreement for approximately 1,469 square feet of office space located in Lehi, Utah. Commencing on April 1, 2022, the Company entered
into a three-year lease with Victory Holdings, LLC. Under the terms of the lease agreement, we are required to make the following monthly
lease payments: Year 1 is comprised of April to May 2022 $&lt;span id="xdx_902_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zLqPaRZ7Udbl" title="Lease payments next twelve months"&gt;867&lt;/span&gt;, June 2022 to March 2023 $&lt;span id="xdx_906_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zix5ICNVP0Aj" title="Lease payments next two and three months"&gt;3,550&lt;/span&gt;, Year 2 $&lt;span id="xdx_90F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zRVZpEFDeug" title="Lease payments next three months"&gt;3,657&lt;/span&gt;, Year 3 $&lt;span id="xdx_909_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20220630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_z658OYxLUFF" title="Lease payments next four months"&gt;3,766&lt;/span&gt;. As a condition
of the lease, we were required to provide a $&lt;span id="xdx_90E_eus-gaap--SecurityDeposit_c20190915__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--VictoryHoldingsMember_p0p0_zAWCi1qng081" title="Security deposit"&gt;3,766&lt;/span&gt; security deposit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 1, 2022, the Company entered into a lease
agreement for approximately 2,000 square feet of office and warehouse space located in Houston, Texas. Commencing on April 1, 2022, the
Company entered into a month-to-month lease with JVS Holdings, Inc. The lease may be terminated at any time or for any reason with a 30-day
written notice to terminate. The lease requires a monthly lease payment of $&lt;span id="xdx_905_eus-gaap--OperatingLeasePayments_c20220101__20220630_z7jRn6qWYVWe" title="Lease payment"&gt;2,000&lt;/span&gt; as long as the Company remains in the space.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The right-of-use asset for operating leases as
of June 30, 2022 and December 31, 2021 was $&lt;span id="xdx_90C_eus-gaap--OperatingLeaseRightOfUseAsset_c20220630_p0p0_znoAEiwv99Xj" title="Right-of-use asset for operating leases"&gt;721,550&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_p0p0_c20211231_zVYNxWCFLV6c" title="Right-of-use asset for operating leases"&gt;663,291&lt;/span&gt;. Rent expense for the six months ended June 30, 2022 and 2021 was $&lt;span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20220101__20220630_p0p0_zi3WAtVjcQYc" title="Rent expense"&gt;199,170&lt;/span&gt;
and $&lt;span id="xdx_900_eus-gaap--OperatingLeaseExpense_c20210101__20210630_p0p0_zV2tAXW27wI7" title="Rent expense"&gt;186,086&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reconciles the undiscounted
cash flows for the leases as of June 30, 2022 to the operating lease liability recorded on the balance sheet:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zqifXTNooFfb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B1_zYjrq6de3fO1" style="display: none"&gt;Schedule of lessee operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20220630_zadUSdZUWBE2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_p0p0_zYW4kqHEMVk9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 84%; text-align: justify"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;180,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_p0p0_zdXfilqhHpW5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;370,902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_p0p0_zclp4fjqMg5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;304,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_p0p0_zaTLS6ljJFvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,135&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_p0p0_zNnwA4Llgmgg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Total undiscounted lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;872,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_p0p0_zKkqEP2TpC8k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;93,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--PresentValueOfLeasePayments_iI_p0p0_zhFjN12vDg3j" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Present value of lease payments&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;779,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_p0p0_zpkR0DztXUj2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Operating lease liabilities, current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;364,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OperatingLeaseLiability1Noncurrent_iI_p0p0_zsAsIsmBHRTh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Operating lease liabilities, long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;414,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Weighted-average remaining lease term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zpMy8KS20sR2" title="Weighted-average remaining lease term"&gt;2.36&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Weighted-average discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z7h5q93x9gTk" title="Weighted-average discount rate"&gt;7.0&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The discount rate is the Company&#x2019;s incremental
borrowing rate, or the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an
amount equal to the lease payments in a similar economic environment. Based on an assessment of the Company&#x2019;s borrowings the incremental
borrowing rate was determined to be 7%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Employment Agreements&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In June 2022, the Company entered into employment
agreements with its Chief Executive Officer and Chief Financial Officer, which provide for annual base salaries of $375,000 and $350,000,
respectively, and provide for incremental increases in their salaries upon the Company&#x2019;s achievement of specific performance metrics.
The Company is currently accruing substantial portions of both executive&#x2019;s base salaries (see Note 7). The employment agreements
provide for the grant of stock options to the Chief Executive Officer and Chief Financial Officer to purchase up to 955,093 and 917,825
shares of the Company&#x2019;s common stock, respectively, at an exercise price equal to 110% and 100% of the fair market value of the
Company&#x2019;s common stock on the date of grant. The stock option will vest after two years of continuous employment, subject to acceleration
if terminated without cause or resignations for good reason. The agreement also provides that it is anticipated that the executives will
receive bonuses for 2022 which will be determined by the Company&#x2019;s Compensation Committee and Board of Directors after taking into
account the general business performance of the Company, including any completed financings and or acquisitions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;











</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2022-06-30_custom_JamboreeCenterMember"
      decimals="0"
      unitRef="USD">21927</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2022-06-30_custom_JamboreeCenterMember"
      decimals="0"
      unitRef="USD">22832</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2022-06-30_custom_JamboreeCenterMember"
      decimals="0"
      unitRef="USD">23737</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2022-06-30_custom_JamboreeCenterMember"
      decimals="0"
      unitRef="USD">24712</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2022-06-30_custom_JamboreeCenterMember"
      decimals="0"
      unitRef="USD">25686</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2019-09-15_custom_JamboreeCenterMember"
      decimals="0"
      unitRef="USD">51992</us-gaap:SecurityDeposit>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2022-06-30_custom_SpeedwayCommerceCenterMember"
      decimals="0"
      unitRef="USD">1950</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2022-06-30_custom_SpeedwayCommerceCenterMember"
      decimals="0"
      unitRef="USD">2028</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2022-06-30_custom_SpeedwayCommerceCenterMember"
      decimals="0"
      unitRef="USD">2110</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2019-09-15_custom_SpeedwayCommerceCenterMember"
      decimals="0"
      unitRef="USD">2418</us-gaap:SecurityDeposit>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2022-06-30_custom_VictoryHoldingsMember"
      decimals="0"
      unitRef="USD">867</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <VIVK:LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree
      contextRef="AsOf2022-06-30_custom_VictoryHoldingsMember"
      decimals="0"
      unitRef="USD">3550</VIVK:LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2022-06-30_custom_VictoryHoldingsMember"
      decimals="0"
      unitRef="USD">3657</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2022-06-30_custom_VictoryHoldingsMember"
      decimals="0"
      unitRef="USD">3766</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2019-09-15_custom_VictoryHoldingsMember"
      decimals="0"
      unitRef="USD">3766</us-gaap:SecurityDeposit>
    <us-gaap:OperatingLeasePayments
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">721550</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">663291</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">199170</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">186086</us-gaap:OperatingLeaseExpense>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zqifXTNooFfb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B1_zYjrq6de3fO1" style="display: none"&gt;Schedule of lessee operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20220630_zadUSdZUWBE2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_p0p0_zYW4kqHEMVk9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 84%; text-align: justify"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;180,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_p0p0_zdXfilqhHpW5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;370,902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_p0p0_zclp4fjqMg5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;304,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_p0p0_zaTLS6ljJFvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,135&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_p0p0_zNnwA4Llgmgg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Total undiscounted lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;872,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_p0p0_zKkqEP2TpC8k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;93,074&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--PresentValueOfLeasePayments_iI_p0p0_zhFjN12vDg3j" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Present value of lease payments&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;779,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_iI_p0p0_zpkR0DztXUj2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Operating lease liabilities, current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;364,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--OperatingLeaseLiability1Noncurrent_iI_p0p0_zsAsIsmBHRTh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Operating lease liabilities, long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;414,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Weighted-average remaining lease term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zpMy8KS20sR2" title="Weighted-average remaining lease term"&gt;2.36&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Weighted-average discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20220630_z7h5q93x9gTk" title="Weighted-average discount rate"&gt;7.0&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">180195</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">370902</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">304892</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">16135</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">872124</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">93074</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <VIVK:PresentValueOfLeasePayments contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">779050</VIVK:PresentValueOfLeasePayments>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">364103</us-gaap:OperatingLeaseLiabilityCurrent>
    <VIVK:OperatingLeaseLiability1Noncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">414946</VIVK:OperatingLeaseLiability1Noncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2022-06-30">P2Y4M9D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2022-06-30" decimals="INF" unitRef="Pure">0.070</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LongTermDebtTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_803_eus-gaap--LongTermDebtTextBlock_z5BZZphgdMKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 10. &lt;span id="xdx_825_zc3OJwZWRKMk"&gt;Long-term Debt&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;To assist in funding the manufacture of the Company&#x2019;s
Remediation Processing Centers, between 2015 and 2017, the Company entered into two agreements which include terms for the purchase of
participation rights for the sale of future revenue of the funded RPCs. The RPCs are estimated to enter scaled up operations in 2022 and
make estimated payments. The Company estimates future payments based on revenue projections for the RPCs. Due to delays in scaled up operations
(see Note 1 &lt;i&gt;Long Lived Assets&lt;/i&gt;) the effective interest rate of these agreements increased from approximately 33% to 36%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Long-term debt consists of the following:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zOV77MkwcL4e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-term Debt (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zzLEroAMHtZi" style="display: none"&gt;Schedule Of Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20220630__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zuAukLD4uUvj" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20211231__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zS8b9c9ISsZ9" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_p0p0_zLfN7oyrf1Hg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 68%"&gt;Principal&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,196,233&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,196,233&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_p0p0_zGGHXuiTkjpg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,049,304&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,205,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_p0p0_zjy9ZaN5Lxvf" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(219,380&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(226,823&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebt_iI_p0p0_zdK2D4HHVXOe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Total long term debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,026,157&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,174,554&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LongTermDebtCurrent_iI_p0p0_zGGJmy4B41D5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Long term debt, current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8,565&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,256&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermDebtNoncurrent_iI_p0p0_znzh3ubHqmQ1" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Long term debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,017,592&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,171,298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AB_zRuxNy5PZzz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth the estimated
payment schedule of long-term debt as of June 30, 2022:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zTrvZMAYzY6d" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-term Debt (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zBvBSpEAcOpj" style="display: none"&gt;Schedule of long-term debt maturities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zZd90qCh3nvk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;3,525&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_zGNuNRo4riy7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,795&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_znnugAX2pyMe" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,078&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_z6PpCCxR0SSh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,359&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zOau1F6hYCBh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,943&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zV8midIH7ml" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,125,533&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LongTermDebt_iI_p0p0_ziNLzqwGtbY5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,196,233&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AA_zB9HULwk0Q1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfDebtTableTextBlock_zOV77MkwcL4e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-term Debt (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zzLEroAMHtZi" style="display: none"&gt;Schedule Of Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20220630__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zuAukLD4uUvj" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20211231__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--LongTermDebtMember_zS8b9c9ISsZ9" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_p0p0_zLfN7oyrf1Hg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 68%"&gt;Principal&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,196,233&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;2,196,233&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_iI_p0p0_zGGHXuiTkjpg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,049,304&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,205,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_iI_p0p0_zjy9ZaN5Lxvf" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(219,380&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(226,823&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebt_iI_p0p0_zdK2D4HHVXOe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Total long term debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,026,157&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,174,554&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LongTermDebtCurrent_iI_p0p0_zGGJmy4B41D5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Long term debt, current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8,565&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,256&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LongTermDebtNoncurrent_iI_p0p0_znzh3ubHqmQ1" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Long term debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,017,592&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,171,298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">2196233</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">2196233</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">3049304</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">4205144</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">-219380</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">-226823</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">5026157</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">6174554</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">8565</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">3256</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2022-06-30_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">5017592</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2021-12-31_us-gaap_LongTermDebtMember"
      decimals="0"
      unitRef="USD">6171298</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zTrvZMAYzY6d" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Long-term Debt (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B1_zBvBSpEAcOpj" style="display: none"&gt;Schedule of long-term debt maturities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_iI_p0p0_zZd90qCh3nvk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;3,525&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo_iI_p0p0_zGNuNRo4riy7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,795&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree_iI_p0p0_znnugAX2pyMe" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,078&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour_iI_p0p0_z6PpCCxR0SSh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,359&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive_iI_p0p0_zOau1F6hYCBh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,943&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive_iI_p0p0_zV8midIH7ml" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,125,533&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LongTermDebt_iI_p0p0_ziNLzqwGtbY5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,196,233&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <VIVK:TemporaryEquityTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_804_ecustom--TemporaryEquityTextBlock_zOPa5Whmsouk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 11.&#160;&lt;span id="xdx_82D_zVlDTslJPik3"&gt;Temporary Equity&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table shows all changes to temporary equity during for
the six months ended June 30, 2021.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--TemporaryEquityTableTextBlock_zkj1eVS7qNYb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Temporary Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;&lt;span id="xdx_8B7_zuzij8dvxA0i" style="display: none"&gt;Schedule of temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Convertible Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series B&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series B-1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series C-1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zKRrSrWKT324" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 28%; font-weight: bold; text-align: left"&gt;March 31, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zG0XcMv62vu4" style="width: 9%; text-align: right" title="Beginning balance, shares"&gt;213,583&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,281,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zO6JJkRUXzS" style="width: 9%; text-align: right" title="Beginning balance, shares"&gt;459,426&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,445,716&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zOYU5NSXkV0k" style="width: 9%; text-align: right" title="Beginning balance, shares"&gt;260,702&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,615,927&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TemporaryEquityDividendsAdjustment_z1XkWG4e7bAj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Dividend paid in Series B-1 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--DividendPaidInSeriesB1PreferredStock_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z8FHfogLkTDb" style="text-align: right" title="Dividend paid in Series B-1 Preferred Stock"&gt;5,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ConversionOfStockAmountConverted1_zk6AUfJzvZ4d" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Conversion of Series B and B-1 Preferred Stock to Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zN7NpsVoR004" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(213,583&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,281,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zFpJTwGwHzOk" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(459,426&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,445,716&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z3AGUCJqXnR8" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(266,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,658,123&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zDdXOOdbZdi3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_z1Y9MHFEnHh1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1341"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_z2oyf7Af0fC3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1343"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zK0W9oGhcLLg" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1345"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Convertible Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series B&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series B-1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series C-1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr id="xdx_438_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_z3biLnfjToIi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left; width: 28%"&gt;December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zfJYQSxfw5g6" style="text-align: right; width: 9%" title="Beginning balance, shares"&gt;216,916&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%"&gt;1,301,500&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zRj5DOEhbdIk" style="text-align: right; width: 9%" title="Beginning balance, shares"&gt;467,728&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%"&gt;3,507,981&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z9lUUVYMRmI" style="text-align: right; width: 9%" title="Beginning balance, shares"&gt;255,289&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%"&gt;4,550,977&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SerciesC1IssueForReductionInStockPayables_zaia6mKkoECg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Series C-1 Issue for a reduction in stock payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SerciesC1IssueForReductionInStockPayable_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zrx0XXgKLpi2" style="text-align: right" title="Sercies C-1 Issue for a reduction in stock payables, shares"&gt;5,413&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--TemporaryEquityDividendsAdjustment_zM9jXoY9BVo4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Dividend paid in Series B-1 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DividendPaidInSeriesB1PreferredStock_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zfllWXEPraYl" style="text-align: right" title="Dividend paid in Series B-1 Preferred Stock"&gt;5,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ConversionOfStockAmountConverted1_z51aSSgC3AL4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Conversion of Series B and B-1 Preferred Stock to Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zWqfszJKZWha" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(216,916&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,301,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zdBJzBBiFtja" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(467,728&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,507,981&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zbuobMp7Ivfd" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(266,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,658,123&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zpaStK7ArNRe" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zMlVoeKrDZIj" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1368"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zDyhxuL7eay8" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1370"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zKyrmU7mQsId" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1372"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AF_zdanAWU5FfBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the year ended December 31, 2021, all shares of Series B, B-1,
and C-1 Preferred Stock were converted to common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;










</VIVK:TemporaryEquityTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--TemporaryEquityTableTextBlock_zkj1eVS7qNYb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Temporary Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;&lt;span id="xdx_8B7_zuzij8dvxA0i" style="display: none"&gt;Schedule of temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Convertible Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series B&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series B-1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series C-1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zKRrSrWKT324" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 28%; font-weight: bold; text-align: left"&gt;March 31, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zG0XcMv62vu4" style="width: 9%; text-align: right" title="Beginning balance, shares"&gt;213,583&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,281,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zO6JJkRUXzS" style="width: 9%; text-align: right" title="Beginning balance, shares"&gt;459,426&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,445,716&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zOYU5NSXkV0k" style="width: 9%; text-align: right" title="Beginning balance, shares"&gt;260,702&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,615,927&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TemporaryEquityDividendsAdjustment_z1XkWG4e7bAj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Dividend paid in Series B-1 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--DividendPaidInSeriesB1PreferredStock_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z8FHfogLkTDb" style="text-align: right" title="Dividend paid in Series B-1 Preferred Stock"&gt;5,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ConversionOfStockAmountConverted1_zk6AUfJzvZ4d" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Conversion of Series B and B-1 Preferred Stock to Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zN7NpsVoR004" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(213,583&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,281,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zFpJTwGwHzOk" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(459,426&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,445,716&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z3AGUCJqXnR8" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(266,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,658,123&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20210401__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zDdXOOdbZdi3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_z1Y9MHFEnHh1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1341"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_z2oyf7Af0fC3" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1343"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zK0W9oGhcLLg" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1345"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Convertible Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series B&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series B-1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Series C-1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr id="xdx_438_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_z3biLnfjToIi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left; width: 28%"&gt;December 31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zfJYQSxfw5g6" style="text-align: right; width: 9%" title="Beginning balance, shares"&gt;216,916&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%"&gt;1,301,500&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zRj5DOEhbdIk" style="text-align: right; width: 9%" title="Beginning balance, shares"&gt;467,728&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%"&gt;3,507,981&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquitySharesOutstanding_iS_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_z9lUUVYMRmI" style="text-align: right; width: 9%" title="Beginning balance, shares"&gt;255,289&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%"&gt;4,550,977&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--SerciesC1IssueForReductionInStockPayables_zaia6mKkoECg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Series C-1 Issue for a reduction in stock payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SerciesC1IssueForReductionInStockPayable_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zrx0XXgKLpi2" style="text-align: right" title="Sercies C-1 Issue for a reduction in stock payables, shares"&gt;5,413&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--TemporaryEquityDividendsAdjustment_zM9jXoY9BVo4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Dividend paid in Series B-1 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DividendPaidInSeriesB1PreferredStock_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zfllWXEPraYl" style="text-align: right" title="Dividend paid in Series B-1 Preferred Stock"&gt;5,626&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ConversionOfStockAmountConverted1_z51aSSgC3AL4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: left"&gt;Conversion of Series B and B-1 Preferred Stock to Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zWqfszJKZWha" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(216,916&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,301,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zdBJzBBiFtja" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(467,728&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,507,981&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zbuobMp7Ivfd" style="border-bottom: Black 1pt solid; text-align: right" title="Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"&gt;(266,328&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,658,123&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20210101__20210630_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zpaStK7ArNRe" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesBMember_zMlVoeKrDZIj" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1368"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesB1Member_zDyhxuL7eay8" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1370"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--TemporaryEquitySharesOutstanding_iE_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesC1Member_zKyrmU7mQsId" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1372"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesBMember"
      decimals="INF"
      unitRef="Shares">213583</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesB1Member"
      decimals="INF"
      unitRef="Shares">459426</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesC1Member"
      decimals="INF"
      unitRef="Shares">260702</us-gaap:TemporaryEquitySharesOutstanding>
    <VIVK:DividendPaidInSeriesB1PreferredStock
      contextRef="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member"
      decimals="INF"
      unitRef="Shares">5626</VIVK:DividendPaidInSeriesB1PreferredStock>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesBMember"
      decimals="INF"
      unitRef="Shares">-213583</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesB1Member"
      decimals="INF"
      unitRef="Shares">-459426</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-04-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member"
      decimals="INF"
      unitRef="Shares">-266328</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesBMember"
      decimals="INF"
      unitRef="Shares">216916</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesB1Member"
      decimals="INF"
      unitRef="Shares">467728</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2020-12-31_custom_ConvertiblePreferredStockSeriesC1Member"
      decimals="INF"
      unitRef="Shares">255289</us-gaap:TemporaryEquitySharesOutstanding>
    <VIVK:SerciesC1IssueForReductionInStockPayable
      contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member"
      decimals="INF"
      unitRef="Shares">5413</VIVK:SerciesC1IssueForReductionInStockPayable>
    <VIVK:DividendPaidInSeriesB1PreferredStock
      contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member"
      decimals="INF"
      unitRef="Shares">5626</VIVK:DividendPaidInSeriesB1PreferredStock>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesBMember"
      decimals="INF"
      unitRef="Shares">-216916</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesB1Member"
      decimals="INF"
      unitRef="Shares">-467728</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-01-012021-06-30_custom_ConvertiblePreferredStockSeriesC1Member"
      decimals="INF"
      unitRef="Shares">-266328</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_805_eus-gaap--MinorityInterestDisclosureTextBlock_z17kC2771LC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 12. &lt;span id="xdx_82F_zg5hJXUSXsVi"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For the six months ended June 30, 2022 and 2021, the Company converted
$&lt;span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220101__20220630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zBE7xdKCK3j6"&gt;3,025,000&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210101__20210630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zgymMdMJvqQ3"&gt;735,000&lt;/span&gt; in Viva Wealth Fund I, LLC convertible promissory notes into &lt;span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20220630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_ziIdrGSX1lQe"&gt;605&lt;/span&gt; and &lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20210630__us-gaap--LongtermDebtTypeAxis__custom--VivaWealthFundILLCMember_zy4zphagUTRi"&gt;147&lt;/span&gt; units of noncontrolling interest in Viva
Wealth Fund I, LLC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the six months ended June 30, 2021 and 2020,
the Company paid distributions to Viva Wealth Fund I, LLC unit holders of $&lt;span id="xdx_902_eus-gaap--PaymentsOfDistributionsToAffiliates_c20220101__20220630__dei--LegalEntityAxis__custom--VivaWealthFundILLCMember_zpL2UD5ybnfb"&gt;343,889&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--PaymentsOfDistributionsToAffiliates_dn_c20210101__20210630__dei--LegalEntityAxis__custom--VivaWealthFundILLCMember_zxM69rujKWsj"&gt;none&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;
</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember"
      decimals="0"
      unitRef="USD">3025000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember"
      decimals="0"
      unitRef="USD">735000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember"
      decimals="INF"
      unitRef="Shares">605</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember"
      decimals="INF"
      unitRef="Shares">147</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="From2022-01-012022-06-30_custom_VivaWealthFundILLCMember147106531"
      decimals="0"
      unitRef="USD">343889</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="From2021-01-012021-06-30_custom_VivaWealthFundILLCMember147106531"
      decimals="0"
      unitRef="USD">0</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_806_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zfXdlZyus43e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 13. &lt;span id="xdx_82C_zl7zl2ju1pB8"&gt;Share-Based Compensation &amp;amp; Warrants&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Generally accepted accounting principles require
share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income
statement based on their fair values at the date of grant, net of estimated forfeitures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2022 and December 31, 2021,
the Company has granted stock-based compensation to employees, including a &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20180101__20181231__us-gaap--AwardTypeAxis__custom--ShareStockAwardMember__srt--CounterpartyNameAxis__custom--EmployeesMember_pdd_zjDFnAMi6pG1" title="Option granted"&gt;16,667&lt;/span&gt;
share stock award, which was issued in 2018 and vested in May 2022, &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210630__us-gaap--AwardTypeAxis__custom--StockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesMember_pdd_zfA20N4ycmE2" title="Option granted"&gt;166,667&lt;/span&gt;
in employee stock options that were issued in 2020 and cliff vest at the end of five years, and &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__srt--CounterpartyNameAxis__custom--EmployeesMember_zgl1FUCJKfRf" title="Option granted"&gt;1,872,918&lt;/span&gt;
employee stock options granted in June 2022 and vest over a period of two years. For the six months ended June 30, 2022 and 2021,
stock-based compensation was $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__custom--StockOptionsMember_p0p0_z6andRk94JPd" title="Share-based Payment Arrangement, Noncash Expense"&gt;1,340,703&lt;/span&gt;
and $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__custom--StockOptionsMember_p0p0_ztWxi0R0PUxk" title="Share-based Payment Arrangement, Noncash Expense"&gt;223,056&lt;/span&gt;.
In 2020, the Company also granted non-statutory stock options, including &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember__srt--CounterpartyNameAxis__custom--BoardOfDirectorsMember_pdd_zbhppYpa67me" title="Option granted"&gt;133,333&lt;/span&gt;
stock options to the Board of Directors, which vests over 1 year, and a &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember__srt--CounterpartyNameAxis__custom--ConsultantMember_pdd_zNEPRoHiM775" title="Option granted"&gt;333,334&lt;/span&gt;
stock option to a consultant, which vests over 4 years. Non-statutory stock-based compensation was $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember_p0p0_z7I6JPHa6Cr9" title="Share-based Payment Arrangement, Noncash Expense"&gt;855,000&lt;/span&gt;
and $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20210101__20210630__us-gaap--AwardTypeAxis__custom--NonStatutoryStockOptionsMember_p0p0_zYGRu1rVeID9" title="Share-based Payment Arrangement, Noncash Expense"&gt;730,000&lt;/span&gt;
for the six months ended June 30, 2022 and 2021. In 2022, the Company closed on its underwritten public offering in which the
Company granted the underwriter, EF Hutton, division of Benchmark Investments, LLC ("EF Hutton"), a 45-day option to
purchase up to an additional &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630_pdd_zwSoLkwmr5Cj" title="Option granted"&gt;240,000&lt;/span&gt;
shares of Common Stock at the public offering price per share, less the underwriting discounts and commissions, to cover
over-allotments, if any. These options were not exercised and expired.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There were no other options granted during the
six months ended June 30, 2022 and 2021, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The assumptions used in the Black-Scholes option
pricing model to determine the fair value of the options on the date of issuance are as follows:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOWarrantsValuationAssumptionsTableTextBlock_zQxe2cxJVlX5" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share-Based Compensation &amp;amp; Warrants (Details - Assumptions)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B9_zKgxhekKiKXg" style="display: none"&gt;Schedule of warrant assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 51%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48%"&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;December 31, 2020 through June 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zlsfH0sgceil" title="Risk-free interest rate"&gt;0.24&lt;/span&gt; &#x2013; &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zkGhwGDXrYqb" title="Risk-free interest rate"&gt;3.04&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_c20220101__20220630_zKFJEgzrMNXe" title="Expected dividend yield"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected life of warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zVujzUYtl49d" title="Expected life of warrants"&gt;3.33&lt;/span&gt;-&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zL0iUs4YQLQf" title="Expected life of warrants"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected volatility rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zld1UpQFNTgh" title="Expected volatility rate"&gt;169&lt;/span&gt; - &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zCJiRY6v3g9k" title="Expected volatility rate"&gt;273&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zGFuCeOCsRkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes all stock option
activity of the Company for the six months ended June 30, 2022 and 2021:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEyI1V0pVWfe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-Based Compensation &amp;amp; Warrants (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zg4NRCbjG50l" style="display: none"&gt;Schedule of option activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Life (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; width: 52%; text-align: left"&gt;Outstanding, December 31, 2021&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGzyJcHWsoTh" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Shares outstanding - beginning"&gt;650,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWH5k9Nj5ET3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Weighted average exercise price - beginning"&gt;12.00&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zepFeL2sKfjc" title="Weighted average contractural term"&gt;7.53&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zpITgqxeEjd9" style="text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures"&gt;2,112,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zKdW7w1cSeQ5" style="text-align: right" title="Weighted average exercise price, granted"&gt;2.24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZoitAmMkGXd" title="Weighted average remaining contractual life (years)"&gt;6.60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zU3SiJUmuKJd" style="text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"&gt;(16,667&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zMVxfEggfAsf" style="text-align: right" title="Weighted average exercise price, exercised"&gt;11.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zO1xVgNBXkd1" style="border-bottom: Black 1pt solid; text-align: right" title="Stock Issued During Period, Shares, Restricted Stock Award, Forfeited"&gt;(240,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_z6NF080YqpM5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited"&gt;5.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Outstanding, June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zq1XgtFHQFL" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares outstanding - ending"&gt;2,506,252&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z4eNEImGgT3e" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - ending"&gt;4.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSJjJT94Y5B7" title="Weighted average contractural term"&gt;7.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Exercisable, December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvpCM6SpWLge" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable"&gt;180,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zm0pwFkrSd2i" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zV5pZP1dANb4" title="Weighted average contractural term"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Exercisable, June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zVPn5DMyc4F1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable"&gt;890,168&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zWWgs4brn9h9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable"&gt;4.74&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zw77cQjXXW8i" title="Weighted average contractural term"&gt;7.48&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Outstanding, December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9QMEoObEMWe" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding - beginning"&gt;650,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zavK7tgH9tIg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price - beginning"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSYGHhOc5x14" title="Weighted average contractural term"&gt;6.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Outstanding, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTcI7KvBhsni" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares outstanding - ending"&gt;650,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaV1OFdjkvZe" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - ending"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyBOErZ9OBpf" title="Weighted average contractural term"&gt;5.91&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Exercisable, December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7ChZQMefX9d" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable"&gt;47,083&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zPRRaCvxnh58" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNp6f4INXJoc" title="Weighted average contractural term"&gt;3.38&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Exercisable, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTEi1FknJX82" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable"&gt;108,333&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zZ80KZsmpbJ8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvKBpcjVsmld" title="Weighted average contractural term"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A1_zCsd8nAf1O6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2022 and December 31, 2021, the
aggregate intrinsic value of the Company&#x2019;s outstanding options was approximately none. The aggregate intrinsic value will change
based on the fair market value of the Company&#x2019;s common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2022 and December 31, 2021,
the Company had &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightOutstanding_c20220630_pdd_zgJoM7I0zsw1" title="Warrants outstanding"&gt;80,000&lt;/span&gt;
and &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_do_c20211231_za9wJkA3JTWg" title="Warrants outstanding"&gt;no&lt;/span&gt;
warrants outstanding. On February 14, 2022, the Company closed on its underwritten public offering of &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220630__us-gaap--SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis__custom--PublicOfferingMember_zmIsoCpCise" title="Stock Issued During Period, Shares, New Issues"&gt;1,600,000&lt;/span&gt;
shares of common stock, at a public offering price of $5.00 per share. In addition, the Company has issued the underwriter, EF
Hutton, 5-year warrants to purchase &lt;span id="xdx_906_ecustom--WarrantsIssued_iI_c20220630_zoxolq7QqiN5" title="Warrants issued"&gt;80,000&lt;/span&gt;
shares of common stock at an exercise price equal $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20220630_pdd_z9V7vVaikzj7" title="Warrants exercise price"&gt;5.75&lt;/span&gt;.
and were valued with a fair market value of $374,000. We used the Black-Scholes option pricing model to determine the fair value of
the warrants, with assumptions of a risk free rate of 1.92%, an expected life of 5 years, and volatility of 167%. The impact of
these warrants has no effect on stockholder&#x2019;s equity, as they are considered equity-like instruments, and are considered a
direct expense of the offering.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2018-01-012018-12-31_custom_ShareStockAwardMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">16667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-012021-06-30_custom_StockOptionsMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">166667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-01-012022-06-30_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">1872918</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-06-30_custom_StockOptionsMember"
      decimals="0"
      unitRef="USD">1340703</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-06-30_custom_StockOptionsMember"
      decimals="0"
      unitRef="USD">223056</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember_custom_BoardOfDirectorsMember"
      decimals="INF"
      unitRef="Shares">133333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember_custom_ConsultantMember"
      decimals="INF"
      unitRef="Shares">333334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-06-30_custom_NonStatutoryStockOptionsMember"
      decimals="0"
      unitRef="USD">855000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-06-30_custom_NonStatutoryStockOptionsMember"
      decimals="0"
      unitRef="USD">730000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <VIVK:ScheduleOWarrantsValuationAssumptionsTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOWarrantsValuationAssumptionsTableTextBlock_zQxe2cxJVlX5" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share-Based Compensation &amp;amp; Warrants (Details - Assumptions)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B9_zKgxhekKiKXg" style="display: none"&gt;Schedule of warrant assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 51%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48%"&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;December 31, 2020 through June 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zlsfH0sgceil" title="Risk-free interest rate"&gt;0.24&lt;/span&gt; &#x2013; &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zkGhwGDXrYqb" title="Risk-free interest rate"&gt;3.04&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dpn_c20220101__20220630_zKFJEgzrMNXe" title="Expected dividend yield"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected life of warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zVujzUYtl49d" title="Expected life of warrants"&gt;3.33&lt;/span&gt;-&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zL0iUs4YQLQf" title="Expected life of warrants"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected volatility rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zld1UpQFNTgh" title="Expected volatility rate"&gt;169&lt;/span&gt; - &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zCJiRY6v3g9k" title="Expected volatility rate"&gt;273&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</VIVK:ScheduleOWarrantsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-012022-06-30_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-012022-06-30_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.0304</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-01-012022-06-30_srt_MinimumMember">P3Y3M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-01-012022-06-30_srt_MaximumMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-012022-06-30_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">1.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-01-012022-06-30_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">2.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEyI1V0pVWfe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Share-Based Compensation &amp;amp; Warrants (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zg4NRCbjG50l" style="display: none"&gt;Schedule of option activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;of Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Life (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; width: 52%; text-align: left"&gt;Outstanding, December 31, 2021&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGzyJcHWsoTh" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Shares outstanding - beginning"&gt;650,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWH5k9Nj5ET3" style="border-bottom: Black 2.5pt double; width: 13%; text-align: right" title="Weighted average exercise price - beginning"&gt;12.00&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zepFeL2sKfjc" title="Weighted average contractural term"&gt;7.53&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zpITgqxeEjd9" style="text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures"&gt;2,112,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zKdW7w1cSeQ5" style="text-align: right" title="Weighted average exercise price, granted"&gt;2.24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZoitAmMkGXd" title="Weighted average remaining contractual life (years)"&gt;6.60&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zU3SiJUmuKJd" style="text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"&gt;(16,667&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zMVxfEggfAsf" style="text-align: right" title="Weighted average exercise price, exercised"&gt;11.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_iN_di_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zO1xVgNBXkd1" style="border-bottom: Black 1pt solid; text-align: right" title="Stock Issued During Period, Shares, Restricted Stock Award, Forfeited"&gt;(240,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_z6NF080YqpM5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, forfeited"&gt;5.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Outstanding, June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zq1XgtFHQFL" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares outstanding - ending"&gt;2,506,252&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z4eNEImGgT3e" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - ending"&gt;4.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSJjJT94Y5B7" title="Weighted average contractural term"&gt;7.39&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Exercisable, December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvpCM6SpWLge" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable"&gt;180,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zm0pwFkrSd2i" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zV5pZP1dANb4" title="Weighted average contractural term"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Exercisable, June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zVPn5DMyc4F1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable"&gt;890,168&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20220630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zWWgs4brn9h9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable"&gt;4.74&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zw77cQjXXW8i" title="Weighted average contractural term"&gt;7.48&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;Outstanding, December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9QMEoObEMWe" style="border-bottom: Black 1pt solid; text-align: right" title="Shares outstanding - beginning"&gt;650,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zavK7tgH9tIg" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price - beginning"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zSYGHhOc5x14" title="Weighted average contractural term"&gt;6.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Outstanding, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTcI7KvBhsni" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares outstanding - ending"&gt;650,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaV1OFdjkvZe" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - ending"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyBOErZ9OBpf" title="Weighted average contractural term"&gt;5.91&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Exercisable, December 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7ChZQMefX9d" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable"&gt;47,083&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zPRRaCvxnh58" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNp6f4INXJoc" title="Weighted average contractural term"&gt;3.38&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;Exercisable, June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zTEi1FknJX82" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares exercisable"&gt;108,333&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zZ80KZsmpbJ8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price - exercisable"&gt;12.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210630__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvKBpcjVsmld" title="Weighted average contractural term"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember">P7Y6M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">2112919</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">2.24</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <VIVK:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember">P6Y7M6D</VIVK:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">16667</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">11.1</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">240000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">5.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">2506252</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">4.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-012022-06-30_us-gaap_StockOptionMember">P7Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2021-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-12-31_us-gaap_StockOptionMember">P7Y3D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">890168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2022-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">4.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-012022-03-31_us-gaap_StockOptionMember">P7Y5M23D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember">P6Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-06-30_us-gaap_StockOptionMember">P5Y10M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2020-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">47083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-012020-12-31_us-gaap_StockOptionMember">P3Y4M17D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2021-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">108333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-06-30_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-06-30_us-gaap_StockOptionMember">P5Y1M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">80000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-06-30_custom_PublicOfferingMember"
      decimals="INF"
      unitRef="Shares">1600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <VIVK:WarrantsIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">80000</VIVK:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">5.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zKAIkVVYti8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 14. &lt;span id="xdx_82D_zJt9b1mJ0wic"&gt;Income Tax&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company calculates its quarterly tax provision
pursuant to the guidelines in ASC 740 Income Taxes. ASC 740 requires companies to estimate the annual effective tax rate for current year
ordinary income. In calculating the effective tax rate, permanent differences between financial reporting and taxable income are factored
into the calculation, and temporary differences are not. The estimated annual effective tax rate represents the Company&#x2019;s estimate
of the tax provision in relation to the best estimate of pre-tax ordinary income or loss. The estimated annual effective tax rate is then
applied to year-to-date ordinary income or loss to calculate the year-to-date interim tax provision.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company recorded a provision for income taxes of $&lt;span id="xdx_90E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20220630_p0p0_zAPPz3fSvJ3j" title="Provision for income taxes"&gt;800&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--IncomeTaxExpenseBenefit_p0p0_c20210101__20210630_z3nIGzFpfzeh" title="Provision for income taxes"&gt;723,911&lt;/span&gt; for the six months ended June 30, 2022 and 2021, respectively. The
Company is projecting a (0.04)% &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;effective tax rate for the year
ending December 31, 2022, which is primarily the result of projected provision from book loss incurred for the year offset by additional
valuation allowance on the net operating losses. The Company&#x2019;s effective tax rate for 2021 was &lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210630_z7i5CYECk7m2" title="Effective tax rate"&gt;9.18&lt;/span&gt;% which was the result of the
benefit of book income for the year.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2021, the Company had estimated
federal and state net operating loss (NOL) carryforwards of approximately $&lt;span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_dm_c20211231_zsEAWGy76sfk" title="Net Operating losses"&gt;14.3&lt;/span&gt; million. Federal NOL carryforwards begin to expire in
2028.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">800</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">723911</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.0918</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">14300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zgYUv9GSmJhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Note 15. &lt;span id="xdx_822_zjeaVTsUkre5"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company has evaluated
subsequent events through the date the financial statements were available to issue.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;On August 1, 2022, we
closed a Membership Interest Purchase Agreement, (the &#x201c;MIPA&#x201d;), with Jorgan Development, LLC, a Louisiana limited liability
company ("Jorgan") and JBAH Holdings, LLC, a Texas limited liability company ("JBAH" and, together with Jorgan, the
"Sellers"), as the equity holders of Silver Fuels Delhi, LLC, a Louisiana limited liability company ("SFD") and White
Claw Colorado City, LLC, a Texas limited liability company ("WCCC" ) whereby, the Company acquired all of the issued and outstanding
membership interests in each of SFD and WCCC (the &#x201c;Membership Interests&#x201d;), making SFD and WCCC wholly owned subsidiaries of
the Company. The purchase price for the Membership Interests is approximately $37.4 million, subject to post-closing adjustments, payable
by the Company in a combination of 3,009,552 shares of the Company&#x2019;s common stock, amount equal to 19.99% of the number of issued
and outstanding shares of the Company&#x2019;s common stock immediately prior to issuance, a secured three-year promissory notes made by
the Company in favor of the Sellers, and the assumption of certain liabilities of SFD and WCCC. The shares of the Company&#x2019;s common
stock and the Notes will have an aggregate value of approximately $32,942,939.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Sellers have entered
into 18-month lock-up agreements at closing with regard to the 3,009,552 common shares issued for consideration for the Membership Interests.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Under the MIPA, the
Company has committed to make a payment to the Sellers on or before the 18-month anniversary of the closing date in the amount of
$16,471,469 whether in cash or unrestricted common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In the event of a breach
of the terms of the MIPA, the Notes, or the Pledge Agreement, the sole and exclusive remedy of the parties will be to unwind the MIPA
transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The principal amount
of the Notes, together with any and all accrued and unpaid interest thereon, will be paid to the Sellers on a monthly basis in an amount
equal to the Monthly Free Cash Flow continuing thereafter on the twentieth (20&lt;sup&gt;th&lt;/sup&gt;) calendar day of each calendar month thereafter.
Monthly Free Cash Flow means cash proceeds received by SFD and WCCC from its operations minus any capital expenditures (including, but
not limited to, maintenance capital expenditures and expenditures for personal protective equipment, additions to the land/current facilities
and pipeline connections) and any payments on capital lease obligations of SFD and WCCC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In conjunction with the
closing under the MIPA, SFD, WCCC and the Company will enter into a Shared Services Agreement with Endeavor Crude, LLC, a Texas limited
liability company affiliated with the Sellers (&#x201c;Endeavor&#x201d;), under which Endeavor will provide certain operating and administrative
services to SFD and WCCC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In conjunction with the
closing we entered into a Master Netting Agreement, hereto (the &#x201c;Netting Agreement&#x201d;), with Jorgan, JBAH, Endeavor and White
Claw Crude, LLC under which all amounts as a result of all Contracts during a given calendar month shall be netted against all amounts
owed as a result of all contracts and the resulting net amount shall be payable. The Netting Agreement includes contracts such as the
MIPA, the Notes, any pledge agreements, the Shared Services Agreement, the Crude Petroleum Supply Agreement dated January 1, 2021, by
and between WC Crude and SFD, as amended, and the Oil Storage Agreement dated January 1, 2021, by and between WC Crude, as Shipper, and
WCCC, as Operator, as amended.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In the acquisition
of WCCC we also acquired WCC&#x2019;s Oil Storage Agreement with WC Crude, under which WC Crude has the right, subject to the payment of
service and maintenance fees, to store volumes of crude oil and other liquid hydrcarbons at a certain crude oil and liquid hydrocarbon
receipt, storage, blending, throughput and delivery terminal operated by WCCC, which expires on December 31, 2031.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In the acquisition of
SFD, we acquired a Crude Petroleum Supply Agreement with WC Crude (the &#x201c;Supply Agreement&#x201d;), under which WC Crude supplies
volumes of Crude Petroleum to SFD. WC Crude and SFD will be entered into an amendment to the Supply Agreement, in conjunction with the
closing under the MIPA, which provides for the delivery to SFD a minimum of 1,000 sourced barrels per day, and includes a guarantee that
when SFD resells these barrels, if SFD does not make at least a $5.00 per barrel margin that WC Crude will pay to SFD the difference between
the sales price and $5.00 per barrel In the event that SFD makes more than $5.00 per barrel, SFD will pay WC Crude a profit sharing payment
in the amount equal to 10% of the excess price over $5.00 per barrel, which amount will be multiplied by the number of barrels associated
with the sale. The Supply Agreement, as amended, will remain in effect through and including December 31,2031.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In the acquisition of
SFD, we acquired a crude oil gathering, storage, and transportation facility located on approximately 9.3 acres near Delhi, Louisiana,
along with its existing sales agreements, where a subsidiary of a large NYSE traded energy company is obligated to purchase blended crude
oil from SFD in amounts up to 60,000 barrels per month. With prior approval, SFD is eligible to sell to the Purchaser amounts greater
than 60,000 barrels of crude oil per month. In the acquisition of WCCC, we acquired a 120,000 barrel crude oil storage tank, in the heart
of the Permian Basin, located near Colorado City, Texas. The storage tank is presently connected to the Lotus pipeline system&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to June 30, 2022, VWFI has raised $430,000
in conjunction with the $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC units,
to accredited investors to raise funds to manufacture equipment that manufacture RPC Series B. Subsequent to June 30, 2022, VWFI has also
converted $30,000 of convertible debt into VWFI LLC units.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000299"
          xlink:label="Fact000299"
          xlink:type="locator"/>
        <link:footnote id="Footnote000323" xlink:label="Footnote000323" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 &#x2013; Organization and Basis of Presentation for additional information</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000299"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000300"
          xlink:label="Fact000300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000300"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000301"
          xlink:label="Fact000301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000301"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000302"
          xlink:label="Fact000302"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000302"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000304"
          xlink:label="Fact000304"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000304"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000305"
          xlink:label="Fact000305"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000305"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000306"
          xlink:label="Fact000306"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000306"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000307"
          xlink:label="Fact000307"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000307"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000309"
          xlink:label="Fact000309"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000309"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000310"
          xlink:label="Fact000310"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000310"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000311"
          xlink:label="Fact000311"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000311"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000312"
          xlink:label="Fact000312"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000312"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000314"
          xlink:label="Fact000314"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000314"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000315"
          xlink:label="Fact000315"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000315"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000316"
          xlink:label="Fact000316"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000316"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000317"
          xlink:label="Fact000317"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000317"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000319"
          xlink:label="Fact000319"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000319"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000320"
          xlink:label="Fact000320"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000320"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000321"
          xlink:label="Fact000321"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000321"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000322"
          xlink:label="Fact000322"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000322"
          xlink:to="Footnote000323"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001145"
          xlink:label="Fact001145"
          xlink:type="locator"/>
        <link:footnote id="Footnote001201" xlink:label="Footnote001201" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398. As of April 1 2022, the lender agreed to extend the maturity of the note to April 1, 2023 with an initial payment of $52,448 and approximate monthly payment of $29,432 thereafter until the note is fully paid.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001145"
          xlink:to="Footnote001201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001147"
          xlink:label="Fact001147"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001147"
          xlink:to="Footnote001201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001157"
          xlink:label="Fact001157"
          xlink:type="locator"/>
        <link:footnote id="Footnote001202" xlink:label="Footnote001202" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In 2021 and 2020 the Company entered into various convertible promissory notes as follows:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001157"
          xlink:to="Footnote001202"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001159"
          xlink:label="Fact001159"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001159"
          xlink:to="Footnote001202"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>62
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M-L+3Q4#MF?U N$A8')-AKO"QJLU\5W2TS&T7!#W=$-2>U ] XP3DQD3*+ZB
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MNI,%?:^E#&?:U1L* ."A#[%Z ED"/F.L-GIU(F%YN@ _4-J-0@MM8;4IE''
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M7G\P:M6]A+U5QJBJNUQ* 01L /Q^I\ <;S[8][K;]_CS?P%02P,$%     @
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MX:XW<(BGM1<_M/;.=!-&OH<3B ?"&"5CGA$ZK-T8&CHPP6),L 03+,4$RY#
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M<J6_6&1E_3]Z:6Q],(ZW9276NXM!P3K-F]_1K]U '%P ?O07D-T%I'L!,UQ
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MJ,M:]24.:[BO(*2D9,(C]4L])$P9# I,.,J@6$ %A:4Y8^8Q;@<;/*9(Y0'
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M4V2KI-^!*;NO''%3OGM&AHG-BKP(P+C=I]<Z<G8Q!+OPBD#PJ4;?0&&)(%G
M&B*.8]W'-@8,<E8B)X&O+!"O)4LR#GUW89%R8 ZC;.(T3/.BZW2S-L^%LN\R
M!@VG"ROB,IT'-E*CU1<+[)IQ0*XS!DBG%;[^ ':NN( GZZQM(8;IC' 7(YQ5
M6&=)N$^CV\W"Y"LSM$/HAP4&L;#B!A<M/-W$?#/;%V8IK9/IGDR7>6VXD2TH
M[L$*KJNL_0#2R1T61^H-=9Q?8L<YO&7K@\W.87./PDL*A=KE'HMROK;>>OD
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MICUH#Z3WQT' AIM$*%-IA&_+G;&:OJCOIXZGR3XZG=W=LDM3L@3G 5TC@_J
MP>+UR\$X>G.FME%7V^@<^__U\RSE:<$?E448]N&O^6@ E0'U$+L>^J -)ECL
M*&XX\+OT5)5^H3R6-5CG*N(!$D4F8*SC.3#-567HXI7*< JIN<WA@#)5FEI9
M:I6A<8[!!#BI/$$@<Y&NSXK,")-*<_OPA"=G4%GFPTA4S33FQ(\O!-)=-_U_
MEP\U0L[2DVS@V9Z2<@E4)K!"5=*7]0K&@]YX,H;)L!>/+F! R]'%% :C7CR=
MPJD/(SRZ] 7JO;<V0V=%E,W][W8[]UPVIO$4WECO-=-[+@VIS @:]2<7 >C&
MSIJ%5:6WD)VR9$A^FM,? +4+H/>9HL^A7;@$W3]E\0M02P,$%     @ (8DO
M5=LPB"#- @  0 8  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULC57?
M;],P$'[GKS@%Q).U.,[OT5;:!H@A@28FX 'QX";7)EIB%]M=M_^><]*%@KJ*
ME\3GW/?==[[S9;;3YLXVB X>^D[9>= XMSD/0ULUV$M[IC>HZ,M*FUXZ,LTZ
MM!N#LAY ?1<*SK.PEZT*%K-A[\8L9GKKNE;AC0&[[7MI'B^QT[MY$ 5/&U_:
M=>/\1KB8;>0:;]%]W=P8LL*)I6Y[5+;5"@RNYL%%='Z9>/_!X5N+.WNP!I_)
M4NL[;US7\X![0=AAY3R#I-<]7F'7>2*2\6O/&4PA/?!P_<3^?LB=<EE*BU>Z
M^][6KID'10 UKN2V<U_T[@/N\TD]7Z4[.SQA-_JF%+':6J?[/9CLOE7C6S[L
MS^$ 4/!G &(/$(/N,="@\JUT<C$S>@?&>Q.;7PRI#F@2URI?E%MGZ&M+.+?X
M),T=.KGL$&ZQVIK6M6AGH2-J[Q!6>YK+D48\0Y/!)ZU<8^&=JK'^&Q^2I$F7
M>-)U*4X2?MRJ,X@Y \&%.,$73WG& U_\#-^UND?KJ)N<9? 6EPZDJN'=KVWK
M'@\RAQ\72^L,]<K/8X<PQDB.Q_#WY]QN9(7S@"Z(17./P>+URRCC;TYDD$P9
M)*?8_[]2)VF.B_RL'4)R!D=CP(4%O:)#J[!?HH$X&JI"M7$-PI7N-U(]@MXI
MK"%F,2]9GA909)PE901IF;*X%!"1E3"1IW"M"!Z5?Z$;65-!H)VJY".^@H)S
MQCE_>H_KB.59 2)C<9ZQHA!0Y(PG"47(4D&Q4RA8G,8LSW-(HIA%10F"B62$
M1ZR("L;%L$>IB*C8)T@MAU/+#>WQ;\KT[*<3>F'_G- .#9+<8]R'JLJD9%%6
M3JI(8SR>R;'^" ]N=8]F/<PN"Y7>*C=>\&EW&H\7XU3XXS[.5JKKNE46.EP1
ME)_E:0!FG%>CX?1FF!%+[6CB#,N&1CP:[T#?5YHZ9&_X --/8_$;4$L#!!0
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M&+L^-GLG3U/4-",6TRS-:![ZW23*<+L$*4[2W+=[!&%LP1P+& 0$[WM[E!V
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M,Q:5=:#[E:1R=88-T$_M] ]02P,$%     @ (8DO51PSH3Y6!0  WPP  !D
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M6D(H,#<6@='PB&]0" M$-+YTF(->I17<_=Z@OW.VDRTSIO&-%)]Y89:7@\D
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MMH1UO.H1<JM=<B<_DINKFW'!4U2BC2R@J'B\^,-\(*5ZHL5W8Z&)(AN;47[
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MR2T^S\8M<$Y%)"?F,;K[@879GV0AB">7K#SXWF9*ZA!GALJ,/4'G++UG<.3
MY[:)T 8/I1<Z0E-RA[5[LC\;(?$#51"1[DE *N=0;?>7YU=U ?A6/%18DF^1
M_PU<UZ.IX(?=MMCX^1GM*.O<%$\X/X.CS@GY1%'HX)G-H<<,E$8=DDR3(IV
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M8A1:1+9MKIUH436M92$T-JK&7.&7 :1QP/U,"+V;F #]MR;^ U!+ P04
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MIXWD1&.#<F44[@K4,_-SR1H-K"G@FS1<PP6[9ZN*P[MK^]#OCV<&3[&RLWQ
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M/>0N#3+<ID C2BA%/&8+'Z$6G<AOX-/7)?@QR9($_(R$H3<R7NZ06RA1;/B
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M)IU57J$[)^A%V/\0]%*N7L6P$8*+,"D@S]AD%NT2\I)EDVFP!>135HA9L,?
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MU6]7-%Y05IT@OU\6A7@YJ!SL]B@]_Q]02P,$%     @ (8DO5=/YUYIG P
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MQ<P;>R2#G-:EN9.[][!/*+%\3);:?9-=$SO"'5FMC:SV8)Q77#2_]/O>B ,
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M7J">IXS)^XENU9K6//H+4$L#!!0    ( "&)+U6&<,3=[@4  &<P   9
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MXT+(PXT@83$0K.<CL_.1J?31_;EN46(N=<L>9A]=,^QB5]-/KJT'F=0_,VD
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M%%6C6B=4U.U%M1<F',2J8Z>V0^BWG^V$"*V427O@!?'9=[_[V^=STDCUH L
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MV\!P\-X25/MNM(:1E>_5I32V\_VPL$\M*.=@U]=2FKWAVK]_O+.?4$L#!!0
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MCH9 Y%&TG:3R LCN!5ZR-'BC:X/](CO? !_"+*#>DX"#/@IP^RS@$&8!*;.
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MMP#6$/V5I;( 9%\+0(;*;NZC*=#61Z(L +%; -LJ@*RK@!UXUZ'O"DUO@_(
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M&CY4-H">;Z0T]Q-;H&TAX^]02P,$%     @ (8DO55#@L5L+ P  $@D  !D
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MUI^A]A,:OD2DJOPEZRHVQ."D4%ID-1@59(Q7_W13YV$/X 8G %X-\%X*\&N
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MP$4*/C%)!+C'*SS)"'A[0R2FF7@'?@-?'V[ VS?O+@92=:C=!M,U^+@&]P^
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M3YTG5VCM$6C4#G);?T).%8\KM#;YK1*4FQK4?G&IN_#186BM?" M3]HMC1!
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M=V3ON2H[7SDQLO#=9B&-[5U^F-N_!5#.P.YG4IK#Q 6H_S^2WU!+ P04
M"  AB2]5[K@^\^<%  #:)@  &0   'AL+W=O<FMS:&5E=',O<VAE970T-BYX
M;6S-6FUOZC84_BL6FZ[NE5H2)R307HK40K)U6K>JU=8/5_M@P$#4O'!M4\J_
MGY.8D 3'A%Y+6S^4O)SSV#[/\<%^\'";D%>ZPIB!]RB,Z4UGQ=CZVC#H;(4C
M1+O)&L?\S2(A$6+\EBP-NB88S3.G*#0LTW2-" 5Q9S3,GCV2T3#9L#"(\2,!
M=!-%B.SN<)AL;SJPLW_P%"Q7+'U@C(9KM,3/F/VU?B3\SBA0YD&$8QHD,2!X
M<=.YA=>^E3ED%G\'>$M+UR =RC1)7M.;^_E-QTQ[A$,\8RD$XA]O>(S#,$7B
M_?@N0#M%FZEC^7J/[F>#YX.9(HK'2?@2S-GJIC/H@#E>H$W(GI+MKU@,R$GQ
M9DE(L_]@*VS-#IAM*$LBX<Q[$ 5Q_HG>12!*#I;3X& )!ZNM@RT<[+J#V^#0
M$PZ]MBTXPL%IZ^ *!S>+?1ZL+-(3Q-!H2)(M(*DU1TLO,KHR;Q[@($XSZYD1
M_C;@?FSTO$($7]YQ;N9@G$0\82G**/^$HO57\(((03&CX/,$,Q2$] NX!#\#
M ]#4CPX-QON0(ADST=Y=WI[5T)X-'I*8K2CPXCF>2_S':G_WE+^G]H>6 L#@
MP2LB:.TC>&<I$1\0Z0(;7@#+M"S9@-3NOVUB[FXVND_:NT-9.-3N$SPK.B]S
M]]N[FXI8VD4VVAF>?6XVWJ9IN,2\I#$PW8&RW2/:98]OMXC,P;??.22X9SBB
M_\BR,V^_)V\_+>/7=(UF^*;#ZS3%Y UW1I]^@J[Y5<:L3K")3C!/)YBO":R2
M$;TB(WHJ=)$1TY89,3W.B OPYSIUH!?@E[R4!3%XQ"1(^*L_^%=WL@#\.VJ!
M [9IJ&C*'IZ;,SF8FX&E7_MO(ZMG\K^A\5;.!IUM>CK!?$U@E6QPBFQPE-G@
M?=\$;"<8!=\><#3%1#K/E3CG<J83;*(3S-,)YFL"JS#K%LRZ_W'E=W5FA$ZP
MB4XP3R>8KPFLDA'](B/ZIRL_!7PW1!F*YT&\Y$O/*5X&<<RO90SWCTJKZQR7
MUG$[LTD[,Z^=F:\<ZP<C.2@B.5!&\B7;7O$)@]XPX=M%@-\QF044@S4)9OA4
M6'-PIS1":-5">MID<MK$.VWB*P?ZP3!>%6&\.B^,,[Z1('QKO"$H! R32!8]
M)>:Y94?=P3[8840HZ($HW^)8)IBCG6Q-,U$C.0()F@74H G*:]<I=X\$&SOE
MJY'<H^')^E2A%IJ';;#YOU]GJKMX;JX(M,I*$T+K"E[59J;69CVM:+XNM&I6
ME,01^".5\P(L4ZJE.L2=&OIL-G.T09G-KM6K4ZFS34\KFJ\+K4JE=:#2.H]*
M@E/A-5U6%'6<E_$P6&#P.2LT7Z2L*ELYFU5UG_<5K[^O>&YC/=?:+T\KFJ\+
MK<K\05."2H%":VGWQ/PO57=IEFB5F01:N9)?0M=U^_79KU5"THKFZT*KYL!!
M18)J&>ED(=_?R^G4J@ )- C+"UW8A74VM4I 6M%\76A5-@\J$%3+0,\LF;V"
M>THWG-')AJ1%?+_4RK>-%^ )4\:I33G/S<54%FNP!J*URD8"K3)OI6*?UF8]
MK6B^+K0JU0=9""HUAM,3=Z'D4ZOH(]#*&U2GSJ16+4<KFJ\+K<KD0<Z!']!S
M<'8AI4Z38B*H.Y9I+,=T+:<N4T@,I;)/2SO_M%TUG =-!_ZHJ*.(K2891<1V
M<+0UZ74=NQ[8%@)0"QM?;5,-YD'9@6II0>2F""&:AE@:-JU:CD K9\;@RH3N
MH!ZX8SMH#FS;K@=/8C>09>2Q7:_/ >4QM X*BJ564%HDI#J\:OQSPRO0JEG9
MKV^8A94R*UO8^&J;:D0/ZH-UIOK02G \ ;K7XYQ"1;.;-I5C-=2Y/W.<Z%BA
M.>8=:][K>BU'V#@N_P2 71<:8;]1:#1*1V\B3);9(2G*F=K$+#_W4#PM#F+=
M9L>/:L_'\'H")<\]>.WGQZP.\/FIKP=$ED%,08@7O"FSV^?91_*#5/D-2];9
MP9]IPE@299<KC.:8I ;\_2))V/XF;: XSC;Z%U!+ P04    "  AB2]5*6:S
MYB &  !L-   &0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6S%F^]OVC@8
MQ_\5BSM-F[0UQ(% .XI4L*?KZ;95JW9[,=V+$ Q$2V+.-J65[H\_YT<3#)F;
MZ)X3O&A)\/.Q\WWL)WX>R&3/Q0^Y84RAQR1.Y75OH]3VRG%DN&%)("_XEJ7Z
MDQ472:#TH5@[<BM8L,R-DMC!_;[O)$&4]J:3_-R=F$[X3L51RNX$DKLD"<33
MC,5\?]US>\\GOD3KC<I..-/)-EBS>Z:^;N^$/G(JRC)*6"HCGB+!5M>]&_>*
M>C@SR%O\&;&]/'B/LDM9</XC.[A=7O?ZV8A8S$*5(0+][X'-61QG)#V.OTMH
MK^HS,SQ\_TS_D%^\OIA%(-F<Q]^BI=I<]\8]M&2K8!>K+WS_&RLO:)CQ0A[+
M_"_:%VU'EST4[J3B26FL1Y!$:?$_>"R%.##0G&8#7!K@8X/!3PR\TL [-O!_
M8C H#09M>QB6!OFE.\6UY\*10 73B>![)++6FI:]R=7/K;5>49I-E'LE]*>1
MME/3^TT@V+N9EGJ)YCS1\T\&N0=?!<GV/?H6"!&D2J+7A*D@BB7ZE)W)G/L&
MO4-?[PEZ_>N;B:/T4#*@$Y;=SHIN\4^Z]=%'GJJ-1#1=LF6#/;';N]@"<+0&
ME1#X68@9MA)_WZ47R.N_1;B/<<. YNW-W:;KL9L3%FIS-S-WQPWFM+7Y<>^&
M&%XU*[R<YW6=%3?9=%@S'2D46CRAPW9WP5-^^F8?B"7Z_H=&HEO%$OE7T_0H
M^A\T]Y]%QRNY#4)VW=/A3S+QP'K35[^X?O]]DVL@80021H%@AA,'E1,'-OKT
M\S9WV3I;P(UK;%;8^[E]=D=YF.)!7[\FSL.AO-9NNLH+":- ,$/>827OT"IO
M,?<7YMROE\=;](FG82 WB#YFZX<U.:#H87C@ -<;]$=][\@#I^TP]OK#H=F,
M6 ?<55L@F*&M7VGK6[6M;CMZ:R-5D"ZC=-VDGW\R@<<-\]?:5]?Y"PFCI^.O
MQVX(-ZJ$&[43+I)RU[SH1ZTTLW;353-(& 6"&?*.*WG'[>1ECTR$D61H*Z*P
M<6D7H/&!S,.+T=&"G5M[ZZHR)(P"P0R5+RN5+ZTJW^T6<12BSZL5$WKAH^\?
M6;)@HG$?825UW4= P@@DC +!#'>X_3I'Z)]Y.U@. ,B/H#0"2J-0--.5!^F>
M:]^U*![^0+?YW0&17;Z^[O0RX\NWA?NDWKCH]#YO(1M=Y9[<0/3H&FXA]I%T
M]@(DC4+13"_@V@O8Z@6:;&/^Q)BTQC8[I/.B@*014!J%HIGNJ+-=]]SIK@N:
M[X+2""B-0M%,5]8YK_M?DU[W-.MUQR-\F=5=S/@%FO>"TB@4S52Y3GW=%KDO
M*NXEY0(HXQCZ![4,;I#)ZAR41D!I%(IF^JI.I5W_W,$-,B>>@]((*(U"T4Q7
MULF]:\_N6P0WR%1[#DHC[FGEP?5]?V2&70K5J:EQG>&[]A2_"&J%TB]$,,B$
M>PY*(Z T"D4S75*7 ]S+<T<PT#("*(V TB@4S?R.K:XD8&MZ"U(T+[MXN6K>
MT# OF_M'97/[F+LJ#$4S%:X3?-PFP3^.7ZVW979ZUY4 2B.@- I%,_U4EP P
M/G-0PZ#E U : :51*)KIRKI\@*TY;8MMF1W0V15>XT;J>"=%0'NE4#13Y#JQ
MQ_;$7M\8=,(9J)WBX@FUWZ79L9VE!ZT)@-(H%,UT4%T3P,-S!S30D@$HC8#2
M*!3-=&5=,L#VK]]!=FG^R>9K/!R>?DO0T&[DG7Z;0.Q#[BSP_Y'(XSJ1Q_9$
MODTPTUNV&<^6Q><5(I%@H6[[0J@#3?Y!:0241J%HIOOJ&@$>GSO4@=860&D$
ME$:A:*8KZ]H"MO_6H,7>[?)TM^5EK^- !IKU@](H%,W\,6F=]7OVK+]EN)OK
MXUVLM">L8<[>6>??CH+^5@"41J%HIMOJ4H+GGCG,>:#5!E : :51*)KIRKK:
MX-E_</!RF"L!AV$NCW*#HS!G[ZBSR*!U "A:(;)S\%1%PL0Z?YQ%HI#O4E4\
M5U"=K1Z9N<D?%#DZ/W.OYL6#+S6F> [G8R#6D0Z",5MI9/]BI+?!HGBTI3A0
M?)L_N['@2O$D?[MAP9*)K('^?,6Y>C[(.J@>,)K^"U!+ P04    "  AB2]5
MU==,^PT#   V#   &0   'AL+W=O<FMS:&5E=',O<VAE970T."YX;6RM5VUO
MVC 0_BM6-DVMM))70LL@4B%!ZZ1VJ%VW#],^F'! U"3.;/.R?S_;"2DO:4;7
M\ %LYY[G?/=<[*.W)O2)+0 XVB1QROK:@O.LJ^LL7$""68MDD(HG,T(3S,64
MSG664<!3!4IBW3(,5T]PE&I>3ZV-J=<C2QY'*8PI8LLDP?3/ &*R[FNFMEVX
MC^8++A=TKY?A.3P ?\S&5,STDF4:)9"RB*2(PJRO79O=D2OME<'W"-9L9XQD
M)!-"GN3D9MK7#+DAB"'DD@&+GQ4,(8XED=C&[X)3*UU*X.YXRSY2L8M8)IC!
MD,0_HBE?]+5+#4UAAI<QOR?KSU#$TY9\(8F9^D;KW-81'L,EXR0IP&*>1&G^
MBS=%'G8 @J<:8!4 ZQ#@O "P"X!]J@>G #BG>F@7@/:I +< *#'U/%DJTS[F
MV.M1LD946@LV.5!R*;1(<)3*PGK@5#R-!(Y[-VE($D#?\ :=^<!Q%#-TARG%
M4O!S=($>'WQT]OZ\IW/A36+TL& >Y,S6"\PVNB4I7S 4I%.85N#]>KQ;@]=%
ME&6HUC;4@55+^&69MI!M?$2685D5^QF>#C>KPGF;]^!MWD?U<!]" 3>KX'NY
MM,NRL16?_>^R\2,6QH0M*:"?UQ/&J3@L?E652\[H5#/* [3+,AQ"7Q,G) .Z
M LW[\,YTC4]56C5)YC=)%C1)-FJ(;$]CI]38J6/WQI2L(G6!B/L+1;GB'&^
M5:F;<[45E[S-5I[1TU>[DAU;7%A7KM/I[-OYQW:7Q@%7<&S3L>PKT]PW&]4&
M^)_I:Y?I:]>F+YC-0%V;,F=('*A0E;9:CM>^%$V2^4V2!3F9:>R61\NX,H6R
MSY]#]1K:P9YZ;JF>6ZO>G>CIOF8@[\%TCL3YQJK+OI;EM?HU2>8W218T239R
MCUY>T[%5!90%D&NF[_0U"="YZD 9"LDRY?E=5:Z63>ZUZNT.U@=F=VA6K/MF
M-\A[V&?ZO*.^Q70>I0S%,!.NC%9';)?F76H^X2137=6$<-&CJ>%"-/9 I8%X
M/B.$;R?20?E7P?L+4$L#!!0    ( "&)+U5B'!5W-P,  $@3   -    >&PO
M<W1Y;&5S+GAM;-U876_:,!3]*Y&[3JTT-4#6E*R M"%5FK1-E=J'O56&.&#)
ML3/'Z6"_?KYQ"!_U1:P/&RRHQ+XGY]QC^Z9V.RC-4K"'.6,F6.1"ED,R-Z;X
M$(;E=,YR6EZI@DF+9$KGU-BNGH5EH1E-2R#E(NQU.G&84R[):""K_"XW93!5
ME31#$K>AP-T^IT/2C=^3P,F-5<J&Y.GB[8]*F=LW@;N?O3L[ZSQ=WN[&+VK@
MDH1>T>L#1*\Z'5P80$P\/DQ\GS8F?;,M73]^;H4<\1RC]3TTFV7-A Y&3@X:
MSI[1U,)AL]JC0:;D>M$CX@(V,\U9\$S%D(RIX!/-@971G(NE"_<@,%5"Z<#8
M:K-6NA I?SFXZWI0B(U.SJ72=6Z7P7U/FL=W@%4/#'(A6H,]X@*C04&-85K>
MV4[]<!U\ 05-^W%96(<S39?=WC59$^J;33)1.F6Z3=,EJ]!H(%@&=C2?S>%N
M5!$":(S*;2/E=*8DK3VL&$W#RDZ9$ _PEG[/MK07V<::=F!%9=NTAIJFDW$=
MT-]4<]J;LKU7Z08%?U;F4V6'(^L^U J[URSCB[J_R%H#F'H75Z=%(98?!9_)
MG+G!'YQP-* K7C!7FO^RV:!4IC; - F>F39\NAGYJ6GQR!9F54Z+#/?<.T'/
M?W>>9TPR3<6F:5O[QSS+KW;<;&O_PG/]:V77L==D='/\'INM_-A-QJ=@\B26
MNW\*)I.C-!DV&_C&*6'KC-!& SB+#<DW./6)==)@4G%AN&QZ<YZF3+XX*EAY
M0R?VSX0M??M\RC):"?/8@D.R;G]E*:_RI'WJ'B:B>6K=_@+#Z\;M0=#FXC)E
M"Y:.FZZ>3>IF8!LV:W,!81>YJR\_@G$<YD< P_)@#C".8V%Y_J?Q]-'Q. SS
MUO<B?9331SF.Y4/&]0?+X^<D]O*/-$FB*(ZQ&1V/O0[&V+S%,?SXU3!OP,#R
M0*8_FVM\M?$*V5\'V)KNJQ!LI'@E8B/%YQH0_[P!(TG\JXWE 0:V"ECM0'Y_
M'J@I/R>*8%4Q;]@;C"-)@B%0B_X:C6-D=F+X^-<'>TNB*$G\"&!^!U&$(? V
MX@CF #Q@2!35^^#.?A2N]JEP_;^ST6]02P,$%     @ (8DO59>*NQS
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M4$L! A0#%     @ (8DO50=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  AB2]55P\_?>\    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M"  AB2]5F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( "&)+U5/17@:JP,  &4,   8
M      " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M"  AB2]5/,PX(-L'  #3'P  &               @('O"P  >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ (8DO569V6!=& P  IPL  !@
M             ("! !0  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( "&)+U60CFD%QP@  *0G   8              " @7P7  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  AB2]5@]#%<*T-  #]
M?@  &               @(%Y(   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ (8DO50-+.<;1"   $"<  !@              ("!7"X
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( "&)+U6J+U,9
MTQ$  -XP   8              " @6,W  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    "  AB2]5 Q9RKVP"  !<!0  &
M@(%L20  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ (8DO
M54FWH>;) @  7P8  !@              ("!#DP  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( "&)+U7;,(@@S0(  $ &   9
M      " @0U/  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ (8DO5>R@^04E P  Y08  !D              ("!$5(  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  AB2]5[&\0B%,$   Q"@
M&0              @(%M50  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( "&)+U7@J[8V)P,  "L'   9              " @?=9  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ (8DO5: F=B<?
M!P  FA$  !D              ("!55T  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    "  AB2]5Z._9."((   O%   &0
M@(&K9   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( "&)
M+U6O7YO$)P0  .8(   9              " @01M  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ (8DO5?T_+RVE P  O D  !D
M         ("!8G$  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    "  AB2]5P>G(K7X"  #!!0  &0              @($^=0  >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( "&)+U4<,Z$^5@4  -\,
M   9              " @?-W  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ (8DO51D4*T?Z P  1 D  !D              ("!@'T
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  AB2]5< U0
M;ZL*  #6&@  &0              @(&Q@0  >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( "&)+U4GCOO39Q(  )8U   9
M  " @9.,  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
M(8DO56)K>+GL P  10D  !D              ("!,9\  'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    "  AB2]5.%B?2N0"  !W!@  &0
M            @(%4HP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( "&)+U5(NO=;]00  "4+   9              " @6^F  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ (8DO5=>Z$C+8 @
M:@8  !D              ("!FZL  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    "  AB2]5^ =J^0L#   )!P  &0              @(&J
MK@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( "&)+U4B
MW<$O1 ,  - (   9              " @>RQ  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ (8DO57C2@0*5 P  BP@  !D
M     ("!9[4  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "&)+U5W:VZ + (  ,@%   9              "
M@=//  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ (8DO
M5?<+*^]O!@  @2X  !D              ("!-M(  'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    "  AB2]5R/+2%#\#  !."@  &0
M        @('<V   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( "&)+U50X+%;"P,  !()   9              " @5+<  !X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ (8DO52HXIP>H!@  O2(
M !D              ("!E-\  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    "  AB2]5?2(W*X$"  !O!@  &0              @(%SY@
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( "&)+U5'-[Q
MAP,  $0-   9              " @2OI  !X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ (8DO5?Z]]2&F!0  *BD  !D
M ("!Z>P  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    "  A
MB2]5/"0NFML"   T"   &0              @('&\@  >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( "&)+U6>)2DG%@0  !06   9
M          " @=CU  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#
M%     @ (8DO56B>6.P' P  -0H  !D              ("!)?H  'AL+W=O
M<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    "  AB2]5""4;9=4"  "+
M"   &0              @(%C_0  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM
M;%!+ 0(4 Q0    ( "&)+U7NN#[SYP4  -HF   9              " @6\
M 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ (8DO52EF
ML^8@!@  ;#0  !D              ("!C08! 'AL+W=O<FMS:&5E=',O<VAE
M970T-RYX;6Q02P$"% ,4    "  AB2]5U==,^PT#   V#   &0
M    @('D# $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M "&)+U5B'!5W-P,  $@3   -              "  2@0 0!X;"]S='EL97,N
M>&UL4$L! A0#%     @ (8DO59>*NQS     $P(   L              ( !
MBA,! %]R96QS+RYR96QS4$L! A0#%     @ (8DO57)X*M <!   #"    \
M             ( !<Q0! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( "&)
M+U62+*"6N $  .<<   :              "  ;P8 0!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "&)+U6,3^J/N@$  .X<   3
M          "  :P: 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     X #@
*/P\  )<< 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>197</ContextCount>
  <ElementCount>259</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>65</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/BasisOfPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Liquidity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Liquidity</Role>
      <ShortName>Liquidity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Prepaid Expenses and Other Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/PrepaidExpensesAndOtherAssets</Role>
      <ShortName>Prepaid Expenses and Other Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Accounts Payable and Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/AccountsPayableAndAccruedExpenses</Role>
      <ShortName>Accounts Payable and Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Loans and Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://vivakor.com/role/LoansAndNotesPayable</Role>
      <ShortName>Loans and Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Long-term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Long-termDebt</Role>
      <ShortName>Long-term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Temporary Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/TemporaryEquity</Role>
      <ShortName>Temporary Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Noncontrolling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/NoncontrollingInterest</Role>
      <ShortName>Noncontrolling Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Share-Based Compensation &amp; Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Share-basedCompensationWarrants</Role>
      <ShortName>Share-Based Compensation &amp; Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/BasisOfPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vivakor.com/role/PropertyAndEquipment</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vivakor.com/role/AccountsPayableAndAccruedExpenses</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Loans and Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://vivakor.com/role/LoansAndNotesPayableTables</Role>
      <ShortName>Loans and Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vivakor.com/role/LoansAndNotesPayable</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vivakor.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Long-term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Long-termDebtTables</Role>
      <ShortName>Long-term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vivakor.com/role/Long-termDebt</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Temporary Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/TemporaryEquityTables</Role>
      <ShortName>Temporary Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vivakor.com/role/TemporaryEquity</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Share-Based Compensation &amp; Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Share-basedCompensationWarrantsTables</Role>
      <ShortName>Share-Based Compensation &amp; Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vivakor.com/role/Share-basedCompensationWarrants</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Basis of Presentation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/BasisOfPresentationDetailsNarrative</Role>
      <ShortName>Basis of Presentation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/BasisOfPresentationPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Liquidity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/LiquidityDetailsNarrative</Role>
      <ShortName>Liquidity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/Liquidity</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Prepaid Expenses and Other Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative</Role>
      <ShortName>Prepaid Expenses and Other Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/PrepaidExpensesAndOtherAssets</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Marketable Securities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/MarketableSecuritiesDetailsNarrative</Role>
      <ShortName>Marketable Securities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/MarketableSecurities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Inventories (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/InventoriesDetailsNarrative</Role>
      <ShortName>Inventories (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/Inventories</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Accounts Payable and Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Loans and Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://vivakor.com/role/LoansAndNotesPayableDetails</Role>
      <ShortName>Loans and Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/LoansAndNotesPayableTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Loans and Notes Payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative</Role>
      <ShortName>Loans and Notes Payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/LoansAndNotesPayableTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Long-termDebtDetails</Role>
      <ShortName>Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/Long-termDebtTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Temporary Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/TemporaryEquityDetails</Role>
      <ShortName>Temporary Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/TemporaryEquityTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Noncontrolling Interest (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/NoncontrollingInterestDetailsNarrative</Role>
      <ShortName>Noncontrolling Interest (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/NoncontrollingInterest</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Share-Based Compensation &amp; Warrants (Details - Assumptions)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions</Role>
      <ShortName>Share-Based Compensation &amp; Warrants (Details - Assumptions)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/Share-basedCompensationWarrantsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Share-Based Compensation &amp; Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Share-basedCompensationWarrantsDetails</Role>
      <ShortName>Share-Based Compensation &amp; Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/Share-basedCompensationWarrantsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Share-Based Compensation &amp; Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative</Role>
      <ShortName>Share-Based Compensation &amp; Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/Share-basedCompensationWarrantsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="vivakor_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Income Tax (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vivakor.com/role/IncomeTaxDetailsNarrative</Role>
      <ShortName>Income Tax (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vivakor.com/role/IncomeTax</ParentRole>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RetainedEarningsAccumulatedDeficit -  vivakor_s1.htm 139</Log>
  </Logs>
  <InputFiles>
    <File doctype="S-1" original="vivakor_s1.htm">vivakor_s1.htm</File>
    <File>vivakor_ex107.htm</File>
    <File>vivakor_ex2101.htm</File>
    <File>vivakor_ex2301.htm</File>
    <File>vivk-20220630.xsd</File>
    <File>vivk-20220630_cal.xml</File>
    <File>vivk-20220630_def.xml</File>
    <File>vivk-20220630_lab.xml</File>
    <File>vivk-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_004.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="701">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="14">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>68
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "vivakor_s1.htm": {
   "axisCustom": 0,
   "axisStandard": 15,
   "contextCount": 197,
   "dts": {
    "calculationLink": {
     "local": [
      "vivk-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vivk-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "vivakor_s1.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vivk-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vivk-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vivk-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 462,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 61,
    "http://vivakor.com/20220630": 59,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 124
   },
   "keyCustom": 52,
   "keyStandard": 207,
   "memberCustom": 48,
   "memberStandard": 16,
   "nsprefix": "VIVK",
   "nsuri": "http://vivakor.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://vivakor.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Marketable Securities",
     "role": "http://vivakor.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Inventories",
     "role": "http://vivakor.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Property and Equipment",
     "role": "http://vivakor.com/role/PropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Accounts Payable and Accrued Expenses",
     "role": "http://vivakor.com/role/AccountsPayableAndAccruedExpenses",
     "shortName": "Accounts Payable and Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Loans and Notes Payable",
     "role": "http://vivakor.com/role/LoansAndNotesPayable",
     "shortName": "Loans and Notes Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Commitments and Contingencies",
     "role": "http://vivakor.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Long-term Debt",
     "role": "http://vivakor.com/role/Long-termDebt",
     "shortName": "Long-term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VIVK:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Temporary Equity",
     "role": "http://vivakor.com/role/TemporaryEquity",
     "shortName": "Temporary Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VIVK:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Noncontrolling Interest",
     "role": "http://vivakor.com/role/NoncontrollingInterest",
     "shortName": "Noncontrolling Interest",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - Share-Based Compensation & Warrants",
     "role": "http://vivakor.com/role/Share-basedCompensationWarrants",
     "shortName": "Share-Based Compensation & Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "role": "http://vivakor.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - Income Tax",
     "role": "http://vivakor.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Subsequent Events",
     "role": "http://vivakor.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VIVK:Covid19PolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Basis of Presentation (Policies)",
     "role": "http://vivakor.com/role/BasisOfPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VIVK:Covid19PolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Property and Equipment (Tables)",
     "role": "http://vivakor.com/role/PropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Accounts Payable and Accrued Expenses (Tables)",
     "role": "http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables",
     "shortName": "Accounts Payable and Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Loans and Notes Payable (Tables)",
     "role": "http://vivakor.com/role/LoansAndNotesPayableTables",
     "shortName": "Loans and Notes Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://vivakor.com/role/CommitmentsAndContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - Long-term Debt (Tables)",
     "role": "http://vivakor.com/role/Long-termDebtTables",
     "shortName": "Long-term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "VIVK:TemporaryEquityTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - Temporary Equity (Tables)",
     "role": "http://vivakor.com/role/TemporaryEquityTables",
     "shortName": "Temporary Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "VIVK:TemporaryEquityTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VIVK:ScheduleOWarrantsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - Share-Based Compensation & Warrants (Tables)",
     "role": "http://vivakor.com/role/Share-basedCompensationWarrantsTables",
     "shortName": "Share-Based Compensation & Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VIVK:ScheduleOWarrantsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "role": "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-02-132022-02-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - Basis of Presentation (Details Narrative)",
     "role": "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
     "shortName": "Basis of Presentation (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-02-132022-02-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Liquidity (Details Narrative)",
     "role": "http://vivakor.com/role/LiquidityDetailsNarrative",
     "shortName": "Liquidity (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "VIVK:LiquidityTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseDepositLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Prepaid Expenses and Other Assets (Details Narrative)",
     "role": "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative",
     "shortName": "Prepaid Expenses and Other Assets (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LeaseDepositLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:MarketableSecuritiesUnrealizedGainLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Marketable Securities (Details Narrative)",
     "role": "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative",
     "shortName": "Marketable Securities (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:MarketableSecuritiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2020-12-31_custom_OdysseyGroupMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Inventories (Details Narrative)",
     "role": "http://vivakor.com/role/InventoriesDetailsNarrative",
     "shortName": "Inventories (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Property and Equipment (Details)",
     "role": "http://vivakor.com/role/PropertyAndEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Property and Equipment (Details Narrative)",
     "role": "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative",
     "shortName": "Property and Equipment (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Accounts Payable and Accrued Expenses (Details)",
     "role": "http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails",
     "shortName": "Accounts Payable and Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Loans and Notes Payable (Details)",
     "role": "http://vivakor.com/role/LoansAndNotesPayableDetails",
     "shortName": "Loans and Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:NotesAndLoansPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertibleNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - Loans and Notes Payable (Details Narrative)",
     "role": "http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative",
     "shortName": "Loans and Notes Payable (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertibleNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "role": "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - Commitments (Details)",
     "role": "http://vivakor.com/role/CommitmentsDetails",
     "shortName": "Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "role": "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30_us-gaap_LongTermDebtMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - Long-term Debt (Details)",
     "role": "http://vivakor.com/role/Long-termDebtDetails",
     "shortName": "Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30_us-gaap_LongTermDebtMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "VIVK:DividendPaidInSeriesB1PreferredStock",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - Temporary Equity (Details)",
     "role": "http://vivakor.com/role/TemporaryEquityDetails",
     "shortName": "Temporary Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "VIVK:TemporaryEquityTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2021-03-31_custom_ConvertiblePreferredStockSeriesBMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-012022-06-30_custom_VivaWealthFundILLCMember147106531",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfDistributionsToAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - Noncontrolling Interest (Details Narrative)",
     "role": "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative",
     "shortName": "Noncontrolling Interest (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-012022-06-30_custom_VivaWealthFundILLCMember147106531",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfDistributionsToAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "VIVK:ScheduleOWarrantsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - Share-Based Compensation & Warrants (Details - Assumptions)",
     "role": "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions",
     "shortName": "Share-Based Compensation & Warrants (Details - Assumptions)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "VIVK:ScheduleOWarrantsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - Share-Based Compensation & Warrants (Details)",
     "role": "http://vivakor.com/role/Share-basedCompensationWarrantsDetails",
     "shortName": "Share-Based Compensation & Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-012022-06-30_us-gaap_StockOptionMember",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - Share-Based Compensation & Warrants (Details Narrative)",
     "role": "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative",
     "shortName": "Share-Based Compensation & Warrants (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - Income Tax (Details Narrative)",
     "role": "http://vivakor.com/role/IncomeTaxDetailsNarrative",
     "shortName": "Income Tax (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2021-01-012021-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)",
     "role": "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)",
     "role": "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "VIVK:CommonStockOptionsIssuedForServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - Basis of Presentation",
     "role": "http://vivakor.com/role/BasisOfPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VIVK:LiquidityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - Liquidity",
     "role": "http://vivakor.com/role/Liquidity",
     "shortName": "Liquidity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "VIVK:LiquidityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Prepaid Expenses and Other Assets",
     "role": "http://vivakor.com/role/PrepaidExpensesAndOtherAssets",
     "shortName": "Prepaid Expenses and Other Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "vivakor_s1.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 65,
   "tag": {
    "VIVK_AccruedInterestWorkingInterestRoyaltyPrograms": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest (working interest royalty programs)"
       }
      }
     },
     "localname": "AccruedInterestWorkingInterestRoyaltyPrograms",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_AmortizedUsefulLives": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortized useful lives"
       }
      }
     },
     "localname": "AmortizedUsefulLives",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "VIVK_BioreactorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bioreactors [Member]"
       }
      }
     },
     "localname": "BioreactorsMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_BlueRidgeBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Blue Ridge Bank [Member]"
       }
      }
     },
     "localname": "BlueRidgeBankMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_BoardOfDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board Of Directors [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_CapitalizedInterestOnConstructionInProcess": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized interest on construction in process"
       }
      }
     },
     "localname": "CapitalizedInterestOnConstructionInProcess",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_CashAndCashEquivalentsAttributedToVariableInterestEntity": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents attributed to variable interest entity"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAttributedToVariableInterestEntity",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_CashAttributableToVie": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash attributable to VIE"
       }
      }
     },
     "localname": "CashAttributableToVie",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_CashPaidDuringYearForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid during the year for:"
       }
      }
     },
     "localname": "CashPaidDuringYearForAbstract",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for fractional shares from reverse stock split"
       }
      }
     },
     "localname": "CommonStockIssuedForFractionalSharesFromReverseStockSplit",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_CommonStockIssuedForFractionalSharesFromReverseStockSplitShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for fractional shares from reverse stock split, shares"
       }
      }
     },
     "localname": "CommonStockIssuedForFractionalSharesFromReverseStockSplitShares",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_CommonStockIssuedForPurchaseOfLicense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock issued for the purchase of a license(1)"
       }
      }
     },
     "localname": "CommonStockIssuedForPurchaseOfLicense",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_CommonStockIssuedForPurchaseOfLicenseShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock issued for the purchase of a license, shares"
       }
      }
     },
     "localname": "CommonStockIssuedForPurchaseOfLicenseShares",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_CommonStockIssuedForPurchaseOfLicenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for the purchase of a license"
       }
      }
     },
     "localname": "CommonStockIssuedForPurchaseOfLicenses",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_CommonStockIssuedForReductionInLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock issued for a reduction of liabilities(1)"
       }
      }
     },
     "localname": "CommonStockIssuedForReductionInLiabilities",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_CommonStockIssuedForReductionInLiabilitiesCashFlow": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued for a reduction in liabilities"
       }
      }
     },
     "localname": "CommonStockIssuedForReductionInLiabilitiesCashFlow",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_CommonStockIssuedForReductionInLiabilitiesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock issued for a reduction in liabilities, shares"
       }
      }
     },
     "localname": "CommonStockIssuedForReductionInLiabilitiesShares",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_CommonStockOptionsIssuedForServices": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock options issued for services"
       }
      }
     },
     "localname": "CommonStockOptionsIssuedForServices",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_ConsultantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consultant [Member]"
       }
      }
     },
     "localname": "ConsultantMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_ConversionOfSeriesBB1AndC1PreferredStockToCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Series A, B, B-1, and C-1 Preferred Stock to Common Stock"
       }
      }
     },
     "localname": "ConversionOfSeriesBB1AndC1PreferredStockToCommonStock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_ConversionOfSeriesPreferredStockToCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Series A Preferred Stock to Common Stock"
       }
      }
     },
     "localname": "ConversionOfSeriesPreferredStockToCommonStock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_ConversionOfSeriesPreferredStockToCommonStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Series A Preferred Stock to Common Stock, shares"
       }
      }
     },
     "localname": "ConversionOfSeriesPreferredStockToCommonStockShares",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of temporary equity Series B and B-1 Preferred Stock to Common Stock (1)"
       }
      }
     },
     "localname": "ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of temporary equity Series B and B-1 Preferred Stock to Common Stock (1), shares"
       }
      }
     },
     "localname": "ConversionOfTemporaryEquitySeriesBAndB1PreferredStockToCommonStock1Shares",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_ConvertiblePreferredStockSeriesB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock Series B 1 [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSeriesB1Member",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_ConvertiblePreferredStockSeriesBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock Series B [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSeriesBMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_ConvertiblePreferredStockSeriesC1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock Series C 1 [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSeriesC1Member",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_ConvertibleSeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "ConvertibleSeriesAPreferredStockMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_Covid19PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COVID-19"
       }
      }
     },
     "localname": "Covid19PolicyTextBlock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VIVK_DisclosureLiquidityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity"
       }
      }
     },
     "localname": "DisclosureLiquidityAbstract",
     "nsuri": "http://vivakor.com/20220630",
     "xbrltype": "stringItemType"
    },
    "VIVK_DisclosureTemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity"
       }
      }
     },
     "localname": "DisclosureTemporaryEquityAbstract",
     "nsuri": "http://vivakor.com/20220630",
     "xbrltype": "stringItemType"
    },
    "VIVK_DividendPaidInSeriesB1PreferredStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend paid in Series B-1 Preferred Stock"
       }
      }
     },
     "localname": "DividendPaidInSeriesB1PreferredStock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_FexixIronMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fexix Iron [Member]"
       }
      }
     },
     "localname": "FexixIronMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_GainLossOnDispositionOfAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on disposition of asset"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAsset",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_GainOnDispositionOfAsset": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainOnDispositionOfAsset",
        "negatedLabel": "Gain on disposal of asset"
       }
      }
     },
     "localname": "GainOnDispositionOfAsset",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_IntellectualPropertyNet": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intellectual property, net"
       }
      }
     },
     "localname": "IntellectualPropertyNet",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_InterimFinancialInformationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interim Financial Information"
       }
      }
     },
     "localname": "InterimFinancialInformationPolicyTextBlock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VIVK_InternationalMetalsExchangeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "International Metals Exchange, LLC [Member]"
       }
      }
     },
     "localname": "InternationalMetalsExchangeMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_IssuanceOfNoncontrollingInterest1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of noncontrolling interest for a reduction of debt"
       }
      }
     },
     "localname": "IssuanceOfNoncontrollingInterest1",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_JPMorganChaseBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "J P Morgan Chase Bank [Member]"
       }
      }
     },
     "localname": "JPMorganChaseBankMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_JamboreeCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jamboree Center [Member]"
       }
      }
     },
     "localname": "JamboreeCenterMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease payments next two and three months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThree",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_LicenseAgreementNet": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "License agreement, net"
       }
      }
     },
     "localname": "LicenseAgreementNet",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_LiquidityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LiquidityTextBlock",
        "verboseLabel": "Liquidity"
       }
      }
     },
     "localname": "LiquidityTextBlock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Liquidity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VIVK_LoansAndNotesPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans and notes payable, current"
       }
      }
     },
     "localname": "LoansAndNotesPayableCurrent",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_LoansAndNotesPayableCurrentAttributedToVariableInterestEntity": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans and notes payable, current attributed to variable interest entity"
       }
      }
     },
     "localname": "LoansAndNotesPayableCurrentAttributedToVariableInterestEntity",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets",
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_MarketableSecuritiesUnrealizedLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized loss on marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedLoss",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_NanospongeCavitationDeviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nanosponge/Cavitation Device [Member]"
       }
      }
     },
     "localname": "NanospongeCavitationDeviceMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_NationalBuickGMCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "National Buick G M C [Member]"
       }
      }
     },
     "localname": "NationalBuickGMCMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_NonStatutoryStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Statutory Stock Options [Member]"
       }
      }
     },
     "localname": "NonStatutoryStockOptionsMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_NoncontrollingInterestIssuedForReductionInLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling interest issued for a reduction in liabilities"
       }
      }
     },
     "localname": "NoncontrollingInterestIssuedForReductionInLiabilities",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_NoteReceivableConvertedAmountConverted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note receivable converted, amount converted",
        "label": "Note receivable converted, amount converted"
       }
      }
     },
     "localname": "NoteReceivableConvertedAmountConverted",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_NoteReceivableConvertedSharesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note receivable converted, shares received",
        "label": "Note receivable converted, shares received"
       }
      }
     },
     "localname": "NoteReceivableConvertedSharesReceived",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_NotesAndLoansPayableNonCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NotesAndLoansPayableNonCurrent",
        "verboseLabel": "Loans and notes payable, long term"
       }
      }
     },
     "localname": "NotesAndLoansPayableNonCurrent",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_NovusCapitalGroupLLCNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Novus Capital Group L L C Note [Member]"
       }
      }
     },
     "localname": "NovusCapitalGroupLLCNoteMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_OdysseyGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Odyssey Group [Member]"
       }
      }
     },
     "localname": "OdysseyGroupMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_OperatingLeaseLiability1Noncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities, long-term"
       }
      }
     },
     "localname": "OperatingLeaseLiability1Noncurrent",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_PaymentsToAcquireIntangibleAssets1": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PaymentsToAcquireIntangibleAssets1",
        "negatedLabel": "Purchase of a technology license"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets1",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_PercentageOfAccrueInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "percentage of accrue interest"
       }
      }
     },
     "localname": "PercentageOfAccrueInterest",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "VIVK_PreciousMetalConcentrate": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Precious metal concentrate"
       }
      }
     },
     "localname": "PreciousMetalConcentrate",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_PreciousMetalExtractionMachine10TonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Precious Metal Extraction Machine- 10 Ton [Member]"
       }
      }
     },
     "localname": "PreciousMetalExtractionMachine10TonMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_PreciousMetalExtractionMachine1TonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Precious Metal Extraction Machine- 1 Ton [Member]"
       }
      }
     },
     "localname": "PreciousMetalExtractionMachine1TonMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_PreferredStockSeriesC1IssuedForReductionInLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock Series C-1 issued for a reduction in liabilities"
       }
      }
     },
     "localname": "PreferredStockSeriesC1IssuedForReductionInLiabilities",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_PresentValueOfLeasePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value of lease payments"
       }
      }
     },
     "localname": "PresentValueOfLeasePayments",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_ProfessionalServiceAgenciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional Service Agencies [Member]"
       }
      }
     },
     "localname": "ProfessionalServiceAgenciesMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_PublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Offering [Member]"
       }
      }
     },
     "localname": "PublicOfferingMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LiquidityDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_RPCDesignAndManufacturingLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "R P C Design And Manufacturing L L C [Member]"
       }
      }
     },
     "localname": "RPCDesignAndManufacturingLLCMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_RdmMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RDM [Member]"
       }
      }
     },
     "localname": "RdmMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_RemediationProcessingUnit1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remediation Processing Unit 1 [Member]"
       }
      }
     },
     "localname": "RemediationProcessingUnit1Member",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_RemediationProcessingUnit2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remediation Processing Unit 2 [Member]"
       }
      }
     },
     "localname": "RemediationProcessingUnit2Member",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_RemediationProcessingUnitSystemAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remediation Processing Unit System A [Member]"
       }
      }
     },
     "localname": "RemediationProcessingUnitSystemAMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_RemediationProcessingUnitSystemBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remediation Processing Unit System B [Member]"
       }
      }
     },
     "localname": "RemediationProcessingUnitSystemBMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_ScepterHoldingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scepter Holdings [Member]"
       }
      }
     },
     "localname": "ScepterHoldingsMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_ScheduleOWarrantsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of warrant assumptions"
       }
      }
     },
     "localname": "ScheduleOWarrantsValuationAssumptionsTableTextBlock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VIVK_ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of maturities of loans and notes payable"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtsTableTextBlock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VIVK_SerciesC1IssueForReductionInStockPayable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sercies C-1 Issue for a reduction in stock payables, shares"
       }
      }
     },
     "localname": "SerciesC1IssueForReductionInStockPayable",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_SerciesC1IssueForReductionInStockPayables": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C-1 Issue for a reduction in stock payables"
       }
      }
     },
     "localname": "SerciesC1IssueForReductionInStockPayables",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_SeriesAPreferredStocksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stocks [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStocksMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_SeriesC1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C-1 Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesC1PreferredStockMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_ShareStockAwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Stock Award [Member]"
       }
      }
     },
     "localname": "ShareStockAwardMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "VIVK_SmallBusinessAdministrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Small Business Administration [Member]"
       }
      }
     },
     "localname": "SmallBusinessAdministrationMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_SpeedwayCommerceCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Speedway Commerce Center [Member]"
       }
      }
     },
     "localname": "SpeedwayCommerceCenterMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_StockIssuedForConversionOfTemporaryEquityShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock, shares"
       }
      }
     },
     "localname": "StockIssuedForConversionOfTemporaryEquityShares",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_StockIssuedForConversionOfTemporaryEquityValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock(1)"
       }
      }
     },
     "localname": "StockIssuedForConversionOfTemporaryEquityValue",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_StockOptionsGrantedToBoardMembersOrConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Granted To Board Members Or Consultants [Member]"
       }
      }
     },
     "localname": "StockOptionsGrantedToBoardMembersOrConsultantsMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_StockOptionsGrantedToEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Granted To Employees [Member]"
       }
      }
     },
     "localname": "StockOptionsGrantedToEmployeesMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_StockOptionsIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options issued for services"
       }
      }
     },
     "localname": "StockOptionsIssuedForServices",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "VIVK_StockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options [Member]"
       }
      }
     },
     "localname": "StockOptionsMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_TemporaryEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TemporaryEquityTextBlock",
        "verboseLabel": "Temporary Equity"
       }
      }
     },
     "localname": "TemporaryEquityTextBlock",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "VIVK_TripleTNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Triple T Notes [Member]"
       }
      }
     },
     "localname": "TripleTNotesMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VariousConvertibleBridgeNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Various Convertible Bridge Notes [Member]"
       }
      }
     },
     "localname": "VariousConvertibleBridgeNotesMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VariousPromissoryNotesAndConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Various Promissory Notes And Convertible Notes [Member]"
       }
      }
     },
     "localname": "VariousPromissoryNotesAndConvertibleNotesMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VariousPromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Various Promissory Notes [Member]"
       }
      }
     },
     "localname": "VariousPromissoryNotesMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VendorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vendor [Member]"
       }
      }
     },
     "localname": "VendorMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VictoryHoldingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Victory Holdings [Member]"
       }
      }
     },
     "localname": "VictoryHoldingsMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VivaWealthFundILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Viva Wealth Fund I L L C [Member]"
       }
      }
     },
     "localname": "VivaWealthFundILLCMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VivaWealthFundIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Viva Wealth Fund I [Member]"
       }
      }
     },
     "localname": "VivaWealthFundIMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VivaopportunityFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vivaopportunity Fund LLC [Member]"
       }
      }
     },
     "localname": "VivaopportunityFundMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VivaventuresRoyaltyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vivaventures Royalty II, LLC [Member]"
       }
      }
     },
     "localname": "VivaventuresRoyaltyMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_VivaventuresUtsiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vivaventures UTSI, LLC [Member]"
       }
      }
     },
     "localname": "VivaventuresUtsiMember",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "VIVK_WarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants issued"
       }
      }
     },
     "localname": "WarrantsIssued",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "VIVK_WarrantsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants outstanding"
       }
      }
     },
     "localname": "WarrantsOutstanding",
     "nsuri": "http://vivakor.com/20220630",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r427",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative",
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative",
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative",
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative",
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vivakor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r94",
      "r181",
      "r185",
      "r190",
      "r300",
      "r301",
      "r307",
      "r308",
      "r348",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r94",
      "r181",
      "r185",
      "r190",
      "r300",
      "r301",
      "r307",
      "r308",
      "r348",
      "r413"
     ],
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r42",
      "r44",
      "r92",
      "r93",
      "r196",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r195",
      "r221",
      "r235",
      "r236",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r397",
      "r398",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r195",
      "r221",
      "r235",
      "r236",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r397",
      "r398",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r195",
      "r221",
      "r234",
      "r235",
      "r236",
      "r265",
      "r266",
      "r267",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r397",
      "r398",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r195",
      "r221",
      "r234",
      "r235",
      "r236",
      "r265",
      "r266",
      "r267",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r397",
      "r398",
      "r414",
      "r415"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r43",
      "r44",
      "r92",
      "r93",
      "r196",
      "r222"
     ],
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r150",
      "r151",
      "r382"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Accounts Receivable, less allowances of none and $33,000, respectively"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r373",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r32",
      "r351"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued interest"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r12",
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22",
      "r351"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r269",
      "r270",
      "r271",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r238",
      "r272",
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Stock based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Expense"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r27",
      "r152",
      "r156",
      "r157",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts receivable allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r14",
      "r88",
      "r136",
      "r139",
      "r145",
      "r154",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r300",
      "r307",
      "r320",
      "r349",
      "r351",
      "r367",
      "r383"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r31",
      "r88",
      "r154",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r300",
      "r307",
      "r320",
      "r349",
      "r351"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "auth_ref": [
      "r294"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Marketable securities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r9",
      "r351",
      "r404",
      "r405"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LiquidityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r9",
      "r78"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r72",
      "r78",
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, END OF PERIOD",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r72",
      "r321"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r86",
      "r88",
      "r110",
      "r111",
      "r112",
      "r115",
      "r117",
      "r123",
      "r124",
      "r125",
      "r154",
      "r181",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191",
      "r219",
      "r220",
      "r223",
      "r224",
      "r225",
      "r320",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Warrants exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "verboseLabel": "Warrants outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r178",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r95",
      "r96",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20",
      "r351"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $.001 par value; 41,666,667 shares authorized; 15,038,619 and 12,330,859 were issued and outstanding as of June 30, 2022 and December 31, 2021(1)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r305",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r84",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r80",
      "r81",
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Series B and B-1 Preferred Stock to Common Stock"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r80",
      "r81",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Series B and B-1 Preferred Stock to Common Stock, shares"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r17",
      "r369",
      "r385",
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Aggregate principal"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r15",
      "r368",
      "r381",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r219",
      "r220",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r58",
      "r88",
      "r154",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r320"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r80",
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r80",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r17",
      "r210",
      "r369",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Principal"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r38",
      "r87",
      "r94",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r212",
      "r213",
      "r214",
      "r215",
      "r226",
      "r227",
      "r228",
      "r229",
      "r329",
      "r330",
      "r333",
      "r334",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r199",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Prepaid Expenses and Other Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r276",
      "r277"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Deposits": {
     "auth_ref": [
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.",
        "label": "Deposits",
        "verboseLabel": "Office access deposits"
       }
      }
     },
     "localname": "Deposits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails",
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r76",
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r76",
      "r163"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Amortization and depreciation",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStock": {
     "auth_ref": [
      "r230",
      "r379"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Preferred Stock",
        "negatedLabel": "Dividend paid in Series B-1 Preferred Stock"
       }
      }
     },
     "localname": "DividendsPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r52",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r108",
      "r110",
      "r115",
      "r116",
      "r117",
      "r120",
      "r121",
      "r316",
      "r317",
      "r376",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic and diluted net loss per share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r52",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r110",
      "r115",
      "r116",
      "r117",
      "r120",
      "r121",
      "r316",
      "r317",
      "r376",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted net income per share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r118",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Net Income/Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r47",
      "r48",
      "r49",
      "r95",
      "r96",
      "r97",
      "r99",
      "r105",
      "r107",
      "r122",
      "r155",
      "r225",
      "r230",
      "r269",
      "r270",
      "r271",
      "r285",
      "r286",
      "r315",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r346",
      "r399",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r2",
      "r88",
      "r154",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r2",
      "r88",
      "r154",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity."
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Extinguishment of Debt [Line Items]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished."
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r76",
      "r162",
      "r167"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain on disposition of asset"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r55",
      "r88",
      "r136",
      "r138",
      "r141",
      "r144",
      "r146",
      "r154",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r320"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r161",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Long Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r49",
      "r57"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Less: Net loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r56",
      "r77",
      "r100",
      "r101",
      "r102",
      "r103",
      "r113",
      "r117",
      "r298"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Net loss attributable to common shareholders",
        "totalLabel": "Net income (loss) attributable to Vivakor, Inc."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r89",
      "r280",
      "r282",
      "r283",
      "r287",
      "r289",
      "r291",
      "r292",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Accrued tax penalties and interest"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r90",
      "r106",
      "r107",
      "r135",
      "r278",
      "r288",
      "r290",
      "r396"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Provision for income taxes",
        "negatedLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://vivakor.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.",
        "label": "Increase (Decrease) in Accrued Interest Receivable, Net",
        "negatedLabel": "Accrued interest on notes receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.",
        "label": "Accrued interest on notes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r85",
      "r160",
      "r361",
      "r362",
      "r363",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest income"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseOther": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense classified as other.",
        "label": "Interest Expense, Other",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r70",
      "r73",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Acquisition costs"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r29",
      "r351"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r406",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of shares.",
        "label": "Investment Owned, Balance, Shares"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Common stock issued for services"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseDepositLiability": {
     "auth_ref": [
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for lease payments received, including variable lease payments, when collectability is not probable at commencement date for sales-type lease.",
        "label": "Office and warehouse lease deposits"
       }
      }
     },
     "localname": "LeaseDepositLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Schedule of lessee operating lease liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lease payments next twelve months",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lease payments next four months",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lease payments next three months",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lease payments next two months",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r35",
      "r88",
      "r140",
      "r154",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r301",
      "r307",
      "r308",
      "r320",
      "r349",
      "r350"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r88",
      "r154",
      "r320",
      "r351",
      "r371",
      "r389"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r37",
      "r88",
      "r154",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r301",
      "r307",
      "r308",
      "r320",
      "r349",
      "r350",
      "r351"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r200",
      "r211",
      "r212",
      "r213",
      "r369",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Total long term debt",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails",
      "http://vivakor.com/role/Long-termDebtDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long term debt, current"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt",
      "http://vivakor.com/role/Long-termDebtDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt",
      "http://vivakor.com/role/Long-termDebtDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt",
      "http://vivakor.com/role/Long-termDebtDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt",
      "http://vivakor.com/role/Long-termDebtDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt",
      "http://vivakor.com/role/Long-termDebtDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt",
      "http://vivakor.com/role/Long-termDebtDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermNotesAndLoans": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Loans and notes payable, long term"
       }
      }
     },
     "localname": "LongTermNotesAndLoans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails",
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r38",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails",
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities [Default Label]",
        "terseLabel": "Marketable securities",
        "verboseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LiquidityDetailsNarrative",
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Unrealized gain (loss) on marketable securities",
        "negatedLabel": "Unrealized gain (loss) marketable securities",
        "negatedTerseLabel": "Unrealized gain (loss) on marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r41",
      "r88",
      "r154",
      "r181",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191",
      "r320",
      "r370",
      "r388"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions by noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/NoncontrollingInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r41",
      "r57",
      "r297",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MortgageNotesPayableDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for mortgage notes payable.",
        "label": "Loans and Notes Payable"
       }
      }
     },
     "localname": "MortgageNotesPayableDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r72",
      "r74",
      "r77"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r45",
      "r46",
      "r49",
      "r51",
      "r77",
      "r88",
      "r98",
      "r100",
      "r101",
      "r102",
      "r103",
      "r106",
      "r107",
      "r113",
      "r136",
      "r138",
      "r141",
      "r144",
      "r146",
      "r154",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r317",
      "r320",
      "r375",
      "r394"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income (loss)",
        "totalLabel": "Consolidated net loss",
        "verboseLabel": "Consolidated net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r103",
      "r108",
      "r109",
      "r114",
      "r117",
      "r136",
      "r138",
      "r141",
      "r144",
      "r146"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income loss to parent"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash transactions:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestInVariableInterestEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity (net assets) in a variable interest entity (VIE) not attributable, directly or indirectly, to the parent entity. That is, this is the portion of equity in a VIE that is attributable to the noncontrolling interest (previously referred to as minority interest).",
        "label": "Noncontrolling Interest in Variable Interest Entity"
       }
      }
     },
     "localname": "NoncontrollingInterestInVariableInterestEntity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r230",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesAndLoansPayable": {
     "auth_ref": [
      "r17",
      "r369",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Total"
       }
      }
     },
     "localname": "NotesAndLoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails-MaturitiesOfDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesAndLoansPayableCurrent": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.",
        "label": "Notes and Loans Payable, Current",
        "verboseLabel": "Loans and notes payable, current"
       }
      }
     },
     "localname": "NotesAndLoansPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r17",
      "r369",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "verboseLabel": "Total Notes Payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative",
      "http://vivakor.com/role/LoansAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableRelatedParties": {
     "auth_ref": [
      "r21",
      "r91",
      "r347",
      "r393"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from parties associated with the reporting entity as evidenced by a written promise to pay.",
        "label": "Notes receivable"
       }
      }
     },
     "localname": "NotesReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r136",
      "r138",
      "r141",
      "r144",
      "r146"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsDetails",
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liabilities, long term"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r339",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Lease payment"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r336"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Rights of use assets- operating leases",
        "verboseLabel": "Right-of-use asset for operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r342",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r341",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Net Operating losses"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r3",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r30",
      "r351"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInvestments": {
     "auth_ref": [
      "r10",
      "r391"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments classified as other.",
        "label": "Other investments"
       }
      }
     },
     "localname": "OtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtCurrent": {
     "auth_ref": [
      "r15",
      "r16"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer.",
        "label": "Long-term debt (working interest royalty programs), current"
       }
      }
     },
     "localname": "OtherLongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.",
        "label": "Long-term debt (working interest royalty programs)"
       }
      }
     },
     "localname": "OtherLongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncome": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income related to nonoperating activities, classified as other.",
        "label": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDistributionsToAffiliates": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Payments of Distributions to Affiliates"
       }
      }
     },
     "localname": "PaymentsOfDistributionsToAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/NoncontrollingInterestDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Payment on costs of patents"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Distributions to noncontrolling interest"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Dividend on preferred stock"
       }
      }
     },
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r19",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r19",
      "r351"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Convertible, preferred stock, $.001 par value; 3,400,000 shares authorized;(1) Series A- 66,667 issued and outstanding(1)"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Diluted weighted average common shares outstanding"
       }
      }
     },
     "localname": "ProFormaWeightedAverageSharesOutstandingDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from notes receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from sale of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LiquidityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from loans and notes payable"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherInvestments": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale of investments classified as other.",
        "label": "Proceeds from Sale of Other Investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from disposal of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r45",
      "r46",
      "r49",
      "r71",
      "r88",
      "r98",
      "r106",
      "r107",
      "r136",
      "r138",
      "r141",
      "r144",
      "r146",
      "r154",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r299",
      "r303",
      "r304",
      "r311",
      "r312",
      "r317",
      "r320",
      "r377"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Loss before provision for income taxes"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails",
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r169",
      "r410",
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r11",
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Gross Carrying Amount"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails",
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r166",
      "r351",
      "r378",
      "r390"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net",
        "verboseLabel": "Net Book Value"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets",
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails",
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by property that could be leased or is available for lease.",
        "label": "Property Subject to or Available for Operating Lease [Axis]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A descriptive title of whether the property is subject to or available for operating lease."
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale."
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/InventoriesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Payment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Payment of notes payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r230",
      "r351",
      "r387",
      "r402",
      "r403"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "negatedLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets",
      "http://vivakor.com/role/LiquidityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r95",
      "r96",
      "r97",
      "r99",
      "r105",
      "r107",
      "r155",
      "r269",
      "r270",
      "r271",
      "r285",
      "r286",
      "r315",
      "r399",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r50",
      "r88",
      "r133",
      "r134",
      "r137",
      "r142",
      "r143",
      "r147",
      "r148",
      "r149",
      "r154",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r320",
      "r377"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of accounts payable and accrued expenses"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PrepaidExpensesAndOtherAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r38",
      "r94",
      "r212",
      "r214",
      "r226",
      "r227",
      "r228",
      "r229",
      "r329",
      "r330",
      "r334",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of loans and notes payable"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LoansAndNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule Of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExtinguishmentOfDebtTable": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to debt extinguished, including the amount of gain (loss) on the debt extinguished, the income tax effect on the gain (loss), and the amount of gain (loss), net of the related income tax.",
        "label": "Schedule of Extinguishment of Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfExtinguishmentOfDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of long-term debt maturities"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Long-termDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails",
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r243",
      "r258",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule of option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r13"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group of financial instruments held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes that are carried at fair value including securities sold, not yet purchased.",
        "label": "Security Owned and Sold, Not yet Purchased, at Fair Value [Axis]"
       }
      }
     },
     "localname": "SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LiquidityDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Security Owned and Sold, Not yet Purchased, at Fair Value [Line Items]"
       }
      }
     },
     "localname": "SecurityOwnedAndSoldNotYetPurchasedAtFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LiquidityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of financial instruments held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes that are carried at fair value including securities sold, not yet purchased.",
        "label": "Security Owned and Sold, Not yet Purchased, at Fair Value [Table]"
       }
      }
     },
     "localname": "SecurityOwnedAndSoldNotYetPurchasedAtFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LiquidityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of financial instrument held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes that are carried at fair value including securities sold, not yet purchased."
       }
      }
     },
     "localname": "SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/LiquidityDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r18",
      "r19",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Stock-based compensation",
        "verboseLabel": "Share-based Payment Arrangement, Noncash Expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Weighted average exercise price - exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Weighted average exercise price, forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "verboseLabel": "Option granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares outstanding - ending",
        "periodStartLabel": "Shares outstanding - beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price - ending",
        "periodStartLabel": "Weighted average exercise price - beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Shares exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Weighted average exercise price, exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Weighted average exercise price, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected life of warrants"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average contractural term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted average contractural term"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r233",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Share-Based Compensation &amp; Warrants"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r86",
      "r88",
      "r110",
      "r111",
      "r112",
      "r115",
      "r117",
      "r123",
      "r124",
      "r125",
      "r154",
      "r181",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191",
      "r219",
      "r220",
      "r223",
      "r224",
      "r225",
      "r320",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r40",
      "r47",
      "r48",
      "r49",
      "r95",
      "r96",
      "r97",
      "r99",
      "r105",
      "r107",
      "r122",
      "r155",
      "r225",
      "r230",
      "r269",
      "r270",
      "r271",
      "r285",
      "r286",
      "r315",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r346",
      "r399",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions",
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r122",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://vivakor.com/role/MarketableSecuritiesDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails-Assumptions",
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Common Stock issued for services Shares, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r225",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Common Stock issued for cash, shares",
        "verboseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity",
      "http://vivakor.com/role/LiquidityDetailsNarrative",
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Stock Issued During Period, Shares, Purchase of Assets"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "auth_ref": [
      "r19",
      "r20",
      "r225",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "negatedLabel": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r225",
      "r230",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Common Stock issued for services(1)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r225",
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Common Stock issued for cash, net of offering costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Prefered stock Series C-1 issued for a reduction in liabilities"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/Share-basedCompensationWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r24",
      "r25",
      "r88",
      "r153",
      "r154",
      "r320",
      "r351"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Vivakor, Inc. stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r48",
      "r88",
      "r95",
      "r96",
      "r97",
      "r99",
      "r105",
      "r154",
      "r155",
      "r230",
      "r269",
      "r270",
      "r271",
      "r285",
      "r286",
      "r296",
      "r297",
      "r310",
      "r315",
      "r320",
      "r322",
      "r323",
      "r327",
      "r346",
      "r400",
      "r401"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets",
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "Stockholders' Equity, Reverse Stock Split"
       }
      }
     },
     "localname": "StockholdersEquityReverseStockSplit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASHFLOW INFORMATION:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r181",
      "r185",
      "r186",
      "r187",
      "r190",
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "June 30, 2021",
        "periodStartLabel": "December 31, 2020"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDividendsAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).",
        "label": "Temporary Equity, Dividends, Adjustment",
        "verboseLabel": "Dividend paid in Series B-1 Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityDividendsAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r8",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Schedule of temporary equity"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/TemporaryEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockCarryingBasis": {
     "auth_ref": [
      "r232"
     ],
     "calculation": {
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost basis for treasury stock acquired for purposes other than retirement.",
        "label": "Treasury Stock, Carrying Basis",
        "negatedLabel": "Treasury stock, at cost"
       }
      }
     },
     "localname": "TreasuryStockCarryingBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r39",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnearnedPremiums": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.",
        "label": "Unearned revenue"
       }
      }
     },
     "localname": "UnearnedPremiums",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/AccountsPayableAndAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r300",
      "r301",
      "r307",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/BasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Effect of dilutive securities"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r108",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Basic weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://vivakor.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123408481&loc=SL77919106-209958"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35711157&loc=d3e42546-110969"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f,g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r416": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r417": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r418": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r419": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r420": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r421": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r422": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r423": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r424": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r425": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r426": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r427": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r428": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r429": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r430": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r431": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r432": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r433": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r434": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r435": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r436": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0001683168-22-006426-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-22-006426-xbrl.zip
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M?CY+Y%-JNJ-<67%=CKS36IVA]_;&)]F?7]:G4Z^G";/Q<V9;;G_[IM'08Y$
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MNK"XHZTV3^YYF5&<([1?E\<$,Y6(=QX45@D+>#Q3^Y9^#(C9$DFR]9+H*>[
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M$B='%\SGR((SE+IY/K0*-Z<NP.]9,2B?\IEA'>F%>2XJY4')$A?P=VX)])6
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M<YH?<FU97E6AE K\;U=1R2SJ=O[:2%(7T;3;V&((FW-PY>@<QX6,+BN63=O
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M.72\/TO:G&E7$P">B[\Y;8@Y8V/D6[V4T0"+IG83\N/KW1+[+3+<B.]Q'FL
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MN]B9FUOK 0=P_O J74:$W1U2)L[-\HUI6)H6"+TV> =Q*N<][!5H65=LO/G
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M)0)ZFULGBH*<[WHHX)5RPJ+J586_KH5I_[>&5P7[==$4)!X3W0R\HBEIZCB
MDL>ENXFQ&,7TOI6=([H<5$KOR7_-@R+A,E<HC7C@=SQ6$D;>P"W I*=_ (,-
M-',#&^@$K51Y0@K5GDJ+[?2Z ?W7;U)5V-H:V3,7H &WO*8-1G^9C ICZ/<5
MX\<:-V-4G[G/UJ;5G\LN48CMASV-,)0O[E*9IM@"K8+BI"RPSWWQ;33M07XW
MFW',KXGR9I!]I4]_W3+FZC_,]<:WBK<NN_[V-+JJ+!\4(3<W9G(6EN'"A<[U
M^/+W3"R5J45^C4J%#UQ)EZSUL"RH1=XM8-V8PC3$W$]E 6X#829WU:7+4Q*D
M<*A0@'?3/;NLF%.8TM(O-WZKOC-2^:E#'\CCJR*DB%\#NE<1DP=:RZR]S7=@
M%;1QC'KDC%!/W)6_#0T[-(X>UF\]QN=-QQ)"SP\OZ,,<D;&!)\H$XH/-BW*M
M[?BMO-U$#^D3(9N-)(_(>$#-T:B-37AH)^RS;LA/'S[K>E5=3"4!"Y0Y;.1F
M__RI&JN.W91+_&K0T#V%?GF-)_\3%!KW0K9XOV_+WRT*9?$Z ],>^[MH;JH0
M6P?GXZ;5K>@^ 4<_J?Y?Y#XPHR6\=D6A'<3\YKGB?%5(T8^:L*+]ZG<X0*WH
M7$"Z\/8^-/U(DK.;@4T0A@GT2CS^4S%\J:=K8YB;%Y;%$N0^L$5?ZQQVENE@
M9;WZY"B1>HEQN;>;QJ(@9^?=>Q]8-@](W?([HC!,RM'PDYR^[+*K,DICD8>R
MW44&F'G\4F=47(Y4<'3BIH/H9P+]7ZO8T-@:SVY0)6#0H]*J,#(@9]7H=H4+
M9_'$TP<EM28:S*1%U3NE95'_LWO2%C9@K=U06!R6X,M:D,G2/ MW+(6#)**6
MN7%]>2D2? R7"*];*.LX:X:*UH)7"?%EZ>1;JO?NUBZ']_ZM58F@SZVBMU1^
M\-S::<MNO1)T\F_ A2\PJ82E W5NT1Q"RGLU&F7:8ZQIQX54>7RJXOJ3,^94
MU\W[96[2<+S(^^.:@=PHI23M#'7>GI0CR39^B3VHV-3DI!>8.*ZH6L\K)CJ3
M4:9-\- !\IQK$KWYO.NJ_=[]-;W<O#KWOY](AL6<__>OH]<)LMPR$0H.9-6G
M./%/*RURZL[)K[\F4NB/=?CYN@<#_ .PW'S/#O9TKFY:M4?I-4ZFP]0DNC,7
M$3A]-9'QDW5=_9@'??2R-<"3>R2ZX_3 QV/87Y5,C/TZX'^F^[/M9UL/A<N?
M;1E:4'-NUY+@*T</']GX@ C+%+[D>3'EOM+K"IDL#SN7H-MFEH*9 ;=OVYV[
MD5FC;'GC9>5 5W)4VSW;7SN%HNE7VLHTU]7O2-]4VM=I\:IA!,'*5 5,U/,V
M<@/RZ*/TG\'GA?Y1.I@]K#SF">;B =)NGXY$Q]2OL-&XO^ @%@ L^Q]]9M!:
M0WM*(^9>4.CIZ=F&TVSYFQ JU"*%[X2$=X0/WH=L>H+;TX^:[F#VT\(B5R7K
M<R/F,HYYA&&D%<1%H.G Z:RW2[NH]D(#O40UO<\HJR2*ZKK)OO,M;IIO,VI#
M\I[)1?RHD16GV!5U74.M76NV5,8]:P'?,#GAN4QZ\OJS9^]Z1$3 81>KU#-F
M7Q/9KE1C1"+41LE'[Q2NGAN)$T"DE G^.#A52.4(] 93L@T%;/0/,JY^*7$5
M4\F,#?%M*?E9POK=U%0K$3'8_/U.U#O7 M%W?K<\'E04_9Z^?2BGCR3#-[")
M1V?L!9VN][$4\L+MQ1Z%O^246'@VU#T@/YDY[W=UP"$@K)Q04QSD4'^GS"0S
MW&10,/F_I3%RD%%UP5L8=:>(F\^<298Y#8DWUAELE2-(9"U^5Q>B,Y05VSFB
M'3= K+[/9[Z32[1LM<O52QMB]+;J9!DS+[QEN;;[:@<F[)F4A)/<_(\)2E2C
M(%:&SUEXT&&-'(<WY5I+AIO3S4.DS;B16;POLPT"N@:!]+:P)T49>^"?]A(@
MA:..)]2A!>5&6/W.,ZY#Y8$^5X<-O<?&)L*MPZC<?59,UO^-YN2D[F5CI.N!
MWK9U!_KLD8\^J7L;3;Z(R%5(Q4K:^03!48E^)_;A,4]*%-]9!"',^-9'&7UN
M,2=EI'NO']DI;O9N902]DL\X^AKCYL2]1!9R7_56:,NW_O/>\T3V2-J1&BS(
M+>=N,Z #ZD8O8C96LB0+"%V4 ]5*]$;QVT&N9L:TXJ+WU86Q)_HAW[YH"E ;
MZJY'V)5Z4="7!PL[-23J]&%]/[L#:@VT8PNOD7H7+C1>*]JV']WZ&";#?G&M
M.U"<H2\5(^;RIM2&O1/U/E;$X-?R9X* 1JT!=-6=-.Q8\SK(16XD([\V^9,Y
M7R$E*=Q["GT0QE6=XQY8O>&>F),IYZCVR/ 5N;SH[S3@!KU3)/J_G5Z>Q<]G
MENE]5=/>/&O&4JN%\-^ZUPG85+QEG-7.R='J,CSF"4$P$O=96?,3ZE,+&>SR
M'K%S1J9O[LT'T!K57YB%8B""B:*;0%I 3%G?P&[/6[*!A6#AAF%]:_B1(?<&
MS,>;O9"#\8"[4K;_=(8>1/42@*4IQ/VM;;IV:$EGC7C'6X8Z(LY-P 'T*-BF
MT*HWYW3;[)0-9+"6H>[D5NS\_EO7N0-[6@ -?ZNZ%ZM R+T$D!?E7$9M_&8J
MM'\P<RV<+\B3A'UR#'AZXD>][%1G=IE,P&O9"RPC^Z%WCN1 D7#]!EZ^!D^G
MBB+*)S+URZU.CY_=^FECV=<*I !P[GU1/D$CXQ"7IHA>AR.7O4!N5RE'4WP6
MSL?\$JW$^Y+:'?"]7,9Y<&&9U0)W#5)Q>9HMZ?AVRBTI1;3S'$'I''J-$YL=
M]*(F YW:,T\+'I&[T\+%[]^%44:8XST0OAQ"R$40"+A$0"7I*F@7_S/R;H6Q
M@0V7/\UO0+E"F1X4#[[F]2Z%.3!"]T0>7"K^V,6GS0<5A,=P=\%,LRA$)3@"
MBVR_AD4S0B2V-'=<6KC%9,^-S+T24DERJ/;B,4\2PB9Q8X'U?7VA[+/SAZ+O
MQSR!JAVF]]EN29WBR\<\%PX<GAP9XBGMX:P</A]W\!XB.S0JXYTVL.O"2I$$
MNKR77].'JJ$-5B*V$2F_-D]THF='UD^VQ,<NDDRNDO:@]SFVTR@""I$NQQ9+
M#,657_QMD)*&X5K/D]C9^!IOR5)DSQXBJ]V7U;8IQD4!EK"/.*#I@G"3 G!M
MSD6OX'7^?(OZ!+?^3AV.71S*K\PL)YM7K<+U245Z/;(BK9^U?"<"X9[>]Z ^
M9?#]F)"]P(M/L[0Y2^<5/XASX\J=HE]*20B+;%ZFG<Q'#<U!4]S6I*V$3M/K
M "/76Z<* EQ"/MFX*S>T"2;U!7Z8-"AOZ0_4GX0O._=9XM5$Q'V#G>I]YK)B
MCL[ZAQN7;E2R1UB0E4O?S"[UU'"W>LZ^&9!O2'M:N#-]A4VOQU:)64Y1 N*R
MA-W[PJZF+#[ (W18W!YRPBEN+KN\-Q^FRM+(0E2'$,+1'U\X1):OZ]Z$ZNYE
M%]7_LS410H(S+PRLUY2=RI4GYKXAI;A7_J''6*?.P<T7:Y[QQ%X!OH&Z#&"I
M'90?;%"%ZD^W*'UNK;F)]^&#)<@*PEHLJ V.%FVT"YBW9O*0V, ]]'#A<)[F
MXLBZV;X57)F;_XY[BVF2S][UXO O9FV#?<RX;7,"(N#.OZ!(B8.?WPFO(=4P
M6?*_(W-0&1BB/WH!&"_:\\E3JGE%3DP7O&-L$!_8W])C+PU#J@S?@-FI8:02
M !GU-LGPS_J/=2])%];2:FS*5""\-MFRLDF5!NDPDL[[SN\/G##)#2N4'W 3
M[4-A??M4?:C6EW:C3V.?]<LUNEE:KXQ>LSCZ:_6&A3+)GEN#2PW=G4J77\YQ
M+E8ZEO%>2NEW[K8748G4^A8@96%DJZER6&0*!@%G^UK%DJ+:]M,21&$UCFYT
MC!S*V42\O0TVP+%$7<V]'ST*D(*RI&_X&:Z:XKS[6QP(=]L. 8=O_V3Q2+)/
M\V[WN\[K<"?.25),\@9>6M*:?5B#U'ZU77X15N]$KT[AO]G38R!ULS^F7G*I
MU&T(_S\R?_%AQ<+)2CWFA=8WMC49Q7&IBOA6ZD*AY'\*S_-@@=EN^-84V,SY
M/+)^,#HS\81\2>A52,1'!-^OB1EA<+GL,0]3@Q-/)-N*]8H>_<U>S,";7@2%
M(#^2-(CLE?WN/432P:4@C/%.:46P9UDR!/N1(5K*WS82'U4;$KU6O/&F>#4A
M7T9V]L8KN&FJA[=,P;F")GTU4<1YE<Q@_T+3R<&68K+EA?8Z%9B1][4;.?1W
M],%Z>H'->,/1B:5;<Z?!Q0NOL*<C#D)M:.^_J24$=;M$B,ZG#0;EVS."I/1+
MH3/QGOI@ER_OW:UO TXXG4#Y@J\[UMHE"WR5E.4J:WY:CV%IIIK(+I?S(\#!
MY9^>+.]VWN3<[3I9[$;5+K5ZD#[C1#E0BY3,N;1LT,JQ;()J7^0FT&'C#XI=
M+%IP7Z/.,C_DC6_YS"5Q(*.P2@\BR(XO%-*+J3<_C:\Q*6H@GSK"1\4)&W06
M&^(8"55I*ICMS V*QY1:X1HY7V>A'(?\'TXV:2\F.>'B\K/Q7MG4!%TN-B#V
M?*=V4V=G*_7HPE+"-8Y&,@2S:A"8X]L ]@D8MRU*C6; $O7?=N*H2L16$G]
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M@RG#;611<<>6U PH8_I!QNG;KCY.9ZH#6]VQ%.5<UHN#(76+FX_2E5*087P
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M[P.LJH:]KC<P1$4:IV_)+O,=THK,/CA=2*@T<)\F^J[@MX;Z8,!H!MT'TJ6
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MSH10.UI&^5^[L"R9L\/CTI&]0O2N5-_Y\6G*@_R/AZ]MW'XN_RH+L(Z[?^O
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MZ9C+,A_0$316\*<@HIU@J&$KO%B+_L(]?S6TUCEV$NE_K-W47>EH'_)D]&M
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MI-^=I".$V@A7!C*!W4<%LZ=I#//S@T'X[&>_4GAJC"N[\+48Y"',8'I[(ME
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M?S7'_*<JMX/M(AM:5+,C"!OW."FFBY_ZOVQPDJZ,A5W-4%4+J.6)5*9DGA$
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M-V:KZUZ+'5XBU&$1#4/"'9Y[UH9..)U[>'U'Z:>4@F![))4&FS=QV#<%?4=
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M<^>^ !OF(QH%=*9^(SW]%B)4?TK(&>CQ/1<$(.38\ASTG-BZ?S"Q)D'X>X8
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MU%= L57#.B3&_!8/Y<2.]$ >0)YD#(?X4+%^[FJ]#MB3D1^X$Y; T>BK6Z4
M_V$*V;J0:B>(GQVNMJ.I'0MY\PWNO7*2WP[N<V=_"'0/Y3G(N)MPOVB#^UK@
M./28*^U5!WE7<!<.>2#"1@AWDX.9N5QG6&A$VM0_DB)CP7>_N^YX.Y1@9.UR
M*P9*%MAIH0%*ZE$H]S"*;QMGX<7MSS#KRKC"1+R*9DD1,_>XY.7F1B\UP=]<
M5;O)'36__2MR^FSOIY +'1+AKI>(Y$- E138"F]RNKDQUU@F+RF/@*VZ]RX
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M]Y LY1"W8'5CZ.FG<&4Q1\SKAP%GUO2,$+1P),$-6COC$RP)U<Y-$!GP1QE
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M_JS]',9J3!\858YV?TIM1?F=VF\V*$VM@-T;T/EPYAV^^L/#]I/)B6J_BH'
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MEZ)/I;B9K*VH)^'N476"9JE2GV _7SDD45NJ-%Y'^),Z=41FJ!$"PL2X,;E
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M%X48E[]?MM6M$IO&DQ\?-'7C[=ZY9.#PN^;0.W6 !HW>4."].T_>[]YTL4<
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MG_DVY'F18X,/M?R86X%+UO.:MPQPSY,6^Q= 3%Z"4\2QSISJ!ZP:OIN+D[X
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MMVM.*"25)GX1K#[DUQUI]@_0Q->$9!KG2E?S$_5ALOA[Q4-=HM31OMW+?#5
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MM0R#-/B<*7(0[-R_/\.]Y/4Y7K*379)_W?JVU0G9X^$>^0K)_FVN<;Y6R)1
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M/UK>EDK92LBJ 7L[M303Z,2KC"VTWD&88<D9WW;^9KR)2]D2B-$6JB]5AD%
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M^LPCB"QS.;*2PK*LX[9":XK,; FM[1U4C1'QL6UW_^[3F5O,WJHE&^:E?>-
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M*/H:-+ZH_E.A[P1B2<5:J0[$\A"# G.6.]S?V[$,X;"NP)A77/(QD1/;_-3
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M[\_GG^?U>;V?]^=]^3S/\_E4L.B3\PJBA]7K;WL@"E(38#>IN),2Q,BYWKU
MJ**EG6LL$7AB36-#5YH1\T/M?=\_96VE)XD7T=3AGLZOC,=HF1U@/V<C034V
MG.V-Z$P:.1C>N2_8G)%1 F;YJ*' 8-%(_]CU+H@'L&_AN; ^@',*)#H!O7AU
M%H!)HB'K(+O:"<(ZK4YU<ELE]B;=("9XQQ*L4'IDS3QP-69:LX4XRDK@_Q2,
M+/0P;</(K-0E!>@?'W/O9M4P&JS 0]LX;7II_;2LMDNU]T)(F>JS:LY6Y^Z%
M7*%YE_8U.EN6O_%WA5RY,6-[;)A/WKMXY<R#:R'#0^G6I#U"](V)-Z>-)P_$
M>,%GL*^<7[[Y54FY@OA9'*FA]ZV0[#L]SJK9'%]Z,G$G;6!@6S5@1QPE:+:1
M6T48\']+:9"+YNKO#TN:2^+6*_G5@0^\TASGHHO,XY<SE-:_2>B%%S!&N1AK
M4HOL*_&@I=,H]*](V>ZNT 8%T-Z&BS?&GA7)9X]!#OH$F4X78+.=F9*7/P5!
MZM;[>S?DA$?J)#KDMX'1I$237\;$W=,J_5Y8JD=#/1!+@P#0Q,52L^8T)-N<
MQ48ID1Z%A@\\(NEU/EF:A:>DC"Z]I^=HN^SEX[5!56BRZ4IUAX1=&LBOT6RO
MT'3KO3;3TNG9]$%:-X9Z1-QK+-X_. C"1R/G;-#D04/*4B],E4*;[=PS\V.P
M,0(=$29/ 1HZ/T?W+7',D[\'*0848Z]T*[TQ8]1XS(9V?VUH@"1J'V3D^R /
M><ZH<)R9@:X<UQMZ[D4!.QS642H(LC=7 %-=B>W]53CAWBE\VGRCV>:\Y\E+
MTTW9/+++FYF/=D7^!JT'KKQ4NY=^&)YG)YWYX;O2M2&GQD0#P4TP.1-H:C0F
M3FI/QAEV2VV%PDC@X9H=F"9Q= 93+2^4>WV?BF8E+J79LS6RLG3DZ6:K[L\?
MBD50E6;+E5I>P8.Q0./IDFRVKY-&*U4-F\VQU@>#8]>L?3O'H(G#IVK-2<DF
MN4\'V QSWO,'Y9[!^,.2EK*2(;#DIU<-K?KT=);.Z93FU1O7O+]$5WV?53SI
MP?Y&"8&-%D&4Z1@5U'3M[HS1D425*$%"O%DC1$YJ54LWCQ@:-J'N]AD"C\Y>
MZ#&DS:/833]X8C>G8,^&Y%6+X-?&\^['=:MJ ,)3S>6J-9OIX4-,T*UB,X*N
MU"9R/.>^XYP2;S_<@XULRG%/?% ZO4J,8]H#9V*J D./5'WHHJ'D^O\GN"7P
M16'3K_>>O&4+OF$_/O/]QTW &^+4O3Y9[7;J^U<LXHJ'L]))#P8Y^*LWOWR"
M]?3?^;:YFV&+I\/'W2:-RYV-%#K./:U=\HO5^[+C8NK-=J"Y%DUHH^5U5OX!
M1";3R+EMBFFN3==F9)HU_)P)L6]O + O@TW&/KCVB9GK_+%'7]99'^C'#0TY
MZ3+)J4U(V;4"">Z%/J=$N'/QWD"D=&^,:$/N,U&C7?C*4EE(U @T#^>?:#B<
M>[W7V)&Z]_N%L%-K[KDW2]'YAZMZ1-A_J[.OKD70N<W!AB_Y"$-F\QR_BH%Y
MYKLOL=%:H0\'DVQGPY2D6T3SRJ[Y^_$ZTACN$NJI.B:V",S@"%#ILL,SLIUT
M(*^/E+;S@E)[?:8L'IJXZSWA3]^I&G658V5K_M.0G00T4GE[8+XBEW!GI%_L
M*:DL,.8/ZT,TK _9D%#(()6.&L$V(AN3A)"O$<7D3K_R&DR[/SOF5)G?\_V5
M2!*?Z_,E1KGK'E\!)"2VNG@[9-PDQ26HEQ>?V--Z7!A\O"GH5+&=:]FYOM00
M?QU$J$'>#\<7GF-AKYDW'<;=O(/,!S,R,H\_Z'JC.V[B[A)T\(/#1_WSIB,G
MT(535C%CL 0IX>WTL 68N0G:]JF<.]0":#+5A!(PVD!46D[3[D@A!YGR:W1.
M?P#?9/,9YG>GWWVO>5IA/*OQ_A/?>"UWP!%]=Z)KX1QDEZP+5=79+%;'68#(
MD@&P=8S/Z4RJW9!CSZ;OZI0$L[,$P5,>'CF8W C)3Q<053YS)@BB%A%,F#MG
MQ+Q0C+41P9H<,UEJ2+2@YFD+<0]@"-\EM<Z"/5:'[:114PG;<?9CBA90I48A
MZZFU%A@BR3:WS4_FM]U$EZ*G&DR @*3*" 6BO49.7O8SJ17!(O A8"=S6EJO
MBR*RQ=]S6Z]A)_A(R89<,W4W.GHD<1* Q:G9OY=@4D-90@/Z9DF.R[W".UFY
M%')6Y,$.IBIU5H*1+0_Z'85*.WFK'0-.']]7R?J 2]'Q7V%Z5PM/3#3WL7L3
MU,,#7&?"QQ->%KNG_MMW["MT<&+9ND,JME>GAG=/]7P#[E$NN+\#WK\\-#_D
M?77:ULG5<2A\M)PFZ.:&U74W&YQ=M%]^NDZTWB$UDDQ0RS=!T/B<Y]%BK40+
M3NE4PGHT$M2A.,R#W?54=/[>_%FO[LW9R':33,;3Q5M\9TW5\8>=-$0W#,J&
M'$O?]AQATN(APQMRM^NHRD&P#V;SU\.$]:JQ.KP9PK[!879LV?>@E55&Q8;<
MKFXQO>X++4^9'1W"Y//_>/F>&QX3$VO>HX4\5\P,OE-+_ 5*X',7@)A1JTF.
M6!7<(HIDLU3;1)C?L"R'/IQ"R31$Q1@=,02UR1\0:6<^R4DH68%;%Y0$Y^_N
M^I?!B/%QJ*SQO5A]X=Z7TN;5YYL%^B%0WYF\(3?Z9H0!25DB#Z24'09?C[61
M)S[6,O/F*U!"C\3*.]5/AYR,&>\'D-^F,3<5FX/O[J\XG:#J /W6T_83$36N
M^>,;?]G_F,N3]V$%FE<BRK\>=WMYZ'RS[MB"F2'4*H/[H>1P&LXD.HS]HS?L
M?KP]PBWJ^ ^'#HV7AP>I-$JPB:1N9!"O@GT8LR&79'T66QFZ"R6A-NP=*%=W
ML*3%$ ]^JW#D?/NJ=][NSSI?AXL+@XWXE$2A584YOB8B<$73F509O&Q]ZB./
M]D\/USVQQ=SJ65KQ5/Y)6OW%HW0>+0:F//60YY'5(N]I_/'=N9_Z+T(AH_!$
M<81RRHB*7E5]K?K#S>*'5XJR>%OS,8WW W7 V_83]>2P[?$S[8<-/[D]+WYI
M82$?M&9PO5OL]Z$VK5C>L_NSP\FFC$\UL5-W;$,J[N\[LG7^8(%ES*?VRQ<I
M5_ ];ZAF7X?>1+T57#$G/T!ZJ L"?_P88"L[!ZE.A(5.?SI:\NMN7UZ#UO1T
MP8]ALA"F8H[$_G2D=Q\"1IZ,?$9 DB-,NF['L?,-)6D;<ASE'2ALOM45\:6>
M""4/=I;."18WG*+,N>>)O;/<>A%P+W@WFZ/^BB<[U7<WP\,MN?,:2AZ<%$XF
M+9V7GJUH%/GX-=86MZ1;)="#AO?UG5P<0CKT+5J +];L "K;"F77*S43M9M=
M\\145BS.IEC4FPZO.=0\LUBM)Z7PKU?S<%"1XH;<3I#+1K0N=R:8Q.Y3%<#G
MC27KLK^,\^Y>Y1_QD934D&:R<P*2< :EY*G\0SW4!5J>78>C!:E?,,O GP"V
M+3P2C22NMA<-[P#CT11/;*&PF:8#J>F5;B&# 6S-(;JX&9(8;3B16!K<  4"
MGN!LBJ?5AP])Y---XP&UI@:M5.] ==B!.4M3R>P;E30WNSQ$%O/%]=)Q'2_T
M0BEKH1G1[C-=9U&_V0BMYZAM7PN^38C;CP?.58A+LJX@ZIJA6X&^IUF-3/OB
M^"IZ;:\?ESZDNI7AR3Q-'1Q@3A_4HR P<U#5"WL%K,3B^TF_.T2^*[R2$UO?
M-YDUB"6R\5NY&"EA+$0=OA]KTXB(%2<S/80&K\+79E%J6 R;T3.3,_S(**\,
MV5;L6U)-\AI";\CY]_Z9"W_E[#*AD1+NU*N?-'*IET*S^+>6^8DA:^TQ(<H[
M*'S@XAR$XKV!\R(+BQ#38236NAWV]!T=I84SZRUXGWZ-!JB_+L,BX0FQCA>Z
M3IH0S,'9MV@><2=>5R^+;$H1CJC@H,"@3(=71#BJY-P$5Y[A?8@MW['3!E,V
M'?F)2Q_XW2LD8H?\$"_2]('C_=3RB]!+0U>"')&D;QG5/DBT47NF5LE@;E"[
M@,<0AV8)VEG,*:G)9D.6WY!['(1L'"7/$IZ,J,BVM@-&FR14Q^^F2^R(Y=B+
M2HXN71&.2D>N/>[AC[9R#(]Y.>ZN(J.SWK^F>?HN3$1D[1@^>QS>%VOQV3Q^
M(:,@>#/0#JPY@ ^YJ/>TWHH7\.1:5M(E\]BEO.+Q"N)WEMKBAMP!6W3800V5
MEC_KZ%E8'?L$?Z,XS(]"(;%_Q1Y,,YM[$[(XHCP[V22@<@SO-!OBKA=-?PF(
M,FLA[@BM>V]([G<HA:?(JPD:,9$/WK0<<O>WD[W'[P=_LG6,))^X3$O!R !3
MZ6CZ*&N?+2500Z;5=W)IC; #:\,Q/-!C\D=M9H4&PIU.\A;4+ZI'GJGX0:SB
ME%8(QLIZFQ W2(C3+F@SA)/>[DM]N9$3]R.'IFB,Y'OW$T[DYA;+%WQ1,-OA
MF!71Y\!-'9[^>'$:(:VIZT-]P3T R&[@!5&QA/"?K+[-RO^-AQBV<K&R&.ML
MHL;CCS,RKC8@7RVV9?;10K:/-J?^[6C(!,08U92G^4<PL/[O+>(Y:R6 -*\]
MYK/]"F#&A@A<ESW @<*@Y6Q! K$4S:IF/16':[NTM'GVT0XL"/G6:GB>X.\:
MQUC"I;[PJ!UT9GAO^/S%X0B'BG__DEW?K($7EVYLEK>[[[R._CFRR_)TPZFU
M6VD03L.Y(WK./F_VGM%0VB]O[/9+5U]('3 3+KP@W&%]_RERS_-7(J5;.HBT
MX9];W;,Z#$+<V]BUT&;",YW#+X:M'/\)N6C2%XJ[V!855/[\X_L/Q)-?&WS#
MJ\XE65K$(\TSM?6_920_CHP^UI"$(C-61A@-/HF%<<_.A+_K??$BO;ID0?"2
MVBYHN\%=>=%71%DWFH'MV9 +,CBGX0S /U/[":V\%4]5V^TMG2D$I3GQ[QTW
MHO*U =)<&Y#<'[??_5(R1F6HY=E?M*)MSV%'-^3N;LB!!@0.Y*^1O>&8O_*5
MUHDTXE;I!9#@+\2H8\5L4Y@6Y:CDR!3^,%)Y#VCC4,V36JU96VJF51:63#<Y
MKI]I:66OJ$QK]M?4JK3OFW^#@\T=$D%_]Y'Q&HPD_+_P4-Q#P*A,&"Q.9;#V
M66N /]WVX(Y+-)Z&6/H#V1<DO#0)^6I-=;5FYY-;74R+HB';*)&V#8>_BJ\I
M3*I8".=GBF"O-N0D;B'^X1MR ^+EN#[O VG$>%A 7^;A\P%(U"-K=6:$W1\G
M/JWY]@X^3(C8BAM(X%(0^S_>''??=S#;(M.8.W%]XKH+,YR6V4=O2'%-SM)0
M<LFMG/JXQEL9TPNGAD;?O^\4-.B64^<[&VE="-A+U3N75P'7H!+^A?67LGU8
M-^.!=KL9F *H+_)(H;^:KU!U_'*2CP1:T_WI9]_3?%92WB(&KE!.&-+^.,&?
M5IYO6\-AN:.$%-RA4:@RUJ+)]QRQA27/- #DQ2W#T-I,S!&"QN LPQY.[V*:
MD*8T<0QH0#%M#8,)>':=8%+!^-'T:$+F>!3,G,0Z<M0:TN\S1KY'9JU4-Q+0
M]^\*>REWWB<+]X0$%QQ<,5BF&=ZM:OWT1\SK_D.08F)->FNG EB(7'\NM0\0
M6:EYH]3Q;&*U;5]S2[;(1WE/>UB(J)1>G*=;_VQJ<+JV9T;3NF"7^@]OQ$RM
M<P$)OM?,]$<+T?\Y":[FOG^5_AY(";U1G$1-J WW/S?KN"]Q(K6RL*+</O $
MV@OVND/R\>J-8S$'U;74(-$=V(-'CYXHTI<G&N+4CYY^&04]H*=P7$_/Y-Q/
MZ'$>8;246!._DGP(F9X>[9M7#*):8'ON2/IJ$AIV20]+AHN%I<:?Z#!%-H8$
MICA*.+Y'/JI.=362_HFP&/J?EKY?0GT<O"YNE* F&R"H+$B=*GSU$Q=#4,VU
MZ:EO 5>PU8V'/X0,,F<]K7PIF*IM*)9,7@$HB6R*Q8UN0[K%_&'>?N81OZ@'
M=QB=V)].6R/OWU^I;ADV E0U\D1UO4RWLL-??CCJ:JB@W7/'?F-R'/);//Y.
M4K_UH_J@Q0(F:U';M+-Y1/5NN(]-BZ\6&$/"IK>8.Z5-/I,B(I(L#XU.4<6'
MDY;$*FW"=@@',=4=CGKA.-D3[H1T63.INEV=<VV*I??4]RL=\^?+PX ;I$[W
ME_#DI1YFWILW&;Z+ YB'"[$-SF7V_>;=+JGW7I3I3A\O[4W048+WWR^&!AQC
MC.TOFGOA7@,5LYI";&0[LT74! V4SH9< !S4WY!+Q>N#T%8= [ZQ88Q()UM2
MW3Q\N$\::JE=-.V[BW](UL^UQ/B/I01[L#:M4[DFX:V$0GF64N2)YID*LJB&
M]!^=,R._62*! &$\M066/D*KF1,"6J.MK88:+M62]"?6JE($2 !<E'?;E\R8
M;VNH*\,N#-@"B0D%P<1C2C#G%->^)3*[),A\\Z:!97J=28N73UKO!SV$G<\(
MBCC%S0BU? =<!U*:4 <LM6/>?2D$N<)-=7XP*DX8T:2(3=!W2U+L)'=([W#F
M'R68!),\!:C421+9JJ,+4)-A0FO)2AP;F_+96J4>K)?(VBZ!:V.M+9T#:Z(:
MSD?9(:D[H-S"T@0G'3,<N'.649&%PW#1Y<J*>6.Q\L   CNV602RRG##(?6,
MY]LXFO5-/FV[[+Y_4;LX,7Y=?^%&Q?C#8@77)W]2BL>,9ZZ\RW#N^&)R[..0
M%53E8G*$ 9<C+.=FPA^^">0W]3X).'#C8;')B1-[W-,*7&;A0YQUL03"T7;\
MK Y1%R]"$V5'P38@I46 ?UX*=OQD"]QDN27!A#W6NA?\RD _80<]4H3:%6CN
M""8XY@4TK:8_G1M! EFL"*5O'A[N_V,?9>F?+X>+#,ZK+=^0Q)-2673+J[QY
MP,8Q8;*I4PCB,*94=/GE4./Z\TMKVN8#CL#I;LT>/L=7CV_I4.H-1E[M/3E'
MN1O@!+LDK5W/W#2#3:4DH\!6"8J-4L<% !8<X@[I:0I(OD&K HEO9R)UU+HK
M*RRWC]5;*]R5.D61O&889N]]AH/45[VS9$>\7#G*>QN-J-G;%^N:K#7^\AYH
M+QMJ%&&4:/P:#X35^K_FE?E?R#Y'"ZQR\A""T?(1>)1>RZ< K*Z,E[PP,?S#
M4Z_^[QHEQ,?,@Y<*-'&]0I,KZD3C&=VBEY_&%$T"=)!6X<XKC/"^?<=./"M,
M>3$Q'@;/=@L<7@X1S \A@^_BLW &DF6Z$)6@/JS-I30T"Y5W3>>$IL=63O_P
M['<B(3R#W-U7DE<S\WA5A;.(RAH1,M;IA<^6*UT+[<-E9<&N/K&5JV[95#"7
M@D9T/OZ#!5S-WR/Y,/WPS)>H+4'5@RAO+]3_,BX4?ZD81 I0>5"W]XE7>W'!
M;^'A);+;/#^^28B[Q3$J'?H<YS5&W0ZR-^-3 O-ZB=XX?:)@.3?M!'R;#34(
M]CW:B9-U'3D,_H5S93SV+%;:RQ/<("C>G1OKLUQC\(95@@/)#\JDYD#*-,*9
M-3:BC>UTYE8L+)(ANS=-]=J4N5V2$(0:11BL_][JGAEJLC9MHG7C15.(!Y*W
MI(7&&%&*:/3N>4/8!XRUHHJKAF639W('^MB0?;]@Z. -:D<A>7S\ ]ZYM?LB
MUN1Q>"#W'M$\-Q3W@UY;5*A@RF3VU-;]4ASK3+=[K<%>=W23S+,#S1L>F7%8
M3[)/H^"8=V E7">I,H*@,JU>RQ[R]!X"0UO:PV>_+ST-K_]]K*5G5A/+I%=)
MOF7GK+QB-<,3K _6IK3F*"W7BPP?P'M,TO=@784-GT2*0Q?%S</'@'W%Q8PT
M"C;#C2\U%%J04;\3[EJ7E7<&D-":":]%3C9LLV6&AK6IA%+?-]\YY9M6)CW!
MI4/5P0^3[,B&;5Q+Z_"'-" M,66\:WZI,6;;0IQZ7HBH7A')+>EC0H759-1T
M3@C37".19F@^,7"I+N9!.;*^N"81VSH:V93 !!/'TG=+STO88+IHWV12^"M+
MN'K-W9P^YG)(!"E(4%Q"+T%GZ^CUR@X-4C*GF, <XEF]R.N=K)\GAJJ.<<R9
M*C&O[>[,7.BB?"LO<VAVSO[ /)A[1372!5=^-N-^'1QI@6)SS-U.P/P5N$'=
M01YH&GTEQ_&&V#\F(KH.CPLDT CS&I*?SD -)]9FM.53B BFZCV$)8LTFM,-
M1#4I]-A(U_JJ=,[][Q?&8G>/L7T/2$3H;YA-W55NL?Y#YP2-NX2TLIN!GIR2
M_.\7>LT&VSF6^-32V-)"0K@J(<9%G(TMPSF!U(I _'&0_BXP9ZM2*2+(]PA
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MF$9SHY<R%3XNR+^JF]MZG!)D[CULP%NJMWW;NQA3']"\:?H1T3D->23'"L]
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M_G5)HE1US 5$Q@HQR82=E9@E\6[<S<UZ0 %]5QQK>"S:$NH ^H/T#@@'((Z
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MLE2DYN#KF\#:M5K0MMQG0&H)A-13D^2IPC3%ZWT+H29P1; GYN/M_&$!>LD
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MG8 UKAQM(O77>WKP$Y-%>@)S('RAR,)^G!" W(^#C>#NL+TMW*9PB+_6(TJ
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M?U@XI[ZD:LET_G%D_OP_.X6C@4;0/V+=QC863S?RCY!!^0!<=)C/#\3=FH9
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MMN'574OTQ8[@6E_N[>>L1?M8?MH!-@;RC7"2HRW^T/@=S_<X7:#VC>WN54_
M>^&'C-]8 )O;S!SX$X'7YAS)B3%!,%]1IYB[O;NBI[!"D-,KT^(C#Y4:V5O?
M7<.D"Q0_O2>SUZA\$/AO!UJ0B<?#(K?GBT*)N^EVTOF'US*S]!:R1C.?W]O[
M1HREV34F_T.V\M9VR$-TKR*F)Z A/PGAWPK3H <E,EL<L=@E+\/B!+1N/AEO
MD,5&.4( JV"(!';7VSBN:-(*$Q5(6C53??^AN<7C,??"  'Q6#GNZU^NB&LM
M-;*$M9!=L]66NBX:Y!G\"%X&F[O:2C4<Q)G.#9PBQ9,ALD#V'-,SMS.F#,7
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MBE:G%3D9/#4V/H8$-'9"Q9#3TG2R_,4?F*8-,PE@H ,L9G;.9E?[(+WP*L#
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MV5N;8T?Z-$92IK9>5S=&5E1<U_#*6 J<(4-XDH9\(</=B[SC;&H+"YJ\+R"
ML^<(=U O*(":1W%G=R_?OI\;D* %_]^HOC_ZW$\OCND6Y=F6A%919\CEF3\
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M/NT]]9I:RAP*/).N1^^0/!5+-O@[JSR=L5S*D)8BR>\+1)=J-8^O'YF5+M!
M6)2WV:HSPQJB+9_WLO8%I%\9V)R[T=W2/=USR;_U7_4/$98\"7HG[%@;*1ZO
M#R1S_MR]Q=Z.(8N>ZIHE0CS18.=/[T>:G(+,GC[6\Q!<)^8R%G:$_1L^4"GN
M% 1W^\*D]^\+_V8H@+E]0UK0^_G^--9B]!8&!$1>&0H&BP+75U;V!9CHCODY
M2U\B4.S4C#;;=.' $^H]7FT)$R/MZ"UU7R>])JX2*V#$7W!D;3+KK=]7'N84
MJU;O AGI4_&AK4R]\\(;JT;QE!O]CJ]!#-=;"Z&NH:&8\6P-X83/5_.158S^
MQ]S@J7E#A$9D1<AR&#DO]./O+51D69?DS^E5Z5 -],,,FD*Q%JT;OW;-*L#G
ML(/5(;/Y(WTC#>\\NC*;ORJAUPL%\5(\Z[TB_;R6/W GV>!G>#5LV:7%-"<Z
M3^Y>B%S4G^?64:;;2?KW[O^"""$>?7%4)\-/K<"\7YT9[@(S&.Y%[E&+3&B<
MF3B6NR_0!CU)E</*=NYV,6:2[[+[*2QYI\\Q+'B"":@$L9.3H#B,LPKD!'BQ
MJ<7L&;NQ)E2--W(\E*\%%T32K(>"A3'QC>#H[V-;Z^:LLLQ=F[DTA@WW\5XB
MP<_#!B/ PP)']?8<5PBRT+8Y3D%O&US,3'WR!O,A5='3'0MI]3;D#XV2]=S+
MV?UQ%1[+/VW*">UEG=M7ZJ6Y( 6P;*]NCUJUH<@]?6Q.8J!8MJ+@D_+$\NC/
M#O^4KY4_[],UL;7&/E ^[E9AG:]IHL+YNWQ=2L@ZW_CO9UR_K(J['TN325LF
MDIX^CM6LR=?DUXBA8CN)E_-J1D8VS%AGS.".]<SL!I'9<AB+HA6HC_/!JP67
MZ.C@R,O[ L?Z<9;:B<P^E;$^4+L$DFK =DFM8&FD1-Z\T#Q5D,F<^J/>]!K#
M1);R//B3X4_X9YX1:TJW%2K.UUXBB)F!L9>9E#C>'^Q-5Z!Y%@.FS0G/,$2[
M9L1_B8I,NIL3[X./4<56O,4'<8(EJ[(6+1,\*Y8H"'M0[.VZ6'";@=:<3Y$7
M##$-><\V_ S]LV6V!GH8K[G*/S=D=AZ+^3PC9*);/KVD/@L&67&,M[L8A/:]
MNW/M!)]A(N\R^Z<78,[>[HJP&MZRU2'?:#(G+C?H+%.D#6YF<]W6R[P]^2]X
M%IS"-B*865/.@BCPI(8.N) 4GZO%CU%HGK4I%%PV4Q[Y5846O5V;39!"4*CG
M&J)0K8P!6K+:/8Y);DUAD'0S][(^O48S),_TH:WQ]N]%7=:F](^>(.; J<>>
M<X).R4%)1JZR.-VXWK=^W_SE3K/IGVU46&>.!L9EX5K'2N''GO?J/G>5O_MN
M*XI\YL%Y-6;EGL6)3\KMH\4I/;6G<<Z/G.==;[5W]Q/#G8*X+ZM\4 XOWPCK
M+8^6"_YHF'Q3- ^ F(3U.(Y&^XR<K[W4Y&V<#1O2"7EF$ KK:@,_VP[CGV<_
MN(4M^KFK, T_#I_J,R/.DL26=D(&#?A:[)#.O#"3,;19!:K*O3>H?( +ZFSY
MMNK*GLXCS(G&4?\:)_%EO59"0X=676W+6N? ?\Y,V[SOI9E!Z=_KFN@3_1]^
M:OXJE/BV/HCS>I#^KY:>+69=5JHAE+@+Q??#K-BBZZ)LPF>\U$$Y];$06X5_
MXJS8)\I;W1K#GCVHP3"I[(1V^Z-+#1>P2/"I^SOU;MGBGV#FJ!KX-^)&P=A/
M\\"R;U$V[&+6B8@JKYG[0U9^%1XPKZ4=;@R1%A"%CBQ>N7RW<7@KQ;0DE^;!
M7JA./)X]YF*PJG=+NS=RUP-Q]_5,,D!IO>WGZ4$#K"==F*^1+I\Y7FI7R28/
MW5+CU9UR.^:WFAM45;^\RW#Q>5;EFD$;:>_ST<DJ-O[JZ:UZT^),5:(GF^QS
MAF(8Z]AF=N/'>+2K=?[]\\&K3HVQX>)9US;52M4ND?IWM=S@].>W5F M7S>O
M=DEU?'_7Y:OPS]*?KRSJ#5M\KN<\TNV8;Y>^^?M1W-W:K??-DP_OY9=AZM7"
M,M><;OJ''H[^<47I<;SOQ]%LB[/8(R_O[.5QP+/$THYXTAQ)X"];Z3:541/[
MV4OKC+G;;$U1;6UROA!?.G[1DWU"O \S[R5WI1J "8YUM0<AQ6C2']_B?HHO
MW;)0>GREQB-[;ZFIWD.]^M6]UJ_Q;/ADG=E4>[?!R;WV(ZH]_-K9-+%+J/:;
M,8+M.)W4XM36N\4@U]>J,G<?G<Z17+T3^"N\N4Q.ZKIG]W#%Z<87#A763K&9
M4),OCR>]W9\5R(&LG1>E?]];[W4U?)]_V1"['. _-55ZNGYH?M##HDJO:*7-
M2390,J/YWQ?%Y\ &C/DKCVGAZL*5U'-0 YT<ZLML9*)T3:D"Z#[S[GO[TR^>
M)&F__-9?6\DC'NDHJ99#[-JU:T#\ LL QRL7K=ZB,J8;+[;J71UNP][(#$3<
MA03G:)V_F"ANM'[NR"%%^1YX3B&-W:T8E>!%=78^<F]42ZOLFK^?U3G?@/ 0
M3>L,P6L/Z=?<K[ZZDYA[S?Z]W<KJ#]1/DQ^O<R,10SDM'UL^6'K2E#L7XG"=
MD]3K6DUOW_A\=.AKJC2,"_?3_E^PH5-GLDC<7M,?YN$-SS4G=74%K$N,XW*E
M7ZJ]",].UOV767"<>S&INPS%K6U<KM&7$EVLH-SPU7IM)D/<T+[X[$- @/B_
M.A\S+E9'5[&L1F:P5AM"ZP'!(W.)4J/I)>F*&1)H=?>_I22N2+[Z'?<9_N+=
M60H]M>*M[?'W'^@,M8!#O?0Y+UGFMY]*[V,+;MS)?)EQSO5:^LR7=%8[R;.?
M]&8R<7YX\_DJQN0PS<3M+_/'B<K4<<@?/X;!V1>D#C^^:/+VXIF+8==OZ"S4
MY%<B+(YME*?>$U=5D[LW1G$L%IC1(9S_2Y!Q7$#?<-U?OA=7NU*A/3@TI1EZ
ML:=E55>Y^WSM)ZGC2KF.9]3#<'7J!H?ZS6A'XO)42@G5I95*C]_5C?>5J!"4
MOD;]X]EUV-$"FYTCP?@^_;]] ?]HO>3>5\/W>2U=9I+LEN@FTTILG<W(YCQ=
MI38#T01B3:1)(8R]"BC*4^01XT*>$O^,O<+7^V8*%)>?\QR#6F9(G-=LZH_%
MJQ1*FD/.TO+:^L:]M+4?E@B51=L<$>7V/)NSP>Z4LB6N?'I/)5&V\]]SN9?C
M7@2->Y]H IEATDNNR$TJ]S7W=MWGOIOZ_+[W:-'=#ZEJ?S4E7=>]$B2H&Y]^
MSR-=0]<1N?RFT^ZRTF8997.X#U^^*)W) ;<WKE>?PET>7'^H99=3CMRQF*X+
M?V0"9D)%R-$:*$4;:AV[G6\T^A<=4I1L.^A+9B].U-\.L45N[%Q/]A@*GJ;2
MF)0G!*98+75H%J@EXEQB.G+'/LVU)&ZBWV)1GZ'B.)?*&96*JC[FKJE&IYG:
M4$AA?'9$5L/+:3'X"0"_Z#2V0-?,\$).]Z\ZM SS:1S#5M(S6'Z3]&/L!NIN
M<&^OELB=9%A=]"0RU.UB94?Y_0+5706RU#JM@1B\$\"5XF3\F6FZ4'X.R2WP
M8FW&@N5XD#>3*UQOE9C.'6I6"%IK/)K E**R4Q8J6*!XK,G_:K%Q_+, R:E^
M4+693&D<;5*L0M1&/5VD)-P<4S*V>X.I^N*5E== LO^((Z_N@)0F&MUL-: M
MGR[R5&?3Y+#%;<:'H=)*!<.F-M>I8_-#9)& :V/28#GD"VIY*7#H9M*$[?!&
MC:/5O0\?1^X.ZIDB12(=ZV+:U\NP^,ZN6^:_CE ZH@ROT'\M$_&GW%%<1NF(
M\8$R?UWD2.T+/,<1*H&8SO$=?+X?2[CP6<0]_O$"6FMT#PLL-0'#5EFS&UZZ
M[JG0-[?N#2LE+T82P-@T.TY77/"566AR=NB?,VT[-W,8\,_"A8+8Z^&\NPW<
MG8ULBNN,./\L_+["J4'J1%BI#1$;O^OLD:*Q:V<*I653S!1WT>5EWJK)^EIW
MA8_20Q8_TC4W]6VOHYUL1XA-1R3YIUN&>?*F12NR_2DE_[*])Y:YX*]NKL9Q
MORA4Z3S[,;^/R;;1BS?>N2"<2+;T*JE+-L74E ?CN4O&Z$[;,KH5^N'N@P.:
M"AJK1UO.EK1(Z*<CBK 8>PXH=BOY>(@>](2):3$RL=(=T6@[GO K<@HVMNV@
MLNLT7+.E=7<Z\J#.VI?W!7QW0ZM\:WK+S2MVNGAZ.:V0'5UX(A2X. +][0<W
MQ4)IX[FF6=QTUCUZ"$$<F^8\'MRL3-+&CS+7(6T18V4_OK5&"?[$;**57M]G
M>$U--F9GO/#N"U.IB")>O8M*FF&_X/>"?QD!3OL"(@6E^P+_CM+VLF)"FY36
MB[:_5S=JS?! Q/3!JI%-0/5W&?XLLI#M2&($L"R?@&=)R?7[ G%B6/M;['G2
M$Q+.I@10I5$E.:6=.7XH3,ER;GS57*3\&2!K2RXY_V+/7#N,MGINT8G2.%8R
MHHS=NCR?MUH(*%.Z]@7$L(MN>T034#4."D3]0VJ# HIA/$G,-7;YLR;]$MH_
MV*7[C6Z?\V$KIAKM>-6A=;W\L/:-;<.T(--]@6<0B+Y^RZF5T!^WO5_A9CH_
M\I5QQT?UES?K"=%P,1]V:GX%\N+4E;<\C^%2:BV;UYC?T9EVE[&1QQZCV=GZ
MK"G:N&^A@_['<0X#=3E^;!@DK66+G)OYA>$?_QGF4X6[OD?1#LX7^FE?L,@_
MOK4O<$277B-C,I%LZ\J=F'7Y\LY[>4S1+LG+J+3^8UU#H6W2OH [YK+?S$2V
M\(>UN>4.UW9G6H]^K4ZNH_VW\X&.CQL]>QS*C\BT0D/=&A>06H:^0L%L-L*Q
M6&W@^N+YS"Q&E-/KO6\:Y:"-3],.H9;_PDAI6X4GOEK^@[@UX;T2D563*3R-
M);1/:XS,93K9ZEK5-DIS&25SL!A'CZH\#^<QV"5]&V*@4KS(U955Z\C&']BF
MP.JE\4P@Z:?3KLO/:0\/>UVD[JJ"4C/Y R6OCTKV>CSC:O-67-[HP0(U>]8<
M%<QP=OP0?SN4L_,PCP41 23:*&8:;-5G>GT01X(8 PAPY"BDAQ<OY\Z_!+GN
M"R ;V5M]G>D/"A2CZ3#CT>PW>X4A%Q$Y[RR/3*U,>G;).AIN:OK?;RC[,?1O
MAO:HCT+XE&J>]O!MYJTG I^GGL)5?C0&KXXG%\.JJERKWN[5?_2?-V!X[SZR
MWEBN\9]:&ZF):(%EQIFYTV,2SB5Q'R4GE=_+S+/J9A@@#9"]1?2U"0SCZ*KW
M8#7O&/H-3WZ<2.WP?8N(P+2+/LWUHR2>B]PUC+K.[>VB'O_P:2S$R^*A@S89
MA7XXI9R!^INXMB] 'AY>N-$D8</I&"W+Y!AT+WX<U*_@.90!E6U:&@[L^=2X
MM_L" 2M#)HV^2[*4>+U] 2G3#,V"!X:RHLGUG/)O'6B?L%DM1T7]];07O36V
M ?)QOPPUSKPP-ZW4B59_6>]T\_WQX3N#^)5IKFGT;3^A3IUX885@GBHG:;/5
M6P;(9VH4"N),.%%I'7+'BT;(:3)8>]L1G@_3UG%8WD'+Q)R]+]"1<66OEFE[
MW4@_,J$YOA.SMN=I>3@L]#OMQ%CS1[R;W6N/\MAR6W?+;+MZ+WJ&;8]3/3$$
M!1M;F#KMVM%?LGD^,^\QCMZ0]JK&K]$-N;&^93VU+W";:HJU;"N4:/$EQ7$5
M3NWEXT+8M#G5&.*;43W(LP+AO5RR\S#U(G!="V1+UPMB065P>NSIYC*D(UQG
M+$1F"RHQ@W![W,/0K@U2VK[E_<UPGKP9'Z+"#GNB::)3;LN"I\ *VR'/ID]S
M($_J+4;T"R4&BI<8X+9FM\^R9%(,6A$N!IM&&I<_PY]#?%JK%BBP/P'*[6%X
M7-&;(<[4J?*D<CJHLGN%/%6VJOE>;GWSPUXF*#YX0 0)E]LT^VLE=%J._1S&
MIU32RH"\=F-]"DU4:@*1T148A?$M1T2$-%14K_QD( UA?M\^^DK*$!IRGIM!
M<2& ']-+MFL.E$!5QEWF>"SCU49-1#@!3 I/,2*G=<H)1J\&VW-$8Q2VVUO$
MJW_)'W,=+F]N,5[(4DEDY4M<"7H#)*VZ9VV!H)8Y@6:$;++5PM\\(6Y&JH).
MUQ@I_G5&5O':=XYD;F =\M8017(LR<3E!T_939W^QJXQK=G(.M9'*3\SZU<6
M_?UHN5_P\,Q/8?LFCCSE*=X,<.J4#4CD0>?0H':H,,ZFYC[U IWT &?A2\+"
M"/)8BP<AM_4S&GN\6@,X0@C5AI%U+?]X#7TKT!T+/8*?,'EL7P !C1U[WU!0
M!Y0[<D1C:RQ>7_3PE.:08IJLF*Z1S[Y),Q"J_*]:C=+?= +/],GI:.S\WI7=
M%VB5_34CAF@H%#<[SPL&O#B@SWBEP=(X$T7VH<X<O/K[X%!R8ZJ]-.[:\&Q=
M?-N<S<NHRMTV;SE*!O_.$*T22&NKD5':#7+<%XBVPW?/"#5Y'7B;?9LP--%
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MP.CI65BT'EG3+SS*,VL<Y MC)SQ]WWH(:_2N'[/D4.*UJE7O-5%WG1N^;]-
MH-.-CU_.2<EH7-JE?+([O^&(MOK4R;%%CKW]$>CN5PZZU/FR]'1/OP.NFU(9
MF'^C2HW<,WEO8V^JY$HIH56-YSMG'X^_L%=$E<</@H\TA>P:8,'N=$7.=J+)
M*>A!T7/"F I/:[H#E1N(',QL^E!PH1A68<:RH?Y3GOL8SIR(H$HDV-$W3:ZH
M)OTU2-3>).[L"Z00V#=;GNP+"&Z8R!'8&&XW&]Z%D>AB_\ D>9NQ"SLP<:J?
MH4+!6@KP]10)&J(,Y\A.Z["7ZYWS2 -AB^T^T7%&Q:JQ3<:N,_:?QGGFA#(
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ME4E!N!;K^?MAHQ@G$S'$0+GZLH@7TK6=ZT7T#,Y9:=:=&4,J_XG>4M@AET!
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M@CUVI>O5150(OXG@]P$@DCY*W?P<,37$-*/+H.C9 (UJL\Y/DY;6B@,9T[-
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MB0?BDI$7#SP.N=[HP G,QZ,?&:Z=??S36EV0>M4DU89$B4Y1>\0+()C!3[T
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M9R/G]NI^5*A!I#"SOF90<OY;J$%."=1#8'K9S@O75XSQS,TN%N!15C,851^
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M;G;G?X!/P_^7HO!";%7&SOY@NQ]"!RC /(<O/@8BZ=8K86V>,X\V"<ESFX)
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M#B5#):K;(2>"FWX ,;-Z,0N3+!V]X4WU:91*?U1W&+-I9F[;R7LB>ZLWK(:
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M6#9%>92^].F7.;9AM5#@Y:,/K*A$-O;="L(/P)5W:<6_PB->WI=GZ0:>LUK
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MO4G553L_(EM NR(8M'BG0O5DRZ2L  /D?L#F=C0I,0(B#W;SCOWNX,-LB@J
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M>LXD_:\A5OT8YY][(M]\HU RKZ(E/[P^58A?N>-4A-#):GP]GE5/?U*N@<8
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MGYHD/! +.<2*&'2] B!XJ#O,IDMP[,D6U_.\<.'S2#9"M\_Y9@.07(GUFO_
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M1WM/O]!($)2X/@HBJ$:"U2SW7RNV1_^N=>Z_ K,J#W[OW,5YHYWO$+_['=<
MS!I98JZ#3-CQ=:(W?D^@:)^I$O8-U9)KSS7\HT>U0[_V]S:^6;^D. "^<1?
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M:FM3%K"5])Z4*8-C716&30LS4JL\7_O'NJ=FISE/Y,284)I!*RM8;$[]Q'6
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MF$M$DT-H$Z:>I+1NM=!4FL?7K&NN8+S]1L:.W.LO4FNQW].<('.;=.-8I>1
M^V;V5\%JPKK%E.IUN%5F">*7C80OGK*3+!NN^G!$520R FX FOHW_K+PX!8B
M=^45?!JRB_*0S" K7=WC\[KW%GI>V1EZEV[!RZL'O0@WU^?#9ZZ8I0?HUND<
M Y&"-\KGW.@P1U;5;Z"UUQRW'(1!C(6/P=V%+0+_Q6ZLRPLJVF$M!Z3GMVLM
M8=5BU2Y/ES)(/V_;2^+,RWIA[ -P7H(WT:X(/\YT?!?GM/G^C##R$HCR#>OK
MQ-T#6^?ISZWVNY.9*\OG<6N$-IL&H^XLU6OS:F]>B6TZK-5&2)%T; F;!BR?
MQS!A7:2"VEJB-_2&2XBSEA+(6YPP/7)NY*T*!D"F#OV>EZ$T7B\>@"H[UB'G
M'(?6;13N(XOFVK=Z4IENK/+Z[8)E0YIJ74=%6_'\92348T0*KOX,FW1(MW28
MF5+ITN]#5R_NN=>,<R*RUNDF=+UVH4G)]([<2:ES2Q9W,W6C-<$<FB:UC1->
M:_/T/2O@)R4A(O[YRCY'9&X CR[NZFHXS^J<M^!KD;'07 R^B5D"CJKT=9B:
M#Q14E1551B!30_.N57YY^\;+LO KF9Q>_5MI[NHCCNO@N[OMQJ?<@]_X#?PH
M?&GP:8+YY%OJ+'5);T6RM.;5GC4VRI43XE[2K';DY*WSI['.KG_YB F\BA0C
M;37KW%H.Y)USI?A?<<D=)L+ZI .B.JA(GYS:/FI7Z#M>DG;BP1Y7H5:R?NS"
M8^/0GY&43O-]"4*+MJDC4G#5$C.(ZM79>NC+9_ X?$LUL2+')^WV!P7T3-8I
M,=J6*IAH3:(I5_6<9[=RFQ'.=R#&XCS1N%=S:V&>N#>P'*G@.%(BSI_!G5BX
M&AQCU;_:L2H?K*E$%R=;/BA!MO0#]%ST.D '_T294 24ES1(''>M!%YT^8-0
MN:5J.X,;0#97ZK2R<2.2!:. &>A1J?F0<>$CDKAF!@+W$/ZRDA&*%D@<2>S0
M@&':'G_#"O\2B+C'?9AV326+NQW*4R'4V(9SF^\Q *'*@[M6S1'1>1>:1XW'
MUC.@^EIZ1,0C)I4T93)H/^XU0L[=N'77.=9QR@X.=J6ON_;[X+/L!92N):6?
MI,ZYEE=XVF*PT'=RKKWH1"&/TH%6#6Z1&W'W&BVG)[F-6OK-0.5AS'%D?ONP
M([QT NV/9'84Z9*:FRE4QGB[[WD90X)"1RU.44S3I!Z"- =!#[]0,,?5X2<(
M>'&>6SZ 056D:7O+07'K-'[ODM*#"Q_>+L5T$5OE5>\((\N+J+EY:5R$'Q>8
M85A!IK(!A"/!*FQ,&1DK'HQ!G3O.R4JDN>Q].GE1>&PQL,W3Q8^7;.P<Y[(1
M9VL_<J$A[EJ7B6?4G1TY..Q.$(Q7.'5 W#[CR3:&A.S(W4=8NYR)M" 4QRLA
M=^2Z0>B4B,+0),PLKG1>S:6YG!0M8/Z>8S^ZCC7R8 &PMA[U0P 3 =&YPO)8
M3V!Q,)5?W</[)X)N V+A 6F*YX#@H)B%6;-/&K_99YXMA9E&W\WV^',M9'.N
M@^5>;!@K6<V^FBTN70GWZA,@*?+L=@;6VZ>;_*KSQJ5NYYPC2O[)I247NTAJ
MM&I.UV)6,<U1HHANT]V1"]Z14X"*QT5&VTWK66,E77EJ'MU5-:A#VX15?@3]
MJ/H;6WW/IT6F+4W#&]A]"MYLL&>^0]+,*;4W_(.O-(X.O3#B?9M+4&^;.HP"
M<XWXJ[\B241G=<DY7I;<DALRK8W*(A/\+K+6X_SYCR=%#'Z)1<@C$NGH[4_O
MKKT&;4/%_5R(UXQ)P?\' :ANH5-#(^7K_&GBA+B#G+JRZ4(?0,K&F:HO2ZHB
MS_Q7G[TYP:#\5)I=6!7*3A"0%5Z6 5@]/_KM:%_5CYZVK/16<D\'^J\BXVUL
M+;%+3)%<E5[_T,2P]!.L=HB>RGX33+9P?/$EXI;OB&ONXM +N4*CF\W1X)OL
M\M$(A,LTQ#I(^L/@DWN;$E.P_OV@KXU>C>_K)_<[%%/+,G*#E4%]82,7O3*<
MD%' PQ7 GSS?I7O96%YR<G6\6.8_,]HQZ^UDUAJ8CL?<P9]P+TOJB3T/WN^R
M "J]\CJHYUCZ_8:0XWKN6;HO52F.'P/;M$Y%2!05>HXM<)"YCQ\)-I]%.C\P
M3H29P#45ATB7?$K_5'MD:AIU]JQ<^R_W&YYYM<BAM 5SW=!DMJ:2L+4;FH23
M0^E=*(BM6[(Y(M-6'XN(LW!F2O.+IER9ZTSE 1)/O<G_%3%.E8]YN'BT3=\
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MNI*PX-[]+F]_Z$-E@B_?5/.;&RO_7^G@H/$>JEF)(<A\X=(?=9::%H*\/$V
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MZ7-))[(E"WE$Z8(.2+;"=@N[$#:J7R^,QNURKA1C".JJT]I3CZ0"(&47# D
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M#J6U\M]-T".B:FDS U5I%3:=9_Z1>91KT_TNO(3QLO;>>,./*CKC:M5(5O\
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ML-2L;LOTP%(T["YTG.#/A%,=J\'*A)']GV12-9?G3+?#,_-=4G82-96?;X+
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M1&?G4/'=KH+J*=ZA *L@<9-@Q<+'Z!(ET/>7FK*>>T:6695KXP(C"Y?"'7_
ML<6^3?XQVW-<_9>\[N.5)U+]E)&^$4@SR,=$0]/O)@VKY/@?9S]6,=HN*$_
M-/UZ+FNV_W/Y>]N'W%&^R Q-@==-=U<F-W//#+DM9L /I 8W\_S-_Q".99Y8
M%^DB><2S@9*G&KVD<[9@^[7>ZY@Y2C/T,05<=W ]=Z"'(WGFK*(\A]/S5$]B
M.T3G?$6_1'8?-5\Z3]HPOL\QJM(>MSB*2\X,O^!A<ZW8R#;%2K@"MSH):?UB
M%P/'K7YX@[/Q_QQH<5/1Z^O02T!@Q)==G:7 @U,B7$5;[G0[+$5X%G7==E2G
M57_)U(B1M?M[?J24S'O.(N@S-!*(U=XM!CGYV0&LB%]G\3=\MB37IV1R-60
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MT3CKIX&!Y>K92-R@AG,SIK>5$C)DK@#_2GA,)(_4AQRT&"F\E?^;)S+C<RC
M4AX(0@GV%-&KX9#8MX.3O@/H%U.,16(Q$NCT#ND !.XKZ^CV$*Y-C=N,F/2
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MT8C*_Y ?8C2U#NCE$G>CB7H$>K%%:("2\]\5U\-[7'E]@[H#)M<_P%^"!H#
M9GI(Q;HWXI+Q&A*I(\T<M_Z<OA96U?DURUG"#A08/OC%,\<LGP\C0GBW6(-4
M![;.4?,R1+I%,-XG6_HG*4IE='TN9S!L%#A "F%HZ_@_;GH[D1=JZ[*RMJ:[
M5Z>"+R9W["(PT>J,X''GD'1KYU!0"ZSOH&(W]&:H9(/;&,08"E0.C0@9Q<\\
M]2CFRA,C9=W/NCEI@'3IQ3[2J?'9<U-Z]5E]4"#(PW0L% ?GCC]XZS>#$$PQ
ML(5/]=MG@YI?@O/"P")HTS#_M/@M-_M#@?;RF]2KYJ4I)P#47+N1'PVQAE.
M0MIP]>#4J71$!#3D1=^LZ]ZM@CUGL%>V]<V\M#CJO=K.0X'SDW:DYO]6F5]V
M?YF/(/UTER.6KVPIY\C=1@#$(X&@T(B(.J&5_U1K6RD(1+QG3_"V^_F,/?F#
M[PBF.^5G/')-4[>C?GAK@<B<<)74YJ>X>M;EO<K>6"O,GUM5'L*A17J3LZ8]
MX]X4VYPE;2?64CK';ACT?LTD.S=O.)L8]=GXZXY,Y*T1'A?T[>\J&,#0V+;0
M<+G]%6E]HB?[:MF26BEB=Y44GIGU<5>WZZ:#[8!NC^'V[_")T&L3$XOGU&$N
M8^B7]WYI7D[]/C7![S\4.+W>@=T4&J&MKV#YW:,+YCQ54.,H6<AIBNEF!/O(
M7#1XZINCZ*L66LJT\I>PK4./1A):5H=Z;FX:?)S\3T>+X1S;IX%/25N)-#YX
M;JKPYU%EK \%V!HH^)@*=?KW@\]V:>//4#V4OJE(8:8QR/(N9&.V0\=O1RO
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MW9:-\=IOT),+!0 @/>Z<[M712I<E@V,J#2.*(U'"?'_J1^H@@;#J>#'VSE7
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M]A]65)]44Q$WQU56#:IWCT1)Z_-T]2>*!>V\UQOU;K*\-X%^>%[5T2'0'L\
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M#D4)R@WFHHW7"=9[(IU@QERAO$V[-B8/W1A/0N U9A5/_98&:\1=F:?^;1$
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M0;)T:<\;%/8@4VFGH+\\S:>@]G>)IZ!;BCAQD8UA+R.O4] Y[@%NLLTIJ'
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MP11U/1J3 AVV'3[9E@+(M&/B'2S/.J!9=^L*6/1X!5X4_@TD:R'?]U=:S4\
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M*V?\<:V"@X/KPB6J[9*>G*-WW>-QRU:%U/S1\8U8OD>-34\5<M6M8EV8O5@
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M[Z&KJTTH2E :4T*>@^@/:QHN4SDJB9NPB2<6GC!BE 746!0LA1G^E-'3F/>
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M)UGU7.C5#-%T19&9$JF<<(UIVD#N*AFY>T21A:#1>$!5BU+@IR =)&"YW@5
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M?*4*#5YS\%_\22QGMSPB96RNM*3&P;B<YL%@$J.%-=31L/[+3#-#ZLJ7U*2
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M7&+]AM8ZF^=-0SQ$AZ1%&MS2_=1:&#2,8FBV413S(>-Y8_ B74:ZL)PK_%$
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MRQJT7=87W%SZ">5#UP2NY[F*.?9<%/SY86LVNP_1P2&O&+[A+UR>:(PG/RD
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M=4XE<&VU-'/V&T5J&^H/P&V\7FHK757\?=/<J,CN2="H0:L(DO42I'[?M,Y
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M0S7QNS?=QDMN0X5^!Z3Q6I/E?U^P>@3)ZQ#O8-;L"5SNB]R_H5)ED.R!9Y
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MT-G5+->S;*S8C ?QI#8B^GVA4F1Q^8&"X;'6O1BUVQ#04V):G"29%R_) (E
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MRS\]US7I6 -_]WO2/?KP@O-Y9?&27B%+/=-WBDANI^1\5W\F']_\/<B@BO"
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MTEYJ?6%ZE.^$%GH(%LC^,+C!UR^D'QYPYG/ZP0 Z=/G[ZINC"L-5MRJD)GI
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MV=Q,_S<"USS_\@T^]<V(M(G@%/$>\DTO+^0D1N)2HMQF)_?!=[$'C1 LE=Q
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MGHZ3,YVJN_!9Z_*4Q0TYD>2'&>_>EFJ\J0&H9;ELXTJ[<D#'\[R,]%%TTZV
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MW7&\?WM%/9]A%?B=-)R=C/]S:$%'+K2V\C*09F^,\P!2(LZ_XGU.F(@^V"0
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M63H[4U-->J79U*\IJ>%M_<^ZB91H42?>E/7X@MS]<RW-99GR9N>&]DUFI3F
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MD:G-XSM'%:0$U5D:TWU^U-QP^!WF=X=CF5)[G$=0P@M8O3B&,:L?N0;<(=7
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MS_G4^N!D41OJ#->$?%5KL-+D@S>,B\&'>^NXZL B]O(UWKW+.9407(+A.OA
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M6<8X*O%+S_6$>D3[&0RI.%:R$LR-RFNO 6;]K4)\ E&>.CI:6I7"R#(+ZFN
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MD_YB2K]O0P,?X%@GFH6OE^#KIFZ]O-/$ Y5N=7.=JLN9\?'@!]HZQQY_]6*
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MZ\$@NCZZ9D6:Y<*0R:=GQ"A'T<6?6LK.VF&2<;QG>QB)F^-ABBE=+-F$1HC
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M,KCW G65#>^UH840!G+*%*<ZZJ8+5FC/*&_MCM\*#I:F[=*&']Z,TJO ZQB
M68<<; '2ET+9AC$T71* S<[P LV=*8QVQ<YI=2"*E=%#4&%I5MD;7&=Q)N+_
M.8)?X2]%YY$"IQ*JE;N+-'?B-/>(O$"E$<Y2Z)"#1)!EUL1BLFXZRJR'$(5U
M;));'C8Y)-*_^=PL<,#>*E B<:8Z?E.QST^.R.%ODG%$6CKA5FIQ3_[>*S_
MW@\N5,"=V7L'OD:'"#_.$)[=&-S"<'>-G^(O\-]:_T;B8 *IPZ[9V!=DZY);
MY1*OH;TZ =Y*W@H;6!L^D>&RF-AW/PF\5,()"V8SB2#($NZ8\. 'A+^\*A(
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M(IKW9SUN=M)BJ[RHQ3&C^M=I\.$].:.,?PQM[G<:5,%AG3>^@N/8!D534'M
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M6I8LF$,()1L#*^#/2T80G?D<NM;SGK7+B=IX-[.![ GC\9QL;()_YY-RQ=L
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M/M=---SP423[#/8-'4D%\LYNS-.Y>L1I1N2UX=[)<#"]V+C0J$DA=XZ;-I_
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M^XF,&T>J3.WC2I1!JOX]1A55F0=LP.^V2"D#7@Y GF4*TQX3A7)3F/X4SH?
MI'ENFP%]B82_.X@W,[JO/2H#:B0A>,S3O1N:)WU1&96X!02P*:'?,KT8<[6D
M*ER()IT2LA!U)G)T_AR3G4).ZI1D*M->+)K&[U"O8+*F06+:]-SXO0@3#R)4
M+<+@"&"*F0@@5ZG^\8W_[&SR/.$T(1:26>STW'XN,E<OCO<3(V].@WZQ:RPN
M#X.L9&3T4L6%I#LJ84-#)VQ?\@SB#8DQ5/.+CVBN=1_A<SX.H;;!!T&'D*6I
MW.'HS1 U+HU5<8;RQ74*);_C_CZ,$?<))FQ!!_;!A%T8(&I*/J=Z!*"7I'U^
M_WT-;*=;J+-*K^@]7Y7_<6[M#]A/I]7<_9QW?=# @(9Y".'3%#,3^XCJDK_"
M\P4KT<\$??"[8""W4#"OV.L%5BZ)&]HNNDT]5-;N<U^S_T(:IC$2%9HEAE_S
M-M!RI622]NU $Q\*YG>]/+O"E8M@#_I%'G5AQ?->"-I[]VFY:;!G$_JI:\N.
MS.+XU?'A^I;$9]\DTA"&6"\-T>2J[-$LA'616%G5B*P-7/D7_X,F+ H?<*R]
M-.$&NK^:DWOPEV$^9+/H!6'SNM"][R[L2JZ)>?()T4_J5Q1JY-XNSFD7O!3G
MC[S*B+?DG(%MK6NC4P\3WHH_FU2]3CWF'K!-WK&E,>A7<VBK>??6IOWG09!J
MT)MCW-/T!1][;H4&(_D9U:]U"CE>,4\[.PEJ2?I3'I4@>[S;BLJP/[=PM#)J
MOS7YCE>.>C8U]VO1],;F\_,+CG72.QF)MP<>TKV[9^WWN\, K6B$F45R4)/Z
MOXK':7WYJ/>C#1&?^O1F:U-%)Y<Y)*4=A;F5]YIY*33&IE"%(;4T/ELAR+3Z
M>:E5?YV8ZGV7&U( #BO;O,!"H5$8R' R.OM)E7EE*VYI5*#7X0O=]97MW6J4
MGZ;")ORR1:'6]]Y1#."_YQ4/<?)O;(G2<4_U;^=*L<,M<U1OS#BL;'59)D=A
MHC82%@LUJ,@ODS3[0KH-B_WHPGMZUK[?<2K*SQL."^[>G[M$CR^D/@DH_G>^
MJ2^N8P)X#0D)3-'$ N@&;JW8-KI&*E&VCNE*+31SF]P],LL'W@C7."W45XY+
M(R5@I/U-QB(-V#_/%7G';<U9HW<L<>X^G3\>TLGS,M0>03'GZ''CIBTA8W3Y
M%W<@-0 WAO5\=]";,:G=O,D4IQ^<CF77G<S53MBZ[?/F$U\];Z2+)S#-D0R;
M_LCK$P@T\B)L[<MT41-%60#VR,DI'#[)5$&L$!Q7\Z2;.#MZ*5($M++TIJS8
M-%7K9G#:L<? "5NSQL9Y.GGA:A9-G%K6*4Y4>+5WARLU'.".G +.,"U:"6H<
M.B.*V >4_^P)YBBBQ,3ND;EWGW:TJ^L,K-T)A:_;DP=PD $K6P::8S0QB9\B
M'N\MXRI?8Z"9RP*F3BY^?^*=4KJH+<$*^Z>P,;JZ+.#"IX_0W<3H=UPZDJ/U
MN?^I>9XM:_-!:_K8+,%?G%,S(?;^"EVWI?3.Z#;6W"7TR]*?''[!N-$=[1\A
M5H/NN53Z5*!<JSK_^;V/K>X5\4C#1Q=^R55;Q<*[6-_%43<2-CAEXG5A+)[O
MJM DC>G C>8^91&8TL'3<5UQNH-C4Y$\IW#O.Z;<]W ."N=9RE:J FH-D"*>
M*%2<@ SD%*=ZX>[0WXWK*E>;UXKZ[R)9EV06.(7[<"B#WJCKJT%\S7FY/>8:
MW452M/R9+XV*N4EHDT ]=;+3\,/5MOBD*\J!GRVLR.:XXB/GF;XHB$>@^#*T
MERM:3(\F_B4C%BC"M"MA%%O2BON UQB+9K3LT=92M;B<5@KRLC/LN3'=.W[O
MC&Z%#<'!FA@(EF\YGX; 7GS8GF51_"S=J$7\,Y#V("IQ' ;>[Z.3HF7N"8LG
MZHO3^O.]?RH7RM+YWH<%1_W5*/GN8GR$DA-AS*E'H>;ZLZ&?I)WB1*TT%X<;
M]-OI\EQ)\1P\#F>,8-J-50EPX_.7!0)C2M62^[<'.#:DX@,ZFZSP!?)6N3(-
M:7+BZ-?Z5^/$1 9]Y&Z\C/#*(,D]XCE_><^'6FU7HV ..P9R"EIR9VLS5V,E
MK._%V2ZOMF5'/8IZQ?4#T"O.><(&0K*OX<ZC-XP<]15_=]Z9"#Q"\CIQ^I"_
MG,);MR&%L,@Q=@W6OV_R@BX=5SF(K&O$X%<P+!E48_0)FVDL[#^3&R,XRD%?
M!X!ZL)Y!/6%+F;M*TZ\1CPL<W/O?]5X> ]/$MV4OVS1Z+_F^VMPK%._C8UUD
M9*H"YH48?Y%[<PY(XS[7&0Y6^+Z-& !Y1K[_D_@Z<G^18-/GQD</0I<_JDZ#
M?IF_HG\+-MRS_VQ0_Z!M7&$7P=%KY7I[9D;R_1@EPKAWQ]$1.1T^8C%O\8\N
M0^C)"5O!%D,QJL=5OD=<=*!73]YQ?!,U-BU,64ZC>Q&>QA]9LJ;P:NC&A&[6
M70!"9B,36%=<N7;H2%?/K3$!GT=3UZ;C/YZUU(^+D@^/NK+,N_*K<RZV<D T
MWE$NJZ"RV^=-C%W50ZR<@6=B+&V[&FY1%E&P,@27[3>UMEQC)*?+E9M8LFM/
MPG.'8$DV/4<@(UY1VRK;JOAGR45B%2B3JO&\;.WD&Y]*K:]G,H7'.Y5 1'MU
M$->_V$<@2L>]$44$^O?N+O3N17MLV-%7RA/1S@FS,3^UF5J28>'L?W'@Z8/>
MC(NK;?8E?ZT%J<?8XM6>T*5Z;5P,<>9YLY))D%2X9%#@D_?=WR2-_7CD[JLC
MN]OS2RA'MY6\/F[<;$7_\V+F5EC(G";^[CG(M6LA87\KN-U?_I/J>=.#44TV
MS^IAR3;GW-Y9/=3'U1B?>ZV:=.Z[9&;22$='07*MT"W,,M4Q^;Z$\/NW B=L
M#X[K@K:%>-)!T7TVO4L[5=J:6$R1^ __!5MWHS27-H2:JSZT!E\A9V%E54[.
M2\?U%MM3#@O,DDJ.L_YSI\->#65K.G1[V36DHXK4U602D?'?[NYI:0GEJ-=2
MK/"5A4_@'#L&OHP(FL[ W/WC#.#B.E=I>=+"B 5Q>K_[P,&?VN%M^;9N=\3,
M9EP5A)",WQPPJC>WZ76N&:MQ',J3_E@S/TUV,7XID;ML[D&QAJ&1=8C-]5T.
MS<":2V@GY5=0W7R(O1F[X:"9?;3 N-+MG!Z;/-LTQ1=A_6!065Q,X7Q,%(J_
M=RM^6CR6R;^PML$W;U9L0_)5NCVYJ\CETA(=!MNS1(^4Z^,\*YV=#1$P_[XV
M7$(@AV!MW<:>Z+TMJVA;19@SUXOO3'FJLIA/)!\C;.&_ASYS6O<984\)=6=G
M\FMFO:C[^W,1XT,[,X-7?!H?6TTRVQ] )>Y$/QG[-:/BH$F]DI]8R8C31?)G
M_T0O&I]1:$NMOQ'5\%I070REWVZ?92='K7S3[8CU*)"?]"\4>E^Q#K) KKC8
M-Z:+?VN\+,)QA<3^\=>[ZAW#CQ::3(W]47EMY-['A4JT0*V>C]O^Q:LK0SE\
M9D5JDFO4$$W<O_.7ZSIOSN"^@ VN,X"6I%^,+"K'N0DTN,6YQ^R[KAH4#AOK
M=9/#XDN37>U0IWFE+TKG^WR@CFE\3+V(>K]14#;.(K.^ =D"@:=JZ!7CFF*%
M5\8:T(5=:.M%MVDKX[H/%@JCC&-ZW&[2%#>F^ZH9WL;TX@0U@%U'<>]T4K$M
MMC[?D/"B8.6^<GR@HLD)VTU]?K#S"5O\QNY6H@&GZ@D;EQ)\48_+BJ#K":**
MRHW9$]!K.A4$-.,%J:ZB5:C'F1'5.R=.&TO:Q5W];>,(6-/N? _UKG.-<A^I
M))L='2Q +XY0$3)=8LH%4W,_& .4K00D%GH^KK N3KK"PZ],:J0B_95:VC7P
MH>=HTX*>C:N*SVLPM&S.\>4H2W#B+(C?C7M"X82-ETZ^WA]RP2'WIQCAK-F_
M_E>N\K#'I D%K'FH_&!R]/URM'CE^40AX%;,%X\5BH_U&\>G+I4V2&NN&US!
MNR=L[+(T>W^;&_DV3G%N.E^6/\:%!X")50G=G@RAW7HG,:6"N[P^9NS:_S$)
M"E7)</MF=0GVAS9Q0JMQQNR1*0S^/N>@IO*I-?H\J.@N80/>BI_O7:&T>K8V
MX/!*V#2;!_0+<$D,BQ]#OYB AN@AMI15DVYII_YUON,[JCTN7A9W [=0FNOL
M6T/G-\)]CR1#PN"@SMNTB1P-AWOS@!_ZN4@N7I!S''RI%UG)D4,(AX+*9KKG
MGJ7"(HEWZBY9CT?FAI]O;FG!H\)V0%"JT^9T]S:)6LJ\G=63MU]:.MMW/KLV
MR. :]X%=BC7MG8=N)R^6N'?LO*W'M\]Y>4A/N.=0*;NBXB>4R7L6B-]B:3.Z
M28;M>0\^.[W<UXY##Y<A00A7$)]0Z< 5$UZ5GAL#\;ZZRK#::KQ+Q"??8$ST
M=]+VIKG)@"I$5I-0X;:!R)Z0B*C].6T&\45UC,TV:6,9E]K[--S8@0XO^ZVM
M4WPWCU]M#14A[N\E4(SCPV7IG\7/A =B"<@ZM2UQYFV:V+\2Z%9\K?ND30]?
MT4U,%F!B@;:9!">[K"4%4C>>#]L6K6W@U<;>+C2"R4YJ9T'E$4LTXI!D<Y9Q
M?9,1*@[MB)B;5%(TQ%J!@QVRIJ=#@B])OE6ZTEA;<=_\YLZ5OI]D\:6+3&X/
MJOI[*G1JT8&&^#E=5B1/LTP*]_STZ .!3WA6^"C,A@@)0,A1(0Z6MMN00,U;
M'S?SQ-$1GZ8?5W'DOST\?Z0<'CA^BJKRB\ NX?X4,SKT7[7?>QT"0W9*NF84
MJ,#+PZA>,PZRP(LBJI9W$PV7RM175OC<WI*'=_1%8(\2$=R_=[Q4"K7W?BN!
M>BY]0J>XC>:#;/"'#\(,>4FE!!L1C:8 BIVA42#*]W#(?","_:S-O&)V_A'-
MFW55 *^HJT$WHR@G(^R7?M&;N\G#E^HD)J$.1UR]8NQTC<)S7G,Z28H51T%O
MJ4>5E%$O3%CK]46S9R;,,L9%[VJF!P-W=-^G_C?)^2I:04SLE'V3H'6[0,[?
MG8I9"VG'G3EYHRG5JTNU920UK@0^9YG8O2IOIWXDM48'8?0H."*BN@_8!*2]
MCHI7DQ\QWG]5WTAXD;G5?[&OB)^V]Y.X=8V(-O=WHXT@4$JYW&-!R'\BOU>O
M0<!7GGX'#.PG??Z8:3!=L_^PG>%$)U"!7Y3C._GHF&;(@IYE]PXC5$_X[XX)
M-='[;G2-M^%:]-M;EH12&CH&X(S)HHZ)K[5Y?3S?@/E86_:O(KQF%$+:Q>;?
MKXBFU"*Y'I9%H>@,W6FTP,3!BDU%-&(/9)M9,&%[:Z]:!)65_.'/]%)F.X/9
MP[Y7=[/&X0:_0OMYP!DS'A&=- 7#)\]E1VM+!1\6D)%" 3YJSE8?/A=*%M:E
M&:0":<_ XE-K5.^X$S;OL52QBT2LW0)YBTWO5Z(GPZY2U*/W^S20X3UPJ!&C
M*T&)N.B68/Z="2IA-"[=I)VP]1DTK!+%Z3+$<#.X857?+Y_#B$CAR.\X5%2?
MY?0:==V FQF@L,L!!J=Q/&2$T=9ZU*^OS''3+L:@4O(Y(/+=;B+X10SZB%==
MW5X[$%-1.2,/%KO=41]]9!,&"'.5,2/@RN=_8(:-<?2Q]$XQIK]3N!F]J0O#
M;4B!"LT,^%'F16!O+(6/BZ"B/OK<]9DG;&;U-&0??PM=/R$*L2:4D^&/@#5N
M[$UA_[9 5#/2=::!Z&#F];']QPS.(Z%P7\8![;-!TBG3 &.+SC<S4BCF'KTG
M;-RWL.-88S"E VP\H0L"4=/.8'6)@]6K11<L^0RA4J68XO*UC7(WQT>-^)?+
MM?G:W0L4BW09#FW'U>1L<0C[D:EFWI[+PIJ1+FN,XZ*U[42KIWP?X*/4EEM8
M-J'/@WYC>\;5="I0UK1<J$CZ0TDB//Y9V7$6J-D>/O&A8IA?3\1=>"I*=YY#
M:I+Y@ [MG1/$*_P*(U!0$\1#/8L["G&%:<RV,DC0BTSVD6\D8A#I&L!8I.F1
MWH<W6R8WTPV/U>FX#3]:\WX)37Q];*'X&DB[YS0?5/B32\8C;\(R[ E(">(N
MU[7?KQF 7C?>EF9<X[B:J[ 7VMT= =(7TS:J\?8,*9D%]E%G+<P^I)VPB>I?
M6G5N3M+UI"OWJ8BO,Z!UJD]N-K4TH2=,'X$YQD BRR^R@Q1+[(,Q19P'_/K/
MCW?99Y@/VB8@:I7*'A-*AM](F6L']YI47T>],B7NR_KS<NJ.G'L/.K0O].#^
M R?.C4Z).14I;B1<?ZYB"UK6U-0B5/RW<,=]S2%'GFRSCQ;*5510J%*N,3&R
MSW8._+F*##$2VHDX8?M7P)% =XAK6K>_+#"C9))''/6(S78P).;8Q)\N=-/,
M\/G. KEJ.X0%W(>W%<E[:@: 5P@EA5(C3DV5M+<I+3>OU-0Y%K;TR%XVYGC;
M3>W,/<[#@7$Q!A?5M@1@9WNUC=.*>SNU"8&N.OVA=?!2F;1.X:CN,Y4,+K=F
MVD'2;@GE6-Y\0E>BDF'61Y3H=M.D_>H%=-CTL*1HT!1O^D!<>!A%?O:^#2UU
M/@'(&6Y%CP?R_NCR7@0 KRCLCRLTP3KJ2";JN8IE@Q#>-G^)X7L^[)4K_BO;
MQB(7P"&+F1SOS\S-E^$XUY7VY#4@SX_1G$;S3CG=NWU@*/R'<9AWV0_5;0!(
M/?[)/VTR]J@6_IV1L.I7F.#T=4$7)"40%NTF2JWV8@VSYSV?XT;KZHM%$FU*
M;/C^R#Z_X6!D^[LZ<J3+XGZ-5;]_Q?JB4&;6"=MS_U&!(?VL\!NGSL3"R"=K
MRMQAD8?]KQ $XU@CJ?=UE8R6[,OMM*.<RQI0*F;\1A6-O?]0'L;+<\0/R+6,
MN8LH&E3B%AKR^G*3=3F/^!GQ*W4!XM?!\VSA(?2SSK3@Q#TS<Z +#2O4W_S9
M&:1QN P'E\#DG]+UJ\)*0-^%-T)[ND/UCIDY_,]64Y2J(+J9]&G@@#+G;_%S
MNAZ??P/I-[.L:>KHA0B>APT3K#EE<2I_/(*I5K/VKD^JXX-]6R1<Q$&(59L3
M%#2>9D_WLC2PF^ #(RV.VUD78 ?[<<?1!@M%IR_&=*_R$1KKQL6+\W2J.S$6
M@$-JBM;* LTI:L478 _Q3D^]B$!.V'JX_,3>QSV=(_]@^ G;RT<4X?R4HPU+
MTW:#PLZ;;ZW[+16^-@P$5IB]3I',$'FG7PH&*]R3WHB^F:NPQGOK=L8_<C&I
MD8BNC\?A1PEOL$'R_")>VA@9L8:9I@IG.52#&_YZVA-4U;9UC9'J[ZX[-B67
MGU6\7!&G#_3Z"I1T%WCW:?'Q7Z!IZB+5!I:<(BX'R@U:]WBVIH/^C=,/72-/
M^L8+Q<*!UV6?UVB,.1V9-"OGZ,L!!@+AC#RJ32=Q!*M6$7+^&W&9N+V][_JT
M]JG;O6WT1I.+CE&PI0A@^*X]$H-[@4QQN^E%:W.9,PS\;!"/M5((NC[]C[,E
M"%KEN%;FAE5^O3U8.P!+O(;U,VKX;")IH;)MV<]U<56,B_'H8KKO+H['C%*<
M**9*5XX/F'VH=T\:$V'<0^03JB6^=GW@KWJP/*2I)#*KG^;[/'DZA'.2,!#T
MZHAKJM2B@Q8<LR[9@GV,HT5%,Q_460:S.]ULG0S$\0/*U'.Y$C-772U^]=;
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M"[4XV=<8I5UF/.EO;DHM<2[6P#%O4!7#<7<7:\EZ%1\)@WXPQC^+NHH"U%]
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MLVH'!%<:%$XT'&?_X3=FT6@T)[54AFEB9ZE>^?VL6;W05]BL_^]TQ8$ 77
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MAY2KN1!"1<#RYYAN\"1QDWCL)<['W9/=S9*Z$W2#9^ $S>B:T4BDN'8"U/0
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M7\7GCL=Q?2*=T""YC/?>!N]LS914R[T&BT*6P]:>4-[YM=HDXYH6NC$7,P]
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M=K0]4-[S %2<^5'OIO*+7\_>+RR7SM42>_Z]O9_;]28HO^W?2/6GS&+D=<_
M9QW_JHFZ7Y:JK^QH@>O,,,=#2BLY@DN+32M?FN#5.6TIT/) &&^O=7UX5EL.
MHW!DZR]TZ/2+A*[8OGY#=F57^LLKSTV_'%6P>=01=?2Y8LM@\]+>X"=9[*WG
MA(QRL:-/'?3W7CU["E;>'-K39MN?2XHX\N[4!>3XZL=FT(W[:J'^88*1(!!V
M_3L5O#[)NA7S#[7KQUDO,=3>P]C%>*7%^"__/*UZAGXP7?98(I%X+#!IC%D:
M-D9-4^$N1N@A5%R2C"K'Y_155PV3WKMSP6']U-:-;4HK:22K<HA%M>*YHGAB
M]A3H'\MK%PV]$OPK3O6I"X%>\IPYRQUTY\S3A5.!>04A+S(4'Z\^;D8?@_7?
M/!Z8%GX BO4!2)&S)G%=IY_/38TO@+-N/_*8D[H&T?"+YC[ES&?7/5>KW1-W
MH4X*<FS])$>1Q]1L/K+?Y/FS/E"YDI18KM+7>M5G[ZED'F_RA&HEA7$ RE?)
MMX!-\ G6-W+L&H ::,WDECPO. GWL'?N '3L[2%QYA^)=-SQ8.F^_??$,9\P
M%LT1M'#RZ.-D@?]L4W%?G-14C*WZ/\/XU]9&^;=%/Y!_'Y:AR"C,%1:L"P?(
MIK'/OL:8"T5[.^Z_:O'=\>C\&_!,6%>N0AY<<^;&E1!(5DG]^DWL;2)LJ:HD
M2EIFZZ83*/S,2?W:GR_#DCT+WA^ ?+!/14\_<)O?04;VT9'SK R=%[WU$H(6
M(R3+H ^.E4(ZIO6-Y:-$&Y6=1^5BRK\/0-"V#*!%!9;"?%7%=SY5E<?QJ+Q9
M*U=%!K'_;?#R)R6ELG[U)"IZ>[A]]@ $:+T]<3A:(J!@^6CN'PZTTO/JT3UY
MHQ_&IZ"L*+PE\H]YCSL_< 6YL*%KQ8_1!,@LLR6X*#$^.$5D/H:8W*8XR]9E
M&:2$G'N$/ #Q+]=;G.Q\LAM1A!!N"!-)PY@&T/72>%;3+>BM\H86 3?3>PND
MV<J'O(H$_7]S;.#BN>?8X^Q04=LO$B;#U^8C2W9/+,!><%*"R4?0)D9CFF+*
ME#3!59=H\8+"8WT<@:09F-W[VL:<S8M^* )54X_@)T?KW=VR>#O\)LU\V.]-
MSLYNGREE3%6%O,0QVR_^F0RUH2.F:*XQ/F3O045?BWTO5>SEO.+^QOLODS-(
M_>LEB^"IM@3KH/GU5;6<*,ZHC0U"[_'H8V26A7]ZK87&.G686%Z&+OY_SQ<D
M^;J? \(9JH+H.,;#D"9('/1ZTVQV,?LZI84%CBW-N5?BNUM-.0!Q:<=N:E@(
MTY;=<B"Q1&N6R0NB1=4!J/-J641V$$X1PG11G?1DI'7 X[-Q=?E4'^Q9)KP7
M)N!CBWBB&] #/H/&=X?AXJ%*=!SWBNYV=BK&B#''K>'^+Q5E3!%T\<VR^3MT
M#G_?]/=K9662"JPL38RM#-RK6''\">329_ IEX(K)3V[F_S3&<K:CL SON2=
M)MF9F(WV.(Q^V232H0FUOGN[B?K[?7"S5CLERB9KPB26__%;QZ'#TM &PGYH
MIUAUXDZRM<>@LJRC'\:?Y"2[GP>0]Y@["WWU;4I !!D9=C\,8W,';;QUB\67
M7GHMD# KEUVU$E:0271!\)O@0I80I3R4=$ I&IUR:%5/^^SL.00;PD,#C\)(
M=/4MZ$ICS_#M2CZ7C KCY 65FP.F%Q\/SN L E5N_<JK%(PK%AT2.T6MC-[?
M(^Q],W]1\6532*%?Z$)>:*-+8L #_$_^/?4?^-KLGK2SO(([S_>+9/9SY4>+
MZM)-6 5I=%$#&?2)(3NU@;N[06C76ZW,O G!:='?^BJTORB+$YPE(Q[EL=$G
M.UG('7A4X:'H[=GB8VQO.B[!AC,,J]])*Y]&3!A( F-,B&G2/"D[%I7D5.QF
MVRGB<J*5]7)^QLHK1)8T3?N;[N::H,*7*]E:4E]C+C\(H?Q9SUP8FI1?*,;H
MCE*M62%Q4C.4?-6^HQV_?#@B0/E\A$>O4;9I8P-+\GN3T9<&PD>_2VRK8L-*
MWW':@^;[GG$VPER>J%!60>O"AJ$12S@&3</6T <-.C>WKB>P/1X:ORY#[(Z1
M7F76*:M/]-"\=JJ"UT[16YAC62_"0V3'M@F+T2N> 1I7M'?SZ2*2CR(@X,M!
M@^__Z'<,$U/*H7+FS\ON(:F$I.[KI-,#X/CB+*O+^5#U<O=2;5Y'R)=E,R>,
M$??;[R4'H&1T7UQ08HN1>Y9@W"/[0(AC(#GQ,Z/".H#+V-_)N8-Q1]*L=I$0
M6VF6XM0/IEVO4U;:Y]^[M7( .CZ[0-]*;/?&\V*<F,1GV[^!V GQY1Z'1GQW
M5M-BZW9J_@))2E)@9,J<:4&9R:^B81O WR@24ZVN9JP'^&ITNDUS$Z666L71
MEY-4C- ZHU%IH=Z+?)_^'X>:LTK;W%RLEKK:_FX]^+U'Z\N9T;E51.7L?E;G
M+MU=.JPM*&TUBL-%8A%W8$##G@[[]'XZYR+Z./0:BU>3+(2._-4Q)\Z!3"%G
MS[+2NN4:6:K=$BGP+I<L@G\3ZO^O$-2.K173/J943_FXG/>AC:WEV@9&;,+K
MX6Q!P?F /M4HVN+$.HL93D_K#$C>M?C @D2C8*=^O 54N]RONH979HZR>:N4
MDY__$-8*FWZP'1SAKR3WCHJYAB1.N;7H!F<[:L$_YGDQGAP//'3'>U?.M1L4
M1O<%\AF$8E&Y8UUVY)3^54_)<WS>:43+6''''EN"(D76,M_*:_"D+,XG>^.U
MU7$/[R[G)ZI'7WE15F\/7*YN@T?9-_IX2L<EUSA!-:T0#@+!BIJBQJ2;EIAW
M*=1D9_8WM@!0N:>.=NP@>2_@OP'L.ZQIQXGLG.P$<KMO0 (,C)7R5=5H\T];
M9 L!@<P#T'^ZM\2Q><K!:\60;I(1QE V(Z<1?S-KX_<4C!MXP6JV!0@1*,(4
M1AR084YUT!Z45PP6#3+3Z"5AD,1@"3M*\ A&IH)]HWU4\P DBFZ_)?S3Y!*M
M(8F,(@NLNF16XRM]<WJV^_TQ 2(^[CJ /@O9"^-JDT;;PIE_DGXG+5)5V,J:
MR>#RR=7Q\>>RTW*S>N/OFW.E;AV ?!.'JQ[4Y-YJ:1B5?]=6]S[@/G!U[R)V
M&%^G/-H& 5#SKOLACE22[9W:D>*W]G4UPRIOQDLB?_482&?]]H'Q;<GA#9O>
M4J59?CW1G'_' @2FC!+-[T[$[4;I,-JXB73W.Q7+.->^@?/$J')+,0+&6((K
M@2A^N5BAMUY=])R<T(AUJZ(:2?'7]QB"MA!X^1P^#CT(O,ZSCS6WXLEH&9KJ
M;=]Y( AV%8KRKZML0BG0Y9-[/-W@(3E5Y<9Y]U?'28J*MZ$+]*$8W ,>TM%N
M<T9:*DRDBO/OCZRMRCF,2-J\2DKE$&/&V,W(XRUS,XZU"T[)"8EKT2\$R$-/
M9X!E.' S!_^L<'1!BW.$M3^;?<$E;03'S1'##L'K'.,Q:DR]G1! D_6K$R?&
M4>ABM/+0M]-Z#T"T=+K;<N?0$:#A^O^74>C]N-#";%BO?(/N8R0=@.X"KM9?
MZ\HH,^;T3$)];7BQ1?7<+,*!UNWYC6U[R#H90 PSJ1-WVD -V.H640Y@X/@!
ML LP4XKV_I =-DX^E$N'RU9JL*2@(TOX6?71"$_&FNJQE1"MXNY/)=/?3 C3
M4Z8,TVUMYG8IP1.Q%[+'B_T /][&S1EQAP*-=%4Q5V#!I1YP+D2'=+E(;B4&
M*WOVXL PNN+X=B\K@S;8+$91YEMV8^ZGQ0;KG7W/Y$3>16!L>6DS4VYR>/F^
M0$ARRY4NCN2#G\4%2U?3^+OBE!8;'01YAO;QIU$N9YF7NQ8(W'9+Y2.]]KM#
M,DN$I [Z$H=BDLU7 T%D +;=8D2)>5EH^J4/S/5:C)9GCD?@V96!R]GORFU:
MUN[.KXU&VC]BIH"KC,WJ!5K1U%BIJF7[$8Y_VPG,)=@1=L2> UL:V,0X[NEA
M?(?;_@$2M[K,/8N!;%/@F4AJ\'8=*R2J1=;/<WYM3?F*PXB!W!T:.M3VUG@=
M6/"'^Z7A:M*VG\(ZRDVWSR']S6'X:+#-<J8XW&),.M2$D8)TBNMS<>SY\7VX
M6F5;>T13V<2!Z4#F:Y>KI;N&O/QEW3+J)SVNX7>=)JE^U:MV=+'637?:L&UB
M3PC8WY-BB^T3(!]VLWLBSN]CK)FK2Y[__YK'VS:[BR,_$ERY<@%1QP4U*1U$
MAFO'^I,?Y/P&?+TCI'C=EY9M*+%*:\T# _A/0[$'H)J37?!OOW8.H3"!E30/
M[R33O&W'@Y4%ON".S*#3YQW*640ZMI@1 $$HD#!6%.96*@5\.BDTM4S>0G?.
M?513SVK=PGVMQT",,UH[/$O["5LZ%]6-(6MV+CBH9]V+_EQQ3[]-!FRF4>%5
M-\/]J.L+VI<2:)>3XJV+(H@GC!,';+C5;P=E_SZA%\5Z?]J!9W7L$8IIQQ(@
MGC9RM-&9[&TUM4\DK_^PM_K6JUY\$FV,S*PGR. /83)R_7?:<>P@_-V?CH#C
MGS6&8MWY@'(&!##Z/9 T,5ZM82&$D:U8S0F(V=#,_;:E&=\B0G\R1N'!\3KY
M9C=%_G!Y^--G7"2IU-G0$_QE:T\?2.^$,Z_/@8&=*3,6[YXY$0CJYEQE6:3D
MB1-C^CJW)#%N3&S[_!"?;S;M"2%(*HT!.8&>A"HQS+-&UX/-$QP9Y%2QX+?"
MX<U;(V0:;(=[GW  \M^*XDB/M/O A=A@P)9UF/-]W3.N\]N]V?/W6">[A M.
M_?]7Y,K@CB;+?)8 8\!V6/4W1 QM8E,_3JXC"Z*%!WJ>% CE"_W>.CU[4^ W
MAD(_ $UV<;B/$#E][N</]?0$&/AP"'&:2"7(/]J=:[AX Q +UMD#2%;^:)-B
M\>$9D%B.^HA_BV>)"U)\+*72IT"XEJ4:UV+%@(#A*SD:;7*UU W/QMJW]61'
MWMX\F$.6^-E:<;YJP2OI?=?M"XWYNTP* KNII(1@!0^?!NL*,EAA-+I\4-'&
MU*Y $QVB%BLCZ5 MA>T3S*:F"KA_05VMZ'AOF;<RO%-;://5$D^QCKE!1=T+
M$6(#;"D R91P!<+G*Z?PM$K+KY2ZVI&-EA Z";Z#!2CAX&C-I*2$!^(N0%SG
M%:#!BF5G/=7G'5*(3M4#\TVN6:_R?_OKL!(@5WCR TQL^6L++RN\AZ8:L]W'
MPL4&0\[-3 .X[G2$2:<N,?[20TK\-E+9Y#:S;I<8KP*%*$_[G0THF5L-&UPJ
M6#]=NL%X.=GN!D/ )A=VD@[IWDVP%R<&\SRVCR_\NAZ\%<=18_5U\2K=/O2]
MS@ Q8/8JQ7F=;?3F4[&[K\'9X=R^%Q;$;S. 55=32E_DMI]_IP6\LTV<29@M
M1M%SW7/G_[ %3O;"ZV'1U1S9PZMNF,?'S@G7[1M^'C/@QY@QEU/K>(4'_LMU
MB1Q139 2!PATDI+]&&K#W*6Q870=8TI71M(M8[S>J/F\81F0Y0@>LIRB0T=&
MJZHQEZ.OY%D)74>]JWH"MQ6,WGG;,Z2<"54=)5A[O)NN+Q531+W]K>S0IO:U
MW-@I=)BX073)A"RG2LUOGA\ UN)_KL-X1V-%KG1X%)J+%U]2AG:8BVR_']G1
M^?QI(AN*=+!)N73,]VO%VG5*V'.")2E@J)T?XP)(@3L&<73B_U76LQ"A:D.%
MVH8B6.D,[2B.W@_L^9:W/\=Q?#X'(!XHC"E"QZ8%%?E*Y&VRM,H9?L;K1KQY
ML$EWB\%IO GP:\&X&,>T[=V%Q>"\K9[BN%OTY5X0UL2S2,R%+O%I*376*69U
M;3$:;_BV>10K#Q0S8,E0$3\M<HG+K1T<F&TAC*_PE>,)GPP([H[L]"]>@+,%
M*G=R]K,]D_I@PIPS4^A?'[1<2N.8O[ISMF(Y"@CAL#N7T4G6KZ&P!<F3O0Z[
MAJ9%,]?*#D!%Z/#;K/:GJG5)Y:H;P1'>]+H&%]]!5!03OA.T7]KNHX07P*@!
M0<P'<XRE[$+G68UV6M,#8C'"QG7E2].HKOU<TOEF9GTN$2BZ^/R.R_10M<\?
MW<7M8ODXS^=S29I?XA+/R;RZJ].LV><ID^LU&>MJQ?NLS[ZGB]]<T+W WE6%
M9*7>;2)H"+YN1G"Q+;0D<2E>R9"U'(E,T5]CJO+?"SRGG3E_N>ZM:)74/:CQ
M%?!ZI75E3!>TQQ/1TI:!^$)PZD\D&?*["]E5]FCJ]%\)A$;MW 3^BCS%R#*D
M*SA?VH\8R*S]X4 G-!-0 8E-*N1*MOD(J<4(493K\UO"S;NW0/!0ULD:[P/6
MR=["+MMM%0*[>W8%C--N5;:<S]A^?-T),B/?I%<\H <6,RO&Q,<)?TK_;[1%
MFKG5Z<X-N,XGN-X:555F7RD']#JQ/,,M"O/M$FLKA%7:<BP;@=H9Q/5BI:GD
M.E.H2:4E33\#DH&ODU_?6 !//IZS'V\)9,KLQ.[GL*WDV3+U4A)2ZFE=$&'.
MZ;6F_,W6XOI*27+O\1$V""-V+.S?L2V,=E$%.XAU>C?ZB0LX'O7J4G4IZSA^
MZ@#T=J@3GG( J@-W#:7@>3!'&;CCLY@ UNDPU806H06\N _+)RL+QP?5DWNM
MF@S55DW\C1R(<)@T;I1-BYNX=8A&21AI!L^@Y\TQJ&$QKKO6;*+EZL\6Q[X[
M"GF H:U"#WWYG#M?*7P]2,>>Z*C28<+UZCJ<!G$KN,)_\6L!=\L^!2H$N9_S
M,@_?-#?,7.8)/.'(<-PA*7X+B24;"B]'!0B=PZK2YHFB]PRJF+_+1\O/V7F4
M6PDY7 G,OM1::4HN_!T 7%)NZ N0P"@SM[J'(J6$ =1^THZ$DE6:.#BEQ98Q
M%"]N65ZT$E(@PB0FJFKDPD\"GCUD>FAPRO6]KK"MN!8]QKZG_3OFGT2VH7X5
M%L8<#2-VXH7F#A.A)TFO?5*>KMH]X^OFZYH$2W*8@"!&6ZZ2>$7,=.>B4?!3
MO@9\<;9MS*'HS=]EYP-XG59S]/&)+;)T-QO.8$GLUJW:ULMSOA \1*#]+IP6
ML*/6WL#ZTSL4TZ;R%2I)QZ_OY4LPAKK2 !,#&8S^5ZA)Q<P4$-+QB=%,TN[!
M@MN9K:5D1JOC3:I?BR,D_A+*"CPW>/Q+.CU- GY\F+#!4<=VMHL=)B)?'Q$X
MR@!WSR4GE:-]Q__8-3+M\;T!R0TN]>5O3FFZ\IKWND"2JW_/\;OXN*06>S.<
M,%<9.Y3QX%[AIA<UK!-ORH]G%0+^1U7I[Q?4J]RMD[OHCRLT0Y==LN1*94#?
M%UVG3-8H@9H*],J@L9$4WZ\Q<\U&)K;;B9.ICWY.#_"^OE=A_[F"P"T::DLT
M$9A_&9AQ^44A]ZN<X 6KUU]>5BV<_;L\6/07R>':8LR!T)X+9_&2VU8),+X6
M-4]F]=*QI YWZ::)8I9)FA_%3QM.1:W!06Z3@$T SPVH=NFJ$D,?N] 3-A%[
M-_SLZ^ L%E^EW_&4B=]!K '&\@<\S;9+"D3%2@$0:^#MPQ91#KCN/;YKV9@5
M$(U*VN(WJ; HGT6'6T]H1'C_-\PV1* J\#R^NP,I@LXLWAR:)8E@I@K_.[Z?
M@/-,HQ'I[1L2S.(NK"Z@RC*APQ-:U!9$.1=G7("L*2, 05YM$_WJ]8P&/NX+
M%UJH8>(34!%AKM[,6?PYZS4'K90R<Q7"N0?C*/C<?O@"O N<"&\X *5Y?.6<
M0N,6O-G_%O "5DS/!?WV% WR,<#SL&J<-CB/-% ;KRID]46JH(Z-_X:)&+U!
MV_194K$7V!K,;G%<)-2[Z #D[:M=_%_2M82ML%^K3F&O\VI$=;=$K,!9]F1+
MIU"Z5QSA^I44<<Q8H;9X78WH:TNUW KZ()>UJY')N1Q*J!=G0.BZ#L*A3_%Q
M"NYAQ7C%2@7Y#XI22K_.CUWWR-2,R/6FQVUL+VSQ?3OL)I8&IP"BX5<-H3&#
M(QAE ,( "P(!O2&Z)^/9RB3T5M<[7YQP,!FL,7N2Q3L;1?8)1,Q>9&:E!&L$
M\!\/U]=BFZK[\IOZS!47G,1!.---U0U[=Q'BWK$:!Z 41YPHYKA4)7/N@TLQ
M8'Z3]=^(<LM1YNZ4"U.KEN%FXM1(A9J3?'7ON\36_3&0'JO[B,HWIN?TF8^X
M?YO!VK$Q$]BSP-I.,K!5QK8'KE6R55BXQ#8YWS\;%6BXPRC%2@"MW66*0Y4"
M6&HWC(MS?A59RC8>'HIC#!</JT"5%H8BW[;PIWA075ERV<JE*:HK?6S! ] "
MN!/\; Z, H, 9(_#;EPBWJV)59F6@/1B.G8$SJR*:Z5[5A_"BSYC4/?P[!O9
M.?F;<:09N:@2)W2(&2LN\??]]IK1WWA>=+KA^^'"W[67],6\7HF//J*L'H+$
M\7/*NF,2%;,B@GO3-]S,=!*L[183@DM+5X;X+>T4^C/-$!9#_1_&*VHO^5UE
M*'2!DWKLN_M?!D6FGL]<N.[>3U*T;R7H*#17=F6YR-'2]\7WDS$A>X)LX3'8
M?%%36PWKZ/QX'*NX^P $,3  \(S[D#/2S+DNG(!V%%NA^)-?$5K;'"<PXP2$
M=.^$X>(U5$6!MBU3P(=6FE^\.JMDH8X,&0M&C^'D8!X608S2UZ48Z?TBK) 5
MX1O0WN$B'XW2"_<2C^GI+=H] ,79FH^W0)O\\Q&H(-(*K3>[?#7'H,;[?/;+
M\57<N_^\GUV(^SFTD\2<2VM1J&0; R]8$O20;C#7CP/0.6@@"]Q;'T9,Q"@Q
M]H]V82^/0BU(OCD]WSE\[2R5!"(-^>3VK)GWEP39[IJ_TIL>]057/> S0X#<
M85MP)<>UOS/ !U1B+K(<TLO0/)W9.(%@,A?&@;D<9P#[YJNK3$P@J="VYD.2
MMV>$,+9E0$ W$VX4&#*/V/9#=N-Y@E-D>NJ%X[H3H5?ECV/2>;*^#OY"+XE.
M1V"6(5'E+OF6SM3.VQ^^5R=UWBZ/+3=PNEX4&.UK0Q"W*SPQY4_4]I>X4IE"
M?CHP*Q#+7>!J?J;<,C?#RQV=C)'?J# FZ6C*]R]NZKXL5^C_1!"!_/\3TT'
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M7P8VV2MJWB#3M)T,)J7^NA24;SN38<0@U$&%,;U=G,Y7/;5V4:?/,+9C%TO
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MQ-U08>3:)B^(.3;B:TKWI9G*7,KLI] 5F[:Q7LI-71TS)H$H8S-TA%J#496
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M/.C_WB'29ZX;C, 2K_BFJZ"W-P3((4&WWX-&?39AH1,5OK:**%B8)_3!09#
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M73&OC'(AMB JS$B6S=7WG^56.R/)67JV.M\9:N->R;W0B!-Y2J"LIKH'Z:9
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M?P.+_FI(LIYU8ZU?OM-72315HHEN*XB%-UV_>WU._7F<0H[1'U+H-+N+P+3
MS R=P'N'R= SL^JKP&-G#)H$K/C'#QK_ZUO7*.=%@T+,C>R>[-L&?P1+ITM_
M",BF. V1:"<5JS=KWZTVUU[")HA(9Q;.[_C4&#O.?)M;Z(JN479F?O'0Z6%H
M)AE#*)D1;7K+^DG[.+V S%/!^T;W?3ZI:*MH>WH@FABK,$%/L)NT>'7.4<;A
MY9^@%Y<3\DEJ_6)@WEI1.) =\"1?5/F;Z ?L9-$D+^O1Z-$FK%<^ZP8BA6=+
MZ2XJ?2KS>S&_#6Y>VS.K4$Y;-\M63L,SV=,ST]/ER/@I< 6Z1Z8*.^TT]<Z[
M!KCFYS6D=)PX&YNF%%14I")ZH?6(OZ48V.D/' 1%2XI;A6>X[$P+V8>RM+CD
M2Z@^*3_729<^+Y60-7Z4(W,?SF=H\#OZ&@""+!J>ZA&+3C@688&S+<N,J;QO
MS#,5)%@ZS*3:-L'L\X*J.[O);.=@D&K"K?>KCGE-FJ#E3N\U@!+OJ3J<=U.&
MOZN];CT"+?O]'=5-;64TTU9"-Q G=/;_+SRH/(:2^B6O,?1< NG])I6G4 RG
M9TK"F.I(6_G@'DTW_YA*+YV:*+2^^&LK%:L^\;#L:4)4R.@A7=!+3%VO$RM%
MOY'"V0UD&MUDWXM[AE_%FBND=>$M'51">^_J^*RPKA]_299/Y?WZ49\M0/?>
M0$#O*B].'[]X'+\VPH96>E .M3D:PK*:)\KK]ERI%-YI_CLI6FXAB34.UOA8
MJ<L@KUW;_]Y61F[L8WF/<$_]=TAX: L7'<#=:V]4>R4,]'6K4IDC3GK=943]
M\D^@N]S%,5M('LQQ%,^")BIC&R(2]LLX<IR",,TA]%GL2Y">MWNX .R;H6L
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MFR<DWV2[!A1.!G@!]CDI>J&4-S6^N7L.)X9;I"LD::MWC00[GXX1AX5@#-X
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M3JZX/[1<'T<\>Y.>S.6TL].H7W43$\R-<&=3C6BB;(Y[R9__DPE[W5U*O&P
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MDU'L\%MGPW5$W9/?0L932Q3N]KUQ35FV7QD!P"^M?8::;9%PRO81B7$!>+8
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M_JZ5XU3^A=0E"-*MO0]S9./M-8D,@SF 'IHXF9#'"1/8=@A,L^W.7KFX443
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M*/@E]PIVD@&5\W1SJP2$LNL(L6?N1 O/'G/YL\\9H7*W(\_ C"O8"9SC$L_
M'";/2NET*6<B.3BES<+,W+-!*C0/R[3K&@<5*#]7)WBFG6L A[74&>+&<X)
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M"%Y=6O!T/:%T!G1W# _LX.E2Z-+8S;*0BPAOM#!+D'$:5H/@:K[$%XBG?^)
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MO_SWM,\KC'@]U1H01L)^XM#H*&M7=?"K"@&)U+5'9H?N_0&$F WO.;?]SEG
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MU:%QXC # H.0&^8"S#SV_KM3 X>:GA!E1T<IM0,$US[C1P7'A7!,Q$!VM6%
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MJ36[\!XDGM;=CN#[MRB-!;PEGQ>V\,8"DB=HOM1C4 ;!;)/+$93G8D37B+C
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ML94FG:YF=WN8);EK9V,9"*T-NT/1?$?X4>'?B.;/4YY[OPWXUTBW$/AWQ_H
M0>(M(B5VE6QNEE=(?$6@&225YM"U.009N+B;3[G2[R8WE>HXIN,FM8W<7=JU
MU9[-)W6FJ?WZG%=V:Z.U_D[K\>S0FN_LS_ GXG?!7PE\+-9T#3_%/@K2=!B7
MP?XAM[FW&KH9WN9KCQ;X<\4:;B2VU+6M1N=1U/4;G3[B2RO+J^O;>ZCN+>2=
M'_!#]JG_ ()M_$GX!_VSXU\&RWWQ,^$MDDVHW6J:=ID"^./"&FPJ)+EO$^AI
MJ"V^NZ;8*DT\_B+1%MBMF/,O]+BDM9[F[_4#P_-\2_@%\2+FXUR&WL)O%MVL
M46FK?W5G\&OC+;Z=IK227/AV_EL+F;X6_%"SGDOM<O"=.O#J#S3V^NZ;XBT(
MP>*+'Z[TGQW;?&Z\E\%Z=9:IH^@>')= UOXI?VYY&F^)FA$L6KZ#X&TG3+.^
MO'N=%U_5;:S/BKX@6US=>%;SP[I^H>"= EU/6?%-WJ?@UB/XZ(9;<I]MT]DN
MK7]XK3QW"RQ/$C.CF>WCA@=8U(83K,7CB=7C<QS(RK-%*MPORV"(F[#7=C:M
M<JI/.7CG8Q$J><BX@?<I9MYPC?U _M8?\$Z/A;^T++J_COP9<V_PJ^,%_*=0
ME\8Z%I,,NC>)]355VR>-/#]JUJ;F>?:4N/$>BW&F^((LBZGDU;R6LY_YW?CI
M\!OBW\ /%2^%_C/X9ETZ>[ED7P_XIMKPW?ACQ.L*>:\WAGQ \)L]0N/)_>WN
MCW=I:Z[;H7>ZM+38US0!Y1&NIQQ2+!?(UJC / EW$J.JOE6GTU  ZDDMODMI
M#&?EWHP#FD#8R,QFF6%F&?-L+83G>[#YGAN9[2.560D9@N(MC9(20?*9$L89
M,&UOQ<% K1PV]M)]N5PS%0D+S6\3N#RBP73EEVA'W D1M=0JS)<6\UTV=N^X
ME-I<!E?YFE-LKRJQ.[(FGG;!V-NVAJ )T"QAELQ)<QL?GCDFW!B#N1_[/C@A
ME; /'SN$!.XJOS"-;N*=O*BLXHI^3NL($N9!L(W,UO<%W< *3^ZF@6-SSNX6
MG%H7YM?L\+[_ /4W"*)U+[OECGF:2"103PS/#(QPWEIAA4DESJ=QNMKI+N[C
M"A1#.)HHD&5*LKQ&"-<94!Y)&CSS]T[0 2.-0D1U>^\V$LK-#=76U]V5*%M-
MG:25,?*0J0D(%/S%,$UY39H LV6D5F$GV2VDA*?+@H\=X\2 JYR0D:$9'8&H
M_L]JQPL\5L5#DQ3LERGR_P#/.YL8RC@G 5/(C"DY,SC)+Y2\$2&<S7<;D"%7
MBC:U\O&3]GOY7N""A/,$$*L3N)6,C!3V^3_](J!_7XH_<;]N3R#_ ,&QW_!-
MS[,)5A/[>'Q)*B9D,@)\3_\ !07?O*(J??+;=JD %02^"S?RQNN%+@\A=P4
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M-][VMH_G8PE-K31V>FK_ *6K_P" - 5FX (&Y6SD_-E3@Y]\D#IZ5]??\$^
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MHDZIH%C:.S1>8DD=Q-X@T2[0@D(TIAUBU"J\BAMZ22*$B4CKH"T=Y(A*[C(
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MP/X?](;_ )-O4_[*3AKI=/\ VO'+;JOS/T?PRUXCE;3_ (3\<EKM[E.VJ?\
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MV&5&W*_MD?LOLQ4#M\;O!(;(&.22,Y_VN>,5XG&%)1X.XP>W_&)\4/W4K/\
MXQO/=;6O_6YZF0R2SW)%N_[8RE:^>99>M-%Y6N^O5Z'T;_P5YMY$_P""G/[:
MI+0(K_&21D\RYC5B'\'>%9&/EIYDB@ \%D7<2%4D@BOSED2UPJR7H.<DK:64
MER\9'&TM>3:9$6YP!"\HXR'.[ _1_P#X+$0^3_P5 _;3)(4?\+9LY.>!FX\
M>#7#'@=?,X.[( ( Y!K\W(K6>Z,CVL5Q/&I.^6WA,L$; ;L331JT4(4$L6FD
M3:,$[<BO\,9?'+TB_P *2_+8_P!-(TW**E'5MMVNEH^;7=Z_UU/8?V?/%EGX
M+^/'P>\2I;7"6UA\0_#=K?S7%\C.=)UV\7PYK$@C@M;>.$?V5JMZ3'-)><@
M2L=C#]W/'-G]GU:]1N0L4L149W!U9U<@J"!\XR % (*C&3FOYQULWB96-Y:V
MC(Z2I(MVLDT;1D-#)']B6Y8S1-M:,IEU9%.!M)K]-/!G[<FFZAX8TF'XMZ9J
M4VKZ==0:+=^-O#%HUU::H1:BXAU#6]!G:+4;6_:*-UO+W2I;V'4[B&:X32])
MWF.1"<)+1Q:_KU/HW6K<IM)&2&6,@@*0=\B\@]#R21R3\PYZB'R3=Z??6A^8
M75M>6^S<3N%Q;O"!@,O+%RHS@CCH>:X.Q^-GPO\ 'LTFG>$O%46K:JT$^H'2
MXM+UI=4^RV\D8EG^RRZ:K/%;M<P+,\;L(O-4D;2,\_<_'_X2>%[V]L-6\701
M:CI\OV:^TZ#2=;NKVWN;9V\RWFACTX 3QD%60L&W+D@*<T)*_O:IM77EI=?=
M?_@"5T^S7YV=OQLSL/!\US)%:0W2,KMIURDP;.U+@P:-<.!EB&<NMU(9 $W*
MR*5.TLL&M[+>Y@N'=88H#)+.\CK'%'!$AFEFFFD98XH(X@TDLLA2-$5I&9$!
M:O(9?BO!I'PRF^*'A+3!XHL(KS5H--TW5[VX\.FY6&_\2:1=7DKQZ5JEQ:-:
MQZ)),;![83ZAF&Q2\L9;J.4^(_M#ZSJWBGX8_#SQ:-7NWT/Q7?(^HZ18S+%X
M>G%SI!U73H)(8&87T=E)93S1G4;B^*W'ESL6=(&B_.O"N]'@ZAE3NGP]GO%_
M#?+))<M/)>+>(*.'C%)M<BPF,P?)HK0Y?B3YW]/QC[^>SQ=E;,LMR/-4XII2
MEC\ERV=66K>KK8>NYOI-R35TS@OVAOB?X?\ B/XJTF'0X9=1T/PC87>EV>JQ
MW,4%IK-[J5S!=:I=6T0LWNI-)B^RVUC93"\MFO&MKR]CC^S3V4C>,7UVEY9P
MZO!:6:W220Z?K#/&URTES'&4T_4U:YEF*B_L[9H;J.2-PVH:?-=O(QU)8;;)
MMK2ZO$,MK:3W$2Y+W,<;FVCV8R9KUE2U@"A6+-//& JG!("XO6"V]G,XU&YM
MH]/N;=[#4H8I3=3BUG*OYT/V2&Z47%A<1P7UJX_=FXMEBE;R9IE;]%U^RW%]
MU9O[GI^!\PG9I]N^QFSW=Y<J8FNIS;G@P1DV]MD@_*+.W$-J  %8D0?,3DGE
MLTE383^[&T9SL7& X*^H.T DD$@AR!D@'.Q>6NGZ9<7%E.]_J$T$@5VA-II5
MDQ\N.5)8G9M<FO+:XC=)H9-FGEH7C< APXJ_;MIS!86$ 7.UO*ENW'!4_-?3
M7*;@>264J<96)!G&?-&"?-.]G:\K+71-:679O72Z[QB]JG*]G%*U[ZZ:7=[O
M9):O2U[MI(ONDNOQ/=V\$MSJ]DL(U:&W1[B:^LRT-K;:TL,:,PEBE>"RU5E#
M"1S::A(=]Q>N*(L9QG[1):VP(:,BXNHED0$@.7@A%Q<1LN -LL:,2<E5 JN_
MB&:QN;1;G5/+E>9I+33;B8"&]>2-[:2.WT92L5XMS;22VLUI:VCFYMIY;;!6
M5D;T[2_@W\2?%+Q77A/X>^*)-)OX([N"?6K'_A&+3368%I[*YG\3RZ5+)%;,
MK-9WBP,+O3GM[EUAG:XMX?/S3.LHR/#_ %O/,TR[),,TVJ^<8[!Y72FDU?V4
ML?B,%[9JZTHQQ+;=E%NZ71@\!C,RJ+#Y?A,7CZRWIX'#5\7-7M\4</2K\BLT
M_P!Y.C>/O74;2?G#16$;8DNY[P%A\EE:_94;C!Q>WY$T)R"!_P 2J=>#(&.5
MQM&6WU@&2TTU&UU$9V2Z=[Z?6XE0.TL:1+9VTFN0)O:816,<FK0)YT2-J"W,
MEYWMQ\(]"\.W!M_B3\:_AOX-NH2#<:!X6@U/XJ^+XBI#36UUI>CW'A^R\/7$
M<9)%W=7>MVD3%6DMY$=15ZU/P(TF'[5H'@CXN_%N:V=7&K^+?$-E\,/!\DZ2
M"1%DO-%M8;JT,)C5X1'I=U<22*J,99#YA^3CXCY/CH_\8UE7%/%_-9TZW#W#
MF8/*YIRY.9<1Y_'A;AMTT[2E6IXW&4_9R4J;KPM.?L_ZJX[#M/-,9D^2<OQ4
M\TS3#?6T^6_*\LRQYQF:E9M.,L/0G&:]FX\W-R>(7.O"Q%M'<:G#IRW<OD6<
M44MOI,E]*5^6"WCMVM9=3D) "P)]HEY!50>3W?AOX1_%+Q<J3^&_AUXKG@<[
MH[_4M.?PS9,X+DS"^\1MHQVF1-JW2QR1,Y0QS,Q4-Z?:_%_Q'I=K?3_#K2_A
M9\(KL1ROJT?@#PG#KGC2[TQ?WDUW-XUU;==:V\"[I]32XT^QF%M&VH+=QVJW
M<]KY/K_C#7/%4DY\4^)?&7CE;@8E3Q5XDNXM&N <$+)X1TB9--41@?NPVJW*
MR ;I%V$QJYXWQ(S)+ZKD?"O"5&3TK\09SC.*<R4=?>64\+8?+,H53E<7[.OQ
M%5IPDWSNK!:+V/"N%:>(S'-\YG&]Z668"CE&$<K6498W-JF-QLH-[RIY7%M)
M+D3>GMVE_!+08+FWUCXQ?%?X9>'DTVZM6UKPUX5\3VOBOQOX@:XFA%II6H6-
M@J_\(]J,LLJ+J-_9Z?XD;4=.:16ETG49%UP<%\8/&-U\4O',WB33]"O- \,Z
M9IECX4\*66K1PZ<\.C:-)?S2S:C<3S_84U75=8U'6M;O-/MKZ\CTC^T8M"AN
MKV+2H[RX\JM[I[2);73[73-+MHAMAATO3[6V6%.<B*7RGFMMP+ BVEBQP&,A
M)87GNSK#%M8NF?5F14M]=O)'FDNHT4(ECK=Q+YD[(D("6FLR23RVICCM+Z-[
M&1+W2O0RCAS%87.?]8,^X@Q7$6>0R^MEF"D\#@LERC*L#BZV'Q6.I97D^75<
M7:MC:V"PJQ&89GF>9Y@\-A:.#I3P^#4Z=?EQ^;T:N"_LS+LNI99@)XFGB\1_
MM6(Q^.QU>A3K4L-+&8W$JDO94(8BO.EA<-@\+AXU:\ZKBYJFJ=-;>"/+S:E!
M'+'(K+'9)->70*$$20LIM+420LNY?,U"V)P7B<84-JM=Z3J#8FM9/[2.TC6-
M1N##::E,,DG4;#31 NG3RD[1J!O]2CE8 :E$/-?4+?%F@EM;B:VN8'@N;9_*
MGAE7;-"X ^1U(XRN&4@[)$>.6-GCE5S$Q499B%"\L2<  =R<@ X[G& >_;Z^
M4YM*W*M=5K\-DDE9O9:+RL>$79;_ %.SEGMML>ES*8]Z6=O!:S(LZJ\;P74*
M?:UAGA>.6.2WO!!-'+YL9EBE#O/X>T#6O%.MVVG:);SWFKW4L;+,@NG=)F8)
M;R75S!'<3HTD[PP6\S#"W+PAGBC+2Q6=-6YGAM&O=/:^T:$R1V=U>8M[:T,A
MD;987UU<V%O>0"9WNI=%CO%CNV,JP2Z=<S_;T^]?@1X4\(Z;I>F:GH&H0W-S
M?PW-U<W,I6UU,00Z=)!?Z>RK_9UO+9) ]VL6K2QWOVGS=2BB?3K:XECKR,YS
M&.5X26(<9S;E&E3BK*"G4C)Q=1Z2Y;QL[2B[Z=3IPM-UIN%^56<F^NEEIT[]
M&>&Z-^S/XR\2Z-/J'B&2'PKK3MI\NDW#VL-W!X@BN[AX+I-5@^UZ5/I]W:QJ
M+R'5+5+XW:"6QGL3<B:XL^GT']E&RT[4I)_&_BV"YTU&3[)HVG#^QKNX4W"J
MB^(M4)U>ST@F!HY3INERWMU=F1A::G''$)9OLGSK>WM[MK2%!(L85)]*@ATZ
M!/M=U+>RV-F__'I:7<BO"97,TAGN!^\25EBCALN94M;W?'';AQ]CDD:[:Q_M
M+%VL)L+G63;7URICM \GDV]C,)5MYOLKP6P,\7P-?BO-ZWM8QJTZ,:C;3I48
M<U).,(.-*<N:4&^12Y[2J)M\LHIIGJ+!8=6;BY-;MR?O.][M*R\K+2QYWI7@
M3P'IEA>:;9^#=!T_3[*S1K:4Z<FKW-XBRN[K=74ND0ZO.TJ!]1EL)-6O3]JC
MB@-W&R11U\P?&;X.Z/HK3>-/#NEZD_AZZ@FO]1M--G"IX:$/E?:-6U*UDMI[
MRZ\.W[3I(EM:M9:KHJO+>37-_8"&&OMHVS/>3S"Q2WM7CLW\^VM;F:9H(A/Y
M5M=">]$8AM;>?RH#]J>:SLXI(HK"*691;U( \D,>I2OJ<TAC:V20K%<3/$D9
M94#V=O<Q72[;N;R)(I[B$17+0W+137$B6?#@,XQF Q+Q'M*F(C4TKT:U6I4C
M5B]7;VDYQIU%;W:O+)QNTU*+DBZV'IUH<EHP:^"2BKQ\O.+6C79NVNI^23RS
M6B6\]O#80039%M?VL4>HPW+*@=TCOKX7A^T1(<F)A!>P ^:%5&1VI2RSRW N
MYKFYFNU"[;N6>:2[0H/E:.Z9S<1E."I23Y,G;CDC]-/$WP8\ >,[C5-9:S?2
M]:U!3%JIT:U33[;$4]E>27>MQ W.C-J+Q-=M/=C2=5FB6]<6JW-Y8QRR_ WB
M'X>Z[H-[-::C:6^@3QW^H645IK6M:5%'=)8SQHMW8W$\UM=?9KJ.:(VWVRPB
MCN@'N+*[D02V=E^D95GN#S52C2YJ->G%2G0J\J:4F[>RFGRU4EII[^G-*$5)
M(\BOA:E!7?O0;LI1N_.[23<;^;?J<:9H;AB+R)DD<EC?VD<0D5RQ;==:?F*W
MO%8DAC#-83H6\X2W31FVN()K.XBA-PLD5Q9JZQF]M\R6RN[;8XYPR1RVC2G_
M %4=Y%;O*&*Q*^TFKDMG9V4TUO?W-U+=P2F.?3K"V>W6.3 W1W&IZE&OV9\%
M&0V^D:JEPC[O,B4B2B+4)+5S+IMM:6$K120&<J=0N7AF""6.>6^$MM/',J!9
MX1906TOWD@A(4#UYP4KMRE%\K5XNWV:CZ;[];^1R_P# _-'[??MK'=_P;%?\
M$V2"IS^WA\3,%3E3_P 57_P4&Y!SR#]:_EWP%4'H,J3Z# Y/L*_J2_;ANYKW
M_@V5_P"";EQ<L7F?]N[XDAFRS B'Q/\ \% 8$QN)VJ$5 L:!8HE'EQ(D2(@_
MEN/S*5!P3D#O@'.,CCC.!R!_2O\ 1;Z,Z_XU903;?_&3<3*[>K7UC*U?U9_,
M'BP_^,NFE_T+LNYOG"NOPO?[AP93C!SDX'UQG^7/TJK(FW)YRSMSSR.>N>_'
M;CIC((JPJD;1Z-SU_N$?U'6HYR,*,<YR#^!R!]>_':OW=KE;5].CVTZ?D?FL
M?=E97M):_+F:^YF?(%7)Q@[DP<G&,J&ZG'3=G\::?F!'3(_F.1]<$>O7OR*E
ME4LHQC(93\Q]#T!_A[<\YYXZ5%SG! R0W*G/W2 ?IR21R>/7-<[NF[[W?S5W
M9_,ZHN\4[W:\]K6M\OG<@((/(/'0D8_B'IP. 1W^\!U)PR0%MH S\PR< @#!
M!)SZ9&.OZ58D'&?[N3[$' ^H/7D>HZ\U'7/.-I/LW?IJ]WM\CHC*]GI?MT_K
MJ5@,<$8/7'3VR/;BF#1]=U22[?\_SV/+7+FW5&KFSMR3I\Q<*:6E"2I9N4.<
MB8I26>Z1NUQDIF8.<N?$;69J[M04@<P<**32K2#^_'S/^?W+X>*^WO?[]7Z-
MPSG7-2M;]/E8JNWK+N-FL5'*M\G:2SS Q=%F!7"L+%U;LE%O5QHK@[UQ"%+J
MMAH^!+FDQ*V]9;5'1M0J*?K[\U4' %)VMU]4GNVW-S;JU-LYEL#NQ2YE@T^8
M*$=](]#\^%A"UDN$SBUN'QE-H([.05E)K,=S  C+YKK:R9!DV+SU05Z#MVJ5
M7P./J57]4\K'";R:JY,VU_V77>?BY^[%'8(&_*XHID#0Q3)[7:R1@$U?)L<1
M1.[/SRU@NQJP-#L+%/)<1R-$$O-H&P95.7-]7221J7?#7>"'<J]\H]<T>4$H
M[,^H5,!<K7.]+81S_UHI2Z\<>0B:-I%HJNA_P'0Z&(;8\(VQ- Y!Z<D=N-G9
MZ*9WBH3MNKDM%[XA/FYL%R=DJ=S [S7/KW*F"'IJ=_@^^\LT=:2&-K+)['&5
M&=^LSJ_7[")76(M7-S1,*FC.]B##'G]2Q>)5SB%5#Z".1WN]A.V";FW45X0>
MI$1=6!N_(A>P=I]B3^,I2)Z*CJQ6?',&TJL9<*;=6X;Q:T0X[T:,);7(]YKU
M52J-=:3 %Y)+T)XC';1^@B<%PC]<;AKQ#@CMR?#EWA?*M<WA+:GRALQJSGLU
M+J%3>/AL(@Y!0EU5!XWPK3,P(*+?0#T65>G.D(0^C^+*L&S_YM<AC0;WZ3@*
MSL*\.BY$=V9+:._N[+LTY+=,%[TSYRVLZ_.LX/*5UK35Y+G^M\>!YM,T?0D!
M!XKMQLO8BCE-R96_9]OA)89$CXVUM9W&Y+G%4&S'5<[2M^]V FNSR,5?2BJ6
M?4Q"FR)F<6^Q-7B6  >##40R;3""=&P?<?;D@&XX^ G!2SWZ:)?!>%%?'*WJ
MN2M7S3>V$F#N1,]U&7R#,6MIGJ92=[9.?_?-%@VOATW.*7\/8W-_VWD=HFK+
M UT'SQZ"EOK+*)$G&3U3+$ZFGA>Q(:<WE1OC!%QJ+.2<60:B+V2] 1Z02YN8
MUE#Z2<=42YIG+R0VIVD^KZOC3.-L^;JHPYDG$V8^JUC_X;W73 Z6\#>6+'V"
M$3*Y6V#"$[BYSL@'_OF ]?W^FS80=MF<CK=HF=!*=+&^6<-5\KM0FCTFF'=1
MBXY]&AI.7_TKT"6'<)\#"$NLW)/4*[0(2DALWWH[QP!.(HH/()A.=@BC(214
MRJ\);7#T_LS (8BJJ@D;-U'$6-*,DS1\;['LQQ'6'6,*TW[D2%F[0@:/ODE_
M#M:I!XVQZUD!.S(R/JS]S+KP<9+N5US$W=W4Y)<LY7)Z/*%$8=0VYOSSY>,/
M?^3: 7Z7"F7TVO+6>9.\F5)K9T*636>9WDNTL3=95M\?W1'6O3.0'G)I]VW9
M4?"",0C)Q&/:JH8P@&^I.>K,[T-0;4Z_N@0& A IN"0";P-!#/VLAY33@WA.
MX [AXG'L@8!#"GS[9MCG)XV$E^"CI^<PMW!]+<<'XMLBU5[P/5%!0&T4'.C'
M)*Z7_\*=9O, IF3'5!.>.0#!2 .\Z2=).8E8K]3GB&-L=71%IP/X3"7&E/08
M**NV=EMJ!]^LHX\^V\&?\:*SS!LGC!"DK9A%W?%ZXXAKAZ#G+;U.P ?$"?,0
M[K1]2 ]JSKR36-= Z"9RLCAHJ+Y? );&A 'K9)0@.I:,2C3B62(DB-HP_V,9
MT_ ]."$OR*D-MB1.! U=*DPD11IVYSJFL PA\QWGP?PLR[20+?ZYWS6F6OO]
MC35,QP'W:M;IR8:MI/^=?MD_R@M(,A(!,[IG[V-PO0B>EGHUX1!T [A%61#M
MSPV-86DN08ZC\_HEU..,HE:@S>T(\#I!P$CUS5V7KA,XSZ5DB6G&=J\#T=Z&
M+O? X/8J^1R?>T+PVDATN?YU7XW<D(7P3_FVIP.@'-P\4K:7D6KF<>4)09F7
M#D&B<;%\^A]JLR5"C*N%;Y=8M3Z7E=\]17@@(?3Q^R,;7?FD;),&":';CO7!
MWB1G_?6]O[W06!-1NFB\D1,9,/)E7F!) )#_W8J^OO2WI]VZT^0T0'H+0\\[
M?--6/D#U+G*-M?USLB>^XQQ [(.<;M-\#T!M@*?TR^3%GNX,RVJO\D,09U."
MD>5[[<Q\%J(6%]? 8TW&F,C3#T'=D;*=AR ^-AAM2%&KH@O>GC&Z0>0S@M):
MR:BXC6!CC@'7,W219%(J8+GY:-'F"H; /8]6&QTXLWX?R]WS1B'N$4HK$24^
MK0UY1A!@J?(],5&'#"!X5DV. WWT 8IG%RX>P15,Y$ G]BV>:3QXVX ZA6!!
M@3MTOF[$F3:WI:T3Z_LN+ (?2Y2<+'MWK$/6.TJ.9MM40H1;>I-Q7#ZKTDUN
M5>RQJ%-3;1QT:U)3;#U6P O,5PIHT**7H)W9T[OMX($_@.-1$<>B%)Q8UUOH
M?$?&0BB-I Y8L,(H!:C>CHMTD7:WI5%N/I[5EL:F!V^\D3+)[U;W$]=C4@*L
MA#X&LQNLSO@E+2../R^0$ NU/_;^OA?9)6RR_WZ9Q*=!<OD=OP)=6\Q:3FV9
MQ.P,^W.5/OE#)*RX7&PJR9M,URB'M98DA]"F?IOS2:!OJ/C8=?9P&>B6Z]K1
M"MP=_%(S@%A28;1),^UOMP3^B$I.DDZTTQ4VCO3C5(<TZ\X,6];;]2*],)K<
M;K/#]R] Z7,,1SS5QO.PI,=-U%\]>@AX'143,JQ@7SN&KQ\50*_;TC:3([S)
M7/@00)-YB>4#[-$@C&(@B)9#6L13B E17, J\Y*/R64@P*3N'=H'RK, 2$.\
M#T&G@09MKF080UFS'/T _JFYMFU" )[:@%A]_/EA8U/6+A?DZL0AR"]O@.;8
MPZ7J20%3FVG;3D# $HJ/I1?;#:[#)D?)W&4I 4W%@,YL/?'$6A 1Z"=/]&+_
M95EB2VW<2*-Q$MGQ2ZDI,'EV5C$,&+ 8T[()C SL7Z>H7E]#B+&_0.I-RLA4
MV[\.TT>@MF /P0HV&]XOF.)])&;BM/^'PFG'O[GOME1TTA9],WY$MM[TK3M(
M#HC$"KAT'>2$7AA;]MBMB__9_"[@V_+-NW=LU9Z?S7)_W:\\>_MMIL^W+#[W
M"R7Z@[?])JS_WMRM51*_'<3*6M[\$]1GD.R8_W.UK;:B(3P$I11"<9I^MGPK
MNNPXNG'*<C\[[P@YU4=R_FKMIJ4G>?3[^MT3NPU\C6MGT$S2-/Y>"_)GCDAC
M-M7S _K399L3V8.\%>(Q>S*_UKX;I03OFJ9#EM*/W$J5@V2K]=:L*9Q&;M^9
MSM&%\26SA> ^V.^/<V*8UPEUN4.]+=Y3B^S-[3L9]O63#9$7][[D4&["$\M5
M9K9]U'F!6_7K7-9(OIZ-Z?MA@SC3";4+K9,\7S\FSN)+$O;_B'.GK1W/_L55
MUI+I8BW?F[,>7&%]FX9[D7N[$,4+/)X><W"4N!$E1?MF^;.E0>?MOG*JG(_7
ML>[%.3)9<CY/>3ZQ=3ZZY.YP!(<S&V4^9WMIN>)D+;:EHZUFBN#=9+WZNPGB
M7&5YQ::^JK7.EYR9[N"[Z#<RJ.MKDMU$/1*,I1QP4T>R6YF3[D8K62\#6ONL
MWS"/((+1S[OS$IX<\XN\BG$+"@@PGNL3_IEH1";/+;W5WOV=HES$0'0B  7$
M0-/D+@\?XPD@3(=W2>B4E\"=T(YD5'2;-6V^EQ]SB2XER*D2@A='2Z!$G* 4
MZ/'*RZJX.*T#Y5X#AQJDNU2.A%;EQ-Z<YW8Q;:2GZZACR)(?@')/CN8H]L.[
MW!\*3%UXK48]<38-0%A,M*DB98I\!>:KAIE$GZ!5A,^S_>.147N>-I"MT=D>
MLLEKFK(K@9X:;2+-TI@V"I5_KL,^12<DLX1]Z;SK)&C"SGP%?!XK"FCVB#KF
M0F,D>P<3[]1--B1&--<_.&90G1[SR[@G,=W.KI[\L^3B%Z,/JB:>57OO*O\Z
MV,P'S\]D7W8>6LAT&/[B:.>"E+F]\]AV-+2E9E^3>2MJ%"<(<8=$[T-[B ET
M[ZV@$.8U]% ?C+>IV*?JO5>A+*T5 Z:IY2#)7.99JOC*L\RHQ/=S@YZ53E>P
M/'V9[Q,#)*Y1$J9-1 "149).$4FORF^"D0(\H*UT$>H'>I,M&\(NC&^92+&N
MM+;$.@..2-*266/>!XP,$%*).0?@*M:_[<WH'D6N3. /\0Z<"\53&?0GW#-5
MBRB$4:%!>R%S_Z[T(X3J$PGSOKTR%X$W-3XM4744J,SJOGD7.$;B.5LJQVY:
M.UED>FZF]]^1B1Y8<N?DHY%HDO7\8+VDHOO'\9UF%/" L0ATZ?9Q\<5WZ-,(
MG5!^%Z"X3[>.93WQR.3_+)DIA7 ,W;BT2N!G\9_LTV,)>I.!V 2,9+D/6Y"]
M.!D2VW'&&6Y=91TJY8B"K(9I:=Y)=__8.1&8(E"J*^B =;J+OA_ WP]+$;\:
MO&YDQ;C9VU+_KKQGSK%;%V:40,Q9&?]2OC+[CKXK*_'J_=+'8,JN9URAQ(L;
M?/45"4%W+O8GWG$Y;O4V?V7C]_W[Y4,%=?,=0AAUP)',Q\D>Z !/M;G0;,</
M04=\FDIV41YH*E3\9J+B0Q#UG*":J*&52?VOEXC1B^<GC/YYCX9WSA%C5>0F
M5;>T"QSV>VPG,2YDH=8,QTF6MKOT<-FH3B$?C9$JFF!D_X&% JS+,)HTUXHW
M7DU$P9"+)O*EL:$4A(!N',(2""'A>1%H#ELZ(<$(>2*>1(4Z3=ZOI>TV/BVY
M.U^RL!)')6=/4,^L(L0Q\DOK6[,2E&X)OL1=7[Y9*#DVF16&<J?HLR#%:ZX:
MM'X\_:\9T$"R$9%<X(/3C=LD-DQ$OMGW+%Z<\E/%V3;19;5_%;9T%+J_#"T\
M=5!DI$CKL082:3.DV%2L+^I?S&4Z/D$+$3<-YC?25._AD:2$/N\X^WL_JKQX
MK;%EX-G.(4A$O><0)(4QH(-C=HW!UAT3$)(;$-0'\ZLCN4!Z'^N6*N_5:_S6
M6Q'SOJ_DMFC0-+VLM"E8=/UM&9AJ\*WB8L6D/QZJ7BA.*N_/2_;JKF (1^;?
M9HT\P@E+&4M9=]FCS23X\Y6G2T:.#.SOD=-V_K$F,M4/I!P;,W(+.*W2T0D!
MJ!S$%4"]''B[#9_<Z)#'R&1TLF4 TV*67S0Y87UN \QC9$:K<Z;_89FTS>PD
MSM!V.LZEWJ(1XU0:YGE\>T3WCY<EX%S'M/FX?\^IE5>N2:A6%V\13H482T!F
M]\D\AC=M;"]BO8AQ#@;7JWP]0TJ\8%4%A![U:/_&C]3WWG3?QFS->4NA:5_&
MN??=I==:/[ZNZGN]A[<#ED^FJ$9IFI4#&11LKP4F@M;:A>7%B)(121WG:67Q
M;2[W%OF/.@..9Y]KIG,;:'KO>T;O\,"V>G+GO%T%OLT/A!I<;T"7EZ.C;SVS
M+K@Z]*U#!J%W@*M7?JW:/6?#O(:QKT_GLA19DN-G20+B/.^SO@;6(U5^NZ=E
MBPMH]9:>?^]>S7O6*1.($* W%"@J[3WTZM=#CR5%KDY6V'UHK= ?0=J5<UH5
MZ%G/*?DG>60: CY.2!.YKH'C8E_4"GVI[]9M*WPNE=D6Z'F?]KF4Y&XG:%MB
MV==UI_*'_#!5\<. ITRO]UO?>/?':.>KO[[:(M\FG,C56_S5[U3U#N*C$W>A
M4+$W5J.D4MW:4,QATT4_>X1AB;PPV)0NICYGM-70EJ)QC'O)1AGUY^ME<P.M
M]Z4>FF'KZ!BAA&]K\JHZKPM']#PT%ERN17T=5TSU"CJK>_U2A7+MA577NS,8
MI.NH<[8EZNR$6]H[IC,GEI'X*LML8?:"SFN>'_S62(_:V+:FP6Q)-#6N8&(H
M 3+\<#,]*+@4;Q@T)RP%\U.<S\G)<0Q%U>):OQZ"[H8(/:2(E9M[;9L-KB(1
MJM2JS2U/;.ND?'N]=^B/\S;+YI)7%.;/7/$;U7HY+ 1/2S_V\M+SZ^,\W_FU
MZP.5;"Z8U&'=O#V-IE^:(_TG8$Y7/VJ$R7@_'#)O'6F=%6Z!&K[N';=0G;;D
MEAN6,A]N@ JM/<Y->S95>)=[RR_/Q(NJBFPTO7@:KJM$RW)(I5ZZ:\:?;BX
MKZ\QN0K,]\RAXNM_-]B(6J65:G+*0R\,W4I0UE?]*6@N_:E1_;QUB'17',RE
MON9#C]3-Z]*RU8ZW(BP&^'6%0P9O66E.^=KE$T+E5?6;<ALH)EY]\N(?,-_2
MGSL7X SJLZIW\I%R^$C98ML?C4AP":(N,I/&XCSXM-)2UU23N\4(IM]2=@^0
MFJX[BK&GH*GOX$5"7@2/YDQ;?(#X#]N=D_*\Q.VWXS,2CW&M+U54/MJ"_G?=
MQ!,97"P)\?LI4QEXBC&GF3)^=X@*: TS]8&/!X5PK4:F"@\)%6_]J"8SW53%
M\('APSTC,LSYS&WU/=+J*P./(\]UCRE[1"?7$\<);5$O"L=+3_;F:!5#J":B
MOQ+MG!N'-&^_G:R>L)JQ:9]HM='<RUL5(I=T6XGZ!V]'&,\?,/B)KDTMORL3
M?2"\YJ:I-V@:@$P[;[C$8T[(E:>I_SD?A.L:G_1[_?F#[>()L8)W:>DG0?_T
MA^E+^QL$)=1)^7 >\\3?A_!VK,@2"Z<.AFUSD;I?-G;_-D1L5.>Y)H:L82]_
M<6YES,I'@D.!N#3^(9GF8Z K8JLIYL:<@[_-;R2\"AXPX@X8T6.L&/-"_\;:
M!G[@$-SFYGG^!W0VW18:^-^CIRF7@@9[BX1>=A9>/G4L'R];;E*@WW_=MT0N
M.U>>_:@_L+&V92.]%N;BNWT(,CSUH4_:TBC]4L0),QF@<W][,G=_F\VY?^J@
M_1#D5IE/8?0?O *)@7?@&%Z#"#[;5_N.@Z#CH'\F*1PSX$(]%L1@?X7-R9)D
M2U(8DDM/#T$\R<Q+N](!]*8NF=?K\Q,G]? XBMY\M%[_JBZ[/,!V'CNHB]M_
M;,P+SL-<2?/=;-N^Z(U=@*HY=+2W^ )@ZT-0U\-J5S"@)$K-_ZAR<95N:(XU
MW)C>TO,$4$O9 P4J@09G FHRCO&^NB<6Y?'#V7G!4M(%:DRI[G5HR;7.D)'D
MKJG?7+Q[\\J=&VID_V8%2!F$YI1HR<<2/LGH*;14O9> B,O5N/ZII2D^'_^D
M3?D,UXE#4'TM>^O?*_S)J9L]6R2LIKC6CGB.G3<BW:VN5I,CY;%D8FN5B=9@
MOZM0ZY\N-=F73Z6Q+RZWYJ<[8FJ:"C-S%E;+V6^N6FFX_H&IXB<*YC\XCY)7
M']Y#K+?POKYL5KYN8/+:L%\NP?# =N2+9QR$F*+\FN09I^>N]C2SQ2!RZ;_V
M,O1 =]WOJ N-"&%TX+5&&UG7L[XMKN>M;6YIQ9<\<CE^QQY_-5W#O;O.?;(0
MXHZ]CQ5D14%G4WL6N0[R.Q31=:0+Y63H'()11H?&;STRT5@["KV<1MJT/ ;\
MH- (2Y8.[7>5F_!KTRU)5NXV$9S 0"OA!:[ZTX,\:S"_7.H<U)Z.ZL?/KW2&
MZR23A[;F9<G0Q#8>,H_]35H6/CE*.&HZ-Z<WE6O5]1)2@LR>Z>DX-X51)S,K
MMDX#,? +J?")*FVFBW&#J@[G5G!S]?W:%IU#D'VV?]6-4;X755(SZCVW^_KM
MRV+QW*85PA)9WO+H*Q-1X\%*3+DUQ<F;.2H(N=2TX4_=^GX*PE?#'$S:C>0H
M$J]:+O<H07.S),9K,S/'WU5,V.?4!<0:"9466"#HT*5#4!_B-,L B'Z#;K*;
M#FX.]E(-:?4EJCO3#JKZA@O+2EPZ8VT-.BI*9A?J8;'?9=RDY_;\BZU:%T3$
M#0Y!$ABK@RPC4S*6']UJ3W?LY3&UH_,6J96V.,:T.=+*;,=4W?^<;4K@>M_@
M"S^PH@3-O59_5T\WJ[CQ]X+U/_=E+Z5^XT+-%S/P;0F^K:AY449T2[)10TMS
M*N5ORJ]KZ<&.T51-]7@<SWF+VFON ;]Z22\SSWT0/F@]!/D\$+2%(,&IS\[\
M+O0_<D!^8YPR1*JB> 9;(/EI<O5ZEIVESIL?3\[MS7R/DO)XC/PEINQ5\/%[
M_]1T!5*F'=-D'M-F,80/<_\^Y0L)[^ )4ML?0AIEX3[O>7;BA-C2-C1)LC.;
MN^U;Y5F:*K6?X%N,3NV5T$TJ3C$^C^+&7-7-J7%5FAM"O5_PEE$0:0SEBN#-
MNNSNA\>\"/CS-S5*V7ON$!2_V2#M.] A,>6IU"3A6A1:X67GG"SK8-&0"*V1
MF[&OROW1%\(S//$]#!KP^-A,.M3H_I5]XMNCJ?T/XI/*Y2*_6,6\BPF9?*1>
M92FRCQ](E8#7OU0[C?#.R0E?GNO]F/=B6][B8=.G!/>GA0L_$WY!S"<(?H1D
M1UA,@1>A'D4U^3LS5YCV[@(N@'X(&M#Y./]C_6_,Q(UTZU@@M=Q()T<BZ9G>
M2IY%R_>J\U<\98\UH9X/M6F09<2_HG'I L-_6(>@. TCFV<5T66F?%(=U0]R
MW(.W;YQ06'_%DMNH:;Y=4T_G37@6<[FJ2,U\=.<N3O#/#0I7QO;-\F>]R\TN
M*J5M <+-A>?<Z.CFI?4)AIY5)D6]@E)\]7;[.VPT9[^?IF74J2'*Z&D?B><Z
M=>C1_Z:T(S)JO_2P!92EX4[-2H2UC?K?FYL-RF^+?VG,P5N/B=_DOV0,Z>D
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M?W1IIF=TU_U+=V\<U_LBK'1Q0&WH08Z;E*?$G8?E-[NG4.FV-^N=4U>>(<0
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MG((]>F:6\@=/3J85>G^;O(AC&J+G>]FZT0-8H4VL1P6/*,4S<=?%SOA!_]Q
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M_$0&]6IOT@W7[7XJS/7C8ZH"(A#F@TK2-YEM9?[5YB=K:JM^35T*XR)X+[C
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MD?#OWU(*D]?F*\W^71Z/ 391T_*L)@XM%'J0MS]K/:_?+L.^PGM,KBXNM1)
M-UTB,IP*VOO! ,5"ZZ6]*Q=NLXB&+E9";H4R%)R=/AF%@:7EZR3L.9%MW:>9
M]A7G:.48W]>OFVJA!V\7/Q/=Y],A:YIXB)3&'Y13'EWLN.G=[ I6^XMMGN#7
MMG 1]2>%[UV ]SD-!&<X82TA?IS":QI?2]5%[A,G(9A8*KZQK/K0H_LRU ;K
MT+;/H@:?4(K/V_/TB0 _BK()LUV.PM#_*>J?O LH&'B+*PD@L)%JMJ%-OJTP
MU4:@*+P_7*QW29^$W0SWBQ6*0N5U&?>)1.2ES\]34L:)LC13P#9@@/..&'IQ
M/H;HA8$43CH?[1%2\2T6*1+9[ ^W^M-HRJYY$]#=?<$HB=0_R0+?W5[@G/ST
M2],HZ?PM2,LC-;_?:[$]V\2:*1T1&KA':+.]/\+5C>VA!A,&?OP@,85"98AL
MM"]9:.2G_6ZP,#*FCJ>#YJ [H\86/DU6':!S8NJ*C$BQGHO&2NWS]P'T5/>6
MX-$V:E'D:-7YPB=/6.YGS]N[KM:&]CZ]*'+*.I@ZB*,. %)0"0?WPN==_BW6
MK*-E:(WWV-W(TY^B#2M8*JY??RVDKI2MOB8W$$R1^EKA.7<9=03%4J%!DHQI
M0"Q\%5O9,UTSPV_@Q1C_/JO];HM0$O0MJ('OEW[WZCSE#+<U1*V()KN<KSMP
M6W?F%4KSJ(301$>6<I-J33@2&Q>M(I9G\=O!UO>>ZN)::CA !9<LIK:>$GA>
MZ1*]5^'^0(V.74)>_'+'XF3-H:$!YZ(WG-4/1*-[FW\>+2^7XPES5M7X  #H
M\6U,@K))'I27/'K*6*E1(NG?>8G-/@J&9[+Y^G[7W?W*$22UW%<[OJK+@S$_
M[(X)KZR9+Q9>5)$ $>7 9IA-I;K%&=NGIX:;1^GX8M<=Q>&?U9O+?^A;@3/3
MO'VJJ!K*5TEJHV0C419H:A+#9]E/5XN]:  "-)3T3$)4L6"@\GCO:_R'#@JL
MRGL.$M<+P&PH8O6NI#L<L1,[:>E)PTB31M;@BB1/WZ0C3PKZ'!.,XFH*UF+=
MZS\.XZ]O_+[TJQV(47YN-<"&D18+#R;2E'8!%>]N7JO.4#\PLKEYP;H7U FG
MA$?]"8)??OK+G62]M$E8K.=)6FR[>7QN":M.QKVY4SGQPD]2\N*\!%;J^T7C
MWNN#TNN^*H"GDF\QS#P+W1XIQ4@IGTE5_#^B+1);BQA%(:(R)NE"E*LJ&JZ0
M A9MX:2T=RSW0<+%413YY=P+]X8^N@=RR-_*DJZ^HL<;U;Y[RX/^J)E3"^7I
M@']G#@D9APH!H@K8A1&WCF4@S.= (NSB+KXNX_6G2GA8-_8PJ0XI _?X\LQT
MI$BP'G.M9^F7#KA=)IU/_-/PS?=-@/OS=PVE/O'[Y4)6WLT6&8J"^_X!^!@[
M6,M-[8UJ@5TR5P-(50DK!<:TJZ,H,+5(4PM=(HU$N&B 57X>&'.:5&%7+U^W
M=+W:XJVJ:VZ@@8])C(9+A:-^A>,3FQAU\<=O+D4O78I*GS7^>KUH_R%'#-41
M\]LN_#',SGFJS%$ZO<S83@_UN-2X7D[#XGI$1$Z.HS4N1(JM8<^5T8KAU1,"
M',"^Z(<SQQ4E,!'AIIGA8K*JV(_(KJ\$2JDZ/\R#]80(77=!_"-I&2R75=K+
M6M%'9W<6"FU;:0F)P%0,Q6A,%FO5S@'^-?5RH37@45H&F'KRHO *%A-%6B !
M&'KNX6Y[?UTXR7_#F/AYLG[MP)"M[=_ZL+AEVQQVJ1?7&F>4Y-@?94##DXI?
MTR9R!!Y?8"Y2TXMD>0*_'^ HQ7.Q/^1;H5B"$<:%ML;\@/*5701]@*N<(/Y0
M2Q.5?Q3_(#%JL#^J?24I@8K+V?.IUCPMI:_'SLC/Q[H'KJ9<1A95/FPA7J7X
M?KM91Q6C1T6OIV $4O3@+B E&B\:GBA8>YTR\;N +PCOY2SIS;FKO 38S>)E
M]#J_P6P$Q'#$L4][2/[W79US3'^R)OR!!#-?_UQ$'<QX>4GOTO^%41/'_N$]
MX1VN9FAVAIU>"3F4PLIK7Q^^+]83B\ZYZF^K&"J*]RT@&0,0DXUVD0FLE>N^
M=^0:MU-4HM5511A@-<#>6$8 \@N4DDA@=QI?^E8]:R=/"BF<Y=3B?) UBO;(
M;8VHY20<V_W[)H$WL/V)#F+'P[@RNK*AO'ID@&Y/U"Y@O\<7E=MI>9_2L"9W
M'O&5W008[2."&HCTTU:*NX#N,>:QQ9R\A+AE]C,V7@)\_/[7U$@I+Z"IU3?A
M5.#5]<;[U!')%VF8]8+M1(ZX$T52='074.6I6)3#M[936*+C6>(K]<-KP![%
MZS')J@.LN(:HIT%A')S9(/1_ ,'")@5Y8OKA?W%X[@+F?='?H[GC_VUY#;!/
M^QQ 3WJSBD2$B=RSR(-Y L2_12;& M5B(:1N%$ -H*-;L%Q$5(JZ;Y&0#'ZM
MEX8%S*.HX[H# $0[K4JMJGVSCP$4-FW43"N.;73+.L(2A":-I[*+&EL>1B.7
ME1-_DCF^^B38FYVMIRQ[+@3/%S]AMD7_P+&-5D%VCS,/M<OU6&+W]5_\2E5D
MA.O]%$"C(TBQ3!T0LP14UPB!@8Y"+/MH$;L =%Y6H6G2_2/,5P^L)G2BAC5Y
M4PV2.O&+F$WBBS?:AQQNAK<_6DMIEP,#S3#S@ M80$>/IW#[5@##&ZA>U@IW
MRW+!!Y)Z/SL-<6XL91UC:K6=.S$@'6;Q"=4_L8IDT;5#&TA-+#P70N2+*R[9
M\"=!=<U8 '".^*#'SIP.[NB)P-E=N4AF.$FQ3Q<V*+"F>*^C1J38'LHG^J<8
M\3B ]*!$RD#5$>9U49<4==-XRGUBA:)O)9UW]6IE?*R2CNR:%;7-U$IV4RWN
M+6QV2^3KCW 84#-N-E19H*,+PIJ&);7F[LU,7<'6"1#,".X3W"N7/Y,7IS@P
MOK*_ )6# EH<:.'8[@)FQYG 78 :<F>Q5O!<5X#6 XP4.X0\$=2DD*P%SU&3
M0,92]H!7V7&UV<HG[D>UU(0W;O28^0Y BRO@#].V,JVXT)U=@/MO!+!#RGY3
M,UTZH9J!EPS>;'LJ7\]?O\$,.[S*?T\+B;_["[V<>\N^ <07_R\":3F!]YCD
MO5Z#.Q*.(BQ[^R,M)_8.Z?>:/A!JGJOE0B;YXJ<KPKB&JW2C83#T:*N%5#!&
M 9N^I10>J8]!>/6^BI[WJS6F*;=]!M/&*GLK?D^E\R@FF#63\#;>WGV+*<-8
MA'#'@?.-^FG#]LA-[RS2[T+RAHE&A/=AFUT ,Q_V+.['I_V;H][R _AAOGB<
M("+95*MR^\E$UK^P/.>"JX0CK>9ZA7F-ARW6/UHKP^]-VT"G-3/5DHL0  %&
M+_D"UAS>@,^-(@/(N=?A)7:Y=\:BMYC\-Y<?:Q4LN<)^PQJ:VN-0L-[(GTVN
MX@/<+3VJJ1@5LM[73I7E1JUHAG7R3X\ACM4N\E4':YY-\#MO=16OT?!A17-C
M%,T]8\,:72]$5H[W*#F3.ID#::W'O_PR#3X'S(+':7YG,)][[M4$%OK?,#CS
M,[VD-'NGYE96S&FW0,UG(<UZ-D'33O9+QK OYU3ZHL[$,.6P_NA.YT"L]H%L
MXIUEC:&%:R.OEN[<+77'=1_S>_VHXJQZ#,^(7<WZP*NM_Z&\-$1FU;)YY4FO
MU6\8'-"<LZ@/B@M=:<E78]@J"!-XSM_N"XN$#%6O<(O939RH_UX)-Y-A/PPY
MPV%1>)7GSO<M@,:;<=RSWH?5)WU\"'_7YV;3W1J6OU3*%?DK!U_]>D.=@)!F
M=[WD6C.FR^G5:FY7CI)O#"WDU^V$#($/UQ8!"FVM;R'8ZF*0WLG^XTJ*DF5S
M65UGI>8LL\*BK]TY^>1<*>A.\X3<W',SN%4)\!OVE.=D_SY9STJUCVYK!'%2
M.SSIB\L:5G/V*EKN?LR, BB3. ^V4)=.?WRW5/&N?(VJQI<13*GU<&75I;**
MG#)W PU.:[WWRJ]I1<NC_C)19J#^#^,(OWOKL[2L[Q&/3\\5?V$T_FMY1-:I
M^L< T$ALI-1]XXU1G#Q2",^5X?#%S^]%SC9! _? 12V[!PX?C(=ND OR+1)3
M,",POCA2D%&*QL(L*J_B,:8 E^-U I@?'O_O^GWK'C!0A.*[H)U-EM@4L)-_
MO.3*F$H!/:XE8.)%SK>&UKJ9<AON=]]&U"&9L;]=HJW=6F^;U@U5FBAIJ0JH
M2)T(= BQPJGP(L1ML_]8!GR_;N<LDZU\C,*UD#YB<^3]YF(X6<KFR''C'NL:
MSY?6-D;S&+614N-^/>MN7 II@%VQW[T&= A#>UP]B"EU?7[UFW*%7?B3\GU7
MYC96\ LYJ)=3_G)0? E?/$TP &7(+J KDC^BE@^ ,AH0ED13*XZY:JWPXJ_L
M-_^5BTL"*A2JT%@T7F6X\939.3C:>'J-JI\?&8$29Q=><0;4',/:0U"HE!4+
MI$2>J$N1CN])A\/=UNT@G?XY^Q$.0%+2JK<:)\*XT^)YO!/_"+E^;=YP\F-?
MW;;'BD'%%^[%O[L O'Z.C2M)KV>C;74Y=-KD<P(H',T^H\V524^M8"WQ*J/6
M)9"=4TR04J3]CMVJ$U&5W'H8V7$=27EUKP**MZ=;Z.+3F'%?TH_T.OXZ!F!V
M],WGE4'0F9C\5XBNUY:R?:%(Y7W*[0S=Z[UF=ZP&1!3WA,O0%D2$VF6-32\G
MRE.K.Q"*@J'*HO>KOW2=;<V^:=K0Q_&N^+&QE'68>6"8/_5C(N'7PHW^(D&)
M+0F*3?JV"Y"R_ \6&-^^FE7F15YS0]B88?9C[23#(TT4L7W_K_V@V/]^/G 5
MHVRF#7],.52XCV.MML<B80-DP[Z2*9N22]!H-S4&@U4+VJ%9]@ZH/>8]0NWM
M5*5F/]_A^BC;5+9Y^;=.3ZUWL;L JE+OIC<;MLF3?/+E*2L7%M]L-X&\1X5N
MO^)@!!QU)%!>O8K@Q":/D*/O [O)AR.3H"2::IXEM;W2GGM$FR\N6 <L?W$<
M(SI ##S"%C/[:1>@;6HQ=(%ZJDTN&30<KKB3'P] MI!*E;,JWSBIO:=>R).2
MZSW[Q!@\FRTWG];R6Z2R$R'7>3:@$Z/=4,WS[!6H __]Z[L 53A3.6$S?BRD
MIIHO$U%,XB^$))D><_I#SO5N<*-'<"S@OO8,-^+ A"W5J,<>N*A\O('I53Q;
M^V#&9+3U^LL _NF/P_4AAP>^'$U(XOZ0<7_7\*@VR,3/Z*$1$?:&?$FR;PKW
M[Y0B7O$@F#XHG-)_45C=>,6LX;UL[[Y>(3LIKZ=RE#C #G/SNX0>!I8:KD\*
MG0.J2?A)MCUO5/4\YY'RM?+M*>^4#G]V:$*]JX)01A?E_<\J1P>7NY4^]WS^
MO'FB>(=F8&V'^!#U^-FUJ-&>N8CZ6\%>)]I.?7*F+,V=&7EWO5O3'#R*H=VK
M?H5Y=^2E1_Y!!?8G5*2%":L'60O^H_OC[JV,[=[;RP.R6EV#D7H7B3[]=F!\
MVB -0C.-+8P8SANGONC7=8')W@;0&]?OFP47J=<&'T)%/?H34_^J.(E_K0:;
MX=3\I*:5[\9SQW^OZ;J0P(B$4Q133=_KZ,%79S(5RGQZ;DH-&W/#H<5>U\Y9
M2(+[!N3 \WZ10ANR/6!E]O5VE?4\J6'AQ<E= .G&F'70K\G^::AT2'3"J5>$
M\RQZ9+:CR0ZUPC,\$KRU8K(E]\/K,B Q,[3)U *J: 1)D&]=ZDK=&[E/Y='S
M7[0*S[SYQ+O5-F4^JIE7C$U[]EIQLQ(6GDUX96]]_MM&MZLT#1GR\KBP^.GG
M+=Y,T?%0E.YHQ$I4/F!SF7W8U/K@^O-72#'HY3^)D2:2$:E2@4\90A :4):F
ME$+\ *W%'YS'-O7;J\5TR!'WCR@;RZZ8QB_4-9.O(,\B?RCI3$Q#O0@G-(PU
M'SU*U4N@A+3S8<N%NL]"K)9NI.JVFUHO1?R1\B&#YJ;1_ '>!I+]C!8>LHKT
M9N_]66BMO0;=_24D!/C_U_\!4$L#!!0    ( "&)+U6O6!)LW T  *0.   -
M    :6UA9V5?,# T+FIP9Z745U#3[;,'\%](()1(#0A()_3>$<%0)! 4D(XT
M!:2&(#T4Z1(1(711Z2 2@L"+@BA%19 J2N]([T5Z42!'_W/*S;DXY?O,7NW.
M,_.9G5GR*'D&8#1 H5$ " 0"[OQY 'D"T &HJ:B@5)344"B4AH::%@:_ *.C
M@W$PLS# N3EY>;@YN;CX$-(B? *2@EQ<HBIBDK)RBHJ*O"*7-53EU:45%.7_
M?@*BH:&!T<'8+UQ@E^?GXI?_7X?\"6"B!M# (A@D % P@<!,('(KP L ($K0
MOP+\>T 48 @E%92:AI;NST M(T ! H,I(&!*2@CD3S?\3Q^ ,%$R\\MI4;&8
M.$(%?.'RT:F%U(+:U<VLIGW;" 4GOQ@:6K:+[!R<0L(BHF+BBDK**JJ7U72N
MZ:+T]-$&9N86EE;6MVR<[[JXNKE[>/H'! ;A@D-"8Q_$X1_&/TI(2\_(?)+U
M]-GSHN(7)2]+B66DUV]J:M_6O7M?_[FE]4M;>T=G5__ X-#PR.C8^.S<_,+B
MTO+*ZMK.[M[^P>'1\<FOORX0  ;]1_Y;%],?%P4$ H9 _[I %+B_ TP02GXY
M*F8M$ZBC+XN ?#0U7#NUL+J91E#!=)O5R:^/E@VA."NT\Y?V+]G_#!;S?Y+]
M)^R_7., # SZLSPP$X $CM9$*ZUN[PQGS4Y=N^4@U&W@S+RD"+F3IJ&GSDG4
M-@M*:! HT6]V,.I8(U;J&!\G%7H*WU<?7H6AK$(&10%&65DC(_VYZLH(Z=55
M,5NL\I(%]%)NIL(65.F53^V+C:(MIYT I\J%5Z%:!59"L].\'@[\^1LD1$T]
M,DBL>H\,U.O=+J5Z=?RX+=0*_[FDN[$.!K+F;_;B648 5U\6]A)+.N9^CM8Z
M9"<CY:O[70FU2YB=F-X/O.@<O;QR@?031NBZ_9.X.?LKK<IMMARONY-V9%M>
MANL=K%J8,5@^;YR_:ZAN(4[HS1RK0YL'<IMVHVLQV>L/8OA/C4+S-=72-R0>
M-AW7O6R1$"J)Z_D$B=K0ICH"IY]$FQG%&7R$>%O8Z8K?OE2],EB[]#:2;0,1
M:-ND-L>H3UE\9R9L/O9T_5U_;2[RUEN%U2.3250IS'RWM#>V VD3*'L@=M_S
M<TE\B=4,3M']5)QC.6&<[;D'F^J@R[.G0/%@NMW5TATSU.O,HAH\YC,R299H
M7*V>WY6I9D;<I/0C698:.GBWA_\R<7"&?OEMNF#G849:?N5'A4P%GXRX%087
M7]^!A;WRUDJ!U=Q0KC_3BR1VD,KQY88.)KT)UB0+^T*)-WX)1C6)0941F8]Z
MU1(,G-4*0?&0'-A1 8WHRQ@Q.EH@G/76UF:1Z7=U_<(8YF\ +"P\G*2_2#!G
MN"11MF*^P#/ESMKI3OQAGH2[0LD!1LSX&\-A-J)%4;1_BKE1;^[C*8&&##@\
M(@.%2F&!P<E?[IUPF9TW#I !;<^?W<CD7;?<YY'@)8*83L<ZE^=7ZSC:)NOE
M:,+IB&[(##:HQ8 S<;B@#9",1P?PO'"JN*]4AS[U\+;W7VS;!<(U/YT';L7A
MQ"R!V'7[T<8 XJ!)PIY;?NRGMB:1RTC$_69X%:13\4:G@*R+BZJXGHZ-I4U$
M^5RN?:O!WJ0^#BWA!IY,426%9ERG*@N!.5.G=Y T "?H;I7ML>$]SF//)1_H
MTR-)CH84X-.9\;(].^F\*ZLF8>3TVWTI!HS5F$KI[=3%7],/#Q@8INC"CK6?
M<%C=R+Q7R!=A3@8N8.X58(:/"L<<+5N[/K8^))[7KD<R;SIE-V<QU\=LJZEC
MS_JMQ<[8$[8?QUS3FXP^-I_U//-\O.QPXY4A;[F5 <,;U%%\HV[(G(969:5=
M//Z:'#WK10V-[V45R?2G:A]'-BP/*DW[H2*.=R6_:FC.)]\?D2NQK?A1[8SE
MZS+TY<*V!;L"9$#M%X/M8%;+.<^[)@)(8 *EW$H/X@!@AZ]\ _.X49FLKCW_
M9%CR=U6X!20C=GA;NC?!QIB5+=-=^._?SN)=&K[I[1\PN7U*Y3U0,\)A3X=X
M1$#G^/J4\<E<0^=5&0[&XA5WBVA*PS8M[N83#.<]SI4DNKAM[YR*FLT[5HNJ
M,V==]7ZMJN^&XWZN&.K/#@X2OTV',"2>NJ@\\F86I=-U9(>@C*>]_'KV+X-7
MGY?,)E-/!Q=Y0.C_T>%1Z1%(DP^#!2*3_&4_''=C)Y*-#O8?QDGR#]R7<[Q'
M$:6>&23XWC$MDMG#R>U S4!Q*%OB GJN7,7B1WO.[5/A#V]KTC!8@RN/F-"[
MX\PE_ZB!TWM\GAQ=#,7.]4#2FGU9?% 6T=!",D#[RY]817^<7:KK,O=&TBZ<
MQ"\A+8?O-(WDKB5 .=0& DAK&,)G5**%@8WU@0PU9GH[Y3CB4OO--Q3.&?39
M#TVO-D5R3J5O\1+/ Q=O4XO<J_%\NTCX).C3%-U-$9FUZ$ B VO?!R/5]JK-
M,\7[8T;WMS/M;>2R)X,DD@9O&SULY8P>QL*Z>HMM%=J;;FFV"##\W.J<3T]=
MM<_TK\^/=QOP_@EZ@Y;RFD.[I7]OV?0Z&YJ(06F@,.P.FX(&3UYC,UP:/F*M
MNO KMI#G0OB+7MZ)I/3=3:'Z?T1PD# 3M6^'3R[BLH[8S_N<K"E-.)/E-'\W
MJ<'R;7Z<CU?37 HI9;8+S_0K?79Y?E]]V*4N87-+<3F_*^ =8[< JJ.KTNSR
MS=8[>9?;]RND?W00K"NFNJSDT"&58Y(EAWK$+L "8&7$<\Q#\\[//(F#2LH$
M!";:*]_5@VGL@=:+'RV\/@M1%Q?GJT)7)ASJZM(<?33'G<T)2FZIS[)4QZ$B
MJWE0U0H)3$9#M$ARL!X'J+><@<C'=-R_A F@I;55>#3L75FBPG:$4Z!YLC7F
MB%<$(1)?,X\*(KRGTB<H&F;[$VG%A:3O9B;QTUM.';$EB)8I_CTWC"/QIU9D
M(/4+<KT/N2]<Y5W%=ER"5?\@C2)PV$=TQ/H5"E[)[K6*L.FOK!K+"W+-+BP-
ML#RV)0.".9$'GXU7'19".7=D\,H#7^;A'GRI5ATIWBY\00=57FL:Q*\V@5L-
M_"Z/2&SA8WO*562 OTGG_(,+&>A-"B4#GY-/X"_(0%7IN79CL>7K]VI#O^D\
M]%7D&:]A.R;#RX<CV'01#O!4%Q3JMUF.+-\^ZT1RA@/'K4-5'R8,\_Z6_7$J
M&1"0+CQ()@,HJ6 XT5Z9T.CK<+;#Q&,,F2Z2D!.^"F>.')8*SBW)[?U0AW3-
MYG&*[%8^WSXLELIQUJV;.M?Y6BQF96G/9#F,JVG ST*_TY43KY*T>(E5(0D_
M#7=&\$)U"3-%WZ)=S 7O&Z;H\R6;V"4G17#W('K*W'VH9)[D3>.$'OWN0CX]
M+>_1?U^=@6>Q-5 KFTQ$5IC/&[-G%$J@F:!F5)-NE[[D99:?JF^?/W0ZPM4W
MS?%Q49A)A@,3G56R=^BU%V+71UCEPK+'@"FEUES\K>^+/;@/%XY#</XAW(>U
M(/P0=4!T]E+*X>05F>J%85*D96R@VU<R4)&8<_6-8IEVQU[MV[11=E<4&BID
M?2<J-")S\R-#HQFF;&7;8^!&6;A7#%**0$><U3^8N7,F]D%U&WFXCPDK%1 N
MBA*#^;R6*;Q:$(","Z'<R@\OL:O!!>W9=I4>9Q#"DW4.6-,SU0,5LVM2FT@S
MI/<VJ_GZ]@ZV8[8:7[YVPD7EO_5$(3FW9=@QW7.\C#TX)J2;IN!#0:C[S^,T
MXWGK[_[^@;6(O%OAK$_K5NW=XNZ#B!C_=J4->1N/L^N\F9.A0,BIIX?CZLQ/
M4[\&VN.$I]UF#[P(Y;/260C.\*U2$;J ;BYG;NUEJ7W$_':57OI6_I][P9W[
M@DTYU=:V31"O1$LJCJ*\+C*)-#E=[ZBR&"(N_<H;YDDK,=0*X+9.#\88U@]/
MF]='B^20(/3R+-XA/!_#FK#/YY4&B'889CN;<6/%4,]RS;YWH!*$0@S=A1;7
M7ED&R:DUONS0*ZPF+RJ'>J#;WY^%<<4<:D%PD5CKH-B]G 66$6\T7T2-WFR,
MU/#X]1-$#"+5V3!!.0O"K+\>U<I0]LU3<7 <:]+8_?NIWTXV)O !-I4#OK"(
MONST*2?1N2[4=ZVN7?^)K[_/.&%(A6V)Z[%O(Y6X\H%%)Y">X_:\3PRG<#;M
M;!I)3R-M.&@EP_JY'GT)"Y& B/HU-9L&GV&<(,&%NFEF$M%[EX&[9U"*]\I#
M]P3>25$.OEE-G=2I7\Q@P4\U^<%=]#K\)WR7"9)C/Z8]K<3+ _WA#!J?8-51
M!F*@B-T<>B.&4-/$O W?'+:.-?\>*5_EK*SKQ#$'AVZ_;UXN]J2HD,K*X#:Y
M=U6J<T6OAVHQ+QN3A'/-V'I84KC*0K3KKL"Y9$QB*&7NMI5+M^-R3.Q<7T@7
M-[Q1N8@3IK._ ;X*\,,X3N+9!?VQWZX,E5\P6CRU4,KHORZ);2H2BXHO]@93
M@*D69A9BA[,$:P<X256N]:-KQ**$V)N*_04'%+EHS0I?"I !E9IIGV;;!D_L
M;@&@9E:-$F5->>!6(=R\(C9XDXUQ*.SQ)=M:BKEQL:A- :KS0->T!^.CG(:W
M,K'[ZU?4SYX/L_N/="=*1_);5NO")^[YF%R_RTY\68</$)-$"^21UJA/DPS1
M: \257I?QFS_AE3^?3;+'23I&BE25GP4""@IPD],/=*52F'2;_&;7S4JBHF%
M3S4N-ZDE -Y]6C<]W LL6=R+W>%KHG071D7'Y<7<"R2%I_TU;]*'#1 +''7A
M-T'_CX*2Q_X-4$L#!!0    ( "&)+U5D],N(4 4  !-!   1    =FEV86MO
M<E]E>#$P-RYH=&WM7%MSZC80?N],_\..SV62#H1+2$B"PPSATC!#@ &G[7D4
M1H :VW)ED83^^JYM##F$TQ NCN$X,X"#+'VKU;>K72%9O=7N&L5??U%OJZ4*
M?H+[IVIUK5$MJBG_$TM3TV+UIE7Y!EWM6Z-ZK0RX):\@D[8E:,RD#C3I$W2X
M2:R$_T4"NE2P@8(5L6K[O?4*8!(Q9-85N+>FE>)7J^?8!375WDZ#!9#T62:)
MP8;XE6##D52*ZDVQ^M=M_::N88-Y-753W"W>EONT8R7IU))4>%HJEQKE^T9)
MJ[>:T*I!K=ZH-W^'6K7:!:UTTZCN4'6!%&%UM=;JW$$WF0FA2T<U+DS0)C8]
M/A#EJ??%/]@C>> B 75+/U%3]\4P%%E])KJ$)C$I\ %TZ) Y4A!+ G&@:U.=
M#1CM [.@/"("JVQ/WZ]TZ]D#E*N-1KM4J:"97"MI)0#I<=&G(NFY@ROH&41_
M@ PVXW"#]0LP+>YQ*;FYI'QU&9]87X[<6]-?%,_3JUIGZO%5K;(@CN3V$K!I
M$]G3+S/!##IX+;82M+M[ZNX0!LFK,6EX_*D2?31G[6Y!RP9Q' 0-"Z]+];%@
MDF%+DD./AH7KVR05M!\@8L1168^2ES\%(\,C?LGD8TN&Q828=E'G0UMPFSMS
ME>T:[XX\,W-LA@77&@SP=FL(;<'TT)C8I@+N+2:!"W"ONQB)A ,^)\[ZW,]D
M8_(?!/E+PZ&@0R)#X_UR:UN?B>=O$/$'@M1:3>UE%Y,.^Y?Z_?33/DJA@VJ!
M(QN-\W,&3&88C%O'OL1N]4W,)_U3F$_8(4N(<7.04TKD1%B8R,D-[.61"LET
M8@0-^UGEC)+YCV6DF_H0(290X^*)B#[,UD*B/R?NFV89IK7-L=FC(M;MEG5;
MQXB.$0.J.,OIDCU2J(0UM^Y2S1\]7[G.CQENU## >;DMZ"/C8\>80)LP5^E0
MYI;E*IQ;*+(<^<+<6RA;'Q:7., =,G?];SIH'S$Z^-8)UN$"O,4QP)%27@QC
MN=7HMDO-:R7S:OUP^9CN("I"#:#2YTGT"]TNQD71ZN'?8T>RP62UP,_CR0WU
MR'6U2K]ZB#P4&('TDSHWN+@",>P=94\O$M/7L;*A/>)=;QG@__>LS$T3C:,K
M.=8:432+W@1'S_",:CJ*DQ&:"Q7.^N'MN\5>AX>GB73Z,G%VEHVXG)\S)^=9
MM7O?+AYE,&UP+Z(N<2YQD3]+Y/*YJ MZF3W)IZ,N9.XL<W)YOKZ4[Q<HF&5B
MJ,VA5G/T?XZ8I#OW[AM-9@OATJL9+8*FDTPG8PEC"?=;PGUQ=(<)M6+^@2CO
M"MZCD(5]O^3POA1LKV:P)K=H;'\Q5 QU,%";+Y_,//#I:@YX0U<5; U^RREK
M7!(#9K]N^C](O7+)$8QQMI'TA\B^.'6/H7:4ND?:LRQ+Y3?S+OLRFE'T#QNL
M/1ZFVO<%ZL#C#\]+8!#BT$UCCWT9T-@[[(':]P7JL *')I6N0X#*F,:^X*-\
MP6^QVO<3:NX+4MX9OF(43^@J\Z.4-CAR8M!M-+6%;G[*G*<+_ON2HY#H+<O!
M4<@?'(U<ZVSC;,C14QO$=M ,@RMET:^_L1EI>M?256N_7]ZNCF6<7%JG3 Q]
M;!!)^V"/A3-V3Z-*#IVQ02%WEC_2CP&G&"I CNC++6LE72:@1QRLQRVOD*#D
M9.B=3'3_'>%L ,3J^V(8_ EL=V>]$Y3/3[]^_721S>0+#NK$VPSD>)N!B ."
MVEQ('Z%)G#[Y!\K$9FY >4?$ TXC[M8A:DOJ;AJ%3"X!V70V>[)+.YE2Q]X:
M(SW#^][\W(<;N \U*'I/.7 ?AO ?4$L#!!0    ( "&)+U5^&#PLEP(  *X5
M   2    =FEV86MO<E]E>#(Q,#$N:'1M[9C=3]LP$,#?)^U_.$6"I](6! _0
M4*E-PH<4H&LR)A[=QFUN<^+(<6BSOWZ7)BV@ @-&I8VE#[&<W%?N?CT[-L_\
M"[?[^9-YYO1L&J'XF?ZY[SI=LU6.]+15/3;[5_8->/Z-ZQP;$QGK(]AM)QI\
MC'@*EWP&0QFQN%'>:(#'%4X,4B35P5(O8FJ*\1&TC:[9[SKS$$>H86^WN6NV
M^N1U\+3\=CQ*D\ZZR$M#Z<#*&(FV.Z#Y7.\P@5.Z->:QYFH1E)>-4@R0*>3I
MXT&]T>.[O\+F#?J]ONN Y;BN-^A9YY>GQT;;6,P'/=M>SE_M=(:!#@O1]I:Q
M ,_TATLKMUQI'#.QK(R6B5'!:?KV4JJRL+>?S.^"]NUG!3M01+B3XD]>ADGE
M/KFZ]._'OS-A$8K\"+P\&DGQB,IVA$$@-;DK=+N/>[V/UO<LU3C)7^7]-_E;
MLW2-M^R:$,X4J5VPF$UY1%.P9)2P.&_ >3QN-H"1R5L6,!A+E4C%-$JR/0NE
M$#G(6<R#!Z]%EV%9GM8"A.X[(%9>FP<8/_P#5EFJ"?R'"?22D"O^%\%6(_;1
M$%LUN2L4X+$X2.]P^ZI96,-6P_8NL T'%M@\)7] E!5K:C9A8V(/XRFXKK4"
M3F"$F@<TLA$*U#DA6"VZ-7XU?F_$ST-!>8.3C(N4.!0A-I;4N3+#%&F/5Z-7
MH[<!]+Z%!!58@LWH\T'06AI(L BN%8 ^G[/T#^%[:8V>K<=Z/I\1?ED:[UG8
M=+ ?A9<'VS(GYFJ:PZF26;+V(6#=[<TZ<'C8/-BJ&"F6V)J3_X"3'U+!!<4F
M.#@LU>!63<1=-9'5B06#+TPS]72?(6J21,DY1DQS:C?[AR5.*@TQ:6YZS=O\
MV5NK.&\M#V"+<]I?4$L#!!0    ( "&)+U46F[+B#@(  #P'   2    =FEV
M86MO<E]E>#(S,#$N:'1MW55+;]LP#+X'R'\@<LC)JQ,/NS1N@*3-U@!N&S3I
MAAX5FXZYV9(GT6WZ[TL_4FSK!NRP]# ?+(L/\2/YT0HO-U?1M-\++Q>S"UFA
M?L+-<A,MIJ'?KJ+U.W4XO[FXA_7F/EJ<#5*C^13&HY)A0P4ZN,9'N#6%TEXK
M\&"-EM*!.(KKZN!7*+LC?0JCP32<3Q?[C+;$$+P_&8?^7**N_FP_U%M73EZ;
M_"V4";P<)J:C"3#N^9W*:2>BKY5C2I\:5.=&.]0,)H6E3K!$><GV%G?D&"TF
ML*JV.<4PBV-3:2:]Z_<^DBU^G\*_Q?<V5?A,#^J;L9X4(#XY=K (,_+@CE7V
M?Q3O"T+<48@-<(90.032S>?*&E=BS)5KC)BX:@FDH%2V(1UGY#JV6<5D-*Q9
M,19RH%?K367!8FG$.A%Y K/24@[C#QX$HR#P /<Q"K[46+@V+.D$ 2B=R)B!
M<C6FQXSBK(%3'P 2[DH]0=#Y]WL6<U6C.N!754(=M#8WDU,;.B6M=$PJ!W?
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MN)&SOZ/^KGKX<W0>18F %0AA4'=N$QLO7M1=6-1T2;_)!?AV$G2[@4\M#IO
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M)F[S^^<O*U+,?A1;+YSPRSKAY:8O>M,74:B<51U#L?D8ND[[92EZHV;_LGA
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M(+"),,X67JAPU\:BV?$#+VBK3%SAW[EAX",9(DD&'EU <$VA  .R)SD9@(^
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M)*W*G28C3"A@.*\,[#8_\#=S+E#9HK'J-C4O\W%?<]+[*_?N-7W-YC*;59@
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M6#TWBA)4'2GX5W[+:>4]Z>5R,PE?LD6[U_-49;"6ZQD1@&0&AME%UDF@@[U
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MA[)B !+$/98]VSAB.RG,*U<M]SX(/0?D*.#1X@'T_<A-@=>,8BC, VX_WB)
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M@(S5)BM8_JS$6.$09!#>"' -UH^'JHLMJ<_E #.5>R597ZLLGV/*H<5$UD:
M1; *9*D6RWR:PBGDIXA>4U=J1NBJY*2NK!Q(MG.2>.\('$VB$O).6TX8]-!H
MA\$3/VWO52LY$5(FVK""I8O$14F$A9),S/Z<T$TRYGV(L)T^+H#+>*$@&R^-
MM+<(]6=0&Z14!(:@8SK0>6A4]QF7599^EAZ5 O,*:QOLC4?1@MREB&=!U'@?
MJ.P\@K@1_B87DD:YOX(I:9R1F$5SU2=*[SG:=%V,'DW!':5JH*+96'O&7/:*
ME?@4_"\C>[AB&Q,H<?]BS9A@=@:)AA(#C';(PZM3"^(.?,TI9G@^$:-31?T\
M]-PPDX>((]BR3J7>1G]6AHQE?0VM+A2]U!#IT#GA"Q5.NP$,A6.**!))OB%[
MD^F_N;/XGO5/1[1L3.V6#XVYO9<ZJDMI)=)!1B8?KHC7Y+5N<K8;CJ5)T  "
M3?XO]6"-;04VXOEP_>KD\U]?^Y2@I^54>!V7+(UT4_R);5LGGGV?]V["&XLV
M'L\QGF6T#?FWQ ?1:D^9D._AHLA9A;\PHB="\9\KJ(=K=?\56XB_G%\?YVS"
MOP5A&_;8<&]HF_!%@'MJ^P5F80683';AG=WWW K]\S5M\F\?CW^U?@T\AZ.O
M98ODOA[#R(Q?*TF0TLZSU6NY-YEU+C^I8]W:,$IG)Y/!0+O"'CHP%)G8S<1I
MY6GSD1D/C+'^Z51UQN4U1M+U)+-')[PV(U,^8 ,A5V(J]*%"KIN:9Y%P?IR
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MHZ7IT5MI4MJ%[%!?B9KL7JQ<AR<&98&TUC*7BK(1+UP? Q660YPL#%'OQP'
MTTVV*YG,#T.[?,+K0&!NO"U8I2#;@&K<2M^6#I$7O05Y?BEKT B+F&->ZJ&;
MW.=+W&XV0\6&$I_N& WWA5\( FN1-@UZK*"MY)$<AA[BZZ$H0"^^*.6;GU C
M/+&CCO4)[1JOR#S2,CU2-/37[.GU98G NNC%JL:6DD]4@!\HOI(5A8)Q5)07
M^!X=B0+M>:^VJX/@AQDG0)3TCN(.* \)VJ))A7B-UC7A.W!S 5O35*E_I,D;
M_>8B"E3Y!C@EBZ;118>Y O%AKH8L4XA!$23#ZEL!W0E4:YZE3OC_?N9N+!(+
MIDOE!!J#50*(+=E]\CS!>#' G=1]I%@$HO'Q6[@Q8Z[1@G=CQ'=C5N)$Z2/,
MVCP,2<@&RJ9J9V$_9P!>7U,7^?*2TT)9GHPT<=-H L[SPT5GM"JU3#*SB,50
M*4 ;V@DFQPW*@B]Y:3'^Q^/#0W0O :3H4C%/E3Z.E?0TI8D2?$0C?9IDIE7V
M]NCE/%)TDG5DE4R\QJ IFT5#)V@F)'FE<KX<G94;''^;H9)[,7![Y?2IE'!X
M("P,AX)_1SIJ)S;*+X("R3U!,<E]F>^M3)HQ#L<\L<S./O.G?4-^A-L-;B>1
M:L7FV+#-0II</%6^V"B,19M1QXG%V"EC,180BW%8QF*4L1A/S<5!4+I'DW&L
M(;DX)@ATUNQXN+4#(C":E2C]1)FJE8UZR_I*]YO.XT\M*A4"E4P#SLFE144=
MK<N_ZF>J2J%,?6\6!0LK\XHV1&/<1V&8\& 6#5=YAI5R?17V&4FCSCZ#FZHD
M'/2_DR*V9:&:(25N6H8[%%"HD0A+UK==F>0<R5+J62.0ZJ5-:&\2,#;;&0E"
MZ2"-KK,)/7EK5*W*3F(UFHJ4-_2Z&[E^2:^'(E@J*9!.\^>)15F3%4,.P1U2
M,15 :5$DZ9)LIGM;$L559A,&G(*>#;L>7'>*\4TE'YA8K/*[]%(6)4K!6*:0
MYF7)+*^!<GB9PKE28A^:8RC]L?%@DF%!ME1Q.9TOG"^L_2DWUZD[9>SD*L)U
M'S^[:LLH_:SR]"-+^HC(%*O2E0M30.M=8#@4G9(B)- 2Z2"&P3S,%+_=+*NG
M#D(APE%Q6N6+U9H6F\!KMIO)Q-3YNZGB<Q'$291/WM4*U_!48.OQ3.#U-9T*
M_%7K41RZSG%^@_=+17,T.CL29IE@*6V)G)%?N*%<%>.XY)F'TS*]#&1KS 1D
M"2ZPOK:TF<C+>*C0X@ DBYD&7H!5/JRHHV!?L#YG48P-2T$(Q*[]IQ5M[:F0
M![373ZLN(Z9J',/N4#G<4&#,0V2=/73<AAM;VUNUE4AA';&/G^C$$""_(Q#2
M@E""%)B8]A44AMX,1#<\'GF#/E\M_GVPK4XH6K]L_(_];:=ZL''T\6O]_/*L
M7O_PQC[:'*//];6Q.EWT*9E3EO+8V!IH.?8\'03 KLTK<H>O5GG *],K5!RT
M(H.*;50B HX(4%$\35XG.!"U_?W*_OZ!LN+W)" , R2%Z&(3=RY#$DK//?"1
M+\!8.C#Z2[<91(3TG<!%W7%%"_B+:"8$\4=9GH+1IG=V=BH[.[MP54[2#7(T
M/R)41 RJ^GB!0FI:1?R$'Y*BB&F_JW)A<-:\&WV/=&JMBCM'H**/$K9S59+H
M&7Y)U[/,W&]  FGD2$A+@CXBON#Z06+<FO8]VJG9'B3AY*CB4],E''R"S+B3
MU9QD?6SR7E'<"0N4NC9+Q;#G4Z\5KH?%EP=B1 4(/\'P3U)X*63\VQNTD=8G
MJAH2(?-787F1,*+3.7X?D[9!3%V]8IUP=H:91)]''<_,W5. JB8Q3&V)7+K)
MR*5I.'K3X,GW_*Y!Y&AH0A[G4HDK)'+71XG-UTD[0+>(MA=UM,N'BD+J0R/!
M$&30[11K)HY:W)&TM2QU&T?OW%B8FKR_E"T-!Q7.L4QDB!*$"R0]%2O1$9"R
MW&#,?\9<  -;$-4D*D<18HX*!>4Q'HZL;B.#6>46IC,I=W+\,RA+*PW4DU/E
MZ1JB'Y#*[W)!'-'M>6PZELBMK/E3:&)H(BNE:-2D'F,)%-6FN=5WH&30?@=4
M1PCD,]Y]-@:$%&?J>>4IG7AO\78^N?KC_'2S=F@A@J[HNDVR2W1L1]9]ZJ=Y
M0'&@:C#Y&%B+TJ@+#!@3V/CRUXPS]4+@/I<[\R.G+D23MPPZ0YS6T!4J$/>[
M']R#EM$6J@YA-S7RQL+N5JR/@1V2/>N4(&<#&0!P[-RY%"E-SU-@>62SU)9/
MG)24>QG4,F$7;^#S;"_2:F8[&)J$<U(T8Q!,$85,K:IO;6]K-^N*+.6SZ5#I
M" V#XE88#AMX!5X?[<1+D8X2GZ&'T6=#15W).HS&&* ?!<+'%F.A2P*H G"F
M6X&I:@@?*AG/#VTI%\CJ9[:6%S@->>/BR0Y\&?;E3>$G+1NMWESSC!]EX+A3
MZDA\E4'!U:X0E%ICT92[]B/715KHP1$]Y7&@\M#N=^2Z9D(OUOW@E\A-JE*_
M4IL 1\8+!?N=.7(&3A&7$*42,[QK4R\N_Q)VKDBK<3#,7::Z!+&0UR46< 8Q
M@*HE<-'FK?*L3+KBYRU4)5L([$%.Q^_LR;OMA")"0ZYUK2J<8G5 -%;=NQA.
M$E)49<8+F7J)Z&<CLI0LK-VN;7!,"AZ6"%Z)?X\:<<'NH6#RV-KEUFWPSPGW
M:ZP><[)%=6M[#X.MAH2CZ<<_L)/CW5*\W^/^#T_:!/7-7TAHX(S0&TO!QV'2
M2[.,.O:_(,<.FH^H=N$DHTAO157N,ZT^:=A&L\5+5.^VU)]=H*R0<O)2QC'9
M,-#"XC9=X4N8!W22T8 (EF6 *$N"G %!:ME*ER51.K76D)AUR-@MD)*!ZLB)
M X384N;.Q%=7ABQ]/=DH,!>.[WBJO/-/XE*J_19OB55/R.%-?9+P3>$*AC"
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M8=O<15'-[=OY=V54.Z_B6G3$"AS53TAL+,01_?"*>0<\43EW?P\&L_%,M#B
MO@<E:X0?GNZDNWO/T_W] _'"?MC;3Y_O[:1[^(%];H7ADDHTWE*OBH$B43!6
MQNY.&B2-1G.GQ(0YLDMH1\H.QU;IB>I44["UAWNJ%HDJ7R$!NB=>-3VH@M.H
M'U8M?"#C6S@55/['V>+*T\9:*$;K,UN21RHD.4$FK(HD3.([#'<VH5]*5]AD
M0E< YZ!'[,0[$/"V$<8+=83S%WG:@"];=!C?PSY (*M)S) FV.;3(J2-,M(_
M@4>4/[L31'JY)1[43OG,(NW<<B=Y'W.1,4,#>9S7DPE@=!X0/ER,;EEL:R[N
MD@MMW8V>"$/X=ZB;N$V>*^3X,$KAWV C?"[F6A)40, 1QQ,Q(YMNIB1B&H4S
M$ 79.Y!1K09 0#0XBCMX82Z:BB6(7J?!R:JFY:E.520=? 0-IH,?D4*H(<"*
MC^'"=3DY8*4-5LA<L]8,PV#8WI9W]G 1#WVU5"T<H(XA'5K&M*Z"L"@[HI)X
M5S!?BI*OQCNK".0BGC"N'%WB:9W3P.8)#&>41[9U5<$R<Y)E^0RZ.Q=/M!Y.
M00WFK"*A$2A8MP7U:EP^HH^7")X#\2<_HYF5$KW$)P7$9/HHV/Z"46$A:8^.
MY_#0Q#R+A)3.:WU062U.3:KS(H,:UU/IHHEFJ?-T+_X1%"K#J9%57O%X)@"'
M]6>"2S* U #RCPH]'^%@##"?QPF"UL&(L4]7T([\MG?H'1>R7U8E\7Q=)7$?
M51)[ZRJ);W!'?2J"\)+V'+ WD?L@ANIN.DT0(M9S,(P+WJQ:?$G9=])3]<T.
M$:! 1\G/67M6CJ,R\6,VP^'HV!V*\50WGR5:SV3%#BT8QZ$_QSO<MU(RV%I$
M'.S&965!9I>2"(XAA[,YXAB>\SMZIBVP+Y)@ L6B#W/EL <Z^?)+CD>UB%S^
M?46BW<[4=Q8R8)7+P0SEETU6MD( X7/G VG4BTB3(-4H]N!,^3#P_F@":48'
MYEW"L^)8[!<@4K/&RLO1S,@C2$ 8!9H]/]_@K+SC*<*G#/@\@,\AQ1#E>3DJ
M6)*\UVNRH)45L :'0\4F724[_=.RN$1>,%%'&)C05>-N?5D1YP;'>B@,..@\
MNJB]BU:$44ZX;7SRBJO$-;D!(KQ8L*"7AF4J5;7L>$=!Y=1A,UMN :)7!(+'
M8VU="WH(G+'8CLZ Z+6P"Y,8>T&P[%M$2[*UN7$4&[V++W=/$/W==O,#O9D
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M_*<XFZRL2$R"3@"4$\,JKP$["/1:?:+H.(C6H3/N+..SJ&UFJGH]N.>B[/-
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MBNM\7<A T=2'=1-FY47U -Q3^GI,+>4) R58Q4M7S/K[)GJ-0G;/M,@INL7
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M^ZQY-<FK_RPRQ$_QI;1E58YG8Z^9;9!:J(K3E,38%IDN&RWJ[U2P&4C?,3$
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M+-;_$,Q==HJQ1^AYC"P:HG-*K%<W^VI(K%-NYE3ROE?T$E>];Q\M]!$Q#+H
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MFL>K]J1X%KFV5E3DPT<D6FH$ S\;6/B4O!(B"N5(@^$V.7_@A!M\6,Z*VZY
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MBK%6M*@8R-PR'F6QHHA>W$)3VFTINY,C:T/^I]DS6(0+)<TB0[?Y\,9#"YU
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M',D*9=H+@2J]/<(8+".JZ* UB3/<W=/X$?0A)-P'0<?:< 9]8&; S: KUB4
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ML_#Y)%3 ,_;OR*U(0!N#M5/1;340OE8"1+,RS?68XZ1HJ\R=G71G9R?J1F@
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MD^ML. .VS4R>"+D8+5.A,&,7NH<SZJL4T_#%#H9,*I"??HYUY4IQ)\C+7FI
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M,6?#]J7_4=)&O>H?<12,7<F07>TPW?6 !ACBK0##HU6[G0?F7-AS[A;>-DW
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MW(7.JM)2N+EGNN#&<@H6!7?8H[[P$1:]VHS0QF)8L62@J":E"HM3058 :V/
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M;M%8>O7C\VZG=F\\0O$^.$ Q(,865MG9XI\.TWKJEV2QWL5"W,T&Z?IJN>8
M[MT(WG% <K&9_'+FTC^?1'68QU \0W5[3D)$3#N(^IR:O>LL1RP=)A#"2Y^E
M+=OG[6U3)Q2,FDB"2X7_<7LM/]]M&'%/QE*O6@?9/W.V?Q$E.X<W&1ISN+74
M($G:NH(I;SZ;H [O_=>YEW0[0'V<9>R:Y6XB#TSM%J0]G^:PF_A),K+Y988D
M*;X5@NGB-F^>OG0Q&_^DI9M'YIE@O^2'>3Z4H3S-A]<%!1WWOBCA#,D<W/<
MC.8M(-_B#62W3<R%/8G0B^5/B0JODZ.CS:.];[N=5K.POCS/U#^( .+1A)^$
MV?N>HK&UN;7W;7M8;/E3;=.),W"=#YE.#C$%3_\]'P/Z/"RTPL9MNY/HVWR$
MB8&<$*!-=A'M7?JE\/25IGGC&=O^O+ 9?.%GT,ME9C6.RR=YM:S+3_\QUA&,
MP(MC;:5B]:M/+".X.J?S::VU''A#6 K+K'8^@&<,W$RFN15$ _LDIKIEG6F8
M)GJ#8ILWNX3A2G^A@_N#5$3I[)VG+K(OTTMV"8?$,,8V5\Z'D/$U KP,PF$+
M30L%/B]6L?"<9T%6&. (8&14.2XK+$3;V%D^9HH($>="JX:U;LXUC%1,\W1@
M_%Y#+7'P'5OY8@.Y5#FI56:FA&T8%A$Q.@HJ^#H.R:.4-'#,BD.=*[H^UBWA
MWS(&H+]9F;O9[3QC%7PP)U@5;R]->-QIO(0A"X[NOF5.PBI;$4>81^LO:!QH
MG#3TV]40NVOS2'KX,%<7=TT1&(0#S=I YM$7Q(5_XJL4$UW4>N_5 !@?YE=@
M+/>O*T:HTE2"OL;'H?2*WY;-Y173,"G(QR(8@[(ERX):*>G=1 $@&E86,1J3
M(S_J[*;Q%@2J^I"5FHR(6(H0]!U?AAHE"N\:( YCV>&)"-YPYFJ5QN58"?\A
MC!9F5@-122\FY->;>9(\:Q/).K A!CB(UYQ!8X<H(XUY!787F?, 8;3O(8:1
MIY7;8+Z#JK:4JASOO8=&)"_%M4/H.$W"F(T- ..F$&'0_0PK'06]$ 7/[BK6
MP[E)[&>3 HM;SF?XS>))UL1JQO;)$;$+-J[, 9ZL$:G&:!-VTVR"TF[9^,(B
M<&X3^$-3*]Y%E0WGFGQR_=CK57(#V?%7+A!H3P2.)*[DF6J1&O].6!]8,9/L
M"MW!9XY!7BR"Z^)"*U)E74>HQ; 5"A*.Q6.QTL_C=V-T_:@/1O6!3C,Q1&Z5
M+-JJ/:T9@;.ANB!A1%CH\A4:)N=W:69LWOI.IBAT[A5M!Z%D18H1%F+BB%]D
MH9D+@^+E%# EN,@CSHL5<4I^R(JAP7NY(5P!&_*4?<I&72>E[E!%4W?92]"+
MW#3<%D'Q:DF>$UG7CX"HDS+6,HDFN^)#V(5IJ[SX-RQ='-W0:94FA ;3[!8<
MKZ!N]5Q"@%E.,]_'H"_:1'5N?\IF$<.@LU(2>[+CSU39P'RCFG[0*-DRG>*$
MM5_WRT5]>ZA9>R&\CP-0>&/-TJJ)0C]3;9CK9G8S^:F\S:G!&BNC9X5NQ-K2
M- ]%^7<V'82LH7/1<FN7HH1(J [O4^]9/?RTIH)LYYFB=RQDEBP8ES(,V7)<
M$IV"*CX65'5#TWS09*^8:W#Q5P ;AM"ZX$]]K=IMA6)IFEI'<ZFI2Q+_?);@
M,$02B/;*;8F=.6 I<Q'#/)+7)^=VJ=-&VM[;D3S@H3@0I@7,MP V2'V%.M3T
M8Y>&+]NEH67._->P=8,(Q&M=Y8-T^W [[>T?:'V[6=67I>,!P:*+PU-N5'VH
M*.W>@ZBB'.?66IYM?+/;2)VH/P:Q*5WMM;LX']2O-;/,7WH%KO$K46$(4YSV
M9R5BJ;U]1DX/G-]2&$P%5(N,LV[O?45M NY9A7CFC]+M@^WT:'OKGIG/ ( I
M,DSVJ/A59TJY&65C9L,[1H/<$9XIZ22Y)IF.&NA,(LB-<VLZU?Y/T2HA7E6.
M2O(,\C\KT%<-VIX.YWJ*A*]* U?2/=-?'L2#QX_KF\:V8U84W,?A[XC>RU^9
M>+YFU863&K%DU5%A<8:XP<I[5LST/\P(53!EW[<0E/G!V1B$YR6!&\P3]/;K
MDN.#] <4GL//WX_A^V0I-\9OE:R',6\$^>MMI4>]G?1H:X="=_:/L_-G+Y/C
M5T^3E\_.?SI]FOQP^D9.CN>O?DR.DQ]>')_]E#S[Y?CUZ9OC<_GA_#0Y>_;Z
M6/[C6?+D^?G/+Y^]XKT__>/IF].3XS=/3E\E)Z>OGCY[=89+W*+\D%],YT@S
M'*4&X(K7Q<%Z#_'CSE%M$GY/6[NN5']^V,K4%F;W(-W=VX\6YHS+<?[3L^39
M_SE_<WQR_EPF^/0'/_<_O#E]F9P^?Y&<<05ESM\\/W[AYUW.<-L/^S;QRO)"
M%,@X@.JH37<.[>-_+TKUM16OA17 "8ZCO10CN;?_7>] EJ2W16F3_]S;VTU[
M>X=I'>-*X^<XLGI>E9O+_O;=SV< S7^WM7NX=WB0N@ -1Z%TO37[Z>]OOWO]
M'1"5WVUM;?5ZO3I#E%:,.K2,P8>(WE1J%Y;[&",M@SF![]%K<ZO@'(&& <<I
M.HX6EW.+$<JI,02H,.<I#'_[\[=O664LR]<)G-E[!,Y\!N!,[Q$X\[O9.L^H
M'_-\A9)SQ[Z$86 8%U94RT$"CWPFUGFH#UT\@>/-M[-E)V^W RJA#0#8$P?0
MU)XZN9N_E-D0*T6U M*39Z=I<O+#J8%U0\N;;( @,XMA2:HX=C1H<?6Z_*L"
MN\)P4\[8<>Z:AR,JY5[*:)@OH\HMXS[,+IAFMTA\%"W+J'>4M!?%]HBJTU$*
MQ.4.6C!&<*_6RYAD=.^0:9M,2#/!4'N]L:R%&ZL0;_2]7(TLNC;T2GZJ+DF5
MOVI1M4__,:]]&F)U]JZ%ZNI%>4=)UK=J%>:."1Q7[$VW$U WGM';&"T>0FB1
M+.&S"#"4Q>$<M P'G)V+["F.91S[X'VL+4JP4'CV\Q5)[+R-"6)9H8O:U/Z<
M&J@$!:)H@0FX*HIQ\B+GD@*$E28OLBKY)6?T2S%*:?)3*8]%EL9F%[/_?'I3
MC&4Q3^3-<NZ/BZS.6<-%Y(N1^)_FU_(,3=PMO(#/<^_H=J*74".R0$G;NI'5
M8ZCL;X0VA99DY\U6W)5G&7%I<[D<=<N!4)&< +6D:)X[GGY")B! UH=.)TM!
M%OYK0.;AX2B6MEX]Y/\+0A;8(#I?,=*,'PC@*13"ZID9-.-.IH>X&-0:UW<[
MBN'0U*4OKXE+>K0M?2@\#P $(V]&[BLF< XOP=[QOC00-?.9*\HOHY39^"[@
MBA+(^)6A4;(9&_Q8"&!%M-GC6Q[?\OB6Q[<\ON7Q+8]O>7S+XUO^"&]Y4&IA
M_[$#\9?(-6Q_Q;F&WV,'XD^ZH_Q*7UCJNQC\]Y^R_[>S=8A-QDC[R^-7QS\^
M>_GLU?DG=.ZC<7R" (86[T8-?+EY02UGI2V+W4 0W]$$ '#?W4XS1&:M[&,>
M"!](_WBN]=>((M2MTP(D;"C6B[IBY=I"6>C*UE 7]^$.[W_J4BDZOOI,+WI=
M*MW.6K7N7_@0-(J^IPUC]3^>\?_%6)67V6QV+8OWJNC+Z[(/^*JV4>\>/N !
M?SVY+O++Y)F7^U.5^V3MM:<B7/A1.?V>VK[Y"'-AN*,PJG-YP%0$>5B!X>@_
MFX;MAT_##THU(]_<,@V+/VJO1??[<;\/DBMH'C=/GT9,GDXWDZ?@F!DF/V75
M=3'Z#V=HYP,$Y:Q?D)BIZ+N/_!3+?RRSG4^GV?0_W0,'6P_YM(\HR??LZB?9
M\-U_^#G[O4_X.;7]QY:&9[/L"L'^SZ"&EHSYXV'!/KJ%I2B.IFK\N*F1ST@X
MUSA[$GS'/\L"U9FNQ#^K$BH!%/ VCPLV\K[."C&OQ@X%\J3,IDQI;&_U>IO0
ME,KRA<<Z++[G!7@I2LV]NU]N7&)3R;N?YO)$4;I*^BG/ZAT='8%%8( ?9JSX
M\+1G-4)/SVO %$_$U=C;;F-P[.T12.*Z>1(S ?0*<T-L"@JX1A4^4K^X=GBR
MX2ZG(U @UK\,#P*BH[(N LC?C)J/21I/Z>=S;E=9T\%W%]]ER9L<%=G]+'GK
MFA22BM@AFKL=I9&.7VQ+^4:N98L[QT)1E9<SY#-K4^=*U1JM=1LI>ZV^2VN3
M$J_\9K?3,H(@&'*MV_7,Z;_*IOW_DYR56LI:^2$ZKCG.!Z ^:+<WG5^A+)L=
M&&I=O:PXU(A#>T>.2I23<KA4SC397(FE#R\V+)-<TB[6\A^O"6PB2X=FSC/2
MFXHP7A8SZ[Z-/IG7!=JS &5@$]KME TR(-QODJH,/1AL FMB:&AI(*7KH^=P
M=:#VN/9Y/<G&XVQRG<DWO/G5S^ID?C$L^HYA_LYQETZS0>[K_D_/3Y*7KJ-F
M_&K/3HX=\B3K7\L"<7F.IR#JS(%J4GSP$WCYV2CYA\SS5?+SN"#YS^S.L, O
MGQSSNF[G=3Z1N1R@;TVX:O.!33SCL<F(R']P:3R[G")72-@R0Q>9B;A\"VK0
MT ->]CZJB(?YX,I7=7A<0[5TO^*;+G(M'9>[,#GF78O2S<?DO W +D_!PERQ
M%25EVF,^%N<T0 SB36JI9N5=2<"[PO?_O'FVZ0O3=8M6T4M7)!]\&M%;:1T!
M]+<NDU+58W?.\KY.YQ,4HEZ[E7R*9H SQVW_-SPS%.^(\ '/QYVI1.3R,-&^
M,M_%3*ESLK&O6@:$)+_.AI?N]A^ +Z%W! UU',$-"6UQY?0/5.L*@HFE&PS,
M5SB*#(N0W!2EP_FY(6A9,(>2<ASZF).R&N4SMD*>4= =0M#UY!G%9$TIT(SY
MT'%G#O 5Q<7<4UP/YJ! Y7P,"N7KJN83:\=A[:M8V S.#3EFYN@FD@%;*:]1
M^?WG?&SKXZ9E<098?# ?#[-;[2D9QB$#FX\)$+MA(ZU;'@J.GS4:GK*W5A<B
M X-EHSTFB%3^#8;O/K076+M;QDJ2-"4N*\.)F[!,J'?@/IN/2NQ)CC.A"I]'
MU1BJUUN_0V&>'_HA+>^/FQ@96$6CI_^?O2_M:AM9&_S..?P'3=[T#)D17._@
M[KXYQVP=TFP-).GN+SFR+6-U9,DMR8#SZ^=9JDHE6?("-AC'[\R]-X!=RU//
MOL;GP;+MP$:ZT?)@30.D6 ^HPZ3^S2-M:+I8L4/Y5 G$@:V0.D2NE$(B8D$1
M+BIGMG"%29N:6:7:#XQ9E<&BEA6M.'JJHEB()N,>Y#+P7'I$)^1^<[)9S_%A
M@R=7C-PX36Y.*'<@6>+YR'ZXI34N(F:_@, 0S6<!B_NV2 MR0 +8E+JKVE6P
M%):$K[7V52]Q3].&0S^Q+2DZ6$Q##5QZ(G=8=IT%/2O!3KCO>#Q7 U?(F0_"
MNOD>=Y\+X7J&"^]L4]]N!9:52V=+.I>:[XV4G4-)AB@B*.]<S#R+Y?ZH'XC!
M6(F52*4^QMGK>=]EA?,:GT?VDB\(98L.2%WUC8/+!G;9]PF=L-P549FZ3N(,
M$#"O\ R-0=MA)> H'F9PY83?$#ZBB4.$^;L^DH9Q>GII;'VZ;KP3A$JEMY'Q
M!0APT/M_^X%_#P"^/-@Q/MAR6R1.4!E=A\B-2V<9Q[!AA,^=6#SL'E\PFE@!
M+!H\83]W:F-Q9WL#>^335?EA?<0W9?6W>>XY)N+)XEH?Y 10+I(9:M(=!5&4
M($XDC =!<#3%70Z6D?HSP[5IW\+F>#$Y@N!T_Q2UAHY-[ )6)%W"C4@:$KUP
M5C%W?.;Y"Z <W,J!,U;<E=T4ZH(K]&PUZ=X4G1[9\&L14L17\"52R/>B"7(.
MLW;M[%@'X1 D4<%U(J&P@Z(SJM\R4T2F0>,9_-BVG'Q?;4O;"JA3DQB_H_J1
M'K*RC^C'_D^X"K8EDKQ64_EARQ,<Y^<[X;;Q*6A:GH7&%:C50*)";BMK(F.#
M(V%12<SC)HGX%]GH3N^$R69%GOVQ(GKP*NTR5;1_=QWM?XEH?WD=[7^-%-7,
MBA6-*CRQ8W<TO".4&S!M<"E>@Y2<3)>&$+LXES3DCIF>'[;X;X&88&+&(X+B
MQICAT,.2#0?+^4!)QAH_Z0U!\R,N8$?)ZOEWEFH>&;M*4*7&8G,LR_/L ?6J
M)=DO"P"I=9YM\<2@^*9V!],#N,Y=@<1C%9IL9+L=CW6 TZ0 D?3I'I-#,3!3
MCN*C"W+%75\#;>'0' 1#8HX5_$G-L&*=$%7*'?H*J8 (RAA>$IBL>60Y;\G0
MX\Z5X<BH*L"L06CC^$HYQ!9@E]R!!_4]D.EJB$-BKTR@NVU0V]JN+<Y+W^L(
M^]CBKH0^=Y]L!:);CRDF!;M8?,5#;M&*CE0+S;9CF:)[:1\,OHYZ;:K4ZG/K
M2OJ8;#NJCHT7]LDKK YO<B]#,)!LK?NJR:-=0+_H$:X$=B>>[R+]<%I-I9J?
M?:8].!A0X7@UY4R!\%I@_I$'I&K;[(8FS>@*2"<$U$(_E>\."8<!$T^$"FN;
M4L6Y[!ZRLG^%%K6F3,D&B,BT$+5&=\5;(;)INR\P964NX32EM<XYBK:H?*/1
MN!ENL'T-B" H9C1 **AF>5\B3YA,Y8G'G!PM>-^$(XT*&TOE7$G_./  S02F
M3DG2#!9K&3A@-XCY[+DE2KHESB 17-F1!?SB?X--\4O"$TR.$N"5D;%_>&&
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MT5#81Q4I]N*5JF*6LD5NIGB$N]&TO&_HT\*NG*A["M:HC0>EN*GCQ[]!7Z=
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MN,G(N [$[,&3JF^G-/)&3.O-#:D+$7(IOZM4>YT>QW!MJ4B)T&M<!Q;[QGB
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M[HB<-A'3"'P0[H"H,I;&,V+8=13[V B.7<N[Y<H0#K'I'\!5I;S/%@+*D\0
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MFY//1\;!Q=GET?EUX^;DXGR!*9#:F9ZUG/AZT.MAMG,B*_<&L>M5JD'HU.H
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MY.V-GN,-@'"==Q1L&WAP9I=RQVZ1L+:L=IL4R/1?73\,W_%8;1[LS'X\(*&
MLMQ,6!+6I,*,S8W1[A<4!O1"F]$;/BL_;/A]D62&/:"YSQ 63@.9A>H.C3;B
M"?PU=9GV()#-O4$G0RX3D.M-C*.)LA^,@XC8C0A@05%6]79.PLG7"M)MBN3T
M0'BYMT7MM>*O\PEYI'W\H)L;XJAXI!N<)R-KQ&)<'_3Q*&]K IUQW!8-Y8J
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M+] K?>;W(?GMX$6:@X@USX1! -LCG^E9XH^@Z+TM,CF#:$)=[PR;_)$,BKK
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M2UKK4)' !B:FA8X&F9,481D ?]&S;_W(L7AJGM/"W*E&)J#QN^AJX1+MN-1
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MX9M"9%8TL(M/K#SHK'X-L"3 M"QMJNP#OFJ00K8&5!)0Z7[Y49=R I+L3Q1
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M&5N?E$/_$3D(36#)MX$_\-K(,_W@9YKF;H_)1T@PTHDSY*2)EK-/QGPYF=:
M3'9: W:"XW^4=Z>8M'RA2GW_*\:F"K5RX>OWCG=V>7%\\N?I'V^R5LH^R+1[
MSNO >WC@8K%4!KPZO#G^].GOH\+':.X'5K&6\0^=\9Y$:_<VRAG\E-O..\#X
M#\;K OX@+?[W3>E-[E>S44;&'V?;^5F/J/NN9CSF%"-#%O!(OQC3YR%E@&62
MBC@EV)!HTT?-.%?&>J_OHL5Y7%1'%L5,"H=?[4&X?6M9_>WM1AC:4=AH8A58
M*_KJ['_]_N?E/]_^V:]XQU;[S<PH1K=IVRV?XRX_<^VAZWCVQ,LS.VI<7Y.J
M\#B2G(X,,YGM;!2LR>,95YAI\[ESGI0/]HDGS\:OZ@A^'7#[R1C-"D5 -/?R
M[M;ZZ#6]PB1$R](L@MOF5JF\9XK_O,M#QL3AQ4&P6SH<Z^?YB.F,SV487,^E
M-,SW--DO7-)>&&,U#:^-_X,1N#O+16=_(SJP@F (#(N<!_#BI9.O/>O@N]O>
M^_K]\K3_^^^_G[?O3JQ'O/PL.J708FNUG[)PF>),JH.#'1\_Q[ N_32>[TB=
M.7.SMSF+%G.L]5^=AY\]WSL.Y 0<JP=?$G#_>2JPOZ&Z8UCZ"H,VC?"B@R)T
MNU#;+H/%PA6R_WWC/$0_>X->VX^ <3L]RWUCB'^$9-D,/(<7^'1]^.9]Q:P7
M]LQRN?+K?Y('S/-&9$-CK -E)>!<W"Z6MLO%Q\*Y:);J97.WMCL_.&<3<_VK
MS9.4\FE9-!UOW_B?K<!!<_A$C-8X\B(G&J;(N^WO=OX\KI[<-UN+8>R3K,<)
MU(T3J\6-,'IY)^ZDYH7@, FXU:+Y<3;B?3[Y_'LNUDUZB$40?*E>,TO5R6CX
M4F+MN<#X5'JNU\UZM?1$,&:3<$77N#B7,*3@/%S^U+>\\(JF,^!%S^U(*$%,
MM/U"OQ!3[EWE]/C;L/+'7K^V8,&<H?F+@QOQ84V#VEI;KNO?8R(>98K$/DB\
M?+UPK%]>?O+8#P[]03/J#%RY;KSL5T?<N^U];<6>H/)5O^(Y%;]9*+\Q  WP
MZ.I0@?IV?)Q)LF.ZTTQ-L]NAW4*$NP<C,[2]L=@&A[(S4(W<F\03WZ;!6)P=
MC"WEE")H?M^W>[<WYYW"QX\O#K\G$FNY;!8*A3P FK(!CW-GNR\D)A2,IB7W
M18B&O4KUE8F%^8#MB=CU=+!EBP&=A/<'H>,!\SR(9Q_#]?Q;S_ENMT\P#]WI
MD.03'J 6SS% 4,331AHT5*PMS7?ZY!FUCL=OQMVY4OI?.;C^Y_(Z/"C^7G])
M_2\^J=8:ZV71[EE?91$47S3WBGMFH51_I73_\@_P1-Y1 IH T["XMW .<N+A
MI"\_& (S3!%X+;KXIW[^X?#FX_.KB?)8+T[+.GP68G>52CE*R&L@M(G0>;(Y
M-0_HY#JPI4?D$O16QQ^$9T#;[H'OH1\]L**T0S.\W3_]J_/AXFSHOJ3$DZ<U
M>GA<A+H\[PL:X7D@7(QX*M9JYF[AM8FGV0'U9._B? "5ZU)48N0"^S$FPD I
MVBG\>7-_]_'B-'0JSRQ,<H*]=&(1(IHB"ONT=AS3HM(LZTS%H$??92%"K+QK
M5DJ3O5Z9T>UI8?/#/<H3B7^W;):F,$$?\2;9[& _+R",@> ;8 41LP)D"?=_
M__WU^]Y1K_;7W;%]^QCU<F9I6IJ%.=SX)%D3<>35Q<>%\X<]LU:IF]5Z;<TA
MYO4B3V0.5;-8W35WRPMYD:FSUZ81]4N<-K%<I\GFRKMI)0U-MC"B6DUDS"<Q
M/[X[WKO\&'T>WE@+,F]&SW\AVGBK([VL.9L&T&(R*UZON3\5?)[(F>8!G\GV
M"D4$XDC %<^-N;0"X>C6Z:+>^^MF^-<'J_2E,T?39?0&7&@=A]!>]JW'0FA!
M5GVU8.Y6RJ^4.&8'V-.M^WH%>.UBPDQZ]M]E@%.3HN&E:WE1PVMCFD4?.0 [
MC75B^=#NN8W/?JU[YCR7$)&GHXBW+8]F&IX=O2Q&C /;0LSPJKFWNV?6RZ]5
MOLP,L*>&62IFK5XRB\7B0DBHINM>W*3(NSVUK="^0FA<=#Z%'(%*T5"Q_F=X
M7+B-'H+N0@4.G8*R;0:A+:S<;3D@S;N%3^$LZQ=6.<;!;1%$M%LJFM7J:Z6@
MV<'U1!*JU<IFJ;X8^M$B-*=."[LB-FX#V\X6/*VC?G#\=^GPKEU]+L$C#F58
M\E0O*',HMI !I87(&7QQLUYY:IKC4L/HR1'\\F[!W%N0<G804P;FM+HX$FQ@
MN5)^9JAE>S??KX_N+OYJ/:8*9UJ1DN--U8^(X[SHC E:61T/'N%8SILLQ&K"
M',:262U,KM3XP7VK,[_,4\VSLEFKE<Q">7)2_0)C,%\=$7HA-G#ZH?)GY;@^
M*'<?X\I86,REM%.-HR[315O$5V;&0/J>T?8'8*)/55<TXRHSN/<7P0ZJ1;!H
MZF:I-GO@C^[T>(:PJ@_R5'?FKKE;J3PJ$CO5@ZQC+<L3:]&YKYY(ZK7U=K;<
MP391C']9Z/QM[Q[=G?[V&(-_6MOE*07[IR>-_9/3DYN3HVNC<7YH7-]<'/S^
MX>+T\.CJ6DUV^./3R<U?R_A<RW6:R=$)#7FRB^J'CO_[Q]^K'SXUYYF:.WIL
M64GOQ@=:E],_\H'W,LKW+JTAI:%[;?A-,+#;HR\?Y]&=1<'7[Q__^A TK(^?
MK=M_7C('555\]?D&Y'NW^ Z&_=!'$_NQGL,1B3^[.)\>O(M0PL DJX$>5GQV
M)^++0^[)7I-"J6S6]Q9?.95TE,K;#;.)SO<^_'OW[P?_RZ/D\],J(2Z2[GB=
M%9LR0VV9?,YI4"Z$P&H5LUAXK8'B1\#KJ62U!U9(;3%9X W-28_EE< R*!(N
M.$@V0?T='AU_//RK[K46%"6>CK;HP"2Z/,J]$,+LA>F*W=3YL%P$1=5K);-2
M>&UUOH^"U).S+JK%HEFI/+551JX).04US=*KA>CM:K??_-BI?__C]#'T]C0!
M-HG(EK]/RY->8C$!N'(!6=_K#,#-'9I/;0-A5HHUL[R[&/E82"?@GOK>[8T=
M] [M9I1CX_WQY?+;U1_=<L-^.>F8$\O#TV_#B_0 HLW(V+KW@V^HG"IJ#?RA
MY49#C//=!E8O?#<B35<GI)3(B\UXU\744E0?X=S_P6)]CWJ8)[.14G7AY139
MQFRFUTC67"%+0=;2^Z/_]?N?)^7=WR]ZA3!X3-..Z12![*A?NJA*LV-?UAQ[
M'I\0EN%6S'KQM:G8,T+IJ36+9JE2,O>F*$M:8%1LC !=8J?S<ITFFV<=3W;
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MT4HAY[V<EY%=W\:[NVCA2CC5/0=5?](;SF%T/TEB?FZ45VJ!CC1#PYU\(4>
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M@QM.8>E3Y)JAD'NQ=M^6E/-"XZQ^W]]X&"#R8FV3\0&Q.7D8Y$\$71P5[E<
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MMH-DQ./FK%'V0Z]A\(W^W<&NB9B]E^-V5[NKG#>N>*Y6/_ZRCE=.QT0..LI
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MV7X_@*RI9K3[(WC]I6F![QMK=+E^W9R,E<:M9%:<P54GG>HT3 '=4#6X6#K
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MC<N1U>XIMM;H7"!/PK U" *N#$XFI[7NG[/N1'Y\ZFQ'>-SI:=R0T@#@N(+
M#*;#NP;C41]<+Q9?_VH\*%Y8\GA008\X)+.G*C78+K7TRD ;JC]*K4C8/E?8
M4T#M<RBW4< NKI8UF5%+-4/A36%U<4?25&$Z]*<M17<0SCI$+&5W?EW<'6R]
MHU'*KJ.QEI.Z^AE,;]!=Q8,@P3T>FP;"SC9Z3Z-SHR%(8"G6F" $? ^P- IA
M*'T@7GXO_[V_O+A0,QP^9YL'I.*P[7,:WK\[*H^':7D\IQ@J=SP[-H]S3"[0
MU>4]@_I=A#U0L+'TF9J%]DL>Q]0P?L7(?;^J70[N1[(/XZ=P/M[H!RQ)ZHWZ
M F6H+\EM)7)=3BPWY1645Z@.>>_$3<4_*/,Y* ?,9?@F*B8Z+6_]C.[RUOLX
MY>SZ..L]M&\YCD6^(+PU73#<62A/ 9O&$!X=DLL[>;Z\.GV^E"?GZBH@_VVA
M> (N3+*VT&ST]P@_=\M)635E=I9RE&J:=TJS !^*\FKUAAF3CH*0V='*L7>P
M[?"G(&07_J1Z0C=[]L*1@NRK ZJH#P@T0/#!OC'G:!'L&+<46U,A-*$9M@(?
MNH)X@HVP "4(24.^TMIFU\!/(:&/R57EYL89__US^_*XR9 B 1YX%XAQWC8^
MF$7=+2<1;;9E.4VL=B#MTYX%U")),B]D.<(45\9*F96QN#O(+BJ/N0-1R.P.
MMN"<;_8$AV.?JA<E 40'/;(:G? ^!V)S<B\\WYVK ^OT:>V!$K8ZN,,Q NOC
M=+K L*(A56LY'\QH[Y:3B*K+KH,6=P?9C4_'W4%V<W#B[F#+@#%V\R,-P9*P
M-I4Q;G(2:4;;3-[-4F[NG8L;2:GJSSHZ#JH=[.G:U.O-H3 4FJK>G!3^''6.
M?Y_>.LHJ11")Q4+84M'?=!7*-%E.R&P>R >SEKOE)&$%I.RZ37%WL/57!E)F
MKPPBNC_.T:-+VN"W-G:<:G0A\6)Y%8?TW\R(0V;!<9KBL"E^AZ,%_WB$NN;4
M$!@::!>F;3<GSO/-Z/+AXC3W=Y41!V^+-*"E( P :^$^]]%J(L<YBRM-]ITS
MZV*1M"SSG,46,W(&QJ)E[/:_V_^V[#^V/8CL?K4CV33)(B]D=B2;)EGD#=#'
M(=E"E!.  QN%NJ*0Y\MB=+CDPS N I^^A7/)! KG]* G@U)*N>ALXYBLW&I<
MF#P7$V"0F"OSY1C=8Y=C4*CS@:1N/?/:3IH3W;X=#:R3YU%>VF24\\?(T#A9
MP"/81.[SR%#0;AQ-C91CZ4M^)4G&W^-4<X0(%$.8O9I$>?$0J9-US$V[NK!^
M//VY;/]N>..D3O "YLZ26I((\;J;QIHQQ11I1H:IA0K0ZM8P+?F;F26Q&@-G
MA[)MR?[GGK^((6YO/'^+ZG>_/XGM?*5D'FF][3EU*;7@D7BI+/(Y,3KNMB7R
MEM!YV]A,E_3: @&KHT<C[=B\$3:GDI6;+_#EHL#G8S05_5ALW]PLM&F^;W!B
M76R6;PR[OSMNIS?Y3LS!5+7HG@,?ANF9X7DJB6EYY*;G\CNMGBF6KYQZ7T0F
MNLR7RBDYO20VA?X#&T,_H9^'[($#Q>KJZ%N"]Y7A_(^X?\2/X@B;\([:6K]/
M%^?^;@^5-ON=/@N:=!URHH 8&='BB\T7%(1_OM(70;"JKPQM[9!C/WUR@VYO
MO[]GKNFI4&Y.JI,_LGK4J?P>%^>&TQQS.$MZ=^4YF+DJ_CMU3-R7B*?-R<NP
ME+]7?K_\&K9#6SQ!/8G>&;N/+!?HM,F.:3J&Z6CX<:?T%V3S"[G<)^YUT#]$
M7BRBNV8<W%Y_^H:=/=QS:JA9Q+/EE &BA6-S/>49\5'3#,[2D*R#V#UK_3&G
MX&(638665);6Z6MM!_>K13[V 9+R Z>G6\X8_0E:>VAH\5#H:0_[NL-IG8Z&
M'\.=:BUK!%VPQ!R_OX<.BO0%L5?CZK!TD:.75%S#ZBJ&/L&E,'B91XJMVU!8
M<8F.'/+IR5]PX84+DSG=(*<-EY/Z:/+-3W$W+.L*_U*B'U]<W8>ACPI!J6AK
MH#L0&]#.E3:4P2K&&((-L%H;"(Q4"@ZB*T#PCFXH1EM7^OM[-HMQV(DM+?&]
M(H%LN<]L?4OVN<D_,62E_W-PP)WJ6E\]Y"Z5+C(MU]K32#/:T/H0L1+77J'7
M<0<'3*I4_3GNK0A9P0%2%8=< 50U_0?VA0+NO$C4:4P=.E<93BE-7PM'H!6\
M9JZ:#%5EG_R6ASY:EJ,F[\JY?\+E__3 3VI&Y*_<S7B(EEBQE);>_LK5D=$F
MC*B;0/*\_TO_8=^"O\Q[O_Q/*#J8MHA,)?SW/XB=89Q%GMGC04M#6@8M:(@E
M(QXW9S6,'S4-@V_T[PYV3<0LBR<]G*OH3-W5[BKGC2N>J]6/OR1Z9.>\<K6V
MH42CX.^"V52:@E#\Q/J!'C?JU9/Z]4EU?P_]>-VXJ%4K-R=5[OH&_>?G2?V&
M:YQRQY7K[]SI1>/^FNR2)E>D3=\4M.LR[XJGG!BPD06I*8I2<W*K7^6O'LSS
MW"6TH!@-T/O'^"/H[#.[QAUP+N&Y.'3G/M^Z-XHK@,IXJC-)4!F"ZABUD\ST
M=:^<RU6X+)'<:Q,)7YM,*N:X^E"J')]?=4.19OB:UI.E[*V]T@RY\ID<EZHG
MEW\EZ4GO)[YVZAI%L=K'T3FO"70?;B$O<XZ;C.0$M,;_?2I\FOO5.?!1?^5^
MHH_V;.[$4#5UN14$$A22WJN7"1"=E1)"@"@,%9- +/4@5B+'ME%+2II:H!N2
MH-0V;%1,6B2\\H)\L+S@6+%[EY8)U1/JT?C6UM2:T4!>-W)3C6X%O&(\GZG2
MLAT(\33UH^9$SO_\>36Z/ZUVTJQ/#*C QN7)5>6F5C_C*L<WM;O:3>WD^C#M
MFI--V)9D5Q-=CQJL,-&1(1LHQY,+R6Q.2KGSR]KK[>])-\EJ$PI;"H5_PORW
M8W]@P= <#DI-YOA-TC]SCF;P8V+HBV8BN.S3<YRQ-V<&2B0ST#')SXGD!N;Y
M<E[F2^7H6Y2%M)BY.=E* F\R]3(.>://HJ\?#\3RD6:N(:_#OC&AL8[1UOM:
M@ HWYBK*NV6-&QVI6KCPA7!35MZ^?9'H+-T-/N"TI@S]._P&F^9&T'U/-SB3
M;853W+WLE/Z*2M]O]ZO:$#%!QZ'HBJ%6!G"=1,+901/@M$KF0^'A6"MK21<<
M!I;O7Q .J"N^):5-XXC*TOFT2E[/3W4"EY%R%S,\N"M1PB77RD,J\F4QG?;I
MQ=!QCW.;J <.4^UEH#QW\M\O8=+B>C0OG<UB;[J=>KSA7$OUT$WPG)7R6]LU
M9U7J;44'XB.?R?+: ^'-(H5RKUB6@B"%;ZL-Z[BOZ -R[E3!.WIWC\BQJ-7&
MC1_=5.U8X+QEYIPQC;P4#5<[=!/-,E6$X1;*C%OKN57G+3DJ)M>  MD"08C.
ME7VCI3M3=*-A5'5[:-HXF:'1J=BVYL QJT/'JH%-SYE]^N?EYO3'.%=8Y9RM
M9.)@<1QBDHJ7I_3Q7&)87=I2,L=AQ6IY'L72MF02GUNI(VIF&M 4WMC;,-K)
M_JE8CQJ^(;Q& FYAI_+6L#3TR(FF N-8)"PHVG>3\D3N'EE7-[E438BW%JX+
MHDV:K<!E*%TV,B9LW9M5A/$HN;9@6$Z4>;%4SJQ5B0APO8&:B=D3F2_*.5XJ
M1N?I+AGE.O$C.:,-)01:52/_K1E56I!)0ELWRJOFGC_!.X!E];7R5#XJWSRD
M.71V*BQ!FQRR(!4L;</H(P[U$L5N<X[;EH.XE<F8?)BY*(J\4$S'A9JI63V:
M;N4>C%%8$[-X_,L>(1%)U<IAZ'RP_CDK,0I<9RB4-F@3>3DG\$5A6P-]2U M
MX>;_J]BIZ#-366BLW/L56O#H7:Z@<S3):X]EX56J_CU*LZE%,.;04XRN9D]=
MF("W8>-0>E]76GI_=WGR1F=X@4A4VFU<FW"EM37]&2!<"'SY(8V/Q*/GX]*=
MGJ!F#38T@8S"L!M(MD"X>J,KS)KYG:7A#L2D1L7D,4R!SXOI:./CA4>O9CQK
MAF-"8Y>0,S>Z.WKH-[I=>9S27??L\?OTC2UIO&&'<B&QTL8T*]\*I!^)2IAH
M$6=I$_HHQFW*+*QQ>IKEY8Y@^# ;!!/N.[7^I=PWU%6F-+[-B.$54F"3N:,5
M1K[4_89"CA>+T26X6W#(8I,OA20OF2\)JQ Q^L3EHD\<,]B7RABL->1)M-O6
M2%,O/-0>]-"5L_O2I?+SYKJU2AQZ)9NV$%(.R<I)U@Y9.Z>]@AN8?JALM6,:
MA^9KBUK+@LSG\M%=CC9PB-=,W>2/=DZ4^&)AE42@A<%L.<H9A-VR]@L>$J^'
M79C^>"G>6^KC^=U*J?1O]@KQ:74'!0*+<87W^MS$I65L$7E3-[@2GRNL<MN>
MO:.Z-!F3B]SQN5+B]TM13B+9)55)]"!Z)O5"^'-U6O@A_S4+FS.I<VJ/YA]2
M:GBG*;=-[9:7]\6F&9GZD1=S?#FW?*_)=]OG/"66)7>%7<XC)1V=!; "PZ)O
MV.+7TX$"NFD.'**!0!.)=^?-R>11[NH7O>OZR?PF/F^_?INC:NIQZB^V67:C
M2XQB<F]MWH&$?-,27RQ'7PWNNO._E7_)^Q\2+^1EOB MWR4M?NO^).%*AJ_E
MLK6:N4/CHRP!!)/M!<5YWX]>QG;NV%+5=),,:_6[D^M=.74R?/?/QT ,;VN:
M:H-..3;[T(4.9_]" [FI^V%6H%"1JLW)Z?CUO#A^U']T4TINBQ<28,OG.FC]
M:P\&+%;O,4F;MD>0QT776WIC_!8:KG;1M;[[+7\, 'D;N-SXQJRTGT:ZA1P1
M1S&Z.@0DZ=66&X?#Y\^Y>I'5LUS^05ZE-N]M<3BZ6/#LVZ;MX#Z20\4A7113
MEI9X:?E%H?"VM/R-1;XB!2%=;U04>%E:)25]8;2KZI7F1.Y/))(N>*)>5<_Z
MIX5>\:JWBH^9G*D96>V>8FNX7@?]O=TST!NZ8ZZOM^'R:#.*$E?O1!-UEYNT
MN/YI10HF5QCWQO23\'-7F /TKI6^UNB@?U%'N(TP-3%^?/=B&T>-$^OZSTJU
MWV^T+P%0YZ^3TQ!OAL"H[*"2<%JF#>H*6UC__4;J91W.G2R"<VB'0W1ZQI=]
MQ7 JAGK"!'D:UY4+US^[FM*Z+O779^Q"8VI^>S=S[MYA-"X^S]*OKQ"E<JS\
MU%T0]:UL2PXY\[*<0XQ+.O*]<E/$D-!=4R=7.*!IW"L<^[3]^_Q.J1AR/@-7
M.#I;]8>^P@GAW=JN<$1>*!3Y?&'Y078?4/N\D7]IM "42[E8"7J[*YQW$,H_
MCK8#IV3:R=PK'.OY]$07^Z-&*<FNJ;.;.:W5*_7CW15.(GSWEWQ>:4.*@1J=
M"]/HWFC6H*JUG&!]T5GW9W,R.NK9CB)*1Z_EC8;26 "YP_71@@\<M&*DW5H;
M=NOG$7(7/(NT@TN1+KE>;GQ13CPULSHG:(:OG&A6&$;/^$2=GUTI9^>Z_-I;
M)14SR3A9WU0,4D =FFZY^5B/GX#IN]#E E)2*R4_9RU&%DFWQ,Y3@2\4"GQ)
M3*=!FS3G8'G]Z7S-(5DP&A^RX6-'&9U4S)]W&4HVL)4^CHVU?2T4LR,TH41-
M/RHMK7R1D;53%Y^ 60],E^=@Q8!!\\+0^,2UY>MS_5ZW?WQ/LJW.TNAPK99L
M"8BS3E,F%8N\&&,2\8+ RS90+,EZG>1+Z*JAESL_=<.T=&>,&PK1P<?^] 5\
ME$['PYYY_N?6NEZECTJZQ3I5W28#F7&?;1AI$!C)[!;QO.,(WF)NIMYV(B?S
MI1@](#]"J#5Q/FVDTT5B=3JEE4)[[(H'5(][Q2-UK"/M:2)7GGL;O.(9TM5S
MK3$;P?QNKGE6NB4(85_:^J;(YTM%7DJNPN.]%PB^D75)NN9Y]'\QL7N=>0IH
M=[F3F2"_OU(3A!#^#]D,STI?PSW3 +RU'4V%/U0,-?@/OD]>:I9NJM.UKB>O
M[?X(1 7]@%LR7BF.=M+I:' Q1*P(MA[6WS^%[A\K-[Y.<Q;% NNATX5SGU6Z
M]'\A50 ;%8AWXA\T;[OO5QNM5PI2![]\413X4C$5G;9C?RKL3[!UNR26^+R<
M6+[4<I>F;R)E4[]N3JK]JZ?3IXO;DKQ*:[D5.N?.T9!X='NE7B4SW$]^W=;N
M*A<G]9MKGCLZ.:O5ZW#EWCCE+D^N:HWJ[G"$<C0HZQ6[T<$2+DH'LKCZ'52N
M#"HNE=X..P[&X:#P-@[*Y1)?%J*#B8EIJ$)R&NJD.7&N._5CLSL4?J_2379U
MX"9]R4<HIA/TK[%5$GW<TB*-O\>IYJC5UV(-_%WR*1N2Z;>6 _.2D./SY>@[
MWE ^K*Z7=FR<,BYOA$\%L<CGY.4#.;'8N(L(9#(BX&^)?#T:#OL:Q,25/@C<
M:=]\J1E$FF""K3_'\SPO7!E&SKG[D_*4E-O+RXN3GTC)5RZPVC^]:-QSM?II
MX^IGY:;6J.\2/E?DO.";XPOQ2$57JR,+G>L_FF*=FE: W2^/CZ;B5'L-;6U3
M#8]QA!^MBE/QLCBGIW%CM#;0;SNNK\CU4J!-)&M,IZNL(^1DHI^_7I_IHZMN
MDO/.PZ<$!*^"ER3>C)5>V@1/[3_UM L)F5AY[=/YUD.GY.K6"WQ97F6 YW)I
M2[X99W[Q5X7FY.''L5/[??W\*F\T-[#V]H%[2;!^FDSO;RCRVJB4S;2^-^OX
M#-O ;*TF.HFY;AIP]>05^QFJ>R]<<[1!L,ZJ)<B_SBLOU?LS)1U%U4$R?(!_
M/N0,D-1^F**BB^;0P@R;B*,=Z*H$CV$/X(J"@%4>=Z,/-)NK:R_<E3E0#)[\
M \]=:Y;>^?3M<*K+4I88F:W5S W\N?#>1/)DV;C-&5!7LX^.1"1:Q^*E14=^
MXESD&].?+H_18.G\J''SW#Z]_IOD36T\ ^@M&Q)WR<*Y"L\=H?\=B#R^J#T^
M$#EW$QQ>."0=DGV0W]=N%7#[GY5HGGX-BR1L))L^,\1,#*:6^5RAR!=BA/)7
MC,IXA]?=$100:"IRS:\TW-S&-&J&;Z0("]F0D]O)#UXJ8NNZ?K=*$6YB*/;8
M5\O"Z7@#0'%.X2RV"<B\\$WHW)2(+4OF-?1LR>7X<GF5P3B;/:R)4#*Y[/U"
MCB^]6>7-'8K*SFD]D.?.7.8("I"C>MM^_?.C\FLXN"BMW<C6P]/SLWQ45Z)T
M^IE'@I3?0M.:'#&3J\&6DR!DI&$-0@<"*X[%. <6@D0YK6'TK/SM8S>E*==Q
M"T@9]B46EJ)D@,49/L$KD7X7>$J-BLGEE"/ DD_GY!XOAL2LMV"C<T&:YWI'
MU3DM7%T5'TK#'ZNT*'FK#QL.?^$N:QAH__NVGK\I8+99BNY.8')D2P[>)@([
MYI8+>%?$0]U!7Y]X$_,:!O++;<=B6@;7NML4T^:/'[0+01L/ZYMU/[UE!^;'
MM7TK!Y,X)&O?D!C%IFWJ5Y3Y J+W6Z?8;QG]$CN*)4GBBRD=1<D[BE4="L<,
M%:Z::@:-ATU%PESC]WA5$@7]LEP;)=F++=[A8PLE61SHE%%T>C0;M-V,X,2A
M9')&KU8_]4D,KC6VM]7RK4RY50];./%R$B^6$TL6^(\#O230S_M[_QT&+Z^B
M;ZR^<@/%ZNKH#?!1(7@>$!! >@E1M.6^N85>/$SS7=>:!M/(S<%0,<80VR&M
M3QP3&S](J%<<0*/D?E'I[^_9#OJ7 :EW2VAI:6UY"Y_+'O4_!P?<J:[UU4/N
M4NEJ7]'GGT::T=8.N9+XE;M3^B/TH\@='+!SK.K/"S.1?142Y*4'CCD\Y J@
ME>D_L"\4(/'JOUC.D:#T^U218V,&O]M#I<U^#[X2682^,K31TMA/7[D7775Z
M0 WAGZ\<N2Q&1ICE=RU(+D#K"S,8OB-+'RW+_\R[%&6?R/T3+O^G!WY2,R)_
MY6[&0[3$BH5<XO97KHYT&F%$W022%_Q?^@_[%OQEWOOE?T*SOZ<U#-,N__T/
M8F<89RU->3QH:4@;H@4-L63$XZ8KFSZ)\]X_#+[1OSO8-1&S1"3<>V.Z&A09
MH,IYXXKG:O7C+VM0I.B5))T!T)C2%(02G&:<G%!OW)Q<<S<-[N;["7?<J%=/
MZM<G5?CING%1JU9NT"^T2VWE8G_O^@;]"^0R7Z]AV>MB1XBV).:X/AJ@Y[1C
MXR?-;BM#L-;62/LTE6'5L+J*H4]P'OJQ:[X@*1UA$ 0%(&>=S'$[9?;LVK5F
M5=UN]TU[9&DW:!U'?< F<&P8NBX%ZCB3?E5S,BC]&E4O[-]G Z\?_EOL$W2^
MXL0OG">5>!=2H3DI5/2_DC;Z^_NV]>G;D6+K>)2:?]EN6DVBUBU587M CH_>
M&7_ZUC"X4ZUEC11KS(DYG@/IX;D7C=-P>3%",\H44<J"["]P %A*^_M -8TS
MOM(@L4 C$=1A7W>:;7@H0J=RLTE_RC4G?P;W?ZQ?Q^UV7?W$.;H#6_,_[/]3
MAJ;]E2//Y#GZ5)J/@I_KHNG%IT(Z$&7WI]ST*8BQ_D_?Q -D0M"!XBSR-X3K
MX \,)-/W,PT&XF&.+/1_!\$_ \  9V-T/=V)DOL,04MP5R3A:\@.\5_$K_]R
MS[J"XYL='5\IXNAF&P! !T$ AW2XQ(7A"#\XO?T]^&Q=>U94!<E"V](<8"]D
M_,"IXEYZ>KO'O2@V9;+^C&"M@U\ JP/KS'K[.9:BTC?"EOQ)0%\X9-X[U#]0
M^KXMPH.."4C&KECQJ[V_%]CWB][O<RV-A6_12N ^Q1[U'?;]$&I\X2K&..2-
MY(NP2MSR<\ZW\3OW]]!+L3N.WCH: G*'CQN:@J-8+T@0-/)8]#*T1+8^Y'#[
MN>G?"\\-@Q=&)(MJJ%GD09PR0.]S;'#6"84]3V%_SW45.,]3P-_OF*9#O O=
M@.)_]/2>9FGH(3T%L:NE:0;:N&.9N#63UA]SB@J'&GT.;0JM"*9PHA?J-A-:
M2GHLN>0*"VUPB/L-(/8,B3[3U"]I:YPIO9:<8:/Q8^1%B^5+1.+V>(YMR@42
M^<(^CPS,;2LW'/SM/;=:;S4P<^@0P$!X785B<W+]?20,!R]7[4;WT[?CQEVM
M>@"UZ<D;F'C<2<_J_%0LI(1$$9L<@<=GX]ZT^BKW75/Z3H_S@X;]O<]42]Y_
M;[A:4=7:?07.'58XE%9P4#'PAW. 3KO"=?MF"QTP1$%5&^CM+US-X,!'PP$8
MJ@%4I"SA!,+I)DK1AIAV;X0VR/7UCH87B(X)?0C2#' 0<6\TI#ZZ"E:BE@[5
M?O0!\'UX-'V]AD3;'"!+UM>(2D5O5G7;&@U)7T<X],]F'ST(G<\QTQ;TRYZ:
M0-1]U!S[R_[>3Q-IK-LOUU^(ZB!/0,L=HT.$% X."V)=0978$$1<QPK%T; "
M1"M AV#((5U@]\T78F%&%OH/^@>D$!25:6.T4.A#LF[=D-);7%$!BL'V,!61
M APB1FA,)!BK]_= BT/#06QM#0=T+;&;M(*.LO8+=P,JFH./&Q 20A;0PF$!
MI(!!KSL]9&5I@SVN.T(V /Q@Q69OI'(3D&97X ;*>'\/^(GM"^^WF>3P@ T<
M@'EGXM<); -++/*CT>I'!F '!8D8$, >M1[P:TV*(;YP]XCCT&;4X<::PST:
MKFP@BX$(BC:SOT<?[SLL/E*0%5%9!31I:Q:L'#!$:V3KAF8CEID6P4G(".%3
M;N.C210#* 7X(K*)0]-2+!VMVQ[90R*YWE?V]] VSD<O"C)JL)M;1^EQZ@AS
MT25BUT06T,"8QJ+UW_!=GGRZIQ ,,0@\&$X@;/@+>SI\#)E,\\5WWTQ1#GH9
M(D@+D]36$0O04VS3,+0^0FXV8;"E,6P5V# 2&3#->&<V?B\^LSU%]2L6';V&
M:!0_!9G\(GE#<@G*SD#KZ"(LCZ1T3,3M12-@"YAI:/30$SKZ-ZMT%3S7B_+9
M&5E:&"IS=>AZ#NK46Z;A=L+0 5]TZ0/7!?75:2^&$V4/3L1_1G-B.JU^0:A?
MZ;V'1'S8_^HS@ *YK^7.G5K\]>.'^;=$ZT/U >>NC_,MT$49>M*N[#IB]*[0
MH!,5#-*/#&6$K#V2?20B*N0/J'%0^ N<*V0%AQAB@+)$#[6(S@8O"_^.#"V\
M8F@AE*XCVV]S7<U IZH/1J+=UH8.^2ZV,@9>Q#6QUNA$5;#@*AS#-F"&]O?.
M*I5+%^* HM$IT[Q5ZA[3B+,QLJ /OL,,B37J4SQ@:=U1GYYQ>H:10SBR<.(2
M_@1K*89].P05X)EL0=<GQVPE:&''U&A,OUUU S0VK4CJCSVO13?F7([X:;V(
MS-@X U&P9@0/3C-\G 0C,M =\%RX"OXJ8DB?6"!;F\/R\%78/7.$\">XB(!]
MR,H?D+7$6\6+ 0)2:0*7-NJ)#&!86A]_B'ATS'K@RGMBT*H:\KE;"'?)!!"+
MV#)$BF[X59//170)"[SB6CAZ!0_0;;#B;$_(3N#1CDA\Z!?\&T6[,$9H7[&V
M"_88<YYG8F\.=8,6'*$3K73Q9WGL?1*7%7^79\NBT09:VD9D& DL;E>@0[T>
MC^P8)!Y 2(-1LJ/H%C?TA>1<?+($_PG)J5%$;R.FSV.7T[/@_@\@D_[*#9#2
MZMF4?3]&AL;) @F?40#HN.M$V 7(HD*L!JPY71I[OO8Z))$V=S> LYAPP$J8
M=! E2D5$VHP11D97P^T(-;\1E.3CYN2I>]/HR:=Z::*GY#/[;V!\"XE:F%:M
MY_.MZY-<6\O0PHZ:D]']Y.]UZP=2GOVTH@R12UIT>2KM+D\W?'E:_("7I_&/
M4*DYD1YOG.']?5N9=#9PMM-S2=RF9O[[LL5^2* 5]8*O(4UM_+[5JE;Q_/3-
MKL>"Z.:L/R(@?T3MY/[F3%ET5*BU<'$S,HJ!-:?EC6PT\G3CBQET3 @FV%SE
M^I@KB<(!_"_OA87(10X$I6APQN=N %"X0[@"JTV6G\F=H#]B6,_@^UWMQ(7O
M7(5#OT(0"#%$@T_2 (%J8MCN$-!HCSH=B!(B;*CAVS"X&+)T^W%_#RV!H"8-
MX3#;-Q("+]4<.6Y0%5#5J(61^#38&@V'IN60BQH3!QH1VH2'X&C02\]$D)V^
MF P9-RV;PT8%2&9VR-46\EC@%@C1'=&U;=/[,%_-G=]5(M0! CPSDOE*\H <
MY$WDRLNBRW(_0J(H$$)16K9IM3C8 (D\X==2(L,EEX?DD#MD@TQ; %XUP'SL
M6PS\$1;,?A.]4U<!;5N:,[(@0G1*4>%<T+F_1U G J:+/ H"+;'0X2@WDQ9
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M*1HF?P0-$6C%#\;D\M@=]OC%?0OIR0;EA"K^MJ4@&TF?X/O&$>[*@FM6(#V
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M_Z"2R0(N?G??3WU1\%,1!B0=]1& 1@\&??&%JW5<^$6ZVI%NLM@![$";:;?
MBV)\%P>[%Q!X@= $1<422#IU(_^Y#RX"6I$16-'^GG=[ZSZ+QXU=O,U#>PT.
M-\-OFUT##Z_$GA'R(K"'-[(9J,.]!#&1O> W 9;XP7CL@>_!T(L&D7!_#S<+
M0;!RA$<!J"/+18F+>V<@-L1I"(E=,K\C!4@2R0Q,*:#1#/1MA+B'X-[;;&*#
MYUGU%6/* :%=:O#"77;1[B;^9WWA8O1KW]_S-VSG-M*O?7]OJF%[L/MU^OW:
M]_?F-FSGUM2OG?138 W;76?5;.$6W"INP01^60]:N?HWY-5=SO0>QTH 7]R
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M\ * $7MJ+!ODQ[RV\7GL!,HZ$.MU YOUF6$;/C3)A:3.1>UL?^^S!H2F<.6
M#-3TP3*6^X)#GS@*B=!B"Z-(,D6(P@Y\S[O@:Z2=M,+0&UTNW+Z@SSF40\AY
MQ>O'P(\ZI[Y(WW32MR\(&RW?'=\V_>@4VP6>0W9.0_;U48/0 X[1(@W"1S^7
MI<_A'#76?OL%\HU(\%=32?# SV=RZT1MD<JB$4,(EYLC&[ALDP0$=(Y<R]_1
MB%D%$.]?+<<62S0)CKN@52,EA)-P\(?T'O)HB %$9W! 7HZ^E<<)1&U\[<\B
M;9[A#1H%MWTA"2^,#/I -HN/\0AR.TC<B\5B@S%<4,YQXV&A9@EY!_<XV@3X
M!<?!T?^4_MC6Z=OQ663)"0X.KT"PV0C$O=GY>5-TV^O1_?YB'Q45WR*#FW@,
MNBK^'5S$-YN37Z=GI3_JR4OY25WK^(:CYN38'/TZN?RA=VZZG[[Y%LJ=D!RC
M-8]M(.MDO%W/._V[)E9(L=P<*Y5DSI%;(*QP]O=8O)=E5.(_$R-('\,2M&(>
M*CBE&S@TJ3)R?0?S1+$,1'3[4K.N(8-Y\<'T]Y6,^&9SXES>_OG1N!Q??D\K
MD2C\8!XW)Z_7MS=VY>*T\%CZ]*V.[&L-AZ7^<P&0 RV8PRM^EU-5CA2$?CE#
M<V@HCOL,MO1?7XJ\CEW0?GO49QER]JCEX*H,C$C'OB'N;@$27/G@RR[O>FSF
M'62.G:K#2%\W\XX%S@Y8X,P8X:M<N))BV95D=+V_7IF=?8(@>7>J"AM0X<U(
M"&1H^NK'OG!5O8_A0#@MR/=8R0&>!#@8CBA!\!Y82'/V^Y%;X_P["U:US6YR
M?X_B9%],U0NH.A:^81O3'0YPN2])HH?X';VNU2%%'6T7(<LOW*4)7A6YJ"/_
MAM8/0)X.)IRMMB%!25Q%3B<6!GW3PY :$E9-[O\+25@/%#<L[$V-5LF6Z$WB
M/"$Y0RJHM&/,%,SM1F=:XU2P0Q,>)4OJ'4?C\ =,-0TZ]HC@+X5F55VJVIQ(
MLC!N/_?MVX&O$[+OV?Y9I&QYY*#Y%@B<8TOT%!G/$5)$=L5*@MZ?XH4(63.>
MA92)65)6JY_ZBLKP6B#<"A7@<[NJ$I%>V$([,>D37>D3LRI]PQ^EX</@QG@]
M4M^?](FN](EKDSY)*O)B?H'X,:O6"9@H/J O61VBS^(2-3^C5--7HZJQ24WJ
M5M5Z&R?$J5PRTEP#9=@-AW36S3V^?+^_MPOO3YYGM2FMRXU'G;BM1\,%&VU8
M6TZI%M^34EU2$+%R_7MF_VV)3W*CTW]_PCBK7%<7QF65;*%0X N%!47ZX4J6
M^TRFS474$$\5L[G9!L&B+U_E+XXWX.)5EO $!,#3($NRS,NR3'T9Y J1;YLT
MG[!K*0;-$]0&P[XYULBJ%W;DW79TS(X2EH8&H<09(<2-><+(X#](SQWUY,R\
M;3U4>N_O(,W5ZG'H\S:LP@MRF<^7\A\8+"\OC(5S\<^K^O?Y^\E'TNJI"Z-8
MPIIR69W^A;N>IU&/3,52W5)]>F\YZCL*S1.9EFOYPRA93!G",[MA'7MD\<MY
M2;$N<\>GCZUNBF+^$2#C2BR8=+_?YW\7CB:ON?+[4S/+V;P(6KU)[6R'HDV3
M KFY8'IA)^JY(!OG 3,U'!)4]F[F:%D"_@)NQ?*B6!;6SK2\!Y=B^2+C2*F?
MG'+?1XY#1'M!\N0]?50-/\G7Z@SKMNZCW6B</9FO1UXKK?O@RV>54VGVZ0UO
M<=.O^/M8UV7EQW/G5W'V%;Y-+>S4%=S%HF9H*1R"P I\.TUM&27<;B8Q00R1
MO2\<R)RM>9*&A<_7%0-$C@FOKSX1]WNBCN'^GK\_U(SW..T99J2W1*DY>>V.
MVO67FIA_$C/4PJ'<G%0'DY/&=T,ZE7,96EB^.>G_/CL_^W'TJR1V,ME;(K?K
M+;'AWA+E76^)!4>HVIP,;AN]U\[SW<EEZ5WVEKBU-03\:"ZE/948XX_;!3^(
M_*M6;71DFKF[L_Y:\V"0(1A7:M+3I5R7^^U/WVZ)87-7]B[37VYZ@2):V+!7
M?HYKS4D2!.GT!1A&=\:T&H%6_I%"-=PO$1+Q:0.T_AC^K@U]55FW4'BB<M>D
M@AW:/F)I4UBM@>TK92.=+A\U-QL7;>MAI';Q:GB6:CH:#&DQ+DXW]667^ZK_
M3,M?&>9O=A6Z4_SH-FU_S68!V#A%E]680V9L&UP>2)OW4<%=*^LGQF+JOL20
MJV Q#6 S7V$>C&%AO^)\6]YMP$V;3Y F;AC('9 :.EBJ9MBTO1O-O'&45T2R
M_3V2[T)26FAJ$DGP]D$[G&2-,YM5K079V+A\ 9LVV_7M>%+!AUY),WTUW$[?
M3;!QVV3:N.N![6]/M[_GF\#%+_HF27]F1=\8K;(21%IYZ=(%=UG3<!-#J(MZ
M+U5!/;U/!,P5IFEAQQFCF/7[>[1^\M$P7_J:VM7\\D0K88@\LSI_G &.8;H#
MIXN>"E++R</GH',*J4$GC5-][?A4':"\V^O!UOP"/[7(]Y>2?:KH%L:4C<XI
MTQLU+TTLM"3=;^9B?;\YN3^2_IZ.SV^$H_9:K9_0G/PJ]8;5?KOTNR<AU >E
MS7>L1L==,>=;\KLUB%X_X#XN;*YX*OX:?'W%4FWT(147E9"B(E]UG=NRI@0=
M,NB_^\CYD[0 \:Q-5;?!C8:V(&'%>N@Q[)$\SH'TE8+X)QNR=D3H+#J!1D0&
MKHD"M8!;5H(&_\+1)\,11II>MWN@:%B<@%:)LIQ1W\-HGYWA$%E"<CW[JI.:
MP5F[CQ82BA"PK79MOJ^.R/>>@8](_-0B.Q8ZF"^F]8@71SZ)\T/=K_-L7 7Z
M#])-JDM@3FE!6BRN%)SS-E+HHZBT03' %$HJEH)/1J:1!AU>ZY_I6W$/7+ N
M5-#PUE>EQ;0L]%"!1Y/ENB4]WJ+?BVUSZ0C2A1[F8P!M3T4J)DE?4])EG521
M:K@"S*$=O-V"4^A5INBD:2MT20;KI+AG I= P5PG<+NA5,MKI(QDV'F!MO"L
M4E.Q2-L8?"0=VLK:E0G2*0*=&=I("J2<=\4B3)(]'(,;.^O0GY8UDGG5!\BY
M]W^:]%>B'2>&(WJV<=/XX"<APC;SX2\T=,>^2KJZFP#;H'H=@5;SY?!]2- %
M+JP3#[D*5D"DW([.:[8"RA!I!N2EX-)84H0&9'D:F0!YL931 FL,C6F;+=+"
M!/?_P, ^[,'OY"@20DJK$I**&BZW),6,0=(2;\S2_)+MULRRH^N=4ZR.D0H(
M/@2^8*,3T%>8R<,*U+^X&19^#7E&!$?A(4P L%NK&_:H _V3 40_FWT$=DAY
M<P?WF09U$.C)_AEW%@RNX]^ON$C;5+7^ 792T))<G6![9=O^$FO?^?61#=?R
MXO94[#GN; +<.QNA69[<X5N6V3(M6J/"^Y]!M1Q28LI[K/I*]8S(JYZ1$$W-
MP@&>=2 ^,.[[[QT:OU#0;_B,D=OE?*;59/@A>2<:RX_+<<7Q1,/-\7PXRU>T
M0R-4'4UQ6[BWD+8*<,T7Q/"F4'B.3@CH)YDS+L)C(/VT<GWD@GX?Y+7IU\B4
M$JSD?$O\PMW2M^JV^U'>MYTY,!\DI-U'?T0BXL:UH+()O=32T&;<SDJP'V@>
M:#ND(AVW/L"2Z%:CAXA:."R>TU5F87BMI?3QD#X$VYEU]4)+,#C#S=.8VA,R
M!=32,R+0_%3?B8JAYV>L0_@F(%BWW"Z@N0)/PJ:Z.Q6/<(J8Q.D8'A4*KPB,
M!ADMN,QGWZ=-P$@E&&,JZT5 V$(5.>TX%F"TW4-;(%&\ 0@]#2XZ%!KZQ.Z&
MN/[LND1I/W;Q8 *XF3*M0[!,CO;I&]SG0LS14JGM(L<H6,PVNV*V=7]KM);6
M5KQ^O>C?#87$FRP2V,4=OMR1L][Z51(H1LI5';'^E6[0(1.7QZ?-R<59NW)C
MY?0?Y8<,W=$>-R<O0DW]=8.<R:MBAA8&K;AS-=6ZN3F]:*46XGK3Y7%^=WF\
MX<MC4=C='B\X0\7F9/R])CPUJM\=-:T$C&5NC].+ON-<JPL=P305680Y?19@
M#C3+0)O];'-R)3UUKI]^3QX>NNG%U*%>DI.^3.7>E:1*<S*<_/G3UEK*\5,7
MN15L@:XE6TNGD_4-(6"]C (=,<&EQC/:H#N UZUH?X]UYH)I6JRUNJ^G*+YL
M\CHWLYO?D/F7+_!:TI"(M?N"5#4\"8G4,P6'"$YG,0J^NYHK:$-G:"K+6ZUX
M3ZR2!S;U>JVIZJ\7OO3&23YW4;$>O_<&W[W4QL/#W]7?AX<Y$1W;?+[,LB<I
MY:':\$!_/>CI*D*OAQQ:BJ2_MJR^4"I+G[[EQ"_R=%+?0._WR:"WD!122@0R
M,"]D]*V_1 6FG?J3,_$H5:LD_?R3?_Y^*[0#LU2C$H+Q9]Z>_S@S##7/2T*.
MSY?%N>-0@VURZ/Q)Q> 6YB*&Y,B6?:3!N<8DM[2*[Q8N<<<)DH^)#@?^DQU1
MQD#SHL>-%R1)%4.]-OLJ4A)_-.>2SE%4*XY[*QA,C;_$ZVW0Y?JK#VYZPTII
M*&F_"H\N@TBE!UDO1Q;,7=).(&3-/#[29-E1K(RW^>72U\/V\[:J&+X@S,N*
MC2@HARC+C$"XO1JG)I32&[=NUP+E!/G;T!+'/SI[YHSY:S4NZ0>!/D W\"0;
MUK72AY0G''MH#@W9D)OJ8-W2-''.'P:M[TB;G'J2Q-9+]"Y;,<2[8,TX'0JO
M.DJ&HO>]-ODYD)'-1T8(K:XPK5U*\Z6'JEF>W*60@17JB/3\<54+_,):8^,,
MF<% MVW/4)%H@"MDS-/_PEVRASJ^$;#8AI'X#VD N+_GFUE IOOIN.<@&<,
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MUKVVJ#O^1N_IX-CT9&'%!:N-$_WV^:*22O'WJ1A%-L:USTZF[%+1= ,[3Z?
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M'Q .^KQSSIQ[?S#"O7?[ 5R\HB"8B\*LFXN"YI^!FQ[()Y"\%+FB$OLOM&X
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MJ4G-C8,9OUHWJK:QWE3!B6)*-OXQAB<03&:?$"\=EK^!%[:_AP',K/M6.OX
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M#)K:X!L4=D$*G$ZVT%Q<GL%W:#YLI,)E1-2:B#R@?I\<<0$\B*=*3@B:LC,
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M6=Y(# 6( #@?S@R]ZKU+^VFS.O^'-Z(&%HK3DB>8Q4PYR<KQ,3B/EY=+[#2
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M@!L'.6_];ISBM7;K:G>G6JE6#V'#? <!A!W7D=BV<Q9?>&'P-P$^T31?>TE
M#L>/H-<!:^*_P+".ESF5@G" 'D;\*>?)S5''.C2LUWT(<6>\7B\:C;WP!A5;
MKI*# P!ME^0-&>:#(/3"7N -=W>H=[* :2^Z6[/>@F5TAE[ 6 O];NZ+5HOT
MC]2&77>!?^5T0.Q]12<]#,2=TXE;VVW<[] WRK5TOU>3ZW*MJW5L(OC;UZ4(
MM_.O(FX^R\UJM5_F"3O]1/V78CIY>V!OM=[DWYS/-V.8XE$,&DCO-^>#-_+Y
M(#Y$N.75:JZ'O7X-_S1O G,Z!4Z+)LUX?O\5SK/H:&/?^W[0]8%KP8S&1!KE
MCG-6PME2?YP?T5X=+IOI;(5OT%PN\/7TZ]$_SSXIY_3#\>%RAN0P5M#_[Q=>
MM?9"1Z&.SSZ<G[T[?7/T^01Q N%_WI]\^'SNG+UUSCZ>?#KZ? H/_.P$9V=4
M4I& :>\=88\_D@;]_2>;R(.4KGM/KQR[>O%X]O\*)]*LUFQ*1M+G;ZU-#/.[
M+&?++.AH7[+E\[]\+W9.P.SMWV_L\O;X U;YH&[7S<?NMV['^$LY,-9MQQ;1
MH7XFA6"U&J$_WD++(3\MGB1*+[UH'?,_M< O+]J3E_4,Q^+1*S],9RO9GZ8A
M>*7=5O7J3 +WFC0$=U4=F\C-%C$];4OP0GYP'"43=)O$<\Y_K=SHJH)8*JWG
MC+17:R!(Y9.7/I3@/N4B]W_&49)@(Y-!L/"DH1I<VM5I+.]6@(]49H)B3Q7&
MS V9X:UIV.QM#<.3ITR4B2R_^./<&TJ$;41=W^&-16]6N]Y1;F5E$)0;S1;6
MT*[ Q2IW8G_Z(=RV(:/5]T=!&"38!CRX6G@7Q;IJ-JJJLD*(YJI=:2+]K^/-
M>^WU">-.\\S%\ZB5*NW''EZSX>T5O77SLEU'$8QNA1W[_CCV>X$54EQ7Q;'>
MK*KZ@],^-T%U;L .-*M/WKG]WOSF >7NT8S^MLY'UU2=)C8(? RK9SUWH*XZ
MH&.UGKYI>WD3XAW:=8,X&FEBC,*%HZ7O :54&X@[=;<86GQA2%VUZVU5F^6Y
MB\FJ+YO:ES?TI 4[ KAN3;S5U5=>_''"N9%!>.4GDQ&U(8 ;]LQTS+U:"^1
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MD,\%@M/4$[!P2?S<2U*-DI#PU05'?I]X^ANNJ@<S ?Y,+E$+3M/X@]Z^.<W
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MYQBU!>>(]OR+!D>V.X3-UGKK^*O.OK?CAJ_F%L6J@@+DW9T2E==ERZL1G-O
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M.\E0M_@EZ(R \?,Q%<+'B$<\_3 ?@E16]61E2I+R: \H.\KR)L@]M@#C^@P
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M#B@J/LR[I$EAWQSP%("3 =EQ85%\[2WE5TMIV6Z]\ (P9*G3*N[6/"6X5S<
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M,<(T(30.PF&1JLH*#)[\LQ?D&P8DH?$5QG2\@#Y^E[I^+-LK"*3 K^_>*UQ
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M_P+P\:D _*3-[$F;F6Y;FT']^-+Q2;TF$>.Q=HLZ,JH-**B-R.6.ADLG2NY
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M), T1@5ES$J+],E07%[.(:MRIM<>T$ DWG@^.GI@&^F%-'N>L$M;2ZX0!XB
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M4Q.DUU**]=-X22Q5G:^5\P3;2-CCVG%JMZY"&-< 2H!8]^)K 8%,.2I8C2/
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M$+R&%LQAT;.>.>B.S,G8.BK%=/5JX%40; 7_5(S9*0?G8^5+(0Y8VU<CA(O
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M&EN#\W[WW!Z<6]TRSIGQDMA-$M^50$LE?!\3R$ 5, V\A=2\&)D.I[=Y6%D
MXWX/L.^K0QMSB]M.+(Y\BF5;N?;.TFE<Q?$0&:PB;(KIR["(.)W#=#RT&+5(
M+7X5E"#6BG(G4IQ8,;W*"Y2CUPR44<H#VW0PHBWPZ'A^1VRQ_'#K>O$<R5G$
M,]$/.G)8&!O[Z7H"(H7=U73-Z5F\4E&X!/KXX:UQUNT,=38E,79*CP,AM8CS
M0(G=^I53QX"]@F(+8T\T)5Z(S#P4O"L-?/-ZB)&I(075PXDIA;+=HO1'KFA
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MX0'3FJ&>9LQ!ZL(ID>SB.C1B9 =B8@6^$E=?C>,3$=?DDL,@%&I!< =1[8B
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MNP+A@3$IJB:XXKNA+8(/\'4/@5<G9O@L(D:!6)&BP7^'#BI]E73Q35!5H.X
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M6H<Y_N?=.U>(A1DFC+U0W[7*CJC?<W[6"GVQQZ2O2"R>"-(7&^%VH:^:+.J
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MX_"KZS)XUY-/#LO'R4G0T2-Z#2_1O%*MA^[@0@1@,76Q]440^V'NPD[AA@]
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M5-U2L8A:RK4[/(7E.^M8">?F0S"7C&H/S2*EJRPBND'/GA+\=CLB0JCKWIJ
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M-:F6&TJTWX_+%MV\J[:59N>9M>U4EVX 50CEB=UY>,@E:[<-(9[A:^W[^?7
M*C6BC%JJ#I['=GEF%]OY6"L3;^J56G;*9K52XU8I%H2GU+4YL1[D1NSIX2X7
MZ]P]9&O&T##FPC1Q+S3DNGK[S([95E,T9KET*C&NPG,S>E*(IPQ-ZC9'A:I1
M*O&%&9-YX)I%+E\M,X4Q:\C7U]D;X[D_4K.7S'->2:0NIS>#A[N[)[K\T.[>
ME!KEW!T?K>:-FV'SOEMXOC3R]VKU:9")5^SZY*:C-<7RI!*?#0J7%2 W)ELK
M]+4^)^2&^:1NJFS#ZC\^*I/!8[T5218[3#G[F.1&UR8_*3TSG&QT'BX'EM9,
M3:S'W- T8D.Z+/34LM QU,:C7N$S.>9RVIKTTO6(:/-WL\=2+U.Q^>H\6RK?
MR7K>R K\HWI9U*O]FJ;3DU'>'FL)NG'?F5]/YJU:2TJ+*GLK]IKWY=GXL:WJ
MI7![<%W/=V.->;/;"'-/C,@;<3X]DU-QO:SPB3233DET.?%452=A_?DAWWPJ
MYOGX;>(VG..F\FUW4A@9K5OQ0;L>U#MLYE*/ET#@ N8&G?NGSG5ADHK?/ERJ
MF4J*'L8OM6@J*I252CLO6&KT:3R4[1I;?D[?]$K9/!RM:!7[=JDD=L*#?%BR
MP[%V/J.(N;XBU)]8/3\OEM5Q6!<+C?+#O&9K0A^$!'NC<E%>?TS&V4JLPSQ+
M768NEXM:U>"4D:Q5IXU:+%^_LU+MV]I3A9G9]Z4<:_8S]0H],,4GNE8J:/>Z
M6+K+Q\RH,*W>]K7<<T:?F^J]4$FG[<?)I1EOY;6*VM?4L9G2C'#=Z$V>U<O;
ML)S6NTQO%$ZIMLJ,1JG+:O_N.B\^I=7X9&)&6"7?:TX9&^2"R$_2'<"K?CD7
M)+8Q9E/W]9M*NR?EC6F/J13OM';8SD2;F5FXE98>QL4\4S/[A?8U%S&?'TOP
MIVF[UIS7JNIL6*-']Q'QV:(5(V,UB[,.+4KVX]C@V%2I'!=K^1I_/^Y'VP_#
MY&7$+$S54FMP&V^EHI(];!;UN:@*MYHJ:M=5QLIK3*%(I^ZX\J S3U5J"E<T
M*[Q^W8L83"[>BPN1^P>^U9TS+2TU?XXHL?OQ[: ]BE9N4X51M=(M"FJ[7VGF
M]9C-Y'O/EZUV(=*8U-4'4&%/L^:T+[5RMM(:3Z?Z0TZ)1.)I.ZR%LQVN$*\-
MZ-I-*=52KO-LXR["T*K(3JN258X5L\QSJ0]_>$X+S43FDHX\3"?=IUG5S%>T
M#AM-W.4?P\]3>3AJQ+(#7IH:+:5<Z]@-+BDFG@VSJ=B9<;55[(.9F'_HSKEL
MOM!ZNF?'G;2=C5>J?+PRNQMH.=##\E"Q&27;+$?H3NKR/MO6M%;Q<=A3^EJC
MJK:>K0@7K]PE:F6^J_4[7(UAY<BMU= [L?O&8-K+A&_ZYD.WD&$>K$;62&5N
M]$[I^9+1XO,'-C<?MQ[H^VI,$H0.WZ[<WC_&"IF2/>J+Y?EC<L[4.C=VA!F!
MRHS8G"3PA<ZH-2Y>WJ3&@U9RGLG6*G(Z-N*,5OY9YK+5QY;0:+:NKT<Y[F9X
M*9J/=_-69UJ5B[G'^TK-Z-Z7ANH\+G?K?#9:R_3GE[2N-F8I(YRQ1\S]H_10
M%H>YV'/4N$F+?+&OLD^\8>G/8%S-F.MIHTE':C/Q?FX_UIA$112Y?'Q,<[5B
MU*+K[$SB9*&5'&OI<;JE3!\B*39B#7+SRW D*HK3>"DO]7BQ'<X5<IT;M9@S
M.IUT96;$NXE*-/TX^*]C]OU_4$L#!!0    ( "&)+U4C6K,"<1   &VR   1
M    =FEV:RTR,#(R,#8S,"YX<V3M75MS&CD6?MZMVO_0ZX?=;$UAC#W.3#S)
M3 '&"3,8/ 8[DZ<IT2U Y48BK6YL]M?OD?I"7]7=Q!DK"WY(H,]%YYQ/MR,)
M]=M?GI:VL<8.)XR^.VH=GQP9F)K,(G3^[NANW&B/N_W^D?'+S__XNP%_;__9
M:!A7!-O6A7')S$:?SMA/QA M\87Q'E/L()<Y/QGWR/;$$W9%;.P87;9<V=C%
M0/!+NC#.CUOGIM%H5-![CZG%G+O;?J1WX;HK?M%L/CX^'E.V1H_,>>#')EM6
M4SAVD>OQ2-O)TTGP5TW\FG S$O[N-[9B/SS=DC_FF/[H]:9_K*Y':'.%T(V[
M.3\__?SIX6F]O#V?W='/9YO^ZE-_;39)TUZ]^>Z]^>GWKE_D6VXN\!(9  ;E
M[XZ$?X%[CV?'S)DW3T].6LT_K@=CR7?D,UX\V80^Y+&WWKQYTY34D#7#^31U
M[%#U65.0IXCC2#-0B8*?4.XB:B;X+3<2B#.?-WUB@I7DLK[V64G(:N$4'\?F
M\9RMFT  _M/3D-'CC3E"JXAYAOA4*N6.V^#>2C)_/@O9X6DN:T*G$'4W*\SS
MM4I20L!RG91 (FY ;@JRD#EIG+0:IZU0\KY__ULDM"9K], <49VE^I/79Z)1
MVGB)J7O%G.4EGB'/!@\^>\@F,X*M(\-%SAR[HG[R%3*Q6EE8QQ&E#)H"M,?@
MB7BV6A&HZ_#@;V]%I;APF(TG8+8A/D CS%4M:,TN@W[DR"#6NR/_HU "*J4:
M"\\();*LH+&UC(9H6IYP"SY*D;?--'-,A<>Q-:(_R\\K!W.0D\8/X$$@&+ 4
M")G(-CV[GLS6E%R1X$$8I-W"1BU,02-\X,PF%G*QU4&V:%[C!<8N#V-:RJ<.
M^"E$671].(SX:'C9&XY[E^+3>#3H7[8G\*73'K2'W9XQ_M#K3<;&JSN*/(M
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M,NO#RCNQ;-^QDFZLO)^.N.<6H2XR/7BSR?2:U"K2=L0HJT)UB;_!)G\EBL[
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M>YWWYN.NC(*?;$L!-1I0COE;UZ-NT@+GM\&6'NO:7GB3Z7BZ[J:&K[CL)BJ
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MSE4M:V%6-2X5 E'[.F1])I2RJ"OLF!;W:1PM(IH<XB-9?&91("N53,@5(=0
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M_\?I^CCOSSZ85GB 0AVB_5GNJ3@*71+D^ *OTSPJZB 6*C]"N:S;\",:N-T
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M*LK2L:3=XPUH#?V2AU&T^A*UK+]FWH.K)EDI"+21=]$)3*)GJV5\2^]T:7(
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MH%-_>2Z,OJ7BVK@)!SU2X$-.R8)Y\2QW!);) :H +;Q^#=3)=DOI"6+RGFJ
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MC47J7"ZS5 %094.1JBI,K0JED9%N@70!Q9:&'RAHT"+RZWJE<':UUP90ASN
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M-53A#)XJ4D_ 4A6E&6+*IG F[9^NR5_DY^HG\E^4]^27_P=02P,$%     @
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M._J?CQ?7=[>CV>5H-K^X&=]=T0+X#P1DM^IW(NA/CZ05L*Y=/9(@55VYWY=
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M6@,*S5 S'Y_OLO'Y2*+[,":HXW,>A0M"W)@Y,9E83K @L^C68?DCLRL<<N6
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M^86$673#[GZ4[H3(M4!?TWJ/;%M]@()VU)JA#+FZ)M_XGY1/$<'J/]\L&T8
M8NJ*Q-8L;BEE,DBLS'JAYY>20B2E)<:E<"*JW/';_3'._QHK7A)HV=SSR_70
M#0^I<ASX:N-50'\D=\X3Z!+C3V_JEQBS^B/:@#WW%/<R[7JJO[2HK(0S<G==
M8L$204S.2$"6'D2&>@7DC1J D-JHTHB./JE>+)=DP51\UU'V'@.[_>P%*;\F
M3?)P6CE;)FU@;YO,&31'")W4O$O!:AK&\81.8MME&+$U0$&BJ@[VWL:<-#T"
M1BM6_A?V_]CE>?J;_P]02P$"% ,4    "  AB2]5=/-:+. 3  !5%0  #0
M            @ $     :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    ( "&)+U7T
M7-&)B"@( .XT"  -              "  0L4  !I;6%G95\P,#(N:G!G4$L!
M A0#%     @ (8DO5:]8$FS<#0  I X   T              ( !OCP( &EM
M86=E7S P-"YJ<&=02P$"% ,4    "  AB2]59/3+B% %   300  $0
M        @ '%2@@ =FEV86MO<E]E>#$P-RYH=&U02P$"% ,4    "  AB2]5
M?A@\+)<"  "N%0  $@              @ %$4 @ =FEV86MO<E]E>#(Q,#$N
M:'1M4$L! A0#%     @ (8DO51:;LN(. @  / <  !(              ( !
M"U,( '9I=F%K;W)?97@R,S Q+FAT;5!+ 0(4 Q0    ( "&)+U5$[NL?E*<#
M #/#'0 .              "  4E5" !V:79A:V]R7W,Q+FAT;5!+ 0(4 Q0
M   ( "&)+U4C6K,"<1   &VR   1              "  0G]"P!V:79K+3(P
M,C(P-C,P+GAS9%!+ 0(4 Q0    ( "&)+U7ZA)XRRA   .[6   5
M      "  :D-# !V:79K+3(P,C(P-C,P7V-A;"YX;6Q02P$"% ,4    "  A
MB2]58I$KQHDD  "V3P( %0              @ &F'@P =FEV:RTR,#(R,#8S
M,%]D968N>&UL4$L! A0#%     @ (8DO50L/OS<%5P  $/ $ !4
M     ( !8D,, '9I=FLM,C R,C V,S!?;&%B+GAM;%!+ 0(4 Q0    ( "&)
M+U5(FD0$\CT   X3!  5              "  9J:# !V:79K+3(P,C(P-C,P
>7W!R92YX;6Q02P4&      P # #W @  O]@,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
